0001213900-24-028253.txt : 20240401 0001213900-24-028253.hdr.sgml : 20240401 20240401085554 ACCESSION NUMBER: 0001213900-24-028253 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 120 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jeffs' Brands Ltd CENTRAL INDEX KEY: 0001885408 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-MISCELLANEOUS RETAIL [5900] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-41482 FILM NUMBER: 24805786 BUSINESS ADDRESS: STREET 1: 7 MEZADA STREET CITY: BNEI BRAK STATE: L3 ZIP: 5126112 BUSINESS PHONE: 0097236899124 MAIL ADDRESS: STREET 1: 7 MEZADA STREET CITY: BNEI BRAK STATE: L3 ZIP: 5126112 20-F 1 ea0202280-20f_jeffs.htm ANNUAL REPORT

 

 

FORM 20-F

 

 REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File No.: 001-41482

 

Jeffs’ Brands Ltd
(Exact name of registrant as specified in its charter)

 

Translation of registrant’s name into English: Not applicable

 

Israel

(Jurisdiction of incorporation or organization)

 

7 Mezada Street.

Bnei Brak, Israel 5126112

Israel

(Address of principal executive offices)

 

Viki Hakmon
Chief Executive Officer

Tel: +972-3-7713520

victor@jeffsbrands.com

7 Mezada Street, Bnei Brak, Israel 5126112

 (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Ordinary Shares, no par value per share   JFBR   Nasdaq Capital Market
Warrants to Purchase Ordinary Shares   JFBRW   Nasdaq Capital Market

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

 

 

 

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 1,215,512 ordinary shares as of December 31, 2023.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes ☐   No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act of 1934.

 

Yes ☐   No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.

 

Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer, “accelerated filer,” and emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer Accelerated filer Non-accelerated filer
      Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards † provided pursuant to Section 13(a) of the Exchange Act.  

 

†The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing.

 

U.S. GAAP

 

International Financial Reporting Standards as issued by the International Accounting Standards Board ☐

 

Other ☐

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

 

☐ Item 17   ☐ Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company.

 

Yes ☐   No

 

 

 

 

 

 

TABLE OF CONTENTS

 

  Page
INTRODUCTION iii
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS iv
     
  PART I 1
    1
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS. 1
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE. 1
ITEM 3. KEY INFORMATION. 1
A. [Reserved] 1
B. Capitalization and Indebtedness. 1
C. Reasons for the Offer and Use of Proceeds. 1
D. Risk Factors. 1
ITEM 4. INFORMATION ON THE COMPANY. 32
A. History and Development of the Company. 32
B. Business Overview. 33
C. Organizational Structure. 50
D. Property, Plants and Equipment. 50
ITEM 4A. UNRESOLVED STAFF COMMENTS. 50
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS. 51
A. Operating Results. 51
B. Liquidity and Capital Resources. 55
C. Research and development, patents and licenses, etc. 56
D. Trend information. 56
E. Critical Accounting Estimates. 56
F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation 57
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES. 58
A. Directors and Senior Management. 58
B. Compensation. 61
C. Board Practices. 63
D. Employees. 80
E. Share Ownership. 80
F. Disclosure of a registrant’s action to recover erroneously awarded compensation. 80
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS. 80
A. Major Shareholders. 80
B. Related Party Transactions. 82
C. Interests of Experts and Counsel. 83
ITEM 8. FINANCIAL INFORMATION. 83
A. Consolidated Statements and Other Financial Information. 83
B. Significant Changes. 84

 

i

 

 

  Page
ITEM 9. THE OFFER AND LISTING. 84
A. Offer and Listing Details. 84
B. Plan of Distribution. 84
C. Markets. 84
D. Selling Shareholders. 84
E. Dilution. 84
F. Expenses of the Issue. 84
ITEM 10. ADDITIONAL INFORMATION. 85
A. Share Capital. 85
B. Memorandum and Articles of Association. 85
C. Material Contracts. 85
D. Exchange Controls. 85
E. Taxation. 85
F. Dividends and Paying Agents. 94
G. Statement by Experts. 94
H. Documents on Display. 94
I. Subsidiary Information. 94
J. Annual Report to Security Holders. 94
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 94
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES. 95
A. Debt Securities. 95
B. Warrants and rights. 95
C. Other Securities. 95
     
  PART II 96
     
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES. 96
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS. 96
ITEM 15. CONTROLS AND PROCEDURES. 96
ITEM 16. [RESERVED] 97
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT. 97
ITEM 16B. CODE OF ETHICS. 97
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES. 97
ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES. 98
ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS. 98
ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT. 98
ITEM 16G. CORPORATE GOVERNANCE. 98
ITEM 16H. MINE SAFETY DISCLOSURE. 100
ITEM 16I DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. 100
ITEM 16J. INSIDER TRADING PLANS (10B5-1) 100
ITEM 16K. CYBERSECURITY 100
   
  PART III 102
     
ITEM 17. FINANCIAL STATEMENTS. 102
ITEM 18. FINANCIAL STATEMENTS. 102
ITEM 19. EXHIBITS. 102
SIGNATURES   105

 

ii

 

 

JEFFS’ BRANDS LTD

 

INTRODUCTION

 

In this Annual Report on Form 20-F, “we,” “us,” “our,” the “Company” and “JFBR” refer to Jeffs’ Brands Ltd.

 

We are an e-commerce consumer products goods, or CPG, company, operating primarily on the Amazon.com marketplace, or Amazon. We were incorporated in Israel in March 2021, under the name Jeffs’ Brands Ltd, to provide a variety of professional and business support as well as marketing support services to Smart Repair Pro that operate online stores for the sale of various consumer products on Amazon, utilizing the Fulfillment by Amazon, or FBA, model. As of the date on this Annual Report on Form 20-F, we have five wholly-owned subsidiaries: Smart Repair Pro, Top Rank Ltd., or Top Rank, Fort Products Ltd., or Fort, Jeffs’ Brands Holdings Inc., or Jeffs’ Brands Holdings and Fort Products LLC. We also own a minority interest in SciSparc Nutraceuticals Inc. or SciSparc U.S., to whom we provide management services.

 

In addition to executing the FBA business model, we utilize internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products. We also use our own skills, know-how and profound familiarity with Amazon’s algorithm and all the tools that the FBA platform FBA has to offer. In some circumstances we scale the products and improve them.

 

On August 30, 2022, we completed our initial public offering, or IPO, pursuant to the Company’s registration statement on Form F-1 (Registration No. 333- 262835) originally filed with the SEC on February 18, 2022, which was declared effective by the Securities and Exchange Commission, or the SEC, on August 25, 2022, of (A) 3,717,473 units, or Units, at a public offering price of $4.16 per Unit, with each Unit consisting of one of our ordinary shares, no par value per share, or Ordinary Shares, and one warrant, or Warrant, to purchase one Ordinary Share, at an initial exercise price of $4.04 per Ordinary Share (and an exercise price of $2.02 following the Exercise Price Adjustment, as defined below), (B) warrants issued to Aegis Capital Corp., the underwriter in the offering, or Aegis or the Underwriter, to purchase up to 185,873 Ordinary Shares, at an exercise price of $5.20 per Ordinary Share, or the Underwriter’s Warrants, and (C) Warrants to purchase up to 425,912 Ordinary Shares issued to the Underwriter pursuant to its over-allotment option. The Ordinary Shares and Warrants were immediately separable from the units and were issued separately. The Ordinary Shares and Warrants began trading on the Nasdaq Capital Market on August 26, 2022 under the symbols “JFBR” and “JFBRW,” respectively. We received gross proceeds of approximately $15.5 million before deducting underwriting discounts and commissions and before offering expenses ($13.4 million net proceeds after deducting approximately $1.05 million of underwriting discounts and commissions and approximately $1.05 million after deducting other offering costs).

 

Our reporting currency and functional currency is the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references in this Annual Report on Form 20-F to “NIS” are to New Israeli Shekels, and references to “dollars” or “$” mean U.S. dollars.

 

Effective as of market open on November 3, 2023, we conducted a reverse share split of our issued and outstanding ordinary shares, no par value, or Ordinary Shares, at a ratio of 1-for-7, or the Reverse Split. All descriptions of our share capital, including share amounts and per share amounts prior to the effective date of the Reverse Split in this prospectus are presented after giving effect to the Reverse Split.

 

This Annual Report on Form 20-F includes statistical, market and industry data and forecasts which we obtained from publicly available information and independent industry publications and reports that we believe to be reliable sources. These publicly available industry publications and reports generally state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the information. Although we believe that these sources are reliable, we have not independently verified the information contained in such publications.

 

All trademarks or trade names referred to in this Annual Report on Form 20-F are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report on Form 20-F are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend the use or display of other companies’ trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

 

For periods beginning on and after January 1, 2022, we report our financial statements in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. Historical filings of our consolidated financial statements were previously prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB.

 

iii

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information included or incorporated by reference in this Annual Report on Form 20-F may be deemed to be “forward-looking statements”. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.

 

These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition, expected capital needs, and expenses, statements relating to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.

 

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate.

 

Important factors that could cause actual results, developments, and business decisions to differ materially from those anticipated in these forward-looking statements are listed below. The below is also a summary of the risk factors described in Item 3.D “Key Information – Risk Factors” of this Annual Report.

 

Risks Related to Our Businesses, Strategies, Technology, and Industry 

 

We have a short operating history in an evolving industry and, as a result, our past results may not be indicative of future operating performance;

 

We may not be able to manage our growth effectively, and such rapid growth may adversely affect our corporate culture ;

 

Our e-commerce operations are reliant on Amazon and FBA and changes to Amazon, Amazon’s services and their terms of use may harm our business;

 

We rely on data provided by third parties, the loss of which could limit the functionality of our platforms, cause us to invest in the wrong product or disrupt our business;

 

We rely on other information technologies and systems to operate our business and to maintain our competitiveness, and any failure to invest in and adapt to technological developments and industry trends could harm our business;

 

If we fail to keep up with rapid technological changes, our future success may be adversely affected;

 

Our business depends on our ability to build and maintain strong product listings on e-commerce platforms. We may not be able to maintain and enhance our product listings if we receive a substantial number of customer complaints, negative publicity or otherwise fail to live up to customers’ expectations, which could materially adversely affect our business, results of operations and growth prospects;

 

  Our efforts to acquire or retain customers, and our efforts to sell new products or increase sales of our existing products, may not be successful, which could prevent us from maintaining or increasing our sales;

 

If we fail to acquire new customers or retain existing customers, or fail to do so in a cost-effective manner, we may not be able to achieve profitability;

 

iv

 

 

Our efforts to expand our business into new brands, products, services, technologies and geographic regions will subject us to additional business, legal, financial and competitive risks and may not be successful;

 

Potential growth of our businesses is based on international expansion, making us susceptible to risks associated with international sales and operations;

 

Use of social media and email may adversely impact our reputation or subject us to fines or other penalties;

 

If our emails are not delivered and accepted or are routed by email providers less favorably than other emails, or our sites or mobile applications are not accessible or are treated disadvantageously by Internet service providers, our business may be substantially harmed;

 

If we are unable to manage our inventory effectively, our operating results could be adversely affected;

 

Risks Related to Information Technology

 

Assertions by third parties of infringement or misappropriation by us of their intellectual property rights or confidential know how could result in significant costs and substantially harm our business and results of operations;

 

Our inability to acquire, use or maintain our marks and domain names for our sites could substantially harm our business and operating results;

 

Any significant disruption in service on our websites or in our computer systems, a number of which are currently hosted or provided by third-party providers, could materially affect our ability to operate, damage our reputation and result in a loss of customers, which would harm our business and results of operations;

 

Risks Related to Legal and Regulatory Matters

 

We may be subject to general litigation, regulatory disputes and government inquiries;

 

A failure to comply with current laws, rules and regulations or changes to such laws, rules and regulations and other legal uncertainties may adversely affect our business, financial performance, results of operations or business growth;

 

We are subject to U.S. governmental regulations and other legal obligations related to privacy, data protection and information security. If we are unable to comply with these, we may be subject to governmental enforcement actions, litigation, fines and penalties or adverse publicity;

 

  Increased regulatory scrutiny of nutritional supplements as well as new regulations that are being adopted in some of our markets with respect to nutritional supplements could result in more restrictive regulations and harm our results if our supplements or advertising activities are found to violate existing or new regulations or if we are not able to effect necessary changes to our products in a timely and efficient manner to respond to new regulations;
     
  Our amended and restated articles of association provide that unless we consent to an alternate forum, the federal district courts of the United States shall be the exclusive forum of resolution of any claims arising under the Securities Act;
     
  The pest control products sold by Fort are subject to local environmental regulations. Therefore, if we cannot find a licensed supplier of the active ingredient in our pest control products in a country in which we wish to sell our poison products, we will not be able to sell our pest control products there.

 

v

 

 

Risks Related to our Operations in Israel

 

Conditions in Israel, including the recent attack by Hamas and other terrorist organizations from the Gaza Strip and elsewhere in the region, and Israel’s war against them, may adversely affect our operations and limit our ability to market our products, which would lead to a decrease in revenues;

 

Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings;

 

Risks Related to Our Status as a Public Company and Ownership of our Ordinary Shares and Warrants

 

  Issuance of a significant amount of additional Ordinary Shares due to exercise or conversion of outstanding warrants and/or substantial future sales of our Ordinary Shares may depress our share price
     
  We incur significant increased costs as a result of operating as a public company. Our management is required to devote substantial time to new compliance initiatives as well as compliance with ongoing U.S. requirements;

 

Our internal control over financial reporting may not meet all of the standards contemplated by Section 404 of the Sarbanes-Oxley Act, and failure to achieve and maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business;

 

Future sales of our Ordinary Shares and Warrants could reduce the market price of our Ordinary Shares and/or Warrants;

 

As a “foreign private issuer” we are permitted, and intend, to follow certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to investors under rules applicable to domestic U.S. issuers;

 

The estimates of market opportunity, market size and forecasts of market growth included in our publicly filed documents may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all;

 

Our management team has limited experience managing a public company;

 

We are an emerging growth company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies could make our securities less attractive to investors;

 

The market price of our Ordinary Shares and/or Warrants may be volatile. Market volatility may affect the value of an investment in our Ordinary Shares and/or Warrants and could subject us to litigation; and

 

We cannot assure you that our Ordinary Shares and Warrants will remain listed on Nasdaq or any other national securities exchange.

 

Readers are urged to carefully review and consider the various disclosures made throughout this Annual Report on Form 20-F which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. 

 

You should not put undue reliance on any forward-looking statements. Any forward-looking statements in this Annual Report on Form 20-F are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. 

 

vi

 

 

PART I

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds.

 

Not applicable.

 

D. Risk Factors.

 

Our business faces significant risks. You should carefully consider the risks described below, together with all of the other information in this Annual Report on Form 20-F. The risks described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs, our business and financial condition could suffer and the price of our securities could decline. This Annual Report on Form 20-F also contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these forward-looking statements, as a result of certain factors including the risks described below and elsewhere in this report and our other Securities and Exchange Commission, or SEC, filings. See “Cautionary Note Regarding Forward-Looking Statements” above.

 

Risks Related to Our Businesses, Strategies, Technology, and Industry

 

We have a short operating history in an evolving industry and, as a result, our past results may not be indicative of future operating performance.

 

We have a short operating history in a rapidly evolving industry that may not develop in a manner favorable to our business. Our relatively short operating history makes it difficult to assess our future performance. You should consider our business and prospects in light of the risks and difficulties we may encounter.

 

Our future success will depend in large part upon our ability to, among other things:

 

  manage our inventory and supply chain effectively;

 

  successfully develop, retain and expand our consumer product offerings and geographic reach;

 

  compete effectively;

 

  anticipate and respond to macroeconomic changes;

 

  effectively manage our growth;

 

1

 

 

  hire, integrate and retain talented people at all levels of our organization;

 

  avoid interruptions in our business from information technology downtime, cybersecurity breaches or labor stoppages;

 

  maintain the quality of our technology infrastructure; and

 

  develop new features to enhance functionality.

 

We may not be able to manage our growth effectively, and such rapid growth may adversely affect our corporate culture.

 

We expect to rapidly and significantly expand our operations and anticipate expanding further as we pursue our growth strategies. Such expansion increases the complexity of our business and places a significant strain on our management, operations, technical systems, financial resources and internal control over financial reporting functions. Our current and planned personnel, systems, procedures and controls may not be adequate to support and effectively manage our future operations, especially as we employ personnel in several geographic locations.

 

We are currently in the process of transitioning certain of our business and financial systems to systems on a scale reflecting the increased size, scope and complexity of our operations, and the process of migrating our legacy systems could disrupt our ability to timely and accurately process information, which could adversely affect our results of operations and cause harm to our reputation. As a result, we may not be able to manage our expansion effectively.

 

Our entrepreneurial and collaborative culture is important to us, and we believe it has been a major contributor to our success. We may have difficulties maintaining our culture or adapting it sufficiently to meet the needs of our future and evolving operations as we continue to grow, in particular as we grow internationally.

 

In addition, we are currently in the process of developing and maintaining our culture as a public company, with the attendant changes in policies, practices, corporate governance and management requirements. Failure to successfully develop or maintain such a culture could have a material adverse effect on our business, results of operations, financial condition and prospects.

 

Our e-commerce operations are reliant on Amazon and FBA and changes to Amazon, Amazon’s services and their terms of use may harm our business.

 

Our products are sold predominantly on Amazon and orders are fulfilled entirely by Amazon utilizing the fulfilled by Amazon, or FBA, model. In order to continue to utilize Amazon and FBA, we must comply with the applicable policies and terms of use relating to these services. Such policies and terms of use may be altered or amended at Amazon’s sole discretion, including changes regarding the cost of securing these services, and changes that increase the burden of compliance with its requirements, may cause us to significantly alter our business model or incur additional costs in order to comply, which could negatively impact our results of operations. Non-compliance with applicable terms of use and policies can result in the removal of one or more products from the marketplace and suspension of fulfillment services either of which could have a material adverse effect on our business and results of our operations. Although we exert efforts in order to ensure ongoing compliance and no notices of non-compliance have been received to date, we cannot assure you that events of this kind will not occur in the future.

 

We rely on other information technologies and systems to operate our business and to maintain our competitiveness, and any failure to invest in and adapt to technological developments and industry trends could harm our business.

 

We depend on sophisticated information technologies and systems, technology and systems used for websites and apps, customer service, logistics and fulfillment, supplier connectivity, communications and administration. As our operations grow in size, scope and complexity, we will need to continuously improve and upgrade our systems and infrastructure to offer an increasing number of consumer-enhanced services, features and functionalities, while maintaining and improving the reliability and integrity of our systems and infrastructure.

 

2

 

 

Our future success also depends on our ability to assimilate different analytical tools as well as internal methodologies, including logistics and fulfillment platform which leverages, to meet rapidly evolving e-commerce trends and demands. The emergence of alternative platforms may require us to continue to invest in new and costly technology. We may not be successful, or we may be less successful than our competitors, in adopting technologies that operate effectively across multiple e-commerce platforms, which would negatively impact our business and financial performance. New developments in other areas, such as cloud computing providers, could also make it easier for competitors to enter our markets due to lower up-front technology costs. In addition, we may not be able to maintain our existing systems or replace our current systems or introduce new technologies and systems as quickly or cost effectively as we would like. Failure to invest in and adapt to technological developments and industry trends may have a material adverse effect on our business, results of operations, financial condition and prospects.

 

We rely on data provided by third parties, the loss of which could limit the functionality of our platforms, cause us to invest in the wrong product or disrupt our business.

 

We use third party software to determine market trends and what markets to enter into. Our ability to successfully use this software depends on our ability to analyze and utilize data, including search engine results, provided by unaffiliated third parties, primarily, Google and Amazon. Some of this data is provided to us pursuant to third-party data sharing policies and terms of use, under data sharing agreements by third-party providers or by customer consent. The majority of this data is sourced for free or for de minimis amounts. These sources of data allow us, along with A.I. tools, to determine trends, performance and consumer sentiment on products and searches within e-commerce platforms. This functionality allows us to help determine which products to market, in some cases manufacture through contract manufacturers, import and sell on e-commerce marketplaces. The connection to multiple e-commerce platforms through application programming interfaces, or APIs, allows us to develop the automation of the purchase of marketing and automate the change of pricing of product listings on those e-commerce platforms.

 

In the future, any of these third parties could change its data sharing policies, including making them more restrictive, charging fees or altering its algorithms that determine the placement, display and accessibility of search results and social media updates, any of which could result in the loss of, or significant impairment to, our ability to collect useful data. These third parties could also interpret our, or our service providers’, data collection policies or practices as being inconsistent with their policies, which could result in the loss of our ability to collect this data. Privacy concerns may cause end users to resist providing the personal data necessary to allow us to determine market trends as well as our ability to effectively retain existing customers. Privacy advocacy groups and the technology and other industries are considering various new, additional or different self-regulatory standards that may place additional burdens on us. Any such changes could impair our ability to use data and could adversely impact select functionality of our proprietary software, impairing our ability to use this data to anticipate customer demand and market trends, as well as adversely affecting our business and our ability to generate revenue.

 

If we fail to keep up with rapid technological changes, our future success may be adversely affected.

 

Modern technologies are subject to rapid changes and our technology is yet to be fully automated. Our future success will depend on our ability to respond to rapidly changing technologies, to adapt and further develop our own functionality or our services to our evolving industry and to improve the performance and reliability of our systems. Our failure to adapt to such changes could harm our business.

 

In addition, the widespread adoption of networking or telecommunications technologies or other technological changes could require substantial expenditures to modify or adapt our products, services or infrastructure. If we fail to keep up with rapid technological changes to remain competitive in our rapidly evolving industry, our future success may be adversely affected.

 

3

 

 

Our business depends on our ability to build and maintain strong product listings on e-commerce platforms. We may not be able to maintain and enhance our product listings if we receive a substantial number of customer complaints, negative publicity or otherwise fail to live up to customers’ expectations, any of which could materially adversely affect our business, results of operations and growth prospects.

 

Maintaining and enhancing our product listings is critical in expanding and growing our business. However, a significant portion of our perceived performance to the customer depends on third parties outside of our control, including suppliers and logistics providers such as FedEx, UPS, postal services and other third-party delivery agents and online retailers, mainly Amazon. Because our agreements with our online retail partners are generally terminable at will, we may be unable to maintain these relationships, and our results of operations could fluctuate significantly from period to period. Because we rely on third party logistics companies, like FedEx, to deliver our products, we are subject to shipping delays or disruptions caused by inclement weather, natural disasters, labor activism, health epidemics or bioterrorism. In addition, because we rely on national, regional and local transportation companies for the delivery of some of our other products, we are also subject to risks of breakage or other damage during delivery by any of these third parties. If these third parties do not meet our or our customers’ expectations, our brands may suffer irreparable damage. In addition, maintaining and enhancing our current and future brands may require us to make substantial investments, and these investments may not yield sufficient returns. If we fail to promote and maintain our brands, or if we incur excessive expenses in this effort, our business, operating results and financial condition may be materially adversely affected. We anticipate that, as our market becomes increasingly competitive, maintaining and enhancing our brands may become increasingly difficult and expensive. Maintaining and enhancing our brands will depend largely on our ability to anticipate market trends and customer demand and to provide high quality products to our customers and a reliable, trustworthy and profitable sales channel to our suppliers, which we may not be able to do successfully.

 

A substantial number of customer complaints or negative publicity about our sites, products, delivery times, customer data handling and security practices or customer support, especially on blogs, social media websites or our sites, could rapidly and severely diminish consumer views of our products and result in harm to our brands. Customers may also make safety-related claims regarding products sold through our online retail partners, such as Amazon, which may result in an online retail partner removing the product from its marketplace. Such removal may materially impact our financial results depending on the product that is removed and the length of time that it is removed. We also use and rely on other services from third parties, such as our telecommunications services, and those services may be subject to outages and interruptions that are not within our control.

 

Our efforts to acquire or retain customers, and our efforts to sell new products or increase sales of our existing products, may not be successful, which could prevent us from maintaining or increasing our sales.

 

If we do not successfully promote and sustain our new and/or existing product listings and brands through marketing and other tools, we may fail to maintain or increase our sales. Promoting and positioning our brands and product listings will depend largely on the success of our marketing efforts, our ability to attract customers cost effectively and our ability to consistently provide a high-quality product and maintain consumer satisfaction. We also use promotions to drive sales, which may not be effective and may adversely affect our gross margins. Our investments in marketing may not effectively reach potential customers, potential customers may decide not to buy our products or the spending of customers that purchase from us may not yield the intended return on investment, any of which could negatively affect our financial results. The failure of our marketing activities could also adversely affect our ability to promote our product listings and sell our products, and to develop and maintain relationships with our customers, retailers and brands, which may have a material adverse effect on our business, results of operations, financial condition and prospects.

 

If we fail to acquire new customers or retain existing customers, or fail to do so in a cost-effective manner, we may not be able to achieve profitability.

 

Our success depends on our ability to acquire and retain customers in a cost-effective manner. In order to expand our customer base, we must appeal to and acquire customers who have historically used other channels to purchase the wide variety of products we offer and may prefer alternatives to our offerings, such as those offered by other vendors on Amazon, traditional brick-and-mortar retailers and the websites of our competitors or our suppliers’ own websites. We expect competition in e-commerce generally to continue to increase. Competitors have introduced lower cost or differentiated products that are perceived to compete with our products. If we are unable to correctly anticipate market trends and customer demand, our ability to sell our products could be impaired. If we fail to deliver quality products, or if customers do not perceive the products we offer to be of high value and quality, we may not be able to acquire new customers. If we are unable to acquire new customers who purchase products in numbers sufficient to grow our business, we may not be able to generate the scale necessary to drive beneficial network effects with our suppliers, our net revenue may decrease and our business, financial condition and operating results may be materially adversely affected.

 

4

 

 

We believe new customers can originate from word-of-mouth and other non-paid referrals from existing customers. Therefore, we must ensure that our existing customers remain loyal to us in order to continue receiving those referrals. If our efforts to satisfy our existing customers are not successful, we may lose these customers or we may not be able to acquire new customers in sufficient numbers to continue to grow our business, or we may be required to incur significantly higher marketing expenses in order to acquire new customers. For example, since 2016, Amazon has maintained a policy whereby they will purge all reviews they believe are paid for. While we do not ask customers to leave a positive review or change a review, some of our reviews may be purged by Amazon in accordance with this policy if Amazon believes they were questionable or not authentic. If Amazon purges reviews or if we are unable to maintain our positive reviews, it may adversely affect our ability to acquire new customers or retain existing ones.

 

In addition, we believe that Amazon has, from time to time, placed limitations on the daily volume of reviews that may be provided for any specific product listing. This limitation or others relating to customer engagement with our product listings could impact the success of our product listings, which could adversely impact our financial performance.

 

If we fail to offer high-quality customer support, our business and reputation may suffer.

 

High-quality education and training of customer support personnel to deliver high-quality customer support are important for the successful retention of existing customers. Providing this education, training and support requires that our support personnel have specific knowledge and expertise of our products and markets, making it more difficult for us to hire experienced personnel and to scale up our support operations. The importance of high-quality customer support will increase as we expand our business and pursue new customers. If we do not provide effective and timely ongoing support, our ability to retain existing customers may suffer, and our reputation with existing or potential customers may be harmed, which would have a material adverse effect on our business, results of operations, financial condition and prospects.

 

Our efforts to expand our business into new brands, products, services, technologies and geographic regions will subject us to additional business, legal, financial and competitive risks and may not be successful.

 

Our business success depends to some extent on our ability to expand our consumer offerings by launching new brands, products and services and by expanding our existing offerings into new geographic regions.

 

Our strategy is to use our skills to determine which markets to enter and optimize the mix of products and services that we offer.

 

Launching new brands, products and services requires significant upfront investments, including investments in marketing (namely digital marketing and PPC (Pay Per Click), information technology and additional personnel. We operate in highly competitive industries with relatively low barriers to entry and must compete successfully in order to grow our business. We may not be able to generate satisfactory revenue from these efforts to offset these costs. Any lack of market acceptance of our efforts to launch new brands, products or services or to expand our existing offerings could have a material adverse effect on our business, prospects, financial condition and results of operations. Further, as we continue to expand our fulfillment capability or add new businesses with different requirements, our logistics networks will become increasingly complex and operating them will become more challenging. There can be no assurance that we will be able to operate our networks effectively. 

 

We have also entered and may continue to enter new markets and provide product offerings in which we have limited or no experience, which may not be successful or appealing to our customers.

 

The CPG industry is subject to evolving standards and practices, as well as changing consumer needs, requirements and preferences. Our ability to attract new customers and increase revenue from existing customers depends, in part, on our ability to enhance and improve our existing tools that enable us to pinpoint new markets and introduce new products. The success of any enhancements or new instruments depends on, in part, market-accepted pricing levels and overall market acceptance. We may not be successful in these efforts, which could result in significant expenditures that could impact our revenue or distract management’s attention from current offerings.

 

5

 

 

Increased emphasis on the sale of new products could distract us from sales of our existing products in existing markets, negatively affecting our overall sales. We have invested and expect to continue to invest in new businesses, products, features, services and technologies. Such endeavors may involve significant risks and uncertainties, including insufficient revenue from such investments to offset any new liabilities assumed and expenses associated with these new investments, inadequate return of capital on our investments, distraction of management from current operations and unidentified issues not discovered in our due diligence of such investments that could cause us to fail to realize the anticipated benefits of such investments and incur unanticipated liabilities. Because these new strategies and offerings are inherently risky, no assurance can be given that they will be successful. Our new features or enhancements could fail to attain sufficient market acceptance for many reasons, including:

 

delays in introducing products in new markets;

 

failure to accurately predict market demand or end consumer preferences;

 

introduction of competing products;

 

poor financial conditions for our customers or poor general macroeconomic conditions;

 

changes in legal or regulatory requirements, or increased legal or regulatory scrutiny, adversely affecting our products;

 

failure of our brands and products digital promotion activities or negative publicity about the performance or effectiveness of our existing brands and products; and

 

disruptions or delays in the online retailers and, or in addition to, logistics providers distributing our products.

 

There is no assurance that we will successfully identify new opportunities or develop and bring new products to market on a timely basis, which could materially and adversely affect our business and operating results and compromise our ability to generate revenue.

 

Potential growth of our businesses is based on international expansion, making us susceptible to risks associated with international sales and operations.

 

We have historically mainly sold products in the United States, and since 2021 began selling products in, the United Kingdom, Germany. We intend to expand our operations to reach new markets and localities. For example, in 2024, we expanded the Fort brands to France and have completed the requisite processes in order to offer certain of our products through Amazon in other major European countries, including Spain, Italy, the Netherlands and Poland. We may not be successful in increasing our sales in any or all territories and currently do not have an estimated commencement date for sales in these other major European countries. Conducting international operations subjects us to certain risks, which include localization of solutions and products and adapting them to local practices and regulatory requirements, exchange rate fluctuations and unexpected changes in tax, trade laws, tariffs, governmental controls and other trade restriction. To the extent that we do not succeed in expanding our operations internationally and managing the associated legal and operational risks, our results of operations may be adversely affected.

 

Use of social media and email may adversely impact our reputation or subject us to fines or other penalties.

 

We use social media and email as part of our digital marketing efforts. As laws and regulations rapidly evolve to govern the use of these channels, the failure by us, our employees or third parties acting at on our behalf to abide by applicable laws and regulations in the use of these channels could adversely affect our reputation or subject us to fines or other penalties. In addition, our employees or third parties acting on our behalf may knowingly or inadvertently make use of social media in ways that could lead to the loss or infringement of intellectual property, as well as the public disclosure of proprietary, confidential or sensitive personal information of our business, employees, customers or others. Any such inappropriate use of social media or email could also cause reputational damage.

 

6

 

 

Customers value readily available information concerning retailers and their goods and services and often act on such information without further investigation and with no regard to its accuracy. Our customers may engage with us online through our social media platforms, including Facebook and Instagram, by providing feedback and public commentary about all aspects of our business. Information concerning us or our retailers and brands, whether accurate or not, may be posted on social media platforms at any time and may have a disproportionately adverse impact on our brand, reputation or business. The harm may be immediate without affording us an opportunity for redress or correction and could have a material adverse effect on our business, results of operations, financial condition and prospects.

 

If our emails are not delivered and accepted or are routed by email providers less favorably than other emails, or our sites or mobile applications are not accessible or are treated disadvantageously by Internet service providers, our business may be substantially harmed.

 

If email providers or Internet service providers, or ISPs, implement new restrictive email or content delivery or accessibility policies, including with respect to net neutrality, or begin enforcement of existing policies, it may become more difficult to deliver emails to our customers or for customers to access our sites, products and services. For example, certain email providers, including Google, categorize our emails as “promotional”, and these emails are directed to an alternate, and less readily accessible, section of a customer’s inbox. If email providers materially limit or halt the delivery of our emails, or if we fail to deliver emails to customers in a manner compatible with email providers’ email handling or authentication technologies, our ability to contact customers through email could be significantly restricted. In addition, if we are placed on “spam” lists or lists of entities that have been involved in sending unwanted, unsolicited emails, our operating results and financial condition could be substantially harmed. Further, if ISPs prioritize or provide superior access to our competitors’ content, our business and results of operations may be negatively impacted.

 

If we are unable to manage our inventory effectively, our operating results could be adversely affected.

 

To ensure timely delivery of products, we generally enter into purchase orders in advance with manufacturers. As a result, we are vulnerable to demand and pricing shifts and to suboptimal selection and timing of product purchases. We rely on our procurement team to order products and we rely on our data analytics to inform the levels of inventory we purchase, including when to reorder items that are selling well and when to write off items that are not selling well. In these instances, we may be unable to always predict the appropriate demand for our products by customers with accuracy, which may result in inventory shortages, inventory write offs and lower gross margins.

 

If our sales and procurement teams do not predict demand well or if our algorithms do not help us reorder the right products or write off the right products timely, we may not effectively manage our inventory, which could result in inventory excess or shortages, and our operating results and financial condition could be adversely affected.

 

Our business, including our costs and supply chain, is subject to risks associated with sourcing, importing and warehousing.

 

We source the products we offer from third-party vendors and, as a result, we may be subject to price fluctuations or demand disruptions. Our operating results could be negatively impacted by increases in the prices of our products, and we have no guarantees that prices will not rise. In addition, as we expand into new categories and types of products, we expect that we may not have strong purchasing power in these new areas, which could lead to higher costs than we have historically seen in our current product categories and types. We may not be able to pass increased costs on to customers, which could adversely affect our operating results.

 

In addition, we cannot guarantee that products we receive from vendors will be of sufficient quality or free from damage or defects, or that such merchandise will not be damaged during shipping or storage. While we take measures to ensure product quality and avoid damage, including evaluating vendor facilities, operations and product samples, conducting inventory inspections and inspecting returned products, we cannot control merchandise while it is out of our possession or prevent all damage while in our distribution centers. We may incur additional expenses and our reputation could be harmed or if current or potential customers believe that our merchandise is not of high quality or may be damaged.

 

7

 

 

Risks associated with the suppliers from whom our products are sourced could materially adversely affect our financial performance, as well as our reputation and brand.

 

We depend on our ability to provide our customers with a wide range of products from high quality suppliers in a timely and efficient manner. Our agreements with most of our suppliers do not provide for the long-term availability of merchandise or the continuation of particular pricing practices, nor do they usually restrict such suppliers from selling products to other buyers or directly themselves. There can be no assurance that our current suppliers will continue to seek to sell us products on current terms or that we will be able to establish new or otherwise extend current supply relationships to ensure product acquisitions in a timely and efficient manner and on acceptable commercial terms. Our ability to develop and maintain relationships with reputable suppliers and offer high quality products to our customers is critical to our success. If we are unable to develop and maintain relationships with suppliers that would allow us to offer a sufficient amount and variety of quality products on acceptable commercial terms, our ability to satisfy our customers’ needs, and therefore our long-term growth prospects, would be materially adversely affected.

 

We also are unable to predict whether any of the countries in which our suppliers’ products are currently manufactured or may be manufactured in the future will be subject to trade restrictions imposed by the U.S. or foreign governments or the likelihood, type or effect of any such restrictions. Any event causing a disruption or delay of imports from suppliers with international manufacturing operations, including the imposition of additional import restrictions, restrictions on the transfer of funds or increased tariffs or quotas, could increase the cost or reduce the supply of merchandise available to our customers and materially adversely affect our financial performance as well as our reputation and brand. Our competitors may have greater existing inventory positions and other advantages that may allow them to price more competitively relative to our products. Furthermore, some or all of our suppliers’ foreign operations may be adversely affected by political and financial instability, resulting in the disruption of trade from exporting countries, restrictions on the transfer of funds or other trade disruptions.

 

Manufacturing risks, including risks related to manufacturing in China, may adversely affect our ability to manufacture our products and could reduce our gross margin and our profitability.

 

We rely on third party manufacturers in China to manufacture our products. As a result, our business is subject to risks associated with doing business in China, including:

 

trade protection measures, such as tariff increases, and import and export licensing and control requirements;

 

potentially negative consequences from changes in tax laws;

 

difficulties associated with the Chinese legal system, including increased costs and uncertainties associated with enforcing contractual obligations in China;

 

unexpected or unfavorable changes in regulatory requirements; and

 

changes and volatility in currency exchange rates.

 

Economic regulation, trade restrictions, and increasing manufacturing costs in China could adversely impact our business and results of operations.

 

We contract with manufacturing facilities in the People’s Republic of China. For many years, the Chinese economy has experienced periods of rapid growth. An increase in the cost of labor or taxes on wages in China may lead to an increase in the cost of goods manufactured in China. Significant increases in wages or wage taxes paid by contract manufacturing facilities may increase the cost of goods manufactured in China which could have a material adverse effect on the Company’s profit margins and profitability. Additionally, government trade policies, including the imposition of tariffs, export restrictions, sanctions or other retaliatory measures could limit our ability to source materials and products from China at acceptable prices or at all. For example, both the United States and China have implemented several rounds of tariffs and retaliations with respect to certain products imported from the other country, some of which may impact certain products we import. Moreover, the U.S. Congress passed the Uyghur Forced Labor Prevention Act in an effort to prevent what it views as forced labor and human rights abuses in the Xinjiang Uyghur Autonomous Region, or XUAR. If it is determined that our third-party suppliers and manufacturers mine, produce or manufacture our products wholly or in part from the XUAR, then we could be prohibited from importing such products into the U.S. In addition, Chinese trade regulations are in a state of flux, and we may become subject to other forms of taxation, tariffs and duties in China. We do not currently have arrangements with contract manufacturers in other countries that may be acceptable substitutes. We cannot predict what actions may ultimately be taken with respect to tariffs, export controls, countermeasures, or other trade measures between the U.S. and China or other countries and what products may be subject to such actions. To the extent such actions inhibit our transactions with contract manufacturing facilities and suppliers in China, our business may be materially adversely affected.

 

8

 

 

Shipping is a critical part of our business and any changes in shipping costs or any interruptions in shipping could adversely affect our operating results.

 

If we are not able to negotiate acceptable pricing and other terms with vendors or if vendors experience performance problems or other difficulties, it could negatively impact our operating results and our customers’ experience. We are also subject to volatility in ocean freight rates that are driven, in part, by seasonality, capacity availability and other factors, including fuel-related regulations affecting the shipping industry. In addition, our ability to receive inbound inventory efficiently and ship merchandise to clients may be negatively affected by inclement weather, fire, flood, power loss, earthquakes, labor disputes, acts of war or terrorism and similar factors. We are also subject to risk of damage or loss during delivery by our shipping vendors. If our products are not delivered in a timely fashion or are damaged or lost during the delivery process, our customers could become dissatisfied and cease using our products or services, which would adversely affect our business and operating results.

 

We depend on highly skilled personnel, including senior management, and if we are unable to retain or motivate key personnel or hire, retain and motivate qualified personnel, our business could be harmed.

 

We believe our past success has depended, and our future success depends, on the efforts and talents of our senior management and our highly skilled team members. Our future success depends on our continuing ability to attract, develop, motivate and retain highly qualified and skilled employees. The loss of one or more of our key personnel or the inability to promptly identify a suitable successor to a key role could have an adverse effect on our business. In particular, our Founder and Chief Executive Officer has unique and valuable experience leading our Company from our inception through today. If he were to depart or otherwise reduce his focus on our Company, our business may be disrupted.

 

Competition for key personnel is strong, especially in Israel where our headquarters are located, and we cannot be sure that we will be able to attract and retain a sufficient number of qualified personnel in the future, or that the compensation costs of doing so will not adversely affect our operating results. Similarly, competition for well-qualified employees in all aspects of our business is intense globally. We do not have long-term employment or non-competition agreements with any of our employees. If we do not succeed in attracting well-qualified employees or retaining and motivating existing employees and key senior management with the appropriate skills at cost-effective compensation levels, or if changes to our business adversely affect morale or retention, our business, results of operations, financial condition and prospects may be adversely affected.

 

In addition, in making employment decisions, job candidates often consider the value of the stock options or other equity incentives they are to receive in connection with their employment. If the price of our shares declines, or experiences significant volatility, our ability to attract or retain key employees may be adversely affected. Also, as employee options vest and the lock-up agreements expire, we may have difficulty retaining key employees. If we fail to attract new personnel or fail to retain and motivate our current personnel, our growth prospects could be severely harmed.

 

9

 

 

We may not accurately forecast revenues, profitability and appropriately plan our expenses.

 

We base our current and future expense levels on our operating forecasts and estimates of future income and operating results. Income and operating results are difficult to forecast because they generally depend on the volume and timing of orders, which are uncertain. Additionally, our business is affected by general economic and business conditions around the world. A softening in income, whether caused by changes in consumer preferences or a weakening in global economies, may result in decreased net revenue levels, and we may be unable to adjust our spending in a timely manner to compensate for any unexpected shortfall in income. This inability could cause our income (loss) from operations after tax in a given quarter to be lower or higher than expected. We also make certain assumptions when forecasting the amount of expense we expect related to our share-based payments, which includes the expected volatility of our share price, and the expected life of equity awards granted. These assumptions are partly based on historical results. If actual results differ from our estimates, our operating results in a given quarter may be lower than expected.

 

Our operating results are subject to seasonal fluctuations.

 

The e-commerce business is seasonal in nature and the fourth quarter is a significant period for our operating results due to the holiday season. As a result, revenue generally declines and loss from operations generally increases in the first quarter sequentially from the fourth quarter of the previous year. Any disruption in our ability to process and fulfill customer orders during the fourth quarter could have a negative effect on our quarterly and annual operating results. For example, if a large number of customers purchase our products in a short period of time due to increased holiday demand, inefficient management of our inventory may prevent us from efficiently fulfilling orders, which may reduce sales and harm our brands.

 

General economic factors may adversely affect our business, financial performance and results of operations.

 

Our business, financial performance and results of operations depend significantly on worldwide macroeconomic economic conditions and their impact on consumer spending. Recessionary economic cycles, higher interest rates, volatile fuel and energy costs, inflation, levels of unemployment, conditions in the residential real estate and mortgage markets, access to credit, consumer debt levels, unsettled financial markets and other economic factors that may affect consumer spending or buying habits could materially and adversely affect demand for our products. In addition, volatility in the financial markets has had and may continue to have a negative impact on consumer spending patterns. A reduction in consumer spending or disposable income may affect us more significantly than companies in other industries and companies with a more diversified product offering. In addition, negative national or global economic conditions may materially and adversely affect our suppliers’ financial performance, liquidity and access to capital. This may affect their ability to maintain their inventories, production levels and/or product quality and could cause them to raise prices, lower production levels or cease their operations.

 

Economic factors such as increased commodity prices, shipping costs, higher costs of labor, insurance and healthcare, and changes in or interpretations of other laws, regulations and taxes may also increase our cost of goods sold and our selling, general and administrative expenses, and otherwise adversely affect our financial condition and results of operations.

 

Any significant increases in costs may affect our business disproportionately compared to our competitors. Changes in trade policies or increases in tariffs, may have a material adverse effect on global economic conditions and the stability of global financial markets and may reduce international trade.

 

Natural disasters or other unexpected events may adversely affect our operations, particularly our merchandise supply chain and shipping efforts.

 

Natural disasters, such as earthquakes, hurricanes, tornadoes, floods and other adverse weather and climate conditions; unforeseen public health crises, such as pandemics and epidemics; political crises, such as terrorist attacks, war and other political instability; or other catastrophic events, whether occurring in Israel or internationally, could disrupt our operations in any of our offices and fulfillment centers or the operations of one or more of our third-party providers or vendors. In particular, these types of events could impact our merchandise supply chain, including our ability to ship merchandise to customers from or to the impacted region, and could impact our ability or the ability of third parties to operate our sites and ship merchandise. In addition, these types of events could negatively impact consumer spending in the impacted regions. To the extent any of these events occur, our business and operating results could be adversely affected.

 

We are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability due to the ongoing military conflict between Russia and Ukraine. Our business, financial condition and results of operations may be materially adversely affected by any negative impact on the global economy and capital markets resulting from the conflict in Ukraine or any other geopolitical tensions.

 

U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the start of the military conflict between Russia and Ukraine. On February 24, 2022, a full-scale military invasion of Ukraine by Russian troops was reported. Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine could lead to market disruptions, including significant volatility in credit and capital markets.

 

10

 

 

Additionally, Russia’s prior annexation of Crimea, recent recognition of two separatist republics in the Donetsk and Luhansk regions of Ukraine and subsequent military interventions in Ukraine have led to sanctions and other penalties being levied by the United States, European Union and other countries against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic, including agreement to remove certain Russian financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Additional potential sanctions and penalties have also been proposed and/or threatened. Russian military actions and the resulting sanctions could adversely affect the global economy and financial markets.

 

Any of the abovementioned factors could affect our business, prospects, financial condition, and operating results. The extent and duration of the military action, sanctions and resulting market disruptions are impossible to predict, but could be substantial. Any such disruptions may also magnify the impact of other risks described in this Annual Report on Form 20-F.

 

We may acquire other companies or technologies, which could divert our management’s attention, result in additional dilution to our shareholders and otherwise disrupt our operations and adversely affect our operating results.

 

Since our IPO, we have acquired Fort and invested in SciSparc U.S. We may in the future seek to acquire or invest in businesses, features or technologies that we believe could complement or expand our market, enhance our technical capabilities or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. In addition, to the extent that we enter into any term sheets or agreements or otherwise announce any intention to acquire any businesses, features or technologies, any such acquisition would generally be subject to completion of due diligence and required approvals, and there can be no assurance that any such acquisition will occur or be completed in a timely manner, or at all.

 

If we acquire additional businesses, we may not be able to integrate the acquired operations, existing contracts and technologies successfully or effectively manage the combined business following the acquisition. We also may not achieve the anticipated benefits from any future acquired business due to a number of factors, including:

 

  failure to identify all of the issues, liabilities or other shortcomings or challenges of an acquired company or technology, including issues related to intellectual property, regulatory compliance practices, revenue recognition or other accounting practices, or employee or client issues;

 

  difficulty incorporating acquired technology and rights into our existing algorithm and operations and of maintaining quality and security standards consistent with our brands;

 

  inability to generate sufficient cashflow to offset acquisition or investment costs;

 

  incurrence of acquisition-related costs or equity dilution associated with funding the acquisition;

 

  difficulties and additional expenses associated with supporting legacy products and hosting infrastructure of the acquired business;

 

  risks of entering new markets or new product categories in which we have limited or no experience;

 

  diversion of our management’s attention from other business concerns;

 

  adverse effects to our existing business relationships as a result of the acquisition;

 

  potential loss of customers, vendors and suppliers from either our current business or an acquired company’s business;

 

  use of resources that are needed in other parts of our business;

 

  possible write offs or impairment charges relating to acquired businesses;

 

  compliance with regulatory matters related to the acquired business or its products; and

 

  use of substantial portions of our available cash to consummate the acquisition.

 

In addition, a significant portion of the purchase price of companies we acquire may be allocated to acquired goodwill and intangible assets, which must be assessed for impairment at least annually. In the future, if our acquisitions do not yield expected returns, we may be required to take charges to our operating results based on this impairment assessment process, which could adversely affect our results of operations.

 

Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our operating results. If an acquired business fails to meet our expectations, our business, operating results and financial condition may suffer.

 

11

 

 

Risks Related to Information Technology

 

Assertions by third parties of infringement or misappropriation by us of their intellectual property rights or confidential know how could result in significant costs and substantially harm our business and results of operations.

 

Our business relies on sophisticated and experienced use and know-how of Amazon’s A.I. market tracker. Third parties may in the future assert that we have infringed or misappropriated their trademarks, copyrights, confidential know how, trade secrets, patents or other intellectual property rights. We cannot predict whether any such assertions or claims arising from such assertions will substantially harm our business and results of operations, whether or not they are successful. If we are forced to defend against any infringement or other claims relating to the trademarks, copyright, confidential know how, trade secrets, patents or other intellectual property rights of third parties, whether they are with or without merit or are determined in our favor, we may face costly litigation or diversion of technical and management personnel. Furthermore, the outcome of a dispute may be that we would need to cease use of some portion of our systems. Any such assertions or litigation could materially adversely affect our business, results of operations, financial condition and prospects.

 

The e-commerce industry is characterized by vigorous protection and pursuit of intellectual property rights, which has resulted in protracted and expensive litigation for many companies. Some companies, including some of our competitors, own large numbers of patents, copyrights and trademarks, which they may use to assert claims against us. In addition, because patent applications can take years to issue and are often afforded confidentiality for some period of time, there may currently be pending applications, unknown to us, that later result in issued patents that could cover one or more of the technologies we use.

 

Certain third parties have substantially greater resources than we have and may be able to sustain the costs of intellectual property litigation for longer periods of time than we can. Even if we were to prevail in such a dispute, any litigation regarding the way we operate and utilize our technologies, could be costly and time-consuming and divert the attention of our management and key personnel from our business operations.

 

The inability to acquire, use or maintain our marks and domain names for our sites could substantially harm our business and operating results.

 

We currently have registered trademarks for certain of our brands in numerous jurisdictions and have registered the Internet domain names for Fort's website. However, we have not registered our trademarks or domain names in all major international jurisdictions. Domain names generally are regulated by Internet regulatory bodies. If we do not have, or cannot obtain on reasonable terms, the ability to use our marks in a particular country or to use or register any of our domain names, we could be forced either to incur significant additional expenses to market our products within that country, including the development of a new brand and the creation of new promotional materials and packaging, or to elect not to sell products in that country. Either result could materially adversely affect our business, financial condition and operating results.

 

Furthermore, the regulations governing domain names and laws protecting marks and similar proprietary rights could change in ways that block or interfere with our ability to use relevant domains or our current brand names. Furthermore, we might not be able to prevent third parties from registering, using or retaining domain names that interfere with our consumer communications or infringe or otherwise decrease the value of our marks, domain names and other proprietary rights. Regulatory bodies also may establish additional generic or country-code top-level domains or may allow modifications of the requirements for registering, holding or using domain names. As a result, we may not be able to register, use or maintain the domain names that utilize the name Jeffs’ Brands or our other brands in all of the countries in which we currently or intend to conduct business.

 

12

 

 

Any significant disruption in service on our websites or in our computer systems, a number of which are currently hosted or provided by third-party providers, could materially affect our ability to operate, damage our reputation and result in a loss of customers, which would harm our business and results of operations.

 

Our ability to sell and market our products relies on FBA platform whose functionality relies upon a number of third-party related services, including those relating to cloud infrastructure, technology services, servers, open-source libraries and vendor APIs. Any disruption or loss of any of these third-party services could have a negative effect on our business, results of operations, financial condition and prospects. We may experience interruptions in our systems, including server failures that temporarily slow down or interfere with the performance of our platforms and the ability to sell on e-commerce marketplaces.

 

Interruptions in these systems, whether due to system failures, human input errors, computer viruses or physical or electronic break-ins, and denial-of-service attacks on us, third-party vendors or communications infrastructure, could affect the availability of our services on our platform and prevent or inhibit the ability of selling our products. Volume of traffic and activity on e-commerce marketplaces spikes on certain days, such as during a Black Friday promotion, and any such interruption would be particularly problematic if it were to occur at such a high-volume time. Problems with the reliability of our systems or third-party marketplaces could prevent us from earning revenue and could harm our reputation. Damage to our reputation, any resulting loss of customers, e-commerce confidence and the cost of remedying these problems could negatively affect our business, results of operations, financial condition and prospects.

 

Our ability to maintain communications, network and computer hardware in the countries in which they are used may in the future be subject to regulatory review and licensing, and the failure to obtain any required licenses could negatively affect our business. Our systems and infrastructure are predominately reliant on third parties. Problems faced by our third-party service providers with the telecommunications network providers with whom they contract or with the systems by which they allocate capacity among their users, including us, could adversely affect the experience of our customers. Our third-party service providers could decide to close their facilities without adequate notice. Any financial difficulties, such as bankruptcy or reorganization, faced by our third-party service providers or any of the service providers with whom they contract may have negative effects on our business, the nature and extent of which are difficult to predict. If our third-party service providers are unable to keep up with our needs for capacity, this could have an adverse effect on our business. Any errors, defects, disruptions or other performance problems with our services could harm our reputation and may have a material adverse effect on our business, results of operations, financial condition and prospects.

 

Our failure or the failure of third parties to protect our sites, networks and systems against security breaches, or otherwise to protect our confidential information and practices, could damage our reputation and brands and substantially harm our business and operating results.

 

We collect, maintain, transmit and store data about our customers, brands and others, including personally identifiable information, as well as other confidential information. We also engage third parties that store, process and transmit these types of information on our behalf. We rely on encryption and authentication technology licensed from third parties in an effort to securely transmit confidential and sensitive information, including credit card numbers. Advances in computer capabilities, new technological discoveries or other developments may result in the whole or partial failure of this technology to protect transaction data or other confidential and sensitive information from being breached or compromised. In addition, our brand’s e-commerce websites are often attacked through compromised credentials, including those obtained through phishing and credential stuffing. Our security measures, and those of our third-party service providers, may not detect or prevent all attempts to breach our systems, denial-of-service attacks, viruses, malicious software, break-ins, phishing attacks, social engineering, security breaches or other attacks and similar disruptions that may jeopardize the security of information stored in or transmitted by our websites, networks and systems or that we or such third parties otherwise maintain, including payment card systems, which may subject us to fines or higher transaction fees or limit or terminate our access to certain payment methods. We and such third parties may not anticipate or prevent all types of attacks until after they have already been launched. Further, techniques used to obtain unauthorized access to sabotage systems change frequently and may not be known until launched against us or our third-party service providers. In addition, security breaches can occur as a result of non-technical issues, including intentional or inadvertent breaches by our employees or by third parties. These risks may increase over time as the complexity and number of technical systems and applications we use also increases.

 

13

 

 

Breaches of our security measures or those of our third-party service providers or cyber security incidents could result in unauthorized access to our sites, networks, systems and accounts; unauthorized access to, and misappropriation of, consumer information, including customers’ personally identifiable information, or other confidential or proprietary information of ourselves or third parties; viruses, worms, spyware or other malware being served from our sites, networks or systems; deletion or modification of content or the display of unauthorized content on our sites; interruption, disruption or malfunction of operations; costs relating to breach remediation, deployment of additional personnel and protection technologies, response to governmental investigations and media inquiries and coverage; engagement of third-party experts and consultants; or litigation, regulatory action and other potential liabilities. In the past, we have experienced social engineering, phishing, malware and similar attacks and threats of denial-of-service attacks; however, such attacks could in the future have a material adverse effect on our operations. If any of these breaches of security should occur, our reputation and brand could be damaged, our business may suffer, we could be required to expend significant capital and other resources to alleviate problems caused by such breaches, and we could be exposed to a risk of loss, litigation or regulatory action and possible liability. We cannot guarantee that recovery protocols and backup systems will be sufficient to prevent data loss. Actual or anticipated attacks may cause us to incur increasing costs, including costs to deploy additional personnel and protection technologies, train employees and engage third-party experts and consultants.

 

We may experience periodic system interruptions from time to time. In addition, continued growth in our transaction volume, as well as surges in online traffic and orders associated with promotional activities or seasonal trends in our business, place additional demands on our marketplace platforms and could cause or exacerbate slowdowns or interruptions. If there is a substantial increase in the volume of traffic on our sites or the number of orders placed by customers, we will be required to further expand and upgrade our technology, transaction processing systems and network infrastructure. There can be no assurance that we will be able to accurately project the rate or timing of increases, if any, in the use of our sites or expand and upgrade our systems and infrastructure to accommodate such increases on a timely basis. In order to remain competitive, we must continue to enhance and improve the responsiveness, functionality and features of our sites, which is particularly challenging given the rapid rate at which new technologies, customer preferences and expectations and industry standards and practices are evolving in the e-commerce industry. Accordingly, we redesign and enhance various functions on our sites on a regular basis, and we may experience instability and performance issues as a result of these changes. Our disaster recovery plan may be inadequate, and our business interruption insurance may not be sufficient to compensate us for the losses that could occur.

 

Any compromise or breach of our security measures, or those of our third-party service providers, could violate applicable privacy, data protection, data security, network and information systems security and other laws and cause significant legal and financial exposure, adverse publicity and a loss of confidence in our security measures, which could have a material adverse effect on our business, results of operations, financial condition and prospects. We continue to devote significant resources to protect against security breaches, or we may need to devote significant resources in the future to address problems caused by breaches, including notifying affected subscribers and responding to any resulting litigation, which in turn, diverts resources from the growth and expansion of our business. To date, we are not aware of any material compromises or breaches of our networks or systems.

 

Risks Related to Legal and Regulatory Matters

 

We may be subject to general litigation, regulatory disputes and government inquiries.

 

As a growing company with expanding operations, we may in the future increasingly face the risk of claims, lawsuits, government investigations and other proceedings involving competition and antitrust, intellectual property, privacy, consumer protection, accessibility claims, securities, tax, labor and employment, commercial disputes, services and other matters. The number and significance of these disputes and inquiries have increased as the political and regulatory landscape changes, and as we have grown larger and expanded in scope and geographic reach, and our services have increased in complexity.

 

We cannot predict the outcome of such disputes and inquiries with certainty. Regardless of the outcome, these can have an adverse impact on us because of legal costs, diversion of management resources and other factors. Determining reserves for any litigation is a complex, fact-intensive process that is subject to judgment calls. It is possible that a resolution of one or more such proceedings could require us to make substantial payments to satisfy judgments, fines or penalties or to settle claims or proceedings, any of which could harm our business. These proceedings could also result in reputational harm, criminal sanctions, consent decrees or orders preventing us from offering certain products or services or requiring a change in our business practices in costly ways or requiring development of non-infringing or otherwise altered products or technologies. Litigation and other claims and regulatory proceedings against us could result in unexpected expenses and liabilities, which could have a material adverse effect on our business, results of operations, financial condition and prospects.

 

14

 

 

A failure to comply with current laws, rules and regulations or changes to such laws, rules and regulations and other legal uncertainties may adversely affect our business, financial performance, results of operations or business growth. 

 

Our business and financial performance could be adversely affected by unfavorable changes in or interpretations of existing laws, rules and regulations or the promulgation of new laws, rules and regulations applicable to us and our businesses, including those relating to the internet and e-commerce, internet advertising and price display, consumer protection, anti-corruption, antitrust and competition, economic and trade sanctions, energy usage and emissions, tax, banking, data security, network and information systems security, data protection and privacy. As a result, regulatory authorities could prevent or temporarily suspend us from carrying on some or all of our activities or otherwise penalize us if our practices were found not to comply with applicable regulatory or licensing requirements or any binding interpretation of such requirements. Unfavorable changes or interpretations could decrease demand for our products or services, limit marketing methods and capabilities, affect our margins, increase costs or subject us to additional liabilities.

 

For example, there are, and will likely continue to be, an increasing number of laws and regulations pertaining to the internet and e-commerce that may relate to liability for information retrieved from or transmitted over the internet, display of certain taxes and fees, online editorial and consumer-generated content, user privacy, data security, network and information systems security, behavioral targeting and online advertising, taxation, liability for third-party activities and the quality of services. Furthermore, the growth and development of e-commerce may prompt calls for more stringent consumer protection laws and more aggressive enforcement efforts, which may impose additional burdens on online businesses generally.

 

If our products experience any recalls, product liability claims, or government, customer or consumer concerns about product safety, our reputation and operating results could be harmed.

 

Our products are subject to regulation by the U.S. Consumer Product Safety Commission, or the CPSC, and similar state and international regulatory authorities, and could be subject to involuntary recalls and other actions by these authorities. Concerns about product safety, including concerns about the safety of products manufactured in developing countries, could lead us to recall selected products. Recalls and government, customer or consumer concerns about product safety could harm our reputation and reduce sales, either of which could have a material adverse effect on our business, results of operations, financial condition and prospects.

 

We may also be subject to product liability claims if people or property are harmed by the products we sell. Some of the products we sell may expose us to product liability claims and litigation (including class actions) or regulatory action relating to safety, personal injury, death or environmental or property damage.

 

Although we maintain liability insurance, we cannot be certain that our coverage will be adequate for liabilities actually incurred or that insurance will continue to be available to us on economically reasonable terms, or at all. Some of our agreements with members of our supply chain may not indemnify us from product liability claims for a particular product, and some members of our supply chain may not have sufficient resources or insurance to satisfy their indemnity and defense obligations.

 

Any failure by us or our vendors to comply with product safety, labor or other laws, or our standard vendor terms and conditions, or to provide safe factory conditions for our or their workers may damage our reputation and brand and harm our business.

 

The products we sell to our customers are subject to regulation by the CPSC, the Federal Trade Commission, or the FTC, and similar state and international regulatory authorities. As a result, such products could be in the future subject to recalls and other remedial actions. Product safety, labeling and licensing concerns may require us to voluntarily remove selected merchandise from our inventory. Such recalls or voluntary removal of merchandise can result in, among other things, suspension of our seller accounts on Amazon and other online marketplaces, lost sales, diverted resources, potential harm to our reputation and increased client service costs and legal expenses, which could have a material adverse effect on our operating results.

 

15

 

 

Some of the products we sell may expose us to product liability claims and litigation or regulatory action relating to personal injury or environmental or property damage. Although we maintain liability insurance and implemented a quality assurance program that includes obtaining necessary certifications, we cannot be certain that our coverage will be adequate for liabilities actually incurred or that insurance will continue to be available to us on economically reasonable terms or at all. In addition, some of our agreements with our vendors may not indemnify us from product liability claims for a particular vendor’s products or our vendors may not have sufficient resources or insurance to satisfy their indemnity and defense obligations.

 

We are subject to U.S. governmental regulation and other legal obligations related to privacy, data protection and information security. If we are unable to comply with these, we may be subject to governmental enforcement actions, litigation, fines and penalties or adverse publicity.

 

We collect personally identifiable information and other data from our customers and prospective customers. We collect this info automatically through the automated sales processes with e-commerce marketplaces. We, at times, may use this information to provide, support, expand and improve our business and tailor our digital marketing and advertising efforts.

 

Our handling of data is subject to a variety of laws and regulations, including regulation by various government agencies, such as the FTC, and various state, local and foreign agencies. Our data handling also is subject to industry standards.

 

The U.S. federal and various state and foreign governments have adopted or proposed limitations on the collection, distribution, use and storage of data relating to individuals, including the use of contact information and other data for digital marketing, advertising and other communications with individuals and businesses. In the United States, various laws and regulations apply to the collection, processing, disclosure and security of certain types of data. Additionally, the FTC and many state attorneys general are interpreting federal and state consumer protection laws as imposing standards for the online collection, use, dissemination and security of data. The laws and regulations relating to privacy and data security are evolving, can be subject to significant change and may result in ever-increasing regulatory and public scrutiny and escalating levels of enforcement and sanctions.

 

In the United States, federal and various state governments have adopted or are considering laws, guidelines or rules for the collection, distribution, use and storage of information collected from or about customers or their devices. For example, fourteen U.S. states have passed comprehensive privacy legislation intended to provide consumers with greater transparency and control over their personal information by providing consumers with certain rights, such as the right to know what personal information is being collected about them, and the right to access, delete, correct, or opt out of the sale of their personal information. The original California Consumer Privacy Act became effective in 2020, with amendments in the California Privacy Rights Act effective in 2023. Similar laws in Colorado, Connecticut, Utah and Virginia are effective as of 2023; and general data protection laws in Texas, Oregon and Montana are set to come into effect over the course of 2024.

 

Numerous data protection regimes apply based on where a customer is located, and as we expand and new laws are enacted or existing laws change, we may be subject to new laws, regulations or standards or new interpretations of existing laws, regulations or standards, which could require us to incur additional costs and restrict our business operations. Any failure or perceived failure by us to comply with rapidly evolving privacy or security laws, policies (including our own stated privacy policies), legal obligations or industry standards or any security incident that results in the unauthorized release or transfer of personally identifiable information or other consumer data may result in governmental enforcement actions, litigation (including consumer class actions), fines and penalties or adverse publicity and could cause our customers to lose trust in us, which could have a material adverse effect on our business, results of operations, financial condition and prospects.

 

16

 

 

In Europe, where we expect to expand our business operations in the future as part of our growth, the data privacy and information security regime continues to evolve and is subject to increasing regulatory scrutiny.

 

The General Data Protection Regulation, or GDPR, which came into force on May 25, 2018, implemented more stringent operational requirements for our use of personal data. These more stringent requirements include expanded disclosures to tell our customers about how we may use their personal data, increased controls on profiling customers and increased rights for customers to access, control and delete their personal data. In addition, there are mandatory data breach notification requirements and significantly increased penalties of the greater of €20 million or 4% of global turnover for the preceding financial year.

 

The U.K.’s Network and Information Systems Regulations 2018, or NID Regulations, which came into force on May 10, 2018, apply to us as an online marketplace and place additional network and information systems security obligations on us, as well as mandatory security incident notification in certain circumstances with penalties of up to £17 million.

 

In recent years, U.S. and European lawmakers and regulators have expressed concern over the use of third-party cookies and similar technologies for online behavioral advertising, and laws in this area are also under reform. Such regulations may have a negative effect on businesses, including ours, that collect and use online usage information for consumer acquisition and marketing, it may increase the cost of operating a business that collects or uses such information and undertakes online marketing, it may also increase regulatory scrutiny and increase potential civil liability under data protection or consumer protection laws.

 

We could incur substantial costs to comply with these regulations. The changes could require significant systems changes, limit the effectiveness of our marketing activities, adversely affect our margins, increase costs and subject us to additional liabilities.

 

Amendments to existing tax laws, rules or regulations or enactment of new unfavorable tax laws, rules or regulations could have an adverse effect on our business and financial performance.

 

Many of the laws, rules or regulations imposing taxes and other similar obligations were established before the growth of the internet and e-commerce. Tax authorities in non-U.S. jurisdictions, including Israel, and at the U.S. federal, state and local levels are currently reviewing the appropriate treatment of companies engaged in e-commerce and considering changes to existing tax or other laws that could regulate our transmissions and/or levy sales, income, consumption, use or other taxes relating to our activities, and/or impose obligations on us to collect such taxes. For example, in March 2018, the European Commission proposed new rules for taxing digital business activities in the EU. In addition, state and local taxing authorities in the United States and taxing authorities in other countries have identified e-commerce platforms as a means to calculate, collect and remit indirect taxes for transactions taking place over the internet. Multiple U.S. states have enacted related legislation and other states are now considering such legislation. Furthermore, the U.S. Supreme Court held in South Dakota v. Wayfair that a U.S. state may require an online retailer to collect sales taxes imposed by that state, even if the retailer has no physical presence in that state, thus permitting a wider enforcement of such sales tax collection requirements. Such legislation could require us or our retailers and brands to incur substantial costs in order to comply, including costs associated with legal advice, tax calculation, collection, remittance and audit requirements, which could make selling in such markets less attractive and could adversely affect our business.

 

We cannot predict the effect of current attempts to impose taxes on commerce over the internet. If such tax or other laws, rules or regulations were amended, or if new unfavorable laws, rules or regulations were enacted, the results could increase our tax payments or other obligations, prospectively or retrospectively, subject us to interest and penalties, decrease the demand for our products if we pass on such costs to the consumer, result in increased costs to update or expand our technical or administrative infrastructure or effectively limit the scope of our business activities if we decided not to conduct business in particular jurisdictions. As a result, these changes may have a material adverse effect on our business, results of operations, financial condition and prospects.

 

17

 

 

We are subject to anti-corruption, anti-bribery, anti-money laundering and similar laws, and non-compliance with such laws can subject us to criminal penalties or significant fines and harm our business and reputation.

 

Israel Money Laundering and Terror Financing Prohibition Authority, the SEC, the U.S. Department of Justice, the U.S. Treasury Department’s Office of Foreign Assets Controls, or OFAC, the U.S. Department of State, and other foreign regulatory authorities, continue to enforce economic and trade regulations and anti-corruption laws across industries. U.S. trade sanctions relate to transactions with designated foreign countries and territories, including Cuba, Iran, North Korea, Syria and the Crimea region of Ukraine, or Crimea, as well as specifically targeted individuals and entities that are identified on U.S. and other blacklists, and those owned by them or those acting on their behalf.

 

Anti-corruption laws, including the U.S. Foreign Corrupt Practices Act, or the FCPA, the U.K. Bribery Act, or the Bribery Act, and Israel Penal Code section 291a, generally prohibit direct or indirect corrupt payments to government officials and, under certain laws, private persons to obtain or retain business or an improper business advantage. Some of our international operations are conducted in parts of the world where it is common to engage in business practices that are prohibited by these laws.

 

Although we comply with laws and regulations, especially as we expand our operations in existing and new jurisdictions which proportionately adds risks of non-compliance with applicable laws and regulations, our employees, partners or agents could take actions that violate applicable laws or regulations. As regulations continue to develop and regulatory oversight continues to focus on these areas, we cannot ensure compliance at all times with all applicable laws or regulations.

 

In the event our controls should fail, or we are found to be not in compliance for other reasons, we could be subject to monetary damages, civil and criminal monetary penalties, withdrawal of business licenses or permits, litigation and damage to our reputation and the value of our brand.

 

As we expand our operations in existing and new jurisdictions internationally, we will need to increase the scope of our compliance programs to address the risks relating to the potential for violations of the FCPA and the Bribery Act and other anti-bribery and anti-corruption laws. Further, the promulgation of new laws, rules and regulations, or the new interpretation of existing laws, rules and regulations, in each case that restrict or otherwise unfavorably impact the ability or manner in which we or our retailers and brands conduct business could require us to change certain aspects of our business, operations and commercial relationships to ensure compliance, which could decrease demand for products or services, reduce net revenue, increase costs or subject us to additional liabilities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years, are interpreted broadly and prohibit companies and their employees and agents from promising, authorizing, making, offering, soliciting or accepting improper payments or other benefits to or from government officials and others in the private sector. As we increase our international sales and business, particularly in countries with a low score on the Corruptions Perceptions Index by Transparency International and increase our use of third-party business partners such as sales agents, distributors, resellers or consultants, our risks under these laws may increase. Under these laws, we could be held liable for the corrupt or other illegal activities of our employees, representatives, contractors, business partners and agents, even if we do not explicitly authorize or have actual knowledge of such activities. Noncompliance with these laws could subject us to investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension or debarment from contracting with certain persons, the loss of export privileges, whistle-blower complaints, reputational harm, adverse media coverage and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, results of operations and financial condition could be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management’s attention and resources and significant defense and compliance costs and other professional fees.

 

In certain cases, enforcement authorities may even require us to appoint an independent compliance monitor, which can result in added costs and administrative burdens. Any investigations, actions, sanctions or other previously mentioned harm could have a material negative effect on our business, operating results and financial condition.

 

18

 

 

Even following receipt of any regulatory approval for our pest control products, we will continue to be subject to regulation of our advertising practices.

 

As a seller of pest control products, which include poisonous active ingredients, we are subject to continual government oversight by the U.S. Environmental Protection Agency, or EPA, and other regulatory authorities. The EPA strictly regulates the advertising and promotion of pest control products, and these pest control products may only be marketed or promoted for their EPA approved uses, consistent with the product’s approved labeling. Advertising and promotion of any product candidate that obtains approval in the U.S. will be heavily scrutinized by the EPA, other applicable state regulatory agencies and the public. Violations, including promotion of our products for unapproved or off-label uses, are subject to enforcement actions, inquiries and investigations, and civil, criminal and/or administrative sanctions imposed by the EPA.

 

Our operations are subject to environmental laws and regulations that may increase costs of operations and impact or limit our business plans.

 

We are subject to environmental laws and regulations affecting many aspects of our present and potential future operations, including a wide variety of EPA labeling and other state regulatory agency requirements. For example, under the Federal Insecticide, Fungicide, and Rodenticide Act, we are required to register with the EPA and certain state regulatory authorities as a seller of disinfectants, and we are subject to EPA labeling requirements. Compliance with these laws and regulations may result in increased costs and delays as a result of administrative proceedings and certain reporting obligations. Public officials and entities may seek injunctive relief or other remedies to enforce applicable environmental laws and regulations. If we are found to not have complied with these laws and are unable to sell our products, our business and financial results will be negatively impacted.

 

Increased regulatory scrutiny of nutritional supplements as well as new regulations that are being adopted in some of our markets with respect to nutritional supplements could result in more restrictive regulations and harm our results if our supplements or advertising activities are found to violate existing or new regulations or if we are not able to effect necessary changes to our products in a timely and efficient manner to respond to new regulations.

 

There has been an increasing movement in the United States and other markets to increase the regulation of dietary supplements, which could impose additional restrictions or requirements on us and increase the cost of doing business. On February 11, 2019, the U.S. Food and Drug Administration, or FDA, issued a statement from FDA Commissioner, Dr. Scott Gottlieb, regarding the agency’s efforts to strengthen the regulation of dietary supplements. The FDA will be prioritizing and focusing resources on misbranded products bearing unproven claims to treat, cure, or mitigate disease. Commissioner Gottlieb established a Dietary Supplement Working Group tasked with reviewing the agency’s organizational structure, process, procedures, and practices to identify opportunities to modernize the oversight of dietary supplements. Additionally, on December 21, 2015, the FDA created the Office of Dietary Supplements, or ODSP. The creation of this new office elevates the FDA’s program from its previous status as a division under the Office of Nutrition and Dietary Supplements. ODSP will continue to monitor the safety of dietary supplements. In August 2016, the FDA published its revised draft guidance on Dietary Supplements: New Dietary Ingredient Notifications and Related Issues. If a company sells a dietary supplement containing an ingredient that FDA considers either not a dietary ingredient or a new dietary ingredient, or NDI, that needs an NDI notification, the agency may threaten or initiate enforcement against such company. For example, it might send a warning letter that can trigger consumer lawsuits, demand a product recall, or even work with the Department of Justice to bring a criminal action. Our operations could be harmed if new guidance or regulations require us to reformulate products or effect new registrations, if regulatory authorities make determinations that any of our products do not comply with applicable regulatory requirements, if the cost of complying with regulatory requirements increases materially, or if we are not able to effect necessary changes to our products in a timely and efficient manner to respond to new regulations. In addition, our operations could be harmed if governmental laws or regulations are enacted that restrict the ability of companies to market or distribute nutritional supplements or impose additional burdens or requirements on nutritional supplement companies.

 

19

 

 

Risks Related to our Operations in Israel

 

Conditions in Israel, including the recent attack by Hamas and other terrorist organizations from the Gaza Strip and elsewhere in the region, and Israel’s war against them, may adversely affect our operations and limit our ability to market our products, which would lead to a decrease in revenues.

 

 Our offices and management team are located in Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly affect our business and operations.

 

In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and a military campaign against these terrorist organizations commenced in parallel to their continued rocket and terror attacks. Furthermore, hostilities along Israel’s northern border with Hezbollah located in Lebanon have accelerated, with Hezbollah conducting missile, rocket, and shooting attacks against Israeli military sites, troops, and Israeli towns in northern Israel, this clash may escalate in the future into a greater regional conflict. In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and southern border (with the Houthi movement in Yemen, as described below). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries, such as Iran, will join the hostilities. Such clashes may escalate in the future into a greater regional conflict.

 

The intensity and duration of Israel’s current war against Hamas is difficult to predict, as are such war’s economic implications on the Company’s business and operations and on Israel’s economy in general. These events may be intertwined with wider macroeconomic indications of a deterioration of Israel’s economic standing, that may involve a downgrade in Israel’s credit rating by rating agencies (such as the recent downgrade by Moody’s of its credit rating of Israel from A1 to A2, as well as the downgrade of its outlook rating from “stable” to “negative”), which may have a material adverse effect on the Company and its ability to effectively conduct its operations.

 

In connection with the Israeli security cabinet’s declaration of war against Hamas and possible hostilities with other organizations, several hundred thousand Israeli military reservists were drafted to perform immediate military service. Although many of such military reservists have since been released, they may be called up for additional reserve duty, depending on developments in the war in Gaza and along Israel’s other borders. As of March 28, 2024, one employee of ours has been called for service in the current war, in addition to employees of our service providers located in Israel. Additional employees may be called for service in future wars or other armed conflicts with Hamas as well as the other pending or future armed conflicts in which Israel is or may become engaged, and such persons may be absent for an extended period of time. As a result, our operations may be disrupted by such absences, which disruption may materially and adversely affect our business and results of operations. Additionally, the absence of employees of our Israeli suppliers and contract manufacturers due to their military service in the current or future wars or other armed conflicts may disrupt their operations, which in turn may materially and adversely affect our ability to deliver or provide products and services to customers.

 

The hostilities with Hamas, Hezbollah and other organizations and countries, have included and may include terror, missile and drone attacks. In the event that our facilities are damaged as a result of hostile actions, or hostilities otherwise disrupt our ongoing operations, our ability to deliver or provide products and services in a timely manner to meet our contractual obligations towards customers and vendors could be materially and adversely affected. Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that such government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse effect on our business.

 

In addition, some countries around the world restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in Israel or political instability in the region continue or increase. These restrictions may limit materially our ability to manufacture or obtain raw materials for our products from these countries or sell our products to customers in these countries. In addition, there have been increased efforts by countries, activists and organizations to cause companies and consumers to boycott Israeli goods and services. In addition, in January 2024 the International Court of Justice, or ICJ, issued an interim ruling in a case filed by South Africa against Israel in December 2023, making allegations of genocide amid and in connection with the war in Gaza, and ordered Israel, among other things, to take measures to prevent genocidal acts, prevent and punish incitement to genocide, and take steps to provide basic services and humanitarian aid to civilians in Gaza. There are concerns that companies and businesses will terminate, and may have already terminated, certain commercial relationships with Israeli companies following the ICJ decision. The foregoing efforts by countries, activists and organizations, particularly if they become more widespread, as well as the ICJ rulings and future rulings and orders of other tribunals against Israel (if handed), may materially and adversely impact our ability to sell our products outside of Israel.

 

20

 

 

Furthermore, following Hamas’ attack on Israel and Israel’s security cabinet declaration of war against Hamas, the Houthi movement, which controls parts of Yemen, launched a number of attacks on marine vessels traversing the Red Sea, which marine vessels were thought to either be in route towards Israel or to be partly owned by Israeli businessmen. The Red Sea is a vital maritime route for international trade traveling to or from Israel. As a result of such disruptions, we have experienced in the past and may experience in the future delays in supplier deliveries, extended lead times, and increased cost of freight, increased insurance costs, purchased materials and manufacturing labor costs. The risk of ongoing supply disruptions may further result in delayed deliveries of our products.

 

Finally, political conditions within Israel may affect our operations. Israel has held five general elections between 2019 and 2022, and prior to October 2023, the Israeli government pursued extensive changes to Israel’s judicial system, which sparked extensive political debate and unrest. In response to such initiative, many individuals, organizations and institutions, both within and outside of Israel, voiced concerns that the proposed changes may negatively impact the business environment in Israel including due to reluctance of foreign investors to invest or transact business in Israel, as well as to increased currency fluctuations, downgrades in credit rating, increased interest rates, increased volatility in security markets and other changes in macroeconomic conditions. To date, these initiatives have been substantially put on hold. If such changes to Israel’s judicial system are again pursued by the government and approved by the parliament, this may have an adverse effect on our business, our results of operations and our ability to raise additional funds, if deemed necessary by our management and board of directors.

 

Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.

 

Our reporting and functional currency is the U.S. dollar. Our revenues are currently primarily payable in U.S. dollars and we expect our future revenues to be denominated primarily in U.S. dollars. However, certain amounts of our revenues and expenses are also in NIS, GBP and Euro. As a result, we are exposed to the currency fluctuation risks relating to the recording of our expenses in U.S. dollars.

 

It may be difficult to enforce a judgment of a U.S. court against us and our executive officers and directors and the Israeli experts named in this Annual Report on Form 20-F in Israel or the United States, to assert U.S. securities laws claims in Israel or to serve process on our executive officers and directors and these experts.

 

We are incorporated in Israel. All of our executive officers and directors reside outside of the United States, and all of our assets and most of the assets of these persons are located outside of the United States. Therefore, a judgment obtained against us, or any of these persons, including a judgment based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the United States and may not be enforced by an Israeli court. It also may be difficult for you to effect service of process on these persons in the United States or to assert U.S. securities law claims in original actions instituted in Israel. Additionally, it may be difficult for an investor, or any other person or entity, to initiate an action with respect to U.S. securities laws in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses, which can be a time consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing a judgment against us in Israel, you may not be able to collect any damages awarded by either a U.S. or foreign court. See “Enforceability of Civil Liabilities” for additional information on your ability to enforce a civil claim against us and our executive officers or directors named in this Annual Report on Form 20-F.

 

21

 

 

Your rights and responsibilities as a shareholder are governed in key respects by Israeli laws, which differ in some material respects from the rights and responsibilities of shareholders of U.S. companies.

 

The rights and responsibilities of the holders of our Ordinary Shares are governed by our amended and restated articles of association and by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities of shareholders in U.S. companies. In particular, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner in exercising its rights and performing its obligations towards the company and other shareholders, and to refrain from abusing its power in such company, including, among other things, in voting at a general meeting of shareholders on matters such as amendments to a company’s articles of association, increases in a company’s authorized share capital, mergers and acquisitions and related party transactions requiring shareholder approval, as well as a general duty to refrain from discriminating against other shareholders. In addition, a controlling shareholder of an Israeli company or a shareholder who is aware that it possesses the power to determine the outcome of a vote at a meeting of the shareholders or to appoint or prevent the appointment of a director or executive officer in the company, or has other powers, has a duty of fairness towards the company. Israeli law does not define the substance of this duty of fairness. There is limited case law available to assist us in understanding the nature of these duties or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on holders of our Ordinary Shares that are not typically imposed on shareholders of U.S. companies.

 

Certain provisions of our amended and restated articles of association may be deemed to have an anti-takeover effect.

 

Certain provisions of our amended and restated articles of association may make a change in control of us more difficult to effect. Our amended and restated articles of association provide for a staggered board of directors consisting of three classes of directors. Directors of each class are chosen for three-year terms upon the expiration of their current terms and each year one class of our directors will be elected by our shareholders. This classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult. At least two annual meetings of shareholders, instead of one, will generally be required to effect a change in a majority of our board of directors. Thus, the classified board provision could increase the likelihood that incumbent directors will retain their positions. The staggered terms of directors may delay, defer or prevent an attempt to change control of us, even though a change in control might be considered by our shareholders to be in their best interest.

 

Risks Related to Our Status as a Public Company and Ownership of our Ordinary Shares and Warrants

 

We incur significant increased costs as a result of operating as a public company. Our management is required to devote substantial time to new compliance initiatives as well as compliance with ongoing U.S. requirements.

 

As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. For example, we subject to the reporting requirements of the Exchange Act of 1934, as amended, or the Exchange Act, and are required to comply with the applicable requirements of the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the rules and regulations subsequently implemented by the SEC, including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices.

 

Compliance with these requirements will increase our legal and financial compliance costs and will make some activities more time consuming and costly. In addition, our management and other personnel might need to divert attention from operational and other business matters to devote substantial time to these public company requirements. In particular, we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act which will increase when we are no longer an emerging growth company, as defined by the JOBS Act. We will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge and maintain an internal audit function. We cannot predict or estimate the amount of additional costs we may incur as a result of operating as a public company or the timing of such costs.

 

We believe that being a public company makes it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our board of directors, particularly to serve on our audit committee and compensation committee, and skilled executive officers.

 

22

 

 

As a result of disclosure of information in our publicly-filed documents, our business and financial condition became more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and results of operations could be materially adversely affected, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and materially adversely affect our business, financial condition and operating results.

 

Issuance of a significant amount of additional Ordinary Shares on exercise or conversion of outstanding warrants and/or substantial future sales of our Ordinary Shares may depress our share price.

 

The issuance of a significant amount of additional Ordinary Shares on account of outstanding warrants will dilute our current shareholders’ holdings and may depress our share price. If these or other shareholders sell substantial amounts of our Ordinary Shares, including shares issuable upon the exercise or conversion of outstanding warrants or employee options, or if the perception exists that our shareholders may sell a substantial number of our Ordinary Shares, we cannot foresee the impact of any potential sales on the market price of these additional Ordinary Shares, but it is possible that the market price of our Ordinary Shares would be adversely affected. Any substantial sales of our shares in the public market might also make it more difficult for us to sell equity or equity related securities in the future at a time and on terms we deem appropriate. Even if a substantial number of sales do not occur, the mere existence of this “market overhang” could have a negative impact on the market for, and the market price of, our Ordinary Shares.

 

Failure to achieve and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business, results of operation or financial condition. In addition, current and potential shareholders could lose confidence in our financial reporting, which could have a material adverse effect on the price of our Ordinary Shares.

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. We are required to document and test our internal control procedures in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act, which requires annual management assessments of the effectiveness of our internal control over financial reporting. In addition, if we fail to maintain the adequacy of our internal control, as such standards are modified, supplemented or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404. Disclosing deficiencies or weaknesses in our internal control, failing to remediate these deficiencies or weaknesses in a timely fashion or failing to achieve and maintain an effective internal control environment may cause investors to lose confidence in our reported financial information, which could have a material adverse effect on the price of our Ordinary Shares. If we cannot provide reliable financial reports or prevent fraud, our operating results could be harmed

 

Future sales of our Ordinary Shares and Warrants could reduce the market price of our Ordinary Shares and Warrants.

 

Substantial sales of our Ordinary Shares and Warrants on Nasdaq, may cause the market price of our Ordinary Shares and/or Warrants to decline. Sales by us or our security holders of substantial amounts of our Ordinary Shares and/or Warrants, or the perception that these sales may occur in the future, could cause a reduction in the market price of our Ordinary Shares and/or Warrants.

 

The issuance of any additional Ordinary Shares or any securities that are exercisable for or convertible into Ordinary Shares, may have an adverse effect on the market price of our Ordinary Shares and will have a dilutive effect on our existing shareholders and holders of Ordinary Shares.

 

23

 

 

We cannot assure you that our Ordinary Shares and Warrants will remain listed on Nasdaq or any other securities exchange.

 

On May 20, 2023, we received a written notice, or the Notice, from Nasdaq indicating that we were not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), we were granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. Although we have since cured this deficiency by, among other things, effecting the Reverse Split and have regained compliance with Nasdaq Listing Rule 5550(a)(2), there is a risk that we could be subject to additional notices of delisting for failure to comply with Nasdaq Listing Rule 5550(a)(2) or other Nasdaq Listing Rules as our shares are currently traded below $1.00 per share.

 

No assurance can be given that we will remain eligible to be listed on Nasdaq. In the event that our Ordinary Shares are delisted from Nasdaq due to our failure to continue to comply with the requirements for continued listing on Nasdaq, and are not eligible for listing on another national securities exchange, trading in our Ordinary Shares and Warrants could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our Ordinary Shares and Warrants, and it would likely be more difficult to obtain coverage by securities analysts and the news media, which could cause the price of our Ordinary Shares to decline further. Also, it may be difficult for us to raise additional capital if we are not listed on a national exchange.

 

As a “foreign private issuer” we are permitted, and intend, to follow certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to investors under rules applicable to domestic U.S. issuers.

 

Our status as a foreign private issuer also exempts us from compliance with certain SEC laws and regulations and certain regulations of Nasdaq, including the proxy rules, the short-swing profits recapture rules, and certain governance requirements such as independent director oversight of the nomination of directors and executive compensation. In addition, we will not be required under the Exchange Act to file current reports and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act and we will generally be exempt from filing quarterly reports with the SEC. Also, although the Israeli Companies Law, 5759-1999, or the Companies Law, requires us to disclose the annual compensation of our five most highly compensated senior officers on an individual basis (rather than on an aggregate basis), this disclosure will not be as extensive as that required of a U.S. domestic issuer. Furthermore, as a foreign private issuer, we are also not subject to the requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act.

 

These exemptions and leniencies will reduce the frequency and scope of information and protections to which you are entitled as an investor.

 

The determination of foreign private issuer status is made annually on the last business day of an issuer’s most recently completed second fiscal quarter and, accordingly, the next determination will be made with respect to us on June 30, 2023. In the future, we would lose our foreign private issuer status if a majority of our shareholders, directors or management are U.S. citizens or residents and we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic registrant may be significantly higher.

 

The estimates of market opportunity, market size and forecasts of market growth included in this Annual Report on Form 20-F and our other publicly filed documents may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all.

 

Market opportunity, size estimates and growth forecasts included in this Annual Report on Form 20-F and our other publicly filed documents are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. For example, several of the reports and data on which our estimates and forecasts are based rely on projections of consumer adoption and incorporate data from secondary sources, such as company websites as well as industry, trade and government publications.

 

24

 

 

Net revenue and operating results are difficult to forecast because they generally depend on the volume, timing and type of orders we receive, all of which are uncertain. We base our expense levels and investment plans on our estimates of total net revenue and gross margins using human judgment and utilizing internal analytic methodologies to assess market trends. We cannot be sure the same growth rates, trends and other key performance metrics are meaningful predictors of future growth. If our assumptions and calculations prove to be wrong, we may spend more than we anticipate acquiring and retaining customers or may generate less net revenue per active customer than anticipated, any of which could have a negative impact on our business and results of operations.

 

In addition, as we enter new consumer product markets in the future, we may initially provide discounts to customers to gain market traction, and the amount and effect of these discounts may vary greatly. No such discounts have been given to date.

 

Finally, we are evaluating our total addressable market with respect to new product offerings and new markets. These estimates of total addressable market and growth forecasts are subject to significant uncertainty, are based on assumptions and estimates that may not prove to be accurate and are based on data published by third parties that we have not independently verified. Even if the market in which we compete meets the size estimates and growth forecasted in this Annual Report on Form 20-F, our business could fail to grow at similar rates, if at all.

 

Our business is also affected by general economic and business conditions in international markets.

 

In addition, we experience seasonal trends in our business, and our mix of product offerings is highly variable from day-to-day and quarter-to-quarter. This variability makes it difficult to predict sales and could result in significant fluctuations in our net revenue from period-to-period. A significant portion of our expenses is fixed, and as a result, we may be unable to adjust our spending in a timely manner to compensate for any unexpected shortfall in net revenue. Any failure to accurately predict net revenue or gross margins could cause our operating results to be lower than expected, which could materially adversely affect our financial condition and share price.

 

Our management team has limited experience managing a public company.

 

Most members of our management team have limited experience managing a public company, interacting with public company investors and complying with the increasingly complex laws pertaining to public companies. Accordingly, our management team, as a whole, may not successfully or efficiently manage the transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will require significant attention from our senior management, particularly from our chief executive officer, and could divert their attention away from the day-to-day management of our business, which could adversely affect our business, operating results and financial condition.

 

25

 

 

We are an emerging growth company and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies could make our Ordinary Shares and Warrants less attractive to investors.

 

We are an emerging growth company and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to “emerging growth companies,” including:

 

  not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act;

 

  permission to delay adopting new or revised accounting standards until such time as those standards apply to private companies;

 

  reduced disclosure obligations regarding executive compensation in our periodic reports and annual report on Form 20-F; and

 

  exemptions from the requirements of holding non-binding advisory votes on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

We may take advantage some or all of these and other exemptions until we are no longer an “emerging growth company”. We could be an emerging growth company up to the end of the fiscal year in which the fifth anniversary of the completion of our IPO, or 2027, although we expect to not be an emerging growth company sooner. Our status as an emerging growth company will end as soon as any of the following take place:

 

  the last day of the fiscal year in which we have more than $1.235 billion in annual revenue;

 

  the date we qualify as a “large accelerated filer,” with at least $700 million of equity securities held by non-affiliates;

 

  the date on which we have issued, in any three-year period, more than $1.0 billion in non-convertible debt securities; or

 

  the last day of the fiscal year ending after the fifth anniversary after we become a public company.

 

We cannot predict if investors will find our Ordinary Shares or Warrants less attractive if we choose to rely on any of the exemptions afforded emerging growth companies. If some investors find our Ordinary Shares or Warrants less attractive because we rely on any of these exemptions, there may be a less active trading market for our Ordinary Shares and/or Warrants and the market price of our Ordinary Shares and/or Warrants may be more volatile.

 

In addition, under the JOBS Act, “emerging growth companies” can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to avail ourselves of this exemption and, as a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies. Section 107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable.

 

Even after we no longer qualify as an emerging growth company, we may qualify as a “smaller reporting company”, which would allow us to take advantage of many of the same exemptions from disclosure requirements (excluding the exemption from compliance with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act) and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. However, as a foreign private issuer we are not eligible to use the requirements for smaller reporting companies unless we use the forms and rules designated for domestic issuers and provide financial statements prepared in accordance with U.S. generally accepted accounting principles. We cannot predict if investors will find our Ordinary Shares and/or Warrants less attractive because we may rely on either of these exemptions. If some investors find our Ordinary Shares and/or Warrants less attractive as a result, there may be a less active trading market for our Ordinary Shares and/or Warrants and our share price may be more volatile.

 

26

 

 

The market price of our Ordinary Shares and/or Warrants may be volatile. Market volatility may affect the value of an investment in our Ordinary Shares and/or Warrants and could subject us to litigation.

 

Technology shares have historically experienced high levels of volatility. There has been and could continue to be significant volatility in the market price and trading volume of equity securities. The market price of our Ordinary Shares and/or Warrants could be subject to wide fluctuations in response to many risk factors listed in this section, and others beyond our control, including:

 

  actual or anticipated fluctuations in our financial condition and operating results;

 

  the financial projections we may provide to the public, and any changes in projected operational and financial results;

 

  addition or loss of significant customers;

 

  changes in laws or regulations applicable to our products;

 

  actual or anticipated changes in our growth rate relative to our competitors;

 

  announcements of technological innovations or new offerings by us or our competitors;

 

  announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital-raising activities or commitments;

 

  additions or departures of key personnel;

 

  changes in our financial guidance or securities analysts’ estimates of our financial performance;

 

  discussion of us or our share price by the financial press and in online investor communities;

 

  reaction to our press releases and filings with the SEC;

 

  changes in accounting principles;

 

  lawsuits threatened or filed against us;

 

  fluctuations in operating performance and the valuation of companies perceived by investors to be comparable to us;

 

  sales of our Ordinary Shares by us or our shareholders;

 

  share price and volume fluctuations attributable to inconsistent trading volume levels of our Ordinary Shares;

 

  price and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole;

 

  changes in laws or regulations applicable to our business;

 

  changes in our capital structure, such as future issuances of debt or equity securities;

 

  short sales, hedging and other derivative transactions involving our shares;

 

  the expiration of contractual lock-up periods;

 

  other events or factors, including those resulting from war, incidents of terrorism or responses to these events; and

 

  general economic and market conditions.

 

27

 

 

Furthermore, in recent years, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies, and technology companies in particular. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions, interest rate changes or international currency fluctuations, may negatively impact the market price of our Ordinary Shares or Warrants.

 

In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could also harm our business.

 

Our investors’ ownership in the Company may be diluted in the future.

 

In the future, we may issue additional authorized but previously unissued equity securities, resulting in the dilution of ownership interests of our present shareholders. Furthermore, we may issue equity awards to management, employees and other eligible persons in the future under our 2022 Incentive Option Plan, or our 2022 Incentive Plan. Additional Ordinary Shares issued by us in the future will dilute an investor’s investment in the Company. In addition, we may seek shareholder approval to increase the amount of the Company’s authorized shares, which would create the potential for further dilution of current investors.

 

Our amended and restated articles of association provide that, unless we consent to an alternative forum, the federal district courts of the United States shall be the exclusive forum for resolution of any complaint asserting a cause of action arising under the Securities Act of 1933 as amended, or the Securities Act, which could limit our shareholders’ ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees. In addition, the agreements governing the Warrants provide that disputes shall be brought in the state and federal courts sitting in the City of New York, Borough of Manhattan, and that a claim under the U.S. federal securities laws may be made in any federal district court.

 

Section 22 of the Securities Act creates concurrent jurisdiction for U.S. federal and state courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our articles of association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act, and our shareholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provision. Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to the foregoing provision of our articles of association.

 

Similarly, the agreements governing the Warrants provide that, and by purchasing Warrants in our IPO, investors agreed that, all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York, irrevocably submit to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any such dispute and irrevocably waive, and agree not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The warrant agent agreement has similar provisions with respect to the Company and the warrant agent. The agreement governing the Warrants and the warrant agent agreement provide that the foregoing provisions do not limit or restrict the federal district court in which a party may bring a claim under the U.S. federal securities laws.

 

28

 

 

However, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities Act) in other companies’ organizational documents and similar agreements has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum provision in our articles of association or the agreements governing the Warrants. If a court were to find the exclusive forum provision contained in our articles of association or the agreements governing the Warrants to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results of operations.

 

Although we believe the exclusive forum provision benefit us by providing increased consistency in the application of U.S. federal securities laws, the Companies Law, or New York law, as applicable, in the types of lawsuits to which they apply, such exclusive forum provision may limit a shareholder’s ability to bring a claim in the judicial forum of their choosing for disputes with us or any of our directors, shareholders, officers, or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, shareholders, officers, or other employees.

 

If securities or industry analysts either do not publish research about us or publish inaccurate or unfavorable research about us, our business or our market, or if they change their recommendations regarding our Ordinary Shares or Warrants adversely, the trading price or trading volume of our Ordinary Shares could decline.

 

The trading market for our Ordinary Shares and Warrants will be influenced in part by the research and reports that securities or industry analysts may or may not publish about us, our business, our market or our competitors. If one or more of the analysts do not publish research about us or initiate research with an unfavorable rating or downgrade our Ordinary Shares, provide a more favorable recommendation about our competitors or publish inaccurate or unfavorable research about our business, the market prices of our Ordinary Shares would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the trading price or trading volume of our Ordinary Shares to decline.

 

FINRA sales practice requirements may limit a shareholder’s ability to buy and sell our Ordinary Shares.

 

The Financial Industry Regulatory Authority, Inc., or FINRA, has adopted rules requiring that, in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative or low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA has indicated its belief that there is a high probability that speculative or low-priced securities will not be suitable for at least some customers. If these FINRA requirements are applicable to us or our securities, they may make it more difficult for broker-dealers to recommend that at least some of their customers buy our Ordinary Shares, which may limit the ability of our shareholders to buy and sell our Ordinary Shares and could have an adverse effect on the market for and price of our Ordinary Shares.

 

29

 

 

We may become a “passive foreign investment company”, or PFIC, for U.S. federal income tax purposes in the current taxable year or may become one in any subsequent taxable year. There generally would be negative tax consequences for U.S. taxpayers that are holders of the Ordinary Shares if we are or were to become a PFIC.

 

Based on the projected composition of our income and valuation of our assets, we do not expect to be a PFIC for 2023, and we do not expect to become a PFIC in the future, although there can be no assurance in this regard. The determination of whether we are a PFIC is made on an annual basis and will depend on the composition of our income and assets from time to time. We will be treated as a PFIC for U.S. federal income tax purposes in any taxable year in which either (1) at least 75% of our gross income is “passive income” or (2) on average at least 50% of our assets by value produce passive income or are held for the production of passive income. Passive income for this purpose generally includes, among other things, certain dividends, interest, royalties, rents and gains from commodities and securities transactions and from the sale or exchange of property that gives rise to passive income. Passive income also includes amounts derived by reason of the temporary investment of funds, including those raised in a public offering. In determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account. The tests for determining PFIC status are applied annually, and it is difficult to make accurate projections of future income and assets which are relevant to this determination. In addition, our PFIC status may depend in part on the market value of the Ordinary Shares. Accordingly, there can be no assurance that we currently are not or will not become a PFIC in the future. If we are a PFIC in any taxable year during which a U.S. taxpayer holds the Ordinary Shares, such U.S. taxpayer would be subject to certain adverse U.S. federal income tax rules. In particular, if the U.S. taxpayer did not make an election to treat us as a “qualified electing fund”, or QEF, or make a “mark-to-market” election, then “excess distributions” to the U.S. taxpayer, and any gain realized on the sale or other disposition of the Ordinary Shares by the U.S. taxpayer: (1) would be allocated ratably over the U.S. taxpayer’s holding period for the Ordinary Shares; (2) the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition, if the U.S. Internal Revenue Service, or the IRS, determines that we are a PFIC for a year with respect to which we have determined that we were not a PFIC, it may be too late for a U.S. taxpayer to make a timely QEF or mark-to-market election. U.S. taxpayers that have held the Ordinary Shares during a period when we were a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC in subsequent years, subject to exceptions for U.S. taxpayer who made a timely QEF or mark-to-market election. A U.S. taxpayer can make a QEF election by completing the relevant portions of and filing IRS Form 8621 in accordance with the instructions thereto. We do not intend to notify U.S. taxpayers that hold the Ordinary Shares if we believe we will be treated as a PFIC for any taxable year in order to enable U.S. taxpayers to consider whether to make a QEF election. In addition, we do not intend to furnish such U.S. taxpayers annually with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year in which we or any of our subsidiaries are a PFIC. U.S. taxpayers that hold the Ordinary Shares are strongly urged to consult their tax advisors about the PFIC rules, including tax return filing requirements and the eligibility, manner, and consequences to them of making a QEF or mark-to-market election with respect to the Ordinary Shares in the event that we are a PFIC. See “Taxation — U.S. Federal Income Tax Considerations — Passive Foreign Investment Companies” for additional information.

 

As a public company in the United States, our management is required to devote substantial time to new compliance initiatives as well as compliance with ongoing U.S. requirements.

 

As a public company in the United States, we incur additional significant accounting, legal and other expenses that we did not incur before the offering. We also incurred costs associated with corporate governance requirements of the SEC, as well as requirements under Section 404 and other provisions of the Sarbanes-Oxley Act. These rules and regulations increased our legal and financial compliance costs, introduced new costs such as investor relations, stock exchange listing fees and shareholder reporting, and made some activities more time consuming and costly. The implementation and testing of such processes and systems required us to hire outside consultants and incur other significant costs. Any future changes in the laws and regulations affecting public companies in the United States, including Section 404 and other provisions of the Sarbanes-Oxley Act, and the rules and regulations adopted by the SEC, for so long as they apply to us, will result in increased costs to us as we respond to such changes. These laws, rules and regulations could make it more difficult or more costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees, or as executive officers.

 

We may be subject to securities litigation, which is expensive and could divert management attention.

 

In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management’s attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant liabilities.

 

30

 

 

General Risk Factors

 

If we engage in future acquisitions or strategic partnerships, this may increase our capital requirements, dilute our shareholders, cause us to incur debt or assume contingent liabilities, and subject us to other risks.

 

We have engaged in various acquisitions and may continue to evaluate various acquisition opportunities and strategic partnerships, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any potential acquisition or strategic partnership may entail numerous risks, including:

 

  increased operating expenses and cash requirements;

 

  the assumption of additional indebtedness or contingent liabilities;

 

  the issuance of our equity securities;

 

  assimilation of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new personnel;

 

  the diversion of our management’s attention from our existing product programs and initiatives in pursuing such a strategic merger or acquisition;

 

  retention of key employees, the loss of key personnel and uncertainties in our ability to maintain key business relationships;

 

  risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or product candidates and marketing approvals; and

 

  our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs.

 

We are subject to certain U.S. and foreign anticorruption, anti-money laundering, export control, sanctions and other trade laws and regulations. We can face serious consequences for violations.

 

Among other matters, U.S. and foreign anticorruption, anti-money laundering, export control, sanctions and other trade laws and regulations, which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, legal counsel, accountants, consultants, contractors and other partners from authorizing, promising, offering, providing, soliciting or receiving, directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities and other organizations. We also expect our non-U.S. activities to increase over time. We can be held liable for the corrupt or other illegal activities of our personnel, agents or partners, even if we do not explicitly authorize or have prior knowledge of such activities.

 

Our business and operations might be adversely affected by security breaches, including any cybersecurity incidents.

 

We depend on the efficient and uninterrupted operation of our computer and communications systems, and those of our consultants, contractors and vendors, which we use for, among other things, sensitive company data, including our intellectual property, financial data and other proprietary business information.

 

While certain of our operations have business continuity and disaster recovery plans and other security measures intended to prevent and minimize the impact of IT-related interruptions, our IT infrastructure and the IT infrastructure of our consultants, contractors and vendors are vulnerable to damage from cyberattacks, computer viruses, unauthorized access, electrical failures and natural disasters or other catastrophic events. We could experience failures in our information systems and computer servers, which could result in an interruption of our normal business operations and require substantial expenditure of financial and administrative resources to remedy. System failures, accidents or security breaches can cause interruptions in our operations. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur regulatory investigations and redresses.

 

31

 

 

Even though we believe we carry commercially reasonable business interruption and liability insurance, we might suffer losses as a result of business interruptions that exceed the coverage available under our insurance policies or for which we do not have coverage. For example, we are not insured against terrorist attacks or cyberattacks. Any natural disaster or catastrophic event could have a significant negative impact on our operations and financial results.

 

Sales of a significant number of our Ordinary Shares in the public markets or significant short sales of our Ordinary Shares, or the perception that such sales could occur, could depress the market price of our Ordinary Shares and impair our ability to raise capital.

 

Sales of a substantial number of our Ordinary Shares or other equity-related securities in the public markets, could depress the market price of our Ordinary Shares. If there are significant short sales of our Ordinary Shares, the price decline that could result from this activity may cause the share price to decline more so, which, in turn, may cause long holders of the Ordinary Shares to sell their shares, thereby contributing to sales of Ordinary Shares in the market. Such sales also may impair our ability to raise capital through the sale of additional equity securities in the future at a time and price that our management deems acceptable, if at all.

 

ITEM 4. INFORMATION ON THE COMPANY  

 

A. History and Development of the Company

 

Jeffs’ Brands was incorporated in March 2021 under the Companies Law in the State of Israel.

 

In December 2017, Smart Repair Pro, a California corporation, was founded by our Chief Executive Officer, Viki Hakmon, and began operating in June 2019. Following its acquisition of the KnifePlanet brand, Smart Repair Pro began selling the KnifePlanet brand on Amazon, using the FBA model. In August 2019, Smart Repair Pro acquired the CC-Exquisite store, which owns the DARTS® brand.

 

In April 2020, Purex Corp, or Purex was incorporated in California for the purpose of purchasing an online store. At that time, Purex was 100% owned by affiliates of Mr. Hakmon. Purex was voluntarily dissolved on July 13, 2023.

 

In October 2020, Medigus, a publicly traded company (Nasdaq: MDGS) incorporated under the laws of the State of Israel, entered into a share purchase agreement to acquire 50.01% of Smart Repair Pro and 50.03% of Purex. This acquisition closed on January 4, 2021.

 

In April 2021, Top Rank, an Israeli company, was formed as a wholly owned subsidiary of Jeffs’ Brands. On May 10, 2021, pursuant to the Stock Exchange and Plan of Restructuring Agreement, or the SEA, entered into by and between the Company, Medigus and Mr. Hakmon, Purex and Smart Repair Pro became wholly-owned subsidiaries of Jeffs’ Brands. Pursuant to the SEA, Medigus and Mr. Hakmon, as shareholders of Smart Repair Pro and Purex, contributed all of the equity interests they owned in Smart Repair Pro and Purex to Jeffs’ Brands in exchange for Ordinary Shares of the Company, or the Contribution Transactions. Following the closing of the Contribution Transactions pursuant to the SEA, Jeffs’ Brands held all of the outstanding shares of Smart Repair Pro and Purex, Medigus held 50.03% of our outstanding Ordinary Shares and Mr. Hakmon, our Chief Executive Officer, held the remaining 49.97% of our outstanding Ordinary Shares. Mr. Hakmon’s affiliates, who were minority shareholders of Smart Repair Pro and Purex, transferred all their holdings in Smart Repair Pro and Purex to Mr. Hakmon, effective immediately prior to the Contribution Transactions pursuant to a Share Transfer Deed dated May 10, 2021.

 

32

 

 

The result of the Contribution Transactions is reflected in the following diagram:

 

 

Our principal executive offices are located at 7 Mezada Street, Bnei Brak, Israel 5126112. Our telephone number in Israel is +972-3-7713520. Our website address is www.jeffsbrands.com. The information contained on our website or available through our website is not incorporated by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website in this Annual Report on Form 20-F is an inactive textual reference only.

 

Puglisi & Associates is our agent in the United States and its address is 850 Library Avenue, Suite 204, Newark, Delaware 19711. The SEC maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through the SEC’s website at www.sec.gov.

 

We completed the initial public offering of our Ordinary Shares and Warrants in the United States in August 2022 and our Ordinary Shares and Warrants began trading on the Nasdaq Capital Market on August 26, 2022, under the symbols “JFBR” and “JFBRW,” respectively.

 

For a description of our principal capital expenditures and divestitures, see Item 5. “Operating and Financial Review and Prospects.”

 

B. Business Overview

 

We are an e-commerce CPG company, operating primarily on Amazon. We were incorporated in Israel in March 2021, under the name Jeffs’ Brands Ltd, to provide a variety of professional and business support as well as marketing support services to Smart Repair Pro that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. Under the FBA model, sellers’ products are stored in Amazon fulfillment centers in order to take advantage of Amazon’s fulfillment infrastructure and allow their products to be eligible for Amazon promotional activities, including free shipping to Prime subscribers. These products are subject to the same inventory control, fulfillment and shipping processes as Amazon owned products; and for multiple item shipments are included in the same box as Amazon owned inventory. As of the date on this Annual Report on Form 20-F, we have five wholly-owned subsidiaries: Smart Repair Pro, Top Rank, Fort, Jeffs’ Brands Holdings, and Fort Products LLC.

 

In addition to executing the FBA business model, we utilize internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products. We also use our own skills, know-how and profound familiarity with Amazon algorithm and all the tools that the FBA platform FBA has to offer. In some circumstances we scale the products and improve them.

 

Our Stores, Brands and Products

 

As of the date of this Annual Report on Form 20-F:

 

  Smart Repair Pro owns and operates three stores on Amazon (i) KnifePlanet with 3 different Brands: KnifePlanet, CC-Exquisite and PetEvo brands, (ii) the Whoobli brand, and (iii) Wingman, which has the Wellted brand. Under the KnifePlanet brand, we offer a complete premium stone knife-sharpening sets, sharpeners and nonslip rubber bases. Under the CC-Exquisite brand, we offer professional steel & soft-tip dart sets and darts holders. Under the PetEvo brand, we offer car door & car seats protectors for pets. Under the Whoobli brand, we offer punching bag sets and party supply kits for children. Under the Wellted brand, we offer reusable, self-cleansing pet hair removers for cats and dogs.

 

33

 

 

  Fort owns and operates the Fort brand which sells pest control products primarily through Amazon UK.

 

  Jeffs’ Brands Holdings, owns a minority interest in SciSparc U.S., a majority-owned subsidiary of SciSparc Ltd., or SciSparc, that owns and operates Wellution, an Amazon food supplements and cosmetics brand.

 

As of the date of this Annual Report on Form 20-F, our material stores on the Amazon platform, brands and products consist of the following:

 

Whoobli Store

 

Our revenues from sales on the Whoobli store for the year ended December 31, 2023 were approximately $1,913 thousand, or 19.12%, of our total revenues for such period.

 

The Whoobli store sells a variety of punching bag sets, including: Whoobli Adjustable Kids Punching Bag with Stand; Whoobli Ninja Inflatable Kids Punching Bag; Whoobli Unicorn Birthday Party Supplies; Whoobli Mermaid Party Supplies; Whoobli Dinosaur Party Supplies; and the Whoobli Construction Birthday Party Supplies.

 

KnifePlanet Store

 

Our revenues from sales on the KnifePlanet store for the year ended December 31, 2023 were approximately $2,424, or 24.22 %, of our total revenues for such period.

 

The KnifePlanet store sells, among others, the following products: CC-Exquisite Professional Steel Tip Darts Set; Premium Knife Sharpening Stone Set; Coarse Flattening Stone; Whetstone Knife Sharpening Stone Set; Leather Strop and Stropping Compound Set; Whetstone Knife Sharpening Stone Set; Honing Guide and Angle Tool Set; CC-Exquisite Professional Steel Tip Darts Set; CC-Exquisite Dart Caddy; Car Door Protector and the Whetstone Knife Sharpening Stone Set.

 

Wellted Store

 

Our revenues from sales on the Wellted store for the year ended December 31, 2023, were approximately $132 thousand, or 1.32%, of our total revenues for such period.

 

The Wellted store sells a pet hair removal product.

 

Fort Store

 

Our revenues from sales on the Fort store for the year ended December 31, 2023, were approximately $5,539 thousand, or 55.35%, of our total revenues for such period.

 

The Fort store sells a variety of pest control products, including, among others: rat and mouse poison, rat traps, and tamper proof rodent bait boxs.

 

Wellution Store

 

Our proportional share of the revenues from sales on the Wellution store for the year ended December 31, 2023, was approximately $2,137. We do not consolidate the financial results of SciSparc U.S or the sales of the Wellution products in our consolidated financial statements.

 

34

 

 

Our Customers

 

Our customers are primarily individual online consumers who purchase our products primarily on the Amazon U.S. and Amazon EU marketplaces, which contributed to our increase in sales year over year.

 

In each of 2023 and 2022, approximately 96% to 99% of our revenue was through or with Amazon sales platform.

 

Like any other e-commerce business, we are affected by the high season shopping, which is from October through December. Our business model is to take into consideration this sales cycle and introduce new products right before high season.

 

Our Competitive Strengths

 

We believe that our competitive strengths include:

 

  Senior and experienced management team;

 

  Sophisticated know-how regarding use of data analysis technology platforms;

 

  Strong logistical capabilities, using sophisticated BI tools to optimize the supply chain management;

 

  Strong proactive approach in purchasing new brands and active stores with low performance and high potential growth; and

 

  Procurement of well targeted products.

 

We believe that these strengths, as further described below, differentiate us from our competitors and provide us with numerous advantages:

 

  Senior and experienced management team: We are led by Mr. Viki Hakmon, our Chief Executive Officer. Mr. Hakmon has vast experience in the retail markets, having served in various capacities over the past 25 years, 15 of which were in U.S. markets. Mr. Hakmon also has a profound understanding and knowledge of developing and discovering products and leveraging their growing market demand.

 

Mr. Naor Bergman, our Chief Operating Officer, is responsible for all the operations and logistics of our business. Prior to joining the Company, Mr. Bergman established and led Amazon’s FBA logistics and warehousing department at Unicargo Global Logistic Ltd. and was part of the management team that transformed Unicargo to become a leader in the field of outsourcing Amazon’s FBA warehousing.

 

In October 2022, we hired Mr. Ronen Zalayet as our Chief Financial Officer effective October 24, 2022. Mr. Zalayet has over 20 years of experience working in financial leadership positions in private and public companies, including in growing fintech and technology companies. Mr. Zalayet holds a B.A. in Economics and Accounting and an MBA from Tel Aviv University, Israel, and is a certified public accountant in Israel.

 

  Sophisticated know-how of data analysis technology platforms: We believe our use of research data and deep analysis software tools enables us to successfully identify new product opportunities, execute a fast and efficient procurement process and offer and sell our goods at a competitive yet lucrative price. Our deep knowledge of analyzing Amazon is one of our company’s key competitive advantages in the fast-changing online CPG market. We are able to identify product opportunities, including relevant product specifications, based on consumer preferences, product trends and attributes and competitive landscape analysis. We also have profound familiarity with Amazon’s algorithm and all the tools that its FBA platform has to offer.

 

  Strong logistical capabilities, using sophisticated BI tools to optimize the supply chain management: Our logistical capabilities were formulated prior to the establishment of our Company. We view the logistical aspect of our business as a main and important factor to our success and we work hard to achieve it. Every product opportunity that we encounter is handled with strong and efficient logistical tools and no opportunity will be neglected due to lack of logistical capabilities or low profitability.

 

35

 

 

  Strong proactive approach in purchasing new brands and active stores with law performance and high potential growth: Our goal-oriented team consists of people with a combined business experience and Amazon’s knowledge, along with a competitive culture and attitude, which allow us to identify low performance brands with high growth potential. We believe in our improvement capabilities to increase brands sales and profitability.

 

  Procurement of well targeted products reduces risk and costs: We believe our approach of identifying products, procuring and handling all logistics fast and efficiently and selling products when they are most desirable reduces risks of not reaching sales targets and also reduces the cost of brand development and the process of introducing a new product to the market. We believe a company like ours should only move forward with products following thorough market research and analysis. We do not proceed before that, hence, we believe allowing us to sell products that the market is already looking for.

 

   
Searching and Identifying +   Purchasing +   Selling and Shipping

 

Industry Overview and Market Opportunity

 

The e-commerce market is expected to continue growing. According to analysis published by Statista, the e-commerce market is estimated to reach $3.2 trillion in 2024. Revenues are expected to show an annual growth rate (CAGR 2024-2029) of 9.47%, resulting in a projected market volume of US$4,997.00bn by 2029. According to this source, in the eCommerce Market, the number of users is expected to amount to 3.2 billion users by 2029. User penetration will be 36.6% in 2024 and is expected to hit 44.4% by 2029 and the average revenue per user (ARPU) is expected to amount to US$1,387.

 

According to IMARC research report, the market is primarily driven by the rising internet penetration. Additionally, the adoption of smartphones and the Internet made it suitable for consumers to shop online, thus influencing the market growth. Moreover, mobile applications and user-friendly websites made the shopping experience seamless and accessible, allowing customers to browse, compare prices, and easily make purchases, thus representing another major growth-inducing factor.

 

Also, besides all of the above, the recent onset of the coronavirus disease (COVID-19) pandemic accelerated the shift toward online shopping, accelerating the sales demand 

 

We believe, this new normal created a huge opportunity for e-commerce players, such as Jeffs’ Brands, which has the capability to respond to the current demand and market trends.

 

Moreover, Amazon, which is the primary platform that our business is based on, continues to rise and grow. In 2023, Amazon’s global sales were $574.8 billion, a 11.83% increase year- over year. Amazon’s sales, however, are not necessarily indicative of our current or future sales, as Amazon sells vast and varied quantities of products on its platforms, whereas we sell only a limited quantity of products on Amazon and are not otherwise affiliated with Amazon. While our sales represent a small fraction of the sales on Amazon, we believe that Amazon provides us with a unique opportunity to grow our sales.

 

36

 

 

Annual Net Sales Revenues of Amazon from 2004 to 2023 (in billion U.S. dollars)

 

 

Source: Statista — Annual net sales revenues of Amazon from 2004 to 2023

 

Note that Amazon’s net sales presented in this chart are not necessarily indicative of our current or future sales.

 

37

 

 

We believe that doing business in the online consumer product market requires a profound understating of material trends and factors impacting the market and this can only be done by analyzing massive amounts of data. Adopting new business models that are using high-end technologies for data analysis is considered by us as the only competitive way to succeed in this market. We see our data driven approach combined with our other capabilities and advantages as our strengths in succeeding in this market.

 

Moreover, we are constantly rethinking our efficiency, logistics and fulfillment networks including investments in warehouses and delivery infrastructure.

 

Amazon’s algorithm is a crucial factor in the success of CPG companies, and we believe we have a profound understating of it

 

According to BCG, top-selling brands on Amazon, often differ significantly from top sellers in brick-and-mortar stores. We believe this highlights how distinct Amazon’s market is and how critical it is for CPG companies to understand how Amazon algorithms drive traffic.

 

We believe our way of analyzing and understanding the consumer trends, searches and preferences enable us to react in the most optimum way. We ensure the availability of the most desired products on the market and we leverage it from buying to selling the product. We are able to do that by analyzing the data and to react to the insights we generate of it in the fastest way possible to us.

 

Our unique process

 

We believe in a 3-phase process of our business lifecycle:

 

Phase I: Search and Identification

 

  Our sophisticated, know-how use of an advanced software, enables us to search and identify high value products. This analysis includes product history, client trends, etc.

Phase II: Acquisition of identified products

 

  We then quickly and efficiently acquire identified products using our strong logistical capacities.

Phase III: Sell and Ship

 

  We then sell the most desired products to our consumers, maximizing our positioning for high profitability (with minimal marketing required, offering the optimum price being both lucrative and competitive).

 

Below are recent examples of products that were identified by our process and offered to consumers, which contributed to our increase in sales year over year:

 

Product Name and Description   Illustration
The Whoobli Store offers the Whoobli punching bag, adjustable stand and boxing gloves for children aged 3-8 years old.  

 

38

 

 

The KnifePlanet Store offers a complete premium stone knife-sharpening set, which includes flattening stone, bamboo base, and two nonslip rubber bases.  
     
The Wellted Store offers the Pet Hair Remover for cats and dogs. It’s reusable, self-cleansing and includes a brush for cleaning furniture, carpets, clothing, car seats, etc.  
     
The CC-Exquisite Store offers CC-exquisite professional steel-tip darts sets.  
     
The PetEvo Store offers car door protectors in sets of two that fit any vehicle and protects from pet scratches and is also waterproof.  

 

Strategy

 

Growth Strategy

 

The key elements of our growth strategy include:

 

  High-end search and identification of high value products and their markets;

 

  Frequent introduction of new products to our customers in various geographical markets;

 

  Effective use of our competitive advantage — our know-how uses of software-based technology;

 

  Leverage of our logistical capabilities and knowledge to reduce costs and increase purchasing power; and

 

  Continued monetarization of our competitors to ensure we maintain our competitive differentiation and advantages.

 

39

 

 

Acquisition Strategy

 

Our growth, as described above, will be generated mainly by our strategic acquisition of high demand products. We also intend to supplement our acquisitions by growing our logistical capabilities, which we believe will bolster our competitive advantage. In 2023, we completed the acquisition of two Amazon marketplace brands. In March 2023, we completed the acquisition of Fort, a company that sells pest control products, and in March 2023, we completed as well the acquisition of approximately 49% of the issued and outstanding shares of common stock of SciSparc Nutraceuticals Inc, or SciSparc U.S., a company that operates and owns the Wellution brand.

 

We intend to execute our acquisitions when all the relevant factors and criteria fit our goals and business aspirations. We will target businesses that have built a market share. We will aim for products with strong unit economics and high product quality. These products will also have to achieve significant positive customer reviews and high search ranking for relevant key words and are in product categories where frequent product improvement is not required.

 

We believe that acquisitions fitting the above criteria will contribute to our revenue growth and operational efficiency, while reducing the risk involved in executing our process.

 

Intellectual Property

 

As of March 28, 2024, we owned 13 trademarks: KnifePlanet, CC-Exquisite, Whoobli, PetEvo, Wellted, Roshield, Entopest, Rempro, Birdgo, ProPest, Topperama and Seaheaven.

 

Competition

 

The consumer goods and e-commerce market are a highly competitive environment. Our competitive landscape consists of various types of companies such as: traditional and non-traditional consumer good companies; discount stores; traditional retailers; independent retail stores; the online platforms of these traditional retail competitors; and e-commerce companies.

 

Among CPG companies, our competitors include: Thrasio Holdings, Inc.; Aterian, Inc. (Nasdaq: ATER); Amazon; Helen of Troy Ltd., Newell Brands (Nasdaq: NWL); Frigidaire Appliance Company; and Trademark Global Inc. Despite the seemingly harsh competitive landscape, we believe that our technology and experience enable us to successfully compete and achieve our financial goals.

 

Category   Companies
Main competition   Thrasio Holdings, Inc., Aterian, Inc. (Nasdaq: ATER)
     
Other CPG competitors   Helen of Troy Ltd., Newell Brands (Nasdaq: NWL), Frigidaire Appliance Company, Trademark Global Inc., and other CPG players who are operating on Amazon

 

We believe that our competitive advantages include:

 

  Senior and experienced management team;

 

  Strong logistical capabilities;

 

  Skillful use of sophisticated data analytics software;

 

  Fast and proactive approach to changes in the market; and

 

  Well targeted products which we believe reduces risk and costs.

 

40

 

 

Development

 

After executing our procurement process and owning new products and brands, we then invest in additional development of the procured products. Our development is focused on upgrading the existing products and/or adding additional value and features to them, such as additional colors or shapes, new design or version. Our developments remain within the product history ranking and overviews on Amazon, hence, the upgraded products are being promoted under the same brand and its positioning on Amazon.

 

An example of such product development are the new parts added to our KnifePlanet product:

 

 

Third-Party Manufacturing and Logistics

 

Our products are currently produced by third party manufacturers in China and the United Kingdom pursuant to manufacturing agreements. These agreements generally provide that the manufacturers will manufacture and deliver to us the relevant products in accordance with our orders and subject to our timely payment. The manufacturing services under such contracts are on a non-exclusive basis, provided, however, that the manufacturers are not allowed to manufacture or supply the manufactured product to any third party. The products manufactured thereby are subject to our successful completion of testing and assembly checks before shipment. We may terminate these contracts at any time with an advance notice. We have strong and long-term relationships with these manufacturers and we believe we have a safe and stable supply chain.

 

As of the date of this Annual Report on Form 20-F, we use third party warehouses to fulfill direct-to-consumer orders, through agreements or terms of services.

 

As of the date of this Annual Report on Form 20-F, we have warehousing and distribution agreements with three warehouses in the United States, one in Canada, one in the United Kingdom and one in Germany, which generally provide that the service provider will provide warehousing services at its warehousing facility and distribution services for our products. Through these third parties, we believe we can deliver products within two days of the order being placed on Amazon through ground shipment across approximately 95% of the U.S. market.

 

41

 

 

Marketing, Distribution Methods and Sales

 

We believe our marketing expenses are lower and more efficient than our competitors since we are only engaged with well established brands that are already familiar to many of our customers and potential customers on Amazon. In addition, we expect to hire managers to handle our digital marketing and advertising efforts.

 

With respect to distribution, we see logistics as a main and important consideration and we prioritize creating an effective and efficient distribution channel. Every product opportunity that we encounter will be handled with strong and efficient logistical tools and no opportunity will be left out due to lack of logistical capabilities or low profitability. Furthermore, we plan to own warehouses in the future in lieu of relying on Amazon or other third-party warehouses, which would improve our distribution channel.

 

Our sales phase, as further described above, is the third phase after a deep analysis is conducted by our software, identification and procurement process. Using the most advanced software, provides us with all the data needed to launch and to operate our Amazon brands in the highest levels. We believe that this knowledge will bring significant competitive advantages for our products. Our spending and approach on advertising is aimed to be as low as possible given the resources we spent prior to the actual sale on selecting the different products depending on the life cycle of products on our platform.

 

Government Regulation and Product Approval

 

We do not anticipate any significant problems in obtaining future required licenses, permits or approvals that are necessary to expand our business.

 

We are subject to a variety of U.S. federal, state and local laws, as well as international laws.

 

These laws are defining and governing the legal ways to process payments, consumer protection, the privacy of consumer information and other laws regarding unfair and deceptive trade practices.

 

The products sold by us in the U.S. are also subject to regulation in the United States by governmental agencies, including the U.S. Consumer Product Safety Commission, the Federal Trade Commission, United States Food and Drug Administration, and similar state and international regulatory authorities. We do not engage in the sale of illegal, unsafe, or other high-risk products that are restricted or strictly prohibited.

 

As necessary, our carriers impose additional restrictions on dangerous products. Our carriers require compliance with international air regulations, such as the International Air Transport Association (IATA) Dangerous Goods Regulations.

 

We are also subject to environmental laws, rules and regulations, including but not limited to California’s Proposition 65, Management of Hazardous Wastes Removed from Discarded Appliances and Lead Poisoning Prevention Act. We are subject to state and municipality regulations on plastic bag warning labels. Statements we make on labels, packages and advertisements are truthful, not deceptive or unfair, and evidence-based.

 

As required by applicable law, we list and register our products with the appropriate governmental authorities and obtain necessary authorizations and approvals therefrom. We require that our foreign and domestic facilities engaged in manufacturing, processing, packing, or warehousing submit additional registration information, such as good manufacturing practice (GMP) and other related quality management requirements. We request certificates and clearances as proof of compliance with the existing laws and regulations. We also declare, certify and conduct testing in reputable or accredited testing laboratories. For some products, we set out written warranties in compliance with the mandatory requirements of the Magnuson-Moss Warranty Act.

 

42

 

 

Some chemicals pose perceived or real risks to the environment and human health. We require our products that contain chemicals regulated by the EPA to comply with certification reporting and other requirements of imposed by the EPA. Products with emission standards for formaldehyde from wood products are compliant with EPA and California Air Resources Board (CARB).

 

Moreover, on March 2021, we received an update from Amazon regarding a new EPA regulation. Following the new EPA regulation, Amazon categorized one of our products as a pesticide product. Amazon requires that pesticide products be filed with evidence of an EPA registration number and/or EPA establishment number or certification that the product is exempt from EPA regulation, otherwise the existing listing (of the product) may be subject to removal. The revenue from the sale of these products is immaterial to the Company and the Company does not currently expect to continue to sell such products on Amazon unless they can be sold absent these restrictions and will instead look to sell such products outside of Amazon.

 

We do not estimate any significant capital expenditures for environmental control matters either in the current fiscal year or in the near future.

 

We are also subject to regulations relating to our supply chain. For example, the California Transparency in Supply Chains Act requires retail sellers that do business in California to disclose their efforts to eradicate slavery and human trafficking in their supply chains. As part of our vendor qualification process, we review supplier’s operations with respect to compliance with applicable labor and workplace standards and other applicable laws, including laws prohibiting child labor, forced labor and unsafe working conditions.

 

Although we have not suffered any material restriction from doing business in the past due to government regulation, legal issues with potential implications may arise in the future as we expand our business.

 

From time to time, we dispose of obsolete inventory, which is disposed of or destroyed in compliance with applicable laws and regulations, such as extended producer responsibility (EPR) or product stewardship legislation.

 

China Government Regulation

 

Regulations Relating to Environmental Protection

 

China has adopted extensive environmental laws and regulations with national and local standards for emissions control, discharge of wastewater and storage and transportation, treatment and disposal of waste materials. At the national level, the relevant environmental protection laws and regulations include the Chinese Environmental Protection Law, the Chinese Law on the Prevention and Control of Air Pollution, the Chinese Law on the Prevention and Control of Water Pollution, the Chinese Law on the Promotion of Clean Production, the Chinese Law on the Prevention and Control of Noise Pollution, the Chinese Law on the Prevention and Control of Solid Waste Pollution, the Chinese Recycling Economy Promotion Law, the Chinese Law on Environmental Impact Assessment, the Administrative Regulations on the Levy and Use of Discharge Fees and the Measures for the Administration of the Charging Rates for Pollutant Discharge Fees. In recent years, the Chinese Government has introduced a series of new policies designed to generally promote the protection of the environment. For instance, on November 10, 2016, the General Office of the State Council has released the Implementing Plan for the Permit System for Controlling the Discharge of Pollutants, or the Plan. The Plan proposes the need of instituting a system for enterprises and public institutions to control their respective total amount of pollutants discharged, which shall be connected with the environmental impact assessment system organically. The Plan also stipulates that it is necessary to regulate the orderly issuance of pollutant discharge permits, to make a name list to manage the permission of pollutant discharge, to promote the administration of such permission system per industry and to impose severer administration and control over enterprises and public institutions located at such places where environment quality fails to reach relevant standards. Furthermore, the Plan requires that a national pollutant discharge permit management information platform shall be established by 2017 to strengthen the information disclosure and social supervision.

 

43

 

 

Regulations Relating to Intellectual Property Rights

 

Patents

 

Pursuant to the Patent Law of China and its implementation rules, patents in China fall into three categories, namely invention patent, utility model and design patent. Invention patent refers to a new technical solution proposed in respect of a product, method or its improvement; utility model refers to a new technical solution that is practicable for application and proposed in respect of the shape, structure or a combination of both of a product; and design patent refers to the new design of a certain product in shape, pattern or a combination of both and in color, shape and pattern combinations aesthetically suitable for industrial application. Under the Patent Law of China, the term of patent protection starts from the date the patent was filed. Patents relating to inventions are effective for twenty years from the initial date the patent application was filed, and the term for utility model and designed patents is ten years from the initial date the patent application was filed. The Patent Law of China adopts the principle of “first to file,” which means where more than one person files a patent application for the same invention, a patent will be granted to the person who first filed the application.

 

Existing patents can become invalid or unenforceable due to a number of factors, including known or unknown prior art, deficiencies in patent application and lack of novelty in technology. In China, a patent must have novelty, innovation and practical application. Under the Patent Law of China, novelty means that before a patent application is filed, no identical invention or utility model has been publicly disclosed in any publication in China or abroad or has been publicly used or made known to the public by any other means, whether in or outside of China, nor has any other person filed with the patent authority an application that describes an identical invention or utility model and is published after the filing date. Patents in China are filed with the State Intellectual Property Office, or SIPO. Normally, the SIPO publishes an application for a pharmaceutical invention 18 months after the application is filed, which may be shortened upon request by the applicant. The applicant must apply to the SIPO for a substantive examination within three years from the date the application is filed.

 

Article 20 of the Patent Law of China provides that, for an invention or utility model completed in China, any applicant (not just Chinese companies and individuals), before filing a patent application outside of China, must first submit it to the SIPO for a confidential examination. Failure to comply with this requirement will result in the denial of any Chinese patent for the subject invention. This added requirement of confidential examination by the SIPO has raised concerns by foreign companies who conduct research and development activities in China or outsource research and development activities to service providers in China.

 

Patent Enforcement

 

Unauthorized use of patents without consent from owners of patents, forgery of the patents belonging to other persons, or engagement in other infringement acts against patent rights, will subject the infringers to tortious liabilities. Serious offences may be subject to criminal penalties.

 

When a dispute arises as a result of infringement of the patent owner’s patent right, Chinese law requires that the parties first attempt to settle the dispute through consultation between them. However, if the dispute cannot be settled through consultation, the patent owner, or an interested party who believes the patent is being infringed, may either file a civil legal suit or file an administrative complaint with the relevant patent administration authority under the SIPO. A Chinese court may issue a preliminary injunction upon the patent owner’s or an interested party’s request before instituting any legal proceedings or during the proceedings. Damages for infringement are calculated as either the loss suffered by the patent holder arising from the infringement or the benefit gained by the infringer from the infringement. If it is difficult to ascertain damages in this manner, damages may be determined by using a reasonable multiple of the license fee under a contractual license. As in other jurisdictions, with one notable exception, the patent owner in China has the burden of proving that the patent is being infringed. However, if the owner of a manufacturing process patent alleges infringement of its patent, the alleged infringer has the burden of proving that it has not infringed. To our knowledge, there are no disputes as to our infringement of any third party’s patent.

 

Trade Secrets

 

According to the Anti-Unfair Competition Law of China, the term “trade secrets” refers to technical information and business information that is unknown to the public, that has utility and may create business interest or profit for its legal owners or holders, and that is maintained as a secret by its legal owners or holders.

 

44

 

 

Under this law, business persons are prohibited from employing the following methods to infringe trade secrets: (1) obtaining the trade secrets from the legal owners or holders by any unfair methods such as stealing, solicitation or coercion; (2) disclosing, using or permitting others to use the trade secrets obtained illegally under item (1) above; or (3) disclosing, using or permitting others to use the trade secrets, in violation of any contractual agreements or any requirements of the legal owners or holders to keep such trade secrets in confidence. If a third party knows or should have known of the above-mentioned illegal conduct but nevertheless obtains, uses or discloses trade secrets of others, the third party may be deemed to have committed a misappropriation of the others’ trade secrets. The parties whose trade secrets are being misappropriated may petition for administrative corrections, and regulatory authorities may stop any illegal activities and fine infringing parties in the amount of RMB 10,000 — 200,000. Alternatively, persons whose trade secrets are being misappropriated may file lawsuits in a Chinese court for loss and damages caused by the misappropriation.

 

The measures to protect trade secrets include oral or written agreements or other reasonable measures to require the employees of, or persons in business contact with, legal owners or holders to keep trade secrets confidential. Once the legal owners or holders have asked others to keep trade secrets confidential and have adopted reasonable protection measures, the requested persons bear the responsibility for keeping the trade secrets confidential.

 

Recently Issued Policies on the Protection of Intellectual Property Rights

 

On November 4, 2016, the Central Committee of the Communist Party of China and the State Council jointly issued a Guideline on Improving the Property Rights Protection System and Providing Law-based Protection to Property Rights, or the Guideline, effective on the date of its release. The Guideline proposes that the country will provide equal, comprehensive and law-based protection to all kinds of property rights and requires that the punishment of intellectual property rights violations should be strengthened and the limits on compensation for violating intellectual property rights laws should be increased. In addition, the Guideline proposes to explore the establishment of infringement punitive compensation system for such intellectual property rights as patent and copyright, including allowing for punitive damages for serious malicious tort. The Guideline also stipulates to perfect the foreign-related intellectual property rights enforcement mechanism, and strengthen the international cooperation in criminal case enforcement and investigation in foreign-related intellectual property crimes. On November 28, 2016, the Supreme People’s Court released the Implementation Opinions on Appropriately and Lawfully Handling Long-standing Historical Property Rights Cases and the Opinions on Giving Full Play to Judicial Functions to Enhance Judicial Protection of Property Rights, or the Opinions, effective on the date of their releases. The Opinions stipulate that, among others, efforts shall be made to crack down on intellectual property rights infringement and crimes in accordance with relevant laws and regulations, provide stronger judicial protection to intellectual property rights, introduce judicial interpretations and guiding cases in due time, promote the lawful application of the punitive compensation system, and impose severer punishments on chain-type and industrialized crimes against intellectual property rights.

 

Foreign Exchange Regulation

 

The Foreign Exchange Administration Regulations, most recently amended in August 2008, are the principal regulations governing foreign currency exchange in China. Under the Chinese foreign exchange regulations, payments of current account items, such as profit distributions and trade and service-related foreign exchange transactions, may be made in foreign currencies without prior approval from the State Administration of Foreign Exchange, or SAFE, by complying with certain procedural requirements. In contrast, approval from or registration with appropriate government authorities is required when Chinese Renminbi, or RMB, is converted into a foreign currency and remitted out of China to pay capital expenses such as the repayment of foreign currency-denominated loans.

 

In November 2012, SAFE promulgated the Circular of Further Improving and Adjusting Foreign Exchange Administration Policies on Foreign Direct Investment, which substantially amends and simplifies the foreign exchange procedure. Pursuant to this circular, the opening of various special purpose foreign exchange accounts, such as pre-establishment expenses accounts, foreign exchange capital accounts and guarantee accounts, the reinvestment of RMB proceeds by foreign investors in China, and remittance of foreign exchange profits and dividends by a foreign-invested enterprise to its foreign shareholders no longer require the approval or verification of SAFE, and multiple capital accounts for the same entity may be opened in different provinces, which was not previously possible. In addition, SAFE promulgated the Circular on Printing and Distributing the Provisions on Foreign Exchange Administration over Domestic Direct Investment by Foreign Investors and the Supporting Documents in May 2013, which specifies that the administration by the SAFE or its local branches over direct investment by foreign investors in China will be conducted by way of registration, and banks must process foreign exchange business relating to the direct investment in China based on the registration information provided by SAFE and its branches.

 

45

 

 

Under the Circular of the SAFE on Further Improving and Adjusting the Policies for Foreign Exchange Administration under Capital Accounts promulgated by the SAFE on January 10, 2014, and effective from February 10, 2014, administration over the outflow of the profits by domestic institutions has been further simplified. In principle, a bank is no longer required to examine transaction documents when handling the outflow of profits of no more than the equivalent of $50,000 by a domestic institution. When handling the outflow of profits exceeding the equivalent of $50,000, the bank, in principle, is no longer required to examine the financial audit report and capital verification report of the domestic institution, provided that it must examine, according to the principle of transaction authenticity, the profit distribution resolution of the board of directors (or the profit distribution resolution of the partners) relating to this profit outflow and the original copy of its tax record-filing form. After each profit outflow, the bank must affix its seal to and endorsements on the original copy of the relevant tax record-filing form to indicate the actual amount of the profit outflow and the date of the outflow.

 

On March 30, 2015, SAFE promulgated the Circular on Reforming the Management Approach regarding the Settlement of Foreign Exchange Capital of Foreign-invested Enterprises, or SAFE Circular 19, which became effective on June 1, 2015. According to SAFE Circular 19, the foreign exchange capital of foreign-invested enterprises may be settled on a discretionary basis, meaning that the foreign exchange capital in the capital account of a foreign-invested enterprise for which the rights and interests of monetary contribution has been confirmed by the local foreign exchange bureau (or the book-entry registration of monetary contribution by the banks) can be settled at the banks based on the actual operational needs of the foreign-invested enterprise. The proportion of such discretionary settlement is temporarily determined as 100%. The RMB converted from the foreign exchange capital will be kept in a designated account, and if a foreign-invested enterprise needs to make further payment from such account, it still must provide supporting documents and go through the review process with the banks.

 

Furthermore, SAFE Circular 19 stipulates that the use of capital by foreign-invested enterprises must adhere to the principles of authenticity and self-use within the business scope of enterprises. The capital of a foreign-invested enterprise and capital in RMB obtained by the foreign-invested enterprise from foreign exchange settlement must not be used for the following purposes:

 

  (1) directly or indirectly used for the payment beyond the business scope of the enterprises or the payment prohibited by relevant laws and regulations;

 

  (2) directly or indirectly used for investment in securities, unless otherwise provided by relevant laws and regulations;

 

  (3) directly or indirectly used for granting the entrusted loans in RMB, unless permitted by the scope of business, repaying the inter-enterprise borrowing (including advances by the third party), or repaying the bank loans in RMB that have been sub-lent to the third party; and/or

 

  (4) paying the expenses related to the purchase of real estate that is not for self-use, except for the foreign-invested real estate enterprises.

 

On June 9, 2016, SAFE issued the Notice to Reform and Regulate the Administration Policies of Foreign Exchange Capital Settlement to further reform foreign exchange capital settlement nationwide.

 

Regulations Relating to Data Privacy and Security

 

Regulations, legislation or self-regulation relating to privacy, data collection and protection, e-commerce and internet advertising (including, behavioral advertising) and uncertainties regarding the application or interpretation of existing or newly adopted laws and regulations, could harm our business and subject us to significant legal liability for non-compliance.

 

Our business is conducted through the internet and therefore, among other things, we are subject to the laws and regulations that apply to e-commerce and online businesses around the world. These laws and regulations are becoming more prevalent in the United States, Europe, Israel and elsewhere and may impede the growth our services. These regulations and laws may cover privacy, data collection and protection, location of data storage and processing, cybersecurity, e-commerce, content, use of “cookies”, pricing, advertising, marketing, distribution of products, consumer protection, taxation and online payment services.

 

46

 

 

For example, we collect, use, maintain and otherwise process certain data about consumers of our products, partners, candidates and employees, consultants, and leads. Our ability to collect, use, maintain or otherwise process personal data has been, and could be further, restricted by existing and new laws and regulations relating to privacy and data collection and protection. In addition, some countries are considering or have enacted legislation requiring local storage and processing of data that could increase the cost and complexity of delivering our services.

  

If we were found in violation of any applicable laws or regulations relating to privacy, data protection, or security, in any jurisdiction, including in jurisdictions where we operate remotely (such as by selling to shoppers residing in such jurisdictions), our business may be materially and adversely affected and we would be liable for any damages and regulatory fines and would likely have to change our business practices. In addition, these laws and regulations could impose significant costs on us and could constrain our ability to use and process data in manners that may be commercially desirable.

 

While it is generally the laws of the jurisdiction in which a business is located that apply, there is a risk that data protection regulators of other countries may seek jurisdiction over our remotely activities in locations in which we process data or serve shoppers but do not have an operating entity. Where the local data protection and privacy laws of a jurisdiction apply, we may be required to register our operations in that jurisdiction or make changes to our business so that shopper data is only collected and processed in accordance with applicable local law. In addition, because our services are accessible worldwide, certain foreign jurisdictions may claim that we are required to comply with their privacy and data protection laws, including in jurisdictions where we have no local entity, employees or infrastructure. In such cases, we may require additional legal review and resources to ensure compliance with any applicable privacy or data protection laws and regulations. In addition, in many jurisdictions there may in the future be new legislation that may affect our business and require additional legal review.

 

We also expect that there will continue to be new laws, regulations, and industry standards concerning privacy, data protection, and information security proposed and enacted in various jurisdictions. For example, in the European Economic Area, or the EEA, we are subject to the GDPR, which imposes stringent operational requirements regarding, among others, data use, sharing and processing, data breach notifications, data subject rights, documentation, and cross-border data transfers for EEA entities as well as non-EEA entities that offer goods or services to, or monitor, individuals in the EEA. Failure to comply with the GDPR could result in penalties for noncompliance (including possible fines of up to the greater of €20 million and 4% of our global annual turnover for the preceding financial year for the most serious violations, as well as the right to compensation for financial or non-financial damages claimed by individuals under Article 82 of the GDPR). 

 

In addition to the GDPR, we are subject to the United Kingdom’s privacy regime, or the UK privacy laws, that imposes obligations and penalties similar to the GDPR including fines up to the greater of £17.5 million or 4% of global turnover. EEA and UK privacy laws are constantly developing, including through case law and regulatory guidance, which increases our compliance costs and regulatory exposure.

 

In the EEA and the UK under national laws, derived from the Directive 2002/58 on Privacy and Electronic Communications, or the ePrivacy Directive, informed and freely given consent is required for the placement of cookies and similar technologies on shoppers’ devices, website users and imposes restrictions on electronic marketing. The GDPR and UK regime also impose conditions on obtaining valid consent for cookies, such as a prohibition on pre-checked consents. Recent European court and regulatory decisions are driving increased attention to cookies and tracking technologies, which could lead to substantial costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities.

 

47

 

 

Additionally, we are or may soon be subject to the California Consumer Privacy Act, or the CCPA, as amended by the California Privacy Rights Act, or the CPRA, which came into effect on January 1, 2020 and, imposes heightened transparency obligations, adds restrictions on the “sale” or “share” of personal information (which it defines broadly), and creates new data privacy rights for California residents and carries significant enforcement penalties for non-compliance. The California Attorney General enforces the CCPA and can seek an injunction and civil penalties up to $7,500 per intentional violation and $2,500 per other violation. The CCPA also provides California consumers a private right of action for certain data breaches where they can recover up to $750 per incident, per consumer or actual damages, whichever is greater, and which is expected to increase data breach litigation. The CCPA may require us to modify our data practices and policies and to incur substantial costs and expenses in order to comply. Additional U.S. states have implemented, or are in the process of implementing, similar new laws or regulation (for example, the Virginia Consumer Data Protection Act, or the VCDPA, that went into effect on January 1, 2023; the Colorado Privacy Act, or the CPA, which went into effect on July 1, 2023; the Connecticut Data Privacy Act, or the CDPA, which went into effect on July 1, 2023; the Utah Consumer Privacy Act, or the UCPA, which went into effect on December 31, 2023; and other upcoming laws which will go into effect on 2024 and in the coming years) that impose new privacy rights and obligations. Further, laws in all 50 states require businesses to provide notice to consumers whose personal information has been disclosed or subject to unauthorized access as a result of a data breach. More generally, some observers have noted the trend toward more stringent privacy legislation and judicial action in the US, including similar laws and decisions in other US states and a potential federal privacy law, all of which could increase our potential liability and adversely affect our business.

 

In addition, we are also subject to the Israeli Privacy Law, and its regulations, including the Israeli Privacy Protection Regulations (Data Security) 2017, or the Data Security Regulations, which came into effect in Israel in May 2018 and impose obligations with respect to the manner personal data is processed, maintained, transferred, disclosed, accessed and secured, as well as the guidelines of the Israeli Privacy Protection Authority. In this respect, the Data Security Regulations may require us to adjust our data protection and data security practices, information security measures, certain organizational procedures, applicable positions (such as an information security manager) and other technical and organizational security measures. Failure to comply with the Israeli Privacy Law, its regulations and guidelines issued by the Privacy Protection Authority, may expose us to administrative fines, civil claims (including class actions) and in certain cases criminal liability. Current pending legislation may result in a change of the current enforcement measures and sanctions. The Israeli Privacy Protection Authority may initiate administrative inspection proceedings, from time to time, without any suspicion of any particular breach of the Israeli Privacy Law, as the Israeli Privacy Protection Authority has done in the past with respect to dozens of Israeli companies in various business sectors. In addition, to the extent that any administrative supervision procedure is initiated by the Israeli Privacy Protection Authority that reveals certain irregularities with respect to our compliance with the Israeli Privacy Law, in addition to our exposure to administrative fines, civil claims (including class actions) and in certain cases criminal liability, we may also need to take certain remedial actions to rectify such irregularities, which may increase our costs.

 

Any failure or perceived failure by our subsidiaries or by us to comply with our posted privacy policies, cookies policies, our privacy-related obligations to users or other third parties, or any other legal obligations or regulatory requirements relating to privacy, data protection, or data security may result in governmental investigations or enforcement actions, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, other obligations, and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for, our e-commerce platforms and websites. Further, public scrutiny of, or complaints about, technology and e-commerce platform companies or their data handling or data protection practices, even if unrelated to our business, industry, or operations, may lead to increased scrutiny of technology and e-commerce platform companies, including us, and may cause government agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.

 

Recent Developments

 

January 2024 PIPE

 

On January 25, 2024, we entered into a private placement transaction, or the January 2024 PIPE, pursuant to a securities purchase agreement, with certain institutional investors, providing for the issuance, in a private placement of 1,884,461 Ordinary Shares; (ii) Pre-Funded Warrants to purchase up to an 820,000 Ordinary Shares; (iii) Series A Warrants to purchase up to an aggregate of 3,380,586 Ordinary, or upon the satisfaction of certain conditions, up to an aggregate of 13,373,208 Ordinary Shares in accordance with the terms therein and (iv) Series B Warrants to purchase upon the satisfaction of, certain conditions up to an aggregate of 7,994,181 Ordinary Shares in accordance with the terms therein. See “Item 5.A. Financial Arrangements – January 2024 PIPE,” for further information.

 

48

 

 

In connection with the January 2024 PIPE, we entered into a registration rights agreement with such institutional investors, or the PIPE Registration Rights Agreement, pursuant to which we agreed to file a registration statement, within twenty trading days of the closing date of the January 2024 PIPE, to register the resale of the registrable securities issued in the January 2024 PIPE. Accordingly, on February 20, 2023, we filed with the SEC a resale registration statement on Form F-3, which became effective on March 8, 2024.

 

Reverse Split

 

On September 5, 2023, our board of directors approved a 1-for-7 reverse split of our issued and outstanding Ordinary Shares, effective as of November 3, 2023, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 7 Ordinary Shares held as of such date. The Reverse Split did not reduce the number of our authorized share capital. Unless the context expressly dictates otherwise, all references to share and per share amounts referred to herein give effect to the Reverse Split.

 

Expansion into the Market of Pest Control Products

 

On March 2, 2023, we entered into a share purchase agreement, or the Fort SPA, with the holders, or the Fort Sellers, of all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales and sells pest control products primarily through Amazon UK, pursuant to which on March 9, 2023, we acquired all of the issued and outstanding share capital of Fort, for approximately £2,000,000 (approximately $2,400,000), or the Fort Acquisition. The Fort SPA provides that for a period of three years from closing, or until March 9, 2026, the Fort Sellers will not compete with Fort’s business.

 

In connection with the closing of the Fort Acquisition, on March 9, 2023, we and Fort entered into settlement agreements with all of Fort’s employees, including the Fort Sellers, by which, inter alia, such employees’ employment with Fort terminated and containing other customary conditions.

 

In addition, in connection with the closing of the Fort Acquisition, on March 9, 2023, we and the Fort Sellers entered into a consulting agreement, pursuant to which the Fort Sellers will provide us with consultancy services for a period of six months following the closing, at monthly fee of £2,500 (approximately $3,000).

 

On September 20, 2023, the Company and the Sellers entered into a new consulting agreement for indefinite period at a monthly fee of £3,500 thousand (approximately $4,500 thousand) effective as of June 1, 2023

 

On February 29, 2024, we entered into a side letter to the Fort SPA to the Fort Sellers, pursuant to which we agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100,000.

 

Expansion into the Nutritional Supplements Market

 

On February 23, 2023, we and Jeffs’ Brands Holdings entered into a stock purchase agreement with SciSparc, or the Wellution Agreement, as amended on March 22, 2023 by Addendum No. 1 to the Wellution Agreement, or the Addendum, pursuant to which, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 57shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, representing approximately 49% of the issued and outstanding shares of common stock of SciSparc U.S., for approximately $3.0 million in cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing, or the Wellution Transaction. The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price adjustments, or the Price Adjustment, related to inventory and working capital which was paid in five equal installments of $97,866. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S, which was released to Jeffs’ Brands Holdings on March 6, 2024, when the final payment was made.

 

49

 

 

Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, we entered into a consulting agreement with SciSparc U.S., or the SciSparc Consulting Agreement, pursuant to which we will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20,000, and received a one-time signing bonus in the amount of $51,000. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days’ advance notice.

 

Also pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, effective as of March 22, 2023, we issued 35,345 Ordinary Shares to SciSparc and on March 29, 2023, SciSparc issued 13,858 of its ordinary shares to us in a mutual share exchange, or, collectively, the Exchange Shares, representing approximately 2.97% and 4.99%, respectively, of the Company’s and SciSparc’s issued and outstanding ordinary shares as of the closing of the Wellution Transaction. The number of Exchange Shares acquired by each company was calculated by dividing $288,238, which was adjusted from $300,000, pursuant to the 4.99% ownership limitation included in the Wellution Agreement, by the average closing price of the relevant company’s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the closing date.

 

C. Organizational Structure

 

We have five wholly-owned subsidiaries: Smart Repair Pro, Top Rank, Fort and Fort Products LLC, e-commerce companies that operate online stores for the sale of various consumer products on the Amazon marketplace and Jeffs’ Brands Holdings, a holding company that owns approximately 49% of the issued and outstanding shares of common stock of SciSparc U.S., which owns and operates Wellution, a food supplements and cosmetics brand.

 

D. Property, Plant and Equipment

 

Our principal executive offices are located at 7 Mezada Street, Bnei Brak, Israel 5126112, and our telephone number is +972.3.7713520. This facility comprises approximately 24 square meters, or 2,594 square feet, of space. Our current lease, which we entered into on September 16, 2022, effective as of October 1, 2022, expires on September 30, 2025, with an option to extend the lease on the same terms for an additional two years. Our monthly rent payment as of December 31, 2023, was approximately NIS 15,665 (approximately $4,350). We consider that our current office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business.

 

We have contracts with third party warehouses in three locations in the United States, one location in Canada, one location in the United Kingdom, and one location in Germany. These facilities are used for storage of the products prior to the shipment of such products to Amazon’s warehouses, based on availability.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

None.

 

50

 

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

A. Operating Results

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes included elsewhere in this Annual Report on Form 20-F. The discussion below contains forward-looking statements that are based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in “Cautionary Note Regarding Forward-Looking Statements” and under “Risk Factors” elsewhere in this Annual Report on Form 20-F. Our discussion and analysis of our operating results for the years ended December 31, 2021 and December 31, 2022 can be found in our Annual Report on Form 20-F for the year ended December 31, 2022, filed with the SEC on April 10, 2023.

 

Overview

 

We are a fast-growing e-commerce CPG company, operating primarily on Amazon. We were incorporated in Israel in March 2021, under the name Jeffs’ Brands Ltd, to provide a variety of professional and business support as well as marketing support services to e-commerce companies that operate online stores for the sale of various consumer products on the Amazon online marketplace, utilizing the FBA model. As a result of the Contribution Transactions which occurred in May 2021 and discussed above, Smart Repair Pro became a wholly owned subsidiary of Jeffs’ Brands. As the Contribution Transactions were consummated among entities under common control, i.e., there was no change in the ownership percentages of Medigus and Mr. Hakmon before and after the Contribution Transactions, Jeffs’ Brands accounted for the Contribution Transactions as a pooling of interests, resulting in the comparative financial information of the Company being replaced with the combined financial information of Smart Repair Pro, the carrying values of asset and liabilities being retained, and no purchase accounting applied. Therefore, our Annual Report on Form 20-F includes the audited financial statements of Jeffs’ Brands as of and for the year ended December 31, 2022, with the financial information in these financial statements being the combined financial information of Smart Repair Pro based on the pooling method of accounting.

 

In addition to executing the FBA business model, we utilize internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, as well as maximize sales of its existing proprietary products. We also use our own skills, know-how and profound familiarity with Amazon algorithm and all the tools that the FBA platform FBA has to offer. In some circumstances we scale the products and improve them.

 

Initial Public Offering

 

On August 30, 2022, we completed our IPO and received gross proceeds of approximately $15.5 million before deducting underwriting discounts and commissions and before offering expenses ($13.4 million net proceeds after deducting approximately $1.05 million of underwriting discounts and commissions and approximately $1.05 million after deducting other offering costs). In connection with the IPO, we issued and sold: (i) 531,068 Ordinary Shares, (ii) Warrants to purchase up to 591,912 Ordinary Shares (after giving effect to the partial exercise of the Underwriter’s over-allotment option), and (iii) Underwriter’s Warrants to purchase up to 26,553 Ordinary Shares, in each case after given effect to the Reverse Split. The Ordinary Shares and Warrants were approved for listing on the Nasdaq Capital Market and commenced trading under the symbol “JFBR” and “JFBRW,” respectively, on August 26, 2022.

 

On September 7, 2022, the Company’s volume weighted average stock price was less than the exercise floor of $28.28 for the Warrants. Accordingly, effective after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the Warrants), the Warrants have been adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of the Warrants to $14.14. In addition, in connection with the Exercise Price Adjustment, the Company issued Additional Warrants to purchase up to 403,504 Ordinary Shares to Qualified Holders (as defined in the Warrant).

 

Comparison of the Results for the Year Ended December 31, 2023 and 2022

 

Results of Operations 

 

   Year Ended December 31, 
U.S. dollars in thousands  2023   2022 
Revenues   10,008    5,859 
Cost of sales   9,032    5,060 
Gross Profit   976    799 
           
Sales and marketing   833    1,198 
General and administrative   4,262    4,113 
Equity losses   1,248      
Other income   (279)   - 
Operating loss   (5,089)   (4,512)
Financial expense, net   (523)   (2,305)
Net loss   (4,598)   (2,201)
Loss attributable to holders of Ordinary Shares   (4,598)   (2,201)

 

51

 

 

Revenues

 

Our revenues consist of revenue derived from sales on Amazon. The following table discloses the breakdown of our revenues, cost of sales and gross profit for the periods set forth below:

 

   Year Ended December 31, 
U.S. dollars in thousands  2023   2022 
Revenues  $10,008   $5,809 
Cost of sales   9,032    5,060 
Gross profit   976    799 

 

Our revenues for the year ended December 31, 2023, were $10,008 compared to $5,809 for the year ended December 31, 2022, an increase of $4,199, or 72%. The increase is mainly attributable to the acquisition of Fort on March 9, 2023.

 

Cost of goods sold

 

Our cost of goods sold consist of the purchase of finished goods, freight, cost of commissions to Amazon and change in inventory.

 

The following table discloses the breakdown of cost of goods sold for the periods set forth below:

 

   Year Ended December 31, 
U.S. dollars in thousands  2023   2022 
Purchases of finished goods  $3,817   $1,738 
Freight  $311   $691 
Storage  $660   $634 
Salary  $70   $- 
Packing Supplies  $14   $- 
Cost of commissions  $4,431   $2,561 
increase in inventory  $(271)  $(564)
Total  $9,032   $5,060 

 

Fright and storage expenses for the year ended December 31, 2023, amounted $971, compared to $1,325 for the year ended December 31, 2022, a decrease of $354 or 26.7%. The decrease is mainly due to Company’s decrease in freight costs which dropped compared to 2022 due to all over decrease in freight costs as well as less purchase of goods from China compared to 2022.

 

Cost of commissions for the year ended December 31, 2023, amounted $4,431, compared to $2,561 for the year ended December 31, 2022, an increase of $1,870 or 73%. The increase is mainly attributable to the increase in sales as of result of the acquisition of Fort on March 9, 2023 and the fees related to Fort’s revenue.

 

Purchases of finished goods for the year ended December 31, 2023, amounted $3,817, compared to $1,738 for the year ended December 31, 2022, an increase of $2,079 or 119.6%. The increase is mainly attributable to the acquisition of Fort on March 9, 2023 and the purchase of finished goods related to Fort that was offset with less purchase of goods in the other brands.

 

52

 

 

Gross Profit

 

Our gross profit for the year ended December 31, 2023, was $976, compared to gross profit of $799 for the year ended December 31, 2022, an increase of $177, or 22%. The increase is mainly attributable to the increase in sales as of result of the acquisition of Fort on March 9, 2023that was offset by decrease in gross profit in the other brands.

 

Operating Expenses

 

Our current operating expenses consist of four components — marketing and sales expenses and general, administrative expenses, equity losses expenses and other income.

 

Marketing and Sales Expenses

 

Our marketing and sales expenses consist primarily of Amazon marketing fees, consultants and other marketing and sales expenses.

 

The following table discloses the breakdown of marketing and sales expenses for the periods set forth below:

 

   Year Ended December 31, 
U.S. dollars in thousands  2023   2022 
Advertising  $754   $1,163 
Wages, salaries and related expenses   79    35 
Total   833    1,198 

 

The decrease of $365, or 30.5% for the year ended December 31, 2023, as compared to the year ended December 31, 2022, is mainly attributable to the decrease in advertising expenses.

 

General and Administrative Expenses

 

Our general and administrative expenses consist primarily of salaries and related expenses, professional service fees for accounting, legal and bookkeeping, facilities, amortization of intellectual property assets and other general and administrative expenses. The decision how much to spend in advertising is the seller’s sole decision according to different parameters that may vary within a short terms.

 

The increase of $149, or 3.6%, for the year ended December 31, 2023, as compared to the year ended December 31, 2022, is mainly attributable to decrease in professional services and consulting fees related to services provided in 2022 and were connected with the IPO. This decrease was offset by an increase in insurance cost in 2023, as 2022 insurance costs started only in August 25, 2022.

 

Revenue sharing payment which included in other expenses is higher in 2023 compare to 2022 due to increase in revenue in 2023 compare to 2023 as well as the revenue sharing in 2022 is referring to the H2 only.

 

The following table discloses the breakdown of our general and administrative expenses for the periods set forth below:

 

   Year Ended December 31, 
U.S. dollars in thousands  2023   2022 
Payroll and related expenses  $989   $831 
Subcontractors   78    39 
Professional services and consulting fees   1,456    2,314 
Rent and office maintenance   169    75 
Amortization of intangible assets   739    570 
Insurance   359    145 
Other expenses   472    139 
Total   4,262    4,113 

 

Equity losses

 

Our equity losses for the year ended December 31, 2023, derive from investment in SciSparc U.S under the equity method. The amount includes $955 thousand impairment loss.

 

Other income

 

Our other income for the year ended December 31, 2023, derive mainly from SciSparc Consulting Agreement, pursuant to which we provide management services to SciSparc U.S. for the Wellution brand. In addition, we provide a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc.

 

53

 

 

Operating loss

 

Our operating loss for the year ended December 31, 2023 was $5,089, compared to an operating loss of $4,512 for the year ended December 31, 2022, an increase of $577, or 12.79%. The increase in 2023 was due to factors mentioned above.

 

Financial income

 

Financial expense consists of mainly interest, bank fees, revaluation of derivatives and other transactional costs.

 

Our financial income, net was $523 for the year ended December 31, 2023, compared to net financial expenses of $2,305 for the year ended December 31, 2022, a decrease of $1,782, or 77.3%. The decrease was primarily attributable to decrease in revaluation of derivatives liabilities and revaluation of securities -fair value through profit or loss offset by Revaluation of securities -fair value through profit or loss.

 

The following table discloses the breakdown of our financial income for the periods set forth below:

 

   Year ended December 31 
   2023   2022 
   U.S. dollars in thousands 
Finance income:        
Change in fair value of derivative liabilities   (841)   (2,822)
Interest income   (4)   - 
Total finance income   (845)   (2,822)
Finance expense:          
Finance expenses in respect of third-party loan   -    83 
Change in fair value of derivative liabilities   -    - 
Amortization of loan discount   -    37 
Exchange rate changes   91    156 
Interest expense on loans from shareholders and related parties   -    203 
Other finance expenses   10    38 
Revaluation of securities -fair value through profit or loss   221    - 
Total finance expenses   322    517 
Finance income, net   (523)   (2,305)

 

Net loss

 

Our net loss for the year ended December 31, 2023, was $4,598, compared to net loss of $2,201 for the year ended December 31, 2022, an increase of $2,397, or 108.9%. The increase in 2023 was due to factors mentioned above.

 

54

 

 

B. Liquidity and Capital Resources

 

Overview

 

Since our inception in March 2021 and since the earlier inception of our subsidiaries, we have financed our operations primarily through funds we received from loans and proceeds from sales on Amazon (after deducting FBA fees and advertising fees) and the issuance of our securities. As of December 31, 2023, and 2022, we had approximately $535 and $8,137, respectively, in cash and cash equivalents.

 

The table below presents our cash flow for the periods indicated:

 

   Year Ended December 31, 
U.S. dollars in thousands  2023   2022 
Net cash used in operating activities  $(2,668)  $(4,840)
Net cash used in investing activities  $(4,814)  $(41)
Net cash from (used in) financing activities  $(86)  $12,625 
Net (decrease) increase in cash and cash equivalents  $(7,568)  $7,744 

 

Our net cash used in operating activities was $2,668 for the year ended December 31, 2023, as compared to net cash from operating activities of $4,840 for the year ended December 31, 2022. Our net cash used in investing activities was $4,814 for the year ended December 31, 2023, as compared to net cash used in investment activities of $41 for the year ended December 31, 2022. Our net cash used in financing activities was $86 for the year ended December 31, 2023, as compared to net cash provided by investing activities of $12,625 for the year ended December 31, 2022.

 

The change in our liquidity for the year ended December 31, 2023, resulted from several factors, including:

 

Operating Activities

 

Our net cash used in operating activities consists primarily of net loss of $4,598 thousand, increase in inventory of $596 thousand, increase in trade receivables of $302 thousand, change in fair value of derivative liabilities of $841 thousand offset by depreciation and amortization of intangible assets of $738 thousand, loss from change in value of investment at fair value of $221 thousand, equity losses of $1,249 thousand, increase in accounts payable and other payables of $1,304 thousand and decrease in other receivables of $182 thousand.

 

Investing Activities

 

Our net cash used in investing activities consists primarily of purchase of SciSparc U.S in the amount of $3,091 thousand and purchase of Fort brand in the amount of $1,681 thousand.

 

Financing Activities

   

Our net cash used in financing activities consists of repayment of short-term loan in the amount of $86 thousand.

 

Financial Arrangements

 

On May 9, 2022 Smart Repair Pro entered into a loan agreement with Amazon, pursuant to which, Smart Repair Pro received from Amazon an aggregate amount of $153. The loan bares an interest at an annual rate of 9.99%. In order to secure the loan, Smart Repair Pro pledged its financial balances on its Amazon account and its inventories held in Amazon’s warehouses, in favor of Amazon. As of December 31, 2023, the remaining loan balance to Amazon was fully repaid.

 

January 2024 PIPE

 

On January 25, 2024, we entered into the January 2024 PIPE, in which we issued Ordinary Shares; Pre-Funded Warrants to purchase Ordinary Shares; Series A Warrants to purchase Ordinary Shares and Series B Warrants to purchase Ordinary Shares. The January 2024 PIPE closed on January 29, 2024. The Company’s aggregate gross proceeds from the January 2024 PIPE were approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the January 2024 PIPE. See “Item 4.B. Recent Developments – January 2024 PIPE” above for further information.

 

55

 

 

The Pre-Funded Warrants were immediately exercisable at an exercise price of $0.00001 per Ordinary Share and do not expire until exercised in full. The Series A Warrants were immediately exercisable, have an exercise price of $2.69 per whole Ordinary Share (subject to certain anti-dilution and share combination event protections) and have a term of 5.5 years from the date of issuance. The Series B Warrants will be exercisable following the Reset Date (as defined below), have an exercise price of $0.00001 per Ordinary Share and have a term of 5.5 years from the date of issuance. The exercise price and number of Ordinary Shares issuable under the Series A Warrants are subject to adjustment and the number of Ordinary Shares issuable under the Series B Warrant will be determined following the reset date, or the Reset Date, which is the earliest to occur of: (i) the date on which a resale registration statement covering the resale of all registrable securities has been declared effective for 30 consecutive trading days, (ii) the date on which the selling shareholders may sell the registrable securities pursuant to Rule 144 under the Securities Act of 1933, as amended, or the Securities Act, for a period of 30 consecutive trading days, and (iii) twelve months and 30 days following the issuance date of the Series B Warrant, to be determined pursuant to the lowest daily average trading price of the Ordinary Shares during a period of 20 trading days, subject to a pricing floor of $0.68, or Pricing Floor. As our Ordinary Shares are currently trading at a price per share lower than the Pricing Floor, we expect that on the Reset Date: (i) the Series A Warrants will be exercisable into a total number of 13,373,177 Ordinary Shares, and (ii) the Series B Warrants will be exercisable into a total number of 7,904,181 Ordinary Shares. As of March 28, 2024, 320,000 Ordinary Shared have been issued following exercise of Pre-Funded Warrants and 2,580,036 Ordinary Shares have been issued following exercise of Series B Warrants.

 

Current Outlook

 

As of December 31, 2023, our cash and cash equivalents were $535 thousand. We expect that our existing cash and cash equivalents as of December 31, 2023, will be sufficient to fund our current operations for the next twelve months taking into consideration the proceeds raised from the January 2024 PIPE. In addition, our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds sooner than planned. Our future capital requirements will depend on many factors, including:

 

the progress and costs of purchasing new brands and their development plans;

 

the costs of manufacturing and shipment of our products;

 

the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;

 

the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and

 

the magnitude of our general and administrative expenses.

 

C. Research and development, patents and licenses, etc.

 

None.

 

D. Trend information

 

Effective January 1, 2022, we prepare our financial statements in accordance with U.S. GAAP. There are certain differences between U.S. GAAP and IFRS, including differences related to lease accounting and accounting treatment related to derivative liabilities. 

 

Adverse macroeconomic conditions, including recent inflation, slower growth, changes to fiscal and monetary policy, higher interest rates, and currency fluctuations have impacted companies in Israel and around the world, and as the future market conditions and possible recession remain highly uncertain, we cannot predict severity of the possible recession and its effects on our customers and their spending habits. See also Item 3.D. “Risk Factors” – General economic factors may adversely affect our business, financial performance and results of operations”. 

 

E. Critical Accounting Estimates

 

We describe our significant accounting policies more fully in Note 2 to our financial statements included elsewhere in this Annual Report on Form 20-F. We believe that the accounting policies described below and in Note 2 to our financial statements are critical in order to fully understand and evaluate our financial condition and results of operations.

 

The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

 

56

 

 

Derivative Liabilities

 

We account for the Additional Warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification, or ASC, Topic 480, “Distinguishing Liabilities from Equity”, or ASC Topic 480, and ASC Topic 815, “Derivatives and Hedging”, or ASC Topic 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC Topic 480, meet the definition of a liability pursuant to ASC Topic 480, and whether the warrants meet all of the requirements for equity classification under ASC Topic 815, including whether the warrants are indexed to our own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. Based on their contractual terms, the Additional Warrants are accounted for as a derivative liability

 

The estimated fair value of the Additional Warrants is determined using Level 3 inputs (as described in the notes to financial statements accompanying this Annual Report on Form 20-F). The Additional Warrants were calculated according to the binomial model under the following assumptions: expected stock-price volatility, expected life, dividend yield and risk-free interest rate and revenue forecast over the life of the Additional Warrants.

 

Intangible Assets Valuation

 

We review our intangible assets and equity investment for impairment when performance expectations, events, or changes in circumstances indicate that the asset's carrying value may not be recoverable.

 

For intangible assets, when impairment indicators exist, we evaluate the undiscounted future cash flows to the carrying value of the intangible asset group. If the evaluation indicates that the carrying amount of the assets may not be recoverable, any potential impairment is measured based upon the fair value of the related asset group as determined by an appropriate market appraisal or other valuation technique.

 

For an equity method investment, ASC 323 requires us to measure impairment that is determined to be other than temporary by comparing the carrying value of the investment with its fair value.

 

Based on the decline in SciSparc U.S revenues and operating losses during 2023, we used the work of a fair value expert, to determine that the fair value of the Company’s investment in SciSparc U.S was impaired. Accordingly, an impairment loss of $955 thousand was recorded for the year ended December 31, 2023, within equity losses in the consolidated statement of operations.

 

The fair value measurement of SciSparc U.S as of December 31, 2023, required significant judgements using Level 3 inputs, such as discounted projected future revenue projections, which are not observable from the market, directly or indirectly. There is uncertainty in the projected future revenues used in the Company’s impairment analysis, which requires the use of estimates and assumptions. Key assumptions in the impairment models included the discount rate and royalty rate.

 

Recent Accounting Pronouncements

 

Please see Note 2 to our audited consolidated financial statements included elsewhere in this Annual Report for information regarding recent accounting pronouncements.

 

F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation

 

None.

 

57

 

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Senior Management

 

The following table sets forth information regarding our executive officers, key employees and directors as of December 31, 2023:

 

Name

  Age   Position   Class
Viki Hakmon   47   Chief Executive Officer and Director   Class III(5)
Ronen Zalayet   55   Chief Financial Officer   N/A
Naor Bergman   33   Chief Operating Officer   N/A
Oz Adler   37   Chairman of the Board of Directors   Class III(5)
Eliyahu Yoresh   53   Director   Class II(6)
Liron Carmel   39   Director   Class II(6)
Tali Dinar   52   Director   Class I(7)
Moshe Revach(1)(2)(3)   47   Director   Class I(7)
Amitay Weiss   61   Director   Class I(7)
Tomer Etzyoni(1)(2)(3)(4)   43   External Director    
Israel Berstein(1)(2)(3)(4)   52   External Director    

 

(1)Independent Director (as defined under Nasdaq listing rules)

 

(2)Member of the Audit Committee

 

(3)Member of the Compensation Committee

 

(4)External Director (as defined under Israeli law)

 

(5)Class III directors shall hold office until the annual general meeting to be held in 2025 and until their successors shall have been elected and qualified.

 

(6)Class II directors shall hold office until the annual general meeting to be held in 2024 and until their successors shall have been elected and qualified.

 

(7)Class I directors shall hold office until the annual general meeting to be held in 2026 and until their successors shall have been elected and qualified.

 

Viki Hakmon, Founder and Chief Executive Officer and Director 

 

Mr. Hakmon has served as our Chief Executive Officer since our inception on March 7, 2021 and as one of our directors since September 2021. Mr. Hakmon serves as Smart Repair Pro’s operating manager since its inception in December 2017. Mr. Hakmon has served as Purex’s operating manager since its inception in April 2020. Prior to founding Smart Repair Pro and Purex, from April 2014 to April 2017, Mr. Hakmon owned and managed six businesses including two retail stores and four kiosks for computing hardware and software services, in various cities in California, including Pleasanton, San Jose and Palo Alto. We believe that Mr. Hakmon is qualified to serve as a member of our board of directors because of his vast business, management and leadership experience.

 

Ronen Zalayet, Chief Financial Officer

 

Mr. Zalayet has served as our Chief Financial Officer since October 2022. Mr. Zalayet has over 20 years of experience working in financial leadership positions in private and public companies, including in growing fintech and technology companies. Mr. Zalayet has served as the chief executive officer and director of Shemen Oil and Gas Resources Ltd, an Israeli company listed on the Tel Aviv Stock Exchange (TASE: SOG) that explores oil and natural gas since July 2021. From November 2019 to June 2021, Mr. Zalayet served as the chief financial officer of Colugo Systems Ltd., a company operating in the transportation field, and from 2016 to 2020, he served as a consultant, director and head of the Israeli office of Access Capital Markets Limited, a finance boutique company headquartered in the United Kingdom. Ms. Zalayet holds a B.A. in Economics and Accounting and an MBA from Tel Aviv University, Israel, and is a certified public accountant in Israel.

 

58

 

 

Naor Bergman, Chief Operating Officer

 

Mr. Bergman has served as our Chief Operating Officer since April 2021. From September 2018 to April 2021, Mr. Bergman established and led Amazon’s FBA logistics and warehousing department at Unicargo, which has 11 warehouses in the United States, Canada, England and Europe and was part of the management team that transformed Unicargo to become a leader in the field of outsourcing Amazon’s FBA warehousing. Unicargo is a one-stop-shop to FBA specializing in logistics services for Amazon sellers and e-commerce. From September 2017 to September 2018, Mr. Bergman was a strategic customer manager at Pick & Pack Ltd., a company fully owned by Israel Cargo Logistics Ltd, an international shipping company. Mr. Bergman holds a B.A. in Economics and Sustainability from Reichman University, Israel.

 

Oz Adler, Chairman of the Board of Directors

 

Mr. Adler, CPA, has served on our board of directors since September 2021. Mr. Adler currently serves as the chief executive officer and chief financial officer of SciSparc Ltd. Mr. Adler has served as SciSparc’s chief financial officer since April 2018 and as its chief executive officer since January 2022. Mr. Adler has experience in a wide variety of managerial, financial, tax and accounting roles. From December 2020 to April 2021, Mr. Adler served as the chief financial officer of Medigus, from 2021 – 2022 served as a director of Elbit Imaging Ltd. (TASE: EMITF) Ltd. Mr. Adler also worked in the audit department of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global between December 2012 and August 2017. Additionally, Mr. Adler currently serves on the board of directors of numerous private and publicly traded companies, including: Clearmind Medicine Inc. (NASDAQ: CMND) (FSE:CWY), Rail Vision Ltd. (NASDAQ: RVSN). Mr. Adler is a certified public accountant in Israel and holds a B.A. degree in Accounting and Business Management from The College of Management, Israel. 

 

Eliyahu Yoresh, Director

 

Mr. Yoresh has served as one of our directors since September 2021. Mr. Yoresh has served as chairman of the board of directors of Medigus since February 2020 and as chief financial officer of Foresight Autonomous Holdings Ltd. (Nasdaq, TASE: FRSX) since March 2010. Mr. Yoresh has also served as a member of the board of directors of Gix Internet Ltd. (TASE: GIX) since November 2020, Elbit Imaging Ltd. (TASE: EMITF) since August 2021 and Viewbix Inc. (Nasdaq: VBIX) since September 2022. From August 2014 to February 2020, Mr. Yoresh served as a member of the board of directors of Nano Dimension Ltd. (Nasdaq: NNDM) and from August 2005 to July 2008 as the chief executive officer of Tomcar Global Holdings Ltd., a global manufacturer of off-road vehicles, from. Mr. Yoresh is an Israeli Certified Public Accountant and holds a B.A. in business administration from the Business College, Israel and an M.A. in Law Study from Bar-Ilan University, Israel. We believe that Mr. Yoresh is qualified to serve as a member of our board of directors due to his financial background and expertise and experience in positions as officer and director of public companies.

 

Liron Carmel, Director

 

Mr. Carmel has served as one of our directors since September 2021. Mr. Carmel has served as chief executive officer of Medigus (Nasdaq: MDGS) since April 2019. Mr. Carmel has vast experience in business and leadership across multiple industries, including bio pharma, internet technology, oil and gas exploration and production, real estate and financial services. Since June 2018 Mr. Carmel has served as chairman of the Israel Tennis Table Association. Since September 2022 Mr. Carmel has served as a member of the board of directors of Viewbix Inc. (Nasdaq: VBIX). From January 2017 to May 2018, Mr. Carmel served as the chief executive officer and director of CannaPowder (PINK: CAPD), a bio-pharma company dedicated to developing and applying innovative technology in the cannabinoid field. From January 2018 to April 2019, Mr. Carmel served as a director of Chiron Refineries Ltd. (TASE: CHR), a company engaged in consulting and initiation of transactions in the refineries field, and as a member of the board of directors of Gix Internet Ltd. (TASE: GIX) which operates in the field of software development, marketing and distribution to internet users. From May 2016 to 2018, he served as vice president, business development at Yaad Givatayim Development, a municipal corporation dedicated to initiate, develop and establish projects of public importance. From 2013 to 2015, Mr. Carmel served as an investment manager and as a research and strategy analyst at Excellence Nessuah Investment House, a wealth management firm. We believe that Mr. Carmel is qualified to serve as a member of our board of directors because of his diverse business, management and leadership experience.

 

59

 

 

Tali Dinar, Director

 

Mrs. Dinar has served as one of our directors since September 2021. Mrs. Dinar is a senior executive with a two-decade track record in public and private companies in a global environment. Mrs. Dinar has served as chief financial officer of Medigus (Nasdaq: MDGS) since June 2021. Mrs. Dinar also currently serves as a member of the board of directors of ParaZero Ltd. beginning February 13, 2022, as a director in Charging Robotics Ltd. since November 2021, a director in Fuel Doctor Holding Inc since April 4, 2023. Mrs. Dinar served as Chief Financial Officer of Novomic Ltd., a private company between January 2019 and January 2023. She has also served as a member of the board of directors of Micronet Ltd. (TASE: MCRNT) between July 2016 and February 2023. In addition, she has also served as a director of Canzon Israel Ltd. (TASE: CNZN) since August 2020 until March 2022. Between 2019 and 2020, Mrs. Dinar served as the Chief Financial Officer of TechCare Corp. (currently Citrine Global Corp.) (OTCQB: CTGL). Between 2009 and 2019, Mrs. Dinar worked at the MICT group and served in various positions, including as Chief Financial Officer of MICT Inc. (Nasdaq: MICT) and as Chief Financial Officer of MICT Telematics Ltd. Mrs. Dinar holds a B.A. in Accounting and Business Administration from The College of Management, Israel. We believe that Mrs. Dinar is qualified to serve as a member of our board of directors because of her diverse business, management and proven leadership skills in managing global finance, holding and industrial organizations.

 

Moshe Revach, Director

 

Mr. Revach has served as one of our directors since September 2021. Mr. Revach serves as member of the city council of Ramat Gan, Israel, and member of the finance committee of the city council of Ramat Gan, Israel, and previously served in various other municipality positions since 2008. Mr. Revach currently serves as a member of the board of directors of L.L.N IT solutions, a wholly-owned subsidiary of the Jewish Agency for Israel, a board member of Biomedico Hadarim Ltd., a board member of ParaZero Technologies Ltd (Nasdaq: PRZO) since 2022 and a board member of PLANTIFY FOODS, INC. since 2023. Mr. Revach previously served as a member of the board of directors of the RPG Economic Society and Jewish Experience Company on behalf of the Jewish Agency. Mr. Revach holds an LL.B from the Ono Academic College, Israel, and a B.A. in management and economics from the University of Derby. We believe that Mr. Revach is qualified to serve as a member of our board of directors because of his diverse management and leadership experience.

 

Amitay Weiss, Director

 

Mr. Weiss has served as one of our directors since August 2022. Mr. Weiss has a vast experience serving on boards of directors and other high positions. He has served as chairman of the board of directors of Save Foods Inc. (Nasdaq: SVFD) since August 2020, chairman of the board of directors of Infimer Ltd. (Maintaince) (TASE: INFR-M) since July 2021 and chairman of the board of directors of Upsellon Brands Holdings Ltd. (previously Chiron Ltd.) (TASE: UPSL) since June 2019. He has also served as a member of the board of directors of Automax Motors Ltd. (TASE: AMX) since March 2021, Gix Internet Ltd. (previously Algomizer Ltd.) (TASE: GIX) since March 2019, Clearmind Medicine Inc. (previously Cyntar Ventures Inc.) (CSE: CMND) since August 2019, as an external director of Cofix Group Ltd. (TASE: CFCS) since August 2015 and as a member of the board of directors of SciSparc since August 2020. Mr. Weiss served as chief executive officer of SciSparc from August 2020 to January 2022. He also previously served as chairman of the board of directors of Value Capital One Ltd. (previously P.L.T Financial Services Ltd.) (TASE: VALU) from April 2016 to February 2021 and of Matomy Media Group Ltd. (LSE: MTMY, TASE: MTMY.TA) from May 2020 to March 2021. In April 2016, Mr. Weiss founded Amitay Weiss Management Ltd., an economic consulting company, and now serves as its chief executive officer. Mr. Weiss holds a B.A in economics from New England College, an M.B.A. in business administration and an LL.B. from Ono Academic College, Israel. We believe that Mr. Weiss is qualified to serve as a member of our board of directors because of his diverse business, management and leadership experience.

 

Tomer Etzyoni, External Director

 

Mr. Etzyoni has served as one of our external directors since August 2022. Mr. Etzyoni has served as a fitness and health instructor at Wingate College since September 2016, professional course, as workshop instructor at Wingate College since March 2012 and as therapist at Dr. Gill Solberg’s Muscle and Motion Clinic since January 2012. Mr. Etzyoni previously served as fitness and health instructor and diagnostician at Wingate College, Si’im Campus from August 2012 to July 2016. Mr. Etzyoni holds a B.A in Physical Education and Movement, majoring in posture from Kibbutzim College, Israel, a certificate in gym and health clubs instructor from Wingate Institute, Israel, posture and kinesiology specialty certificate from Wingate Institute, Israel, Yir Karni’s neuration course, Wingate Institute, Israel, Thai stretches course, from Broshim Campus, Israel athletics instructor certificate from Kibbutzim College, Israel and a certificate in ergonomics and posture specialty from Kibbutzim College, Israel. We believe that Mr. Etzyoni is qualified to serve as a member of our board of directors because of his diverse fitness and health knowledge and his vast experience in fitness and health — issues that are related to the brands we sell or will sell in the future.

 

60

 

 

Israel Berenstein, External Director

 

Mr. Berenstein has served as one of our external directors since December 14, 2023. Mr. Berenstein has also serves as a director of Plantify Foods INC. (TSXV: PTFY –) since July 2023, Save Foods Inc. (Nasdaq: Safo –) since August 2020, and Upsellon Brands Holdings Ltd (TASE: UPSL) since May 2019. Since 2023, Mr. Berenstein has been a solo practitioner in his law firm. Previously, he worked at Ben Yakov, Shvimer, Dolev - Law Office from 2020-2022. Formerly, Mr. Berenstein served in the legal department of Sonol Israel Ltd. from April 2010 to December 2020. Before that, he worked as a commercial lawyer and litigator for a leading Israeli law firm from July 2000 to April 2010. Mr. Berenstein earned an LL.B. in Law and an M.A. in Political Science from Bar-Ilan University, Israel. Mr. Berenstein was admitted to the Israel Bar Association in 2000. We believe that Mr. Berenstein is qualified to serve as a member of our board of directors because of his diverse business, legal and management experience.

 

Family Relationships

 

There are no family relationships between any members of our executive management and our directors.

 

Arrangements for Election of Directors and Members of Management

 

There are no arrangements or understandings with major shareholders, customers, suppliers or others pursuant to which any of our executive management or our directors were selected. See “Related Party Transactions” for additional information.

 

B. Compensation

 

The following table presents in the aggregate all compensation we paid to all of our directors and senior management as a group for the year ended December 31, 2023. The table does not include any amounts we paid to reimburse any of such persons for costs incurred in providing us with services during this period.

 

All amounts reported in the tables below reflect the cost to the Company, in thousands of U.S. dollars, for the year ended December 31, 2023. Amounts paid in NIS are translated into U.S. dollars at the rate of NIS 3.69 = U.S. $1.00, based on the average representative rate of exchange between the NIS and the U.S. dollar as reported by the Bank of Israel during such period of time.

 

   Salary,
bonuses and
Related
Benefits
   Pension,
Retirement
and Other
Similar
Benefits
   Share
Based
Compensation(1)
 
All directors and senior management as a group, consisting of 12 persons for the year ended December 31, 2023(1)  $763   $35   $0 

 

(1)Includes Asaf Itzhaik who served as External Director until his resignation on December 14, 2023.

 

61

 

 

For so long as we qualify as a foreign private issuer, we will not be required to comply with the proxy rules applicable to U.S. domestic companies regarding disclosure of the compensation of certain executive officers on an individual basis. In accordance with the Israeli Companies Law, we are required to disclose the compensation granted to our five most highly compensated officers. The table below reflects the compensation granted during or with respect to the year ended December 31, 2023.

 

Executive Officer  Salary
and Related
Benefits(1)
   Bonus
Payments,
Benefits
and
Perquisites
   Share-Based
Compensation(2)
   Total 
Viki Hakmon  $249   $-   $-   $249 
                     
Ronen Zalayet  $113   $-   $-   $113 
                     
Naor Bergman  $119   $35   $-   $154 
                     
Oz Adler  $110   $-    -   $110 

 

Each of the members of our board of directors is the 5th most highly paid office holder. For further information, see Item 6B above.

 

(1) Represents the directors’ and senior management’s gross salary plus payment of mandatory social benefits made by the company on behalf of such persons. Such benefits may include, to the extent applicable to the executive, payments, contributions and/or allocations for savings funds, education funds (referred to in Hebrew as “Keren Hishtalmut”), pension, severance, risk insurances (e.g., life or work disability insurance) and payments for social security.
   
(2) Share-based compensation includes the cost of our non-cash share-based compensation in 2023.

 

Employment and Service Agreements with Executive Officers

 

We have entered into written employment and service agreements with each of our executive officers. All of these agreements contain customary provisions regarding confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited under applicable law. In addition, we have entered into our standard form of indemnification agreement, in the form filed as an exhibit to this Annual Report on Form 20-F, with each of our directors and members of our senior management. Each such indemnification agreement provides the indemnified person with indemnification to the maximum extent permitted under applicable law and up to a certain amount, and to the extent that these liabilities are not covered by directors and officers insurance or other indemnification agreement. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.

 

Directors’ Service Contracts

 

Other than with respect to our directors that are also executive officers, we do not have written agreements with any director providing for benefits upon the termination of his employment with the Company.

 

Incentive Option Plan

 

Our 2022 Incentive Option Plan, or our 2022 Incentive Plan, was approved by our board of directors on January 19, 2022. The 2022 Incentive Plan provides for the grant of options to our directors, employees, officers, consultants and service providers who are our employees, officers, directors or consultants, as well as those of our affiliated companies. As of March 28, 2024, no Ordinary Shares had been issued under our 2022 Incentive Plan and the total number of Ordinary Shares reserved for the exercise of options granted under our 2022 Incentive Plan is 186,718.

 

62

 

 

Our 2022 Incentive Plan is administered by our board of directors, regarding the granting of options and the terms of option grants, including exercise price, method of payment, vesting schedule, acceleration of vesting and the other matters necessary in the administration of this plan.

 

Eligible Israeli employees, officers and directors, would qualify for provisions of Section 102(b)(2) of the Israeli Income Tax Ordinance [New Version], or the Tax Ordinance. Pursuant to such Section 102(b)(2) of the Tax Ordinance, qualifying options and shares issued upon exercise of such options are held in escrow and registered in the name of an escrow agent selected by the board of directors. The escrow agent may not release these options or shares to the holders thereof for two years from the date of the registration of the options in the name of the escrow agent. Under Section 102 of the Tax Ordinance, any tax payable by an employee from the grant or exercise of the options is deferred until the transfer of the options or Ordinary Shares by the escrow agent to the employee or upon the sale of the options or Ordinary Shares, and gains may qualify to be taxed as capital gains at a rate equal to 25%, subject to compliance with specified conditions. Under Israeli tax law, Israeli non-employee service providers and controlling shareholders may only be granted options under Section 3(9) of the Tax Ordinance, which does not provide the full tax benefits.

 

As a default, our 2022 Incentive Plan provides that upon termination of employment for any reason, other than in the event of death, retirement, disability or cause, all unvested options will expire and all vested options will generally be exercisable for 90 days following such termination, subject to the terms of our 2022 Incentive Plan and the governing option agreement.

 

Notwithstanding the foregoing, in the event the engagement is terminated for cause, including, inter alia, due to dishonesty toward the Company or its affiliate, substantial malfeasance or nonfeasance of duty, unauthorized disclosure of confidential information, and conduct substantially prejudicial to the business of the Company or affiliate; or any substantial breach by the optionee of his or her employment or service agreement, all options granted to such optionee, whether vested or unvested, will not be exercisable and will terminate on the date of the termination of his employment.

 

Upon termination of employment due to death or disability, all the options vested at the time of termination and within 60 days after the date of such termination, will generally be exercisable for six (6) months, or such other period as determined by the plan administrator, subject to the terms of our 2022 Incentive Plan and the governing option agreement.

 

C. Board Practices

 

Introduction

 

Our board of directors presently consists of nine members, including our two external directors appointed under the Companies Law. We believe that Tomer Etzyoni, Israel Berstein and Moshe Revach are “independent” for purposes of the Nasdaq listing rules and SEC rules and regulations. Our amended and restated articles of association provide that the number of board of directors’ members shall be no less than three and not more than twelve (including the external directors). Pursuant to the Companies Law, the management of our business is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible for our day-to-day management and have individual responsibilities established by our board of directors. Our Chief Executive Officer is appointed by, and serves at the discretion of, our board of directors, subject to the employment agreement that we have entered into with him. All other executive officers are appointed by our Chief Executive Officer. Their terms of employment are subject to the approval of the board of directors’ compensation committee of the board of directors, and are subject to the terms of any applicable employment agreements that we may enter into with them.

 

Each director, except external directors, will hold office until the annual general meeting of our shareholders for the year in which such director’s term expires, unless the tenure of such director expires earlier pursuant to the Companies Law or unless he or she is removed by the holders of at least 70% of the total voting power of our shareholders or upon the occurrence of certain events, in accordance with the Companies Law and our amended and restated articles of association. Our amended and restated articles of association provide that the directors are classified, with respect to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable, and designated as Class I, Class II and Class III. The initial Class I directors shall hold office until the first annual general meeting to be held in 2026 and until their successors shall have been elected and qualified. The initial Class II directors shall hold office until the annual general meeting to be held in 2024 and until their successors shall have been elected and qualified. The initial Class III directors shall hold office until the annual general meeting to be held in 2025 and until their successors shall have been elected and qualified. The Board may assign members of the Board already in office to such classes at the time such classification becomes effective. If the number of directors is changed, any newly created directors or decrease in directors must be apportioned by the board among the classes to make them equal in number.

 

63

 

 

In addition, under certain circumstances, our amended and restated articles of association allow our board of directors to appoint directors to fill vacancies on our board of directors or in addition to the acting directors (subject to the limitation on the number of directors), in one of the classes and until the next annual general meeting according to the appropriate class in which directors may be appointed or terminated. External directors may be elected for up to two additional three-year terms after their initial three-year term under the circumstances described below, with certain exceptions as described in “External Directors” below. External directors may be removed from office only under the limited circumstances set forth in the Companies Law. See “Item 6.C. Board Practices — External Directors” below.

 

Under the Companies Law, any shareholder holding at least one percent of our outstanding voting power may ask to add nomination of a director for the approval of the general meeting of shareholders. However, any such shareholder may make such a nomination only if a written notice of such shareholder’s intent to make such nomination has been given to our board of directors. Any such notice must include certain information, including the consent of the proposed director nominee to serve as our director if elected, and a declaration that the nominee signed declaring that he or she possesses the requisite skills and has the availability to carry out his or her duties. Additionally, the nominee must provide details of such skills, and demonstrate an absence of any limitation under the Companies Law that may prevent his or her election, and affirm that all of the required election-information is provided to us, pursuant to the Companies Law.

 

Under the Companies Law, our board of directors must determine the minimum number of directors who are required to have accounting and financial expertise. In determining the number of directors required to have such expertise, our board of directors must consider, among other things, the type and size of the company and the scope and complexity of its operations. Our board of directors has determined that the minimum number of directors of our company who are required to have accounting and financial expertise is one.

 

The board of directors must elect one director to serve as the chairman of the board of directors to preside at the meetings of the board of directors, and may also remove that director as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any of his or her relatives is permitted to serve as the chairman of the board of directors, and a company may not vest the chairman or any of his or her relatives with the chief executive officer’s authorities. In addition, a person who reports, directly or indirectly, to the chief executive officer may not serve as the chairman of the board of directors; the chairman may not be vested with authorities of a person who reports, directly or indirectly, to the chief executive officer; and the chairman may not serve in any other position in the company or a controlled company, but he or she may serve as a director or chairman of a controlled company. However, the Companies Law permits a company’s shareholders to determine, for a period not exceeding three years from each such determination or five years following a company’s initial public offering, that the chairman or his or her relative may serve as chief executive officer or be vested with the chief executive officer’s authorities, and that the chief executive officer or his or her relative may serve as chairman or be vested with the chairman’s authorities. Such determination of a company’s shareholders requires either: (1) the approval of at least a majority of the shares of those shareholders present and voting on the matter (other than controlling shareholders and those having a personal interest in the determination) (shares held by abstaining shareholders shall not be considered); or (2) that the total number of shares opposing such determination does not exceed 2% of the total voting power in the company. We refer to this special majority hereinafter as the Special Majority Approval. The chairman of our board of directors is Mr. Oz Adler.

 

The board of directors may, subject to the provisions of the Companies Law, delegate any or all of its powers to committees of the board, and it may, from time to time, revoke such delegation or alter the composition of any such committees, subject to certain limitations. Unless otherwise expressly provided by the board of directors, the committees shall not be empowered to further delegate such powers. The composition and duties of our audit committee and compensation committee are described below.

 

The board of directors oversees how management monitors compliance with our risk management policies and procedures, and reviews the adequacy of the risk management framework in relation to the risks faced by us. The board of directors is assisted in its oversight role by an internal auditor. The internal auditor undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to our audit committee.

 

64

 

 

External Directors

 

Under the Companies Law, an Israeli company whose shares have been offered to the public or whose shares are listed for trading on a stock exchange in or outside of Israel is required to appoint at least two external directors to serve on its board of directors. External directors must meet stringent standards of independence. On September 29, 2022, we convened a Special General Meeting of Shareholders in which the Company’s shareholders appointed Tomer Etzyoni and Asaf Itzhaik to serve as external directors on our board of directors for a three-year term. On December 14, 2023, Asaf Itzhaik resigned from the board of directors of the Company, effective immediately. Subsequently, Mr. Israel Yakov Berenstein was appointed to serve as an external director in accordance with the Companies Law and as a member of the compensation committee and the audit committee, effective immediately, following the approval by the shareholders of the Company at a Special General Meeting of Shareholders which was convened on that day.

 

According to regulations promulgated under the Companies law, at least one of the external directors is required to have “financial and accounting expertise,” and the other external director or directors are required to have “professional expertise.” However, under regulations promulgated pursuant to the Companies Law, a company whose shares are listed for trading on specified exchanges outside of Israel, including Nasdaq, may elect not to appoint an external director with “financial and accounting expertise”, provided, that all of the Company’s external directors have at least “professional expertise”. Our board of directors has determined that Tomer Etzyoni and Israel Berstein each have professional expertise.

 

A director with accounting and financial expertise is a director who, due to his or her education, experience and skills, possesses a high degree of proficiency in, and an understanding of, business — accounting matters and financial statements, such that he or she is able to understand the financial statements of the company in depth and initiate a discussion about the manner in which financial data is presented. A director is deemed to have “professional expertise” if he or she holds an academic degree in certain fields or has at least five years of experience in certain senior positions.

 

External directors are elected by a majority vote at a shareholders’ meeting, as long as either:

 

at least a majority of the shares held by shareholders who are not controlling shareholders and do not have personal interest in the appointment (excluding a personal interest that did not result from the shareholder’s relationship with the controlling shareholder) have voted in favor of the proposal (shares held by abstaining shareholders shall not be considered); which we refer to as a disinterested majority; or

 

the total number of shares voted by non-controlling shareholders and by shareholders who do not have a personal interest in the election of the external director, against the election of the external director, does not exceed 2% of the aggregate voting rights of the company.

 

The term “control” is defined in the Companies Law as the ability to direct the activities of the company, other than by virtue of being an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder “holds” (within the meaning of the Companies Law) 50% or more of the voting rights in a company or has the right to appoint 50% or more of the directors of the company or its general manager. With respect to certain matters, a controlling shareholder is deemed to include a shareholder that holds 25% or more of the voting rights in a public company if no other shareholder holds more than 50% of the voting rights in the company, but excludes a shareholder whose power derives solely from his or her position as a director of the company or from any other position with the company. For the purpose of determining the holding percentage stated above, two or more shareholders who have a personal interest in a transaction that is brought for the company’s approval are deemed as joint holders.

 

65

 

 

The Companies Law provides for an initial three-year term for an external director. Thereafter, an external director may be re-elected by shareholders to serve in that capacity for up to two additional three-year terms, provided that:

 

(1)his or her service for each such additional term is recommended by one or more shareholders holding at least one percent of the company’s voting rights and is approved at a shareholders meeting by a disinterested majority, where the total number of shares held by non-controlling, disinterested shareholders voting for such re-election exceeds two percent of the aggregate voting rights in the company and subject to additional restrictions set forth in the Companies Law with respect to the affiliation of the external director nominee as described below;

 

(2)his or her service for each such additional term is recommended by the board of directors and is approved at a shareholders meeting by the same majority required for the initial election of an external director (as described above); or

 

(3)the external director offered his or her service for each such additional term and was approved in accordance with the provisions of section (1) above.

 

The term of office for external directors for Israeli companies traded on certain foreign stock exchanges, including the Nasdaq listing, may be extended indefinitely in increments of additional three-year terms, in each case provided that the audit committee and the board of directors of the company confirm that, in light of the external director’s expertise and special contribution to the work of the board of directors and its committees, the re-election for such additional period(s) is beneficial to the company, and provided that the external director is re-elected subject to the same shareholder vote requirements for the re-election of external directors (as described above). Prior to the approval of the reelection- of the external director at a general shareholders meeting, the company’s shareholders must be informed of the term previously served by him or her and of the reasons why the board of directors and audit committee recommended the extension of his or her term.

 

The Companies Law provides that a person is not qualified to serve as an external director if (i) the person is a relative of a controlling shareholder of the company, or (ii) if that person or his or her relative, partner, employer, another person to whom he or she was directly or indirectly subordinate, or any entity under the person’s control, has or had, during the two years preceding the date of appointment as an external director: (a) any affiliation or other disqualifying relationship with the company, with any person or entity controlling the company or a relative of such person, or with any entity controlled by or under common control with the company; or (b) in the case of a company with no shareholder holding 25% or more of its voting rights, had at the date of appointment as an external director, any affiliation or other disqualifying relationship with a person then serving as chairman of the board or chief executive officer, with a holder of 5% or more of the issued share capital or voting power in the company or with the most senior financial officer.

 

The term “relative” is defined under the Companies Law as a spouse, sibling, parent, grandparent or descendant; spouse’s sibling, parent or descendant; and the spouse of each of the foregoing persons.

 

Under the Companies Law, the term “affiliation” and the similar types of disqualifying relationships include (subject to certain exceptions):

 

an employment relationship;

 

a business or professional relationship even if not maintained on a regular basis (excluding insignificant relationships);

 

66

 

 

control; and

 

service as an office holder, excluding service as a director in a private company prior to the initial public offering of its shares if such director was appointed as a director of the private company in order to serve as an external director following the initial public offering.

 

The term “office holder” is defined under the Companies Law as a general manager, chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities of any of these positions regardless of that person’s title, a director and any other manager directly subordinate to the general manager.

 

In addition, no person may serve as an external director if that person’s position or professional or other activities create, or may create, a conflict of interest with that person’s responsibilities as a director or otherwise interfere with that person’s ability to serve as a director or if the person is an employee of the Israel Securities Authority or of an Israeli stock exchange. A person may furthermore not continue to serve as an external director if he or she received direct or indirect compensation from the company including amounts paid pursuant to indemnification and/or exculpation contracts or commitments and insurance coverage, other than for his or her service as an external director as permitted by the Companies Law and the regulations promulgated thereunder.

 

Following the termination of an external director’s service on a board of directors, such former external director and his or her spouse and children may not be provided a direct or indirect benefit by the company, its controlling shareholder or any entity under its controlling shareholder’s control. This includes engagement as an office holder or director of the company or a company controlled by its controlling shareholder or employment by, or provision of services to, any such company for consideration, either directly or indirectly, including through a corporation controlled by the former external director. This restriction extends for a period of two years with regard to the former external director and his or her spouse or child and for one year with respect to other relatives of the former external director.

 

External directors may be removed only by a special general meeting of shareholders called by the board of directors after the board has determined the occurrence of circumstances allow such dismissal, at the same special majority of shareholders required for their election or by a court, only under limited circumstances, including if the external directors cease to meet the statutory qualifications for their appointment or if they violate their duty of loyalty to our company. An external director may also be removed by order of an Israeli court if, following a request made by a director or shareholder of the company, the court finds that such external director has ceased to meet the statutory qualifications for his or her appointment as stipulated in the Companies Law or has violated his or her duty of loyalty to the company. In the event of a vacancy created by an external director which causes the company to have fewer than two external directors, the board of directors is required under the Companies Law to call a shareholders meeting as soon as possible to appoint a replacement external director. Each committee of the board of directors that exercises the powers of the board of directors must include at least one external director, except that the audit committee and the compensation committee must include all external directors then serving on the board of directors and an external director must serve as chair thereof.

 

Under the Companies Law, external directors of a company are prohibited from receiving, directly or indirectly, any compensation from the company other than for their services as external directors pursuant to the Companies Law and the regulations promulgated thereunder. Compensation of an external director is determined prior to his or her appointment in accordance with regulations adopted under the Companies Law and may not be changed during his or her term subject to certain exceptions.

 

If at the time at which an external director is appointed all members of the board of directors who are not controlling shareholders or relatives of controlling shareholders of the company are of the same gender, the external director to be appointed must be of the other gender. A director of a company may not be appointed as an external director of another company if at the same time a director of such other company is acting as an external director of the first company.

 

Under regulations promulgated pursuant to the Companies Law, a company with no controlling shareholder whose shares are listed for trading on specified exchanges outside of Israel, including Nasdaq, may adopt exemptions from various corporate governance requirements of the Companies Law, so long as such company satisfies the requirements of applicable foreign country laws and regulations, including applicable stock exchange rules, that apply to companies organized in that country and relating to the appointment of independent directors and the composition of audit and compensation committees. Such exemptions include an exemption from the requirement to appoint external directors and the requirement that an external director be a member of certain committees, as well as exemption from limitations on directors’ compensation. We may use these exemptions in the future if we do not have a controlling shareholder.

 

67

 

 

Unaffiliated Directors Under the Companies Law

 

An “unaffiliated director” is either an external director or a director who (i) meets the same non-affiliation criteria as an external director, except for (y) the requirement that the director be an Israeli resident (which does not apply to companies such as ours whose securities have been offered outside of Israel or are listed outside of Israel) and (z) the requirement for accounting and financial expertise or professional qualifications, as determined by the audit committee, and (ii) who has not served as a director of the company for more than nine consecutive years. For these purposes, ceasing to serve as a director for a period of two years or less would not be deemed to sever the consecutive nature of such director’s service.

 

Regulations promulgated pursuant to the Companies Law provide that a director in a public company whose shares are listed for trading on specified exchanges outside of Israel, including Nasdaq, who qualifies as an independent director under the relevant non-Israeli rules and who meets certain non-affiliation criteria, which are less stringent than those applicable to unaffiliated directors as set forth above, would be deemed an “unaffiliated” director pursuant to the Companies Law provided: (i) he or she has not served as a director for more than nine consecutive years; (ii) he or she has been approved as such by the audit committee; and (iii) his or her remuneration shall be in accordance with the Companies Law and the regulations promulgated thereunder. For these purposes, ceasing to serve as a director for a period of two years or less would not be deemed to sever the consecutive nature of such director’s service.

 

Furthermore, pursuant to these regulations, such company may reappoint a person as an unaffiliated director for additional terms, beyond nine years, which do not exceed three years each, if each of the audit committee and the board of directors determine, in that order, that in light of the unaffiliated director’s expertise and special contribution to the board of directors and its committees, the reappointment for an additional term is in the company’s best interest.

 

Alternate Directors

 

Our amended and restated articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions set thereto including approval of the nominee by our board of directors, appoint a person as an alternate to act in his place, to remove the alternate and appoint another in his place and to appoint an alternate in place of an alternate whose office is vacated for any reason whatsoever. Under the Companies Law, a person who is not qualified to be appointed as a director, a person who is already serving as a director or a person who is already serving as an alternate director for another director, may not be appointed as an alternate director. Nevertheless, a director who is already serving as a director may be appointed as an alternate director for a member of a committee of the board of directors so long as he or she is not already serving as a member of such committee, and if the alternate director is to replace an external director, he or she is required to be an external director and to have either “financial and accounting expertise” or “professional expertise,” depending on the qualifications of the external director he or she is replacing. A person who does not have the requisite “financial and accounting experience” or the “professional expertise,” depending on the qualifications of the external director he or she is replacing, may not be appointed as an alternate director for an external director. A person who is not qualified to be appointed as an unaffiliated director, pursuant to the Companies Law, may not be appointed as an alternate director of an unaffiliated director qualified as such under the Companies Law. Unless the appointing director limits the time or scope of the appointment, the appointment is effective for all purposes until the appointing director ceases to be a director or terminates the appointment.

 

Committees of the Board of Directors

 

Our board of directors has established two standing committees, the audit committee and the compensation committee.

 

Audit Committee

 

Our audit committee is composed of Moshe Revach, Israel Berstein and Tomer Etzyoni. Israel Berstein is the chairman of the audit committee.

 

68

 

 

Companies Law Requirements

 

Under the Companies Law, we are required to appoint an audit committee. The audit committee must be composed of at least three directors, including all of the external directors (one of whom must serve as chair of the committee). The audit committee may not include the chairman of the board; a controlling shareholder of the company or a relative of a controlling shareholder; a director employed by or providing services on a regular basis to the company, to a controlling shareholder or to an entity controlled by a controlling shareholder; or a director who derives most of his or her income from a controlling shareholder.

 

In addition, a majority of the members of the audit committee of a publicly traded company must be “unaffiliated directors” under the Companies Law. Each member of our audit committee is an unaffiliated director under the Companies Law, thereby fulfilling the foregoing Israeli law requirement for the composition of the audit committee.

 

Audit Committee Role

 

Under the Companies Law, our audit committee will be responsible for:

 

  (i) determining whether there are deficiencies in the business management practices of our company, and making recommendations to the board of directors to improve such practices;

 

  (ii) determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and whether such transaction is extraordinary or material under Companies Law) and establishing the approval process for certain transactions with a controlling shareholder or in which a controlling shareholder has a personal interest. See “Item 6.C. Board Practices — Fiduciary Duties and Approval of Related Party Transactions under Israeli law” for additional information;

 

  (iii) determining the approval process for transactions that are “non-negligible” (i.e., transactions with a controlling shareholder that are classified by the audit committee as non-negligible, even though they are not deemed extraordinary transactions), as well as determining which types of transactions would require the approval of the audit committee, optionally based on criteria which may be determined annually in advance by the audit committee;

 

  (iv) examining our internal controls and internal auditor’s performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;

 

  (v) examining the scope of our auditor’s work and compensation and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering the appointment of our auditor;

 

  (vi) establishing procedures for the handling of employees’ complaints as to deficiencies in the management of our business and the protection to be provided to such employees; and

 

  (vii) where the board of directors approves the working plan of the internal auditor, examining such working plan before its submission to the board of directors and proposing amendments thereto.

 

Our audit committee may not conduct any discussions or approve any actions requiring its approval. See “Item 6.C. Board Practices — Fiduciary Duties and Approval of Related Party Transactions under Israeli law” for additional information, unless at the time of the approval a majority of the committee’s members are present, which majority consists of unaffiliated directors under the Companies Law, including at least one external director.

 

69

 

 

Our board of directors adopted an audit committee charter which was effective upon the listing of our Ordinary Shares on Nasdaq setting forth, among others, the responsibilities of the audit committee consistent with the rules of the SEC and Nasdaq listing rules (in addition to the requirements for such committee under the Companies Law), including, among others, the following:

 

  oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in accordance with Israeli law;

 

  recommending the engagement or termination of the person filling the office of our internal auditor, reviewing the services provided by our internal auditor and reviewing effectiveness of our system of internal control over financial reporting;

 

  recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our board of directors; and

 

  reviewing and monitoring, if applicable, legal matters with significant impact, finding of regulatory authorities’ findings, receive reports regarding irregularities and legal compliance, acting according to “whistleblower policy” and recommend to our board of directors if so required.

 

Nasdaq Listing Rules for Audit Committee

 

Under the Nasdaq listing rules, we are required to maintain an audit committee consisting of at least three members, all of whom are independent and are financially literate and one of whom has accounting or related financial management expertise.

 

As noted above, the members of our audit committee include Israel Berstein and Tomer Etzyoni, who are external directors, and Moshe Revach, each of whom is “independent,” as such term is defined in under Nasdaq listing rules and Rule 10A-3 under the Exchange Act. All members of our audit committee meet the requirements for financial literacy under the Nasdaq listing rules. Our board of directors has determined that Moshe Revach is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq listing rules.

 

Compensation Committee

 

Our compensation committee is composed of Moshe Revach, Tomer Etzyoni and Israel Berstein. Israel Berstein is the chairman of the compensation committee.

 

Companies Law Requirements

 

Under the Companies Law, the board of directors of any public company must establish a compensation committee. The compensation committee must be composed of at least three directors, including all of the external directors, who must constitute a majority of the members of the compensation committee. The chairman of the compensation committee must be an external director. Each compensation committee member that is not an external director must be a director whose compensation is determined pursuant to the Companies Law Regulations. The compensation committee is subject to the same Companies Law restrictions as the audit committee as to: (a) who may not be a member of the committee; and (b) who may not be present during committee deliberations as described above.

 

Our compensation committee acts pursuant to a written charter. Our compensation committee complies with the provisions of the Companies Law, the regulations promulgated thereunder, and our amended and restated articles of association, on all aspects referring to its independence, authorities and practice. Our compensation committee follows home country practice as opposed to complying with the compensation committee membership and charter requirements prescribed under the Nasdaq listing rules.

 

Nasdaq Listing Rules for Compensation Committee 

 

Under the corporate governance rules of Nasdaq, we are required to maintain a compensation committee consisting of at least two independent directors.

 

Our board of directors has determined that each member of our compensation committee is independent under the corporate governance rules of Nasdaq, including the additional independence considerations applicable to the members of a compensation committee.

 

70

 

 

Compensation Committee Role

 

Our compensation committee reviews and recommends to our board of directors: with respect to our executive officers’ and directors’: (1) annual base compensation (2) annual incentive bonus, including the specific goals and amounts; (3) equity compensation; (4) employment agreements, severance arrangements, and change in control agreements and provisions; (5) retirement grants and/or retirement bonuses; and (6) any other benefits, compensation, compensation policies or arrangements.

 

The duties of the compensation committee include the recommendation to the company’s board of directors of a policy regarding the terms of engagement of office holders, to which we refer as a compensation policy. Such policy must be adopted by the company’s board of directors, after considering the recommendations of the compensation committee. The compensation policy is then brought for approval by our shareholders, which requires the approval of a special majority. See “Item 6.C.— Board Practices — Fiduciary Duties and Approval of Related Party Transactions under Israeli law” for additional information. Under the Companies Law, the board of directors may adopt the compensation policy if it is not approved by the shareholders, provided that after the shareholders oppose the approval of such policy, the compensation committee and the board of directors revisit the matter and determine that adopting the compensation policy would be in the best interests of the company.

 

If a company that initially offers its securities to the public, like us, adopts a compensation policy in advance of its initial public offering, and describes it in its prospectus for such offering, then such compensation policy shall be deemed a validly adopted policy in accordance with the Companies Law requirements described above. Furthermore, if the compensation policy is established in accordance with the aforementioned relief, then it will remain in effect for a term of five years from the date such company becomes a public company. Accordingly, our compensation policy will remain in effect for five years from our IPO, until August 25, 2027. The compensation policy must serve as the basis for decisions concerning the financial terms of employment or engagement of executive officers and directors, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy must relate to certain factors, including advancement of the company’s objectives, the company’s business and its long-term strategy, and creation of appropriate incentives for office holders. It must also consider, among other things, the company’s risk management, size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:

 

  the education, skills, expertise and accomplishments of the relevant officer holder;

 

  the officer holder’s roles and responsibilities and prior compensation agreements with him or her;

 

  the relationship between the cost of the terms of service of an office holder and the average median compensation of the other employees of the company (including those employed through manpower companies), in particular the ratio between such cost to the average and median salary of such employees of the company including the impact of disparities in salary upon work relationships in the company;

 

  if the terms of employment include variable components the possibility of reducing variable compensation at the discretion of the board of directors; and the possibility of setting a limit on the exercise value of non-cash variable compensation; and

 

  as to severance compensation, the period of service of the office holder, the terms of his or her compensation during such service period, the company’s performance during that period of service, the person’s contribution towards the company’s achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.

 

71

 

 

The compensation policy must also include the following principles:

 

  with the exception of office holders who report to the chief executive officer, a means of determining the variable components on the basis of long-term performance and measurable criteria; provided that the company may determine that an immaterial part of the variable components of the compensation package of an office holder shall be awarded based on non-measurable criteria, or if such amount is not higher than three months’ salary per annum, taking into account such office holder’s contribution to the company;

 

  the relationship between variable and fixed compensation, and the ceiling for the value of variable compensation at the time of payment, or in the case of equity-based compensation, at the time of grant;

 

  the conditions under which an officer holder would be required to repay compensation paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate and such data was restated in the company’s financial statements;

 

  the minimum holding or vesting period for variable, equity-based compensation to be set in the terms of office or employment, as applicable, while taking into consideration long-term incentives; and

 

  maximum limits for severance compensation.

 

The compensation policy must also consider appropriate incentives from a long-term perspective.

 

The compensation committee is responsible for: (1) recommending the compensation policy to a company’s board of directors for its approval (and subsequent approval by the shareholders); and (2) duties related to the compensation policy and to the compensation of a company’s office holders, including:

 

  recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater than three years (approval of either a new compensation policy or the continuation of an existing compensation policy must in any case occur every three years);

 

  recommending to the board of directors periodic updates to the compensation policy;

 

  assessing implementation of the compensation policy;

 

  administering the Company’s clawback policy;

 

determining whether the terms of compensation of certain office holders of the company need not be brought to approval of the shareholders; and

 

  determining whether to approve the terms of compensation of office holders that require the committee’s approval.

 

Our compensation policy is designed to promote our long-term goals, work plan and policy, retain, motivate and incentivize our directors and executive officers, while considering the risks that our activities involve, our size, the nature and scope of our activities and the contribution of an officer to the achievement of our goals and maximization of profits, and align the interests of our directors and executive officers with our long-term performance. To that end, a portion of an executive officer compensation package is targeted to reflect our short and long-term goals, as well as the executive officer’s individual performance. On the other hand, our compensation policy includes measures designed to reduce the executive officer’s incentives to take excessive risks that may harm us in the long-term, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and the total compensation of an executive officer and minimum vesting periods for equity-based compensation.

 

Our compensation policy also addresses our executive officer’s individual characteristics (such as his or her respective position, education, scope of responsibilities and contribution to the attainment of our goals) as the basis for compensation variation among our executive officers, and considers the internal ratios between compensation of our executive officers and directors and other employees. Pursuant to our compensation policy, the compensation that may be granted to an executive officer may include: base salary, annual bonuses, equity-based compensation, benefits and retirement and termination of service arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer’s base salary. In addition, our compensation policy provides for maximum permitted ratios between the total variable (cash bonuses and equity based compensation) and non-variable (base salary) compensation components, in accordance with an officer’s respective position with the company.

 

72

 

 

An annual cash bonus may be awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may be granted to executive officers other than our chairman or Chief Executive Officer may be based entirely on a discretionary evaluation. Our Chief Executive Officer will be entitled to recommend performance objectives to such executive officers, and such performance objectives will be approved by our compensation committee (and, if required by law, by our board of directors).

 

The performance measurable objectives of our chairman and Chief Executive Officer will be determined annually by our compensation committee and board of directors. A less significant portion of the chairman’s and/or the Chief Executive Officer’s annual cash bonus may be based on a discretionary evaluation of the chairman’s or the Chief Executive Officer’s respective overall performance by the compensation committee and the board of directors based on quantitative and qualitative criteria.

 

The equity-based compensation under our compensation policy for our executive officers (including members of our board of directors) is designed in a manner consistent with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the executive officers’ interests with our long-term interests and those of our shareholders and to strengthen the retention and the motivation of executive officers in the long term. Our compensation policy provides for executive officer compensation in the form of share options or other equity-based awards, such as restricted shares and phantom, options, in accordance with our share incentive plan then in place. Share options granted to executive officers shall be subject to vesting periods in order to promote long-term retention of the awarded executive officers. The equity-based compensation shall be granted from time to time and be individually determined and awarded according to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities of the executive officer.

 

In addition, our compensation policy contains compensation recovery provisions which allows us under certain conditions to recover bonuses paid in excess, enables our Chief Executive Officer to approve an immaterial change in the terms of employment of an executive officer (provided that the changes of the terms of employment are in accordance our compensation policy) and allows us to exculpate, indemnify and insure our executive officers and directors subject to certain limitations set forth thereto.

 

Following the SEC approval of Nasdaq’s proposed clawback listing standards, under Rule 10D-1, or the Clawback Listing Rules, which directed companies to adopt and comply with a written clawback policy, to disclose and file the policy as an exhibit to its annual reports, we have adopted as of October 2, 2023, a clawback policy as contemplated pursuant to the Clawback Listing Rules, and have filed as Exhibit 97 to this Annual Report on Form 20-F.

 

Our compensation policy also provides for compensation to the members of our board of directors either: (i) in accordance with the amounts provided in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director) of 2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel) of 2000, as such regulations may be amended from time to time; or (ii) in accordance with the amounts determined in our compensation policy.

 

Internal Auditor

 

Under the Companies Law, the board of directors of an Israeli public company must appoint an internal auditor nominated by the audit committee. The role of the internal auditor is to examine, among other things, whether a company’s actions comply with the law and proper business procedure. The audit committee is required to oversee the activities, and to assess the performance of the internal auditor as well as to review the internal auditor’s work plan. An internal auditor may not be an interested party or office holder, or a relative of any interested party or office holder, and may not be a member of the company’s independent accounting firm or its representative. The Companies Law defines an interested party as a holder of 5% or more of the outstanding shares or voting rights of a company, any person or entity that has the right to appoint at least one director or the general manager of the company or any person who serves as a director or as the general manager of a company. Daniel Shapira from Daniel Shapira Accountants was appointed by the board of directors on December 13, 2022, to serve as the Internal Auditor of the Company.

 

73

 

 

Remuneration of Directors

 

Under the Companies Law, remuneration of directors is subject to the approval of the compensation committee, thereafter by the board of directors and thereafter, unless exempted under the regulations promulgated under the Companies Law, by the general meeting of the shareholders. In case the remuneration of the directors is in accordance with regulations applicable to remuneration of the external directors then such remuneration shall be exempt from the approval of the general meeting. Where the director is also a controlling shareholder, the requirements for approval of transactions with controlling shareholders apply.

 

Fiduciary Duties and Approval of Related Party Transactions under Israeli Law

 

Fiduciary Duties of Office Holders

 

The Companies Law imposes a duty of care and a duty of loyalty on all office holders of a company. An office holder is defined in the Companies Law as a general manager, chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities of any of these positions regardless of such person’s title, a director, and any other manager directly subordinate to the general manager.

 

The duty of care requires an office holder to act with the level of care with which a reasonable office holder in the same position would have acted under the same circumstances. The duty of care of an office holder includes a duty to use reasonable means to obtain:

 

  information on the advisability of a given action brought for his approval or performed by him by virtue of his position; and

 

  all other important information pertaining to these actions.

 

The duty of loyalty of an office holder requires an office holder to act in good faith and for the benefit of the company, and includes a duty to:

 

  refrain from any conflict of interest between the performance of his duties in the company and his performance of his other duties or personal affairs;

 

  refrain from any action that is competitive with the company’s business;

 

  refrain from exploiting any business opportunity of the company to receive a personal gain for himself or others; and

 

  disclose to the company any information or documents relating to the company’s affairs which the office holder has received due to his position as an office holder.

 

Related Party Transactions

 

Under the Companies Law, we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described above, if:

 

  the office holder acts in good faith and the act or its approval does not cause harm to the company; and

 

  the office holder disclosed the nature of his or her interest in the transaction (including any significant fact or document) to the company sufficient time before the company’s approval of such matter.

 

Any such approval is subject to the terms of the Companies Law, setting forth, among other things, the appropriate bodies of the company required to provide such approval, and the methods of obtaining such approval.

 

74

 

 

Disclosure of Personal Interests of an Office Holder

 

The Companies Law requires that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at which the transaction is first discussed, any direct or indirect personal interest that he or she may have and all related material information known to him or her relating to any existing or proposed transaction by the company. A personal interest includes an interest of any person in an act or transaction of a company, including a personal interest of one’s relative or of a corporate body in which such person or a relative of such person is a 5% or greater shareholder, director, or general manager or in which such person has the right to appoint at least one director or the general manager, but excluding a personal interest stemming solely from one’s ownership of shares in the company. A personal interest includes the personal interest of a person for whom the office holder holds a voting proxy or the personal interest of the office holder with respect to the officer holder’s vote on behalf of a person for whom he or she holds a proxy even if such shareholder has no personal interest in the matter.

 

The Companies Law does not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders to make such disclosures to our board of directors.

 

Under the Companies Law, unless the articles of association of a company provide otherwise, a transaction with an office holder or with a third party in which the office holder has a personal interest, which is not an extraordinary transaction requires the approval of the board of directors or a committee authorized by the board of directors. If the transaction is an extraordinary transaction in which an office holder has a personal interest, first the audit committee and then the board of directors, in that order, must approve the transaction. Under specific circumstances, shareholder approval may also be required.

 

Under the Companies Law, an extraordinary transaction is a transaction:

 

  not in the ordinary course of business;

 

  not on market terms; or

 

  that is likely to have a material effect on the company’s profitability, assets or liabilities.

 

Generally, a person who has a personal interest in a matter which is considered at a meeting of the board of directors or the audit committee may not be present at such a meeting, or vote on this matter, unless the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present in order to present the transaction that is subject to approval. A director who has a personal interest in a transaction, which is considered at a meeting of the board of directors or the audit committee, may not be present at this meeting or vote on this matter, unless a majority of members of the board of directors or the audit committee, as the case may be, has a personal interest. If a majority of the board of directors has a personal interest, then shareholder approval is generally also required.

 

Disclosure of Personal Interests of a Controlling Shareholder

 

Under the Companies Law, certain disclosure requirements also apply to a controlling shareholder of a public company, in which a controlling shareholder has a personal interest. For these purposes, a controlling shareholder is any shareholder that has the ability to direct the company’s actions, including any shareholder holding 25% or more of the voting rights if no other shareholder owns more than 50% of the voting rights in the company. Two or more shareholders with a personal interest in the approval of the same transaction are deemed to be one shareholder. Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private placement in which a controlling shareholder has a personal interest, as well as transactions for the provision of services whether directly or indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder controls, and transactions concerning the terms of engagement and compensation of a controlling shareholder or a controlling shareholder’s relative, whether as an office holder or an employee, require the approval of (i) the audit committee or the compensation committee, as the case may be, (ii) the board of directors and (iii) a majority of the shares voted by the shareholders of the company participating and voting on the matter in a shareholders’ meeting. In addition, the shareholder approval must fulfill one of the following requirements:

 

  at least a majority of the shares held by shareholders who are not controlling shareholders and have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding abstentions; or

 

  the shares voted by shareholders who and non-controlling shareholders and have no personal interest in the transaction who vote against the transaction represent no more than 2% of the voting rights in the company.

 

75

 

 

In addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest with a term of more than three years requires the abovementioned approval every three years; however, such transactions not involving the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer term is reasonable under the circumstances. In addition, transactions with a controlling shareholder or a controlling shareholder’s relative who serves as an executive officer in a company, directly or indirectly (including through a corporation under his control), involving the receipt of services by a company or their compensation can have a term of five years from the company’s initial public offering under certain circumstances.

 

The Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question. Failure to so indicate will result in the invalidation of that shareholder’s vote for purposes of the Special Majority Approval.

 

Approval of the Compensation of Directors and Executive Officers

 

The compensation of, or an undertaking to indemnify, insure or exculpate, an office holder who is not a director requires the approval of the company’s compensation committee, followed by the approval of the company’s board of directors, and, if such compensation arrangement or an undertaking to indemnify, insure or exculpate is inconsistent with the company’s stated compensation policy, or if the said office holder is the chief executive officer of the company (subject to a number of specific exceptions), then such arrangement is subject to the approval of our shareholders, subject to the Special Majority Approval.

 

Directors. Under the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of the board of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general meeting of our shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided that those provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation committee and board of directors, shareholder approval by the Special Majority Approval will be required.

 

Executive officers other than the chief executive officer. The Companies Law requires the approval of the compensation of a public company’s executive officers (other than the chief executive officer and who does not also serve as a director) in the following order: (i) the compensation committee, (ii) the company’s board of directors, and (iii) only if such compensation arrangement is inconsistent with the company’s stated compensation policy, the company’s shareholders by the Special Majority Approval. However, if the shareholders of the company do not approve a compensation arrangement with a non-director executive officer that is inconsistent with the company’s stated compensation policy, the compensation committee and board of directors may override the shareholders’ decision if each of the compensation committee and the board of directors provide detailed reasons for their decision.

 

An amendment to an existing compensation arrangement with a non-director executive officer requires only the approval of the compensation committee, if the compensation committee determines that the amendment is immaterial. However, if such non-director executive officer is subordinate to the chief executive officer, an immaterial amendment to an existing compensation arrangement shall not require the approval of the compensation committee if (i) such amendment is approved by the chief executive officer, (ii) the company’s compensation policy allows for such immaterial amendments to be approved by the chief executive officer and (iii) the engagement terms are consistent with the company’s compensation policy.

 

76

 

 

Chief executive officer. Under the Companies Law, the compensation of a public company’s chief executive officer is required to be in the following order approved by: (i) the company’s compensation committee; (ii) the company’s board of directors, and (iii) the company’s shareholders by a Special Majority Approval (provided that with respect to a Chief Executive Officer who is also a director of the company, the approval of the shareholders by a simple majority. is required). However, if the shareholders of the company do not approve the compensation arrangement with the chief executive officer, the compensation committee and board of directors may override the shareholders’ decision if each of the compensation committee and the board of directors provides detailed reasons for their decision, provided that the chief executive officer is not also a director of the company. In the case of a new chief executive officer, the compensation committee may exempt the engagement terms of a candidate to serve as the chief executive officer from shareholders’ approval, if the compensation committee determines that the compensation arrangement is consistent with the company’s stated compensation policy, that the chief executive officer did not have on the date of his appointment or during the two-year period preceding his appointment, an “affiliation” (including an employment relationship, a business or professional relationship or control) with the company or a controlling shareholder of the company or a relative thereof) and that subjecting the approval to a shareholder vote would impede the company’s ability to attain the candidate to serve as the company’s chief executive officer (and provide detailed reasons for the latter). However, if the chief executive officer candidate will serve as a member of the board of directors, such candidate’s compensation terms as chief executive officer must be approved in accordance with the rules applicable to approval of compensation of directors.

 

The approval of each of the compensation committee and the board of directors, with regard to the office holders and directors above, must be in accordance with the company’s stated compensation policy; however, under special circumstances, the compensation committee and the board of directors may approve compensation terms of a chief executive officer that are inconsistent with the company’s compensation policy provided that they have considered those provisions that must be included in the compensation policy according to the Companies Law and that shareholder approval was obtained by the Special Majority Approval.

 

Duties of Shareholders

 

Under the Companies Law, a shareholder has a duty to refrain from abusing his power in the company and to act in good faith and in a customary manner in exercising his rights and performing his obligations toward the company and other shareholders, including, among other things, in voting at general meetings of shareholders (and at shareholder class meetings) on the following matters:

 

  amendment of the articles of association;

 

  increase in the company’s authorized share capital;

 

  merger; and

 

  the approval of related party transactions and acts of office holders that require shareholder approval.

 

A shareholder also has a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of contract will also apply to a breach of the above-mentioned duties, and in the event of oppression of other shareholders, additional remedies are available to the injured shareholder.

 

In addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any shareholder that, under a company’s articles of association, has the power to appoint or prevent the appointment of an office holder, or has another power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with fairness, taking the shareholder’s position in the company into account.

 

77

 

 

Exculpation, Insurance and Indemnification of Directors and Officers

 

Insurance

 

As permitted under the Companies Law, a company may obtain insurance for any of its office holders against the following liabilities incurred due to acts he or she performed as an office holder, if and to the extent provided for in the company’s articles of association:

 

  breach of his or her duty of care to the company or to a third party, including a breach arises out of the negligent conduct of the office holder;

 

  a breach of his or her duty of loyalty to the company, provided that the office holder acted in good faith and had reasonable cause to assume that his or her act would not prejudice the company’s interests; and

 

  a financial liability imposed upon him or her in favor of a third party.

 

  financial liability imposed on the office holder in favor of a third-party harmed by a breach in an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law;

 

  expenses incurred or to be incurred by an office holder in connection with an administrative proceeding, instituted against him or her, pursuant to certain provisions of the Israeli Securities Law, including reasonable litigation expenses, and including attorneys’ fees; and

 

  any other event in respect of which it is permitted and/or shall be permitted by Law to insure the liability of an officeholder.

 

Our amended and restated articles of association provide that we may incuse an office holder against the abovementioned liabilities. Accordingly, we maintain directors’ and officers’ liability insurance, providing total coverage of $5 million for the benefit of all of our directors and officers, in respect of which we expect to pay a twelve-month premium of approximately $400 thousand, which expires on August 23, 2023.

 

Indemnification

 

The Companies Law and the Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company may indemnify an office holder against the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of an event or following an event, provided its articles of association include a provision authorizing such indemnification:

 

  a financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity as an office holder, including a settlement or arbitrator’s award approved by a court;

 

  reasonable litigation expenses, including attorneys’ fees, expended by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; or (b) in connection with a monetary sanction;

 

  reasonable litigation expenses, including attorneys’ fees, expended by the office holder or imposed on him or her by a court: (1) in proceedings that the company institutes, or that another person institutes on the company’s behalf, against him or her; (2) in a criminal proceedings of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent;

 

  expenses incurred by an office holder in connection with an administrative procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys’ fees. An “Administrative Procedure” is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law; and

 

  any other obligation or expense in respect of which it is permitted or will be permitted under the Companies Law, to indemnify an officer or director, subject to and in accordance with all applicable law.

 

78

 

 

The Companies Law also permits a company to undertake in advance to indemnify an office holder, provided that if such indemnification relates to financial liability imposed on him or her, as described above, then the undertaking should be limited and shall detail the following foreseen events and amount or criterion:

 

  to events that in the opinion of the board of directors can be foreseen based on the company’s activities at the time that the undertaking to indemnify is made; and

 

  in amount or criterion determined by the board of directors, at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances.

 

We have entered into our standard form of indemnification agreement, the form of which is filed as an exhibit to this Annual Report on Form 20-F, with each of our directors and with all members of our senior management. Each such indemnification agreement provides the indemnified person with indemnification to the maximum extent permitted under applicable law and up to a certain amount, and to the extent that these liabilities are not covered by directors and officers insurance or other indemnification agreement.

 

Exculpation

 

Under the Companies Law, an Israeli company may not exculpate an office holder from liability for a breach of his or her duty of loyalty, but may exculpate in advance an office holder from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such exculpation is included in its articles of association. Our amended and restated articles of association provide that we may exculpate, in whole or in part, any office holder from liability to us for damages caused to the company as a result of a breach of his or her duty of care, but prohibit an exculpation from liability arising from a company’s transaction in which our controlling shareholder or officer has a personal interest. Subject to the aforesaid limitations, under the indemnification agreements, we exculpate and release our office holders from any and all liability to us related to any breach by them of their duty of care to us to the fullest extent permitted by law. An Israeli company may not exculpate in advance a director from liability arising from a breach of his or her duty of care in connection with a prohibited dividend or distribution to shareholders.

 

Limitations

 

The Companies Law provides that we may not exculpate or indemnify an office holder nor enter into an insurance contract that would provide coverage for any liability incurred as a result of any of the following: (1) a breach by the office holder of his or her duty of loyalty except for indemnification and insurance for a breach of loyalty to the extent the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice us; (2) a breach by the office holder of his or her duty of care if the breach was carried out intentionally or recklessly (as opposed to merely negligently); (3) any act or omission committed with the intent to derive an illegal personal benefit; or (4) any fine, monetary sanction, penalty or forfeit levied against the office holder.

 

Under the Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with respect to directors, the chief executive officer or controlling shareholders, their relatives and third parties in which controlling shareholders have a personal interest, also by the shareholders. However, under regulations promulgated under the Companies Law, the insurance of office holders shall not require shareholder approval and may be approved by only the compensation committee if the engagement terms are determined in accordance with the company’s compensation policy, which was approved by the shareholders by the same special majority required to approve a compensation policy, provided that the insurance policy is on market terms and the insurance policy is not likely to materially impact the company’s profitability, assets, or obligations.

 

79

 

 

Our amended and restated articles of association permit us to exculpate (subject to the aforesaid limitation), indemnify and insure our office holders to the fullest extent permitted or to be permitted by the Companies Law.

 

The foregoing descriptions summarize the material aspects and practices of our board of directors. For additional details, we also refer you to the full text of the Companies Law, as well as of our amended and restated articles of association, which are filed as exhibits to this Annual Report on Form 20-F and are incorporated herein by reference.

 

As of the date of this Annual Report on Form 20-F, no claims for directors’ and officers’ liability insurance have been filed under this policy and we are not aware of any pending or threatened litigation or proceeding involving any of our office holders, including our directors, in which indemnification is sought.

 

D. Employees

 

As of March 28, 2024, we had ten full-time employees and two part time employees. None of our employees are members of a union or subject to the terms of a collective bargaining agreement.

 

None of our employees are members of a union or subject to the terms of a collective bargaining agreement. However, in Israel, we are subject to certain Israeli Labor laws, regulations and national labor court precedent rulings, as well as certain provisions of collective bargaining agreements applicable to us by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Industry and Economy Office, and which apply such agreement provisions to our employees even though they are not part of a union that has signed a collective bargaining agreement. We have never experienced labor related work stoppages or strikes and believe that our relations with our employees are good.

 

All of our employment and consulting agreements include the employee’s and consultant’s undertaking with respect to assignment to us of intellectual property rights developed in the course of employment and confidentiality provisions. The enforceability of such provisions may be limited by Israeli law.

 

E. Share Ownership

 

See “Item 7.A. Major Shareholders” below.

 

F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation

 

Not applicable.

 

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

The following table sets forth information regarding beneficial ownership of our Ordinary Shares as of March 28, 2024 by:

 

  each person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;
     
  each of our directors, and executive officers; and
     
  all of our directors, and executive officers as a group.

 

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to Ordinary Shares. Ordinary Shares issuable pursuant to outstanding options or warrants to purchase Ordinary Shares that are exercisable, or securities that are convertible into Ordinary Shares, within 60 days after March 28, 2024, are deemed outstanding for the purpose of computing the percentage ownership of the person holding the options, warrants or convertible securities, but are not deemed outstanding for the purpose of computing the percentage ownership of any other person. Percentage of shares beneficially owned is based on 6,000,009 Ordinary Shares outstanding on March 28, 2024.

 

80

 

 

We are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and there are no arrangements known to us which would result in a change in control of our company at a subsequent date. Except as indicated in footnotes to this table, we believe that the shareholders named in this table have sole voting and investment power with respect to all shares shown to be beneficially owned by them, based on information provided to us by such shareholders. Unless otherwise noted below, each beneficial owner’s address is c/o Jeffs’ Brands Ltd, 7 Mezada Street, Bnei Brak, Israel 5126112.

 

   No. of Shares
Beneficially
Owned
   Percentage Owned 
Holders of 5% or more of our voting securities:        
Medigus Ltd.(1)(2)   483,272    37.6%
Viki Hakmon*(3)   209,797    17.3%
Directors and named executive officers who are not 5% holders:          
Liron Carmel        
Eliyahu Yoresh       

 
Tali Dinar       

 
Moshe Revach        
Ronen Zalayet        
Naor Bergman        
Oz Adler(4)   686    0.1%
Amitay Wiess        
Tomer Etzyoni        
Israel Berstein          
All directors and executive officers as a group (11 persons)   210,483    17.3%

 

* Indicates officer and/or director of the Company.

 

(1) Includes Warrants to purchase up to 34,341 Ordinary Shares and Additional Warrants to purchase up to 34,341 Ordinary Shares that are exercisable within 60 days, at an exercise price of $14.14per Ordinary Share following the Exercise Price Adjustment (see “Description of Share Capital — Warrants” for additional information).

 

(2) Based on Schedule 13D filed with the SEC on September 13, 2022 and information provided to the Company by Medigus. Medigus has sole voting and dispositive power over all Ordinary Shares shown to be beneficially owned by it. The mailing address of Medigus is Omer Industrial Park No. 7A, P.O. Box 3030, 8496500, Israel. Medigus is a publicly traded company. To the best of our knowledge, no person has sole voting and sole investment power with respect to the shares.

 

(3) Based on Schedule 13D/A filed with the SEC on February 26, 2024. Viki Hakmon has sole voting and dispositive power over all Ordinary Shares shown to be beneficially owned by it. The mailing address of Viki Hakmon is 7 Mezada Street, Bnei Brak, Israel 5126112.

 

(4) Includes Warrants to purchase up to 343 Ordinary Shares exercisable within 60 days, at an exercise price of $14.14 per Ordinary Share following the Exercise Price Adjustment (see “Description of Share Capital — Warrants” for additional information).

 

Significant Changes in Percentage Ownership by Major Shareholders 

 

On May 10, 2021, pursuant to the SEA, Smart Repair Pro and Purex become wholly-owned subsidiaries of Jeffs’ Brands. Pursuant to the SEA, following the Contribution Transactions, Jeffs’ Brands held all of the outstanding shares of Smart Repair Pro and Purex, Medigus held 50.03% of our outstanding Ordinary Shares and Hakmon, our Chief Executive Officer, held the remaining 49.97% of our outstanding Ordinary Shares Hakmon’s affiliates, who were minority shareholders of Smart Repair Pro and Purex, transferred all their holdings in Smart Repair Pro and Purex to Hakmon pursuant to the Share Transfer Deed dated May 10, 2021, which was effective immediately prior to the Contribution Transactions.

 

On August 30, 2022, Medigus purchased in our IPO 240,385 Units comprised of 240,385 Ordinary Shares and Warrants to purchase up to 240,385 Ordinary Shares for an aggregate purchase price of approximately $1,000,001. In addition, in connection with the IPO, on August 30, 2022, in accordance with the Assignment Agreement, the outstanding principal amount of the loans due to Medigus were automatically converted into 1,160,133 Ordinary Shares. Following that, Medigus held approximately 35.27% of our issued and outstanding share capital. In addition, following the Exercise Price Adjustment, on November 28, 2022, Medigus was issued Additional Warrants to purchase up to 240,385 Ordinary Shares. Also in November 2022, Medigus purchased a total of 60,000 Ordinary Shares in open market transactions, at an average price per share of $1.88. Following that, Medigus held approximately 39.61% of our issued and outstanding share capital. In December 2022, Medigus sold a total of 5,813 Ordinary Shares in open market transactions, at an average price per share of $1.14. Following that, Medigus held approximately 39.54% of our issued and outstanding share capital.

 

81

 

 

On August 30, 2022, Pure Capital purchased in our IPO 180,288 Units comprised of 180,288 Ordinary Shares and Warrants to purchase up to 180,288 Ordinary Shares for an aggregate purchase price of approximately $750,000. Also, on August 30, 2022, in accordance with the Assignment Agreement, the outstanding principal amount of the loans due to Pure Capital were automatically converted into 31,535 Ordinary Shares. Following that, Pure Capital held approximately 4.99 % of our issued and outstanding share capital. In August 2022, Pure Capital sold a total of 65,202 Ordinary Shares in open market transactions, at an average price per share of $2.86. Following that, Pure Capital held approximately 4.19% of our issued and outstanding share capital. Also in August 2022, Pure Capital purchased a total of 89,600 Ordinary Shares in open market transactions, at an average price per share of $1.4. Following that, Pure Capital held approximately 5.29% of our issued and outstanding share capital.

 

On November 1, 2022, Viki Hakmon, our Chief Executive Officer, purchased 7,500 Ordinary Shares in an open market transaction, at a price per share of $1.28. Following that, Hakmon held approximately 17.65% of our issued and outstanding share capital.

 

All shareholders have been diluted due to the January 2024 PIPE. See “Item 5.A. Financial Arrangements – January 2024 PIPE,” for further information.

 

Record Holders

 

As of March 28, 2024, there were 42 registered shareholders of our Ordinary Shares. This number is not representative of the number of beneficial holders of our shares nor is it representative of where such beneficial holders reside, since many of these shares were held of record by brokers or other nominees.

 

We are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and there are no arrangements known to us which would result in a change in our control at a subsequent date.

 

B. Related Party Transactions

 

The following is a description of related-party transactions we have entered into since January 1, 2021, with any of the members of the board of directors, executive officers or holders of more than 5% of any class of our voting securities at the time of such transaction.

 

Employment and Service Agreements

 

We have entered into written employment and service agreements with each of our executive officers. All of these agreements contain customary provisions regarding confidentiality of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable law. In addition, we have entered into agreements with each executive officer and director pursuant to which we have agreed to indemnify each of them up to a certain amount and to the extent that these liabilities are not covered by directors and officers insurance. Members of our senior management are eligible for bonuses each year. The bonuses are payable upon meeting objectives and targets that are set by our Chief Executive Officer and approved annually by our board of directors that also set the bonus targets for our Chief Executive Officer.

 

Shareholders Agreements and Loans

 

In February 2021, Smart Repair Pro received loans at an amount of approximately $4,010,000 under the Medigus SPA.

 

On February 2, 2021, Smart Repair Pro acquired the seller account “Whoobli”, pursuant to a purchase agreement. In order to finance the purchase of the Whoobli store, Smart Repair Pro received an additional loan from its shareholders, whereby Medigus transferred directly to the Whoobli Seller an amount of approximately $3,200,000 and the minority shareholders transferred an amount of approximately $800,000.

 

Effective as of May 10, 2021, pursuant to the transactions contemplated by the SEA, Purex and Smart Repair Pro became wholly-owned subsidiaries of Jeffs’ Brands and the Contribution Transactions were completed.

 

Pursuant to the Contribution Transactions, on May 10, 2021, we issued 5,003 and 4,997, Ordinary Shares to Medigus and Mr. Hakmon, respectively, in exchange for the equity interests they owned in Smart Repair Pro and Purex.

 

As of August 30, 2022, Smart Repair Pro had outstanding loans to Medigus, Mr. Hakmon and Pure Capital of $4,010,000, $940,000 and $109,000, respectively. On May 3, 2022, we entered into the Assignment Agreement with Smart Repair Pro, Medigus, Mr. Hakmon and Pure Capital. In accordance with the Assignment Agreement, on August 30, 2022, the outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital converted into 1,160,133 Ordinary Shares, 271,951 Ordinary Shares and 31,535 Ordinary Shares, respectively. Any accrued and unpaid interest due to each such party at that time was paid in cash. On July 25, 2023, we entered into an amendment to the Assignment Agreement, pursuant to which, among others, the outstanding debt between the Company and Smart Repair Pro was converted into and paid in capital of Smart Repair Pro.

 

On April 29, 2022 and August 24, 2022, Medigus advanced $80,000 and $70,000, respectively, to the Company for certain working capital matters, which the Company fully repaid on September 6, 2022.

 

82

 

 

For further description on the agreements and loans described above, see “Item 5.B. Liquidity and Capital Resources – Financial Agreements” above.

 

Consulting Agreement with Pure Capital

 

On October 26, 2022, we entered into a consulting agreement with Pure Capital, a company owned by a family member of Mr. Viki Hakmon, our Chief Executive Officer, pursuant to which Pure Capital provides us with consultancy services for a monthly fee of NIS 57,750 (approximately $16,042). In addition, we paid Pure Capital a one-time signing bonus in the amount of NIS 425,000 (approximately $118,055) for their services to us from the day of our inception until the closing of the IPO. In addition to the monthly payments, pursuant to the consultancy agreement, Pure Capital is also entitled to the following payments: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and chairman of the board of directors based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after three years from October 26, 2022 by either party upon a 30 days of advance notice. As of December 31, 2023, we paid $516,000 to Pure Capital pursuant to the agreement.

 

Agreement with Pure Logistics

 

In November 2022, we entered into an agreement with Pure NJ Logistics LLC, or Pure Logistics, a U.S. based storage and logistics center, intended to support our plans to sell our brands’ products directly to consumers and launch new e-commerce platforms. Pure Capital holds a majority of the equity interest in Pure Logistics. Mr. Eliyahu Yoresh, a director of the Company, is also a director of Pure Logistics. Naor Bergman, the Chief Operating Officer of the Company may be deemed to have a personal interest in the matter, due to a promise by Pure NJ Logistics LLC to grant him options upon an initial public offering of Pure Logistics for the year ended December 31, 2023, the total expenses related to Pure Logistics were $545,015 pursuant to the agreement.

 

Stock Purchase Agreement with SciSparc

 

On February 23, 2023, we and Jeffs’ Brands Holdings entered into the Wellution Agreement, as amended on March 22, 2023 by the Addendum, pursuant to which, among other things, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, representing approximately 49% of the issued and outstanding shares of common stock of SciSparc U.S. Pursuant to the Wellution Agreement, we also entered into on March 22, 2023, the SciSparc Consulting Agreement, pursuant to which we will provide management services to SciSparc U.S. for the Wellution brand. Mr. Oz Adler, the Chairman and a member of our board of directors is the chief executive officer and chief financial officer of SciSparc, Mr. Amitai Weiss, is the chairman of the board of directors of SciSparc, and is a member of our board of directors, and Mr. Moshe Revach is a member of our board of directors and SciSparc’s board of directors. See “Item 4.B. Recent Developments – Expansion into the Nutritional Supplements Market” above for further information.

 

January 2024 PIPE

 

 On January 25, 2024, we entered into the January 2024 PIPE pursuant to a securities purchase agreement, with certain institutional investors, providing for the issuance, in a private placement of our securities. As part of the January 2024 PIPE, Pure Capital, a company owned by a family member of Viki Hakmon our Chief Executive Officer, participated in the private placement as a purchaser. See “Item 4.B. Recent Developments –January 2024 PIPE” above, for further information.

 

C. Interests of Experts and Counsel

 

None.

 

ITEM 8. FINANCIAL INFORMATION.

 

A. Consolidated Statements and Other Financial Information

 

See “Item 18. Financial Statements.”

 

83

 

 

Legal Proceedings

 

From time to time, we may become involved in legal proceedings that arise in the ordinary course of business. During the period covered by the financial statements contained herein, we were not subject to any material legal proceedings that has had a material adverse effect on our financial position. No assurance can be given that future litigation will not have a material adverse effect on our financial position. When appropriate in management’s estimation, we may record reserves in our financial statements for pending litigation and other claims. 

 

Dividends

 

We have never declared or paid any cash dividends on our Ordinary Shares and do not anticipate paying any cash dividends in the foreseeable future. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem relevant.

 

The Companies Law imposes certain restrictions on our ability to declare and pay dividends. See “Divided and Liquidation Rights” in Exhibit 2.8 to this Annual Report for additional information.

 

Payment of dividends may be subject to Israeli withholding taxes. See “Item 10. E. Taxation” for additional information. 

 

B. Significant Changes

 

No significant change, other than as otherwise described in this Annual Report on Form 20-F, has occurred in our operations since the date of our consolidated financial statements included in this Annual Report on Form 20-F. 

 

ITEM 9. THE OFFER AND LISTING.

 

A. Offer and Listing Details

 

Our Ordinary Shares and Warrants were approved for listing on the Nasdaq Capital Market and commenced trading under the symbol “JFBR” and “JFBRW”, respectively, on August 26, 2022.

 

B. Plan of Distribution

 

Not applicable. 

 

C. Markets

 

See “Item 9A. Offer and Listing Details.”

 

D. Selling Shareholders

 

Not applicable.

 

E. Dilution

 

Not applicable.

 

F. Expenses of the Issue

 

Not applicable.

 

84

 

 

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

Not applicable.

 

B. Memorandum and Articles of Association

 

A copy of our amended and restated articles of association is attached as Exhibit 1.1 to this Annual Report on Form 20-F. The information called for by this Item is set forth in Exhibit 2.8 to this Annual Report and is incorporated by reference into this Annual Report on Form 20-F.

 

C. Material Contracts

 

For a description of each material contract, other than material contracts entered into in the ordinary course of business, to which we are or have been a party, for the two years immediately preceding the date of this Annual Report on Form 20-F, see “Item 4.A. History and Development of the Company,” Item 4.B. Recent Developments “Item 4.B. Business Overview,” “Item 5.B. Liquidity and Capital Resources – Financial Arrangements,” “Item 6.C Board Practices - Indemnification,” “Item 6.C Share Ownership – Share Option Plan,” “Item 7.A. Major Shareholders,” and “Item 7.B. Related Party Transactions” above.

 

D. Exchange Controls

 

There are currently no Israeli currency control restrictions on payments of dividends or other distributions with respect to our Ordinary Shares or the proceeds from the sale of the shares, except for the obligation of Israeli residents to file reports with the Bank of Israel regarding certain transactions. However, legislation remains in effect pursuant to which currency controls can be imposed by administrative action at any time.

 

The ownership or voting of our Ordinary Shares by non-residents of Israel, except with respect to citizens of countries that are in a state of war with Israel, is not restricted in any way by our memorandum of association or amended and restated articles of association or by the laws of the State of Israel.

 

E. Taxation

 

The following description is not intended to constitute a complete analysis of all tax consequences relating to the ownership or disposition of our Ordinary Shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign, including Israeli, or other taxing jurisdiction.

 

Israeli Tax Considerations and Government Programs

 

The following is a description of the material Israeli income tax consequences concerning the acquisition, ownership and disposition of our Ordinary Shares. The following also contains a description of material relevant provisions of the current Israeli income tax structure applicable to companies in Israel, with reference to its effect on us. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are subject to special tax regimes not covered in this discussion. To the extent that the discussion is based on tax legislation which has not been subject to judicial or administrative interpretation, there can be no assurance that the applicable tax authorities or the courts will accept the views expressed in the discussion in question. The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the tax consequences described below. The discussion is not intended, and should not be taken, as legal or professional tax advice and is not exhaustive of all possible tax considerations.

 

85

 

 

The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership or disposition of our Ordinary Shares. Shareholders should consult their own tax advisors concerning the tax consequences of their particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.

 

General Corporate Tax Structure in Israel

 

Israeli companies are generally subject to corporate tax, currently at the rate of 23%. However, the effective tax rate payable by a company that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below) may be considerably less.

 

Capital gains derived by an Israeli resident company are subject to tax at the regular corporate tax rate. Under Israeli tax legislation, a corporation will be considered as an “Israeli resident company” if it meets one of the following criteria: (i) it was incorporated in Israel; or (ii) the control and management of its business are exercised in Israel.

 

Law for the Encouragement of Industry (Taxes), 5729-1969

 

The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for “Industrial Companies.”

 

The Industry Encouragement Law defines an “Industrial Company” as an Israeli resident-company incorporated in Israel, which has 90% or more of its income in any tax year, other than income from certain government loans, derived from an “Industrial Enterprise” owned by it and located in Israel or in the “Area”, in accordance with the definition under section 3A of the Israeli Income Tax Ordinance (New Version) 1961, referred to as the Ordinance. An “Industrial Enterprise” is defined as an enterprise which is held by an Industrial Company whose principal activity in a given tax year is industrial production.

 

The following corporate tax benefits, among others, are available to Industrial Companies:

 

  amortization of the cost to purchase a patent, rights to use a patent or know-how, that were purchased in good faith and are used for the development or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in which such rights were first exercised;
     
  under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and
     
  expenses related to a public offering are deductible in equal amounts over three years commencing on the year of the offering.

 

Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.

 

Law for the Encouragement of Capital Investments, 5719-1959

 

The Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets).

 

The Investment Law was significantly amended effective as of January 1, 2011, or the 2011 Amendment, and as of January 1, 2017, or the 2017 Amendment. The 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.

 

86

 

 

Tax benefits under the 2011 Amendment

 

The 2011 Amendment canceled the availability of the benefits granted under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a “Preferred Company” through its “Preferred Enterprise” (as such terms are defined in the Investment Law) as of January 1, 2011. The definition of a Preferred Company includes a company incorporated in Israel that is not fully owned by a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 16% with respect to its income derived from its Preferred Enterprise, unless the Preferred Enterprise is located in a specified development zone, in which case the rate will be 7.5%. Income derived by a Preferred Company from a “Special Preferred Enterprise” (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or 5% if the Special Preferred Enterprise is located in a certain development zone.

 

Dividends distributed from income which is attributed to a “Preferred Enterprise” or a “Special Preferred Enterprise” should generally be subject to withholding tax at source at the following rates: (i) Israeli resident corporations - 0%, (although, if such dividends are subsequently distributed to individuals or a non-Israeli company the below rates detailed in sub sections (ii) and (iii) shall apply), (ii) Israeli resident individuals - 20% and (iii) non-Israeli residents (individuals and corporations) - subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate, 20%, or such lower rate as may be provided under the provisions of any applicable double tax treaty.

 

We currently do not intend to implement the 2011 Amendment.

 

Tax benefits under the 2017 Amendment

 

The 2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January 1, 2017. The 2017 Amendment provided new tax benefits for two types of “Technological Enterprises,” as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.

 

The 2017 Amendment provides that a technology company satisfying certain conditions should qualify as a Preferred Technological Enterprise, or PTE, and thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as “Preferred Technological Income”, as defined in the Investment Law. The tax rate is further reduced to 7.5% for a PTE located in development zone “A”. In addition, a PTE will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain “Benefited Intangible Assets” (as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January 1, 2017 for at least NIS 200 million, and the sale received prior approval from the National Authority for Technological Innovation previously known as the Israeli Office of the Chief Scientist), to which we refer as IIA.

 

The 2017 Amendment further provides that a technology company satisfying certain conditions (including a group turnover of at least NIS 10 billion) should qualify as a “Special Preferred Technological Enterprise” and will thereby enjoy a reduced corporate tax rate of 6% on “Preferred Technological Income” regardless of the company’s geographic location within Israel. In addition, a Special Preferred Technological Enterprise should enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain “Benefited Intangible Assets” to a related foreign company if the Benefited Intangible Assets were either developed by the Special Preferred Technological Enterprise or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from IIA. A Special Preferred Technological Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500 million should be eligible for these benefits for at least ten years, subject to certain approvals as specified in the Investment Law.

 

Dividends distributed out of Preferred Technological Income to Israeli shareholders by a PTE or a Special Preferred Technological Enterprise, paid out of Preferred Technological Income, should generally be subject to withholding tax at source at the rate of 20% (in the case of non-Israeli shareholders, subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate, 20%, or such lower rate as may be provided in an applicable tax treaty). However, if such dividends are paid to an Israeli company, no tax is generally required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, the aforesaid should apply). If such dividends are distributed to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company and other conditions are met, the withholding tax rate should be 4% (or such lower rate as may be provided in an applicable tax treaty, in either case, subject to the receipt in advance of a valid certificate from the ITA allowing for such reduced tax rate).

 

We are examining the potential impact of the 2017 Amendment and the degree to which we may qualify as a PTE, the amount of Preferred Technological Income that we may have and other benefits that we may receive from the 2017 Amendment in the future.

 

87

 

 

Taxation of our Shareholders

 

Israeli law generally imposes a capital gains tax on the sale of any capital assets by residents of Israel, as defined for Israeli tax purposes, and on the sale of assets located in Israel, including shares of Israeli companies, by both residents and non-residents of Israel unless a specific exemption is available or a tax treaty between Israel and the seller’s country of residence provides otherwise. The Tax Ordinance distinguishes between real capital gain and inflationary surplus. The inflationary surplus is a portion of the total capital gain equivalent to the increase of the relevant asset’s tax basis attributable to an increase in the Israeli consumer price index or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of disposition. Inflationary surplus is not currently subject to tax in Israel. The real capital gain is the excess of the total capital gain over the inflationary surplus.

 

Capital Gains Taxes Applicable to Non-Israeli Resident Shareholders. A non-Israeli resident (whether an individual or a corporation) who derives capital gains from the sale of shares in an Israeli resident company purchased upon or after the registration of the shares on the TASE or on a regulated market outside of Israel (such as Nasdaq) should be exempt from Israeli tax unless the capital gain derived from the sale of shares was attributed to a permanent establishment that the non-resident maintains in Israel. However, a non-Israeli “body of persons” (as defined under the Tax Ordinance, which includes corporate entities, partnerships and other entities) will not be entitled to the foregoing exemption if Israeli residents: (i) have a controlling interest of more than 25% in such non-Israeli entity or (ii) are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli entity, both, whether directly or indirectly. In addition, such exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed business income.

 

If not exempt, a non-Israeli resident shareholder would generally be subject to tax on capital gain at the ordinary corporate tax rate as specified in section 126 of the Tax Ordinance (23% in 2023), if generated by a company, or at a marginal tax rate according to section 121 of the Tax Ordinance but up to a rate of 25%, if generated by an individual, or 30%, if generated by an individual who is a “substantial shareholder” (as defined under the Tax Ordinance), at the time of sale or at any time during the preceding 12-month period (or if the shareholder claims a deduction for interest and linkage differences expenses in connection with the purchase and holding of such shares). A “substantial shareholder” is generally a person who alone or together with such person’s relative or another person who collaborates with such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the “means of control” of the corporation. “Means of control” generally include, among others, the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. Individual and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income (a corporate tax rate for a corporation as specified in section 126 of the Tax Ordinance (23% in 2023) and a marginal tax rate (up to 47% for an individual in 2023) as specified in section 121 of the Tax Ordinance (excluding excess tax as discussed below)) unless contrary provisions in a relevant tax treaty apply.

 

Additionally, a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty between Israel and the shareholder’s country of residence. For example, under Convention Between the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended, or the United States-Israel Tax Treaty, the sale, exchange or other disposition of shares by a shareholder who is a United States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to claim the benefits afforded to such a resident by the United States-Israel Tax Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate located in Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii) the capital gain arising from the such sale, exchange or disposition is attributed to a permanent establishment that the shareholder maintains in Israel; (iv) such Treaty U.S. Resident holds, directly or indirectly, shares representing 10% or more of the voting capital of the company during any part of the 12-month period preceding the disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel for a period or periods aggregating to 183 days or more during the relevant taxable year. In each case, the sale, exchange or disposition of our ordinary shares would be subject to Israeli tax, to the extent applicable.

 

88

 

 

Regardless of whether our non-Israeli shareholders may be liable for Israeli capital gains tax on the sale of their Ordinary Shares, the payment of the consideration may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the ITA may require from shareholders who are not liable for Israeli tax to sign declarations in forms specified by this authority or obtain a specific exemption from the ITA to confirm their status as non-Israeli tax residents, and, in the absence of such declarations or exemptions, may require the purchaser of the shares to withhold Israeli taxes at source.

 

Capital Gains Taxes Applicable to Israeli Resident Shareholders. An Israeli resident will generally be subject to a capital gains tax as an individual on any real capital gain at the rate of 25%. However, where an individual shareholder claims a deduction for interest expenditures or he is a “substantial shareholder” at the time of the sale or at any time during the preceding twelve months period, such gain will be taxed at the rate of 30%. Individual holders dealing in securities in Israel for whom the income from the sale of securities is considered “business income,” as defined in section 2(1) of the Ordinance, are taxed at the marginal tax rates applicable to business income (up to 47% in 2023 excluding, excess tax, if applicable, as described below).

 

An Israeli resident corporation that derives capital gains from the sale of shares of an Israeli resident company will generally be subject to tax on the real capital gain generated on such sale at the corporate tax rate of 23%.

 

Taxation of Non-Israeli Shareholders on Receipt of Dividends. Non-Israeli residents (whether individuals or corporations) are generally subject to Israeli income tax on the receipt of dividends paid on our Ordinary Shares at the rate of 25%, which tax will be withheld at source, unless relief is provided in a treaty between Israel and the shareholder’s country of residence (provided that a certificate from the ITA allowing for a reduced withholding tax rate or a tax exemption is obtained in advance). With respect to a person who is a “substantial shareholder” (as detailed above) at the time of receiving the dividend or at any time during the preceding twelve months, the applicable tax rate is 30%. Dividends paid on publicly traded shares, like our Ordinary Shares, to non-Israeli residents, are generally subject to Israeli withholding tax at a rate of 25%, so long as the shares are registered with a nominee company (whether or not the recipient is a substantial shareholder), unless a lower rate is provided under an applicable tax treaty (provided that a certificate from the ITA allowing for a reduced withholding tax rate is obtained in advance). However, subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced withholding tax rate, a distribution of dividends to non-Israeli residents is generally subject to withholding tax at source at a rate of 20% if the dividend is distributed from income attributed to a Preferred Enterprise or PTE, unless a reduced tax rate is provided under an applicable tax treaty. For example, under the United States-Israel Tax Treaty and subject to the eligibility to the benefits under such treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our Ordinary Shares who is a Treaty U.S. Resident is 25%. However, generally, the maximum rate of withholding tax on dividends, not generated by our Preferred Enterprise or PTE, that are paid to a United States corporation holding 10% or more of the outstanding voting capital throughout the tax year in which the dividend is distributed as well as during the previous tax year, is 12.5%, provided that not more than 25% of the gross income for such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income attributed to a Preferred Enterprise or PTE are not entitled to such reduction under the tax treaty but are subject to a withholding tax rate of 20% for a shareholder that is a U.S. corporation, provided that the condition related to our gross income for the previous year (as set forth in the previous sentence) is met. The aforementioned rates under the United States-Israel Tax Treaty would not apply if the dividend income is derived through a permanent establishment of the U.S. resident in Israel. If the dividend is attributable partly to income derived from a Preferred Enterprise or PTE, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. U.S. residents who are subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for United States federal income tax purposes in the amount of the taxes withheld, subject to detailed rules contained in the Code. We cannot assure you that we will designate the profits that we may distribute in a way that will reduce shareholders’ tax liability.

 

89

 

 

A non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer, (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed, and (iii) the taxpayer is not obligated to pay excess tax (as further explained below).

 

Taxation of Israeli Shareholders on Receipt of Dividends. An Israeli resident individual is generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%. With respect to a person who is a “substantial shareholder” at the time of receiving the dividend or on any time during the preceding twelve months, the applicable tax rate is 30%. Such dividends are generally subject to Israeli withholding tax at a rate of 25% if the shares are registered with a nominee company (whether the recipient is a substantial shareholder or not). If the recipient of the dividend is an Israeli resident corporation such dividend income will be exempt from Israeli corporate tax provided the income from which such dividend is distributed was derived or accrued within Israel and was received directly or indirectly from another corporation that is liable to Israeli corporate tax (although, if such dividends are subsequently distributed to Israeli individuals or non-Israeli shareholders, the above shall apply). An exempt trust fund, pension fund or other entity that is exempt from tax under Section 9(2) or Section 129(C)(a)(1) of the Ordinance is exempt from tax on dividend. 

 

Excess Tax

 

Individuals who are subject to tax in Israel (whether any such individual is an Israeli resident or non-Israeli resident) are also subject to an additional tax at a rate of 3% on annual income exceeding NIS 698,280 for 2023 (which amount is linked to the annual change in the Israeli consumer price index), including, but not limited to, dividends, interest and capital gain.

 

Estate and Gift Tax

 

Israeli tax law presently does not impose estate or gift taxes.

 

U.S. Federal Income Tax Considerations

 

THE FOLLOWING SUMMARY IS INCLUDED HEREIN FOR GENERAL INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH HIS OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND SALE OF ORDINARY SHARES, the Warrants, and the Ordinary Shares issued or issuable upon exercise of the Warrants, INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND POSSIBLE CHANGES IN THE TAX LAWS.

 

Subject to the limitations described in the next paragraph, the following discussion summarizes the material U.S. federal income tax consequences to a “U.S. Holder” arising from the purchase, ownership and sale of the Ordinary Shares, the Warrants, and the Ordinary Shares issued or issuable upon exercise of the Warrants, collectively, the “securities”. For this purpose, a “U.S. Holder” is a holder of Ordinary Shares that is: (1) an individual citizen or resident of the United States, including an alien individual who is a lawful permanent resident of the United States or meets the substantial presence residency test under U.S. federal income tax laws; (2) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) or a partnership (other than a partnership that is not treated as a U.S. person under any applicable U.S. Treasury regulations) created or organized under the laws of the United States or the District of Columbia or any political subdivision thereof; (3) an estate, the income of which is includable in gross income for U.S. federal income tax purposes regardless of source; (4) a trust if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust; or (5) a trust that has a valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury regulations.

 

90

 

 

This summary is for general information purposes only and does not purport to be a comprehensive description of all of the U.S. federal income tax considerations that may be relevant to a decision to purchase our securities. This summary generally considers only U.S. Holders that will own our securities as capital assets. Except to the limited extent discussed below, this summary does not consider the U.S. federal tax consequences to a person that is not a U.S. Holder, nor does it describe the rules applicable to determine a taxpayer’s status as a U.S. Holder. This summary is based on the provisions of the Internal Revenue Code of 1986, as amended, or the Code, final, temporary and proposed U.S. Treasury regulations promulgated thereunder, administrative and judicial interpretations thereof, (including with respect to the Tax Cuts and Jobs Act of 2017), and the U.S.-Israel Income Tax Treaty, all as in effect as of the date hereof and all of which are subject to change, possibly on a retroactive basis, and all of which are open to differing interpretations. We will not seek a ruling from the IRS with regard to the U.S. federal income tax treatment of an investment in our securities by U.S. Holders and, therefore, can provide no assurances that the IRS will agree with the conclusions set forth below.

 

This discussion does not address all of the aspects of U.S. federal income taxation that may be relevant to a particular U.S. holder based on such holder’s particular circumstances and in particular does not discuss any estate, gift, generation-skipping, transfer, state, local, excise or foreign tax considerations. In addition, this discussion does not address the U.S. federal income tax treatment of a U.S. Holder who is: (1) a bank, life insurance company, regulated investment company, or other financial institution or “financial services entity;” (2) a broker or dealer in securities or foreign currency; (3) a person who acquired our securities in connection with employment or other performance of services; (4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder that holds our securities as a hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction transaction for U.S. federal income tax purposes; (6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) a U.S. Holder that expatriates out of the United States or a former long-term resident of the United States; or (9) a person having a functional currency other than the U.S. dollar. This discussion does not address the U.S. federal income tax treatment of a U.S. Holder that owns, directly or constructively, at any time, securities representing 10% or more of our voting power. Additionally, the U.S. federal income tax treatment of partnerships (or other pass-through entities) or persons who hold securities through a partnership or other pass-through entity are not addressed.

 

Each prospective investor is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing, holding or disposing of our securities, including the effects of applicable state, local, foreign or other tax laws and possible changes in the tax laws.

 

Exercise or Expiry of Warrants

 

No gain or loss will be realized on the exercise of a Warrant. When a Warrant is exercised, the U.S. Holder’s cost of the common share acquired thereby will be equal to the U.S. Holder’s adjusted cost basis of the Warrant plus the exercise price paid for the common share. The expiry of an unexercised Warrant will generally give rise to a capital loss equal to the adjusted cost basis to the U.S. Holder of the expired Warrant. The holding period of the common share acquired thru the exercise of a Warrant includes the holding period of the Warrant.

 

Taxation of Dividends Paid on Securities

 

We do not intend to pay dividends in the foreseeable future and U.S. Holders of Warrants are not entitled to dividends. In the event that we do pay dividends, and subject to the discussion under the heading “Passive Foreign Investment Companies” below and the discussion of “qualified dividend income” below, a U.S. Holder, other than certain U.S. Holder’s that are U.S. corporations, will be required to include in gross income as ordinary income the amount of any distribution paid on securities (including distributions paid on Warrants if such warrants were to become entitled to dividends and the amount of any Israeli tax withheld on the date of the distribution), to the extent that such distribution does not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. The amount of a distribution which exceeds our earnings and profits will be treated first as a non-taxable return of capital, reducing the U.S. Holder’s tax basis for the securities to the extent thereof, and then capital gain. We do not expect to maintain calculations of our earnings and profits under U.S. federal income tax principles and, therefore, U.S. Holders should expect that the entire amount of any distribution generally will be reported as dividend income.

 

In general, preferential tax rates for “qualified dividend income” and long-term capital gains are applicable for U.S. Holders that are individuals, estates or trusts. For this purpose, “qualified dividend income” means, inter alia, dividends received from a “qualified foreign corporation.” A “qualified foreign corporation” is a corporation that is entitled to the benefits of a comprehensive tax treaty with the United States which includes an exchange of information program. The IRS has stated that the U.S.-Israel Tax Treaty satisfies this requirement and we believe we are eligible for the benefits of that treaty.

 

91

 

 

In addition, our dividends will be qualified dividend income if our securities are readily tradable on the Nasdaq Capital Market or another established securities market in the United States. Dividends will not qualify for the preferential rate if we are treated, in the year the dividend is paid or in the prior year, as a PFIC, as described below under “Passive Foreign Investment Companies.” A U.S. Holder will not be entitled to the preferential rate: (1) if the U.S. Holder has not held our securities for at least 61 days of the 121 day period beginning on the date which is 60 days before the ex-dividend date, or (2) to the extent the U.S. Holder is under an obligation to make related payments on substantially similar property. Any days during which the U.S. Holder has diminished its risk of loss on our securities are not counted towards meeting the 61-day holding period. Finally, U.S. Holders who elect to treat the dividend income as “investment income” pursuant to Code section 163(d)(4) will not be eligible for the preferential rate of taxation.

 

The amount of a distribution with respect to our securities will be measured by the amount of the fair market value of any property distributed, and for U.S. federal income tax purposes, the amount of any Israeli taxes withheld therefrom. Cash distributions paid by us in NIS will be included in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange in effect on the date the dividend is includible in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such NIS for U.S. federal income tax purposes equal to such U.S. dollar value. If the U.S. Holder subsequently converts the NIS into U.S. dollars or otherwise disposes of it, any subsequent gain or loss in respect of such NIS arising from exchange rate fluctuations will be U.S. source ordinary exchange gain or loss.

 

Taxation of the Disposition of Securities

 

Except as provided under the PFIC rules described below under “Passive Foreign Investment Companies,” upon the sale, exchange or other disposition of our securities, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between such U.S. Holder’s tax basis for the securities in U.S. dollars and the amount realized on the disposition in U.S. dollar (or its U.S. dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if the amount realized is denominated in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of securities will be long-term capital gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition. Individuals who recognize long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses is subject to various limitations.

 

Passive Foreign Investment Companies

 

Special U.S. federal income tax laws apply to U.S. taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for U.S. federal income tax purposes for any taxable year that either:

 

 

 

75% or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25% or more of the shares by value), in a taxable year is passive; or
     
  At least 50% of our assets, averaged over the year and generally determined based upon fair market value (including our pro rata share of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of, or produce, passive income.
     

For this purpose, passive income generally consists of dividends, interest, rents, royalties, annuities and income from certain commodities transactions and from notional principal contracts. Cash is treated as generating passive income.

 

Based on the projected composition of our income and valuation of our assets, we do not expect to be a PFIC for 2022, and we do not expect to become a PFIC in the future, although there can be no assurance in this regard. The tests for determining PFIC status are applied annually, and it is difficult to make accurate projections of future income and assets which are relevant to this determination. In addition, our PFIC status may depend in part on the market value of our securities.

 

92

 

 

If we currently are or become a PFIC, each U.S. Holder who has not elected to mark the shares to market (as discussed below), would, upon receipt of certain distributions by us and upon disposition of our securities at a gain: (1) have such distribution or gain allocated ratably over the U.S. Holder’s holding period for the securities, as the case may be; (2) the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition, when shares of a PFIC are acquired by reason of death from a decedent that was a U.S. Holder, the tax basis of such shares would not receive a step-up to fair market value as of the date of the decedent’s death, but instead would be equal to the decedent’s basis if lower, unless all gain were recognized by the decedent. Indirect investments in a PFIC may also be subject to these special U.S. federal income tax rules.

 

The PFIC rules described above would not apply to a U.S. Holder who makes a QEF election for all taxable years that such U.S. Holder has held the securities while we are a PFIC, provided that we comply with specified reporting requirements. Instead, each U.S. Holder who has made such a QEF election is required for each taxable year that we are a PFIC to include in income such U.S. Holder’s pro rata share of our ordinary earnings as ordinary income and such U.S. Holder’s pro rata share of our net capital gains as long-term capital gain, regardless of whether we make any distributions of such earnings or gain. In general, a QEF election is effective only if we make available certain required information. The QEF election is made on a shareholder-by-shareholder basis and generally may be revoked only with the consent of the IRS. We do not intend to notify U.S. Holders if we believe we will be treated as a PFIC for any tax year. In addition, we do not intend to furnish U.S. Holders annually with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year in which we or any of our subsidiaries are a PFIC. Therefore, the QEF election will not be available with respect to our securities.

 

In addition, the PFIC rules described above would not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder of our securities which are regularly traded on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the securities to market annually, recognizing as ordinary income or loss each year an amount equal to the difference as of the close of the taxable year between the fair market value of the securities and the U.S. Holder’s adjusted tax basis in the securities. Losses are allowed only to the extent of net mark-to-market gain previously included income by the U.S. Holder under the election for prior taxable years.

 

U.S. Holders who hold our securities during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC. U.S. Holders are strongly urged to consult their tax advisors about the PFIC rules.

 

Tax on Net Investment Income

 

U.S. Holders who are individuals, estates or trusts will generally be required to pay a 3.8% Medicare tax on their net investment income (including dividends on and gains from the sale or other disposition of our securities), or in the case of estates and trusts on their net investment income that is not distributed. In each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder’s total adjusted income exceeds applicable thresholds.

 

Information Reporting and Withholding

 

A U.S. Holder may be subject to backup withholding at a rate of 24% with respect to cash dividends and proceeds from a disposition of securities. In general, backup withholding will apply only if a U.S. Holder fails to comply with specified identification procedures. Backup withholding will not apply with respect to payments made to designated exempt recipients, such as corporations and tax-exempt organizations. Backup withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder, provided that the required information is timely furnished to the IRS.

 

Pursuant to recently enacted legislation, a U.S. Holder with interests in “specified foreign financial assets” (including, among other assets, our securities, unless such securities are held on such U.S. Holder’s behalf through a financial institution) may be required to file an information report with the IRS if the aggregate value of all such assets exceeds $50,000 on the last day of the taxable year or $75,000 at any time during the taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance); and may be required to file a Report of Foreign Bank and Financial Accounts if the aggregate value of the foreign financial accounts exceeds $10,000 at any time during the calendar year. You should consult your own tax advisor as to the possible obligation to file such information report.

 

93

 

 

F. Dividends and Paying Agents

 

Not applicable.

 

G. Statement by Experts

 

Not applicable.

 

H. Documents on Display

 

We are subject to certain information reporting requirements of the Exchange Act, applicable to foreign private issuers and under those requirements will file reports with the SEC. The SEC maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC will also available to the public through the SEC’s website at www.sec.gov.

 

As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report containing financial statements audited by an independent registered public accounting firm, and may submit to the SEC, on a Form 6-K, unaudited half-yearly financial information.

 

We maintain a corporate website www.jeffsbrands.com. Information contained on, or that can be accessed through, our website and the other websites referenced above do not constitute a part of this Annual Report on Form 20-F. We have included these website addresses in this Annual Report on Form 20-F solely as inactive textual references.

 

I. Subsidiary Information

 

Not applicable.

 

J. Annual Report to Security Holders

 

Not applicable.

 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our current investment policy is to invest available cash in bank deposits with banks that have a credit rating of at least A-minus. Accordingly, some of our cash and cash equivalents are held in deposits that bear interest. Given the current low rates of interest we receive, we will not be adversely affected if such rates are reduced. Our market risk exposure is primarily a result of U.S. dollar/NIS exchange rates, which is discussed in detail in the following paragraph.

 

Impact of Inflation and Currency Fluctuations

 

Our functional and reporting currency is the U.S. dollar. We incur some of our expenses in other currencies. As a result, we are exposed to the risk that the rate of inflation in countries in which we are active other than the United States will exceed the rate of devaluation of such countries’ currencies in relation to the dollar or that the timing of any such devaluation will lag behind inflation in such countries.

 

94

 

 

Global inflation has risen in 2022. To date, we have not been subject to inflationary pressures. However, to mitigate any identified potential inflationary pressures, the Company purchased more inventory at the beginning of the year in order to avoid price increases that may be caused by the increase in inflation or shipping costs. We cannot assure you that we will not be adversely affected in the future.

 

The annual rate of inflation in Israel was 3.0% in 2023 and 5.3% in 2022. The NIS revaluated against the U.S. dollar by approximately 3.1% in 2023 and 5.3% in 2022.

 

Impact of Supply Chain Disruptions

 

As a result of the attacks by the Houthi movement on marine vessels traversing the Red Sea, we have experienced delays in shipment of inventory to and from the United Kingdom and increases in the costs of vessels. However, as of the date of this Annual Report on Form 20-F, our business segment, products, lines of service, projects and operations are not materially adversely affected by supply chain disruptions in light of such attacks and we do not expect to be materially impacted by any supply chain disruptions in the future.

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

A. Debt Securities.

 

Not applicable.

 

B. Warrants and rights.

 

The information called for by this Item is set forth in Exhibit 2.8 to this Annual Report and is incorporated by reference into this Annual Report on Form 20-F.

 

C. Other Securities

 

Not applicable.

 

D. American Depositary Shares

 

Not applicable.

 

95

 

 

PART II

 

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

 

None.

 

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

 

In connection with the IPO (including a partial exercise of over-allotment option), the Company issued and sold 531,068 Ordinary Shares and Warrants to purchase up to 591,912 Ordinary Shares and received gross proceeds of approximately $15.5 million before deducting underwriting discounts and commissions and before offering expenses ($13.4 million net proceeds after deducting approximately $1.05 million of underwriting discounts and commissions and approximately $1.05 million after deducting other offering costs).

 

The net proceeds from the offering have been used, and are expected to continue to be used, for the following purposes:

 

  approximately $7.5 million for the purchase of new Amazon brands, the development of new brands, and improvement of existing brands;

 

  approximately $2.15 million for the repayment of certain outstanding indebtedness; and

 

  the remainder for working capital and general corporate purposes, including potential acquisitions and collaborations and investments in warehouse, logistics software and facilities to strengthen our supply chain process.

 

ITEM 15. CONTROLS AND PROCEDURES

 

(a) Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2023, or the Evaluation Date. Based on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective.

 

(b) Management’s Annual Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. We have a program for the review of our internal control over financial reporting to ensure compliance with the requirements of the Exchange Act and Section 404 of the Sarbanes-Oxley Act. Our internal control over financial reporting includes those policies and procedures that:

 

  pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

  provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP;

 

  provide reasonable assurance that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

  provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of December 31, 2023. In conducting its assessment of internal control over financial reporting, management based its evaluation on the Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission as of December 31, 2023. Based on its evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2023.

 

96

 

 

(c) Attestation Report of the Registered Public Accounting Firm

 

This Annual Report on Form 20-F does not include an attestation report of the company’s registered public accounting firm due to an exemption for emerging growth companies under the JOBS Act.

 

(d) Changes in Internal Control over Financial Reporting

 

During the year ended December 31, 2023, we completed the process of documenting our internal control procedures to satisfy the requirements of Section 404(a) of the Sarbanes-Oxley Act, which requires an annual management assessment of the effectiveness of our internal control over financial reporting. We have established formal policies, processes and practices related to our internal control over financial reporting and to identify key financial reporting risks, including an assessment of the potential impact and linkage of those risks to specific areas and activities within our organization. 

 

ITEM 16. [RESERVED]

 

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

 

Our board of directors has determined Moshe Revach is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq listing rules. Each of the members of our audit committee is “independent” as such term is defined in Rule 10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under the Nasdaq Stock Market Listing Rules.

 

ITEM 16B. CODE OF ETHICS

 

Code of Business Conduct and Ethics

 

We have adopted a written Code of Business and Ethics that applies to our officers and employees, including the Chief Executive Officer, President, Chief Financial Officer, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, Controller and persons performing similar functions, as well as our directors. Our Code of Business Ethics is posted on our website at www.jeffsbrands.com. Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 20-F and is not incorporated by reference herein. If we make any amendment to the Code of Business Ethics or grant any waivers, including any implicit waiver, from a provision of the code, we will disclose the nature of such amendment or waiver on our website to the extent required by the rules and regulations of the SEC including the instructions to Item 16B of Form 20-F. Any waiver of this Code for any Covered Person may be made only by the Board or the Audit Committee and will be promptly disclosed to stockholders and others, as required by applicable law. The Company must disclose changes to and waivers of the Code in accordance with applicable law. We have not granted any waivers under our Code of Business Conduct and Ethics.

 

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Pre-Approval of Auditors’ Compensation

 

Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm, or Brightman, has served as our principal independent registered public accounting firm for each of the two years ended December 31, 2023 and 2022.

 

The following table provides information regarding fees paid by us to Brightman, including audit services, for the years ended December 31, 2023 and 2022.

 

   Year Ended December 31, 
   2023   2022 
Audit fees (1)  $215   $150 
Audit-related fees (2)   -    30 
Tax fees (3)   15    15 
Total  $230   $195 

 

(1) Includes professional services rendered in connection with the audit of our annual financial statements, review of our interim financial statements.

 

(2) Includes comfort letters.

 

(3) Includes US tax compliance for the year ended December 31, 2022 and Israeli tax compliance for the year ended December 31, 2023.

 

97

 

 

Pre-Approval of Auditors’ Compensation 

 

Our board of directors have adopted an audit committee charter setting forth, among others, the responsibilities of the audit committee consistent with the rules of the SEC and Nasdaq Listing Rules (in addition to the requirements for such committee under the Companies Law), including, among others, the following:

 

  oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in accordance with Israeli law;

 

  recommending the engagement or termination of the person filling the office of our internal auditor, reviewing the services provided by our internal auditor and reviewing effectiveness of our system of internal control over financial reporting ;

 

  recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our board of directors; and

 

  reviewing and monitoring, if applicable, legal matters with significant impact, finding of regulatory authorities’ findings, receive reports regarding irregularities and legal compliance, acting according to “whistleblower policy” and recommend to our board of directors if so required.

 

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

 

Not applicable.

 

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

 

None.

 

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

Not applicable.

 

ITEM 16G. CORPORATE GOVERNANCE

 

The Sarbanes-Oxley Act, as well as related rules subsequently implemented by the SEC, require foreign private issuers, such as us, to comply with various corporate governance practices. In addition, we are required to comply with the Nasdaq Listing Rules. Under those rules, we may elect to follow certain corporate governance practices permitted under the Companies Law in lieu of compliance with corresponding corporate governance requirements otherwise imposed by the Nasdaq Listing Rules for U.S. domestic issuers.

 

In accordance with Israeli law and practice and subject to the exemption set forth in Rule 5615 of the Nasdaq Listing Rules, we have elected to follow the provisions of the Companies Law, rather than the Nasdaq Listing Rules, with respect to the following requirements:

 

 

 

Quorum. While the Nasdaq Stock Market Listing Rules require that the quorum for purposes of any meeting of the holders of a listed company’s common voting stock, as specified in the company’s bylaws, be no less than 33 1/3% of the company’s outstanding common voting stock, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our amended and restated articles of association provide that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement of business at a general meeting. However, the quorum set forth in our articles of association with respect to an adjourned meeting consists of at least one shareholders present in person or by proxy.

 

98

 

 

  Nomination of our directors. With the exception of directors elected by our board of directors and external directors, our directors are elected by an annual meeting of our shareholders (i) to hold office until the next annual meeting following his or her election or (ii) for three-year term, as described below under “Item 6.C. Board Practices—External Directors.” The nominations for directors, which are presented to our shareholders by our board of directors, are generally made by the board of directors itself, in accordance with the provisions of our amended and restated articles of association and the Companies Law. Nominations need not be made by a nominating committee of our board of directors consisting solely of independent directors, as required under the Nasdaq Listing Rules.
     
  Compensation of officers. Israeli law and our articles of association do not require that the independent members of our board of directors (or a compensation committee composed solely of independent members of our board of directors) determine an executive officer’s compensation, as is generally required under the Nasdaq Stock Market Listing Rules with respect to the chief executive officer and all other executive officers. Instead, compensation of executive officers is determined and approved by our compensation committee and our board of directors, and in certain circumstances by our shareholders, either in consistency with our office holder compensation policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the Companies Law (see “Item 6.C. — Board Practices — Fiduciary Duties and Approval of Related Party Transactions under Israeli Law” for additional information).
     
  Independent directors. Israeli law does not require that a majority of the directors serving on our board of directors be “independent,” as defined under Nasdaq Listing Rule 5605(a)(2), and rather requires we have at least two external directors who meet the requirements of the Companies Law, as described above under “Item 6.C. Board Practices—External Directors.” We are required, however, to ensure that all members of our Audit Committee are “independent” under the applicable Nasdaq and SEC criteria for independence (as we cannot exempt ourselves from compliance with that SEC independence requirement, despite our status as a foreign private issuer), and we must also ensure that a majority of the members of our Audit Committee are “unaffiliated directors” as defined in the Companies Law. We have established an Audit Committee and appointed external directors compliant with applicable rules. Furthermore, Israeli law does not require, nor do our independent directors conduct, regularly scheduled meetings at which only they are present, which the Nasdaq Listing Rules otherwise require.

 

  Shareholder approval. We will seek shareholder approval for all corporate actions requiring such approval under the requirements of the Companies Law, rather than seeking approval for corporation actions in accordance with Nasdaq Listing Rule 5635. In particular, under this Nasdaq listing rule, shareholder approval is generally required for: (i) an acquisition of shares/assets of another company that involves the issuance of 20% or more of the acquirer’s shares or voting rights or if a director, officer or 5% shareholder has greater than a 5% interest in the target company or the consideration to be received; (ii) the issuance of shares leading to a change of control; (iii) adoption or amendment of equity compensation arrangements (although under the provisions of the Companies Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation plan); and (iv) issuances of 20% or more of the shares or voting rights (including securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of the book or market value of shares. By contrast, we follow Israeli practice, which is to have equity compensation plans approved only by the compensation committee and board of directors, unless such arrangements are for the compensation of chief executive officer or directors, in which case they also require the approval of the shareholders. In addition, we follow Israeli law, under which a private placement of securities requires approval by our board of directors and shareholders if it will cause a person to become a controlling shareholder (generally presumed at 25% ownership) or if: (a) the securities issued amount to 20% or more of our outstanding voting rights before the issuance; (b) some or all of the consideration is other than cash or listed securities or the transaction is not on market terms; and (c) transaction will increase the relative holdings of a shareholder that holds 5% or more of our outstanding share capital or voting rights or will cause any person to become, as a result of the issuance, a holder of more than 5% of our outstanding share capital or voting rights.

 

99

 

 

  Approval of Related Party Transactions. All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required under the Nasdaq Listing Rules (see “Item 6.C.— Board Practices — Fiduciary Duties and Approval of Related Party Transactions under Israeli Law” for additional information).
     
  Annual Shareholders Meeting. As opposed to the Nasdaq listing Rule 5620(a), which mandates that a listed company hold its annual shareholders meeting within one year of the company’s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholder meeting each calendar year and within 15 months of the last annual shareholders meeting.
     
  Distribution of periodic reports to shareholders; proxy solicitation. As opposed to the Nasdaq Listing Rules, which require listed issuers to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. In addition to making such reports available on a public website, we currently make our audited consolidated financial statements available to our shareholders at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC’s proxy solicitation rules.

 

ITEM 16H. MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

ITEM 16J. INSIDER TRADING PLANS (10B5-1)

 

Not applicable.

 

ITEM 16K. CYBERSECURITY

 

We use a third-party sub-contractor to manage all Information Technology (IT) issues, including protection against, detection, and response to cyberattacks.

 

The measures that are taken to ensure proper protection include:

 

All computers are protected using a cloud-powered endpoint security solution that helps enterprises prevent, detect, investigate, and respond to advanced threats on their networks. It offers endpoint protection, endpoint detection and response, mobile threat defense, and integrated vulnerability management. It also provides, among other things, malware and spyware detection and remediation, rootkit detection and remediation and network vulnerability detection.

 

100

 

 

All Company computer hard drives are automatically encrypted.

 

All Company e-mails are protected by a cloud-based email filtering service designed to protect the Company against advanced threats related to email and collaboration tools.

 

Periodically, all users on the Company’s computer network are required to perform multi-factor authentication.

 

The Company uses a cloud-based identity and access management service that enables access to external resources.

 

Backup is performed using a secure, automatic cloud-based backup and restore service.

 

Additionally, we believe that our third-party vendors and service providers have their own respective cybersecurity protocols which our management believes to be adequate for protecting any of the Company’s data that might be in their possession from time to time; however, having such protocols is not necessarily a condition for us using or not using the services of any such vendors or providers.

 

Cybersecurity threats have not materially affected, and are not reasonably likely to affect, the Company, including its business strategy, results of operations or financial condition while we are strategically focused on pursuing FDA approval and have pre-commercial operations. The Company is not aware of any material security breach to date. Accordingly, the Company has not incurred any expenses over the last two years relating to information security breaches. The occurrence of cyber-incidents, or a deficiency in our cybersecurity or in those of any of our third-party service providers could negatively impact our business by causing a disruption to our operations, a compromise or corruption of our confidential information and systems, or damage to our business relationships or reputation, all of which could negatively impact our business and results of operations. There can be no assurance that the Company’s third-party vendors’ and service providers’ cybersecurity risk management processes, including their policies, controls or procedures, will be fully implemented, complied with or effective in protecting the Company’s systems and information.

 

101

 

 

PART III

 

ITEM 17. FINANCIAL STATEMENTS

 

We have elected to provide financial statements and related information pursuant to Item 18.

 

ITEM 18. FINANCIAL STATEMENTS

 

The financial statements and the related notes required by this Item are included in this Annual Report on Form 20-F beginning on page F-1.

 

ITEM 19. EXHIBITS

 

The following documents are filed as part of annual report.

 

Number   Exhibit Description
1.1   Amended and Restated Articles of Association of Jeffs’ Brands Ltd (filed as Exhibit 3.1 to Form 6-K (File No. 001-41482) filed on August 31, 2022 and incorporated herein by reference).
     
2.1   Form of Warrant (filed as Exhibit 4.2 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
2.2   Form of Underwriter’s Warrant (filed as Exhibit 4.5 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
2.3   Form of Additional Warrant (filed as Exhibit 4.2 to Form F-1 (File No. 333-262835) filed on May 24, 2022 and incorporated herein by reference).
     
2.4   Form of Investor Warrant (filed as Exhibit 4.5 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).
     
2.8*   Description of Securities.
     
4.1+   Form of Indemnification Agreement (filed as Exhibit 10.1 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).
     
4.2   Form of Warrant Agent Agreement (filed as Exhibit 4.1 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.3+   Jeffs’ Brands Ltd 2022 Incentive Option Plan (filed as Exhibit 10.21 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.4#   Common Stock Purchase Agreement, dated October 8, 2020, by and between Smart Repair Pro, Purex Corp., the stockholders of Smart Repair Pro and Purex Corp., Viki Hakmon, and Medigus Ltd. (filed as Exhibit 10.2 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).
     
4.5#   Amendment No. 1 to Common Stock Purchase Agreement, dated June 22, 2021, by and between Smart Repair Pro, Purex Corp., the stockholders of Smart Repair Pro and Purex Corp., Viki Hakmon, and Medigus Ltd. (filed as Exhibit 10.3 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).
     
4.6   Stock Exchange and Plan of Restructuring Agreement, dated May 10, 2021, by and between Jeffs’ Brands Ltd, on one hand, and Viki Hakmon and Medigus Ltd., on the other hand. (filed as Exhibit 10.4 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).

 

102

 

 

4.7   Purchase Agreement, dated February 2, 2021, by and between Smart Repair Pro and Beard Revive Inc. (filed as Exhibit 10.7 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.8   Loan Agreement, dated April 8, 2021, by and between Smart Repair Pro and Amazon.com (filed as Exhibit 10.8 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.9   Unsecured Loan Agreement, dated July 1, 2021, by and between Smart Repair Pro and Tamrid Ltd. (English Translation) (filed as Exhibit 10.9 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.10   First Amendment to Unsecured Loan Agreement, dated July 13, 2021, by and between Smart Repair Pro and Tamrid Ltd. (English Translation) (filed as Exhibit 10.10 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.11   Second Amendment to Unsecured Loan Agreement, dated November 23, 2021, by and between Smart Repair Pro and Tamrid Ltd. (English Translation) (filed as Exhibit 10.11 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.12   Loan Agreement, dated July 5, 2021, by and between Smart Repair Pro and M.R.M MERHAVIT Holdings and Management Ltd. (English Translation) (filed as Exhibit 10.12 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.13   First Amendment to Loan Agreement, dated July 13, 2021, by and between Smart Repair Pro and M.R.M Merhavit Holdings and Management Ltd. (English Translation) (filed as Exhibit 10.13 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.14   Second Amendment to Loan Agreement, dated November 23, 2021, by and between Smart Repair Pro and M.R.M Merhavit Holdings and Management Ltd. (English Translation) (filed as Exhibit 10.14 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.15   Form of Assignment and Assumption Agreement (filed as Exhibit 10.15 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.16+   Employment Agreement, dated April 1, 2021, by and between Jeffs’ Brands Ltd and Naor Bergman (filed as Exhibit 10.15 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).

 

4.17+   Services Agreement, dated November 28, 2021, by and between Jeffs’ Brands Ltd and Viki Hakmon (filed as Exhibit 10.16 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).
     
4.18+   Amendment to Services Agreement, dated May 4, 2022, by and between Jeffs’ Brands Ltd and Viki Hakmon (filed as Exhibit 10.20 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).
     
4.19+   Services Agreement, dated October 24, 2022, by and between Jeffs’ Brands Ltd and D.S. Blue White Assets (2006) Ltd. (filed as Exhibit 10.20 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).
     
4.20*+   Consulting Agreement, dated October 26, 2022, between Jeffs’ Brands Ltd and L.I.A. Pure Capital Ltd.
     
4.21   Warehouse Services Agreement, dated October 31, 2022, between Pure NY Logistics LLC and Smart Repair Pro. (filed as Exhibit 10.24 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).
     
4.22+   Compensation Policy for Executive Officers (filed as Exhibit 10.25 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).
     
4.23   Stock Purchase Agreement, dated February 23, 2023, by and between Jeffs’ Brands Ltd, Jeffs’ Brands Holdings Inc. and SciSparc Ltd. (filed as Exhibit 99.2 to Form 6-K (File No. 001-41482) filed on February 27, 2023 and incorporated herein by reference).
     
4.24   Addendum No. 1 to Share Purchase Agreement, dated March 22, 2023, by and between the Company, Jeffs’ Brands Holdings Inc. and SciSparc Ltd. (filed as Exhibit 10.2 to Form 6-K (File No. 001-41482) filed on March 31, 2023 and incorporated herein by reference).
     
4.25   Share Purchase Agreement, dated March 22, 2023, by and between Jeffs’ Brands Ltd, Jeffs’ Brands Holdings Inc., Craig Philip Davies and Sarah Jane Davies-Broadhurst (filed as Exhibit 2.1 to Form 6-K (File No. 001-41482) filed on March 7, 2023 and incorporated herein by reference).

 

103

 

 

4.26*   Side Letter to Share Purchase Agreement dated February 29, 2024, from Jeffs’ Brands Ltd. to Philip Davies and Sarah Jane Davies-Broadhurst
     
4.27+   Consulting Agreement, dated March 22, 2023, by and between Jeffs’ Brands Ltd and SciSparc Nutraceuticals Inc. (filed as Exhibit 10.3 to Form 6-K (File No. 001-41482) filed on March 31, 2023 and incorporated herein by reference).
     
4.28+   Consulting Agreement, dated March 9, 2023, by and between Jeffs’ Brands Ltd, Sarah Davies-Broadhurst and Craig Davies (filed as Exhibit 10.3 to Form 6-K (File No. 001-41482) filed on March 23, 2023 and incorporated herein by reference).
     
4.29   Form of Settlement Agreement, dated March 9, 2023, by and between Jeffs’ Brands Ltd, Fort Products Ltd. and the individual identified on the signature page thereto (filed as Exhibit 10.2 to Form 6-K (File No. 001-41482) filed on March 23, 2023 and incorporated herein by reference).
     
4.30   Form of Securities Purchase Agreement, (filed as Exhibit 10.1 to Form 6-K (File No. 001-41482) filed on January 29, 2024, and incorporated herein by reference)
     
4.31   Form of Registration Rights Agreement, (filed as Exhibit 10.2 to Form 6-K (File No. 001-41482) filed on January 29, 2024, and incorporated herein by reference)
     
4.32   Form of Series A Warrant, (filed as Exhibit 4.1 to Form 6-K (File No. 001-41482) filed on January 29, 2024, and incorporated herein by reference).
     
4.33   Form of Series B Warrant, (filed as Exhibit 4.2 to Form 6-K (File No. 001-41482) filed on January 29, 2024, and incorporated herein by reference).
     
4.34   Form of Pre-Funded Warrant, (filed as Exhibit 4.3 to Form 6-K (File No. 001-41482) filed on January 29, 2024, and incorporated herein by reference).
     
8.1*   List of Subsidiaries.
     
12.1*   Certification of the Principal Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.
     
12.2*   Certification of the Principal Financial and Accounting Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.
     
13.1%   Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350.
     
13.2%   Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. 1350.
     
15.1*   Consent of Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm.
     
97*   Clawback Policy for Recovery of Erroneously Awarded Compensation
     
101   The following financial information from the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Report of Independent Registered Public Accounting Firm; (ii) Consolidated Balance Sheets; (iii) Consolidated Statements of Operations; (iv) Consolidated Statements of Changes in Convertible Preferred Shares and Shareholders’ Equity (Deficit); (v) Consolidated Statements of Cash Flows; and (vi) Notes to the Consolidated Financial Statements, tagged as blocks of text and in detail.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Filed herewith.
% Furnished herewith.
+ Compensatory arrangement.
# Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

 

104

 

 

JEFFS’ BRANDS LTD

CONSOLIDATED FINANCIAL STATEMENTS

 

TABLE OF CONTENTS

 

    Page
     
Report of Independent Registered Public Accounting Firm (Firm Name: Brightman Almagor Zohar & Co / PCAOB ID No. 1197)   F-2
Consolidated Balance Sheets as of December 31, 2023 and 2022   F-3
Consolidated Statements of Operations for the Years Ended December 31, 2023, 2022 and 2021   F-4
Consolidated Statements of Changes in Shareholders’ Equity for the Years Ended December 31, 2023, 2022 and 2021   F-5
Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022 and 2021   F-6
Notes to the Consolidated Financial Statements   F-8 – F-33

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of Jeffs’ Brands Ltd

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Jeffs’ Brands Ltd and its subsidiaries (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Brightman Almagor Zohar & Co.

 

Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

 

Tel Aviv, Israel

April 1, 2024

 

We have served as the Company’s auditor since 2021.

 

F-2

 

 

JEFFS’ BRANDS LTD

CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)

 

      December 31 
   Note  2023   2022 
ASSETS           
CURRENT ASSETS:           
Cash and cash equivalents      535    8,137 
Restricted deposit      17    
-
 
Trade receivables      629    327 
Other receivables  3   597    779 
Inventory  4   2,386    1,791 
Total current assets      4,164    11,034 
NON-CURRENT ASSETS:             
              
Property and equipment, net      59    41 
Investment accounted for using the equity method  7   1,940    
-
 
Investment at fair value      67    
-
 
Intangible assets, net  5   5,714    4,452 
Deferred taxes  12   168    110 
Operating lease right-of-use assets  6   127    138 
Total non-current assets      8,075    4,741 
TOTAL ASSETS      12,239    15,775 
              
LIABILITIES AND EQUITY             
CURRENT LIABILITIES:             
              
Trade payables      709    131 
Other payables  8   1,533    391 
Related party payables  17   66    32 
Short-term loans  9   
-
    86 
Total current liabilities      2,308    640 
NON-CURRENT LIABILITIES:             
Derivative liabilities  10   1,375    2,216 
Operating lease liabilities  6   45    98 
Total non-current liabilities      1,420    2,314 
TOTAL LIABILITIES      3,728    2,954 
              
SHAREHOLDERS’ EQUITY:             
Ordinary shares of no par value per share – Authorized: 43,567,567 shares as of December 31, 2023, and December 31, 2022; Issued and outstanding: 1,215,512 shares as of December 31, 2023; 1,153,461 shares as of December 31, 2022(*)  13   
-
    
-
 
Additional paid-in-capital      16,787    16,499 
Accumulated deficit      (8,276)   (3,678)
TOTAL SHAREHOLDERS’ EQUITY      8,511    12,821 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY      12,239    15,775 

 

(*)Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.

 

The accompanying notes are an integral part of the consolidated financial statements 

 

F-3

 

 

JEFFS’ BRANDS LTD

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)

 

       Year ended December 31  
       2023    2022    2021 
Revenues      10,008    5,859    6,509 
Cost of sales      9,032    5,060    4,560 
                   
Gross profit      976    799    1,949 
                   
Operating expenses:                  
                   
Sales and marketing      833    1,198    1,314 
General and administrative      4,262    4,113    1,480 
Equity losses      1,249    -    - 

Impairment loss of intangible asset

      

-

    

-

    

87

 
Other income  17   (279)   -    
-
 
                   
Operating loss      (5,089)   (4,512)   (932)
                   
Financial (income) expenses, net  15   (523)   (2,305)   629 
                   
Loss before taxes      (4,566)   (2,207)   (1,561)
                   
Tax (benefit) expense  12   32    (6)   (21)
                   
Net loss      (4,598)   (2,201)   (1,540)
                   
Basic and diluted net loss attributable to shareholders per ordinary share  16   (3.88)   (*)(3.32)   (*)(3.73)
                   
Weighted-average ordinary shares used in computing net loss per share, basic and diluted      1,184,484    (*)663,411    (*)413,192

 

(*)Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.

 

The accompanying notes are an integral part of the consolidated financial statements

 

F-4

 

 

JEFFS’ BRANDS LTD

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(in thousands, except share and per share data)

 

   Ordinary Shares   Additional   Retained
earnings
(Accumulated
     
   Number (*)   Amount   paid-in-capital   deficit)   Total 
                     
BALANCE AT DECEMBER 31, 2020   413,304    
-
    287    63    350 
Loss for the year   -    
-
    
-
    (1,540)   (1,540)
Share-based compensation to service provider   -    
-
    75    
-
    75 
Issuance of ordinary shares   -    
-
    1,250    
-
    1,250 
Share-based compensation   -    
-
    60    
-
    60 
Transactions with shareholders   -    
-
    1,058    
-
    1,058 
BALANCE AT DECEMBER 31, 2021   413,304    
-
    2,730    (1,477)   1,253 
Loss for the year   -    
-
    
-
    (2,201)   (2,201)
Debt extinguishment of shareholders’ loans (Note 11)   -    
-
    769    
-
    769 
Issuance of ordinary shares upon initial public offering, net of issuance costs (Note 13)   557,774    
-
    6,194    
-
    6,194 
Issuance of warrants to third party upon initial public offering (Note 13)   -    
-
    26    
-
    26 
Conversion of shareholder loans (Note 11)   209,089    
-
    3,461    
-
    3,461 
Reclassification of derivative warrant liabilities to equity (Note 10)   -    
-
    3,319    
-
    3,319 
BALANCE AT DECEMBER 31, 2022   1,153,461    
-
    16,499    (3,678)   12,821 
                          
Loss for the year   -    
-
    
-
    (4,598)   (4,598)
Issuance of ordinary shares to SciSparc Ltd. (Note 7)   35,345    
-
    288    
-
    288 
                          
BALANCE AT DECEMBER 31, 2023   1,215,512    
-
    16,787    (8,276)   8,511 

 

(*)Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-5

 

 

JEFFS’ BRANDS LTD
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 

   Year ended December 31 
   2023   2022   2021 
CASH FLOWS USED IN OPERATING ACTIVITIES:            
Net loss   (4,598)   (2,201)   (1,540)
Adjustments to reconcile net loss to net cash used in operating activities:               
Share-based compensation   
-
    
-
    60 
Exchange differences on cash and cash equivalents   34    
-
    
-
 
Depreciation and amortization of intangible assets   738    570    524 
Impairment of intangible asset   
-
    
-
    87 
Accrued interest and amortization of discount on third party, related party and shareholders’ loans   
-
    298    546 
Gain from debt extinguishment   
-
    
-
    (14)
Loss from change in value of investment at fair value   221    
-
    
-
 
Equity losses   1,249    
-
    
-
 
Changes in fair value of derivative liabilities   (841)   (2,822)   75 
Interest expense on short-term loan   (1)   (25)   
-
 
Changes in deferred taxes, net   (58)   (15)   (115)
Issuance costs on derivative liabilities   
-
    1,416    
-
 
                
Changes in operating assets and liabilities:               
Decrease (increase) in trade receivables   (302)   39    (282)
Decrease in related party balance   
-
    
-
    40 
Decrease (increase) in other receivables   182    (743)   (290)
Increase in inventory   (596)   (564)   (449)
Increase (decrease) in related party liabilities   
-
    (213)   241 
Increase (decrease) in accounts payable and other payables   1,304    (579)   254 
Decrease in operating lease right-of-use assets   67    14    - 
Decrease in operating lease liabilities   (67)   (15)   
-
 
Net cash used in operating activities   (2,668)   (4,840)   (863)
                
CASH FLOWS USED IN INVESTING ACTIVITIES:               
Purchase of property and equipment   (25)   (41)   (2)
Restricted deposit   (17)   
-
    
-
 
Purchase of investment accounted for using the equity method (see note 7)   (3,091)   
-
    
-
 
Purchase of intangible assets (see note 5)   (1,681)   
-
    (4,728)
Net cash used in investing activities   (4,814)   (41)   (4,730)
                
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:               
Short-term loans received   
-
    752    981 
Short-term loans repaid   (86)   (1,518)   (134)
Proceeds from initial public offering, net of issuance costs   
-
    13,391    
-
 
Loans received from shareholders   
-
    
-
    4,800 
Loans repaid to shareholders   
-
    
-
    (100)
Loans repaid to related parties   
-
    
-
    (1,102)
Issuance of ordinary shares   
-
    
-
    1,250 
Net cash from (used in) financing activities   (86)   12,625    5,695 
                
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   (7,568)   7,744    102 
                
LOSSES FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS   (34)   
-
    
-
 
                
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR   8,137    393    291 
                
CASH AND CASH EQUIVALENTS AT END OF THE YEAR   535    8,137    393 

 

F-6

 

 

JEFFS’ BRANDS LTD
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 

Supplemental disclosure of cash flow information:            
Taxes paid   28    73    116 
Interest paid   2    477    4 
Supplemental disclosure of noncash investing and financing activities:               
Deferred offering costs included in other payables   
-
    
-
    86 
Share-based compensation included in deferred offering costs   
-
    
-
    75 
Issuance of ordinary shares upon conversion of shareholders’ loans   
-
    2,839    
-
 
Issuance of 35,345 ordinary shares to SciSparc Ltd. in consideration for 13,858 ordinary shares (see note 7.b)   288    
-
    
-
 
Consideration payable to sellers of Fort Products Ltd. included in other payables   332    
-
    
-
 
Consideration payable to seller of SciSparc Nutraceuticals Inc. shares included in other payables   98    
-
    
-
 
Substantial modification of shareholders’ loans recorded in equity   
-
    982      
Right of use assets obtained in exchange for lease liabilities   57    152    
-
 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-7

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — GENERAL INFORMATION

 

  a. General

 

Jeffs’ Brands Ltd (the “Company” or “Jeffs’ Brands”) was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements the Company has five wholly owned subsidiaries — Smart Repair Pro (“Smart Pro”), Top Rank Ltd. (“Top Rank”), Jeffs’ Brands Holdings Inc. (“Jeffs’ Brands Holdings”), Fort Products Ltd. (“Fort”) and Fort Products LLC (“Fort US”) (the “Subsidiaries”). The Company and the Subsidiaries (“Group”) are engaged in the acquisition, improvement and operation of virtual stores (the “Brands”) mainly on the Amazon.com (“Amazon”) website.

 

References to the Company hereinafter, unless the context otherwise provides, include Jeffs’ Brands and the Subsidiaries on a consolidated basis.

 

Smart Pro, a private corporation founded in the State of California, was established on December 20, 2017, and commenced its operations in June 2019. As of December 31, 2023, Smart Pro operated four brands on the Amazon website.

 

In April 2021, Top Rank, an Israeli company, was established as a wholly owned subsidiary of Jeffs’ Brands.

 

On February 23, 2023, Jeffs’ Brands Holdings Inc., was established and registered in Delaware as a wholly owned subsidiary of Jeffs’ Brands.

 

On March 9, 2023, the Company purchased all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information see note 5.

 

On April 23, 2023, Fort US, was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands Holdings.

 

On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of common stock of SciSparc Nutraceuticals Inc. (“SciSparc U.S”). For additional information see note 7.

 

F-8

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — GENERAL INFORMATION (cont.)

 

b.Initial public offering

 

On August 30, 2022, the Company completed its initial public offering (“IPO”), for additional information see note 13.

 

c. Concentration risk

 

The Group’s activities are mainly conducted through Amazon’s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon’s terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.

 

In addition, the Group is engaged with a small number of suppliers as part of the production process of its brands. Any material changes in the supply process, whether temporary or permanent, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.

 

e.Liquidity

 

During the year ended December 31, 2023, the Group incurred a net loss of 4,598 thousand and cash flows used in operating activities were $ 2,668 thousand. As of December 31, 2023, the Group had an accumulated deficit of approximately $8,276 thousand.

 

The Group has funded its operations to date through the sale of its products, through equity financings, loans from shareholders and other third parties, and sale of its Ordinary Shares and warrants. The Company intends to continue to finance its operating activities through the sale of products via its Brands and through raising additional capital, as needed.

 

On January 29, 2024, the Company entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement with certain institutional investors for aggregate gross proceeds of approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement.

 

Management believes that expected cash flows are sufficient to support the Group’s current operations for more than 12 months from the issuance date of these consolidated financial statements.

 

F-9

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a.Basis of preparation of the financial statements

 

The Group’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

Prior to 2022, the Group prepared its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB), as permitted in the United States based on the Company’s qualification as a “foreign private issuer” under the rules and regulations of the U.S Securities and Exchange Commission (the “SEC”).

 

b.Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances, fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent liabilities, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group’s assets and liabilities.

 

c.Functional and presentation currency

 

The functional and reporting currency of the Group is the United States dollar (“U.S dollar”) as the U.S. dollar is the currency of the primary economic environment in which the Group has operated and expects to continue to operate in the foreseeable future.

 

The Group's transactions and balances denominated in U.S. dollars are presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.

 

d.Cash and cash equivalents

 

The Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and to be cash equivalents.

 

e.Accounts receivable

 

Accounts receivables are stated at realizable value, net of an allowance for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point of sale, therefore, no provision for credit losses has been recorded as of December 31, 2023 and 2022.

 

F-10

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

f.Inventories

 

Inventories are stated at the lower of cost or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in accordance with first-in, first-out Method (“FIFO”). The cost of inventory includes all costs of purchase, and other costs incurred in bringing the inventories to their present location and condition including shipment and freight costs.

 

g.Property and equipment

 

Property and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.

 

The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:

 

    %
Computers equipment   33
Office Equipment/Furniture   5-7
Plant & Machinery   5
Leasehold improvements   Shorter of remaining lease term or estimated useful life

 

F-11

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

h.Leases

 

In accordance with ASC 842, the Group determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical expedient to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease.

 

ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Group’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.

 

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option. An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.

 

Operating lease expense is recognized on a straight-line basis over the lease term.

 

i.Asset acquisition

 

The Group accounts for a transaction as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs are capitalized as part of the asset or assets acquired.

 

j.Intangible assets

 

The Group’s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.

 

The estimated useful lives of the Group’s intangible assets (Brands) are 10 years.

 

F-12

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

k.Impairment of long-lived assets

 

The Group’s long-lived assets (assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.

 

In determining the fair values of long-lived assets for the purpose of measuring impairment, the Group’s assumptions include those that market participants will consider in valuations of similar assets.

 

l.Loans from shareholders and related parties:

 

On the borrowing date of loans received from shareholders or related parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with ASC 470, “Debt” (“ASC 470”), Subtopic 50— “Modifications and Extinguishments” (“ASC 470-50”). For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt is recorded as an in-essence capital transaction.

 

m.Income taxes

 

The Group accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. As of December 31, 2023 and 2022 a partial valuation allowance was recorded on the Group’s deferred tax assets.

 

The Group implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. As of December 31, 2023 and 2022, no liability for unrecognized tax positions were recognized.

 

F-13

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

n.Revenue recognition

 

The Group accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). The Company derives its revenue from the sale of consumer products mainly through its online Amazon stores. 

 

The Company considers customer order confirmations to be a contract with the customer. Customer confirmations are executed at the time an order is placed through third-party online channels.

 

Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligation is satisfied), which typically occurs at the shipment date. A performance obligation is a promise in a contract to transfer a distinct good to the customer and is the unit of account in ASC Topic 606. A contract’s transaction price is recognized as revenue when the performance obligation is satisfied. Each of the Company’s contracts have a single distinct performance obligation, which is the promise to transfer individual goods.

 

Under the Group’s standard contract terms, customers have a right of return within 45 days. For contracts with rights of return, the Group recognizes revenue based on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance for returns in the amounts of $21 thousand and $70 thousand as of December 31, 2023, and 2022, respectively. The allowance for returns is recorded as (increase) decrease in revenues, respectively against other payables.

 

The Group evaluates the criteria outlined in ASC 606-10-55, “Principal versus Agent Considerations”, in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these arrangements; therefore, sales are recorded on a gross basis.

 

Sales taxes collected from customers are presented on a net basis and as such are excluded from net revenue. 

 

  o. Cost of sales

 

In accordance with Amazon’s terms of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making binding sales. Sales commissions would not have been incurred if the contract had not been obtained.

 

Cost of sales primarily consists of cost of goods sold, expenses related to Amazon’s commissions, storage costs and freight.

 

  p. Advertising expenses

 

The Group expenses advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $719 thousand, $1,163 thousand, and $1,211 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.

 

F-14

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

q.Employee benefits

 

Groups employees are employed by the company and by Fort and subject to the local labor laws.

 

The Company’s employees

 

Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Group’s employees in Israel are entitled to a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve the Group from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group’s balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.

 

Fort employees

 

England labor laws generally requires an employer to make contributions to National Employment Savings Trust on behalf of its employees. Since April 2019, the minimum employer contribution is required to be 3% of an employee's salary. These payments relieve a company from future obligations with respect to its employees. The aforementioned contributions are not recorded as an asset on the Group's balance sheet and there is no liability recorded as the Group does not have a future obligation to make any additional payments.

 

r.Fair value measurement

 

The Group applies ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

 

In determining fair value, the Group uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent from the Group. Unobservable inputs are inputs that reflect the Group’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:

 

Level 1 - Valuations based on quoted prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

 

Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

 

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

The carrying amounts of cash and cash equivalents, trade receivables, other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value due to the short-term maturity of such instruments.

 

The Group’s derivative liabilities in respect of Additional Warrants are classified within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable inputs. For more details, see Note 9.

 

The Group’s financial asset in respect of the investment in SciSparc Ltd. (“SciSparc”) as of December 31, 2023 is classified within Level 1 of the fair value hierarchy, because the ordinary shares have quoted prices as they are traded on the Nasdaq Stock Market LLC.

 

s.Warrants

 

The Group accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance.

 

The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, “Distinguishing Liabilities and Equity”, are indexed to the Group’s own stock and whether the warrants are eligible for equity classification under ASC 815 (“ASC 815”), “Derivatives and Hedging”, Subtopic 40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.

 

F-15

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

Warrants that meet all the criteria for equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings at each balance sheet date thereafter.

 

t.Legal and other contingencies

 

The Group accounts for its contingent liabilities in accordance with ASC 450, “Contingencies”. A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with loss contingencies are expensed as incurred. As of December 31, 2023, and 2022, the Group is not a party to any litigation that could have a material adverse effect on the Group’s business, financial position, results of operations or cash flows.

 

u.Basic and diluted net loss per share.

 

The Group calculates basic net profit (loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All outstanding share options and warrants for the years ended December 31, 2023 and 2022 have been excluded from the calculation of the diluted net loss per share since all such securities were anti-dilutive.

 

  v. Investment in affiliates

 

The investment in affiliated company is accounted for by the equity method under ASC Subtopic 323-10, “Investments - Equity Method and Joint Ventures”. The Company uses the equity method when it has the ability to exercise significant influence over operating and financial policies of an entity but does not have control of the entity. Under the equity method of accounting, an investment is initially recorded on the balance sheet at cost, representing the Company’s proportionate share of fair value. The investment is subsequently adjusted to reflect the Company’s proportionate share of net earnings or losses recognized, distributions received, contributions made and certain other adjustments, as appropriate. The Company does not record losses of the equity method investee in excess of its investment balance unless the Company is liable for obligations of the equity method investee or is otherwise committed to provide financial support to the equity method investee. As of December 31, 2023 the Company held investments in SciSparc U.S.

 

The Company evaluates its equity method investments for impairment at each reporting date, or more frequently if events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when determining whether an investment has been other-than-temporarily-impaired, include, but are not limited to, the length of the time and the extent to which the market value has been less than cost, the financial condition and near-term prospects of the investee, and the Company's intent and ability to retain the investment until the recovery of its cost. An impairment loss on the equity method investments is recognized in earnings when the decline in value is determined to be other-than-temporary. The Company recorded an impairment loss of $955 for the year ended December 31, 2023 on its investment in SciSparc U.S.

 

w.Recently Issued Accounting Pronouncements

 

Recent Accounting Pronouncements Not Yet Adopted

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendment also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

 

F-16

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — OTHER RECEIVABLES

 

   December 31, 
   2023   2022 
   U.S. dollars in thousands 
Advances to suppliers   559    641(*)
Government institutions   38    130 
Other receivables   
-
    8 
    597    779 

 

(*)As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information.

 

NOTE 4 — INVENTORY

 

   December 31, 
   2023   2022 
   U.S. dollars in thousands 
Goods in transit   219    8 
Finished goods   2,167    1,783 
    2,386    1,791 

 

F-17

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 — INTANGIBLE ASSETS

 

Total intangible assets consisted of the following as of December 31, 2023 and 2022:

 

   December 31, 2023 
   Gross
Amount
   Accumulated
Amortization
   Net
Balance
 
   U.S. dollars in thousands 
Brands   7,774    (2,060)   5,714 

 

   December 31, 2022 
   Gross
Amount
   Accumulated
Amortization
   Net
Balance
 
   U.S. dollars in thousands 
Brands   5,783    (1,331)   4,452 

 

Amortization expense was $730 thousand, $570 thousand, and $524 thousand, for the years ended December 31, 2023, 2022, and 2021, respectively. Estimated annual amortization expense for each of the next five years is expected to be $769 thousand.

 

On March 2, 2023, the Company entered into a share purchase agreement (the “Fort SPA”), with the holders (the “Sellers”), of all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately £2 million (approximately $2.4 million) (the “Fort Acquisition”). As of December 31, 2023, the Company had an outstanding liability to the sellers of $332 included in other payables in the consolidated balance sheet.

 

On February 29, 2024, the Company extended a side letter to the Fort SPA to the Fort Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100 thousand (approximately $128 thousand). these adjustments were included in the outstanding liability as of December 31, 2023.

 

On March 9, 2023, the Company recognized the amount of $1,991 thousand paid in connection with the Fort Acquisition amortized over a period of 10 years.

 

As part of the Fort SPA, the employment of these employees was terminated within three months, with all termination costs to be borne by the Sellers.

 

Also, in connection with the closing of the Fort Acquisition, on March 9, 2023, Fort and the Sellers entered into a consulting agreement, pursuant to which the Sellers will provide the Company with consultancy services for a period of six months following the closing, at a monthly fee of £2.5 thousand (approximately $3 thousand). On September 20, 2023, the Company and the Sellers entered into a new consulting agreement for an indefinite period at a monthly fee of £3.5 thousand (approximately $4.5 thousand) effective as of June 1, 2023 (the “Fort Consulting Agreement”).

 

The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations.

 

F-18

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 — LEASES:

 

The Company leases office space and a warehouse with a remaining useful life of less than 3 years.

 

As of December 31, 2023, the Company’s operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $138 thousand and $127 thousand, respectively.

 

The Company uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2023, the Company’s operating leases had a weighted average remaining lease term of 3 years and a weighted average borrowing rate of approximately 10%.

 

Future lease payments under operating leases as of December 31, 2023, were as follows:

 

2024  $95 
2025  $43 
Total future operating lease payments  $138 
Less: imputed interest  $(11)
Present value of lease liability  $127 

 

F-19

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 — INVESTMENT IN AFFILIATE

 

  a. On February 23, 2023, the Company and Jeffs’ Brands Holdings entered into a stock purchase agreement (as amended on March 22, 2023, the “Wellution Agreement”), with SciSparc, a related party of the Company (see note 17), pursuant to which, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S, a wholly-owned subsidiary of SciSparc that owns and operates Wellution, an Amazon food supplements and cosmetics brand, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S, for approximately $3.0 million in cash. The Company reviewed the transaction and deemed it to be the purchase of assets for accounting purposes under ASC Subtopic 805 “Business Combinations” (“ASC 805”), and not as a business combination. The Company reviewed the guidance under ASC 805 for the transaction and determined that the fair value of the gross assets acquired was concentrated in a single identifiable asset, a brand. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024. See also note 17.

 

In connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.Sfor the Wellution brand for a monthly fee of $20 thousand. Additionally, the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the Company and SciSparc agreed to reduce the monthly fee to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.Sas of December 31, 2023, was $15 thousand and $8 thousand, accordingly. See also note 17.

 

Jeffs' Brands Holdings owns 49% of the voting rights in SciSparc U.Sand has the right to appoint two out of five directors. Management has determined that it has significant influence over SciSparc U.S and accordingly accounts for its investment under the equity method.

 

The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations 

 

Management assesses whether impairment indicators are present that may indicate an other than temporary impairment ("OTTI") exists. Management determined that the decrease in revenues and operating losses of SciSparc U.S were indicative of an OTTI impairment as of December 31 2023. Accordingly, management's fair valuation expert performed an impairment test of the equity investment and determined that the carrying value exceed the discounted cash flows. As a result, an impairment loss of $955 thousand was recorded within equity losses in the statement of operations for the year ended December 31, 2023.

 

The activity in the investment in SciSparc U.S account was as follows:

 

   February 23,
2023 –
December 31,
2023
 
   USD in
thousands
 
Balance as of January 1, 2023   
-
 
Purchase on February 23, 2023   3,189 
Equity losses   (1,249)
Balance as of December 31, 2023   1,940 

 

F-20

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 — INVESTMENT IN AFFILIATE (cont.)

 

Summarized financial information:

 

Summarized balance sheet of SciSparc U.S:

 

   December 31,
2023
 
   USD in
thousands
 
Current assets   924 
Long-term assets   3,189 
Current liabilities   (154)
Equity   3,959 

 

Summarized statement of statement of operation of SciSparc U.S:

 

   February 22,
2023 –
December 31,
2023
 
   USD in
thousands
 
Revenues   (2,137)
Cost of sales   1,409 
Impairment of intangible asset   1,042 
General and administrative   748 
Sales and marketing   468 
Taxes on income   22 
Net loss   1,552 

 

b.Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company issued 35,345 ordinary shares, no par value per share (“Ordinary Shares”) to SciSparc and SciSparc issued 13,858 of its ordinary shares to the Company in a share exchange, (collectively, the “Exchange Shares”), representing approximately 2.97% and 4.99%, respectively, of the Company’s and SciSparc’s issued and outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288 thousand by the average closing price of the relevant company’s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the closing.

 

The investment in SciSparc was accounted for as financial asset through profit and loss.

 

The activity in the investment in SciSparc’s shares was as follows:

 

   March 23,
2023 –
December 31,
2023
 
   USD in
thousands
 
Balance as of January 1, 2023   
-
 
Value of shares obtained in connection with share exchange on March 23, 2023   288 
Change in fair value   (221)
Balance as of December 31, 2023   67 

 

F-21

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8 — OTHER PAYABLES

 

    December 31,  
    2023   2022  
    U.S. dollars in thousands  
Government institutions     428     36  
Employees and related benefits     85     49  
Operating lease liabilities     82     40  
Liability to sellers     (*)430     -  
Revenue sharing payment payable     140     40  
Accrued expenses and other payables     368     226  
               
      1,533     391  

 

(*)Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information.

 

NOTE 9 — SHORT-TERM LOANS 

 

  a. On May 9, 2022, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $152 thousand from Amazon. The loan matures within 12 months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged its financial balances on its account on Amazon and its inventories held in Amazon’s warehouses, in favor of Amazon. The loan was fully repaid on February 27, 2023.

 

  b.

In July 2021, Smart Pro entered into a loan agreement with two third parties (“lenders”). The loans bore annual interest rate of 10% and were payable in January 2022. Smart Pro was entitled to extend the loans by an additional sixty days, with additional interest of 1% per month. In addition, pursuant to the loan agreement, in the event of an IPO of the Company, the lenders would be entitled to Ordinary Shares of the Company at an aggregate value of $250 thousand with a conversion price at the IPO price. In July 2021, the loan principal of $750 thousand was received. The proceeds from the lenders were first allocated to the liability (see note 9.a) to issue a variable number of shares based on its fair value at the date of issuance in an amount of $62 thousand, with a corresponding discount recorded on the third-party loan. The derivate liability was revalued at each period-end and amounted to $137 thousand as of December 31, 2021.

 

On November 23, 2021, the loan agreement was amended to extend the maturity date of the loans to the earlier of (i) March 31, 2023, or (ii) the closing of an IPO of the Company. Based on management’s assessment, the amendment resulted in a substantial modification to the loan in accordance with ASC 470-50. As a result of the debt extinguishment, the Group recorded, a gain in the amount of $14 thousand within finance expenses, net for the year ended December 31, 2021 as the difference between the net carrying value of the original loans and the fair value of the loan bearing the modified terms.

 

Following the IPO in 2022, the Group repaid the third-party loan. Furthermore, Effective as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreement (the “Issuance Date”), the Company issued 60,096 warrants to the lenders (“lenders warrants”) to purchase up to 8,586 Ordinary Shares, exercisable at an exercise price of $28.28 per share, exercisable for three years following the IPO. The warrants have cashless exercise mechanism.

 

On the issuance date of the lenders warrants, all conditions for equity classification under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were reclassified to equity.

 

F-22

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9 — SHORT-TERM LOANS (cont.)

 

  c. On February 22, 2022, the Company entered into a loan agreement with Bank Leumi Le-Israel (“Bank Leumi”) to provide for a line of credit in an aggregate amount of up to $1,000 thousand, which the Company may draw in two tranches at its request, but in no event after July 21, 2022. Pursuant to the loan agreement, amounts drawn bear interest at a rate of Secured Overnight Financing Rate (“SOFR”) plus 3.25% annually. On March 3, 2022, the Company drew $400 thousand under the line of credit. On June 2, 2022, the Company drew another $200 thousand million under the line of credit. Following an agreement with Bank Leumi, the loan was extended until October 31, 2022. All amounts outstanding under the line of credit were fully repaid on September 6, 2022.

 

NOTE 10 — DERIVATIVE LIABILITIES

 

In connection with the IPO the Company issued 3,717,473 warrants to purchase up to 531,068 Ordinary Shares (“IPO Warrants”). Given their contractual terms, from the issuance date and up until the 90th day immediately following issuance, the IPO Warrants did not meet the U.S. GAAP definition for equity classification. As such, they were classified as a liability up until November 28, 2022. Upon issuance, the IPO Warrants (which included the right to issue Additional Warrants) were accounted for as derivative instrument which was classified as a liability and measured at fair value through profit or loss. The fair value was approximately $8.2 million.

 

On November 28, 2022, following the adjustment to the exercise price and issuance of 2,824,525 Additional Warrants to purchase up to 403,504 Ordinary Shares, the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair value of the IPO warrants as of November 28, 2022, at the amount of $3,319 thousand, was recorded as a component of Company’s shareholder’s equity. The term of the Additional Warrants is five (5) years from the issuance date and exercisable for up to 403,504 ordinary shares at exercise price of $14.14 per share. Each Additional Warrant holder receives semi-annual payments equal to approximately 2.3% of the Company’s gross revenues, calculated for the first and second six-month fiscal periods, shared pro rata among qualified holders (“Revenue Sharing Payment”). The Revenue Sharing Payment related to 2023 and 2022 was $269 thousand and $40 thousand, respectively.

 

The value of the IPO Warrants upon issuance and the Additional Warrants upon issuance and at year-end was calculated based on the binomial option pricing model.

 

For the year ended December 31, 2023 and 2022, the Company recorded finance income of $841 thousand and $2,710 thousand, respectively to account for the change in the value of the IPO Warrants and Additional Warrants during the period.

 

The following table presents changes in the fair value of the derivative warrant liability (in thousands)

 

Balance as of December 31, 2021  $137 
Issuance of warrants in connection with the IPO   8,220 
Change in fair value   (2,822)
Classification to additional paid in capital   (3,319)
Balance as of December 31, 2022   2,216 
Change in fair value   (841)
Balance as of December 31, 2023   1,375 

 

F-23

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 10 — DERIVATIVE LIABILITIES (cont.)

 

The following table lists the significant unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:

 

   2023   2022 
Expected volatility   101.39%   77.57%-78.89%
Exercise price  $14.14    $14.14 
Share price  $3.05   $10.71-13.055 
Risk-free interest rate   3.93%   3.27%-4.04%
Dividend yield   -    - 
Expected life   3.91    3-4.74 
WACC   20.4%   21.5%-23.3%

 

Additionally, the revenue forecast over the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of December 31, 2023 and 2022.

 

NOTE 11 — LOANS FROM SHAREHOLDERS

 

    As of May 3, 2022, Smart Pro had outstanding loans to Medigus, Mr. Hakmon and L.I.A. Pure Capital Ltd. (“Pure Capital”) of $4,010 thousand, $940 thousand and $109 thousand, respectively. On May 3, 2022, the Company entered into Assignments to Loan Agreements with Smart Pro, Medigus, Mr. Hakmon and Pure Capital, pursuant to which the Company assumed Smart Pro’s obligations under the outstanding loans and agreed that unless earlier repaid pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of IPO, all outstanding principal due to each such party will be automatically converted into a number of Ordinary Shares equal to the quotient obtained by dividing the outstanding principal amount due to such party, by the per Ordinary Share price obtained by dividing $10,000 thousand by the fully diluted issued and outstanding Ordinary Shares as of immediately prior to the closing of the IPO. Any accrued and unpaid interest due to such party as of such date will be paid in cash.

 

Based on management’s assessment, the modified loan terms including an equity conversion feature upon IPO represented a substantial modification in accordance with ASC 470-50 and is accounted for as an extinguishment of the original financial liability in the amount of $3,821 thousand and the recognition of a new financial instrument in the amount of $2,839 thousand. The difference between the fair value of the instrument bearing the modified terms and the carrying values of the original loans immediately prior to the modification, was recorded as an increase in equity in the amount of $982 thousand.

 

As the convertible note was not issued with a substantial premium or with an embedded conversion feature required to be bifurcated under ASC 815, the convertible note was accounted for as a liability in its entirety.

 

In accordance with such assignment agreements, on August 30, 2022, the outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital at a total amount of $5,059 thousand were converted into an aggregate of 209,088 Ordinary Shares. In addition, accrued interest of $393 thousand was paid.

 

F-24

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 — TAXES ON INCOME

 

Jeffs’ Brands and Top Rank are taxed according to Israeli tax laws. The corporate tax rate in Israel is 23% for 2021 and thereafter.

 

Smart Pro, Purex Jeffs Brands Holdings Inc and Fort US are taxed according to US federal California state and Delaware state laws. The blended corporate tax rate is 28% for 2021 and thereafter.

 

Fort is taxed according to UK tax law. The corporate tax rate is 19%.

 

Capital gains are subject to capital gain tax according to the corporate tax rate for the year during which the assets are sold.

 

For financial reporting purposes loss before taxes includes the following components:

 

   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands 
Israel   (2,866)   (2,081)   (1,096)
Foreign   (1,700)   (126)   (465)
                
    (4,566)   (2,207)   (1,561)

 

Income tax expense (benefit) was as follows:

 

    Year ended December 31  
    2023     2022     2021  
Current:   U.S. dollars in thousands  
Israel   7     -     -  
Foreign     78       12       94  
Total current income tax expense     85       12       94  
Deferred:                        
Israel     -       -       -  
Foreign     (53 )     (18 )     (115 )
Total deferred tax income     (53 )     (18 )     (115 )
Total tax (benefit) expense     32       (6 )     (21

 

F-25

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 — TAXES ON INCOME (cont.)

 

A reconciliation of the Group’s statutory income tax rate to effective income tax rate is as follows:

 

   December 31, 
   2023   2022   2021 
   U.S. dollars in thousands 
Loss before taxes on income   (4,566)   (2,207)   (1,561)
Statutory tax rate   23%   23%   23%
Tax (tax benefit) computed at the statutory tax rate   (1,050)   (508)   (359)
Increase (decrease) in taxes on income resulting from the following:               
Tax rate differences applicable to subsidiaries   (46)   (110)   (78)
Tax losses and timing differences for which deferred taxes were not recognized   1,128    612    416 
Taxes on income   32   (6)   (21)

 

Deferred taxes are comprised of the following components:

 

   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Deferred tax asset        
Intangible assets   388    110 
Operating lease right of use asset   28    32 
Operating loss carryforward   1,476    890 
Total deferred tax assets   1,892    1,032 
Valuation allowance   (1,696)   (890)
Total deferred tax assets after valuation allowance   196    142 
           
Deferred tax liabilities          
           
Operating lease liability   28    32 
Total deferred tax liability   28    32 
           
Net deferred tax assets   168    110 

 

Deferred tax assets on losses for tax purposes carried forward to subsequent years are recognized if utilization of the related tax benefit against a future taxable income is expected.

 

Carry forward tax losses of Jeffs’ Brands were $6,418 thousand and $3,870 thousand as of December 31, 2023 and 2022, respectively. Jeffs’ Brands did not record deferred tax assets in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future. There is no expiration on net operating loss carryforwards in Israel.

 

Smart Pro, Fort, Jeffs Brands Holdings Inc and Fort US did not have any net operating loss carryforwards as of December 31, 2023, and 2022. The net deferred tax asset as of December 31, 2023 and 2022 is with respect to Smart Pro.

 

F-26

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 — SHARE CAPITAL:

 

  a. The share capital composed of ordinary shares as follows:

 

   Number of ordinary shares
December 31
 
   2023   2022 
Issued (*)   1,215,512    1,153,461 
Authorized   43,567,567    43,567,567 

 

(*) Retroactively adjusted.

 

The Ordinary Shares confer upon their holders the following rights: (i) the right to vote in any general meeting of the Company, (ii) the right to receive dividends, if and when declared by the Board of Directors and (iii) the right to receive upon liquidation of the Company a sum equal to the nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares which may be issued in the future.

 

On February 17, 2022, the Company’s Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February 17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares. Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect to the two subsequent reverse share splits) ordinary shares.

 

On May 3, 2022, the Company’s Board of Directors approved a 0.806-for-1 reverse split of its issued and outstanding Ordinary Shares, effective as of May 3, 2022, pursuant to which holders of the Company’s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.

 

On June 16, 2022, the Company’s Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June 16, 2022, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85 Ordinary Shares held as of such date. The reverse stock split proportionally reduced the number of the Company’s authorized share capital.

 

The share capital before consummation of the IPO was comprised of 413,304 issued and outstanding ordinary shares. In accordance with an assignment agreement (see also Note 11) and in connection with the IPO (see above), on August 30, 2022, the Company converted outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital into 209,088 Ordinary Shares.

 

On August 30, 2022, the Company closed its IPO, and the simultaneous partial exercise of the underwriter’s over-allotment option, for aggregate gross proceeds of approximately $15.5 million, before deducting underwriting discounts and estimated offering expenses. The Company issued 531,069 Ordinary Shares, (“Ordinary Shares”) and 3,717,473 IPO warrants to purchase up to 531,069 Ordinary Shares. The Ordinary Shares and IPO Warrants were sold together in the IPO as units (“Units”) at an initial public offering price of $29.12 per Unit.

 

The IPO Warrants had an initial exercise price of $28.28 and expire five years from the issuance day. The IPO Warrants became exercisable immediately after the completion of the IPO (and until August 30, 2027). On the 90th day after the closing of the IPO, the exercise price of the IPO Warrants was adjusted to be equal to the lowest quoted share price during the 90 days. The daily quoted price used in the determination of such minimum was calculated as the weighted average price of each day. The exercise price, however, may not be reduced to less than $14.14.

 

The IPO Warrants contain a down round protection, so that for a period of two years from the date of issuance of the IPO Warrant, the exercise price is adjusted to the price in subsequent fundings of the Company, if shares in these fundings are sold at a price per share below the warrant exercise price at the time of such future fundings (or if other instruments with an exercise / conversion price at a price below the warrant exercise price are sold). The exercise price, however, may not be reduced to less than $14.14. On November 28, 2022, the IPO Warrant’s exercise price was adjusted to $14.14.

 

The Ordinary Shares and IPO Warrants trade on the Nasdaq under the symbol “JFBR” and “JFBRW”, respectively.

 

F-27

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 — SHARE CAPITAL (cont.)

 

In addition, On November 28, 2022, the Company issued 2,824,525 Additional Warrants to purchase 403,504 Ordinary Shares. Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. Each Additional Warrants holder will receive semi-annual payments. The total annual payment depends on the amount of the Additional Warrants outstanding. As of December 31, 2022, the payment will be equal to approximately 2.3% of the Group ’s revenues for the period from November 28, 2022 until December 31,2022. The Additional Warrants may be redeemed by the Company at any time at a price equal to three times the Initial Exercise Price, or $42.42.

 

As the IPO Warrants and the Additional Warrants are not separable at the issuance date, the IPO Warrants and the Additional Warrants were initially accounted for as derivative instruments which were classified as a liability and measured at fair value through profit or loss. See also note 10.

 

Applicable issuance costs, amounting to $2,193 thousand, were allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and was recorded in the consolidated statement of operations, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand were recorded in equity as a reduction of the paid in capital for the year ended December 31, 2023.

 

As part of the IPO, on August 30, 2022, the Company issued to the underwriter 185,873 Warrants to purchase up to 26,554 Ordinary Shares (the “Underwriters Warrants”) exercisable beginning on February 21, 2023 at an exercise price of $36.40, and will expire on August 25, 2027. The Underwriter’s Warrants may be exercised on a cashless exercise basis in certain circumstances. The Underwriters Warrants were treated as issuance costs, which amounted to $109 thousand based on a third party valuation, and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $58 thousand was considered as issuance costs allocated to the Underwriter’s Warrants and were recorded in profit or loss as finance expense, while costs allocated as issuance costs of Ordinary Shares in the amount of $51 thousand were recorded in equity as a reduction of the additional paid in capital.

 

On August 30, 2022, the underwriter partially exercised its overallotment right to purchase 425,912 additional IPO Warrants to purchase up to 60,845 Ordinary Shares for a total consideration of $4 thousand. These additional IPO Warrants were treated as issuance costs, which amounted to $1 thousand based on third party valuation, and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $0.5 thousand was considered as issuance costs allocated to the additional IPO Warrants and were recorded in profit or loss as finance expense, while costs allocated as issuance costs of Ordinary Shares in the amount of $0.5 thousand have been recorded in equity as a reduction of the paid in capital.

 

Effective as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreement (the “Issuance Date”), the Company issued the Lenders Warrants to purchase up to 8,586 Ordinary Shares, exercisable for three years following the issuance date at an exercise price of $28.28 per share. The warrants may be exercised on a cashless basis.

 

On the issuance date of the Lenders Warrants, all conditions for equity classification under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were classified to equity.

 

In addition, effective as of August 30, 2022, the Company issued 18,565 warrants to purchase up to 2,653 Ordinary Shares at an exercise price of $28.28 per Ordinary Share (and an exercise price of $14.14 following the Exercise Price Adjustment) to an advisor. The warrants were exercisable immediately and are exercisable until August 30, 2027.

 

On October 17, 2023, the Company’s Board of Directors approved a 1-for-7 reverse split of the issued and outstanding Ordinary Shares, effective as of November 3, 2023, pursuant to which holders of the Ordinary Shares received one Ordinary Share for every seven Ordinary Shares held as of such date. The reverse stock split proportionally did not reduce the number of authorized share capital. The effect of such reverse split was applied retrospectively for all the number of shares, warrants, related par value and others presented in this note and elsewhere in the consolidated financial statements prior to the effective date of the reverse stock split.

 

On November 14, 2023, the Company issued 26,706 ordinary shares as a result of rounding following the aforementioned reverse share split.

 

F-28

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 14 — SHARE INCENTIVE PLAN

 

On January 19, 2022, the Company’s Board of Directors adopted the 2022 Incentive Option Plan (“Plan”). A total of 186,718 Ordinary Shares were reserved and subject to the Plan. The Plan is intended as an incentive to retain directors, officers, employees, consultants and advisers of the Company. As of December 31, 2023, the Company had not granted awards under the Plan.

 

NOTE 15 — FINANCE (INCOME) EXPENSE, NET

 

   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands 
Finance income:            
Change in fair value of derivative liabilities   (841)   (2,822)   - 
Interest income   (4)   -    (14)
Total finance income   (845)   (2,822)   (14)
Finance expense:               
Finance expenses in respect of third-party loan   -    83    77 
Change in fair value of derivative liabilities   -    -    75 
Amortization of loan discount   -    37    85 
Exchange rate differences   91    156    10 
Interest expense on loans from shareholders and related parties   -    203    381 
Other finance expenses   10    38    15 
Revaluation of securities -fair value through profit or loss   221    -    - 
Total finance expenses   322    517    643 
Finance (income) expense, net   (523)   (2,305)   629 

 

NOTE 16 — NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS

 

The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders:

 

   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands (*) 
Numerator:            
Net loss applicable to shareholders of ordinary shares   (4,598)   (2,201)   (1,540)
                
Denominator:               
Shares of ordinary share used in computing basic and diluted net loss per share   1,184,484    663,411    413,192 
Net loss per share of ordinary share, basic and diluted   (3.88)   (3.32)   (3.73)

 

F-29

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS (cont.)

 

The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:

 

   Year ended December 31 
   2023   2022   2021 
             
IPO Warrants and Additional Warrants (Note 13)   6,541,998    6,541,998    - 
Underwriter warrants (Note 13)   611,785    611,785    - 
Other warrants   78,661    78,661    - 
    7,232,444    7,232,444    - 

 

(*) except share and per share data

 

NOTE 17 — RELATED PARTIES 

 

  a. Transactions with related parties:

 

   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Labor cost and related expenses (included in general and administrative) (c1)   249    358 
Directors’ fees (included in general and administrative)   282    172 
Consulting fees (included in general and administrative) (c2)   180    218 
Inventory storage (included in cost of sale) (c2)   545    395 
Revenue sharing payment (included in general and administrative) (c6)   40    6 
Other income, net (c4)   (255)   - 
Interest expenses on loans from related parties and shareholders   -    203 
    1,041    1,352 

 

F-30

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 — RELATED PARTIES (cont.)

 

  b. Balances with interested and related parties:

 

   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Assets:        
Advances to suppliers (c2)   -    228 
    -    228 
Liabilities:          
Related parties (c3), (c4)   66    32 
Chief executive officer salary (included in other account payable) (c1)   18    - 
Revenue sharing payment (included in other account payable) (c6)   21    6 
Liability to SciSparc (included in other account payable) (c7)   98    - 
Liability to supplier (included in trade payable) (c2)   69    - 
Liability to consultant (included in other account payable) (c2)   17    - 
    289    38 

 

  c. Additional information:

 

  1. On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).

 

  2. On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.

 

F-31

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 — RELATED PARTIES (cont.)

 

  3. On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively.

 

  4. As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.

 

  5. During September 2022, the Group repaid: (i) a related party balance to Medigus, in the amount of $150 thousand and (ii) another related party balance in the amount of $175 thousand and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing of the IPO.

 

  6. During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.

 

  7. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.

 

F-32

 

 

JEFFS’ BRANDS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 — GEOGRAPHICAL INFORMATION

 

Revenues are attributed to geographic areas:

 

   Year ended
December 31,
 
   2023   2022   2021 
   USD in thousands 
             
America   3,863    5,422    6,402 
Europe   6,145    437    107 
    10,008    5,859    6,509 

 

NOTE 19 — SUBSEQUENT EVENTS

 

1.On January 25, 2024, the Company entered into a private placement transaction, or the January 2024 PIPE, pursuant to a securities purchase agreement, with certain institutional investors, providing for the issuance, in a private placement of 1,884,461 Ordinary Shares; (ii) Pre-Funded Warrants to purchase up to an 820,000 Ordinary Shares; (iii) Series A Warrants to purchase up to an aggregate of 3,380,586 Ordinary, or upon the satisfaction of certain conditions, up to an aggregate of 13,373,208 Ordinary Shares in accordance with the terms therein and (iv Series B Warrants to purchase upon the satisfaction of, certain conditions up to an aggregate of 7,994,181 Ordinary Shares in accordance with the terms therein. The January 2024 PIPE closed on January 29, 2024. The Company’s aggregate gross proceeds from the January 2024 PIPE were approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the January 2024 PIPE. Pure Capital participated in the private placement as a purchaser.

 

As of the issuance date of these consolidated financial statements 2,900,036 Warrants were exercised into 2,900,036 ordinary shares of the Company.

 

The Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with Aegis, dated January 25, 2024, pursuant to which Aegis agreed to serve as the exclusive placement agent for the Company in connection with the Private Placement. The Company agreed to pay Aegis a cash placement fee equal to 8.50% of the gross cash proceeds received in the Private Placement and to pay for expenses of the Purchasers’ and Aegis’ legal counsel up to an aggregate amount of $90 thousand.

 

2.On February 5, 2024, the Company paid to Pure Capital $100 thousand in connection to the IPO and in accordance to the consultant agreement.

 

3.On February 29, 2024, the Company extended a side letter to the Fort SPA to the Fort Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100 thousand.

 

F-33

 

 

SIGNATURES

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on Form 20-F filed on its behalf.

 

  Jeffs Brands Ltd
     
Date: April 1, 2024 By: /s/ Viki Hakmon
    Viki Hakmon
    Chief Executive Officer

 

 

105

 

 

3.32 3.73 3.88 1184484 413192 663411 http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent P2653Y 1184484 413192 663411 3.32 3.73 3.88 false FY 0001885408 0001885408 2023-01-01 2023-12-31 0001885408 dei:BusinessContactMember 2023-01-01 2023-12-31 0001885408 jfbr:OrdinarySharesNoParValuePerShareMember 2023-01-01 2023-12-31 0001885408 jfbr:WarrantsToPurchaseOrdinarySharesMember 2023-01-01 2023-12-31 0001885408 2023-12-31 0001885408 2022-12-31 0001885408 2022-01-01 2022-12-31 0001885408 2021-01-01 2021-12-31 0001885408 us-gaap:CommonStockMember 2020-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001885408 us-gaap:RetainedEarningsMember 2020-12-31 0001885408 2020-12-31 0001885408 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001885408 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001885408 us-gaap:CommonStockMember 2021-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001885408 us-gaap:RetainedEarningsMember 2021-12-31 0001885408 2021-12-31 0001885408 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001885408 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001885408 us-gaap:CommonStockMember 2022-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001885408 us-gaap:RetainedEarningsMember 2022-12-31 0001885408 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001885408 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001885408 us-gaap:CommonStockMember 2023-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001885408 us-gaap:RetainedEarningsMember 2023-12-31 0001885408 2023-10-01 2023-12-31 0001885408 us-gaap:SubsequentEventMember 2024-01-29 2024-01-29 0001885408 srt:MinimumMember 2023-12-31 0001885408 us-gaap:ComputerEquipmentMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001885408 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001885408 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001885408 us-gaap:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001885408 2023-03-09 0001885408 us-gaap:SubsequentEventMember 2024-02-29 2024-02-29 0001885408 2023-03-09 2023-03-09 0001885408 2023-09-20 0001885408 jfbr:BrandsMember 2023-12-31 0001885408 jfbr:BrandsMember 2022-12-31 0001885408 jfbr:SciSparcUSMember 2023-02-23 0001885408 jfbr:SciSparcUSMember 2023-02-23 2023-02-23 0001885408 jfbr:SciSparcUSMember 2023-03-22 2023-03-22 0001885408 2023-03-22 2023-03-22 0001885408 2023-11-30 2023-11-30 0001885408 srt:MaximumMember 2023-01-01 2023-12-31 0001885408 srt:MinimumMember 2023-01-01 2023-12-31 0001885408 jfbr:JeffsBrandsHoldingMember 2023-12-31 0001885408 jfbr:SciSparcUSMember 2023-01-01 2023-12-31 0001885408 jfbr:SciSparcMember 2023-03-22 2023-03-22 0001885408 jfbr:SciSparcMember 2023-03-22 0001885408 srt:MinimumMember 2023-03-22 2023-03-22 0001885408 srt:MaximumMember 2023-03-22 2023-03-22 0001885408 jfbr:WellutionAccountMember 2023-12-31 0001885408 jfbr:WellutionAccountMember 2023-02-23 2023-12-31 0001885408 2023-03-22 0001885408 2023-03-23 2023-12-31 0001885408 2022-05-09 2022-05-09 0001885408 2022-05-09 0001885408 2021-07-31 0001885408 2021-07-01 2021-07-31 0001885408 us-gaap:WarrantMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember 2022-08-30 0001885408 us-gaap:WarrantMember 2022-08-30 0001885408 2022-02-22 0001885408 us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-02-22 0001885408 2022-03-03 2022-03-03 0001885408 2022-06-02 2022-06-02 0001885408 us-gaap:IPOMember 2023-12-31 0001885408 us-gaap:IPOMember 2022-11-28 0001885408 us-gaap:CommonStockMember 2022-11-28 0001885408 2022-11-28 0001885408 2022-11-28 2022-11-28 0001885408 us-gaap:IPOMember 2022-12-31 0001885408 us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001885408 us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001885408 us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001885408 us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001885408 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001885408 us-gaap:MeasurementInputDiscountRateMember 2023-12-31 0001885408 us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001885408 us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001885408 jfbr:MeasureInputWeightedAverageCostOfCapitalMember 2023-12-31 0001885408 srt:MinimumMember jfbr:MeasureInputWeightedAverageCostOfCapitalMember 2022-12-31 0001885408 srt:MaximumMember jfbr:MeasureInputWeightedAverageCostOfCapitalMember 2022-12-31 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember jfbr:MedigusMember 2022-05-03 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember jfbr:MrHakmonAndLIAMember 2022-05-03 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember jfbr:PureCapitalLtdMember 2022-05-03 0001885408 us-gaap:IPOMember 2023-01-01 2023-12-31 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember 2023-01-01 2023-12-31 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember us-gaap:IPOMember 2023-01-01 2023-12-31 0001885408 jfbr:PureCapitalLtdMember jfbr:MrHakmonAndLIAMember jfbr:MedigusMember 2022-08-30 2022-08-30 0001885408 2022-08-30 2022-08-30 0001885408 jfbr:IsraeliTaxLawsMember 2023-01-01 2023-12-31 0001885408 jfbr:UKTaxLawMember 2023-01-01 2023-12-31 0001885408 jfbr:MedigusMember 2023-01-01 2023-12-31 0001885408 2022-02-17 2022-02-17 0001885408 2022-05-03 2022-05-03 0001885408 2022-06-16 2022-06-16 0001885408 jfbr:PureCapitalLtdMember 2022-08-30 2022-08-30 0001885408 jfbr:MrHakmonMember 2022-08-30 2022-08-30 0001885408 us-gaap:OverAllotmentOptionMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember us-gaap:IPOMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2022-08-30 0001885408 us-gaap:IPOMember 2022-08-30 2022-08-30 0001885408 us-gaap:IPOMember 2022-08-30 0001885408 2022-08-30 0001885408 us-gaap:CommonStockMember 2022-11-28 0001885408 jfbr:UnderwritersWarrantsMember 2022-08-30 2022-08-30 0001885408 jfbr:UnderwritersWarrantsMember 2022-08-30 0001885408 jfbr:UnderwritersWarrantsMember jfbr:FinanceExpenseMember 2022-08-30 2022-08-30 0001885408 jfbr:UnderwritersWarrantsMember jfbr:ReductionToAdditionalPaidInCapitalMember 2022-08-30 2022-08-30 0001885408 us-gaap:WarrantMember us-gaap:IPOMember 2022-08-30 0001885408 jfbr:FinanceExpenseMember us-gaap:OverAllotmentOptionMember 2022-08-30 2022-08-30 0001885408 jfbr:ReductionToAdditionalPaidInCapitalMember us-gaap:OverAllotmentOptionMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember us-gaap:IPOMember 2022-08-30 0001885408 us-gaap:IPOMember 2023-08-30 2023-08-30 0001885408 jfbr:AdvisorWarrantsMember us-gaap:IPOMember 2022-08-30 2022-08-30 0001885408 jfbr:AdvisorWarrantsMember us-gaap:IPOMember 2022-08-30 0001885408 jfbr:AdvisorWarrantsMember us-gaap:IPOMember 2022-11-28 0001885408 2022-02-17 0001885408 srt:BoardOfDirectorsChairmanMember us-gaap:CommonStockMember 2023-11-14 0001885408 us-gaap:CommonStockMember 2023-12-31 0001885408 us-gaap:CommonStockMember 2022-12-31 0001885408 jfbr:IPOAndAdditionalWarrantsMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001885408 jfbr:IPOAndAdditionalWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001885408 jfbr:IPOAndAdditionalWarrantsMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001885408 jfbr:UnderwritersWarrantsMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001885408 jfbr:UnderwritersWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001885408 jfbr:UnderwritersWarrantsMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001885408 jfbr:OtherWarrantsMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001885408 jfbr:OtherWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001885408 jfbr:OtherWarrantsMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001885408 srt:BoardOfDirectorsChairmanMember 2022-08-01 2022-08-03 0001885408 srt:BoardOfDirectorsChairmanMember 2022-08-25 2022-09-01 0001885408 2022-08-25 2022-09-01 0001885408 2022-10-10 2022-10-26 0001885408 2023-03-01 2023-03-31 0001885408 2022-05-10 2022-05-21 0001885408 jfbr:MedigusMember 2023-01-01 2023-12-31 0001885408 jfbr:MedigusMember 2022-01-01 2022-12-31 0001885408 jfbr:SciSparcUSMember 2023-12-31 0001885408 jfbr:MinorityShareholderMember 2023-03-22 2023-03-22 0001885408 jfbr:SciSparcMember 2023-01-01 2023-12-31 0001885408 jfbr:MedigusMember 2022-09-02 2022-09-30 0001885408 us-gaap:RelatedPartyMember 2022-09-02 2022-09-30 0001885408 us-gaap:InterestExpenseMember us-gaap:RelatedPartyMember 2022-09-02 2022-09-30 0001885408 jfbr:PureCapitalLtdMember 2023-01-01 2023-12-31 0001885408 us-gaap:RelatedPartyMember 2023-12-31 0001885408 us-gaap:RelatedPartyMember 2022-12-31 0001885408 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001885408 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001885408 country:US 2023-01-01 2023-12-31 0001885408 country:US 2022-01-01 2022-12-31 0001885408 country:US 2021-01-01 2021-12-31 0001885408 srt:EuropeMember 2023-01-01 2023-12-31 0001885408 srt:EuropeMember 2022-01-01 2022-12-31 0001885408 srt:EuropeMember 2021-01-01 2021-12-31 0001885408 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 jfbr:SeriesAWarrantsMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 us-gaap:SubsequentEventMember jfbr:OrdinarySharesMember 2024-01-25 0001885408 jfbr:SeriesBWarrantsMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 us-gaap:SubsequentEventMember 2024-01-25 2024-01-25 0001885408 us-gaap:WarrantMember 2023-12-31 0001885408 us-gaap:PrivatePlacementMember 2023-12-31 0001885408 us-gaap:SubsequentEventMember us-gaap:IPOMember 2024-02-01 2024-02-05 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:ILS
EX-2.8 2 ea020228001ex2-8_jeffs.htm DESCRIPTION OF SECURITIES

Exhibit 2.8

 

DESCRIPTION OF SECURITIES

 

Jeffs’ Brands Ltd has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: ordinary shares, no par value per share, or Ordinary Shares, and warrants to purchase ordinary shares, or IPO Warrants. References herein to “we,” “us,” “our” and the “Company” refer to Jeffs’ Brands Ltd and not to any of its subsidiaries. The following description may not contain all of the information that is important to you, and we therefore refer you to our amended and restated articles of association, or Articles of Association, a copy of which is filed with the Securities and Exchange Commission, or the SEC, as an exhibit to this Annual Report on Form 20-F.

 

ORDINARY SHARES

 

As of December 31, 2023, our authorized share capital consisted of 43,567,567 Ordinary Shares. All of our outstanding Ordinary Shares have been validly issued, fully paid and non-assessable. Our Ordinary Shares are not redeemable and are not subject to any preemptive right.

 

Our Ordinary Shares are listed on the Nasdaq Capital Market, or Nasdaq, under the symbol “JFBR” since August 26, 2022.

 

Articles of Association

 

Purposes and Objects of the Company

 

Our purpose as stated in our Articles of Association includes every lawful purpose.

 

The Powers of the Directors

 

Our board of directors shall direct our policy and shall supervise the performance of our Chief Executive Officer and his actions. Our board of directors may exercise all powers that are not required under the Israeli Companies Law – 1999, or the Companies Law, or under our Articles of Association to be exercised or taken by our shareholders.

 

Rights Attached to Shares

 

Our Ordinary Shares shall confer upon the holders thereof:

 

  equal right to attend and to vote at all of our general meetings, whether regular or special, with each Ordinary Share entitling the holder thereof, which attend the meeting and participate at the voting, either in person or by a proxy or by a written ballot, to one vote;
     
  equal right to participate in distribution of dividends, if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata basis; and
     
  equal right to participate, upon our dissolution, in the distribution of our assets legally available for distribution, on a per share pro rata basis.

 

Transfer of Shares

 

Our fully paid Ordinary Shares are issued in registered form and may be freely transferred under our Articles of Association, unless the transfer is restricted or prohibited by another instrument, applicable law or the rules of the Nasdaq. The ownership or voting of Ordinary Shares by non-residents of Israel is not restricted in any way by our Articles of Association, or the laws of the State of Israel, except for ownership by nationals of some countries that are, have been, or will be, in a state of war with Israel.

 

 

 

 

Election of Directors

 

Under our Articles of Association, our board of directors must consist of not less than three but no more than twelve directors. Each of our directors, other than the external directors, for whom special election requirements apply under the Companies Law, are appointed by a simple majority vote of holders of Ordinary Shares, participating and voting at an annual general meeting of our shareholders. Our directors are classified, with respect to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable, and designated as Class I, Class II and Class III, with one class being elected each year at the annual general meeting of our shareholders, and serve on our board of directors until the third annual general meeting following such election or re-election or until they are removed by a vote of 70% of the total voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events in accordance with the Companies Law and our Articles of Association. The initial Class I directors will hold office until the first annual general meeting to be held in 2023 and until their successors have been elected and qualified. The initial Class II directors will hold office until the annual general meeting to be held in 2024 and until their successors have been elected and qualified. The initial Class III directors will hold office until the annual general meeting to be held in 2025 and until their successors have been elected and qualified. The board of directors may assign members of the Board already in office to such classes at the time such classification becomes effective. If the number of directors is changed, any newly created directors or decrease in directors must be apportioned by the board among the classes to make them equal in number. In addition, our Articles of Association allow our board of directors to appoint directors to fill vacancies and/or as an addition to the board of directors (subject to the maximum number of directors). A director so appointed will hold office until the next annual general meeting of our shareholders for the election of the class of directors in respect of which the vacancy was created, or in the case of a vacancy due to the number of directors being less than the maximum number of directors, until the next annual general meeting of our shareholders for the election of the class of directors to which such director was assigned by our board of directors. External directors are elected for an initial term of three years, may be elected for additional terms of three years each under certain circumstances, and may be removed from office pursuant to the terms of the Companies Law. See “Item 6.C. Board Practices — External Directors” in our Annual Report on Form 20-F.

 

Dividend and Liquidation Rights

 

We may declare a dividend to be paid to the holders of Ordinary Shares in proportion to their respective shareholdings. Under the Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company unless the company’s articles of association provide otherwise. Our Articles of Association do not require shareholder approval of a dividend distribution and provide that dividend distributions may be determined by our board of directors.

 

Pursuant to the Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to the Company’s most recently reviewed or audited financial statements (less the amount of previously distributed dividends, if not reduced from the earnings), provided that the end of the period to which the financial statements relate is not more than six months prior to the date of the distribution. If we do not meet such criteria, then we may distribute dividends only with court approval; as a company listed on an exchange outside of Israel, however, court approval is not required if the proposed distribution is in the form of an equity repurchase, provided that we notify our creditors of the proposed equity repurchase and allow such creditors an opportunity to initiate a court proceeding to review the repurchase. If within 30 days such creditors do not file an objection, then we may proceed with the repurchase without obtaining court approval. In each case, we are only permitted to distribute a dividend if our board of directors and, if applicable, the court determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due.

 

In the event of the Company’s liquidation, after satisfaction of liabilities to creditors, its assets will be distributed to the holders of Ordinary Shares in proportion to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights which may be authorized in the future.

 

2

 

 

Exchange control

 

There are currently no Israeli currency control restrictions on remittances of dividends on Ordinary Shares, proceeds from the sale of the Ordinary Shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of countries that at the time are, or have been, in a state of war with Israel.

 

Annual and Special Meetings

 

Under the Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year, at such time and place which shall be determined by our board of directors, that must be no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to as special general meetings. Our board of directors may call special meetings whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Companies Law provides that our board of directors is required to convene a special general meeting of our shareholders upon the written request of: (a) any two of our directors or such number of directors equal to one quarter of the directors then at office; and/or (b) As a company listed on an exchange in the U.S., one or more shareholders holding, in the aggregate, (i) 10% or more of our outstanding issued shares and 1% of our outstanding voting power or (ii) 10% or more of our outstanding voting power.

 

Under the Companies Law, one or more shareholders holding at least 1% of the voting rights at the general meeting of shareholders may request that the board of directors include a matter in the agenda of a general meeting of shareholders to be convened in the future, provided that it is appropriate to discuss such a matter at the general meeting. Our Articles of Association contain procedural guidelines and disclosure items with respect to the submission of shareholder proposals for general meetings. Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of record on a date to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four and forty days prior to the date of the meeting. Resolutions regarding the following matters must be passed at a general meeting of our shareholders:

 

  amendments to our Articles of Association;
     
  the exercise of our board of director’s powers by a general meeting if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management;
     
  appointment or termination of our auditors;

 

  appointment of directors, including external directors;
     
  approval of acts and transactions requiring general meeting approval pursuant to the provisions of the Companies Law (mainly certain related party transactions and certain compensation matters) and any other applicable law;
     
  increases or reductions of our authorized share capital; and
     
  a merger (as such term is defined in the Companies Law).

 

Notices

 

The Companies Law and our Articles of Association require that a notice of any annual or special shareholders meeting be provided at least 14 or 21 days prior to the meeting (as applicable), and if the agenda of the meeting includes, among other things, the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, approval of the company’s chief executive officer to serve as the chairman of the board of directors or an approval of a merger, notice must be provided at least 35 days prior to the meeting.

 

3

 

 

Quorum

 

As permitted under the Companies Law, the quorum required for our general meetings consists of at least two shareholders present in person, by proxy, written ballot or voting by means of electronic voting system, who hold or represent between them at least 25% of the total outstanding voting power. If within half an hour of the time set forth for the general meeting a quorum is not present, the general meeting shall stand adjourned the same day of the following week, at the same hour and in the same place, or to such other date, time and place as prescribed in the notice to the shareholders and in such adjourned meeting, if no quorum is present within half an hour of the time arranged, any number of shareholders participating in the meeting, shall constitute a quorum.

 

If a special general meeting was summoned following the request of a shareholder, and within half an hour a legal quorum shall not have been formed, the meeting shall be cancelled.

 

Adoption of Resolutions

 

Our Articles of Association provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required under the Companies Law or our Articles of Association. A shareholder may vote in a general meeting in person, by proxy or by a written ballot.

 

Changing Rights Attached to Shares

 

Unless otherwise provided by the terms of the shares and subject to any applicable law, any modification of rights attached to any class of shares must be adopted by the holders of a majority of the shares of that class present a general meeting of the affected class or by a written consent of all the shareholders of the affected class.

 

The enlargement of an existing class of shares or the issuance of additional shares thereof, shall not be deemed to modify the rights attached to the previously issued shares of such class or of any other class, unless otherwise provided by the terms of the shares.

 

Limitations on the Right to Own Securities in Our Company

 

There are no limitations on the right to own our securities in our Articles of Association. In certain circumstances the IPO Warrants have restrictions upon the exercise of such warrants if such exercise would result in the holders thereof owning more than 4.99% or 9.99% of our Ordinary Shares upon such exercise, as further described below.

 

Access to Corporate Records

 

Under the Companies Law, all shareholders generally have the right to review minutes of our general meetings, our shareholder register (including with respect to material shareholders), our Articles of Association, our financial statements, other documents as provided in the Companies Law, and any document we are required by law to file publicly with the Israeli Registrar of Companies or the Israeli Securities Authority. Any shareholder who specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction with a related party which requires shareholder approval under the Companies Law. We may deny a request to review a document if it determines that the request was not made in good faith, that the document contains a commercial secret or a patent or that the document’s disclosure may otherwise impair its interests.

 

4

 

 

Anti-Takeover Provisions

 

Acquisitions under Israeli Law

 

Full Tender Offer

 

A person wishing to acquire shares of a public Israeli company who would, as a result, hold over 90% of the target company’s voting rights or the target company’s issued and outstanding share capital (or of a class thereof), is required by the Companies Law to make a tender offer to all of the company’s shareholders for the purchase of all of the issued and outstanding shares of the company (or the applicable class). If (a) the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and the shareholders who accept the offer constitute a majority of the offerees that do not have a personal interest in the acceptance of the tender offer or (b) the shareholders who did not accept the tender offer hold less than 2% of the issued and outstanding share capital of the company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. A shareholder who had its shares so transferred may petition an Israeli court within six months from the date of acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer was for less than fair value and whether the fair value should be paid as determined by the court. However, an offeror may provide in the offer that a shareholder who accepted the offer will not be entitled to petition the court for appraisal rights as described in the preceding sentence, as long as the offeror and the company disclosed the information required by law in connection with the full tender offer. If the full tender offer was not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the company’s voting rights or the company’s issued and outstanding share capital (or of the applicable class) from shareholders who accepted the tender offer. Shares purchased in contradiction to the full tender offer rules under the Companies Law will have no rights and will become dormant shares.

 

Special Tender Offer

 

The Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of 25% or more of the voting rights in the company. Similarly, the Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of more than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company. These requirements do not apply if (i) the acquisition occurs in the context of a private placement by the company that received shareholder approval as a private placement whose purpose is to give the purchaser 25% or more of the voting rights in the company, if there is no person who holds 25% or more of the voting rights in the company or as a private placement whose purpose is to give the purchaser 45% of the voting rights in the company, if there is no person who holds 45% of the voting rights in the company, (ii) the acquisition was from a shareholder holding 25% or more of the voting rights in the company and resulted in the purchaser becoming a holder of 25% or more of the voting rights in the company, or (iii) the acquisition was from a shareholder holding more than 45% of the voting rights in the company and resulted in the purchaser becoming a holder of more than 45% of the voting rights in the company. A special tender offer must be extended to all shareholders of a company. A special tender offer may be consummated only if (i) at least 5% of the voting power attached to the company’s outstanding shares will be acquired by the offeror and (ii) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, its controlling shareholders, holders of 25% or more of the voting rights in the company and any person having a personal interest in the acceptance of the tender offer, or anyone on their behalf, including any such person’s relatives and entities under their control).

 

In the event that a special tender offer is made, a company’s board of directors is required to express its opinion on the advisability of the offer, or shall abstain from expressing any opinion if it is unable to do so, provided that it gives the reasons for its abstention. The board of directors shall also disclose any personal interest that any of the directors has with respect to the special tender offer or in connection therewith. An office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause the failure of an existing or foreseeable special tender offer or is to impair the chances of its acceptance, is liable to the potential purchaser and shareholders for damages, unless such office holder acted in good faith and had reasonable grounds to believe he or she was acting for the benefit of the company. However, office holders of the target company may negotiate with the potential purchaser in order to improve the terms of the special tender offer, and may further negotiate with third parties in order to obtain a competing offer.

 

5

 

 

If a special tender offer is accepted, then shareholders who did not respond to or that had objected the offer may accept the offer within four days of the last day set for the acceptance of the offer and they will be considered to have accepted the offer from the first day it was made.

 

In the event that a special tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity at the time of the offer may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer. Shares purchased in contradiction to the special tender offer rules under the Companies Law will have no rights and will become dormant shares.

 

Merger

 

The Companies Law permits merger transactions if approved by each party’s board of directors and, unless certain conditions described under the Companies Law are met, a simple majority of the outstanding shares of each party to the merger that are represented and voting on the merger. The board of directors of a merging company is required pursuant to the Companies Law to discuss and determine whether in its opinion there exists a reasonable concern that as a result of a proposed merger, the surviving company will not be able to satisfy its obligations towards its creditors, such determination taking into account the financial status of the merging companies. If the board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of directors of each of the merging companies, the boards of directors must jointly prepare a merger proposal for submission to the Israeli Registrar of Companies. For purposes of the shareholder vote of a merging company whose shares are held by the other merging company, or by a person or entity holding 25% or more of the voting rights at the general meeting of shareholders of the other merging company, or by a person or entity holding the right to appoint 25% or more of the directors of the other merging company, unless a court rules otherwise, the merger will not be deemed approved if a majority of the shares voted on the matter at the general meeting of shareholders (excluding abstentions) that are held by shareholders other than the other party to the merger, or by any person or entity who holds 25% or more of the voting rights of the other party or the right to appoint 25% or more of the directors of the other party, or any one on their behalf including their relatives or corporations controlled by any of them, vote against the merger. In addition, if the non-surviving entity of the merger has more than one class of shares, the merger must be approved by each class of shareholders. If the transaction would have been approved but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the valuation of the merging companies and the consideration offered to the shareholders. If a merger is with a company’s controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with controlling shareholders.

 

Under the Companies Law, each merging company must deliver to its secured creditors the merger proposal and inform its unsecured creditors of the merger proposal and its content. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of a merging company, and may further give instructions to secure the rights of creditors.

 

addition, a merger may not be completed unless at least 50 days have passed from the date that a proposal for approval of the merger is filed with the Israeli Registrar of Companies and 30 days from the date that shareholder approval of both merging companies is obtained.

 

6

 

 

Anti-Takeover Measures

 

The Companies Law allows us to create and issue shares having rights different from those attached to the Ordinary Shares, including shares providing certain preferred rights with respect to voting, distributions or other matters and shares having preemptive rights. No preferred shares are authorized under our Articles of Association. In the future, if we do authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the market value of the Ordinary Shares. The authorization and designation of a class of preferred shares will require an amendment to our Articles of Association, which requires the prior approval of the holders of a majority of the voting power attached to our issued and outstanding shares at a general meeting of our shareholders. The convening of the meeting, the shareholders entitled to participate and the vote required to be obtained at such a meeting will be subject to the requirements set forth in the Companies Law and our Articles of Association.” In addition, as disclosed under “— Election of Directors,” we have a classified board structure, which effectively limits the ability of any investor or potential investor or group of investors or potential investors to gain control of our board of directors.

 

Lastly, Israeli tax law treats some acquisitions, such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably than U.S. tax laws. For example, Israeli tax law may, under certain circumstances, subject a shareholder who exchanges his Ordinary Shares for shares in another corporation to taxation prior to the sale of the shares received in such stock-for-stock swap.

 

Changes in Our Capital

 

The general meeting may, by a simple majority vote of the shareholders attending the general meeting:

 

  increase our registered share capital by the creation of new shares from the existing class or a new class, as determined by the general meeting;
     
  cancel any registered share capital which have not been taken or agreed to be taken by any person;
     
  consolidate and divide all or any of our share capital into shares of larger nominal value than our existing shares;
     
  subdivide our existing shares or any of them, our share capital or any of it, into shares of smaller nominal value than is fixed; and
     
  reduce our share capital and any fund reserved for capital redemption in any manner, and with and subject to any incident authorized, and consent required, by the Companies Law.

 

Exclusive Forum

 

Our Articles of Association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for any claim asserting a cause of action arising under the Securities Act of 1933, as amended, or the Securities Act. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. This choice of forum provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favourable for disputes with us or our directors, officers or other employees and may increase the costs associated with such lawsuits, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our Articles of Association inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition. Any person or entity purchasing or otherwise acquiring any interest in our share capital shall be deemed to have notice of and to have consented to the choice of forum provisions of our Articles of Association described above. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction.

 

7

 

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our Ordinary Shares is VStock Transfer, LLC. Its address is 18 Lafayette Place, Woodmere, New York 11598.

 

WARRANTS

 

As of December 31, 2023, we have issued and outstanding IPO Warrants to purchase up to 591,512 Ordinary Shares, with an exercise price of $28.28 per Ordinary Share ($14.14 per Ordinary Share following adjustment to the exercise price), issued as part of our initial public listing, or IPO, and are listed on Nasdaq under the symbol “JFBRW” since August 26, 2022.

 

IPO Warrants

 

Exercisability. The IPO Warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance. The IPO Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice and, at any time a registration statement registering the issuance of the Ordinary Shares underlying the IPO Warrants under the Securities Act is effective and available for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased upon such exercise. If a registration statement registering the issuance of the Ordinary Shares underlying the IPO Warrants under the Securities Act is not effective or available the holder may, in its sole discretion, elect to exercise the Warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of Ordinary Shares determined according to the formula set forth in the Warrant. No fractional shares will be issued in connection with the exercise of an Warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.

 

Exercise Limitation. A holder will not have the right to exercise any portion of the Warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of Ordinary Shares outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the IPO Warrants. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days following notice from the holder to the Company.

 

8

 

 

Exercise Price. The exercise price per whole Ordinary Share purchasable upon exercise of the IPO Warrants was $4.04 per share at initial issuance, or the Initial Exercise Price. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our Ordinary Shares and also upon any distributions of assets, including cash, stock or other property to our stockholders. The exercise price will also be downward adjusted if we, or through a subsidiary, sell or enter into an agreement to sell, grant an option to sell, reprice an outstanding security to acquire ordinary shares at a price less than the exercise price.

 

The exercise price will also be adjusted downward to the price of the newly issued security or adjusted price of the outstanding security, but will not adjust to less than a floor price of 50% of the Initial Exercise Price, or $2.02, which is subject to adjustment for stock splits, combinations and recapitalizations, as stated above. The downward adjustment will not be made for certain Excluded Securities (as defined in the Warrant), including employment related option and similar security grants, exercise of such options and security grants, exercises of currently outstanding securities so long as not repriced, and issuances for acquisitions and strategic transactions. In the event that such adjustment shall cause the exercise price to be 50% of the Initial Exercise Price, then in connection with such adjustment, each holder of at least 120,192 IPO Warrants, shall receive one additional warrant for each IPO Warrant held by such holder on the date of adjustment.

 

The exercise price will also be reset, if, on the date that is 90 calendar days immediately following the Issuance Date, the Reset Price, as defined below, is less than the exercise price at such time. If so, the exercise price shall be decreased to the “Reset Price” which means the greater of (i) 50% of the Initial Exercise Price and (ii) 100% of the lowest volume weighted average price of our Ordinary Shares occurring during the 90 calendar days following the Issuance Date; provided that the Reset Price shall in no event be less than a floor price of 50% of the initial public offering price of the Units in this offering, or $2.02.

 

On September 7, 2022, the Company’s volume weighted average stock price was less than the exercise floor of $4.04 for the IPO Warrants. Accordingly, effective after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the IPO Warrants), the IPO Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of the IPO Warrants to $2.02.

 

Home Country Practice. For so long as any of the IPO Warrants remains outstanding, the Company will elect to follow home country practice in lieu of any rules and regulations of the trading market that would limit the Company’s ability to effect the provisions of the IPO Warrants, including but not limited to shareholder approval rules related to the issuance of securities or adjustment of terms of this Warrant for the benefit of warrant holders.

 

Transferability. Subject to applicable laws, the IPO Warrants may be offered for sale, sold, transferred or assigned without our consent.

 

Warrant Agent. The IPO Warrants were issued in registered form under a warrant agent agreement between VStock Transfer, LLC, as warrant agent, and the Company. The IPO Warrants were initially represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.

 

9

 

 

Fundamental Transactions. In the event of a Fundamental Transaction (as defined in the Warrant) and generally including any reorganization, recapitalization or reclassification of our Ordinary Shares, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding Ordinary Shares, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding Ordinary Shares, the holders of the IPO Warrants will be entitled to receive upon exercise of the IPO Warrants the number of Ordinary Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation, or depositary shares representing those shares, and any additional consideration receivable as a result of such Fundamental Transaction by holders of the number of Ordinary Shares for which the IPO Warrants are exercisable immediately prior to such Fundamental Transaction without regard to any limitations on exercise contained in the IPO Warrants. The holders of the IPO Warrants may also require us or any successor entity to purchase the IPO Warrants from the holders by paying to the holder an amount in cash (or other types or form of consideration in special circumstances listed in the Warrant) equal to the Black Scholes value of the remaining unexercised portion of the Warrant on the date of the fundamental transaction.

 

Rights as a Stockholder. Except as otherwise provided in the IPO Warrants or by virtue of such holder’s ownership of our Ordinary Shares, the holder of an Warrant does not have the rights or privileges of a holder of our Ordinary Shares, including any voting rights, until the holder exercises the Warrant.

 

Right of Participation. Subject to certain exceptions, a holder of at least 120,192 IPO Warrants as of the time the Company engages in a subsequent placement (as defined in the Warrant) will be entitled to participate in such subsequent placement subject to the terms and conditions set forth in the Warrant.

 

Governing Law. The IPO Warrants and the warrant agent agreement are governed by New York law.

 

Exclusive Forum

 

The agreements governing the IPO Warrants provide that, and by purchasing IPO Warrants in this offering investors will agree that, all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by the Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) will be commenced exclusively in the state and federal courts sitting in the City of New York, irrevocably submit to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any such dispute and irrevocably waive, and agree not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The warrant agent agreement has a similar provision. In addition, the warrant agent agreement provides that the Company and the warrant agent each waive the right to a trial by jury in any action or proceeding arising out of or relating to the warrant agent agreement. Each of the agreement governing the IPO Warrants and the warrant agent agreement provide that the foregoing provisions do not limit or restrict the federal district court in which a party may bring a claim under the U.S. federal securities laws.

 

 

10

 

EX-4.20 3 ea020228001ex4-20_jeffs.htm CONSULTING AGREEMENT, DATED OCTOBER 26, 2022, BETWEEN JEFFS' BRANDS LTD AND L.I.A. PURE CAPITAL LTD

Exhibit 4.20

 

CONSULTING AGREEMENT

 

THIS AGREEMENT (the “Agreement”) is made on this 26 day of October 2022 between Jeffs Brands Ltd., whose address is at HaNechoshet St 3, Tel Aviv 6971068, Israel (the “Company”) and L.I.A. Pure Capital Ltd., whose address is at 20 Raoul Wallenberg Street, Tel Aviv 6971916, Israel (the “Consultant”). The Company and together with the Consultant, each a “Party” and collectively, the “Parties”.

 

WHEREAS:the Company wishes the Consultant to provide the Company with certain services and the Consultant wishes to render such services to the Company; and

 

WHEREAS:the Consultant represents to the Company that it is ready, qualified, willing and able to carry out its obligations and undertakings towards the Company pursuant hereto; and

 

WHEREAS:the Company and the Consultant desire to regulate their relationship in accordance to the terms and conditions set forth in this Agreement.

 

NOW THEREFORE, the parties hereto agree as follows:

 

1.The Services

 

1.1.The Company hereby engages the Consultant as an independent consultant and the Consultant hereby agrees to serve as a consultant to the Company and provide business development, Investors and public relations and strategic consulting services, including ongoing consulting to the Company, its management and its chief executive officer in the following fields: M&A, investment activities, Company’s position in the capital markets, as well as additional services as may be requested from time to time by the chief executive officer or chairman of the board of directors of the Company (the “Services”). The engagement hereunder shall commence effective as of 1 September, 2022 (the “Effective Date”).

 

1.2.The Consultant shall cooperate on an ongoing basis with such employees, consultants and contractors of the Company as determined by the Company from time to time; the person within the Company who shall be in charge of the engagement of the Consultant shall be the chairman of the board of directors of the Company or such other person as determined by the Company from time to time. The Company may require the Consultant to provide reports or other types of ongoing information concerning the Services as determined from time to time, whether or not set forth herein.

 

1.3.The Consultant undertakes that the Services shall be performed personally and exclusively by Kfir Zilberman (“Consultant’s Representative”). Each employee, consultant, manager or any other representative of the Consultant, including the Consultant’s Representative shall be deemed to be personally bound by all the obligations and liabilities of the Consultant as if he was the Consultant hereunder. All references to the term the Consultant hereunder shall be deemed to refer to the Consultant and the Consultant’s Representative jointly and severally. Any breach of this Agreement by the Consultant’s Representative or by any other employee, consultant, manager or representative of the Consultant shall be deemed a breach by the Consultant.

 

 

 

1.4.The Consultant’s Representative shall devote all the necessary time in performing its duties and responsibilities under this Agreement, as shall be reasonably required by the Company.

 

1.5.The Consultant agrees to perform its duties described herein in a faithful, diligent and professional manner.

 

1.6.The Consultant shall be responsible for maintaining, at the Consultant’s own expense, a place of work, any equipment and supplies necessary for the performance of the Services.

 

1.7.Nothing in this Agreement shall be interpreted as preventing or restricting the Company from obtaining or seeking from any other person services of the same nature as the Services, or otherwise from performing or seeking to perform any action or operation. Nothing in this Agreement shall be interpreted as preventing or restricting the Consultant from supplying services to any third party, as long as such services to third parties (i) do not conflict with any obligation or undertaking of the Consultant hereunder, and (ii) do not interfere with the performance of or restrict the ability of the Consultant to perform the Services hereunder.

 

2.Term and Termination

 

2.1.This Agreement shall commence upon the Effective Date and shall until terminated pursuant to Section 2.2 below.

 

2.2.Notwithstanding the above, this Agreement may be terminated at any time after the third (3) anniversary from the effective day by the Consultant or by the Company by giving the other party 30 days’ advance notice in writing (the “Notice Period”), provided that the Company may terminate this Agreement forthwith for Cause (as defined herein) without advance notice. A termination for “Cause” is a termination due to: (i) the Consultant’s Representative’s conviction or indictment of any felony; (ii) a material breach of any provision of this Agreement or its exhibits which is not cured (if deemed curable by the Company) within five (5) days of receipt of a written notice about such breach from the Company; (iii) the Consultant’s continuously disregarding of instructions of the Company with respect to the Consultant’s performance of the Services; (iv) a material breach of trust by the Consultant or embezzlement of funds of the Company or any Affiliate (as defined in Section 7.1 below) thereof; (v) involvement of the Consultant’s Representative in sexual harassment of any employee of the Company or other party in connection with the performance of the Services; or (vi) causing grave injury to the business, assets, operations or reputation of the Company or any Affiliate thereof. Nothing herein shall derogate from the Company’s rights with respect to such termination for Cause, including the right to set off damages against the Consultant’s Consulting Fees (as defined in Section 3.1 below).

 

2.3.In the event of termination other than for Cause, the Consultant shall be entitled to Consulting Fees only to the extent that it provides Services to the Company during the Notice Period.

 

3.Consideration

 

3.1.Consulting Fee

 

3.1.1.In consideration for the Services rendered by the Consultant pursuant to this Agreement, the Company shall pay the Consultant a monthly fee in the amount of NIS 57,750 (plus VAT, if required by law) (the “Consulting Fee”).

 

-2-

 

 

3.1.2.All payments of Consulting Fee hereunder, subject to Section 3.1.1, shall be made on a monthly basis, within 10 days from, and subject to, receipt by the Company of a duly issued tax invoice(s) and receipt(s) by the Consultant for the amount due together with the required reports.

 

3.1.3.The Consulting Fees are inclusive of any and all taxes, and the Consultant shall bear full responsibility for all tax obligations of any kind or nature relating, directly or indirectly, to the Consulting Fee and otherwise to the Services hereunder. To the extent that any such taxes may be imposed upon the Company, the Company may deduct such amounts from any payments due to the Consultant. The Company shall be entitled to withhold and deduct from payments due hereunder any and all amounts as may be required from time to time under any applicable law. VAT shall be charged on all amounts payable hereunder, including any stock options, as required by law.

 

3.1.4.In addition to the monthly payments under Section 3.1.1, Consultant shall be entitled during the term of this Agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of any purchase of a new brand, businesses, or similar events initiated or assisted by the Consultant and approved by the Chief Executive Officer based on agreement with the Consultant. Payments under this Section shall be authorized by the Chief Executive Officer and Chairman of the Board. VAT shall be added on all amounts payable hereunder.

 

3.1.5.As of the Effective Date, the consultant shall be entitled to a one-time bonus payment of NIS 425,000 (plus VAT, if required by law) for his services provided to the company from the day the company was established until the completion of the IPO process on the Nasdaq Stock Exchange and based on the company’s success in the IPO process.

 

3.1.6.Payments under this Section shall be authorized by the Chief Executive Officer and Chairman of the Board. VAT shall be added on all amounts payable hereunder.

 

3.1.7.In addition to the payments under Section 3.1.1, Consultant shall be entitled to warrants. The warrants are deemed earned upon issuance and are subject to board approval.

 

3.1.8.

 

3.2.Reimbursement of Expenses

 

The Company shall reimburse Consultant for necessary and customary business expenses incurred by Consultant, in accordance with the Company’s policy, as amended from time to time, up to $2,000 per month.

 

3.3.Bonus

 

Consultant shall be entitled to a special bonus upon the consummation of an offering of securities of the Company , according to the below distribution, which is based on gross proceeds: (i) between $5.0 million and $10.0 million, the Consultant shall be entitled to a bonus payment of $100,000; (ii) above $10.0 million, the Consultant shall be entitled to a bonus payment of $150,000. Payments under this Section shall be authorized by the Chief Executive Officer and Chairman of the Board. VAT will be added to the payments under this Section.

 

-3-

 

 

3.4.Full Consideration

 

Other than the consideration specified in this Section 3, which consideration constitutes full consideration for the Services rendered hereunder, the Consultant will not be entitled to any other consideration for rendering the Services hereunder.

 

4.Confidentiality, Non-Competition and Invention Assignment Undertaking

 

Simultaneously with the execution of this Agreement, and a as condition hereto, the Consultant hereby executes the Undertaking attached hereto as Schedule A.

 

5.Relationship of Parties

 

5.1.The parties hereto hereby declare and approve, that this Agreement is a Contractors Agreement within the meaning of the Israeli Contractors Law – 1974 (the “Contractors Law”), and that nothing in this Agreement that shall be interpreted or construed as creating or establishing any partnership, joint venture, employment relationship, franchise or agency or any other similar relationship between the Company or its Affiliates and the Consultant or the Consultant’s Representative, and it is specifically clarified that with respect to the Services, no employer-employee relationship will be formed between the Company or its Affiliates and the Consultant or the Consultant’s Representative, and the Consultant is not entitled to any social or other benefits resulting from employer-employee relationship. Notwithstanding the above, the Consultant hereby waives any right to a lien in accordance with Section 5 of the Contractors Law or any other law. The Consultant hereby acknowledges that the Company is relying upon the truthfulness and accuracy of the representations set forth in this Section 5.2 in engaging the Consultant.

 

5.2.The Consultant shell bear and/or will defend, indemnify and hold the Company, or any third party on its behalf, harmless from and against all claims, all damages, losses and expenses, including reasonable fees and expenses of attorneys and other professionals, upon receipt of demand (i) relating to any obligation, future or past, imposed upon the Company to pay any withholding tax payments regarding consulting services, social security, unemployment or disability insurance or similar terms in connection with compensation received by the Consultant or, or which are based upon a stipulation by a competent judicial authority that an employer - employee relationship was created between the Company or its Affiliates and the Consultant’s Representative; and (ii) resulting from any act, omission or negligence on the Consultant’s or any of its employees’ part in the performance or failure to perform the scope of work under this Agreement.

 

5.3.The Consultant acknowledges that the Consultant’s Representative has read and fully understood the terms of this structure of the relationship between the parties as an independent contractor and that the Consultant’s Representative has consulted and received advice of counsel regarding said structure of the relationship between the parties hereto and has had sufficient opportunity to do so.

 

5.4.It is hereby clarified that any right granted to the Company to instruct and/or oversee the Services by the Consultant is granted in order to ensure the performance of the Services in full and not to imply or justify an employer -employee relationship between the Company and the Consultant or the Consultant’s Representative.

 

-4-

 

 

5.5.The Consultant shall be responsible to pay any and all payments, salary, taxes and all other benefits and any amounts due to any relevant social security or similar authority with respect to its employees and/or the Services provided by the Consultant’s Representative pursuant to this Agreement. The Consultant undertakes to acquire for the Consultant’s Representative pension coverage in a customary amount. The Consultant, hereby releases and forever discharges the Company and its Affiliates, from any and all claims, which it ever had, now has, or may claim to have against the Company and/or its Affiliates in connection with the existence of any employer - employee relationship between Company or its Affiliates and the Consultant or the Consultant’s Representative.

 

5.6.In light of the above, should it be held by any competent judicial authority that the relationship between the Consultant or the Consultant’s Representative, and the Company (or any of its Affiliates) in respect of the Services rendered by the Consultant pursuant to this Agreement is one of employer and employee, the parties agree that the “salary” that the Consultant would be entitled to as an “employee” (including for the purpose of social security and social benefits), for the provision of the Services within the framework of this Agreement, shall be 60% of the average monthly Consulting Fee (the “Agreed Employee Compensation”).

 

5.7.The Consultant will be obligated to return to the Company all surplus payments that the Company paid beyond the Agreed Employee Compensation (the “Surplus Sum”), on the day that a demand and/or claim which contradicts this Agreement is filed or on the day that a decision under Section 5.6 is made, pursuant to which it is claimed or decided that the Consultant’s Representative is a salaried employee of the Company.

 

5.8.Any Surplus Sum that the Consultant is obligated to return will be subject to interest linked to the last known Israeli Consumer Price Index on the date said Surplus Sum is to be returned to the Company.

 

5.9.The Company will be entitled to deduct from and set off against amounts due to the Consultant pursuant to this Agreement and/or pursuant to any other agreement, law, or otherwise, any amounts, which the Consultant is required to pay the Company pursuant to this Agreement (including the Surplus Sum), any other agreement, any law, or otherwise.

 

6.Warranties

 

The Consultant represents and warrants that:

 

6.1.The Consultant does not have currently and shall not have during the term of the provisions of the Services, any outstanding agreement or obligation that is or will be in conflict with any of the provisions of this Agreement, or that would preclude the Consultant from complying with the provisions hereof or otherwise restrict the Consultant in any way in performing the Services.

 

6.2.The execution and delivery of this Agreement, the performance of the Services and the fulfillment of the terms hereof will not: (a) constitute, in whole or in part, a default, violation or breach under or conflict in any way with any agreement, obligation, undertaking or commitment to which the Consultant is a party or by which it is bound, including without limitation, any confidentiality, invention assignment or non- competition agreement and (b) do not require the consent, permission or authorization of or notification to any person or entity.

 

-5-

 

 

6.3.The Consultant shall comply with all Company disciplinary regulations, work rules, policies, procedures and objectives, which are relevant to the performance of the Services or otherwise to consultants of the Company.

 

6.4.The Company may monitor the Consultant’s use of its Systems (as defined below) and copy, transfer and disclose such electronic communications and content transmitted by or stored in such Systems, in pursuit of the Company’s legitimate business interests, all in accordance with the Company’s policies in place from time to time, and subject to applicable law. For the purposes of this Section, the term “Systems” includes all of the Company’s owned or leased computers (including laptops), mobile phones and other mobile devices, keys, PDAs, credit cards, printers, card access to any company building, files, e-mails, tapes, programs, records and software, computer access codes or disks, and other similar systems.

 

6.5.The Consultant shall not solicit or accept in connection with the performance of the Services or in connection with the Company, any gift, benefit, favor, loan, or any other thing of monetary value, from a person who is or is possibly connected, directly or indirectly, to either the business of the Company, a competitor of the Company or a potential competitor of the Company.

 

6.6.The Consultant shall not make any representations or warranties to anyone with respect to any contract or otherwise without the Company’s prior written authorization.

 

6.7.The Consultant shall at all times during the term of this Agreement continue to be wholly owned, exclusively by the Consultant’s Representative.

 

6.8.The Consultant shall take all necessary precautions to prevent the occurrence of any bodily injury or property damage, to the Company, its employees or any third party, arising out of or resulting from the performance of the Services and shall be solely responsible, and liable, for any such bodily injury or property damage.

 

7.Miscellaneous

 

7.1.In this Agreement the term “Affiliate” shall mean, any person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes hereof, the term “control” means the power to direct the management or affairs of a person or entity through the ownership of voting securities, by contract, or otherwise.

 

7.2.The preamble and the schedules hereto shall form an integral part of this Agreement. All headings of the Sections and Subsections of this Agreement are intended for convenience of reference and shall not be used in interpreting this Agreement.

 

7.3.Assignment. Neither this Agreement nor any interest herein may be assigned by the Consultant without the prior written consent of the Company. The Company may assign or transfer this Agreement or any of its rights and/or obligations under this Agreement without the Consultant’s consent.

 

7.4.Entire Agreement; Amendments. This Agreement constitutes the entire agreement between the Consultant and the Company with respect to the subject matter hereof and supersedes any other arrangement, understanding or agreement, verbal or otherwise, including the Prior Agreement. No amendment of or waiver of, or modification of any obligation under this Agreement will be enforceable unless set forth in a writing signed by the parties hereto. No delay or failure to require performance of any provision of this Agreement shall constitute a waiver of that provision as to that or any other instance.

 

-6-

 

 

7.5.Law; Jurisdiction. This Agreement shall be governed by the laws of the State of Israel (excluding its conflict of law principles) and the competent courts/tribunals of Tel-Aviv shall have exclusive jurisdiction over any disputes arising hereunder.

 

7.6.No Waiver. No failure or delay on the part of any party hereto in exercising any right, power or remedy thereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy. Any waiver granted thereunder must be in writing and shall be valid only in the specific instance in which given.

 

7.7.Severability. If any provision of this Agreement is held by a court of competent jurisdiction to be unenforceable under applicable law, then such provision shall be excluded from this Agreement and the remainder of this Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms; provided, however, that in such event this Agreement shall be interpreted so as to give effect, to the greatest extent consistent with and permitted by applicable law, to the meaning and intention of the excluded provision as determined by such court of competent jurisdiction.

 

7.8.Notices. Any notice or other communication in connection with this Agreement must be in writing to the address set forth in the preamble to this Agreement (or to such other address as shall be specified by like notice) and will be deemed given: (i) if sent by a delivery service, on the date confirmed as the actual date of delivery by such service; (ii) if sent by registered air mail, return receipt requested, within seven (7) days of mailing; or (iii) if sent by facsimile or email with electronic confirmation of transmission, on the next business day after transmission, if not transmitted on a business day, or on the day of transmission, if transmitted on a business day.

 

7.9.Survival. The provisions of Sections 4, 5, and 6 of this Agreement, including the provisions of Schedule A, shall continue and remain in full force and effect following the termination or expiration of this Agreement, for whatever reason.

 

-Signature Page Follows-

 

-7-

 

 

IN WITNESS WHEREOF, the parties have signed this Agreement as of the date hereof.

 

/s/ Viki Hackmon   /s/ Kfir Zilberman
Jeffs Brands Ltd.   L.I.A. Pure Capital Ltd.
   
By: Viki Hackmon   By: Kfir Zilberman
     
Title: Chief Executive Officer   Title: Chairman and Chief Executive Officer

 

I have read the provisions of the above Consulting Agreement and I agree to be bound by and comply with such terms and perform the Services (as defined above) as if I was the Consultant. I will be responsible towards Jeffs Brands Ltd. (the “Company”) for the compliance by the Consultant with all its obligations under the Consulting Agreement and the Services and shall be further responsible and liable towards the Company for any breach by the Consultant of any of its obligations under the Consulting Agreement and for any other liability of the Consultant under the Consulting Agreement.

 

I hereby acknowledge that it is known to me that I am an employee of the Consultant and not of the Company. I hereby undertake not to make any claim asserting that I am an employee of the Company.

 

/s/ Kfir Silberman  
Kfir Silberman, the Consultant’s Representative  
   
Date: 26 October, 2022  

 

-8-

 

 

SCHEDULE A

 

UNDERTAKING

 

THIS UNDERTAKING (“Undertaking”) is entered into as of the 1st day of September 2022 by L.I.A. Pure Capital Ltd., whose address is at 20 Raoul Wallenberg Street, Tel Aviv 6971916, Israel (the “Consultant”).

 

WHEREAS,the Consultant wishes to be engaged by Jeffs Brands Ltd., whose address is at HaNechoshet St 3, Tel Aviv 6971068, Israel (the “Company”); and

 

WHEREAS,it is critical for the Company to preserve and protect its Confidential Information (as defined below) and its rights in Inventions (as defined below) and in all related intellectual property, and the Consultant is entering into this Undertaking as a condition to the Consultant’s engagement with the Company.

 

NOW, THEREFORE, the Consultant undertakes and warrants towards the Company as follows:

 

References herein to the term “Company” shall include any of the Company’s direct or indirect parent, subsidiary and affiliated companies, and their respective successors and assigns.

 

1.Confidentiality.

 

1.1.the Consultant acknowledges that the Consultant may have access to information that relates to the Company, its business, assets, financial condition, affairs, activities, plans and projections, customers, suppliers, partners, and other third parties with whom the Company agreed or agrees, from time to time, to hold information of such party in confidence (the “Confidential Information”). Confidential Information shall include, without limitation, information, whether or not marked or designated as confidential, concerning technology, products, research and development, patents, copyrights, inventions, trade secrets, test results, formulae, processes, data, know-how, marketing, promotion, business and financial plans, policies, practices, strategies, surveys, analyses and forecasts, financial information, customer lists, agreements, transactions, undertakings and data concerning employees, consultants, officers, directors, and shareholders. Confidential Information includes information in any form or media, whether documentary, written, oral, magnetic, electronically transmitted, through presentation or demonstration or computer generated. Confidential Information shall not include information that: (i) has become part of the public domain not as a result of a breach of any obligation owed by the Consultant to the Company; or (ii) is required to be disclosed by law or the binding rules of any governmental organization, provided, however, that the Consultant gives the Company prompt notice thereof so that the Company may seek a protective order or other appropriate remedy, and further provided, that in the event that such protective order or other remedy is not obtained, the Consultant shall furnish only that portion of the Confidential Information which is legally required, and shall exercise all reasonable efforts required to obtain confidential treatment for such information.

 

1.2.The Consultant acknowledges and understands that the engagement by the Company and the access to Confidential Information creates a relationship of confidence and trust with respect to such Confidential Information.

 

1.3.During the term of the Consultant’s engagement and at any time after termination or expiration thereof, for any reason, the Consultant shall keep in strict confidence and trust, shall safeguard, and shall not disclose to any person or entity, nor use for the benefit of any party other than the Company, any Confidential Information, other than with the prior express consent of the Company.

-9-

 

 

1.4.All right, title and interest in and to Confidential Information are and shall remain the sole and exclusive property of the Company or of the third party providing such Confidential Information to the Company, as the case may be. Without limitation of the foregoing, the Consultant agrees and acknowledges that all memoranda, books, notes, records, email transmissions, charts, formulae, specifications, lists and other documents (contained on any media whatsoever) made, reproduced, compiled, received, held or used by the Consultant in connection with the engagement by the Company or that otherwise relates to any Confidential Information (the “Confidential Material”), shall be the Company’s sole and exclusive property and shall be deemed to be Confidential Information. All originals, copies, reproductions and summaries of the Confidential Material shall be delivered by the Consultant to the Company upon termination or expiration of the Consultant’s engagement for any reason, or at any earlier time at the request of the Company, without the Consultant retaining any copies thereof.

 

1.5.During the term of the Consultant’s engagement with the Company, the Consultant shall not remove from the Company’s offices or premises any Confidential Material unless and to the extent necessary in connection with the duties and responsibilities of the Consultant and permitted pursuant to then applicable policies and regulations of the Company. In the event that such Confidential Material is duly removed from the Company’s offices or premises, the Consultant shall take all actions necessary in order to secure the safekeeping and confidentiality of such Confidential Material and return the Confidential Material to their proper files or location as promptly as possible after such use.

 

1.6.During the term of the Consultant’s engagement with the Company, the Consultant will not improperly use or disclose any proprietary or confidential information or trade secrets, and will not bring onto the premises of the Company any unpublished documents or any property, belonging to any former employer or any other person to whom the Consultant has an obligation of confidentiality and/or non-use (including, without limitation, any academic institution or any entity related thereto), unless generally available to the public or consented to in writing by that person.

 

2.Ownership of Inventions.

 

2.1.The Consultant will notify and disclose in writing to the Company, or any persons designated by the Company from time to time, all information, improvements, inventions, trademarks, works of authorship, designs, trade secrets, formulae, processes, techniques, know-how, and data, whether or not patentable or registerable under copyright or any similar laws, made or conceived or reduced to practice or learned by the Consultant, either alone or jointly with others, during the Consultant’s engagement with the Company (all such information, improvements, inventions, trademarks, works, designs, trade secrets, formulae, processes, techniques, know- how, and data are hereinafter referred to as the “Invention(s)”) immediately upon discovery, receipt or invention as applicable.

 

-10-

 

 

2.2.Consultant agrees that all the Inventions are, upon creation, Inventions of the Company, shall be the sole property of the Company and its assignees, and the Company and its assignees shall be the sole owner of all title, rights and interest in and to any patents, copyrights, trade secrets and all other rights of any kind or nature, including moral rights, in connection with such Inventions. the Consultant hereby irrevocably and unconditionally assigns to the Company all the following with respect to any and all Inventions: (i) all title, rights and interest in and to any patents, patent applications, and patent rights, including any and all continuations or extensions thereof; (ii) rights associated with works of authorship, including copyrights and copyright applications, Moral Rights (as defined below) and mask work rights; (iii) rights relating to the protection of trade secrets and confidential information; (iv) design rights and industrial property rights; (v) any other proprietary rights relating to intangible property including trademarks, service marks and applications thereof, trade names and packaging and all goodwill associated with the same; (vi) any and all title, rights and interest in and to any Invention; and (vii) all rights to sue for any infringement of any of the foregoing rights and the right to all income, royalties, damages and payments with respect to any of the foregoing rights. the Consultant also hereby forever waives and agrees never to assert any and all Moral Rights the Consultant may have in or with respect to any Inventions, even after termination of engagement on behalf of the Company. “Moral Rights” means any right to claim authorship of a work, any right to object to any distortion or other modification of a work, and any similar right, existing under the law of any country in the world, or under any treaty.

 

2.3.The Consultant further agrees to perform, during and after the term of the Consultant’s engagement with the Company, all acts deemed reasonably necessary or desirable by the Company to permit and assist it, at the Company’s expense, in obtaining, maintaining, defending and enforcing the Inventions in any and all countries. Such acts may include, but are not limited to, execution of documents and assistance or cooperation in legal proceedings. the Consultant hereby irrevocably designates and appoints the Company and its duly authorized officers and agents, as the Consultant’s agents and attorneys-in-fact to act for and on the Consultant’s behalf and instead of the Consultant, to execute and file any documents and to do all other lawfully permitted acts to further the above purposes with the same legal force and effect as if executed by the Consultant.

 

2.4.The Consultant shall not be entitled to any monetary consideration or any other consideration except as explicitly set forth in the Consulting Agreement. Without limitation of the foregoing, the Consultant irrevocably confirms that the consideration explicitly set forth in the Consulting Agreement is in lieu of any rights for compensation that may arise in connection with the Inventions under applicable law and waives any right to claim royalties or other consideration with respect to any Invention, including under Section 134 of the Israeli Patent Law - 1967. Any oral understanding, communication or agreement with respect to the matters set forth herein, not memorialized in writing and duly signed by the Company, shall be void.

 

3.General.

 

3.1.The Consultant represents that the performance of all the terms of this Undertaking and the Consultant’s duties as a consultant of the Company does not and will not breach any invention assignment, proprietary information, non-compete, confidentiality or similar agreements with, or rules, regulations or policies of, any other party (including, without limitation, any academic institution or any entity related thereto). The Consultant acknowledges that the Company is relying upon the truthfulness and accuracy of such representations in its decision to engage with the Consultant.

 

3.2.The Consultant acknowledges that the provisions of this Undertaking serve as an integral part of the terms of the Consulting Agreement and reflect the reasonable requirements of the Company in order to protect its legitimate interests with respect to the subject matter hereof.

 

3.3.The Consultant recognizes and acknowledges that in the event of a breach or threatened breach of this Undertaking by the Consultant, the Company may suffer irreparable harm or damage and will, therefore, be entitled to injunctive relief to enforce this Undertaking (without limitation to any other remedy at law or in equity). This Undertaking is governed by and construed in accordance with the laws of the State of Israel, without giving effect to its laws pertaining to conflict of laws. Any and all disputes in connection with this Undertaking shall be submitted to the exclusive jurisdiction of the competent courts or tribunals, as relevant, located in the city of Tel-Aviv-Jaffa, Israel.

 

-11-

 

 

3.4.If any provision of this Undertaking is determined by any court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Undertaking only with respect to such jurisdiction in which such clause or provision cannot be enforced, and the remainder of this Undertaking shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Undertaking. In addition, if any particular provision contained in this Undertaking shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing the scope of such provision so that the provision is enforceable to the fullest extent compatible with applicable law.

 

3.5.The provisions of this Undertaking shall continue and remain in full force and effect following the termination or expiration of the engagement between the Company and the Consultant, for whatever reason. This Undertaking shall not serve in any manner so as to derogate from any of the Consultant’s obligations and liabilities under any applicable law.

 

3.6.This Undertaking constitutes the entire agreement between the Consultant and the Company with respect to the subject matter hereof and supersedes all prior agreements, proposals, understandings and arrangements, if any, whether oral or written, with respect to the subject matter hereof. No amendment, waiver or modification of any obligation under this Undertaking will be enforceable unless set forth in a writing signed by the Company. No delay or failure to require performance of any provision of this Undertaking shall constitute a waiver of that provision as to that or any other instance. No waiver granted under this Undertaking as to any one provision herein shall constitute a subsequent waiver of such provision or of any other provision herein, nor shall it constitute the waiver of any performance other than the actual performance specifically waived.

 

3.7.This Undertaking, the rights of the Company hereunder, and the obligations of the Consultant hereunder, will be binding upon and inure to the benefit of their respective successors, assigns, heirs, executors, administrators and legal representatives. The Company may assign any of its rights under this Undertaking. The Consultant may not assign, whether voluntarily or by operation of law, any of the Consultant’s obligations under this Undertaking, except with the prior written consent of the Company.

 

-Signature Page Follows-

 

-12-

 

 

IN WITNESS WHEREOF, the undersigned, has executed this Undertaking as of the date first mentioned above.

 

Printed Name:  L.I.A. Pure Capital Ltd.  Signature:    /s/ Kfir Silberman

 

I have read the provisions of the above Undertaking and I agree to be bound by such Undertaking and comply with such terms as if I was the Consultant. I will be responsible toward Jeffs Brands Ltd. (the “Company”) or any of the Company’s direct or indirect parent, subsidiary and affiliated companies, and their respective successors and assigns for the compliance by the Consultant of its obligations under the Undertaking and shall be further responsible and liable towards the Company for any breach by the Consultant of any of its obligations under the Undertaking and for any other liability of the Consultant under the Undertaking.

 

/s/ Kfir Silberman  
Kfir Silberman, the Consultant’s Representative  
   
Date: 26 October, 2022  

 

 

-13-

 

 

EX-4.26 4 ea020228001ex4-26_jeffs.htm SIDE LETTER TO SHARE PURCHASE AGREEMENT DATED FEBRUARY 29, 2024, FROM JEFFS' BRANDS LTD. TO PHILIP DAVIES AND SARAH JANE DAVIES-BROADHURST

Exhibit 4.26

 

 

February 29, 2024

 

To: Craig Philip Davies and

Sarah Jane Davies-Broadhurst (the “Sellers”)

Connaught Road, Seaford, East Sussex

BN25 2PT, England

 

Re: Fort Products Ltd. (“Fort”)

 

Reference is made to that certain Securities Purchase Agreement, dated as of March 2, 2023 (the “SPA”), by and between Jeffs’ Brands Ltd (the “Company”) and the Sellers. Capitalized terms not defined herein shall have the meanings ascribed in the SPA.

 

Notwithstanding any other provision in the SPA, the Company has agreed with the Sellers as follows:

 

1.Pursuant to Section 7.3 of the SPA, the Company paid the Sellers an amount of £426,401, which constitutes the Adjustment Amount. Following the payment of the Adjustment Amount, the Sellers requested to amend and to increase the Adjustment Amount by approximately £100,000 (the “Additional Adjustment Amount”).

 

2.Though the Company is not obligated under the SPA to agree to such amendment, it nonetheless agrees to pay the Sellers the Additional Adjustment Amount. Accordingly, effective as of March 2, 2023, the Adjustment Amount under the SPA will be £526,401.

 

Notwithstanding any provision of the SPA to the contrary, to the extent that any provision of the SPA conflicts with the terms of this letter agreement, the terms of this letter agreement shall prevail.

 

Sincerely yours,

 

JEFFS’ BRANDS LTD    
     
By: /s/ Ronen Zalayet    
Name: Ronen Zalayet    
Title: Chief Financial Officer    
       

Acknowledged and Confirmed:

   
     
/s/ Craig Philip Davies   /s/ Sarah Jane Davie Broadhurst
Craig Philip Davies   Sarah Jane Davie Broadhurst

 

 

 

Mezada 7, Bnei Brak Israel 5126112

 

EX-8.1 5 ea020228001ex8-1_jeffs.htm LIST OF SUBSIDIARIES

Exhibit 8.1

 

LIST OF SUBSIDIARIES

 

Entity Name   Jurisdiction of Incorporation
Smart Repair Pro   California
Top Rank Ltd   Israel
Jeffs Brands Holdings Inc   Delaware
Fort Products Ltd.   England and Wales
Fort Products LLC   Delaware

 

 

EX-12.1 6 ea020228001ex12-1_jeffs.htm CERTIFICATION

Exhibit 12.1

 

CERTIFICATION

 

I, Viki Hakmon, Chief Executive Officer, certify that:

 

1.I have reviewed this Annual Report on Form 20-F of Jeffs’ Brands Ltd.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5.The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: April 1, 2024

 

By: /s/ Viki Hakmon  
  Viki Hakmon  
  Chief Executive Officer  
  (Principal Executive Officer)  

 

EX-12.2 7 ea020228001ex12-2_jeffs.htm CERTIFICATION

Exhibit 12.2

 

CERTIFICATION

 

I, Ronen Zalayet, Chief Financial Officer, certify that:

 

1.I have reviewed this Annual Report on Form 20-F of Jeffs’ Brands Ltd.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5.The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: April 1, 2024

 

By: /s/ Ronen Zalayet  
  Ronen Zalayet  
  Chief Financial Officer  
  (Principal Financial Officer)  

 

EX-13.1 8 ea020228001ex13-1_jeffs.htm CERTIFICATION

Exhibit 13.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350

 

In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2023 (the “Report”) by Jeffs’ Brands Ltd (the “Company”), the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:

 

  (1) the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 1, 2024 /s/ Viki Hakmon
  Viki Hakmon
  Chief Executive Officer

 

EX-13.2 9 ea020228001ex13-2_jeffs.htm CERTIFICATION

Exhibit 13.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350

 

In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2023 (the “Report”) by Jeffs’ Brands Ltd (the “Company”), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:

 

  (1) the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 1, 2024 /s/ Ronen Zalayet
  Ronen Zalayet
  Chief Financial Officer

 

EX-15.1 10 ea020228001ex15-1_jeffs.htm CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., A FIRM IN THE DELOITTE GLOBAL NETWORK, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 15.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-269119) and in the Registration Statement on Form F-3 (No. 333-277188), of our report dated April 1, 2024, relating to the financial statements of Jeffs’ Brands Ltd, appearing in the Annual Report on Form 20-F of Jeffs’ Brands Ltd. for the year ended December 31, 2023.

 

/s/ Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

Tel Aviv, Israel

April 1, 2024

 

EX-97.1 11 ea020228001ex97_jeffs.htm CLAWBACK POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

Exhibit 97

 

JEFFS’ BRANDS LTD
POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

 

Jeffs’ Brands Ltd (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11.

 

1.Persons Subject to Policy

 

This Policy shall apply to and be binding and enforceable on current and former Officers. In addition, the Committee and the Board may apply this Policy to persons who are not Officers, and such application shall apply in the manner determined by the Committee and the Board in their sole discretion.

 

2.Compensation Subject to Policy

 

This Policy shall apply to Incentive-Based Compensation received on or after the Effective Date. For purposes of this Policy, the date on which Incentive-Based Compensation is “received” shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is “received” in the Company’s fiscal period during which the relevant Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.

 

3.Recovery of Compensation

 

In the event that the Company is required to prepare a Restatement, the Company shall recover, reasonably promptly and in accordance with Section 4 below, the portion of any Incentive-Based Compensation that is Erroneously Awarded Compensation, unless the Committee and the Board have determined that recovery from the relevant current or former Officer would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company. For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to any Officer’s right to voluntarily terminate employment for “good reason” or due to a “constructive termination” (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.

 

4.Manner of Recovery; Limitation on Duplicative Recovery

 

The Committee and the Board shall, in its sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include, without limitation, reduction or cancellation by the Company or an affiliate of the Company of Incentive-Based Compensation or Erroneously Awarded Compensation, reimbursement or repayment by any person subject to this Policy, and, to the extent permitted by law, an offset of the Erroneously Awarded Compensation against other compensation payable by the Company or an affiliate of the Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered by the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation may be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person.

 

1

 

 

5.Administration

 

This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all determinations necessary, appropriate or advisable for such purpose. The Board may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the “Committee” shall be deemed to be references to the Board. Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company and its affiliates, shareholders and employees. The Committee may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules.

 

6.Interpretation

 

This Policy shall be interpreted and applied in a manner that is consistent with the requirements of the Applicable Rules, and to the extent this Policy is inconsistent with such Applicable Rules, it shall be deemed amended to the minimum extent necessary to ensure compliance therewith.

 

7.No Indemnification; No Liability

 

The Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant to this Policy, nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person’s potential obligations under this Policy. None of the Company, an affiliate of the Company or any member of the Committee or the Board shall have any liability to any person as a result of actions taken under this Policy.

 

8.Application; Enforceability

 

Except as otherwise determined by the Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any Other Recovery Arrangements. Without limiting the foregoing, in the event of a conflict between this Policy and the Compensation Policy, the latter shall prevail, except with respect to the recovery of any portion of Incentive-Based Compensation that is Erroneously Awarded Compensation that would not be recoverable under the Compensation Policy, in which case this Policy shall prevail. Subject to Section 4, the remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or an affiliate of the Company or is otherwise required by applicable law and regulations.

 

2

 

 

9.Severability

 

The provisions in this Policy are intended to be applied to the fullest extent of the law; provided, however, to the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.

 

10.Amendment and Termination

 

The Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to time in its sole discretion. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association in the U.S.

 

11.Definitions

 

Applicable Rules” means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company’s securities are listed, and any applicable rules, standards or other guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company’s securities are listed.

 

Board” means the Board of Directors of the Company.

 

Compensation Policy” means the Company’s compensation policy for officers and directors, as adopted in accordance with the Israeli Companies Law 5759-1999 and as in effect from time to time.

 

Committee” means the Compensation Committee of the Board or, in the absence of such a committee, a majority of the independent directors serving on the Board.

 

Erroneously Awarded Compensation” means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such current or former Officer based on a restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

Financial Reporting Measure” means any measure determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including GAAP, IFRS and non-GAAP/IFRS financial measures, as well as stock price and total shareholder return.

 

GAAP” means United States generally accepted accounting principles.

 

IFRS” means international financial reporting standards as adopted by the International Accounting Standards Board.

 

3

 

 

Impracticable” means (a) the direct expense paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation; provided that the Company has (i) made reasonable attempt(s) to recover the Erroneously Awarded Compensation, (ii) documented such reasonable attempt(s) and (iii) provided such documentation to the relevant listing exchange or association, (b) the recovery would violate the Company’s home country laws adopted prior to November 28, 2022 pursuant to an opinion of home country counsel; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such a violation and (ii) provided such opinion to the relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder.

 

Incentive-Based Compensation” means, with respect to a Restatement, any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person: (a) after such person began service as an Officer; (b) who served as an Officer at any time during the performance period for that compensation; (c) while the Company has a class of securities listed on a national securities exchange or association; and (d) during the applicable Three-Year Period.

 

Officer” means each person who the Company determines serves as a Company officer, as defined in Section 16 of the Securities Exchange Act of 1934, as amended.

 

Other Recovery Arrangements means any clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or provisions of such effect contained in any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (including, without limitation, the Compensation Policy).

 

Restatement” means an accounting restatement to correct the Company’s material noncompliance with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements (a) that is material to the previously issued financial statements or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

 

Three-Year Period” means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare such Restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement. The “Three-Year Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.

 

4

 

 

ACKNOWLEDGMENT AND CONSENT TO
POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

 

The undersigned has received a copy of the Policy for Recovery of Erroneously Awarded Compensation (the “Policy”) adopted by Jeffs’ Brands Ltd (the “Company”) and has read and understands the Policy. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Policy.

 

As a condition of receiving Incentive-Based Compensation from the Company, the undersigned agrees that any Incentive-Based Compensation received on or after the Effective Date is subject to recovery pursuant to the terms of the Policy. To the extent the Company’s recovery right conflicts with any other contractual rights the undersigned may have with the Company, the undersigned understands that the terms of the Policy shall supersede any such contractual rights. The terms of the Policy shall apply in addition to any right of recoupment against the undersigned under the Compensation Policy or applicable law and regulations.

 

     
Date   Signature
     
     
    Name
     
     
    Title

 

 

5

 

GRAPHIC 12 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 13 image_002.jpg GRAPHIC begin 644 image_002.jpg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image_003.jpg GRAPHIC begin 644 image_003.jpg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end GRAPHIC 15 image_004.jpg GRAPHIC begin 644 image_004.jpg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image_005.jpg GRAPHIC begin 644 image_005.jpg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image_007.jpg GRAPHIC begin 644 image_007.jpg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end GRAPHIC 18 image_008.jpg GRAPHIC begin 644 image_008.jpg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end GRAPHIC 19 image_009.jpg GRAPHIC begin 644 image_009.jpg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image_010.jpg GRAPHIC begin 644 image_010.jpg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end GRAPHIC 21 image_011.jpg GRAPHIC begin 644 image_011.jpg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end GRAPHIC 22 image_012.jpg GRAPHIC begin 644 image_012.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#WH]32?C2G MJ:2@89H_&DHZ4"%H-)FD)!HN,7/O2&JUU?6UE'YD\JH.V>I^E8^2#_ M J:D_X1,MS)?S,WJ*P^LUY:PINWFTC1T:2^*:OY79O[P?XP?QI>:YYO"C*N M8K^96[9IC:;KUD,V]Z)P/X6/^-)XFO'6=-V\FF'L:;^&:OYW1TF[WIF?>N30 \-0>>],!![T%@JEF8*!U)I M# Y'_P"NFY)]:R+WQ);Q-Y5I&US)T^4<9JLJ>(-0Y^6UC/3'!K@GC(N![FF[AC[X_.LD>%KF0@W&HR,3UQ3SX10?=O9LU/U MC$[JG^*'[*CMS_@S2(/J::=WJ:RV\.:A;_-;:BV>P:H7NM:T_P#X^[;SXQ_$ MO6CZ[*'\6#C^*_ /JZE_#DG^'YFNR$CJ?SJ!HF[,WYTRQU:TO2$1MDO]Q^M7 M2!7;2JPJ1YH.Z.><)0=I*Q1WR1MU-2I='N34S(#4#V_I6I!86;I U,1)N/J::23W-)D'@51O=5M;+*N^Z3 MLB\FLJM6%*/--V1<(2F[15S0#L.]2+*WXCYM]1D4]LT?6,0M73^YH/947M/\ W\D=Z7/O7-O'X@T_G*W48_. MK%GXC@E?RKQ&MI>GS#BJCC(F*ZLH*L" M.N13LUWIJQS6%R:,GUI**8"Y/K4,TP'PAW?EC^=7TSZG\ZIM/!9P;YY OIGJ:SCK=W=N8]-LV;_;8<5QU ML72IOE;N^RU9O"A.6J6G.LZ;MY-,?L*;^&:^=T79I'GG"*2,FM95\J)5!S@5RMK MJTNGW6-3M'C)_B XKHX+N"[B$EO*KK['I711Q=.J[)Z]GHS.I0G#5K3NB;)] M31SZTF:,UU& O/K1SZTE% "\^IHR?6C-% !D^IHHHI#)C]XTVG'J:2@!*#10 MW H&)R3Q61J^MI8GR(!YMTWW5':EUO5?[/MPD0W7,O"+Z>],T/1/LX^UW>'N MWYR?X:\VO6G.?L:6_5]O^"=-.G&,?:5-NB[_ / *=GH$U[+]JU5R[GD19X'U MKH88$AC"(BJ!V Q4P0@=10>!UKHH86%-:*[[OOW(<,XIQI.::7]JZ MC(<< 4S<*Y3Q+\1-#\-W0L[AWGN2,M'#SL^MH85SMYH=Q8RFZTJ5E*\F(G@UP7B+XJ?:[;[)ILDMF%7,T[ M?> ]![UN_"CQ;JGB:PO!>P.UK;N$MKENL@[Y/?'K7)6PL*NK6JV?5&U.M*'I M^!UNE:S'?CRI!Y5ROWD/?Z5J#//-8VM:.9#]NL_DN8_F^7^*K&CZHNH6N7&) MX^'7^M8X>O.$_8UM^C[K_,TJTXN/M:>W5=C3HHI*](Y!:0@\=J*9-,D$+RR' M:B#))I2:2NQI.]D175W%86QFG? 'YFL!5U#Q'+G)M[ 'C'\7^-%M#-XBOC*=WI#\7_P#L?+15EK+\O^"4['2[73H\01 M#=CECU-:0)P#41!P?ZU0O_$&D:6F;[4;:# Y#2#/Y5Z%.G"G'E@K(Y923 M-;-)G)Q7 ZG\7?#MGE;43WKC_GFN%_,UR&H_&359P1I]C#;*>C2'>PK0D]L/ MUI&7/4<5\S:AXS\1ZFXSW_ M %+0+:]_>1 0SCD.O&3[UF6^HW.FSK::HIV]$FKS.S^*WBBV %P]I<+W#I@G M\J]7TJYMO%_ANWO)8&B\Y3PW56'''M7G5UFM&C"M2]G*VZ MZ,KL@/45"T :KA2F[:ZC SFC>/D9I5N"@RW0= M/V%74?+?W6HS&TTY<9X>7T%:NF^';:T_>2_OY^[, M,@?2KVGZ=#I]LL4*@8^\V.6-7 /EY-+S_S%3_W[%:WAGXJ M:W;:LHU>7[99/Q)\H#1^XQ6=2$9QM-71<.=.\-STMEO_ Z^Y"UQ9,>0>JUT M%G>P7MNLL+[E/7U'UJ2)H;^S26-A)#,@8$C@@US5Y:S^';W[7;Y:UD.'3TKS MW&6%?-'6'5=O3R.E.-9-/27YG4TA.*J17:S0K+&V489!I3*3Q7J)J2NCC::= MF2O)G@5":3=37; IB(9WP,"LFZU 6SB.)?,N&^ZHYQ3M3OC NV,9F?A5K1T/ M0Q:K]IN,/M.I/V-+?J^W_!.RG3A"/M:GR7G26BU[O=F-2M*;UV["]J4GBFD^U4[ MW5+:S7#'<_91UKK2*Y.XUJ[F?,;>4OH*C_M6^_P"?EJW6&D9> MV1U4T$4Z%)8U=2.0U18H'DY9+!+9#^\G;;QZ5SXFM[*DY=C6E#GFH]RIHT# M:MJDFJ3C,:';$#TKJT[_ %JGIUFMC8PPK_"HS]:NIQ6>%I??$GQK<^'XHM+TR)FO[E"Q<#/EITR/>NVO[^#3[.M(@UMI9]WVAD"22Q -Y<8/W5SU/J: /+?$":E+&UP;.Y ME#'#W&PD;CT&?6G66D)IUBYU&5VN7&7&\XMU_JQ].U>L:5&_C15>UW6^B(=T M-ND@W%O[[CWKA/B;H]CITYDT:262UCPMT#R%D/?/O0!R]K>)(](@\(6DL,:6UNJ!%B0UNBH78!N!P%[DUZ3X#U>W MM-7CL]1/Q+5>IO0J!MASZ5M>M;T*OM*<9=R*M-PFX]A:YW6YI-1 MU"'2;?H3NE-;TD@B@>5N BEORK%\,0FYDNM1E&6E;"GT%* MGU>\MKZ\O+:%)F2-5!164'CZURK$RL79O,8]26R3^=?3.OZGI-J!;:A;QW#N MN5C= VLX!V@).[Z__ %JI4:K7-$T]K1;M):G);USM M.5/O074'DU%)#=P/MEA8>O%6+32]0OF"PP$#U(J5&M)V2-+4(^\W<9YJCV^M M20&2X8+#&SGT KH['PA%#A[^7_/0"NY\'ZCJ&I^'H;G4K.*UF;.$B?<-O8U M$W1MRTT1^];O-EC7M,_M&Q)48FC^9"/Y5%H=_P#;K(;S^^B.QQ[^M;1P!DUR M\*#2_%;Q8Q#PKQJ+:6C_1G;3?M*3IO=:K]3H2.::5X)J8KSQ3" M,5Z;.(R-8O/L-B64XED.U/KZU8T#3?L5B'=?W\OS.?3VK,F0:GXGC@/S16PR MP[9KJHU&.O2O,HKVU>51[1T7ZG;4_=TE#J]7^@Y1@=:<.!2$#.:6O3.,,UC^ M(/$EAX;TYKN^D XPD8/S.?054\5>+K+PO9%YF$ET_P#JH%/+'U/H*\ U[6K_ M ,0Z@][J$Q=S]Q/X4'H!0!+XJ\6:AXJOS-=,8[=#^ZMU/RK[GU-<^"1Q3V!J M$@EMJGG^5)NRN5&+D[(> 7;:/S]*]"^'_@=]:N$O;I"MA$V>?^6A]*H^!/!4 MWB&[6612EC&?G?'W_85[_9V4%C:QV]O&$CC&% K-)S=V;N2IJT=R6&-8HEC4 M *HP!Z"H[BW2ZA>"4;D88-3A1COS2X%6TFK-'/=IW1QNFM)IVHRZ9,58K>/[\S;?PKKQ%7DI2EV_/H8485RS'UKU(4 M&]9''.JEL:E[KLT^4MP8TZ;NYK(.68EB23W)HJ"YNX+.(R3N% YZUV0@HZ11 MS2DWNR;(5220 .I/:LRXU!YI?L]HI9CQN Z_2H+9[GQ P-L/W&>I^Z!Z^]:= M[>:7X1TYYYV!FQU;J34U:T**][([JX6;2A;:8BYBD8DO[;NV37G4E[K'BG4))+BZF%J[?+!GY!Z9'> MN]\.6UYH5H$6]E+%MWEYPH^HKQ*N.O/WEK^1Z=/"-QO%_P#!/3UW$AIFK62WVES0D9.TE?J*RQ-+V ME/FC\2U0Z,_9U+2V>C)T=9$5U.589%.[UB>&KDW&E"-S^\A8H<^E;?>NC#U? M:4HR[F56GR3<>PM)10:W,@HI:*0R8CDTG:E/4TT]*!B5S.I#[5XJLK<\K&-Q M'ZUTU2>5 MML<:EV/H!7H'*+<3Q6T+S3R+'$@W,[' 4>M>:/\ &:P?69K2SLI)K2/C[63@ M$_3T]Z\]^(7Q"O?%-P]G:E[?24/" _-+CNWM[5Q-S>22Z>EE"%AASF39U?ZF MF![W#'?>,+Q[^[NQ;:-$N9)E.-X_NIZ+ZGO7E?Q UG1=0U]UT>V0110B R,, MK@=P/4UE7'B_58_"MIH2R-%:("-RD_.,\9/M5/POX9U#QGK*:;IZE85.9YST M1>_/K0!0T;7-1\/W[RZ5--';2+Y;JK9R#UQ78>,KR.'P_;Z79+/]AO&5I+AT M)+N.P/KFO7H?A5X0TR&":6!_]&0%G:3Y3CJQ%1WD$6NWME;VMLJVT#;[2W*_ M*O\ TV<>O]T?C0!X"VBIX>O%6]4BY>(2(C<^6#TS[UZE\+O (->U9KK25;S3"XS++)VC'J":AUCXCZSHFJ M016DD9E#!IK$*#'!&?NQ#'._')-(#V\ 8' %.'W:KV$[7.GV]Q)'Y;RQJ[( M?X21TJR*8'):,IM?$=]:]%;+@?CFNC) &:Y^+CQQ.!T,?/Y5T!KSL#I"45LI M/\SJQ.LD^Z1F>(9C#HDS+U;"_F:LZ! (-)MU'4H&/XUG>*^-%'_705MZ<,6, M''_+-?Y415\9*_2*_%@]*":ZMEJF-]ZGTQ\5%\O:$.P> MX/K7*:+K&N>%$BCL[JX%GG<4FR^1^/\ 2B&.Y-(N_D4\-?62L=?/[R8JSINF:QK$GEV5HMI:YP99!C/T]:U=*^(FDZO"(;^"/S0,\J/Y&L3Q/\ M4XD+6.D*3(?E"Q_XC^0K669IJT(^\0L'9^\]#?FL-!\&V3'4+U1NV,PR MQ] .@KEKWX@ZOXCMQ!9V;:?$PPPW L!^%<]::7JFKW(N-3D9G)R(POC95-&[O\CT:.$Y=5HC)TOPRD@9[@':W+.>K&NYT"1-(N M((K<,L+?)Y>^0_D![^E=AI6BPZC. M4N>3*K581CR1-(K\H].M_(#>HS1OP,GH!FHK?FUBSU\M?Y4L_%M+C^X?Y5NI-TN;R M,[>_8P_# \^]OKL\EGQ^M=*@VFN>\(?\@V4^LIS70J36& 5J*\[O\6:8G^(U MVT_ >3SBN8\4^+HM"A:&WQ-?,/E3LGN:3Q%XF%HCVUBP:?HS]D_^O7FUQ'), M[2R,6=CDL3R:[CG.?U2:XU&\DN[N1I9W.2S']![5CRQY:NDN;?DBN?U&6.V_ M=JPP,%JY%=/=@&UG! M'_+-OY5RGAZ(/8,3T$AKSI*V+C;K%_@SJCKAY7Z-%_*'SO$L$9Y$4 M>\_6M5(U7H*HZ=C_ (2RZ![1#%:8S7DCWDOP)H:_@NX);8 MR-"RD% ,@$5V7!)Q7.>,O$FG^&-%:^U!)G&[;%'"F6=O3VKT*<_9RYK'+./, MK'$#6KN,XDC4_52*F37@?OP?]\FL+2_C'I.IW(MKW0;B!R>HVL /4YQ746FK M>%=:9A;/"6'7*E,5U_7::^)6,EA9M7CJ5+K7HXK9Y(HG+*,D8JOIF@7OB"07 M>JEH;5N5@[M]:Z*/2M+AE2X4*57.07RMVNDV[6\$G[UQ\J@\M[GT%8 MUL?&*M2U;*IX5MWGHD7?$_B6U\-:/)::=-'!=%2D15-V#[#N?Y5YEI5GJ6MR M)+JE]<7;;LYSCK)_@>K3H12YY:17XFAI6E16BJ0H#@<#^[_P#7K8M( M)+RY^SVY#2$_,0<[/N-('/ E3'Z5T MA'%0P!KE_&^F:9JUC'!>JQG#?N]GWL=P?:NR# MNKHYVFMSYF(HJ"6>".^B69=T8.9A'U'M7M]]X0TV_TXVY MA6VF";8I8A@Q_P"->%Z_HM]X>U.33KP88H/]*\;MI%5!%@@CUJQ'%![0>/X?'06*TMY8+52,6\O!N']S_<'4^M>@:;9VVA:;-=W< MZ[MOF7%PYP/_ *P'85\[:"M]K'BO3;31U,2PR KLX"(.I/MBO2O%WB2VN+!I MKIRWA^Q?8J*<'4KD=$'_ $S4]?6E<#F?$WQ(75-7N+B.&7=;?)I<,BX0$]9W M!ZG'W14'PP\+R>(_$)U"[#26UJ_F22/SYLEP M[ "OICPSH%OX:T*WTZW4?(N7;^\W*%WZ(^.2K!JU=)E6;2K=P<_NQ4=_;K%B"/:H;Y,9K]I?D5\6'LNC_ #.@W#UK"\57TMCI+F$$O*=F MX?PBCQ-XITOPIIC7VI2@<8CB'WY#Z 5\W>)OB+KOB;7(KQ9VMK>WD#PP(?E4 M#^]ZUWR7-%QNQ M3Q$)JU[>1Q6J^$T4L'C>WD/(=!E3]*FT+PM;6*"2*/)_BGEZGZ>E=M'.P78R M[U/8UE7$CLQ08.#P.PK*4JC7*Y71K3A33YE&S&JZ0#9"/JWIJLMM;:1 MYJ[$EAF*V3[\G^ KF->UV\UIP)B([:/B.WCX11 M_4^]=.'PUO>J?)'#BL8E[L#H)OB2FEW7DZ-I\ZD0L#N#+P*\2U#4$CW)&06'4]A7)+C,%I$&\L, M/FF)'IZ5Z,')L\M2;=SW _,#]*Y[Q32.S"KW^;HKLZ"%=D:+Z*!3I%W1,OJ"*=W- ZUV]5;1CIWBR>W/"7(RO\ M.NIQD=*XL#)N#@]XMHZ,3_$Y^C29\_0^*;CCSXDE/?/RM5U=?L91^\62$^XW M#\Q7J>H^"=$U)G>:QC#MR63Y3^EG+?0XG6 M=7M;>W)MY4FF<< <@#U-C*=2-*/NZLK7 M3+$"BCYSU]JN7UTMLG3]X>E'A;PQ>^+]9^S0Y2%2&N)R.$'I]325V<*;>K/4 MO@CJTB^&-1LWC;;#<;HFQP=PY'X5WK%F8LQRQZU7TS2[/1=-AL+&(1P1# Z MD^I]ZDE? P.IJ[FR5D;.E$&T?_>K0'2LW1>;)_\ >K2K9;"*6HRB'3[AR>D9 MYK \.IMTI3_>F8*![5/96_V>QABQRJC/UK@7OXNZ^S'\SK M?NT/\3_(G K)1_L_C%.%M+K1VM)[!KZ1OF2)6VX([Y[5T<4JS1)(OW& (->;ZUJKS:[ M/,K$*K;%!Z8%56KN-/FCU'AZ/M)V?0\N_P"$;O;BXD6Z@^RIDX#C/ZT@T#5] M/);3[@%1R?+?'Z&O4XM5\Q=L\:2#W&:26STJ[&3 T3'NA_I7E_6:DM[/U/0E MAZ:=K->C/)Y?$?B?3H9%E@+ CAGB/\QUIF@>&I]3N5U360[O(=R0MU;W;V]J M]2?P^[ _9[P,N.%<5OL+V,5[ MTYIS6S\-;8^&(5\17)F2&:%O)MF;:TD8^]*^?NKZ>N:[Z#Q;IB^&IO&%\WGF M3=%!:J,DL/X ._U]*\J\1>(9?%%Q%8V#--)=,OGLJX$C_P ,2CM&GZG)KJ.8 M]]\,^)M/\5Z2-0T\R",-L99!AE;T-;:D>M<]X/\ #R>&/#=OIRX,N-\S#^)S MUK:N)TM[629S@(I/-1-\JN^@TKNR.=L?W_B[4)1T0$5T0.36!X6C9H+F]DSN MGD/7T%;P]17'@;^SYG]IM_>SHQ+]_E[)+[AU%%)FO0.4,T444ADYZFDI3]XT M4 )5+4K1;VPFMV&=R_+['M5VD)J)Q4XN+V92;BTUT,#PQ>L;>2QGXG@)'/I6 M!XI&HVNHPI"0#:.FM%3_>1V?X,XNYN4M(=\C G')]:\J^(AN+VYL_M-H\ M:X+1S.N-RGL#7M2^"F?5#+<7/F6:89(L(M1CE2#R+"W'E6%HHXC3UQ_>-=9 M\6[;5-+UK^SY;G.BW$C7<48')D/4-ZX[5L_"GX>-=SIXAUB$K"AS:P./O'^^ M14C.F^%?@8Z'I_\ :U_'C4;E,ZQ: M;;Y,LS#G6S2R')QA5'\1K(T*RFGE;5;P?O9/\ 5@]AZUYF)FZL MO84]WOY+_,ZJ,5!>UELMO-FQ9VWV2SBMUQA% J<# I:7VKT8Q48J*V1S-MN[ M(Y'\M"QQTKETF.C^(1*?EMKG[Q[ UT%TV3MZ8K-O[)+ZT,7\756]#7+C*$IP M4H?%'5&V'JJ,G&6ST.'^+W@F]UV.+6=/9YOL\>);9>25_O*/Z5X:MM)O:."W M>XD52S(G48ZYKZGT'4R3_9]V<7$7RH2?O#TINH^#-(N8[^[M=.MXM2GC.V4# M&6 XS6F'K1JP37S\F*K2=*3B_P#ASQ2'Q1;^$K9VT^P@M]<:%0DUI(6B"D<[ MP?XA_.N7L/&OB/3-0ENH-1EE>9BTL\F%>)"5=@>,>H^E=!B>U>"M*UO5O"D5_JC MH+N5RRH4VC9VQZ5U.C^%H[:8W5Z%DESE4'0>Y]36Q87EK=P*;5QY:@ )C:0/ MI5P#%9>QA?FL:^UGRVN?->NZQ?Q>)=1%R'8&X8*LP(.W/&/:LK4-7:6+9$IC M!Z^I^E?2NK>'=)UN(QZA8Q39Z,5PP^AKE]*^$^A:;K8U O+<1IS%;S'*H?7W MJ73=[G-R'%_#WX8/?M'K&OQ%;;(>&U;@R>A;V]J]LC18T6.- J*,!0, "G$8 M^4#C^5(SJ@RQ 4=2:U5HHM*VQ6OKU+&UDN'/RJ/S/I6+X;MG<3:C./WD[';G MTJM=2/XCU06\!(LH3N=NQKI8D6.-$1<*HP![5YM-_6*_/]B.WF^OW';->QI< MGVI;^2'T=**#TKU#C,#Q-;/Y<5_ /WMNE=5>) ME==RL,$>HKFK>63PWJK02DFQF.5;TKRZM\/6]I]F6C\GW.R/[ZER?:CJO3L= M=GVI.>2!S34<.H92"#R".]/3(Q7I)WU1QGSGXF\92ZMKMR+\2(()6BC0?=4 MXZ5BSZC;+"SI*&/9:[_Q+\&]2O-5O-0TW4(6$\K2^3(,$9.<9KA-3^'_ (HT MO=YVD32 ='A^6/O5K> #[4T]6&>E<[K^JLK#3[3YKB7Y6Q_"*B MO7C1A=_+S+I4W.5D5=_]M^(-PR;>V/'U'^-=#C)S572].73K-8PQJV:;WS774@IQ M<9;,QC)Q::Z&1X9O6:W:PF.)K MIJUI]Y?]:@'6MW3[^'4;59X2,'J,\@UYV'EROV%7=;>:Z'74U_>TWH]_)]CD MKSP3<0$O:3)*.RM\IK)DL;VTDQ<1.@'=AQ^=>G@ _6AD#+M26*0% OF2X&\CH,\UWMSH%A<$LL9@?^]&/0#UKZM#;0 % '0#T MKQKQOXIL-&O;V2W@M5ODG,=M9HO)E YN9AZ+GY17HLX#"\5ZU#H]JFE6<:P7 M9M_+6$8(T^W/53_TU?JQZCI70_!_P=@_\)'?0[0!MLT8=!W>N*\">#[GQIKK M3W4DC64.WMX[>%1'%&H5% Z =J0QX_.N<\479D2 M'38,F65AO ["M75M2BTNV::0C=T1?4UA:+:RR3/J=WGSI?N ]A7FXF;JOV%/ M=[^2_P SKHQY%[673;S9N64:6EG#; C$:X_&K0(.,54QGZTX,R]Z]*$%&*BM MD<;DV[LM45$)<8S3PP;H:H!V**3/O12 L'[QH-!^\:0TAA28S2T4 1NBLI5A MD'@@]ZYF\L;G0[LWFG O;LE=02<5&?Z5S8C#1JJ[=FMGV-*51P?==BKI MVL6^HH#$V)/XHVZBKX+CJ!BN?OO#T[)&,J-2+LTQFH:/INK& M+^T+.&Y\IMR>8N=IJVH2(*B *JC 4#H*K2:G9HN6NHL?[PJA<^)M.A7Y9#*P M[(*)XJC#XI(J-&I+9,VBQS[5FZGK=OIL?SD/*1\L8ZDUBMJNKZI^[LK7R(C_ M ,M&]*N6&@0VTGGW3&XN.N6Z URO$5:ONT5I_,]C1484_>JOY(JV>GW.KW:W M^I9$?_+.*NCP.@Z#H*7.1CM1BNG#X>-%=Y/=F56JZF^B6R"FLVU2O7BK%JJG=NY;WIB,G4M.2\C62)O+NX^5<<9]C3 M])\0886>HCRIUXWMT:M&[5=R[>HZXJE>:6EY#^^BZ#Y7'45YU;#3C/VM!VD] MUT9UTZ\7%4ZNJZ/L2Z_X7T7Q3 B:I:),5YCE'#+]#3KGPWI=SHT.G+;1)';@ M>0VP$QD="/>L:/\ M72/]0WVFW'\)Y(K0M_%=JQV7,;P-WR,BICC8I\M1.,O M/;[P>'DU>'O(30]#N;/4'NKN1247RTV'AQZD5TG.:H1:MI\H'EW<7T)Q4AU* MT49^TP_]]BNM5Z;5^9?>C'V4UI9_B6R3Z4G(-9=QKNF0CY[I&([+S69-XK>1 MC%I]H\A/1VZ5C4QE&&G-=]EK^1I'#U9=/T_,Z"YNXK6,R2R*B@(I_LMB#':#[\A[T^/1;O5)1<:K<';U$2FMV""*VC$<*!(QT517.XUL5I)G1V]Z7X+_ #([&QAT^U6"$8'<]R?6K6/>@=!2UZ4(1A%1BM$<7?AZ? M[-> R69/R2>GTKJ;>ZBNHA+ ZNI[BH9X8KB(Q3('0]5-84FC7FGS-/I4Y'K$ MW^>:\Q1K8;X5S0[=5_F=;=.MJWRR_!G3'=TP?K2C..M[C'T.:W=>G%7IK7))R.* M=+#3E/VM=W?1=%_P2IUHJ+ITMNKZL,4N.]**,5Z!R#<9H"TN,44P&% 00W*D M8(/>N;NK&ZT.\-[I_P ]JQS)%Z5T^*3J>1D5R8G#QK1[-;/L;TJKIOR>Z*NF MZM;:E'F%P),?-&3R*OH7Q\PKG[_PY%/,;BR6J?KV-O8QJ:TG\GO\ \$ZHD@=*0&L6W\3:9= ;I_+? MT<8Q6@FHVDH!2[A(_P!\5UPQ-*?PR1A*C./Q1988#(Q7G/CGX8KXJU^UU.TN M8;1V01W9*9:11T(]\5WDFIV48R]W"H_WP:S[KQ1I5NIV2&9AV0=:*F)HP7O2 M01HU)/W8LL:%HUCX>TF+3-/B"01#KCECW)]Z74M;SYF,\_7+= :Y'7JU_=H+3^9Z?=W-_94Z>M M5Z]EO\^PMK97>JWG]H:H"J YCB[8K?.W'%5Q=!OO<5(K9Z$&NS#X>-&.FK>[ M9A6K2J/71+9(DI330:4')KJ, I)9.1!&@]" M*\R=3"RVI\WHO^&.V,*T%\=OF65\,:8IYCD/U:KD.EV%L1LM4!]2,UEF?Q)$ M,M;1N/0"D'B"\MSB]TV1!_>%$*F&@]:?+ZK_ (<4HUI:<]_F="N,8&,=A2D= MZS[+6K&^(6.8*Y_A?@UH<>M>E3JPG'W'=''*$H.TE9@!BEI,CUHS6Y ,P52Q MZ5G.=S%NY]ZLW3D*$'4U4(X//-.PF/AB\YB.@%22P^5\VXX-11.T3';C)'-. M>8RD;NGI0 SC>#V')SWJVUS&5.W.2.E/$403! QCK5'!W87GZ4 20P&0;LX& M:AN;.)GVRQ))D<''-.>_BL%/GLJCT)YK*E\0B>;_ $6TDG/0$# KCKUZ"]V; M3\MSHI4ZLM8+]"8Z)ITD@+PLH/\ =-$GA[2U'RB5F_WJA\[7[C_5:>L8[%J4 M0^(P,^3$?;BO/6[?P_9KA_(7VW'-6/*6$[%14 ]!@ M5G?VGK5GC[1II=?513H==M9Y]MR'@)Z[A6]#$8:+Y4E%^:L95:=9J[?,O6YH MH[HWRDU9CN@W#C!]1492%H#+!('7U!R*@QCK7J)IJZV.)II]C3I:9'S$N?2G M4 %+VI*6@ I*6DH !2>W:C/-(\B1IND=54=23@5,FDKL:UV$>..8;98U<>C M#-9\VA:9-RUJH/JAQ4%UXGLH6,<"O%F _WJ>OAW3(>?)9S_M-5<-XG;GRX1[$" MF2W?B"$9EL5D _NBL4\-'5TVO.QI^]>G/^)I1VMO;\PP1I]%J&Z):5?I5!?$ M(0A;RTE@;OQQ4PNX;IM\,@8>G>N^A6P\O=@TO*UCFJTJR]Z:^>_^9=TX#[1S M_=K4 '8]=;.<.@I*6DQ3 2E%)2T#$HHI0,T"$(!IJJ,$- M@@]JD &>HXK-O=>TZPW*\WF2#^!!DUA4JTX+WW8N,)2=HJY)/I6GW&?-LHR3 MW48JD_A;2W.X12KGL&JDWB2^N6Q8Z4[#LS9-2I/XJE&1:PH/1A_]>O.G4PTM MJ?-Z+_ACMC"M%?';U987PMI:'YHI&]BU6DTW3[;B&TC!'?Q1$,M:0R M#T7_ /747_"1W=L?]/TJ5%[LM*%7#0>M-Q]5_P .*5.M+[=_1_\ #&TWH!@# MM431A^HJ*RU:QU#B&;:_]R3Y35MEV]_>O3IU:=1>X[HXY0E%^\K,J-!Z<_6F M$%#Q5PC%,9 W&:V((5N,??%3+,K_ '343V^3@57:)HSD9!]: -$&E .35!;A MEQNY%6$G5\<_A3"Q/13I]*PM/TZ;6KC[??Y\D']W'ZUPXC$.+5* MDKS?W+S9TTJ2:'D^AG[6*+U_X?L;SE8_)E[.G%9/GZGX?D"7(-S9YX<=14=SXOF@P%A1VR M!A1=<5L+>PWM@L\)RC\8[@^E+#XAS;IU-) M+\?-!6I**]I#6/\ 6C(Y'WN6SQ4UM&'0"/6E>VX[&<7.S[^%[Y-9CZO-+*;/2XO M,E8X,F.!45Y-)JU^;#3\B%?];)[5TFG:9#I]MY<*#/=SU8^]>7.I4Q,G&D[1 M6[[^2_S.U0A0BI5%>3V71>IDV?AA7?S]0F:>4\E<\"MV&VBMT"Q1(@]A4^UL M8XI!D<8KII86G36B_P _O,)U9SW8N>.>M*6II/M6-KGBG2M!B)N[@&;'RPIR MQ_#M70VEJS-)O1&R23BJ5WIEK>J5GA1L]P,'\Z\RN/BGJK7#-:VELD/\*ODM MCWJ(_%'73UM[/_ODUS3=*:M)7.B-&K'6)VEQH5[IC&;3)F>/JT1/7_&IM*U* M*^F\F3]U,/O(>_TJAX:\?6>L,EM>A;2\;@ GY'/L:V-9T-;L?:;;]U=+R&'& MZN3VC_P ^YJ].G2@&L;1M6:YW6=V"MU%P0?XL M5M=*[Z%:-:"E$Y:E.5.7+(*6DH)P*Z#(*,4F) .#]:Z+ MS$(^4Y&,@CO4.H:?!J$)BG0GT8#D5@6EW<:%>_V??$FW8_NI/2N6-2IAY*-1 MW@]GU7D_\S=PC67-!6EU7?T.HI/2C<".#GZ=Z >>]>IE $PQG-5KZ_M]/MS-<.%7L.I/TINH7T.G6IGE.=HP .K&L+3M,GUVX_M M#4<^1G]W$>__ -:N#$8B2DJ5)7F_P7 M(;7+#W8_UN/' 4 #T%/P33 ,MC!X[XI68KV-=BLM#G!A@#ZTU_F&TJ&![$4 M-(=F2"?PH#Y7H?RH=NHS&U'P[97X)5/(F/1TX_2L@R:EH!VW@-Q:9P'')%=< M PSD8I'B$JF.15>,C!!KAJX57YZ7NR\OU1T0Q#2Y)^]'^NIDVUU#=VHGA<-& M?TJ;' Z5AW^GS^'[D7MEN>T;_61=<5M6ES%=VZ30_,C#\CZ5IA\2YMTJJM-? MCYHFM144IP^%[=T_,<1S32O8C-2D<9INTFN\YRN]NK\E/[M% S7)^8TTGFE8_,:8:0!2$\9I-::4Y3[\AV+^- M95JJI4W-]"Z<'.2BNIEL#X@UG8"?L=N>?0UU<2+&@50 J\ "LS0]/%CI\:GB M1QN>G:AKEEI;>7<3()2,A,\FN;!T)6]I+64M7^B-,143:C'X4:I(JA>:Q;68 M(9M\G]U>37-W7B![PE8YXTC/97&35#<&/WU)^M>Q##/[1PNKV-.]UJYNB54^ M7&>R]?SK-))Y/?O37=8U+.P51W)K#N-?:>8VVG1-+)TW#H#77&*BM#%W;-J6 MX2!?F//H*KPI>:I)Y<"E4[GH!]35C1/#-T8_.U:;+$[B@]/?VK$\4?%;2/#L MHL-%ABO9HSB0@XC0^F>YK&I74=(ZLUC2ZL[*RT:WLFB0SQBZE.%>0@$_[H]: MZG<(D^9N%'+'BOFN3XH37FL6VHWME#/+;R;T!) &.@'H*[G3/B%?>.7;34L% MB++NV1L2)!Z$]A7%*4I.[9NDD>KJT%Y 61TEA<8RI!!KF$']@ZP;20G['*@*E3@Y!]ZK:5J$ESI\4FXEE^5L^HK55EN(\E: M[:555*:FNISU(.,G'L4CZ C)K-U:^EBC6S@9C-/\N!V%;+VQ7+?PCDUC:%#_ M &CJ]Q?R?,J2:C2AO+\NIT8>"5ZDMH_F;6CZ:FFVBQK@R,,R-W)K M34_+48'I3+BXBM86FGD2.)>69VP!753IQIQ48Z)&4I2G*[W9/FJ.HZM8Z1;& MXOKE(8^VX\GZ#O7$>(/B;#$'M]%02R=#.X^4?0=Z\WO]0N]4N3 MGT':HG62T1M3P\I:O1'9^(/B7=WF^#2$-M#T\YA\[?3TKA9)'FD,DKM(YY+. M?OR?3T M'O1&+D[($/ YUGQ#-XAN!.L;R[UEF M?<_LJGT]Z[J=/D/,K5N=GH?B/3S$ZZG:C$\1!?'<>M:UA>)J%C%<1G&[[P]# M5MXEEBV,,J1M.>]3+(?DSV%1ZR6U'6;73 M%/R@[WQ72PQK'&(T&%48 KRTOK%=M_##3U??Y'6W[&DDOBE^1*N<4X4F,&H9 MKF*UCW2N% ]>IKTSD)LYJK=:A;V:_O'^;LHZUC7FNR2Y2V&Q?[YZFLAB68LS M$L>I)J)3[$N78T+S5[BY^5"8HSV'4_C6?QZ49J.:9(8R\K;5_G6;;9))GTK. MO-52$[(/FD_O=A5*[U*6Z/E1 I&>PZFEL=-EN)UBC0R3-T Z+[T)#2.C\*^) M+FZ?[!J947!.8F'4J.S>]=%J^FIJ5FT3X#CYD;T->"^(;/6KSQ0FC:1J*F-& MR\EBQ,C/Z%O;VXKWK1X;R#1[2'4)1)=)&%E<S-82<6FNAF> M';]Y(Y+"X)%Q;G SU*UNCK7-Z[&=,UBUU./A7;;)C_/I72 [D#*<@C(KDPDY M*]&>\?RZ'1B(IVJ1VE^?4;(XBC+GH*K6J%V-S)_%G'L*;=,9YTMD/?+>U5]? MN_[/TEHT^])^[7'ZUUUZJITY3?1&%.#G-174RAGQ%KA4Y^QVQQ_O'_Z]4_%7 MBL0&;2-*Y=,1SRQ2A3%D< ?XUT^B6(L-*B3&)&&Z3W)KD?B7#I.D^&TO9;6& M)GN5#2)'\Q)SW')K/ 4XT_WM17E+5_UY&N(GS/EALM$&M;U35K_ %31IKR8J+AFJ4X[G;4I=7U..VLT::5;BX#*P Z8 MQ5B]EM;R\NDA0F*<[=I'WB>O%4/$^BW^FZ?#I.@RQ$7";+YI@!Y:^H]J\#!2 MD^:#UL]&>EC%%2C*UN97L2ZY\2-2_P"$6LKVS25-4U*4_8;11DB,'AV'I6)X M>U_Q'+[)(=I5^1@CT]*V](L_#/ABW$MY?MJMZD0C$JY.U> MR@^GH!4;>,M%U*YDT32M-,#Q-YLS;,8/^T>I-=.,_@2L]5J9X3^-&\='I8Y; M3KCQ99^-$MKG7+R2S>X4_O)C@IG/TZ5[.FKR126[O*#&UT8 V>-N,Y)KSO49 M+"5IY;E28[6(&7C@GL*UM:O;6T\'Z>UW _DRW)4;3RA*<4L-B)5**G+>VI-7 M#*-;D6S;/34N(+M'B.U@1@CJ"*YJ!3X>UHVSL?LEP?D)Z T[PI>6TK006^\[ M+<$L5( _&M/Q)8&_TEC'_K8?G0C]:6)IMP5:'Q1U_P" 8T96DZ<]GHR]@@D4 MW'J*JZ+="_TN&1CEU^1S[BKYB/;FNVE452$9KJCGG#DDX]B$KFD([5)@]^#2 M$#M6Q S%%/P?2BD!<;[Q^M-I6^^?K24 )7.ZTWVK6["SQ\H.YA719KG@/,\; M8;^"/C\J\W':PC#O)+]3KPWQ.79,Z90 >EC!N#NCE>IY _@V^7_5W$+?B14#^%M7C^ZJ-_NR5Z MR^EVAZ*5^AJL^DQ?P2N/J*Z5BI]3/V2/-[+PWJ=XK6ERKQQ[@Q%&P.??O@5Y( MDDC,J[.2<<\"I1NE.U 2:F@MV;#.I8DX"#DDUB67+W1VLOL<2O\ :[J<9,4" M;MH_"O5O"&CQ?#[3SX@UHD:A=1[+>R4X*KU)/]?2M7PCIUMX,\*0:IJMKC4I MAB* \N3V _KZ"O,M=UW5O%VO26[;7FEE\L>4Q*[<\*/]D=_4T >\>$?&%CXO MLIIK2*2)X7V.CC]0>XKHP@96![C%<]X+\-0^&= AM5 ,[#=,W*L+H94?Q2 5KZ>JKI]L MN.!$O\J%[V+=_LQ_-E;4%YO\D8ZSXAU+ M7IO,O;@E,_+$IP@_"K?B?PEJMGX@OFM;":2U:4O&T8SP>:YV6VO;B:CXBO?L]HA$8/SRG@**];\->$[/0H@EM'YMTWWYV')^GH*VI MTW(YZE7E,'PYX%M[",:CK;QF11N$3-A(_P#>-;FM>+M)T*Q5XYX;VZD7]S!" MX91[L1T%8'Q*UO16T]] ,?VZ]8YD"N0D1[9QU/M47P]^&L4,$6H:E#LA'S16 M[=7/]YO\*[(Q45H>=4J2FR?P[X8U+Q=J']N^(W=H#_JXCP&'H!V7^=>I1PQP MQ+%$@2-1A548 %-EFAM+=I962*")V[&R$EI.V8XLD2^ M5_ST/ID]!Z51%CTW.#BN6\0+]EU>POAP2VUB/K7103):YJ%XW.UMBGTKI-Z0J6=@J^I-<]X/4?8)WQ MRTIS69XRN;VRN;9XI3]GD4@H1D!A7+@E:BI=[O[V:8I_O&NUE^!NWNO $I:+ MN/3>>@K$EFDG??*Y9O4USB:_<#&Z.-A[#%3IX@4_?MR/]TUNVVF MM6;?>+I]167J_B00*(;9&>23[BJ.6_P%)(DU=2U>VTV)FD==RCIGI6*D\VI[ M9FW8/(W=A52UTN6Y*SZF^\AMRQC[JUTCZ]4 MET*2&Z;I3SAI,K#;QC=+<2<*HK#U#Q%<:[=#PYX,CD$3G;/>CAI1WY_A7WKD M]#A\5^+[J;18M7N[S3C)N/F#8BI_>;'\J]V\+^%M/\+Z:+:T0-*P_>SD?,Y_ MP]JT4;%%?PAX-LO"UD, 2WSC][.1^@]JZ; -?)<_I6/K7^E^(-/LCRH.XC]?Z5T@4*@4#@5SBCS/'7/\ !'_2 MC&ZPC'O)#PRLY2[)LZ48SE>G2N;\;Z3<:WI5K!;0+.T=RLC(2!P :Z15"C I MP48Z5WM75FWA.0!*#M]@*CN?"VO_ -HSW:Z< MQ7RMB#S #G)->M%: *R]A'EY3?ZS/F4GT/,/#WAC61?B>\M#$(AN78+9&"QHWJ<]<5QT^E:CX=-]JNK6T<=[<2" M2Y"S*S8\Q;5O0*&)E1ESQ2;Z7Z'22ZC#=:.RO/&L.2:\C $Z=,2KT_P *'N'$&S?(O/**Q"GZ MBB-",5RK8)8FYRWAO-OJ.HV!Z(VY1719 M(-!2%P9&'O2TQ"=ZYX,(_&RD_P :BAMK&O-QWP1G_ "R3_0Z\+K*4>Z9U0(YJGJ>I6>DV;WE_S-_]:O01RFQ>?&GP[':S/:QW,\X M.(XV3:']\]A6$OQT)MG671PDY^ZZ294?A7FC6]K*/D S[&JTFF _.\NH\?9X8UR YZ#!ZM6=HWC/PYX,U.VTR\@D:\F0-//U$ M+'G!]_6NZU*72/'^ASV&CZRJWJ*7B>)L-&V,9^G:@#R;QYXQN=3U*6VCDW3G M]W*4.1"O_/)/?^\?PKM_A7X&_LVU76M1C_TB09AC(^X/6JG@;X1R6%^+W7FB M=X3^[MU;<"?4UZV@4_*C+A>,+VI#)%'!^M2BHU'&*"ZHC,> HR:):(1S$&)/ M&URP_@CY_*NA[US?AT-/J-_>MT=]JGVKH_>N# _ Y?S-O\3IQ.DU'LD8_BI= MVBD_W9 :U-/?HT8/WHB4-)/EQ MC_O1_)E;T%Y/\SG_ ![X_P!(\&HOG)-UG>*+^+3T MT6_^U2_P+&)%7W)["NV\4>";/Q/,ER\[P3HFS<%!!'N*X6Y^%>N:;.UQI%U" M9,?>B8Q.1Z5Z!R7:9WUSX?LY@?M&EP.._P"[%8UUX(\/S9)L#$?]AB*XU]4^ M(WAPXE:[>-?^>T0E7\Q5FU^,>I0D1ZGI%O/CJ8V*-^1J7&+W1:J274]%TO3( M+6U2WLXE@@0+OB9J7B M;RM#T*RFM$F #(O,DI/88Z"NV^'OPSA\.1IJFJJL^J.,A#RL'T]3[U26FA$I M.1#\/_AR;)8]7UY-]XWSQP-SL)[MZM7IAP!DD #GZ4$G-3 \*3_ ' > M3ZXKG_ 6@77C'Q8^I:B3)!"XEG%O#L'AG0;?3[<991F5^[L>IH&; "JNU1@ 8 KG_%[#^SH8 M_P"_**Z' )(KE]>;[7K5E9+_ L&85Q8Z5J3CWLOO-\,O?3[:F_ -L$0/9 / MTHD&8)!ZJ?Y4_I173R_NN7RL97]^YA>$&_T&>,]5E.:L>)K&.]TAB\D47DG? MOE;:H'?)JCHO^B:[>V9X$GS+_.G>.O##^+/#,FG0LJR%PP#,0K8['%&I;F2!-5MF=6*DYP#]#Z5J1PQ2PK-'EHF&5=>5(]C M7$ZA\)-7TJ99QHYF6,[AY1\Q3CU'I71VOQ3UW18DLM0T"T>",!5C\HP[1[#I M78XG*:!A7^%ZM6ELK,C;=\O1<#GZ5#!\3O!VH8&IZ+(I #_RQM5.6<^F.]>>0 M/XB^+WB#./L^E6[< ?ZN%?\ V9JI:%X=\1_%SQ VK:M-)%IR-\TO08_N1C^M M?0.CZ18Z%IT6GZ?;K!;1#"@#K[GU-6E8"/0- T_PYIBV-A%M5>6<_>D/J36! MXV\96^B&+28;R+H',CGY;>/NY]_0>M:_B/7?[(BBM[1!/J=SD6\)/ ]7; MT4=2:^?/%NIVNHWYMH&^U>5(6N+XC+74QZX]$'0"F42R?:/&/B"TTK34=;0. M1"K'+')^:5_]H]?TKZ-T?3(-&TFVTZW&(X$"CW/(C!*;C]37G2?-BU;[,7^)UKW:#\W^1H9KG5_=^.1G_EI'_3_ZU;YZ M5SNN$V>MZ=??PYVL?\_6JQNE.,_Y9(6&UE*/=-'4@<5(OW:C!4KD=^:56XQ[ MUWK4Y1Y..:8.34^+>B00WEEIS3R7A0I;RJOR%O M4'VI@=KKNMVV@Z3=W\KJ_P!G7)B#CB7,<@E4_*_7V-/PMS;$ XXRI]*K/.Q@"<<_>H ?-*JS93.['S>Q[4NE M:3?:_J26.GQ-+.Y'/91ZFI=$T34?$NJ)8Z?$7D;&Z0]$'J:^C_!_@RP\(Z<( MH%#W3C,LQ'+'_"@"+P/X(L_!VF[5Q)>RC]],>I]OI76K3<>M-+JB,YX"C)J9 M.PSE[;]YXSO&'1$Q^E=$/O5S_AU3<7E]?GI(^ :Z!1BN+ ZP-/6:H9C^_D_WC3,XJB2^'!K/URT^VZ9(H M'SI\Z_45()".]2K,,8-8U:2J4W!]4:4YN$E)="OX>OA>Z6A8_O8OD8?3I65X MS\%VOC*QABEF>WGMV)BE5"LB!OYUWG,?([3M.R MDX+=!M[UWUIHJ> O"_\ PE&KQ*^K3#;I]HXSY1/_ "T8>W6O6H/AWX6M=7CU M.WTQ([B,Y503L!]=O2K?BKP=IGC#3EM-21P4.Z.6,X9#_4>U 'R63+=W;W4[ M&6:1BS,>I)ZFN_\ ^H:?X<$VMC5T%TD38@,#;7/]W=T)K3U7X*Z];7"QZ6[/@N'\ME7W!K(\8^&)O#K6>A,P6)S?#_ ,5:U%I#:=J&B+IYLL(J."K2>^#0!ZP&[5B^)+_[)8-&I_>S M'8H'\ZM6>H&?3OML\9@4C.'X(%8EI&^NZN;V5?\ 183B-3W->=BZCLJ,/BE^ M"[G11BK^TELC5T>S-EIT,1'SD;V^IK0[8I:6NZE35."@MD8SFYRO%8OB#3VNK=;F#BY@^9<=2*XL93DTJL%K' M7Y=3>A)7<);2_,WL@?G3P,CBLG1-434K7<3^]7B1?>M9#E>*ZJ56-6"G%Z,Q MG"4).,MQ""??VK-OO#VD:FN+W3+:7W* '\Q6KFCK6Q!S>C>"- T'4)+^PL0E MPXV[F.[:/;/2N@P13\4F.* .7\4:Q+;1BPMI5MVDC:6XNWZ6T(ZM[MV ]:^? MO$FO#7;J&UL(WCTBU;;9P'EI6)YE?U9C7L_Q6\*W&OZ MQ8I*]Y;L!Y<1QYJ M9Y4CN.]8GPV^&LEI<)K>N0;95YM[5A]P_P!X^]2QFQ\,? W_ C]B-4U"/.H MW"\*W_+)?3ZUZ*,8I!GO2$]N],")YA$DDCG"+DDGTKF]$W7^K76IN/E!V)4F MO7TES,NDVAW2.?WA'8>E;%E9QV-G';QCA1R?4]Z\R_UBNDOAC^?_ #J7[FF M[[R_+_@EBDHHKU3C.!E&YQZ;J]; I<"F%BK9V5OIUI%:6D*0V\2[4C08 M %5=;U:/1].-PT;32LP2&%!EI'/116F1Q7-^-M)N=5\-W"V%Q);W\ ,MO)'U M# =/Q&10!XYXX\3S1W%UIT-R)=3N1C4[N,\1+VMXSV [FK?PL\#-J]W'K-_" M5T^W/[A",>8P[_05D>!_A[?^)-2W7\$UOI\+YN'D!#2MGD#/KZU]%VEI!96D M5K;1K'#$H5$7@ "DADH(50.F/2E#"FG@G.<5FZSJBZ99%^LK<1KW)K*K5C3@ MYRV14(.Z3'SF6/Y'S[4GB'Q'9>%M'?4KX.4#!%5! MDLQZ"LF8/X?UK[2H/V*X/('0>M)\1;1=5^'NH[,,403(1ST.:Y,)5;C[*?Q1 MT?Z,VKP2?/'9_P!6/+]=^*>L:S%=:5]FMHK6Y7(9.6"_W:XB]PL<4RKCRW!_ M U I"E)% W <4LC2/"T9?*L,?2N\YRW(GGVTD6.H./:H[:8/ '<@97GZ]Z2. MX\L+D%N #BJK. LB@81FW#VH /,"1F-2=NX[3[5H>'?#NH>*M46QT]">?WLI M'RQCW]ZE\,>%=1\7ZH+.Q4K"I'G3D?+&/\:^D_#7AG3_ OI265A&!Q\\A^\ M[>I- $/A3PEI_A/3%M+- 92/WLQ^\YKH *!UI: (\8)/O6+XEO?LFF&.,_O9 MSL4=ZV)YD@C>60[43EC7+62/KNL-?RJ?LL)Q$#T->=BJKM[&'Q2_!=SIH05_ M:2VC_5C8T>S-CI4,)&&QN;ZFKN#^%+WI:[:5-4X*"Z'/.3E)R?4 ,4445J2% M%)10,HS?Z^3_ 'C_ #J.DFE:F:;-%%WTK@Q&&7H=_3\ZSIXQ)\E9EMX(K:%8H4"(.@%28YK M3#X=P;J5'>;_ \D35J\R48JT4+124M=ISA2'K2TAI,:.G/Y$XYV] :\N=*IAY.I M25XO>/ZHZXRC5BHU'9]'_F='O.3QP*4/GM7+V_B26T80:G \;CC>HX-;MM?6 MUTH:&='SZ'FNFEBZ539V?9Z,RG1G'=:%PM[4;O44S<>.#2Y/I71S&(K'UI < M9ICD8Y(P*H7>LV5BI\R=6;^ZIR:B=6%-=M4Y-2U+6W\JQB,%L?O2'BM/2]&M].3>/GG/WI&_I7#*K4Q'N4M(]9/ M]#I5.%+6?Q=O\R/1=(-C$9YVW74O+L><>U:PH]J6N^C1A2@HQ6ASU*DIRYI! M2'IQ2T5L9C<'UK'UK3!?()(CMNH^48<9]JV&( JNV">JM3#^Y5UCTDOU.ITX5O>IZ/M_D=GN.,XHWCTK,M-;L;P?NYE#?W&. M#6B&##UKOIU85%>+3.:4)1=I*PID!XHW<8Q3<>U+SCH:U( 8 'L*4,!5. MXO[:U4M/,B?4UB7/B*6Y?[/IEN\CGC>1P*Y:N*I4]&[OLM6;0HSETT-74]5M M]-A+RD%S]U >6K'T[3Y]4N_[3OQA!S%&?\]*;8:,]Q?^??R>=(O)!.0/:NF; MA< #I@5S1I5,1-3JJT5JH_YFTI0I1<:;NWN_\A@4XP3G\*VK6\PRK#\CZUS]O;8R9".1D8/8UU!X-0W-K!>0 M-#P#+R/YT[! P%"_08S7;S7.E MQV&G0A(U'S-W<^IK4!/I28( P.::\BQ@M(R(HZDG%)RMJ-*X_=SC%1RW<4$; M2RL$1>I)K&U#Q/9P92W)N9N@"=*SET[4-:E6?4I/)@SE81U-<-3%IOV='WI? M@O5G1##NW-4?*O/]!+FXN?$UYY-ONCLD;YG]:Z2WMXK6!(8E"H@P!1;VT5K" ML,*!(UZ 5(?6M,-A_9MSF[S?7]$*K5YTHPTBAU%%%=IS"TE%!H **/PHI#,Z MYB(GD([L35<\&M&=?WK_ %-5F6F(@#$&GALTC(1TIAR/K0!-Q1@5&K$=:=G- M #@:JW%A:W0_>P*3_>'!JS32P0%F(5?4G%9U*<)1M-)KS-(RE%WB]3,.A-$< MVM[+%Z#-/6UUU?ECU('_ 'C4LVKV$!PUP&/H@S4'_"1V8^ZDS?05Y52&$3TG MR^C?Z7.R+Q+U<;^J1-_9VNRC#ZFH!]#2KX7WL&N[V6;UYIB>);0'YDF4?2K\ M&OV$V )PI/9N*4*>#D]9\WJW^M@D\1'[-O1%FRTNRL>8+<*W]X\FKAYIJ2+( MNY6##U!S3J]2E"G"-H*R.*4I-WD[L*6BBMB HHHH *0BEHH 3 I:**5@(IK> M&X39-&KKZ$5CS^&+1VW6\DD!_P!DY%;M5+C4[*UXFN(U(_A!R:XZ]/#RUJ)> MNWXF]*=5.T&S(&BZO#_J-3) [,31_9_B%N#J"X^O_P!:IY/%%@APHE?Z+3!X MKL_^>,X_"O.:PB=E-_>SK7UA[Q7W(B_L"^F/^E:G(1W"YJ[:^'=/MR&:,S/U MW2?X4R+Q'ITIP9&3/]]:TX+F"Y&89DD_W3732IX1RO&TGYN_YF52==*SNEZ6 M)0BKPJ@#&,"EQ117IQ.(****H HHIKMM% $4C9-1$BG,V3FHG8!2: (+B3 V MCO5=(Q(VT\@]J'8LV:M6L6/F/X4G;J%[;%:?0+&Y&?+,3_WDXJNN@WD/_'KJ M<@ [,36Q)<06Z[II40?[1JE+XBTV,X$C2?[JUY=6EA$[NT7Y.QVTYUVK+5?> M5OL/B$#Y=07'N:#H^K3C]_J9 /7:34G_ E-F/\ EA/CUQ3D\3V#'#"1/JM< MZ6$D[.;?S9K_ +0M>5+Y(;!X6M%7;Y;[S@ Q28&<]*R MJ4X5%::NBXSE%WB]3#&@7%N2UAJD\7HKG(IWV;Q*G":A;N/5E_\ K5MW53_>/)_.K>:3G%-60 M$X[UUTZ<*<>6"LC"4I2=Y.['XI0 *3.:7-62+1110 4444 %%%%(8RX7YR?> MJ[+S5R49S]:@(_.F(K%:84SVJ3^]7'B<2J222O)[(Z*-'GU;LNHL^K.TOD6$1FE/&0.! M4T/AR[NR)-2N6 _N(3N=/+;0.GS0Q MGV*BL^XT#3[@/6=+GNGM8=0MGG0X:,2#(-7\'WHG0ISTE%,(U) MQ=TSEY-!OM/8RZ9=L1_SS<]:?9^(/WHMK]#;S],D<&NE(R>G-4-0TJ#4HRLT M>&_A<=17&\/.E[U!V_NO9_Y&RKQGI55_-;DZN"H.1S[TZN6CN+O0;L6EZ2]L MQ^23K@5T"3JP!!!!'!'>NG#XF-9/I);HSJTG3L]T]F6J*:K@]Z6NLP%I#1FB MDP$].:H:CJ]MIJXD.Z4_=C7J?KZ56UC5S;NMI:+ONWX '\-&DZ"(2+J]_?7+ M17BL+6' C@C4>RU M(8(L8\I?^^14@!!R>E*3QUKJ5&"V2,>:3ZE"?2[&,_\!K*N?"L8/F64 M\D$G4#/%;=Q>VL#!99U5O3-1C5;(G_CY6HG@:4U\!<,3.&TC 74=2T>01ZE& M98>@E7M6]:W4%Y")8) ZG\Q4Q$-W$1\DL;?E7-WNF7.C3&]TTDQ=7BZ\5QOV MN%UUE#\5_P UO3K>4OP9TO:BJ6FZC#J5L)8CAOXE[J:NYKTX34XJ47=,YI1 M<7RL#P*@D;.:D=L"J['O5DC2>*J7#\;1UJ=V 0GM67=W:6Z&20]>@[FIJ3C3 MBYR=DAPBYM1CU'O)'"N^5PB#J34"W^H:HYATR$QP]#*W^-&G:1-JLHN[XE83 MRD8[C_"NJA@CAC58D"J.@ XKRU[;$Z_##\7_ )([/W=#3XI?@O\ ,P;;PM$3 MOO9Y)Y.XSQ6I!I5C;C$5M&/JM7]II1FNJGA*4-HHQG6J2WD1&"(#B-/^^:BE ML;69<20QL/=:M'ZT?C6KI0>Z7W&:E+HS"N/#%A-DQJT#]BAK/-OJ^A@O$WVJ MW'5>^*ZK>I/WU_.D)0G[Z8^MSZ?IIGMP/-,J1C*[OO'' M[FM"J>J&Q%@?[0R;? MI$\4P2KO6RF$: &9BP'EY;;T[\U;-IHRV3R-;*L5"Q!,A#8!]JK>)_ M$5SH.GV=X+0'S;@121,WTLI;6D]TUL8/W\07YB(]3N[[3[==J">217,<.\X5$;N>/O'FH8='T&>PO M+=-6G:U,HL[A"!]X=$/&1C/%316FE13+/!JMZ&@B,QD1!A$9<9/'<*/RK5RI MVVU]!:D#>)]5.F)>&18Q-J/V12;;(5=S#*\Y8\5IZ/KM[/-J$>J01PK9P)*V M!@\ACD^F0!Q[UF+I&D64,$AU;5$C>0W2*XR%(.2^,?*,M^M69_#FF7ZW6K2Z MS?-&%V7$@IF)XTU2?3XVAMX)+TWR)Y !&Z!P6&,_P 6 M!CZBK">*+R\UZ&VL64VTLSH'CA\QPH16P03P06(-73IFD7NIZ9.VKW#W/UJ)A4S?>/UJ,\4P(F3(Z4PKQ4I;-5 M-2NA9:?+/W POU-1.:A%S>R'&+DTEU,75))=2OETNU.!G,K5TME90V-JL$"A M5'?U/K63X8L#%9M>2\SSG))ZXK=13DUY^&IN?[ZI\4MO)=#HKR4?W4=H_B^I MRWC'QW8^#[FSM[NUFGEN@67R\< =:\UU7XLZU>7OG:2Z6UFC?NXV0%F _O5H M?'B-UFT2Y5&POF*7 X7.*\ACG"L64Y!'(KTCF-J^U2[UVXEU&_DWW$[98C@# MV [53M,"RXXPQ_G56"=D18V;]W3X9RL!0*,[CS0!9L7,)D=7*21R[@P/.>H- M=#+\3/%D=Z\ZZF2%B 5-@V<>HKD_XW;/#'.*MVFF7FI-LMH25/!=N%%-1BV<3R -%$$9QP,BEN M/%!LL+#<2R2$X55YR:ZOJK>S,/;KJCN]0L8=1MW@E7((X/<&N6RNGTRZ M/S*?W9/>MO0+FZNM(BFNQB9B<@C'%4?%%@6@2_AXEA;G']VO#Q=-T9>VI[QW M\UU/1P\U->SEL]O)EY)2*G68]ZS;2X%S:QS#^(<_6IPQ%>A"2E%26S.:2<6T M^AH!P:H:OJ2Z?9&08,C<(/?UIRRD&L>%3K?B(EN;:U[=LUR8RK*$%"'Q2=E_ M7H;T*:DW*6T2[H&E&$&]NOFN)>.&,O(X4#UKG[[76;,= MKD+_ 'SUK+NKR:[?=*Y([ =!4%=M.@HZR.:=5O1"L2S%F.2>I-)0?<\=ZS+S M4^3%;]3P6_PKI2OL8MF@WB Z,2T9WD?>CSQBNPTO5(-7TZ.YC1E#CE''(^M< M-IVAR2H9YTRY^Y$W\1]ZYH>/-3T_QI'ING6#M#'(%O9)D(+^T:]L=JX<2Z;= MEN=5)22U/0;Z!]"U);ZV'^BRG$B#M711RK+"LL9!1@"#[4EQ E]:/"Z861>X MZ5A:!WD^QZ,OWU+F^U'\NYMNV343&G$U!* M^U237JV..Y7NI5522>!R:S=*LFUF_-U./]&B.%7U-1ZI))/)%91?ZR9N?I76 M:?:QVEFD$8PJ#'U->75OB:_)]F&_FSMC^YI:7..U>DCC%INX4V298T+N0JCJ2<"N3UCQE'&&@TX!WZ&4_='T]:F4XQ5V:0 MIRF[1.@U#5+/38#)Y^@KAM7\3W>H[HH,P6_H#\S?4UC3SS74QFN)&D MD/4L?Y5%T.!7#.O*6BV/7HX2%/66K';Y.GFR?]]&CS'/_+63W.\TQV5$+,<" MJ1>:^F6WMHV8L<*JCK6";VN=5HI7-&S\57&B7J?9RTZNN+GL[#PE9OJ.J2QQNJ;FF;D+_LH.[5T7@'QJGBR& M94TVXM$C&Y&F()D&<9QVKJ>']K2<9=?O7F>36K1552AT_$W='U#^T;-7?B9/ MED'O6C7-3@Z+XE211BVNN#Z9-=*05P#3P=64HN$_BCH_T9AB*:BU*.TM?^ + M534K?[7I[P>1'.6(^21BOX@CH:MUC^*-6ET'0Y-1AC\TQR(&3&203@X]Z[U% MR=EN&-0N) ]U=^2+GRLMA.>X'0FH!XHU2;['&BQ@W$T*$QQ;S MAD+$@9]15^RF%T;FF:,=+TFYM_+@FFED9LR$D."> QJ+5M%N+[6;'5+::-)K M.$B-'Y4L2,@CTQW[5ES^(=7@L]:N/,3%C.((\VWRD94$YSR>>E:.BZMJ$^JF MTOXT6/R'E5]FPNH8 -CMD=J3IR2N%R"3PM=_)+#<0I,]X9;A<':Z$Y _W@>] M/@\,S1VMXDDR>;-8K;1LI( (!!S^=91\:7\UGJK6:6S7",KV"L" \9DV'=GJ M<^GJ*DN/%E[<78AM(E0F6&)U$7F21NRMO7;GJ"OY4>QF@NC9BT)IY=.%XJI# M;P/$\4XXZ5'_ &/J'V*;3_,ABM)+PS-+&_S&/=G:!CKP!4EM-JC> M*VT^:[B:U2T6XV^1M;)8KC.>.E5+OQ/<+,D=M8@;;Y;:59Y 'V'.6V]1TX/> MA0;VU"Y)%X MMR?[O4&J=QXPEN[*5=.M9(Y3.D:2N M05P9-C>P/H*?LIOH%T=,AV2X[5;!XKE3XJ$L>]-,G)2)YGS(H/EHVTO^>>*A MN_&K#37FL=./ MEJZ(USKCS_&D2GI$F?TKAQNL%!?::1U896DY=DV=)%&L2JBX 4!0*D+;06/ M S1L!)ZT.H92OJ,5VP5M#E;,*[UW3KJ-HQ%'=H>"K*"I_.O-?$'@;2]7N&GM MK>.QD/\ # ,*3]*U[OP[?VD\CVQWKO)&PX(YJJ-3O;-MERA..SK@UZ<*-.WN MZG)*_<'']_A1^'>NEC M>RT]1':0K(PX#$8 ^@HMM(US7)DN+EOLEH.=C?>;_P"M5RYUCPMX5N$@O;Z# M[<1D(YRW_P!:E*=&BO,<83J"P:9J.J,&N&,4/7+<<>PK*\5ZU8>#C!%;VLM[ M>3IF)8QR3[M_"*Q/$'C>^\0L]CI2O%:GAI!D$CVJ'1_"4TJ+(T[J5(+.3G]3 M7E5\R?VM%T7<[Z.#O\/S?0]<\":SJ&N>'%N=2T];*4,55%8D,/7FNCFA6:"2 M*3E74@BN:\/:C,DJ65Q,TL94*CN #D=JZGVJ5)58;"G!TY6..T.0H;JS;K%( MLDJMMXJNT X89Q^M:2N#7/@6_9\C^RVON-\2ES\W=)_>,NIOL]E+*3] MU3CZU)X4MO*TPSD?/,VXGVK/UUMNE.!U9@*Z/2T\K3+9/^F:_P J3]_%Z_97 MYA\.'O\ S/\ (N#@=:@N;R&T3?*X ].YK,\0:X-%CB)C8^:2 X&0#7*-K$%W M)ODNKV%Y&I<7LMZXBA!V,< +U-;>DZ&(7629=\YZ+V6BVLK3P[I4EPZ22^2F69 M$+-CT %<;<_%HZCI\EGH&F75K?R/Y333@97M\H]:XZV(;]V&ATTZ27O2W.E\ M6>,%T)O[+TG;<:S+\C,OS"#/;W;VJ_X'\%OI@_M?5RTVIS?/\YW&//K[U7\ M^ ?['4:MJ@\W4I?F 8[O+SU)/=J]$"\9KB-MQO>N5U=?L/B.VNAPLWRM_*NJ M*]:YWQM<&.C^[YUO%IG3AG[ZCWT+[\$BJ=P^3M'-2F3,"MGJH_ ME5-B=K-WP37;S?N^;YF5O?L0:,@O-?EN&^[ ./Y5UR#:.*YGPC&#;W,IZO)C M-;UQ<):VTDTK;8XU+,<=!7%@E^[YWO)M_B;8CX^1=+(L$\UCZMXAL]+4J[>9 M-VC7K^/I7+ZIXSDO T.G,(XCQYA^\1[>E MLS2U77+S5GQ*^R'M$IX_'UK,QVI:3D\]*X9-RW9ZL81BK10O:H9IDB&6Z]A4 M%W?1VZXW@$\9]_:G>']$O]>NFGD!@L\XW-W^GJ:<8.3LB93C#5A9V=YK-V(H M%)]6/W5'J:]!T?0[;2(&*%=^W,MP_&!W^@JG)K'ACPJT.GW6HVUD[C=M=LLW MN:Y;5==U#QUJ0T/0XWCTT'YFZ&7_ &G]%]N]=]*DH>IX^(Q4JFBV)=?OU\A:19QW%G&^YKB5,[B.I'HH]>]>C:!H%KH&GK!" 92/WDN.6/\ A3?#7ANS M\.:<+>W4-*P_>R]V/^%;.VMSC,#Q3:^?I9E'WX6# ^W>KFFW/VO3[>7.=T8S M]1UJS?1"?3[E&YS&?Y5C^%6WZ.!G[DA KS_@QBM]J/Y'7\5#7[+_ #-NJNHV M2:A9BWD=D =7!4 G(.1UJS3)2^PF,*6[!CQ7HM\NIQF#'X4MH8G1+^Y"2HT3 M*57!5CDC&.!DFBW\)6]J83#?W2-!M\O 7C:-H[>E)J&HW)D2.2(0F-MQ&>M: MEE=7%V!(UN(XL<,6Y/X5Y]#-8UJLJ,;W7E]]_0Z)X>48*;,K_A$86GGE;5;X M_:'\R12PVLPQSCIG@4Z\\+IJ%RMS-JU^TJQF,,K!W5LCJ8%V M,,+(&Z57TN]NFB6WCB$NSDN6P!2GFT(XA4;N_I_P!JA+V?M!LOA:&?[,LFH7 M++; "$!4&P<<=/85'-X0M;BZGF;4;Q+B619'DCVHQ91@-P/0FMJ[DN(8A)# MD@'+#=@CZ5B0ZK.;UY4B#F7Y?+ST]*K$YJJ$XPE?5]NG_#BIT)5(N2+2>'6B MN1M5V\*0N\DDFJWC2RNK&1BI;*G*X..,'M6RCW)M M]SPH),<*&X'U-8NH7]RT\4;PB%HGWD9ZT8G-/JT%.5]?+\ I4'4ERH6'PC;0 M2B1-0N]RN'4':0I!R-O' SS@4H\+1*),:G> 22"4K\NW<#G(&,#FM2RNKB[) M=[=8X<=<\FJVH7]S;*ZFW4(PPL@.:UGF:C0]OK;T)C0#K:X6'=J- MWMB!V;=HR"[=ZNZ7?731+;QPK($ZNQQ M@>]:4R[&#?RJ\)CWB::G%LFK2=.7*R6"(001PAF<1J%#.>3CUJ6F(=RBGXXK MH,PS1129!Z&@!<44E% R8_>/UH-*?O'ZTTT@&GK7.H=GC=L_Q1_TKHZYG4P; M7Q197!X60!2?TKSL<^6$)]I+_(ZL+K*4>Z9UBD5!=-*EO*\*[I%1B@/UW6?LT@L89VCFD&6=>2E=M2HJ<>:1A3IRJ.T3PW5/'_C^TUM[F5[?QKM]%^(>E:S%':ZG;K'=D?/Y8+Q@_7J*R=7\&W=Y?/?37TMXC< MD_Q#VKFKOPG(DQET^X83+SASM8?0UQ+')NR=F=CPKRZ%IE[&TEJ_E M\<&,Y'Y5)#I^DZ*/M$BJT[#+.P!8UY!:^*=,[B2VM%>&WSAB#Q_P ";O\ 05TRQ=5PLW9=[Z?YF"H4^;1:]K'=^)/B@L$C M6>FX>3I\IX!]S_05R-OI%_KU\-0U",-,W0[,''M_]>M7P[X.@LMLCCS[CJTL M@X7Z"NRCBCMN(\,W:Q(I:&U4_*@[LQ_A4= MV-:4,,YOF85J\8*R^XOZ1HLCR1WEWNC13E(^Y]S73#K]:\GT7XF7MWXRMM*^ M74+:=BDDD2;55O\ IGZH/4]:]9XYKUH14%9'ESFYN[./N1O\6W&WG"<_E5L9 M4]ZJ:6QN]W;.2J[3^%*.F,E?K%?@P>N'CY- MD'B;2QJNE^7OV,C!@V,XKAI/"]V!^[EB<>G2N_\ $.J#1-!O-2-JUR((RWE* M<%O:OG6?XL^-4U22?[%:I:R-\EN8LJH[?-U_&O7A7G35D<4J<9;G?R:+J,!_ MX]R1ZJJ^@^M:LFFW2#F,. M/;FNA8V75&3P\7LSS=-%N?$$T8>9A;J?WI_O?C_2NYTO28K6-;:SB" #DX_G M5JUL9&E=/+\I %W+R.?+GN(N68GC:G^-8UJ\JFFR-8 M4XPU6YH>.?B$+1Y/#WAIS)=N=EQ=1C<5/]Q/5O?M6S\/OA^NC1+JFJH'U%QN M2-N?*SW/JU5?AG\-AH4":OK,8?4W&Z.-N1"#_P"S5Z?QU)QCDYKF*W(+Z\M] M-L9KRZE$<$(W.Q]*\CUGXE:Q8Z[;BWPS2N&>R91B.(\*I[[SU]J9XZ^(,4VK M+;16\DUA;AFM\C$=Q< X#'U13^9%9GPP\-R^(/$4FM7Y:6&W?S&=O^6LIY_2 MBY1[K%(9H$D92K.@8J>WM6)XN/\ Q*T ZF05O]3^%T]ZZE'] MW;RM^!G?]Y?^MRCX0Q_9\J]Q*%V\B]U"T)P0^X" MNC!!)Q7+@7>BEVNON;-<3I5;^?X'CEUX7U:UED LV=%8@,ASD50DMKVV.)(9 MXR/5371>.?BOI/A?5/L5I:S7]TK8G"_*D?MGUJYX-\>VOCB1X;+2KV-HQEWD M0&-?8MZUH\-'H=$YN'CM;&!@I;NZL]*T^34=3F6"TB&23W] *\=U/7=9^* M'B./3=-B:/3XV^2(_=1?[[^_M75"FH;'G5:SJ,EU15^(OBV,Z7I4,2(?EE9/ MF8?WW/IZ"O8O#?ARR\-Z<+:W&Z4\RS$?,Y_PI/#'AFR\,Z:MK;*&E(!FF(YD M/K4VOZW9^'M'GU*]?9%$N0HZNW91[UHC!(K>(_$2:''%'$JRWDV2D;-A54?> M=CV4"LWP7XZMO&'VJ*.%H9[8\]U=<\,/KZ5XYXI\52:IY@CG\VYO@&NY%Z1I M_!;I[#JWJ:]=^&OAC_A'_#:37"8O+L"23/4#L*91U\[8M;@G^X?Y5@^$QC2& M/8RG%:6M7 MM(N7SR5VC\:J^'H/(T2 'J^7KSI:XN*72+_$Z5I0E?JT:M(>" M,4&LWQ!K,6@:,^H2PM-AU1$!"Y9C@GT%36L M83$KL5'3=U ]*Y4>.YI+&TNH=":2*:X^QOBY7*3;L;1Q\WKD59M M_&MOF,=/>L88%4Y<\86>NO7S-'5X,UO\@889!]TU0U?Q3HNBWB6=_=-',ZA]HC9 M@%)P"2!@"F'QGX;CN)[=M10-"I9WV-L..H5L8)'H*7U&,I>TY+O>^HO:M+EN M;$P,D#Q!RI88R.HJI_95F$1$#))'A@X/S$^]8-Y\0M.MDN[J&)KBTAMHYD** MPD^.U#>)M,BD:*XN0)?,9<1QLP"A]F6../FXHJ895+1G"]NZ"-1QNXL MU[*$6MOY22%HU/RECR!27-E'=/&TK$HASL'0GWK)UWQ+'HTLUJ+*666*V6X) M ^3:7"8R/SJ=O%&C#&ZZ96W;2C(04(.WYACY1DXYI/"J5-0<;Q[#]H^:]]2Y M!910W+30DH&X9!T-3R*&2L^XUBWL;^\ANE,<5O!',9%!8G<2.@^E5K[Q=I=I M82W, ENUB,8;R8R0-Y&.>F>:='#JFK4HV3_KY"E-R=Y/4V(&P=M3]!63J6H_ MV9+8_P"ARR174ZPE\[?+W="0>?PJ2UU5Y-?FTJ>U\MTA\Y'64."N<LZ#]Y VX?2MPTV1%DC:-QE6&"*Y\11]I2E'N:TI\DU+L5=-NUOM/AF4\E M<'ZBN#U[3M1AOIKFX1F1V)#]L=OI6_IDK:%JTFG3-B"4YB8]!75,HD0JRJR' MJ#T-<=&V(IVYA"MV=.#7 M3:GX1M;DF2SQ!)UV_P )_P *Y>;3;O3IMD\97T)Z'Z&N6>%J0\T=D,13GKLS M-OO#KO&RQ&.Y@[(XZ?A5>RT=;>$!T2")>D:#%;JO*C#'Y&LZZ9S,_7?G\JPE M"R_0Z(SUO^)')*JC9&NQ!Q[FKVE:9=:G.L<,9 !^9C]U?KZU/HWAV2_S=7+^ M5:H,M*W&1WQ_C3==\46EIHKFUN#IV@I\C7:#]]=GND _]GKKP^$:C<']Q:\?Q'NWHHKQ>;7]9U:*2S\UIGNYB9 M95'[V[Y^4,>RCLHXHU;6[OQ!-;V-O:&WL4?_ $33HNQ_#KX M^2PTR>8L V,#ZFKV\*Y!/-A M34IW>RU99T&T-OI@=A\\IWG^E:&",\58VA5"J,!> /:FE>*Z:%+V=.,%T,:T MW.;D^I7>,2HR-T8$&L[PO<&WN;K3I3AE;<@-:^WFL/6(9+.\BU6 >R<]-C;E_(UV=G=QWMJD\1!5AG'I[59CR4)(QS7;&:G%26S,)1:=F>':C\& M=:LY#-I5]#/CD8)B>LAK_P")/A)L22ZDD2?\]5\Z,_CS7T6!BFL-PP0"#V/( MJK$V/FG7?BKXKUC1O[(Q$DD[;&DMD*R.#_#CMGVKT#X6_"]-!CCUG6HUDU-Q MF*(C(@'_ ,57HC>'](>_COCI=K]KCY27RQD5I(((K6#R]^(+ M*U7[L$0Z#^I/K7T?X;T"W\.:#:Z;;@'RU^=_[S=R:XCX4>"6TJS_ +--;1U?Z([*:]E2E4>[T7ZLT;:/<^3T%: Q4 M4,810*F (Y'6O5.$Y^Y<:;XFAN\XAG^5C[UU2?*2?6L?5]/&H:>T8'[Q/G3Z MTGAW4C=VAMYCBXA^5@>I]Z\NF_J^(E3?PRU7KU1VS7M:2FMXZ/\ 1G.>)?AK M%K6H3WMM=I'),=S1RQAES7&OX'\8^&MSZ0TJ)G]>X+S]:4 BO2 M.*QX9%\1?&>B.([\+,!U6[@*,?Q%;5G\8[210-3T616Z[[=PP_(UZE-:072% M+F"*93VD0&N8U/X:^&M2W,++[+*W\=NVW].E :GCNI:KK_Q6\3I8V2-':1ME M(OX(4_O,?6ODK9V:9D(S-.P^:1O?V]JE\+^%--\)Z?]DT^,Y8[ MI)GY>0^YK;89Q0/U(;BXBMH)+B>18X8U+.[' %>,>.O%0N(Q>SQAGN%9-*L MI!Q''T-PX]3_ BNC\9^)[22WN9+ER=%L7VR*IP;VX'2)?\ 9!ZUX[!'JOC3 MQ.-P,E_>. 0OW84[ >B@4AHZ;X7^$AKNN+=SIG3[([F)'$DG85]" KMZC K) M\/:#;^'-$M]-M%&V,?.V.6;N:NW5U%9V\DLK81%R??VI2DHQN]AI.3LC"\43 MFXFMM+B.7E;<^.PKBV^\WKOE2IKIOZA6=KVFW&L:-+8V\T<+R8R[IN 'TK1[UC>)WECT@ M&*>2'-Q$KM$2#LW?-T]J]2%^96W.4Q;#P7?:9%=6_>2,,%V] M_2FZQX(OM;NI;F[N+4W#N&#@-\B#C8!V'?/6LQKZ_MF BU&\DC,!^.3C/7M74E-._,K^@M"37/"NKZW MXDBWZA90V[6?DLD+G=*BMDJ0><>]2?\ "NKP3/LOH%M@7:WML,R0,XPS#/7\ M:S(8HX[LR13744D,5TRN&?F1F!7!QR#Z5N:1K)CGU3[3=3L9( 8YIE.&2SCUFV+3VAMW7>274-N#8SQM/0#BB\ M\$/>:?<"YUZSDBENDG:8M]V0+M8 _P"T.HIXO-*OX]&AA:94ABQ<$0E0 5(8 M[\9W GI[UG*;6"[%X1+<:>,P+;-;E6.(]HD* 8Z]^O>FIU'JWKZ(7*NQT.F> M"KW2M>FU>S?3AYH)6 QL40D 94]1P*23PM?Q?;?-O;!!=*V5;=\H+^8V.>>: M8U\(;318%OY7-I9OYJ1LZ+)*JKL5CCUS7/VT]S=2V]S=SWFZ&><6Y<.&0/#Q MG_9WY&34)3EJW^'W#T6AU^I:!JVL3BY:YL566 0ML#D.@8.I_.J=QX.U$ZB] M_OTSSY)6DEWQLP()!QSTY'6LA-3U 6$EY'J5TESYC)MF9E1(O*'.",#YAP?6 MDM]?26X=["^U">VCNH]L,KL0R[!ORXZ ')]#2Y:B7NM?<.Z-_5?#VJZS<&Z- MYIZ;T5?W:LRMMS@\\'J>*KMX+U%K80_;+(*L"0)M5E^Z006Q]XY'>M7PT\-Q MHKM:,1:_:IC#D$83<<=:UEVMQ%<,TCE8SYA8^K'J!T K=W!E/S5 K%),5/.[_I570]:)8V%]E+E#M!;^+_ .O6Z1GO69JNC0ZBF\-Y5POW M9!_6O.KT)QG[:C\75=_^"=-.I%Q]G4VZ/L:V_P!*9+%'-&4E174]01FN7M=8 MO-+E%KJL190<+,/\\UTD%U#=1!X9%<'T-;4L53J:;/JNI%2E*'FNZ,6^\-@Y M:R?:/^>;GC\#5;3O"K-=M<7X&W/$8/WOK74CITI_:M?8P;YK![6:CRW,O7K( MW/AR^M(,(S0,$P.,@9 _2OF4MX@\9ZW&D@:\OA^ZCAC7$<"CC '117U:K75Y;V<9DFF6,>YKG+C6+W693;Z9$R1GAYFXX_I7)6Q5.G[JUEV M6YM3HSJ:[+NRQK6KO+,=.T_YIW.&8=AWJ]I6FKIUJ$SNE;EV]32:9H\.FQ%A M\\[?>D/6M#D]ZSH4)N?MJWQ=%V7^9=6I%1]G3V[]Q,9I"!3^U)CG->BXJP128XI-*6XT[;'+Q33>&[[8X9K*9N#Z5UT%Q%-"LL3;T M;D$52GMXKJ)HIE#(W8U@>7?Z!(7M]UQ9D\IZ5Y:4\(WI>G^*_P" =FE9*^DO MS.QWCTH# ]B*R=/UNSU% (W"28YC;@BM+/3 KNIU855S0=T5+R %XC$<,>.5^A%>:?#3X=3:C>QZGJMJ\- MC;']W!(N#(P]1Z"O>7R /K3/,5 =WRJ!WXI-VU&+O55 P!V'853U+5(--MC M)*WS?PIW:LS4?$<$),-J#<3'H . ?ZU0M],N+RX%WJ3%GZJAZ"O/J8EU'[.C MJ^_1?,ZH4%%>TJ:+MU9#903ZA=F^N1\S'Y%/:M^&((.1S3HXU4# P*F4>M=> M'PZI1MU>K]3"K5=27D*M/&3Z4@%.'6N@R%&?:N?U>QGM;L:G8C#+S+&.XKH< M4>QZ5S8F@JT.79[I]F;4JCA(@TO5+?4;<21$!P/G0]0:O[QC->#]*L:;XDAG(ANQ]GGZ'=T)KDI8ETW[*MI+OT9K.@I+GIZKMU1T1 M8#L:7!J(.& ((*GN#FI,GM7I)W.47ZTUQE<>M./2FMFF!\S^/K358?%?]C7$ MAGAMB?L$4:XR'.%]+^TW:!M4N5!D/7RU_NBNOGTRQN+Z* M\FM(GN8QA)2@++^-07^M66G*3(P>3LB\DUE4J0IKFF[(N$)3=HJY>EN(XHFD ME8(B]2W:N6GDE\37_E192PB;+-_>I?)U'Q'-OFS;V(/"="?\:Z*VMXK2W6&& M,*B] *X'SXMVV@OO?_ .GW:*[S_!?\$=%"D,2QQJ%1!A0.U/QSFEI,5Z:BDK M(XVV]6!JKJ%_;:9:"ZNY/+AWA-V.A/2K6*IZKI=MK6GFRNU+0EU<@=]IR*8% M-/$^FM// ?.CF@$9:-XL$A^A'^>*;+XML(XIY3%ETUO(D\;JPCR4!!8XX&/3(JQ>Z]965Y<6TK2>;;VYN7"ID;1U /K[52;0; M"?[=#%=9O9Y5DEF4#>C+C@=@.!Q39/"%K<.\\UUR.6>Y! 9@1C;CIMQ2: M3"Y,?%6FJ]M'$'F-P$,81 ,[@2.N/2K-KK4=TMZ_V:X@6T3#P\F1A2/4U&-6L/F_XF%L-J"1LN!A?6LY/"\0TRZL_M:L>2)HQ+"P>-NC+T- #= MV2.:MH %JHD9#\C%70.!0 448HI%$Y^\?K24I^\:2F(0T4M)2 2C%+10!#/; M17,9CGC5U/8BL*7PT8Y#)IUT\+_W2([$8>!+E1_%3_\ A);]!^\TM\^V:Z#!]:7)K#ZI4C\%1I>=F:>V@_B@OQ.= M/B/49!B+2WS[YIK2^)+T;5B2U4]_2NC+''/2DSQP:3PE2>DZC_(/;17PP7XG M/V_A@-)YVH73W#_W0>*W88(K:/RX8U1/0"G GU-+752PM*E\*U[]3*=:<]V& M*,445T6,0I"*6EI@,HIV!1@4 ,VBD*C&.M/(%)VI6 Q[W0+2[;S$!@E_O1], M_2JBV^O:>?W%PMP@_A;K718I,"N*>#IN7-'W7Y:'3'$S2Y9:KS,/_A(=5A/[ M_3,XZES#;6M MK5"VEZE?L#J%Z0G]Q370$?6F8H^I*7\2;EY/1?@/V[C\$4OZ\RG9Z=;62_NH MQN_OMR35L+UI0*IFC3-0L3G3[TE1T1S4R:OKULH$VGK*!_$HK1W=;:+N%J]8^';.U822YGFZ[GZ9K4!)ZFEQ M5PP=-.\[R?=ZD2KS:M&R7D&.,#@48I117F AK)\1VMS>:9'#:+O M.87$;;T/*J,Y/- &3_PBUXENV+Q M)I"RYC>1PNT+C&1SP>1ZTLGAC4\@#5B?*_U1+'/S#YR?7GI5*ZO_ !#81;K@ M/')(R[#$BDROP.1Z8SG%2O#XLM((XK61GC=@SNZ@M'ECP/4=*!,?#X1O/,?= M<11P32;Y889'Z<=^ISBG:?I&J6GB:T\PR300@L]R2P&W;@)Z'%3VR:\VMVSW M+W)MXIV#E5"HZE>/EZX![U'+_P )#_:AFS=R0PS2;%3:JR*5^48/8'O0!6G\ M*:RT-Y'%JH,EQ/Y@D=R=HR2"!V(SBI9_"-U=JS3W$?GIYC1W =][LPPK$=L> MU-MF\9/:B:3*S1G"Q,JXD&3RQ^F*BSXH@<&V@NG,MRKN\^W[NT @CL,YQ0(U MM1T;4;J_:XBN8\_9U6-F=E,3@Y) '!#=ZSI_"VH7*RM=3V\IE!9U=V*@[PR@ M>@[$T_[-X@?4].CN9+B2..2.21E"A,8._=CN#C ]*9JEIXCU%KRU9[B.$S#E M-JIY8D7&T]>5W9H D?PI>S2/YMXJHS[G*2/F;J1N],9 X]*:?".HJUJL6IN( M8V#.@D.2VT L">^0?SK0OIM9AU.8V\<\EM%Y9CCB12LB<;P2>=W7 K-D'B6Y M0><;R//ER8B"KLP_*^^1UH M3^&+DZ+965O?O#-$Y\Z8.Q,BM][\>F*I_P#" M&7LA#W-Y'M "44?C12&6#]XTE2[1GI1M'I0!%25-M'I2%1 MZ4 14"I=H]*3:/2@".DQ4VT>E)M&>E $72BI-H]*7:/2BP$1Z4G:IMH]*0J/ M2@"*EJ3:/2EVCTH BH_"I=HQTHVCTH @I:E*CTI=H]*8B&BIMH]*-H]* (:3 M J?:/2C:/2@"OMI*L[1Z4>6G]T4 52!CI3<5;,:?W12^6G]T4 4L<6 MG]T4HC3^Z*0%, 8HVU9\M/[HH\M/[HI@5PM+M-6?+3^Z*7RT_NB@"J.HIW>I MS&G]T4HC3/W10!#BBI=H]*4J/2@#-U!MM#_<_4TB1I_=% #:*DVCTIVT>E $)H[U-M'I1M M'I0!":SM9N;JSTUI[10\JNORE=Q(SS@>M:^T>E"J/2@9R5OJOB&]N9(UL(8, M3;4:9"2BX/)^N!S[TT:YK/V@2R6+012 *&,;/Y8#89BHZ\]/:NP-,+'/4_G2 M$3$&\N$JAR3ZGV(YK=Y'0U,Q.WK2%1GI3 BR<=:3)JQM M'I2;1CI0,@RQYHRWK4Y5<]*7RT_NB@"N"W7-+N8XYJ7:N.E&U<]* (E(1".OI2YJ GRAPHIC 23 ex4-26_001.jpg GRAPHIC begin 644 ex4-26_001.jpg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end EX-101.SCH 24 jfbr-20231231.xsd XBRL SCHEMA FILE 995301 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 995302 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 995303 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 995304 - Statement - Consolidated Statements of Operations (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 995305 - Statement - Consolidated Statements of Changes in Shareholders’ Equity link:presentationLink link:definitionLink link:calculationLink 995306 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 995307 - Statement - Consolidated Statements of Cash Flows (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 995308 - Disclosure - General Information link:presentationLink link:definitionLink link:calculationLink 995309 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 995310 - Disclosure - Other Receivables link:presentationLink link:definitionLink link:calculationLink 995311 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 995312 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 995313 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 995314 - Disclosure - Investment in Affiliate link:presentationLink link:definitionLink link:calculationLink 995315 - Disclosure - Other Payables link:presentationLink link:definitionLink link:calculationLink 995316 - Disclosure - Short-Term Loans link:presentationLink link:definitionLink link:calculationLink 995317 - Disclosure - Derivative Liabilities link:presentationLink link:definitionLink link:calculationLink 995318 - Disclosure - Loans from Shareholders link:presentationLink link:definitionLink link:calculationLink 995319 - Disclosure - Taxes on Income link:presentationLink link:definitionLink link:calculationLink 995320 - Disclosure - Share Capital link:presentationLink link:definitionLink link:calculationLink 995321 - Disclosure - Share Incentive Plan link:presentationLink link:definitionLink link:calculationLink 995322 - Disclosure - Finance (Income) Expense, Net link:presentationLink link:definitionLink link:calculationLink 995323 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders link:presentationLink link:definitionLink link:calculationLink 995324 - Disclosure - Related Parties link:presentationLink link:definitionLink link:calculationLink 995325 - Disclosure - Geographical Information link:presentationLink link:definitionLink link:calculationLink 995326 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 996000 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 996001 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 996002 - Disclosure - Other Receivables (Tables) link:presentationLink link:definitionLink link:calculationLink 996003 - Disclosure - Inventory (Tables) link:presentationLink link:definitionLink link:calculationLink 996004 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 996005 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 996006 - Disclosure - Investment in Affiliate (Tables) link:presentationLink link:definitionLink link:calculationLink 996007 - Disclosure - Other Payables (Tables) link:presentationLink link:definitionLink link:calculationLink 996008 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 996009 - Disclosure - Taxes on Income (Tables) link:presentationLink link:definitionLink link:calculationLink 996010 - Disclosure - Share Capital (Tables) link:presentationLink link:definitionLink link:calculationLink 996011 - Disclosure - Finance (Income) Expense, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 996012 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables) link:presentationLink link:definitionLink link:calculationLink 996013 - Disclosure - Related Parties (Tables) link:presentationLink link:definitionLink link:calculationLink 996014 - Disclosure - Geographical Information (Tables) link:presentationLink link:definitionLink link:calculationLink 996015 - Disclosure - General Information (Details) link:presentationLink link:definitionLink link:calculationLink 996016 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 996017 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives link:presentationLink link:definitionLink link:calculationLink 996018 - Disclosure - Other Receivables (Details) link:presentationLink link:definitionLink link:calculationLink 996019 - Disclosure - Other Receivables (Details) - Schedule of Other Receivables link:presentationLink link:definitionLink link:calculationLink 996020 - Disclosure - Inventory (Details) - Schedule of Inventory link:presentationLink link:definitionLink link:calculationLink 996021 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 996022 - Disclosure - Intangible Assets (Details) - Schedule of Total Intangible Assets link:presentationLink link:definitionLink link:calculationLink 996023 - Disclosure - Leases (Details) link:presentationLink link:definitionLink link:calculationLink 996024 - Disclosure - Leases (Details) - Schedule of Future Lease Payments Under Operating Leases link:presentationLink link:definitionLink link:calculationLink 996025 - Disclosure - Investment in Affiliate (Details) link:presentationLink link:definitionLink link:calculationLink 996026 - Disclosure - Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account link:presentationLink link:definitionLink link:calculationLink 996027 - Disclosure - Investment in Affiliate (Details) - Schedule of Summarized Balance Sheet link:presentationLink link:definitionLink link:calculationLink 996028 - Disclosure - Investment in Affiliate (Details) - Schedule of Summarized of Statement of Operation link:presentationLink link:definitionLink link:calculationLink 996029 - Disclosure - Investment in Affiliate (Details) - Schedule of Activity in the Investment in SciSparc Shares link:presentationLink link:definitionLink link:calculationLink 996030 - Disclosure - Other Payables (Details) link:presentationLink link:definitionLink link:calculationLink 996031 - Disclosure - Schedule of Other Payables (Details) - Schedule of Other Payables link:presentationLink link:definitionLink link:calculationLink 996032 - Disclosure - Short-Term Loans (Details) link:presentationLink link:definitionLink link:calculationLink 996033 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 996034 - Disclosure - Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Warrant Liability link:presentationLink link:definitionLink link:calculationLink 996035 - Disclosure - Derivative Liabilities (Details) - Schedule of Fair Value of the IPO Warrants and Additional Warrants link:presentationLink link:definitionLink link:calculationLink 996036 - Disclosure - Loans from Shareholders (Details) link:presentationLink link:definitionLink link:calculationLink 996037 - Disclosure - Taxes on Income (Details) link:presentationLink link:definitionLink link:calculationLink 996038 - Disclosure - Taxes on Income (Details) - Schedule of Income (Loss) Before Taxes link:presentationLink link:definitionLink link:calculationLink 996039 - Disclosure - Taxes on Income (Details) - Schedule of Income Tax Expense (Benefit) link:presentationLink link:definitionLink link:calculationLink 996040 - Disclosure - Taxes on Income (Details) - Schedule of Statutory Income Tax Rate to Effective Income Tax Rate link:presentationLink link:definitionLink link:calculationLink 996041 - Disclosure - Taxes on Income (Details) - Schedule of Deferred Taxes Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 996042 - Disclosure - Share Capital (Details) link:presentationLink link:definitionLink link:calculationLink 996043 - Disclosure - Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares link:presentationLink link:definitionLink link:calculationLink 996044 - Disclosure - Share Incentive Plan (Details) link:presentationLink link:definitionLink link:calculationLink 996045 - Disclosure - Finance (Income) Expense, Net (Details) - Schedule of Finance (Income) Expense, Net link:presentationLink link:definitionLink link:calculationLink 996046 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders link:presentationLink link:definitionLink link:calculationLink 996047 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 996048 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Diluted Weighted Average Shares Outstanding link:presentationLink link:definitionLink link:calculationLink 996049 - Disclosure - Related Parties (Details) link:presentationLink link:definitionLink link:calculationLink 996050 - Disclosure - Related Parties (Details) - Schedule of Transactions with Interested and Related Parties link:presentationLink link:definitionLink link:calculationLink 996051 - Disclosure - Related Parties (Details) - Schedule of Balances with Interested and Related parties link:presentationLink link:definitionLink link:calculationLink 996052 - Disclosure - Geographical Information (Details) - Schedule of Geographic Areas link:presentationLink link:definitionLink link:calculationLink 996053 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 25 jfbr-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 26 jfbr-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 27 jfbr-20231231_lab.xml XBRL LABEL FILE EX-101.PRE 28 jfbr-20231231_pre.xml XBRL PRESENTATION FILE XML 30 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
12 Months Ended
Dec. 31, 2023
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Financial Statement Error Correction [Flag] false
Document Shell Company Report false
Entity Interactive Data Current Yes
Document Accounting Standard U.S. GAAP
ICFR Auditor Attestation Flag false
Amendment Flag false
Document Period End Date Dec. 31, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus FY
Entity Information [Line Items]  
Entity Registrant Name Jeffs’ Brands Ltd
Entity Central Index Key 0001885408
Entity File Number 001-41482
Entity Incorporation, State or Country Code L3
Current Fiscal Year End Date --12-31
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Contact Personnel [Line Items]  
Entity Address, Address Line One 7 Mezada Street
Entity Address, Address Line Two Bnei Brak
Entity Address, City or Town Israel
Entity Address, Country IL
Entity Address, Postal Zip Code 5126112
Entity Listings [Line Items]  
Entity Common Stock, Shares Outstanding 1,215,512
Ordinary Shares, no par value per share  
Entity Listings [Line Items]  
Title of 12(b) Security Ordinary Shares, no par value per share
Trading Symbol JFBR
Security Exchange Name NASDAQ
Warrants to Purchase Ordinary Shares  
Entity Listings [Line Items]  
Title of 12(b) Security Warrants to Purchase Ordinary Shares
Trading Symbol JFBRW
Security Exchange Name NASDAQ
Business Contact [Member]  
Entity Contact Personnel [Line Items]  
Contact Personnel Name Viki Hakmon
Contact Personnel Email Address victor@jeffsbrands.com
Entity Address, Address Line One 7 Mezada Street
Entity Address, Address Line Two Bnei Brak
Entity Address, City or Town Israel
Entity Address, Country IL
Entity Address, Postal Zip Code 5126112
Entity Phone Fax Numbers [Line Items]  
City Area Code +972
Local Phone Number 3-7713520
XML 31 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Audit Information
12 Months Ended
Dec. 31, 2023
Auditor [Table]  
Auditor Name Brightman Almagor Zohar & Co.
Auditor Firm ID 1197
Auditor Location Tel Aviv, Israel
XML 32 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents $ 535 $ 8,137
Restricted deposit 17
Trade receivables 629 327
Other receivables 597 779
Inventory 2,386 1,791
Total current assets 4,164 11,034
NON-CURRENT ASSETS:    
Property and equipment, net 59 41
Investment accounted for using the equity method 1,940
Investment at fair value 67
Intangible assets, net 5,714 4,452
Deferred taxes 168 110
Operating lease right-of-use assets 127 138
Total non-current assets 8,075 4,741
TOTAL ASSETS 12,239 15,775
CURRENT LIABILITIES:    
Trade payables 709 131
Other payables 1,533 391
Related party payables 66 32
Short-term loans 86
Total current liabilities 2,308 640
NON-CURRENT LIABILITIES:    
Derivative liabilities 1,375 2,216
Operating lease liabilities 45 98
Total non-current liabilities 1,420 2,314
TOTAL LIABILITIES 3,728 2,954
SHAREHOLDERS’ EQUITY:    
Ordinary shares of no par value per share – Authorized: 43,567,567 shares as of December 31, 2023, and December 31, 2022; Issued and outstanding: 1,215,512 shares as of December 31, 2023; 1,153,461 shares as of December 31, 2022(*) [1]
Additional paid-in-capital 16,787 16,499
Accumulated deficit (8,276) (3,678)
TOTAL SHAREHOLDERS’ EQUITY 8,511 12,821
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 12,239 $ 15,775
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 33 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Ordinary shares, par value (in Dollars per share) [1]
Ordinary shares, Authorized [1] 43,567,567 43,567,567
Ordinary shares, Issued [1] 1,215,512 1,153,461
Ordinary shares, outstanding [1] 1,215,512 1,153,461
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 34 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenues $ 10,008 $ 5,859 $ 6,509
Cost of sales 9,032 5,060 4,560
Gross profit 976 799 1,949
Sales and marketing 833 1,198 1,314
General and administrative 4,262 4,113 1,480
Equity losses 1,249
Impairment loss of intangible asset 87
Other income (279)
Operating loss (5,089) (4,512) (932)
Financial (income) expenses, net (523) (2,305) 629
Loss before taxes (4,566) (2,207) (1,561)
Tax (benefit) expense 32 (6) (21)
Net loss $ (4,598) $ (2,201) $ (1,540)
Basic net profit (loss) attributable to shareholders per ordinary share (in Dollars per share) $ (3.88) $ (3.32) [1] $ (3.73) [1]
Weighted-average ordinary shares used in computing net profit (loss) per share, basic (in Shares) 1,184,484 663,411 [1] 413,192 [1]
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 35 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations (Parentheticals) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
[1]
Dec. 31, 2021
[1]
Income Statement [Abstract]      
Diluted net profit (loss) attributable to shareholders per ordinary share $ (3.88) $ (3.32) $ (3.73)
Weighted-average ordinary shares used in computing net profit (loss) per share, diluted 1,184,484 663,411 413,192
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 36 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary Shares
Additional paid-in-capital
Retained earnings (Accumulated deficit)
Total
Balance at Dec. 31, 2020 $ 287 $ 63 $ 350
Balance (in Shares) at Dec. 31, 2020 [1] 413,304      
Net loss (1,540) (1,540)
Share-based compensation to service provider 75 75
Issuance of ordinary shares 1,250 1,250
Share-based compensation 60 60
Transactions with shareholders 1,058 1,058
Balance at Dec. 31, 2021 2,730 (1,477) 1,253
Balance (in Shares) at Dec. 31, 2021 [1] 413,304      
Net loss (2,201) (2,201)
Debt extinguishment of shareholders’ loans (Note 11) 769 769
Issuance of ordinary shares upon initial public offering, net of issuance costs (Note 13) 6,194 6,194
Issuance of ordinary shares upon initial public offering, net of issuance costs (Note 13) (in Shares) [1] 557,774      
Issuance of warrants to third party upon initial public offering (Note 13) 26 26
Conversion of shareholder loans (Note 11) 3,461 3,461
Conversion of shareholder loans (Note 11) (in Shares) [1] 209,089      
Reclassification of derivative warrant liabilities to equity (Note 10) 3,319 3,319
Balance at Dec. 31, 2022 16,499 (3,678) $ 12,821
Balance (in Shares) at Dec. 31, 2022 1,153,461 [1]     1,153,461 [2]
Net loss (4,598) $ (4,598)
Issuance of ordinary shares to SciSparc Ltd. (Note 7) 288 288
Issuance of ordinary shares to SciSparc Ltd. (Note 7) (in Shares) [1] 35,345      
Balance at Dec. 31, 2023 $ 16,787 $ (8,276) $ 8,511
Balance (in Shares) at Dec. 31, 2023 1,215,512 [1]     1,215,512 [2]
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
[2] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 37 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS USED IN OPERATING ACTIVITIES:      
Net loss $ (4,598) $ (2,201) $ (1,540)
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation 60
Exchange differences on cash and cash equivalents 34
Depreciation and amortization of intangible assets 738 570 524
Impairment of intangible asset 87
Accrued interest and amortization of discount on third party, related party and shareholders’ loans 298 546
Gain from debt extinguishment (14)
Loss from change in value of investment at fair value 221
Equity losses 1,249
Changes in fair value of derivative liabilities (841) (2,822) 75
Interest expense on short-term loan (1) (25)
Changes in deferred taxes, net (58) (15) (115)
Issuance costs on derivative liabilities 1,416
Changes in operating assets and liabilities:      
Decrease (increase) in trade receivables (302) 39 (282)
Decrease in related party balance 40
Decrease (increase) in other receivables 182 (743) (290)
Increase in inventory (596) (564) (449)
Increase (decrease) in related party liabilities (213) 241
Increase (decrease) in accounts payable and other payables 1,304 (579) 254
Decrease in operating lease right-of-use assets 67 14  
Decrease in operating lease liabilities (67) (15)
Net cash used in operating activities (2,668) (4,840) (863)
CASH FLOWS USED IN INVESTING ACTIVITIES:      
Purchase of property and equipment (25) (41) (2)
Restricted deposit (17)
Purchase of investment accounted for using the equity method (3,091)
Purchase of intangible assets (1,681) (4,728)
Net cash used in investing activities (4,814) (41) (4,730)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:      
Short-term loans received 752 981
Short-term loans repaid (86) (1,518) (134)
Proceeds from initial public offering, net of issuance costs 13,391
Loans received from shareholders 4,800
Loans repaid to shareholders (100)
Loans repaid to related parties (1,102)
Issuance of ordinary shares 1,250
Net cash from (used in) financing activities (86) 12,625 5,695
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (7,568) 7,744 102
LOSSES FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS (34)
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR 8,137 393 291
CASH AND CASH EQUIVALENTS AT END OF THE YEAR 535 8,137 393
Supplemental disclosure of cash flow information:      
Taxes paid 28 73 116
Interest paid 2 477 4
Supplemental disclosure of noncash investing and financing activities:      
Deferred offering costs included in other payables 86
Share-based compensation included in deferred offering costs 75
Issuance of ordinary shares upon conversion of shareholders’ loans 2,839
Issuance of 35,345 ordinary shares to SciSparc Ltd. in consideration for 13,858 ordinary shares 288
Consideration payable to sellers of Fort Products Ltd. included in other payables 332
Consideration payable to seller of SciSparc Nutraceuticals Inc. shares included in other payables 98
Substantial modification of shareholders’ loans recorded in equity 982  
Right of use assets obtained in exchange for lease liabilities $ 57 $ 152
XML 38 R9.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows (Parentheticals)
12 Months Ended
Dec. 31, 2023
shares
Statement of Cash Flows [Abstract]  
Issuance of ordinary shares 35,345
consideration of ordinary shares 13,858
XML 39 R10.htm IDEA: XBRL DOCUMENT v3.24.1
General Information
12 Months Ended
Dec. 31, 2023
General Information [Abstract]  
GENERAL INFORMATION

NOTE 1 — GENERAL INFORMATION

 

  a. General

 

Jeffs’ Brands Ltd (the “Company” or “Jeffs’ Brands”) was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements the Company has five wholly owned subsidiaries — Smart Repair Pro (“Smart Pro”), Top Rank Ltd. (“Top Rank”), Jeffs’ Brands Holdings Inc. (“Jeffs’ Brands Holdings”), Fort Products Ltd. (“Fort”) and Fort Products LLC (“Fort US”) (the “Subsidiaries”). The Company and the Subsidiaries (“Group”) are engaged in the acquisition, improvement and operation of virtual stores (the “Brands”) mainly on the Amazon.com (“Amazon”) website.

 

References to the Company hereinafter, unless the context otherwise provides, include Jeffs’ Brands and the Subsidiaries on a consolidated basis.

 

Smart Pro, a private corporation founded in the State of California, was established on December 20, 2017, and commenced its operations in June 2019. As of December 31, 2023, Smart Pro operated four brands on the Amazon website.

 

In April 2021, Top Rank, an Israeli company, was established as a wholly owned subsidiary of Jeffs’ Brands.

 

On February 23, 2023, Jeffs’ Brands Holdings Inc., was established and registered in Delaware as a wholly owned subsidiary of Jeffs’ Brands.

 

On March 9, 2023, the Company purchased all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information see note 5.

 

On April 23, 2023, Fort US, was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands Holdings.

 

On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of common stock of SciSparc Nutraceuticals Inc. (“SciSparc U.S”). For additional information see note 7.

 

b.Initial public offering

 

On August 30, 2022, the Company completed its initial public offering (“IPO”), for additional information see note 13.

 

c. Concentration risk

 

The Group’s activities are mainly conducted through Amazon’s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon’s terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.

 

In addition, the Group is engaged with a small number of suppliers as part of the production process of its brands. Any material changes in the supply process, whether temporary or permanent, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.

 

e.Liquidity

 

During the year ended December 31, 2023, the Group incurred a net loss of 4,598 thousand and cash flows used in operating activities were $ 2,668 thousand. As of December 31, 2023, the Group had an accumulated deficit of approximately $8,276 thousand.

 

The Group has funded its operations to date through the sale of its products, through equity financings, loans from shareholders and other third parties, and sale of its Ordinary Shares and warrants. The Company intends to continue to finance its operating activities through the sale of products via its Brands and through raising additional capital, as needed.

 

On January 29, 2024, the Company entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement with certain institutional investors for aggregate gross proceeds of approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement.

 

Management believes that expected cash flows are sufficient to support the Group’s current operations for more than 12 months from the issuance date of these consolidated financial statements.

XML 40 R11.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a.Basis of preparation of the financial statements

 

The Group’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

Prior to 2022, the Group prepared its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB), as permitted in the United States based on the Company’s qualification as a “foreign private issuer” under the rules and regulations of the U.S Securities and Exchange Commission (the “SEC”).

 

b.Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances, fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent liabilities, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group’s assets and liabilities.

 

c.Functional and presentation currency

 

The functional and reporting currency of the Group is the United States dollar (“U.S dollar”) as the U.S. dollar is the currency of the primary economic environment in which the Group has operated and expects to continue to operate in the foreseeable future.

 

The Group's transactions and balances denominated in U.S. dollars are presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.

 

d.Cash and cash equivalents

 

The Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and to be cash equivalents.

 

e.Accounts receivable

 

Accounts receivables are stated at realizable value, net of an allowance for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point of sale, therefore, no provision for credit losses has been recorded as of December 31, 2023 and 2022.

 

f.Inventories

 

Inventories are stated at the lower of cost or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in accordance with first-in, first-out Method (“FIFO”). The cost of inventory includes all costs of purchase, and other costs incurred in bringing the inventories to their present location and condition including shipment and freight costs.

 

g.Property and equipment

 

Property and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.

 

The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:

 

    %
Computers equipment   33
Office Equipment/Furniture   5-7
Plant & Machinery   5
Leasehold improvements   Shorter of remaining lease term or estimated useful life

 

h.Leases

 

In accordance with ASC 842, the Group determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical expedient to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease.

 

ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Group’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.

 

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option. An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.

 

Operating lease expense is recognized on a straight-line basis over the lease term.

 

i.Asset acquisition

 

The Group accounts for a transaction as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs are capitalized as part of the asset or assets acquired.

 

j.Intangible assets

 

The Group’s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.

 

The estimated useful lives of the Group’s intangible assets (Brands) are 10 years.

 

k.Impairment of long-lived assets

 

The Group’s long-lived assets (assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.

 

In determining the fair values of long-lived assets for the purpose of measuring impairment, the Group’s assumptions include those that market participants will consider in valuations of similar assets.

 

l.Loans from shareholders and related parties:

 

On the borrowing date of loans received from shareholders or related parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with ASC 470, “Debt” (“ASC 470”), Subtopic 50— “Modifications and Extinguishments” (“ASC 470-50”). For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt is recorded as an in-essence capital transaction.

 

m.Income taxes

 

The Group accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. As of December 31, 2023 and 2022 a partial valuation allowance was recorded on the Group’s deferred tax assets.

 

The Group implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. As of December 31, 2023 and 2022, no liability for unrecognized tax positions were recognized.

 

n.Revenue recognition

 

The Group accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). The Company derives its revenue from the sale of consumer products mainly through its online Amazon stores. 

 

The Company considers customer order confirmations to be a contract with the customer. Customer confirmations are executed at the time an order is placed through third-party online channels.

 

Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligation is satisfied), which typically occurs at the shipment date. A performance obligation is a promise in a contract to transfer a distinct good to the customer and is the unit of account in ASC Topic 606. A contract’s transaction price is recognized as revenue when the performance obligation is satisfied. Each of the Company’s contracts have a single distinct performance obligation, which is the promise to transfer individual goods.

 

Under the Group’s standard contract terms, customers have a right of return within 45 days. For contracts with rights of return, the Group recognizes revenue based on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance for returns in the amounts of $21 thousand and $70 thousand as of December 31, 2023, and 2022, respectively. The allowance for returns is recorded as (increase) decrease in revenues, respectively against other payables.

 

The Group evaluates the criteria outlined in ASC 606-10-55, “Principal versus Agent Considerations”, in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these arrangements; therefore, sales are recorded on a gross basis.

 

Sales taxes collected from customers are presented on a net basis and as such are excluded from net revenue. 

 

  o. Cost of sales

 

In accordance with Amazon’s terms of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making binding sales. Sales commissions would not have been incurred if the contract had not been obtained.

 

Cost of sales primarily consists of cost of goods sold, expenses related to Amazon’s commissions, storage costs and freight.

 

  p. Advertising expenses

 

The Group expenses advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $719 thousand, $1,163 thousand, and $1,211 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.

 

q.Employee benefits

 

Groups employees are employed by the company and by Fort and subject to the local labor laws.

 

The Company’s employees

 

Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Group’s employees in Israel are entitled to a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve the Group from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group’s balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.

 

Fort employees

 

England labor laws generally requires an employer to make contributions to National Employment Savings Trust on behalf of its employees. Since April 2019, the minimum employer contribution is required to be 3% of an employee's salary. These payments relieve a company from future obligations with respect to its employees. The aforementioned contributions are not recorded as an asset on the Group's balance sheet and there is no liability recorded as the Group does not have a future obligation to make any additional payments.

 

r.Fair value measurement

 

The Group applies ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

 

In determining fair value, the Group uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent from the Group. Unobservable inputs are inputs that reflect the Group’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:

 

Level 1 - Valuations based on quoted prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

 

Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

 

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

The carrying amounts of cash and cash equivalents, trade receivables, other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value due to the short-term maturity of such instruments.

 

The Group’s derivative liabilities in respect of Additional Warrants are classified within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable inputs. For more details, see Note 9.

 

The Group’s financial asset in respect of the investment in SciSparc Ltd. (“SciSparc”) as of December 31, 2023 is classified within Level 1 of the fair value hierarchy, because the ordinary shares have quoted prices as they are traded on the Nasdaq Stock Market LLC.

 

s.Warrants

 

The Group accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance.

 

The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, “Distinguishing Liabilities and Equity”, are indexed to the Group’s own stock and whether the warrants are eligible for equity classification under ASC 815 (“ASC 815”), “Derivatives and Hedging”, Subtopic 40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.

 

Warrants that meet all the criteria for equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings at each balance sheet date thereafter.

 

t.Legal and other contingencies

 

The Group accounts for its contingent liabilities in accordance with ASC 450, “Contingencies”. A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with loss contingencies are expensed as incurred. As of December 31, 2023, and 2022, the Group is not a party to any litigation that could have a material adverse effect on the Group’s business, financial position, results of operations or cash flows.

 

u.Basic and diluted net loss per share.

 

The Group calculates basic net profit (loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All outstanding share options and warrants for the years ended December 31, 2023 and 2022 have been excluded from the calculation of the diluted net loss per share since all such securities were anti-dilutive.

 

  v. Investment in affiliates

 

The investment in affiliated company is accounted for by the equity method under ASC Subtopic 323-10, “Investments - Equity Method and Joint Ventures”. The Company uses the equity method when it has the ability to exercise significant influence over operating and financial policies of an entity but does not have control of the entity. Under the equity method of accounting, an investment is initially recorded on the balance sheet at cost, representing the Company’s proportionate share of fair value. The investment is subsequently adjusted to reflect the Company’s proportionate share of net earnings or losses recognized, distributions received, contributions made and certain other adjustments, as appropriate. The Company does not record losses of the equity method investee in excess of its investment balance unless the Company is liable for obligations of the equity method investee or is otherwise committed to provide financial support to the equity method investee. As of December 31, 2023 the Company held investments in SciSparc U.S.

 

The Company evaluates its equity method investments for impairment at each reporting date, or more frequently if events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when determining whether an investment has been other-than-temporarily-impaired, include, but are not limited to, the length of the time and the extent to which the market value has been less than cost, the financial condition and near-term prospects of the investee, and the Company's intent and ability to retain the investment until the recovery of its cost. An impairment loss on the equity method investments is recognized in earnings when the decline in value is determined to be other-than-temporary. The Company recorded an impairment loss of $955 for the year ended December 31, 2023 on its investment in SciSparc U.S.

 

w.Recently Issued Accounting Pronouncements

 

Recent Accounting Pronouncements Not Yet Adopted

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendment also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

XML 41 R12.htm IDEA: XBRL DOCUMENT v3.24.1
Other Receivables
12 Months Ended
Dec. 31, 2023
Other Receivables [Abstract]  
OTHER RECEIVABLES

NOTE 3 — OTHER RECEIVABLES

 

   December 31, 
   2023   2022 
   U.S. dollars in thousands 
Advances to suppliers   559    641(*)
Government institutions   38    130 
Other receivables   
-
    8 
    597    779 

 

(*)As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information.
XML 42 R13.htm IDEA: XBRL DOCUMENT v3.24.1
Inventory
12 Months Ended
Dec. 31, 2023
Inventory [Abstract]  
INVENTORY

NOTE 4 — INVENTORY

 

   December 31, 
   2023   2022 
   U.S. dollars in thousands 
Goods in transit   219    8 
Finished goods   2,167    1,783 
    2,386    1,791 
XML 43 R14.htm IDEA: XBRL DOCUMENT v3.24.1
Intangible Assets
12 Months Ended
Dec. 31, 2023
Intangible Assets [Abstract]  
INTANGIBLE ASSETS

NOTE 5 — INTANGIBLE ASSETS

 

Total intangible assets consisted of the following as of December 31, 2023 and 2022:

 

   December 31, 2023 
   Gross
Amount
   Accumulated
Amortization
   Net
Balance
 
   U.S. dollars in thousands 
Brands   7,774    (2,060)   5,714 

 

   December 31, 2022 
   Gross
Amount
   Accumulated
Amortization
   Net
Balance
 
   U.S. dollars in thousands 
Brands   5,783    (1,331)   4,452 

 

Amortization expense was $730 thousand, $570 thousand, and $524 thousand, for the years ended December 31, 2023, 2022, and 2021, respectively. Estimated annual amortization expense for each of the next five years is expected to be $769 thousand.

 

On March 2, 2023, the Company entered into a share purchase agreement (the “Fort SPA”), with the holders (the “Sellers”), of all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately £2 million (approximately $2.4 million) (the “Fort Acquisition”). As of December 31, 2023, the Company had an outstanding liability to the sellers of $332 included in other payables in the consolidated balance sheet.

 

On February 29, 2024, the Company extended a side letter to the Fort SPA to the Fort Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100 thousand (approximately $128 thousand). these adjustments were included in the outstanding liability as of December 31, 2023.

 

On March 9, 2023, the Company recognized the amount of $1,991 thousand paid in connection with the Fort Acquisition amortized over a period of 10 years.

 

As part of the Fort SPA, the employment of these employees was terminated within three months, with all termination costs to be borne by the Sellers.

 

Also, in connection with the closing of the Fort Acquisition, on March 9, 2023, Fort and the Sellers entered into a consulting agreement, pursuant to which the Sellers will provide the Company with consultancy services for a period of six months following the closing, at a monthly fee of £2.5 thousand (approximately $3 thousand). On September 20, 2023, the Company and the Sellers entered into a new consulting agreement for an indefinite period at a monthly fee of £3.5 thousand (approximately $4.5 thousand) effective as of June 1, 2023 (the “Fort Consulting Agreement”).

 

The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations.

XML 44 R15.htm IDEA: XBRL DOCUMENT v3.24.1
Leases
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES

NOTE 6 — LEASES:

 

The Company leases office space and a warehouse with a remaining useful life of less than 3 years.

 

As of December 31, 2023, the Company’s operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $138 thousand and $127 thousand, respectively.

 

The Company uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2023, the Company’s operating leases had a weighted average remaining lease term of 3 years and a weighted average borrowing rate of approximately 10%.

 

Future lease payments under operating leases as of December 31, 2023, were as follows:

 

2024  $95 
2025  $43 
Total future operating lease payments  $138 
Less: imputed interest  $(11)
Present value of lease liability  $127 
XML 45 R16.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate
12 Months Ended
Dec. 31, 2023
Investments in Affiliates [Abstract]  
INVESTMENT IN AFFILIATE

NOTE 7 — INVESTMENT IN AFFILIATE

 

  a. On February 23, 2023, the Company and Jeffs’ Brands Holdings entered into a stock purchase agreement (as amended on March 22, 2023, the “Wellution Agreement”), with SciSparc, a related party of the Company (see note 17), pursuant to which, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S, a wholly-owned subsidiary of SciSparc that owns and operates Wellution, an Amazon food supplements and cosmetics brand, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S, for approximately $3.0 million in cash. The Company reviewed the transaction and deemed it to be the purchase of assets for accounting purposes under ASC Subtopic 805 “Business Combinations” (“ASC 805”), and not as a business combination. The Company reviewed the guidance under ASC 805 for the transaction and determined that the fair value of the gross assets acquired was concentrated in a single identifiable asset, a brand. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024. See also note 17.

 

In connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.Sfor the Wellution brand for a monthly fee of $20 thousand. Additionally, the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the Company and SciSparc agreed to reduce the monthly fee to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.Sas of December 31, 2023, was $15 thousand and $8 thousand, accordingly. See also note 17.

 

Jeffs' Brands Holdings owns 49% of the voting rights in SciSparc U.Sand has the right to appoint two out of five directors. Management has determined that it has significant influence over SciSparc U.S and accordingly accounts for its investment under the equity method.

 

The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations 

 

Management assesses whether impairment indicators are present that may indicate an other than temporary impairment ("OTTI") exists. Management determined that the decrease in revenues and operating losses of SciSparc U.S were indicative of an OTTI impairment as of December 31 2023. Accordingly, management's fair valuation expert performed an impairment test of the equity investment and determined that the carrying value exceed the discounted cash flows. As a result, an impairment loss of $955 thousand was recorded within equity losses in the statement of operations for the year ended December 31, 2023.

 

The activity in the investment in SciSparc U.S account was as follows:

 

   February 23,
2023 –
December 31,
2023
 
   USD in
thousands
 
Balance as of January 1, 2023   
-
 
Purchase on February 23, 2023   3,189 
Equity losses   (1,249)
Balance as of December 31, 2023   1,940 

 

Summarized financial information:

 

Summarized balance sheet of SciSparc U.S:

 

   December 31,
2023
 
   USD in
thousands
 
Current assets   924 
Long-term assets   3,189 
Current liabilities   (154)
Equity   3,959 

 

Summarized statement of statement of operation of SciSparc U.S:

 

   February 22,
2023 –
December 31,
2023
 
   USD in
thousands
 
Revenues   (2,137)
Cost of sales   1,409 
Impairment of intangible asset   1,042 
General and administrative   748 
Sales and marketing   468 
Taxes on income   22 
Net loss   1,552 

 

b.Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company issued 35,345 ordinary shares, no par value per share (“Ordinary Shares”) to SciSparc and SciSparc issued 13,858 of its ordinary shares to the Company in a share exchange, (collectively, the “Exchange Shares”), representing approximately 2.97% and 4.99%, respectively, of the Company’s and SciSparc’s issued and outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288 thousand by the average closing price of the relevant company’s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the closing.

 

The investment in SciSparc was accounted for as financial asset through profit and loss.

 

The activity in the investment in SciSparc’s shares was as follows:

 

   March 23,
2023 –
December 31,
2023
 
   USD in
thousands
 
Balance as of January 1, 2023   
-
 
Value of shares obtained in connection with share exchange on March 23, 2023   288 
Change in fair value   (221)
Balance as of December 31, 2023   67 
XML 46 R17.htm IDEA: XBRL DOCUMENT v3.24.1
Other Payables
12 Months Ended
Dec. 31, 2023
Other Payables [Abstract]  
OTHER PAYABLES

NOTE 8 — OTHER PAYABLES

 

    December 31,  
    2023   2022  
    U.S. dollars in thousands  
Government institutions     428     36  
Employees and related benefits     85     49  
Operating lease liabilities     82     40  
Liability to sellers     (*)430     -  
Revenue sharing payment payable     140     40  
Accrued expenses and other payables     368     226  
               
      1,533     391  

 

(*)Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information.
XML 47 R18.htm IDEA: XBRL DOCUMENT v3.24.1
Short-Term Loans
12 Months Ended
Dec. 31, 2023
Short-Term Loans [Abstract]  
SHORT-TERM LOANS

NOTE 9 — SHORT-TERM LOANS 

 

  a. On May 9, 2022, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $152 thousand from Amazon. The loan matures within 12 months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged its financial balances on its account on Amazon and its inventories held in Amazon’s warehouses, in favor of Amazon. The loan was fully repaid on February 27, 2023.

 

  b.

In July 2021, Smart Pro entered into a loan agreement with two third parties (“lenders”). The loans bore annual interest rate of 10% and were payable in January 2022. Smart Pro was entitled to extend the loans by an additional sixty days, with additional interest of 1% per month. In addition, pursuant to the loan agreement, in the event of an IPO of the Company, the lenders would be entitled to Ordinary Shares of the Company at an aggregate value of $250 thousand with a conversion price at the IPO price. In July 2021, the loan principal of $750 thousand was received. The proceeds from the lenders were first allocated to the liability (see note 9.a) to issue a variable number of shares based on its fair value at the date of issuance in an amount of $62 thousand, with a corresponding discount recorded on the third-party loan. The derivate liability was revalued at each period-end and amounted to $137 thousand as of December 31, 2021.

 

On November 23, 2021, the loan agreement was amended to extend the maturity date of the loans to the earlier of (i) March 31, 2023, or (ii) the closing of an IPO of the Company. Based on management’s assessment, the amendment resulted in a substantial modification to the loan in accordance with ASC 470-50. As a result of the debt extinguishment, the Group recorded, a gain in the amount of $14 thousand within finance expenses, net for the year ended December 31, 2021 as the difference between the net carrying value of the original loans and the fair value of the loan bearing the modified terms.

 

Following the IPO in 2022, the Group repaid the third-party loan. Furthermore, Effective as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreement (the “Issuance Date”), the Company issued 60,096 warrants to the lenders (“lenders warrants”) to purchase up to 8,586 Ordinary Shares, exercisable at an exercise price of $28.28 per share, exercisable for three years following the IPO. The warrants have cashless exercise mechanism.

 

On the issuance date of the lenders warrants, all conditions for equity classification under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were reclassified to equity.

 

  c. On February 22, 2022, the Company entered into a loan agreement with Bank Leumi Le-Israel (“Bank Leumi”) to provide for a line of credit in an aggregate amount of up to $1,000 thousand, which the Company may draw in two tranches at its request, but in no event after July 21, 2022. Pursuant to the loan agreement, amounts drawn bear interest at a rate of Secured Overnight Financing Rate (“SOFR”) plus 3.25% annually. On March 3, 2022, the Company drew $400 thousand under the line of credit. On June 2, 2022, the Company drew another $200 thousand million under the line of credit. Following an agreement with Bank Leumi, the loan was extended until October 31, 2022. All amounts outstanding under the line of credit were fully repaid on September 6, 2022.
XML 48 R19.htm IDEA: XBRL DOCUMENT v3.24.1
Derivative Liabilities
12 Months Ended
Dec. 31, 2023
Derivative Liabilities [Abstract]  
DERIVATIVE LIABILITIES

NOTE 10 — DERIVATIVE LIABILITIES

 

In connection with the IPO the Company issued 3,717,473 warrants to purchase up to 531,068 Ordinary Shares (“IPO Warrants”). Given their contractual terms, from the issuance date and up until the 90th day immediately following issuance, the IPO Warrants did not meet the U.S. GAAP definition for equity classification. As such, they were classified as a liability up until November 28, 2022. Upon issuance, the IPO Warrants (which included the right to issue Additional Warrants) were accounted for as derivative instrument which was classified as a liability and measured at fair value through profit or loss. The fair value was approximately $8.2 million.

 

On November 28, 2022, following the adjustment to the exercise price and issuance of 2,824,525 Additional Warrants to purchase up to 403,504 Ordinary Shares, the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair value of the IPO warrants as of November 28, 2022, at the amount of $3,319 thousand, was recorded as a component of Company’s shareholder’s equity. The term of the Additional Warrants is five (5) years from the issuance date and exercisable for up to 403,504 ordinary shares at exercise price of $14.14 per share. Each Additional Warrant holder receives semi-annual payments equal to approximately 2.3% of the Company’s gross revenues, calculated for the first and second six-month fiscal periods, shared pro rata among qualified holders (“Revenue Sharing Payment”). The Revenue Sharing Payment related to 2023 and 2022 was $269 thousand and $40 thousand, respectively.

 

The value of the IPO Warrants upon issuance and the Additional Warrants upon issuance and at year-end was calculated based on the binomial option pricing model.

 

For the year ended December 31, 2023 and 2022, the Company recorded finance income of $841 thousand and $2,710 thousand, respectively to account for the change in the value of the IPO Warrants and Additional Warrants during the period.

 

The following table presents changes in the fair value of the derivative warrant liability (in thousands)

 

Balance as of December 31, 2021  $137 
Issuance of warrants in connection with the IPO   8,220 
Change in fair value   (2,822)
Classification to additional paid in capital   (3,319)
Balance as of December 31, 2022   2,216 
Change in fair value   (841)
Balance as of December 31, 2023   1,375 

 

The following table lists the significant unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:

 

   2023   2022 
Expected volatility   101.39%   77.57%-78.89%
Exercise price  $14.14    $14.14 
Share price  $3.05   $10.71-13.055 
Risk-free interest rate   3.93%   3.27%-4.04%
Dividend yield   -    - 
Expected life   3.91    3-4.74 
WACC   20.4%   21.5%-23.3%

 

Additionally, the revenue forecast over the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of December 31, 2023 and 2022.

XML 49 R20.htm IDEA: XBRL DOCUMENT v3.24.1
Loans from Shareholders
12 Months Ended
Dec. 31, 2023
Loans from Shareholders [Abstract]  
LOANS FROM SHAREHOLDERS

NOTE 11 — LOANS FROM SHAREHOLDERS

 

    As of May 3, 2022, Smart Pro had outstanding loans to Medigus, Mr. Hakmon and L.I.A. Pure Capital Ltd. (“Pure Capital”) of $4,010 thousand, $940 thousand and $109 thousand, respectively. On May 3, 2022, the Company entered into Assignments to Loan Agreements with Smart Pro, Medigus, Mr. Hakmon and Pure Capital, pursuant to which the Company assumed Smart Pro’s obligations under the outstanding loans and agreed that unless earlier repaid pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of IPO, all outstanding principal due to each such party will be automatically converted into a number of Ordinary Shares equal to the quotient obtained by dividing the outstanding principal amount due to such party, by the per Ordinary Share price obtained by dividing $10,000 thousand by the fully diluted issued and outstanding Ordinary Shares as of immediately prior to the closing of the IPO. Any accrued and unpaid interest due to such party as of such date will be paid in cash.

 

Based on management’s assessment, the modified loan terms including an equity conversion feature upon IPO represented a substantial modification in accordance with ASC 470-50 and is accounted for as an extinguishment of the original financial liability in the amount of $3,821 thousand and the recognition of a new financial instrument in the amount of $2,839 thousand. The difference between the fair value of the instrument bearing the modified terms and the carrying values of the original loans immediately prior to the modification, was recorded as an increase in equity in the amount of $982 thousand.

 

As the convertible note was not issued with a substantial premium or with an embedded conversion feature required to be bifurcated under ASC 815, the convertible note was accounted for as a liability in its entirety.

 

In accordance with such assignment agreements, on August 30, 2022, the outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital at a total amount of $5,059 thousand were converted into an aggregate of 209,088 Ordinary Shares. In addition, accrued interest of $393 thousand was paid.

XML 50 R21.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income
12 Months Ended
Dec. 31, 2023
Taxes on Income [Abstract]  
TAXES ON INCOME

NOTE 12 — TAXES ON INCOME

 

Jeffs’ Brands and Top Rank are taxed according to Israeli tax laws. The corporate tax rate in Israel is 23% for 2021 and thereafter.

 

Smart Pro, Purex Jeffs Brands Holdings Inc and Fort US are taxed according to US federal California state and Delaware state laws. The blended corporate tax rate is 28% for 2021 and thereafter.

 

Fort is taxed according to UK tax law. The corporate tax rate is 19%.

 

Capital gains are subject to capital gain tax according to the corporate tax rate for the year during which the assets are sold.

 

For financial reporting purposes loss before taxes includes the following components:

 

   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands 
Israel   (2,866)   (2,081)   (1,096)
Foreign   (1,700)   (126)   (465)
                
    (4,566)   (2,207)   (1,561)

 

Income tax expense (benefit) was as follows:

 

    Year ended December 31  
    2023     2022     2021  
Current:   U.S. dollars in thousands  
Israel   7     -     -  
Foreign     78       12       94  
Total current income tax expense     85       12       94  
Deferred:                        
Israel     -       -       -  
Foreign     (53 )     (18 )     (115 )
Total deferred tax income     (53 )     (18 )     (115 )
Total tax (benefit) expense     32       (6 )     (21

 

A reconciliation of the Group’s statutory income tax rate to effective income tax rate is as follows:

 

   December 31, 
   2023   2022   2021 
   U.S. dollars in thousands 
Loss before taxes on income   (4,566)   (2,207)   (1,561)
Statutory tax rate   23%   23%   23%
Tax (tax benefit) computed at the statutory tax rate   (1,050)   (508)   (359)
Increase (decrease) in taxes on income resulting from the following:               
Tax rate differences applicable to subsidiaries   (46)   (110)   (78)
Tax losses and timing differences for which deferred taxes were not recognized   1,128    612    416 
Taxes on income   32   (6)   (21)

 

Deferred taxes are comprised of the following components:

 

   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Deferred tax asset        
Intangible assets   388    110 
Operating lease right of use asset   28    32 
Operating loss carryforward   1,476    890 
Total deferred tax assets   1,892    1,032 
Valuation allowance   (1,696)   (890)
Total deferred tax assets after valuation allowance   196    142 
           
Deferred tax liabilities          
           
Operating lease liability   28    32 
Total deferred tax liability   28    32 
           
Net deferred tax assets   168    110 

 

Deferred tax assets on losses for tax purposes carried forward to subsequent years are recognized if utilization of the related tax benefit against a future taxable income is expected.

 

Carry forward tax losses of Jeffs’ Brands were $6,418 thousand and $3,870 thousand as of December 31, 2023 and 2022, respectively. Jeffs’ Brands did not record deferred tax assets in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future. There is no expiration on net operating loss carryforwards in Israel.

 

Smart Pro, Fort, Jeffs Brands Holdings Inc and Fort US did not have any net operating loss carryforwards as of December 31, 2023, and 2022. The net deferred tax asset as of December 31, 2023 and 2022 is with respect to Smart Pro.

XML 51 R22.htm IDEA: XBRL DOCUMENT v3.24.1
Share Capital
12 Months Ended
Dec. 31, 2023
Share Capital [Abstract]  
SHARE CAPITAL

NOTE 13 — SHARE CAPITAL:

 

  a. The share capital composed of ordinary shares as follows:

 

   Number of ordinary shares
December 31
 
   2023   2022 
Issued (*)   1,215,512    1,153,461 
Authorized   43,567,567    43,567,567 

 

(*) Retroactively adjusted.

 

The Ordinary Shares confer upon their holders the following rights: (i) the right to vote in any general meeting of the Company, (ii) the right to receive dividends, if and when declared by the Board of Directors and (iii) the right to receive upon liquidation of the Company a sum equal to the nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares which may be issued in the future.

 

On February 17, 2022, the Company’s Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February 17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares. Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect to the two subsequent reverse share splits) ordinary shares.

 

On May 3, 2022, the Company’s Board of Directors approved a 0.806-for-1 reverse split of its issued and outstanding Ordinary Shares, effective as of May 3, 2022, pursuant to which holders of the Company’s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.

 

On June 16, 2022, the Company’s Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June 16, 2022, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85 Ordinary Shares held as of such date. The reverse stock split proportionally reduced the number of the Company’s authorized share capital.

 

The share capital before consummation of the IPO was comprised of 413,304 issued and outstanding ordinary shares. In accordance with an assignment agreement (see also Note 11) and in connection with the IPO (see above), on August 30, 2022, the Company converted outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital into 209,088 Ordinary Shares.

 

On August 30, 2022, the Company closed its IPO, and the simultaneous partial exercise of the underwriter’s over-allotment option, for aggregate gross proceeds of approximately $15.5 million, before deducting underwriting discounts and estimated offering expenses. The Company issued 531,069 Ordinary Shares, (“Ordinary Shares”) and 3,717,473 IPO warrants to purchase up to 531,069 Ordinary Shares. The Ordinary Shares and IPO Warrants were sold together in the IPO as units (“Units”) at an initial public offering price of $29.12 per Unit.

 

The IPO Warrants had an initial exercise price of $28.28 and expire five years from the issuance day. The IPO Warrants became exercisable immediately after the completion of the IPO (and until August 30, 2027). On the 90th day after the closing of the IPO, the exercise price of the IPO Warrants was adjusted to be equal to the lowest quoted share price during the 90 days. The daily quoted price used in the determination of such minimum was calculated as the weighted average price of each day. The exercise price, however, may not be reduced to less than $14.14.

 

The IPO Warrants contain a down round protection, so that for a period of two years from the date of issuance of the IPO Warrant, the exercise price is adjusted to the price in subsequent fundings of the Company, if shares in these fundings are sold at a price per share below the warrant exercise price at the time of such future fundings (or if other instruments with an exercise / conversion price at a price below the warrant exercise price are sold). The exercise price, however, may not be reduced to less than $14.14. On November 28, 2022, the IPO Warrant’s exercise price was adjusted to $14.14.

 

The Ordinary Shares and IPO Warrants trade on the Nasdaq under the symbol “JFBR” and “JFBRW”, respectively.

 

In addition, On November 28, 2022, the Company issued 2,824,525 Additional Warrants to purchase 403,504 Ordinary Shares. Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. Each Additional Warrants holder will receive semi-annual payments. The total annual payment depends on the amount of the Additional Warrants outstanding. As of December 31, 2022, the payment will be equal to approximately 2.3% of the Group ’s revenues for the period from November 28, 2022 until December 31,2022. The Additional Warrants may be redeemed by the Company at any time at a price equal to three times the Initial Exercise Price, or $42.42.

 

As the IPO Warrants and the Additional Warrants are not separable at the issuance date, the IPO Warrants and the Additional Warrants were initially accounted for as derivative instruments which were classified as a liability and measured at fair value through profit or loss. See also note 10.

 

Applicable issuance costs, amounting to $2,193 thousand, were allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and was recorded in the consolidated statement of operations, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand were recorded in equity as a reduction of the paid in capital for the year ended December 31, 2023.

 

As part of the IPO, on August 30, 2022, the Company issued to the underwriter 185,873 Warrants to purchase up to 26,554 Ordinary Shares (the “Underwriters Warrants”) exercisable beginning on February 21, 2023 at an exercise price of $36.40, and will expire on August 25, 2027. The Underwriter’s Warrants may be exercised on a cashless exercise basis in certain circumstances. The Underwriters Warrants were treated as issuance costs, which amounted to $109 thousand based on a third party valuation, and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $58 thousand was considered as issuance costs allocated to the Underwriter’s Warrants and were recorded in profit or loss as finance expense, while costs allocated as issuance costs of Ordinary Shares in the amount of $51 thousand were recorded in equity as a reduction of the additional paid in capital.

 

On August 30, 2022, the underwriter partially exercised its overallotment right to purchase 425,912 additional IPO Warrants to purchase up to 60,845 Ordinary Shares for a total consideration of $4 thousand. These additional IPO Warrants were treated as issuance costs, which amounted to $1 thousand based on third party valuation, and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $0.5 thousand was considered as issuance costs allocated to the additional IPO Warrants and were recorded in profit or loss as finance expense, while costs allocated as issuance costs of Ordinary Shares in the amount of $0.5 thousand have been recorded in equity as a reduction of the paid in capital.

 

Effective as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreement (the “Issuance Date”), the Company issued the Lenders Warrants to purchase up to 8,586 Ordinary Shares, exercisable for three years following the issuance date at an exercise price of $28.28 per share. The warrants may be exercised on a cashless basis.

 

On the issuance date of the Lenders Warrants, all conditions for equity classification under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were classified to equity.

 

In addition, effective as of August 30, 2022, the Company issued 18,565 warrants to purchase up to 2,653 Ordinary Shares at an exercise price of $28.28 per Ordinary Share (and an exercise price of $14.14 following the Exercise Price Adjustment) to an advisor. The warrants were exercisable immediately and are exercisable until August 30, 2027.

 

On October 17, 2023, the Company’s Board of Directors approved a 1-for-7 reverse split of the issued and outstanding Ordinary Shares, effective as of November 3, 2023, pursuant to which holders of the Ordinary Shares received one Ordinary Share for every seven Ordinary Shares held as of such date. The reverse stock split proportionally did not reduce the number of authorized share capital. The effect of such reverse split was applied retrospectively for all the number of shares, warrants, related par value and others presented in this note and elsewhere in the consolidated financial statements prior to the effective date of the reverse stock split.

 

On November 14, 2023, the Company issued 26,706 ordinary shares as a result of rounding following the aforementioned reverse share split.

XML 52 R23.htm IDEA: XBRL DOCUMENT v3.24.1
Share Incentive Plan
12 Months Ended
Dec. 31, 2023
Share Incentive Plan [Abstract]  
SHARE INCENTIVE PLAN

NOTE 14 — SHARE INCENTIVE PLAN

 

On January 19, 2022, the Company’s Board of Directors adopted the 2022 Incentive Option Plan (“Plan”). A total of 186,718 Ordinary Shares were reserved and subject to the Plan. The Plan is intended as an incentive to retain directors, officers, employees, consultants and advisers of the Company. As of December 31, 2023, the Company had not granted awards under the Plan.

XML 53 R24.htm IDEA: XBRL DOCUMENT v3.24.1
Finance (Income) Expense, Net
12 Months Ended
Dec. 31, 2023
Finance (Income) Expense, Net [Abstract]  
FINANCE (INCOME) EXPENSE, NET

NOTE 15 — FINANCE (INCOME) EXPENSE, NET

 

   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands 
Finance income:            
Change in fair value of derivative liabilities   (841)   (2,822)   - 
Interest income   (4)   -    (14)
Total finance income   (845)   (2,822)   (14)
Finance expense:               
Finance expenses in respect of third-party loan   -    83    77 
Change in fair value of derivative liabilities   -    -    75 
Amortization of loan discount   -    37    85 
Exchange rate differences   91    156    10 
Interest expense on loans from shareholders and related parties   -    203    381 
Other finance expenses   10    38    15 
Revaluation of securities -fair value through profit or loss   221    -    - 
Total finance expenses   322    517    643 
Finance (income) expense, net   (523)   (2,305)   629 
XML 54 R25.htm IDEA: XBRL DOCUMENT v3.24.1
Net Loss Per Share Attributable to Ordinary Shareholders
12 Months Ended
Dec. 31, 2023
Net Income (Loss) Per Share Attributable to Ordinary Shareholders [Abstract]  
NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS

NOTE 16 — NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS

 

The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders:

 

   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands (*) 
Numerator:            
Net loss applicable to shareholders of ordinary shares   (4,598)   (2,201)   (1,540)
                
Denominator:               
Shares of ordinary share used in computing basic and diluted net loss per share   1,184,484    663,411    413,192 
Net loss per share of ordinary share, basic and diluted   (3.88)   (3.32)   (3.73)

 

The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:

 

   Year ended December 31 
   2023   2022   2021 
             
IPO Warrants and Additional Warrants (Note 13)   6,541,998    6,541,998    - 
Underwriter warrants (Note 13)   611,785    611,785    - 
Other warrants   78,661    78,661    - 
    7,232,444    7,232,444    - 

 

(*) except share and per share data
XML 55 R26.htm IDEA: XBRL DOCUMENT v3.24.1
Related Parties
12 Months Ended
Dec. 31, 2023
Related Parties [Abstract]  
RELATED PARTIES

NOTE 17 — RELATED PARTIES 

 

  a. Transactions with related parties:

 

   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Labor cost and related expenses (included in general and administrative) (c1)   249    358 
Directors’ fees (included in general and administrative)   282    172 
Consulting fees (included in general and administrative) (c2)   180    218 
Inventory storage (included in cost of sale) (c2)   545    395 
Revenue sharing payment (included in general and administrative) (c6)   40    6 
Other income, net (c4)   (255)   - 
Interest expenses on loans from related parties and shareholders   -    203 
    1,041    1,352 

  b. Balances with interested and related parties:

 

   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Assets:        
Advances to suppliers (c2)   -    228 
    -    228 
Liabilities:          
Related parties (c3), (c4)   66    32 
Chief executive officer salary (included in other account payable) (c1)   18    - 
Revenue sharing payment (included in other account payable) (c6)   21    6 
Liability to SciSparc (included in other account payable) (c7)   98    - 
Liability to supplier (included in trade payable) (c2)   69    - 
Liability to consultant (included in other account payable) (c2)   17    - 
    289    38 

 

  c. Additional information:

 

  1. On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).

 

  2. On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.

 

  3. On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively.

 

  4. As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.

 

  5. During September 2022, the Group repaid: (i) a related party balance to Medigus, in the amount of $150 thousand and (ii) another related party balance in the amount of $175 thousand and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing of the IPO.

 

  6. During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.

 

  7. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.
XML 56 R27.htm IDEA: XBRL DOCUMENT v3.24.1
Geographical Information
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
GEOGRAPHICAL INFORMATION

NOTE 18 — GEOGRAPHICAL INFORMATION

 

Revenues are attributed to geographic areas:

 

   Year ended
December 31,
 
   2023   2022   2021 
   USD in thousands 
             
America   3,863    5,422    6,402 
Europe   6,145    437    107 
    10,008    5,859    6,509 
XML 57 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Subsequent Events
12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 19 — SUBSEQUENT EVENTS

 

1.On January 25, 2024, the Company entered into a private placement transaction, or the January 2024 PIPE, pursuant to a securities purchase agreement, with certain institutional investors, providing for the issuance, in a private placement of 1,884,461 Ordinary Shares; (ii) Pre-Funded Warrants to purchase up to an 820,000 Ordinary Shares; (iii) Series A Warrants to purchase up to an aggregate of 3,380,586 Ordinary, or upon the satisfaction of certain conditions, up to an aggregate of 13,373,208 Ordinary Shares in accordance with the terms therein and (iv Series B Warrants to purchase upon the satisfaction of, certain conditions up to an aggregate of 7,994,181 Ordinary Shares in accordance with the terms therein. The January 2024 PIPE closed on January 29, 2024. The Company’s aggregate gross proceeds from the January 2024 PIPE were approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the January 2024 PIPE. Pure Capital participated in the private placement as a purchaser.

 

As of the issuance date of these consolidated financial statements 2,900,036 Warrants were exercised into 2,900,036 ordinary shares of the Company.

 

The Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with Aegis, dated January 25, 2024, pursuant to which Aegis agreed to serve as the exclusive placement agent for the Company in connection with the Private Placement. The Company agreed to pay Aegis a cash placement fee equal to 8.50% of the gross cash proceeds received in the Private Placement and to pay for expenses of the Purchasers’ and Aegis’ legal counsel up to an aggregate amount of $90 thousand.

 

2.On February 5, 2024, the Company paid to Pure Capital $100 thousand in connection to the IPO and in accordance to the consultant agreement.

 

3.On February 29, 2024, the Company extended a side letter to the Fort SPA to the Fort Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100 thousand.
XML 58 R29.htm IDEA: XBRL DOCUMENT v3.24.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Net Income (Loss) $ (4,598) $ (2,201) $ (1,540)
XML 59 R30.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 60 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Basis of preparation of the financial statements
a.Basis of preparation of the financial statements

The Group’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Prior to 2022, the Group prepared its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB), as permitted in the United States based on the Company’s qualification as a “foreign private issuer” under the rules and regulations of the U.S Securities and Exchange Commission (the “SEC”).

Use of estimates
b.Use of estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances, fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent liabilities, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group’s assets and liabilities.

Functional and presentation currency
c.Functional and presentation currency

The functional and reporting currency of the Group is the United States dollar (“U.S dollar”) as the U.S. dollar is the currency of the primary economic environment in which the Group has operated and expects to continue to operate in the foreseeable future.

The Group's transactions and balances denominated in U.S. dollars are presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.

Cash and cash equivalents
d.Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and to be cash equivalents.

Accounts receivable
e.Accounts receivable

Accounts receivables are stated at realizable value, net of an allowance for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point of sale, therefore, no provision for credit losses has been recorded as of December 31, 2023 and 2022.

 

Inventories
f.Inventories

Inventories are stated at the lower of cost or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in accordance with first-in, first-out Method (“FIFO”). The cost of inventory includes all costs of purchase, and other costs incurred in bringing the inventories to their present location and condition including shipment and freight costs.

Property and equipment
g.Property and equipment

Property and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.

The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:

    %
Computers equipment   33
Office Equipment/Furniture   5-7
Plant & Machinery   5
Leasehold improvements   Shorter of remaining lease term or estimated useful life

 

Leases
h.Leases

In accordance with ASC 842, the Group determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical expedient to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease.

ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Group’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option. An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.

Operating lease expense is recognized on a straight-line basis over the lease term.

Asset acquisition
i.Asset acquisition

The Group accounts for a transaction as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs are capitalized as part of the asset or assets acquired.

Intangible assets
j.Intangible assets

The Group’s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.

The estimated useful lives of the Group’s intangible assets (Brands) are 10 years.

 

Impairment of long-lived assets
k.Impairment of long-lived assets

The Group’s long-lived assets (assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.

In determining the fair values of long-lived assets for the purpose of measuring impairment, the Group’s assumptions include those that market participants will consider in valuations of similar assets.

Loans from shareholders and related parties
l.Loans from shareholders and related parties:

On the borrowing date of loans received from shareholders or related parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with ASC 470, “Debt” (“ASC 470”), Subtopic 50— “Modifications and Extinguishments” (“ASC 470-50”). For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt is recorded as an in-essence capital transaction.

Income taxes
m.Income taxes

The Group accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. As of December 31, 2023 and 2022 a partial valuation allowance was recorded on the Group’s deferred tax assets.

The Group implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. As of December 31, 2023 and 2022, no liability for unrecognized tax positions were recognized.

 

Revenue recognition
n.Revenue recognition

The Group accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). The Company derives its revenue from the sale of consumer products mainly through its online Amazon stores. 

The Company considers customer order confirmations to be a contract with the customer. Customer confirmations are executed at the time an order is placed through third-party online channels.

Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligation is satisfied), which typically occurs at the shipment date. A performance obligation is a promise in a contract to transfer a distinct good to the customer and is the unit of account in ASC Topic 606. A contract’s transaction price is recognized as revenue when the performance obligation is satisfied. Each of the Company’s contracts have a single distinct performance obligation, which is the promise to transfer individual goods.

Under the Group’s standard contract terms, customers have a right of return within 45 days. For contracts with rights of return, the Group recognizes revenue based on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance for returns in the amounts of $21 thousand and $70 thousand as of December 31, 2023, and 2022, respectively. The allowance for returns is recorded as (increase) decrease in revenues, respectively against other payables.

The Group evaluates the criteria outlined in ASC 606-10-55, “Principal versus Agent Considerations”, in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these arrangements; therefore, sales are recorded on a gross basis.

Sales taxes collected from customers are presented on a net basis and as such are excluded from net revenue. 

Cost of sales
  o. Cost of sales

In accordance with Amazon’s terms of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making binding sales. Sales commissions would not have been incurred if the contract had not been obtained.

Cost of sales primarily consists of cost of goods sold, expenses related to Amazon’s commissions, storage costs and freight.

Advertising expenses
  p. Advertising expenses

The Group expenses advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $719 thousand, $1,163 thousand, and $1,211 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.

 

Employee benefits
q.Employee benefits

Groups employees are employed by the company and by Fort and subject to the local labor laws.

The Company’s employees

Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Group’s employees in Israel are entitled to a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve the Group from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group’s balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.

Fort employees

England labor laws generally requires an employer to make contributions to National Employment Savings Trust on behalf of its employees. Since April 2019, the minimum employer contribution is required to be 3% of an employee's salary. These payments relieve a company from future obligations with respect to its employees. The aforementioned contributions are not recorded as an asset on the Group's balance sheet and there is no liability recorded as the Group does not have a future obligation to make any additional payments.

Fair value measurement
r.Fair value measurement

The Group applies ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

In determining fair value, the Group uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent from the Group. Unobservable inputs are inputs that reflect the Group’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:

Level 1 - Valuations based on quoted prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The carrying amounts of cash and cash equivalents, trade receivables, other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value due to the short-term maturity of such instruments.

The Group’s derivative liabilities in respect of Additional Warrants are classified within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable inputs. For more details, see Note 9.

The Group’s financial asset in respect of the investment in SciSparc Ltd. (“SciSparc”) as of December 31, 2023 is classified within Level 1 of the fair value hierarchy, because the ordinary shares have quoted prices as they are traded on the Nasdaq Stock Market LLC.

Warrants
s.Warrants

The Group accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance.

The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, “Distinguishing Liabilities and Equity”, are indexed to the Group’s own stock and whether the warrants are eligible for equity classification under ASC 815 (“ASC 815”), “Derivatives and Hedging”, Subtopic 40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.

 

Warrants that meet all the criteria for equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings at each balance sheet date thereafter.

Legal and other contingencies
t.Legal and other contingencies

The Group accounts for its contingent liabilities in accordance with ASC 450, “Contingencies”. A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with loss contingencies are expensed as incurred. As of December 31, 2023, and 2022, the Group is not a party to any litigation that could have a material adverse effect on the Group’s business, financial position, results of operations or cash flows.

Basic and diluted net loss per share
u.Basic and diluted net loss per share.

The Group calculates basic net profit (loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All outstanding share options and warrants for the years ended December 31, 2023 and 2022 have been excluded from the calculation of the diluted net loss per share since all such securities were anti-dilutive.

Affiliates
  v. Investment in affiliates

The investment in affiliated company is accounted for by the equity method under ASC Subtopic 323-10, “Investments - Equity Method and Joint Ventures”. The Company uses the equity method when it has the ability to exercise significant influence over operating and financial policies of an entity but does not have control of the entity. Under the equity method of accounting, an investment is initially recorded on the balance sheet at cost, representing the Company’s proportionate share of fair value. The investment is subsequently adjusted to reflect the Company’s proportionate share of net earnings or losses recognized, distributions received, contributions made and certain other adjustments, as appropriate. The Company does not record losses of the equity method investee in excess of its investment balance unless the Company is liable for obligations of the equity method investee or is otherwise committed to provide financial support to the equity method investee. As of December 31, 2023 the Company held investments in SciSparc U.S.

The Company evaluates its equity method investments for impairment at each reporting date, or more frequently if events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when determining whether an investment has been other-than-temporarily-impaired, include, but are not limited to, the length of the time and the extent to which the market value has been less than cost, the financial condition and near-term prospects of the investee, and the Company's intent and ability to retain the investment until the recovery of its cost. An impairment loss on the equity method investments is recognized in earnings when the decline in value is determined to be other-than-temporary. The Company recorded an impairment loss of $955 for the year ended December 31, 2023 on its investment in SciSparc U.
Recently Issued Accounting Pronouncements
w.Recently Issued Accounting Pronouncements

Recent Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendment also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

XML 61 R32.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:
    %
Computers equipment   33
Office Equipment/Furniture   5-7
Plant & Machinery   5
Leasehold improvements   Shorter of remaining lease term or estimated useful life

 

XML 62 R33.htm IDEA: XBRL DOCUMENT v3.24.1
Other Receivables (Tables)
12 Months Ended
Dec. 31, 2023
Other Receivables [Abstract]  
Schedule of Other Receivables
   December 31, 
   2023   2022 
   U.S. dollars in thousands 
Advances to suppliers   559    641(*)
Government institutions   38    130 
Other receivables   
-
    8 
    597    779 
(*)As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information.
XML 63 R34.htm IDEA: XBRL DOCUMENT v3.24.1
Inventory (Tables)
12 Months Ended
Dec. 31, 2023
Inventory [Abstract]  
Schedule of Inventory
   December 31, 
   2023   2022 
   U.S. dollars in thousands 
Goods in transit   219    8 
Finished goods   2,167    1,783 
    2,386    1,791 
XML 64 R35.htm IDEA: XBRL DOCUMENT v3.24.1
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2023
Intangible Assets [Abstract]  
Schedule of Total Intangible Assets Total intangible assets consisted of the following as of December 31, 2023 and 2022:
   December 31, 2023 
   Gross
Amount
   Accumulated
Amortization
   Net
Balance
 
   U.S. dollars in thousands 
Brands   7,774    (2,060)   5,714 
   December 31, 2022 
   Gross
Amount
   Accumulated
Amortization
   Net
Balance
 
   U.S. dollars in thousands 
Brands   5,783    (1,331)   4,452 
XML 65 R36.htm IDEA: XBRL DOCUMENT v3.24.1
Leases (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of Future Lease Payments Under Operating Leases Future lease payments under operating leases as of December 31, 2023, were as follows:
2024  $95 
2025  $43 
Total future operating lease payments  $138 
Less: imputed interest  $(11)
Present value of lease liability  $127 
XML 66 R37.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate (Tables)
12 Months Ended
Dec. 31, 2023
Investments in Affiliates [Abstract]  
Schedule of Activity in the Investment in Wellution Account The activity in the investment in SciSparc U.S account was as follows:
   February 23,
2023 –
December 31,
2023
 
   USD in
thousands
 
Balance as of January 1, 2023   
-
 
Purchase on February 23, 2023   3,189 
Equity losses   (1,249)
Balance as of December 31, 2023   1,940 

 

Schedule of Summarized Balance Sheet Summarized balance sheet of SciSparc U.S:
   December 31,
2023
 
   USD in
thousands
 
Current assets   924 
Long-term assets   3,189 
Current liabilities   (154)
Equity   3,959 
Schedule of Summarized of Statement of Operation Summarized statement of statement of operation of SciSparc U.S:
   February 22,
2023 –
December 31,
2023
 
   USD in
thousands
 
Revenues   (2,137)
Cost of sales   1,409 
Impairment of intangible asset   1,042 
General and administrative   748 
Sales and marketing   468 
Taxes on income   22 
Net loss   1,552 
Schedule of Activity in the Investment in SciSparc Shares The activity in the investment in SciSparc’s shares was as follows:
   March 23,
2023 –
December 31,
2023
 
   USD in
thousands
 
Balance as of January 1, 2023   
-
 
Value of shares obtained in connection with share exchange on March 23, 2023   288 
Change in fair value   (221)
Balance as of December 31, 2023   67 
XML 67 R38.htm IDEA: XBRL DOCUMENT v3.24.1
Other Payables (Tables)
12 Months Ended
Dec. 31, 2023
Other Payables [Abstract]  
Schedule of Other Payables
    December 31,  
    2023   2022  
    U.S. dollars in thousands  
Government institutions     428     36  
Employees and related benefits     85     49  
Operating lease liabilities     82     40  
Liability to sellers     (*)430     -  
Revenue sharing payment payable     140     40  
Accrued expenses and other payables     368     226  
               
      1,533     391  
(*)Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information.
XML 68 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Derivative Liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Derivative Liabilities [Abstract]  
Schedule of Fair Value of the Derivative Warrant Liability The following table presents changes in the fair value of the derivative warrant liability (in thousands)
Balance as of December 31, 2021  $137 
Issuance of warrants in connection with the IPO   8,220 
Change in fair value   (2,822)
Classification to additional paid in capital   (3,319)
Balance as of December 31, 2022   2,216 
Change in fair value   (841)
Balance as of December 31, 2023   1,375 

 

Schedule of Fair Value of the IPO Warrants and Additional Warrants The following table lists the significant unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:
   2023   2022 
Expected volatility   101.39%   77.57%-78.89%
Exercise price  $14.14    $14.14 
Share price  $3.05   $10.71-13.055 
Risk-free interest rate   3.93%   3.27%-4.04%
Dividend yield   -    - 
Expected life   3.91    3-4.74 
WACC   20.4%   21.5%-23.3%
XML 69 R40.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2023
Taxes on Income [Abstract]  
Schedule of Income (Loss) Before Taxes For financial reporting purposes loss before taxes includes the following components:
   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands 
Israel   (2,866)   (2,081)   (1,096)
Foreign   (1,700)   (126)   (465)
                
    (4,566)   (2,207)   (1,561)
Schedule of Income Tax Expense (Benefit) Income tax expense (benefit) was as follows:
    Year ended December 31  
    2023     2022     2021  
Current:   U.S. dollars in thousands  
Israel   7     -     -  
Foreign     78       12       94  
Total current income tax expense     85       12       94  
Deferred:                        
Israel     -       -       -  
Foreign     (53 )     (18 )     (115 )
Total deferred tax income     (53 )     (18 )     (115 )
Total tax (benefit) expense     32       (6 )     (21

 

Schedule of Statutory Income Tax Rate to Effective Income Tax Rate A reconciliation of the Group’s statutory income tax rate to effective income tax rate is as follows:
   December 31, 
   2023   2022   2021 
   U.S. dollars in thousands 
Loss before taxes on income   (4,566)   (2,207)   (1,561)
Statutory tax rate   23%   23%   23%
Tax (tax benefit) computed at the statutory tax rate   (1,050)   (508)   (359)
Increase (decrease) in taxes on income resulting from the following:               
Tax rate differences applicable to subsidiaries   (46)   (110)   (78)
Tax losses and timing differences for which deferred taxes were not recognized   1,128    612    416 
Taxes on income   32   (6)   (21)
Schedule of Deferred Taxes Assets and Liabilities Deferred taxes are comprised of the following components:
   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Deferred tax asset        
Intangible assets   388    110 
Operating lease right of use asset   28    32 
Operating loss carryforward   1,476    890 
Total deferred tax assets   1,892    1,032 
Valuation allowance   (1,696)   (890)
Total deferred tax assets after valuation allowance   196    142 
           
Deferred tax liabilities          
           
Operating lease liability   28    32 
Total deferred tax liability   28    32 
           
Net deferred tax assets   168    110 
XML 70 R41.htm IDEA: XBRL DOCUMENT v3.24.1
Share Capital (Tables)
12 Months Ended
Dec. 31, 2023
Share Capital [Abstract]  
Schedule of Share Capital Composed of Ordinary Shares The share capital composed of ordinary shares as follows:
   Number of ordinary shares
December 31
 
   2023   2022 
Issued (*)   1,215,512    1,153,461 
Authorized   43,567,567    43,567,567 
(*) Retroactively adjusted.
XML 71 R42.htm IDEA: XBRL DOCUMENT v3.24.1
Finance (Income) Expense, Net (Tables)
12 Months Ended
Dec. 31, 2023
Finance (Income) Expense, Net [Abstract]  
Schedule of Finance (Income) Expense, Net
   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands 
Finance income:            
Change in fair value of derivative liabilities   (841)   (2,822)   - 
Interest income   (4)   -    (14)
Total finance income   (845)   (2,822)   (14)
Finance expense:               
Finance expenses in respect of third-party loan   -    83    77 
Change in fair value of derivative liabilities   -    -    75 
Amortization of loan discount   -    37    85 
Exchange rate differences   91    156    10 
Interest expense on loans from shareholders and related parties   -    203    381 
Other finance expenses   10    38    15 
Revaluation of securities -fair value through profit or loss   221    -    - 
Total finance expenses   322    517    643 
Finance (income) expense, net   (523)   (2,305)   629 
XML 72 R43.htm IDEA: XBRL DOCUMENT v3.24.1
Net Loss Per Share Attributable to Ordinary Shareholders (Tables)
12 Months Ended
Dec. 31, 2023
Net Income (Loss) Per Share Attributable to Ordinary Shareholders [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders:
   Year ended December 31 
   2023   2022   2021 
   U.S. dollars in thousands (*) 
Numerator:            
Net loss applicable to shareholders of ordinary shares   (4,598)   (2,201)   (1,540)
                
Denominator:               
Shares of ordinary share used in computing basic and diluted net loss per share   1,184,484    663,411    413,192 
Net loss per share of ordinary share, basic and diluted   (3.88)   (3.32)   (3.73)

 

Schedule of Diluted Weighted Average Shares Outstanding The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:
   Year ended December 31 
   2023   2022   2021 
             
IPO Warrants and Additional Warrants (Note 13)   6,541,998    6,541,998    - 
Underwriter warrants (Note 13)   611,785    611,785    - 
Other warrants   78,661    78,661    - 
    7,232,444    7,232,444    - 
(*) except share and per share data
XML 73 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Related Parties (Tables)
12 Months Ended
Dec. 31, 2023
Related Parties [Abstract]  
Schedule of Transactions with Interested and Related Parties Transactions with related parties:
   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Labor cost and related expenses (included in general and administrative) (c1)   249    358 
Directors’ fees (included in general and administrative)   282    172 
Consulting fees (included in general and administrative) (c2)   180    218 
Inventory storage (included in cost of sale) (c2)   545    395 
Revenue sharing payment (included in general and administrative) (c6)   40    6 
Other income, net (c4)   (255)   - 
Interest expenses on loans from related parties and shareholders   -    203 
    1,041    1,352 

  1. On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).
  2. On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.

 

  4. As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.
  6. During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.
Schedule of balances with interested and related parties Balances with interested and related parties:
   Year ended December 31, 
   2023   2022 
   U.S. dollars in thousands 
Assets:        
Advances to suppliers (c2)   -    228 
    -    228 
Liabilities:          
Related parties (c3), (c4)   66    32 
Chief executive officer salary (included in other account payable) (c1)   18    - 
Revenue sharing payment (included in other account payable) (c6)   21    6 
Liability to SciSparc (included in other account payable) (c7)   98    - 
Liability to supplier (included in trade payable) (c2)   69    - 
Liability to consultant (included in other account payable) (c2)   17    - 
    289    38 
  1. On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).
  2. On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.

 

  3. On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively.
  4. As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.
  5. During September 2022, the Group repaid: (i) a related party balance to Medigus, in the amount of $150 thousand and (ii) another related party balance in the amount of $175 thousand and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing of the IPO.
  6. During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.
  7. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.
XML 74 R45.htm IDEA: XBRL DOCUMENT v3.24.1
Geographical Information (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Geographic Areas Revenues are attributed to geographic areas:
   Year ended
December 31,
 
   2023   2022   2021 
   USD in thousands 
             
America   3,863    5,422    6,402 
Europe   6,145    437    107 
    10,008    5,859    6,509 
XML 75 R46.htm IDEA: XBRL DOCUMENT v3.24.1
General Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 29, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
General Information [Line Items]        
Bonus shares and reverse share split, description   On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of common stock of SciSparc Nutraceuticals Inc. (“SciSparc U.S”).    
Net loss   $ (4,598) $ (2,201) $ (1,540)
Net cash provided by (Used in) operating activities   (2,668) (4,840) $ (863)
Accumulated deficit   $ (8,276) $ (3,678)  
Subsequent Event [Member]        
General Information [Line Items]        
Private placement transaction $ 7,275      
XML 76 R47.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Summary of Significant Accounting Policies [Line Items]      
Estimated useful lives 10 years    
Allowance for returns $ 21,000 $ 70,000  
Sales and marketing expenses $ 719,000 $ 1,163,000 $ 1,211,000
Monthly contribution percentage 8.33%    
Employee contribution   50.00%  
Impairment loss $ 955    
Minimum [Member]      
Summary of Significant Accounting Policies [Line Items]      
Employee contribution 3.00%    
XML 77 R48.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Details) - Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives
12 Months Ended
Dec. 31, 2023
Computers equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment percentage 33 years
Office Equipment/Furniture [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment percentage 5 years
Office Equipment/Furniture [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment percentage 7 years
Plant & Machinery [Member]  
Property, Plant and Equipment [Line Items]  
Property and equipment percentage 5 years
Leasehold improvements [Member[  
Property, Plant and Equipment [Line Items]  
Property and equipment term Shorter of remaining lease term or estimated useful life
XML 78 R49.htm IDEA: XBRL DOCUMENT v3.24.1
Other Receivables (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Other Receivables [Abstract]  
Pure capital amoun $ 228
XML 79 R50.htm IDEA: XBRL DOCUMENT v3.24.1
Other Receivables (Details) - Schedule of Other Receivables - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Schedule of Other Receivables [Abstract]    
Advances to suppliers $ 559 $ 641 [1]
Government institutions 38 130
Other receivables 8
Total $ 597 $ 779
[1] As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information.
XML 80 R51.htm IDEA: XBRL DOCUMENT v3.24.1
Inventory (Details) - Schedule of Inventory - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Inventory [abstract]    
Goods in transit $ 219 $ 8
Finished goods 2,167 1,783
Total $ 2,386 $ 1,791
XML 81 R52.htm IDEA: XBRL DOCUMENT v3.24.1
Intangible Assets (Details)
12 Months Ended
Feb. 29, 2024
USD ($)
Feb. 29, 2024
EUR (€)
Mar. 09, 2023
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 20, 2023
USD ($)
Sep. 20, 2023
EUR (€)
Mar. 09, 2023
USD ($)
Mar. 09, 2023
EUR (€)
Intangible Assets (Details) [Line Items]                    
Amortization expense       $ 730,000 $ 570,000 $ 524,000        
Finite-Lived Intangible Asset, Expected Amortization, Year One       769,000            
Share capital issued and outstanding                 $ 2,400,000 € 2,000,000
Outstanding liability       $ 332,000            
Acquisition amortized (in Euro) | €     € 1,991,000              
Consulting agreement amount             $ 4,500 € 3,500 $ 3,000 € 2,500
Subsequent Event [Member]                    
Intangible Assets (Details) [Line Items]                    
Amount payments $ 128,000 € 100,000                
XML 82 R53.htm IDEA: XBRL DOCUMENT v3.24.1
Intangible Assets (Details) - Schedule of Total Intangible Assets - Brands [Member] - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Schedule of Total Intangible Assets [Line Items]    
Gross Amount $ 7,774 $ 5,783
Accumulated Amortization (2,060) (1,331)
Net Balance $ 5,714 $ 4,452
XML 83 R54.htm IDEA: XBRL DOCUMENT v3.24.1
Leases (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Remaining useful life 3 years  
Operating lease $ 127 $ 138
Operating Lease, Weighted Average Remaining Lease Term 3 years  
Operating Lease, Weighted Average Discount Rate, Percent 10.00%  
XML 84 R55.htm IDEA: XBRL DOCUMENT v3.24.1
Leases (Details) - Schedule of Future Lease Payments Under Operating Leases
$ in Thousands
Dec. 31, 2023
USD ($)
Schedule of Future Lease Payments Under Operating Leases [Abstract]  
2024 $ 95
2025 43
Total future operating lease payments 138
Less: imputed interest (11)
Present value of lease liability $ 127
XML 85 R56.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate (Details)
₪ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2023
USD ($)
Mar. 22, 2023
USD ($)
$ / shares
shares
Feb. 23, 2023
USD ($)
shares
Sep. 01, 2022
USD ($)
Sep. 01, 2022
ILS (₪)
Oct. 26, 2022
USD ($)
Oct. 26, 2022
ILS (₪)
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
Investments in Affiliates [Line Items]                  
Outstanding amount               $ 98  
Bonus   $ 51   $ 140 ₪ 480 $ 121 ₪ 425    
Reduction of monthly fee $ 10                
Outstanding payable               $ 12  
Par value per share (in Dollars per share) | $ / shares [1]              
Exchange shares (in Shares) | shares               13,858  
Dividing number of exchange shares acquired   $ 288              
Jeffs' Brands Holding [Member]                  
Investments in Affiliates [Line Items]                  
Owns votings rights percent               49.00%  
Maximum [Member]                  
Investments in Affiliates [Line Items]                  
Outstanding payable               $ 15  
Percentage of exchange shares   4.99%              
Minimum [Member]                  
Investments in Affiliates [Line Items]                  
Outstanding payable               8  
Percentage of exchange shares   2.97%              
SciSparc U.S [Member]                  
Investments in Affiliates [Line Items]                  
Shares acquired (in Shares) | shares     57            
Percentage of issued and outstanding common stock     49.00%            
Cash     $ 3,000            
Management services cost   $ 20              
Outstanding payable               8  
Loss an impairment related to investment               955  
SciSparc [Member]                  
Investments in Affiliates [Line Items]                  
Outstanding payable               $ 15  
Issuance of ordinary shares (in Shares) | shares   35,345              
Par value per share (in Dollars per share) | $ / shares                
Exchange shares (in Shares) | shares   13,858              
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 86 R57.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Schedule of Activity in the Investment in Wellution Account [Abstract]  
Balance at beginning
Purchase on February 23, 2023 3,189
Equity losses (1,249)
Balance at ending $ 1,940
XML 87 R58.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate (Details) - Schedule of Summarized Balance Sheet - Wellution account [Member]
$ in Thousands
Dec. 31, 2023
USD ($)
Condensed Balance Sheet Statements, Captions [Line Items]  
Current assets $ 924
Long-term assets 3,189
Current liabilities (154)
Equity $ 3,959
XML 88 R59.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate (Details) - Schedule of Summarized of Statement of Operation - Wellution [Member]
$ in Thousands
10 Months Ended
Dec. 31, 2023
USD ($)
Condensed Income Statements, Captions [Line Items]  
Revenues $ (2,137)
Cost of sales 1,409
Impairment of intangible asset 1,042
General and administrative 748
Sales and marketing 468
Taxes on income 22
Net loss $ 1,552
XML 89 R60.htm IDEA: XBRL DOCUMENT v3.24.1
Investment in Affiliate (Details) - Schedule of Activity in the Investment in SciSparc Shares - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Activity in the Investment in SciSparc Shares [Abstract]        
Balance as of January 1, 2023      
Value of shares obtained in connection with share exchange on March 23, 2023 288      
Change in fair value (221) $ 221
Balance as of December 31, 2023 $ 67 $ 67    
XML 90 R61.htm IDEA: XBRL DOCUMENT v3.24.1
Other Payables (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Other Payables [Abstract]  
Other payable $ 98
XML 91 R62.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule of Other Payables (Details) - Schedule of Other Payables - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Payables And Accruals Abstract    
Other Liabilities $ 428 $ 36
Employee-related Liabilities, Current $ 85 $ 49
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other Accrued Liabilities, Current Other Accrued Liabilities, Current
Operating Lease, Cost $ 82 $ 40
Notes Payable [1] 430  
undefined 140 40
Accrued Liabilities and Other Liabilities 368 226
Other Accrued Liabilities, Current $ 1,533 $ 391
[1]
(*)Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information.
XML 92 R63.htm IDEA: XBRL DOCUMENT v3.24.1
Short-Term Loans (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Aug. 30, 2022
Jun. 02, 2022
May 09, 2022
Mar. 03, 2022
Jul. 31, 2021
Dec. 31, 2021
Feb. 22, 2022
Short-Term Loans [Line Items]              
Aggregate amount     $ 152   $ 750    
Bears annual interest percentage     9.99%   10.00%    
Additional interest rate         1.00%    
Aggregate amount         $ 250    
Fair value amount         $ 62    
Derivative Liability, Statement of Financial Position [Extensible Enumeration]           Derivative liabilities  
Derivate liability           $ 137  
Finance expenses           $ 14  
Line of Credit Facility, Maximum Borrowing Capacity             $ 1,000
Proceeds from Lines of Credit   $ 200   $ 400      
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]              
Short-Term Loans [Line Items]              
Interest rate             3.25%
Ordinary Shares [Member]              
Short-Term Loans [Line Items]              
Ordinary shares (in Shares) 8,586            
Warrant [Member]              
Short-Term Loans [Line Items]              
Warrants issued (in Shares) 60,096            
Exercise price per share (in Dollars per share) $ 28.28            
XML 93 R64.htm IDEA: XBRL DOCUMENT v3.24.1
Derivative Liabilities (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Nov. 28, 2022
Dec. 31, 2023
Dec. 31, 2022
Aug. 30, 2022
Derivative Liabilities [Line Items]        
Additional warrants 403,504      
Fair value amount   $ 8,200    
Exercise price per share $ 14.14     $ 14.14
Percentage of gross revenues 2.30%      
Revenue sharing payment   $ 269 $ 40  
IPO [Member]        
Derivative Liabilities [Line Items]        
Additional warrants 2,824,525 3,717,473    
Fair value amount   $ 841 $ 2,710  
Ordinary Shares [Member]        
Derivative Liabilities [Line Items]        
Additional warrants 403,504 531,068    
XML 94 R65.htm IDEA: XBRL DOCUMENT v3.24.1
Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Warrant Liability - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Fair Value of the Derivative Warrant Liability [Abstract]      
Balance at beginning $ 2,216 $ 137  
Issuance of warrants in connection with the IPO   8,220  
Change in fair value (841) (2,822) $ 75
Classification to additional paid in capital   (3,319)  
Balance at ending $ 1,375 $ 2,216 $ 137
XML 95 R66.htm IDEA: XBRL DOCUMENT v3.24.1
Derivative Liabilities (Details) - Schedule of Fair Value of the IPO Warrants and Additional Warrants
Dec. 31, 2023
Dec. 31, 2022
Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability 101.39  
Measurement Input, Exercise Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability 14.14 14.14
Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability 3.05  
Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability 3.93  
Measurement Input, Discount Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability
Measurement Input, Expected Term [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability 3.91  
Measure Input, Weighted Average Cost of Capital [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability 20.4  
Minimum [Member] | Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   77.57
Minimum [Member] | Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   10.71
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   3.27
Minimum [Member] | Measurement Input, Expected Term [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   3
Minimum [Member] | Measure Input, Weighted Average Cost of Capital [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   21.5
Maximum [Member] | Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   78.89
Maximum [Member] | Measurement Input, Share Price [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   13.055
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   4.04
Maximum [Member] | Measurement Input, Expected Term [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   4.74
Maximum [Member] | Measure Input, Weighted Average Cost of Capital [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Measurement Input, Derivative Liability   23.3
XML 96 R67.htm IDEA: XBRL DOCUMENT v3.24.1
Loans from Shareholders (Details) - USD ($)
$ in Thousands
12 Months Ended
Aug. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
May 03, 2022
Loans from Shareholders [Line Items]          
Equity amount   $ 14  
Aggregate share (in Shares) 209,088        
Accrued interest $ 393        
IPO [Member]          
Loans from Shareholders [Line Items]          
Dividing stock   10,000      
Loan Payable to Shareholders - Pure Capital [Member]          
Loans from Shareholders [Line Items]          
Financial liability   3,821      
Financial instrument   2,839      
Loan Payable to Shareholders - Pure Capital [Member] | IPO [Member]          
Loans from Shareholders [Line Items]          
Equity amount   $ 982      
Mr. Hakmon and L.I.A [Member] | Loan Payable to Shareholders - Pure Capital [Member]          
Loans from Shareholders [Line Items]          
Outstanding loan         $ 940
Pure Capital Ltd. [Member] | Loan Payable to Shareholders - Pure Capital [Member]          
Loans from Shareholders [Line Items]          
Outstanding loan         109
Medigus [Member] | Loan Payable to Shareholders - Pure Capital [Member]          
Loans from Shareholders [Line Items]          
Outstanding loan         $ 4,010
Medigus [Member] | Mr. Hakmon and L.I.A [Member] | Pure Capital Ltd. [Member]          
Loans from Shareholders [Line Items]          
Capital amount $ 5,059        
XML 97 R68.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Taxes on Income [Line Items]    
Blended corporate tax rate 28.00%  
Carry forward tax losses (in Dollars) $ 6,418 $ 3,870
Israeli Tax Laws [Member]    
Taxes on Income [Line Items]    
Blended corporate tax rate 23.00%  
UK tax law [Member]    
Taxes on Income [Line Items]    
Blended corporate tax rate 19.00%  
XML 98 R69.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Details) - Schedule of Income (Loss) Before Taxes - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Income (Loss) Before Taxes [Abstract]      
Israel $ (2,866) $ (2,081) $ (1,096)
Foreign (1,700) (126) (465)
Income (loss) before taxes $ (4,566) $ (2,207) $ (1,561)
XML 99 R70.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Details) - Schedule of Income Tax Expense (Benefit) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Income Tax Expense (Benefit) [Abstract]      
Israel $ 7
Foreign 78 12 94
Total current income tax expense 85 12 94
Deferred:      
Israel
Foreign (53) (18) (115)
Total deferred tax income (53) (18) (115)
Total tax (benefit) expense $ 32 $ (6) $ (21)
XML 100 R71.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Details) - Schedule of Statutory Income Tax Rate to Effective Income Tax Rate - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Statutory Income Tax Rate to Effective Income Tax Rate [Abstract]      
Loss before taxes on income $ (4,566) $ (2,207) $ (1,561)
Statutory tax rate 23.00% 23.00% 23.00%
Tax (tax benefit) computed at the statutory tax rate $ (1,050) $ (508) $ (359)
Tax rate differences applicable to subsidiaries (46) (110) (78)
Tax losses and timing differences for which deferred taxes were not recognized 1,128 612 416
Taxes on income $ 32 $ (6) $ (21)
XML 101 R72.htm IDEA: XBRL DOCUMENT v3.24.1
Taxes on Income (Details) - Schedule of Deferred Taxes Assets and Liabilities - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Deferred tax asset    
Intangible assets $ 388 $ 110
Operating lease right of use asset 28 32
Operating loss carryforward 1,476 890
Total deferred tax assets 1,892 1,032
Valuation allowance (1,696) (890)
Total deferred tax assets after valuation allowance 196 142
Deferred tax liabilities    
Operating lease liability 28 32
Total deferred tax liability 28 32
Net deferred tax assets $ 168 $ 110
XML 102 R73.htm IDEA: XBRL DOCUMENT v3.24.1
Share Capital (Details)
12 Months Ended
Aug. 30, 2023
Nov. 28, 2022
$ / shares
shares
Aug. 30, 2022
USD ($)
$ / shares
shares
Jun. 16, 2022
May 03, 2022
Feb. 17, 2022
USD ($)
shares
Dec. 31, 2023
$ / shares
shares
Nov. 14, 2023
shares
Dec. 31, 2022
shares
Share Capital [Line Items]                  
Issuance of stock dividend           664.0547      
Aggregate issuance share (in Dollars) | $           $ 6,630,547      
Authorized share capital (in Dollars) | $           100,000,000      
Reverse Shares (in Dollars) | $           $ 43,567,567      
Reverse split       On June 16, 2022, the Company’s Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June 16, 2022, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85 Ordinary Shares held as of such date. On May 3, 2022, the Company’s Board of Directors approved a 0.806-for-1 reverse split of its issued and outstanding Ordinary Shares, effective as of May 3, 2022, pursuant to which holders of the Company’s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.        
Issued and outstanding shares [1]             1,215,512   1,153,461
Price per share (in Dollars per share) | $ / shares             $ 42.42    
Initial exercise price expire     5 years            
Exercise price (in Dollars per share) | $ / shares   $ 14.14 $ 14.14            
Exercise price less (in Dollars per share) | $ / shares     $ 14.14            
Exercise price (in Dollars per share) | $ / shares   $ 14.14              
Revenues percentage   2.30%              
Proceeds from Warrant Exercises (in Dollars) | $     $ 4,000            
Issuance of bonus shares           1      
Aggregate issuance shares           7      
Underwriter’s Warrants [Member]                  
Share Capital [Line Items]                  
Purchase of warrants     185,873            
Ordinary shares     26,554            
Exercise price (in Dollars per share) | $ / shares     $ 36.4            
Issuance costs (in Dollars) | $     $ 109,000            
Warrant [Member]                  
Share Capital [Line Items]                  
Exercise price (in Dollars per share) | $ / shares     $ 28,280            
IPO [Member]                  
Share Capital [Line Items]                  
Issued and outstanding shares             413,304    
Purchase of warrants     531,069            
Ordinary shares     60,845            
Unit, Price per Unit (in Dollars per share) | $ / shares     $ 29.12            
Price per share (in Dollars per share) | $ / shares     $ 28.28            
Additional warrant term             5 years    
Additional warrants description             Applicable issuance costs, amounting to $2,193 thousand, were allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and was recorded in the consolidated statement of operations, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand were recorded in equity as a reduction of the paid in capital for the year ended December 31, 2023.    
Issuance of period term 3 years                
IPO [Member] | Warrant [Member]                  
Share Capital [Line Items]                  
Ordinary shares     425,912            
IPO [Member] | Advisor Warrants [Member]                  
Share Capital [Line Items]                  
Purchase of warrants     18,565            
Exercise price (in Dollars per share) | $ / shares   $ 14.14 $ 28.28            
Warrants and Rights Outstanding, Term     2653 years            
Over-Allotment Option [Member]                  
Share Capital [Line Items]                  
Proceeds from Issuance or Sale of Equity (in Dollars) | $     $ 15,500,000            
Issuance costs (in Dollars) | $     $ 1,000            
Common Stock [Member]                  
Share Capital [Line Items]                  
Ordinary shares     8,586            
Warrants purchase shares   2,824,525              
Purchase of additional warrant   403,504              
Common Stock [Member] | IPO [Member]                  
Share Capital [Line Items]                  
Purchase of warrants     531,069            
Ordinary shares     8,586            
Common Stock [Member] | Over-Allotment Option [Member]                  
Share Capital [Line Items]                  
Ordinary shares     3,717,473            
Reduction to Additional Paid in Capital [Member] | Underwriter’s Warrants [Member]                  
Share Capital [Line Items]                  
Issuance costs (in Dollars) | $     $ 51,000            
Reduction to Additional Paid in Capital [Member] | Over-Allotment Option [Member]                  
Share Capital [Line Items]                  
Issuance costs (in Dollars) | $     500            
Board of Directors [Member] | Common Stock [Member]                  
Share Capital [Line Items]                  
Ordinary shares               26,706  
Finance Expense [Member] | Underwriter’s Warrants [Member]                  
Share Capital [Line Items]                  
Issuance costs (in Dollars) | $     58,000            
Finance Expense [Member] | Over-Allotment Option [Member]                  
Share Capital [Line Items]                  
Issuance costs (in Dollars) | $     $ 500            
Pure Capital Ltd. [Member]                  
Share Capital [Line Items]                  
Conversion of outstanding amounts into shares     209,088            
Mr. Hakmon [Member]                  
Share Capital [Line Items]                  
Conversion of outstanding amounts into shares     209,088            
Medigus [Member]                  
Share Capital [Line Items]                  
Agreement description             The Ordinary Shares confer upon their holders the following rights: (i) the right to vote in any general meeting of the Company, (ii) the right to receive dividends, if and when declared by the Board of Directors and (iii) the right to receive upon liquidation of the Company a sum equal to the nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares which may be issued in the future.    
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 103 R74.htm IDEA: XBRL DOCUMENT v3.24.1
Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares - Common Stock [Member] - shares
Dec. 31, 2023
Dec. 31, 2022
Schedule of Share Capital Composed of Ordinary Shares [Line Items]    
Issued [1] 1,215,512 1,153,461
Authorized 43,567,567 43,567,567
[1] Retroactively adjusted.
XML 104 R75.htm IDEA: XBRL DOCUMENT v3.24.1
Share Incentive Plan (Details)
Dec. 31, 2023
shares
Share Incentive Plan [Abstract]  
Total ordinary shares 186,718
XML 105 R76.htm IDEA: XBRL DOCUMENT v3.24.1
Finance (Income) Expense, Net (Details) - Schedule of Finance (Income) Expense, Net - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Finance income:        
Change in fair value of derivative liabilities   $ (841) $ (2,822)
Interest income   (4) (14)
Total finance income   (845) (2,822) (14)
Finance expense:        
Finance expenses in respect of third-party loan   83 77
Change in fair value of derivative liabilities   75
Amortization of loan discount   37 85
Exchange rate differences   91 156 10
Interest expense on loans from shareholders and related parties   203 381
Other finance expenses   10 38 15
Revaluation of securities -fair value through profit or loss $ (221) 221
Total finance expenses   322 517 643
Finance (income) expense, net   $ (523) $ (2,305) $ 629
XML 106 R77.htm IDEA: XBRL DOCUMENT v3.24.1
Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders [Abstract]      
Net loss applicable to shareholders of ordinary shares $ (4,598) $ (2,201) $ (1,540)
Shares of ordinary share used in computing basic net loss per share 1,184,484 663,411 [1] 413,192 [1]
Net loss per share of ordinary share, basic $ (3.88) $ (3.32) [1] $ (3.73) [1]
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 107 R78.htm IDEA: XBRL DOCUMENT v3.24.1
Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Parentheticals) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
[1]
Dec. 31, 2021
[1]
Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders [Abstract]      
Shares of ordinary share used in computing diluted net loss per share 1,184,484 663,411 413,192
Net loss per share of ordinary share, diluted $ (3.88) $ (3.32) $ (3.73)
[1] Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13.
XML 108 R79.htm IDEA: XBRL DOCUMENT v3.24.1
Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Diluted Weighted Average Shares Outstanding - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
[1]
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Diluted weighted average shares outstanding 7,232,444 7,232,444
Warrant [Member] | IPO and Additional Warrants [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Diluted weighted average shares outstanding 6,541,998 6,541,998
Warrant [Member] | Underwriter’s Warrants [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Diluted weighted average shares outstanding 611,785 611,785
Warrant [Member] | Other warrants [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Diluted weighted average shares outstanding 78,661 78,661
[1] except share and per share data
XML 109 R80.htm IDEA: XBRL DOCUMENT v3.24.1
Related Parties (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2023
USD ($)
Mar. 22, 2023
USD ($)
Sep. 01, 2022
USD ($)
Sep. 01, 2022
ILS (₪)
Aug. 03, 2022
USD ($)
Aug. 03, 2022
ILS (₪)
May 21, 2022
Mar. 31, 2023
USD ($)
Oct. 26, 2022
USD ($)
Oct. 26, 2022
ILS (₪)
Sep. 30, 2022
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
ILS (₪)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Related Parties [Line Items]                              
Bonus   $ 51,000 $ 140,000 ₪ 480,000         $ 121,000 ₪ 425,000          
Consultancy services fees               $ 352,000 $ 16,500 ₪ 57,500          
Percentage of gross proceed                 7.00% 7.00%          
Percentage of total consideration paid                 8.00% 8.00%          
Undefined period of time                 3 years 3 years          
Percentage lease and maintenance expenses related             50.00%                
Lease and maintenance expenses related                           $ 86,000  
Percentage of salary of employee                           50.00%  
Employee provided services                       $ 3,000 ₪ 10,000    
Outstanding payable                       12,000      
Issued to the minority Shareholder                       288,000  
Reduction of monthly fee $ 10,000                            
Revenue sharing payment                       269,000   40,000  
Amount of outstanding due                       $ 98,000      
SciSparc U.S [Member]                              
Related Parties [Line Items]                              
Voting rights percent                       49.00% 49.00%    
Board of Directors [Member]                              
Related Parties [Line Items]                              
Salary     $ 23,000 ₪ 80,000 $ 23,000 ₪ 55,000                  
Minority Shareholder [Member]                              
Related Parties [Line Items]                              
Issued to the minority Shareholder   $ 20,000                          
Medigus [Member]                              
Related Parties [Line Items]                              
Outstanding payable                       $ 43,000   32,000  
Repayments of Related Party Debt                     $ 150,000        
Revenue sharing payment                       23,000      
SciSparc [Member]                              
Related Parties [Line Items]                              
Outstanding payable                       15,000      
SciSparc U.S [Member]                              
Related Parties [Line Items]                              
Outstanding payable                       8,000      
Related Party [Member]                              
Related Parties [Line Items]                              
Repayments of Related Party Debt                     175,000        
Revenue sharing payment [1]                       21,000   $ 6,000  
Related Party [Member] | Interest Expense [Member]                              
Related Parties [Line Items]                              
Repayments of Related Party Debt                     $ 393,000        
Pure Capital Ltd. [Member]                              
Related Parties [Line Items]                              
Outstanding payable                       9,000      
Revenue sharing payment                       $ 17,000      
[1] During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.
XML 110 R81.htm IDEA: XBRL DOCUMENT v3.24.1
Related Parties (Details) - Schedule of Transactions with Interested and Related Parties - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Transactions with Interested and Related Parties [Abstract]      
Labor cost and related expenses (included in general and administrative) [1] $ 249 $ 358  
Directors’ fees (included in general and administrative) 282 172  
Consulting fees (included in general and administrative) [2] 180 218  
Inventory storage (included in cost of sale) [2] 545 395  
Revenue sharing payment (included in general and administrative) [3] 40 6  
Other income, net [4] (255)  
Interest expenses on loans from related parties and shareholders 203 $ 381
Total transactions with interested and related parties $ 1,041 $ 1,352  
[1] On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).
[2] On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.
[3] During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.
[4] As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.
XML 111 R82.htm IDEA: XBRL DOCUMENT v3.24.1
Related Parties (Details) - Schedule of Balances with Interested and Related parties - Related Party [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Balances with Interested and Related parties [Line Items]    
Advances to suppliers [1] $ 228
Assets 228
Related parties [2],[3] 66 32
Chief executive officer salary (included in other account payable) [4] 18
Revenue sharing payment (included in other account payable) [5] 21 6
Liability to SciSparc (included in other account payable) [6] 98
Liability to supplier (included in trade payable) [1] 69
Liability to consultant (included in other account payable) [1] 17
Liabilities $ 289 $ 38
[1] On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.
[2] As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.
[3] On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively.
[4] On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).
[5] During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.
[6] As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.
XML 112 R83.htm IDEA: XBRL DOCUMENT v3.24.1
Geographical Information (Details) - Schedule of Geographic Areas - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Geographical Information (Details) - Schedule of Geographic Areas [Line Items]      
Revenues $ 10,008 $ 5,859 $ 6,509
America [Member]      
Geographical Information (Details) - Schedule of Geographic Areas [Line Items]      
Revenues 3,863 5,422 6,402
Europe [Member]      
Geographical Information (Details) - Schedule of Geographic Areas [Line Items]      
Revenues $ 6,145 $ 437 $ 107
XML 113 R84.htm IDEA: XBRL DOCUMENT v3.24.1
Subsequent Events (Details)
€ in Thousands, $ in Thousands
12 Months Ended
Feb. 29, 2024
USD ($)
Feb. 29, 2024
EUR (€)
Feb. 05, 2024
USD ($)
Jan. 25, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Aug. 30, 2022
shares
Subsequent Events [Line Items]            
Ordinary shares         2,900,036  
Percentage of gross cash proceeds         8.50%  
Private Placement [Member]            
Subsequent Events [Line Items]            
Aggregate amount (in Dollars) | $         $ 90  
IPO [Member]            
Subsequent Events [Line Items]            
Warrant to purchase shares           60,845
Subsequent Event [Member]            
Subsequent Events [Line Items]            
Aggregate gross proceeds (in Dollars) | $       $ 7,275    
Adjustment amount payments (in Euro) $ 128 € 100        
Subsequent Event [Member] | Ordinary Shares [Member]            
Subsequent Events [Line Items]            
Warrant to purchase shares       13,373,208    
Subsequent Event [Member] | IPO [Member]            
Subsequent Events [Line Items]            
Payment to consultant service (in Dollars) | $     $ 100      
Private Placement [Member] | Subsequent Event [Member]            
Subsequent Events [Line Items]            
Ordinary shares       1,884,461,000,000    
Warrant [Member]            
Subsequent Events [Line Items]            
Ordinary shares         2,900,036  
Warrant [Member] | IPO [Member]            
Subsequent Events [Line Items]            
Warrant to purchase shares           425,912
Warrant [Member] | Subsequent Event [Member]            
Subsequent Events [Line Items]            
Warrant to purchase shares       820,000    
Series A Warrants [Member] | Subsequent Event [Member]            
Subsequent Events [Line Items]            
Warrant to purchase shares       3,380,586    
Series B Warrants [Member] | Subsequent Event [Member]            
Subsequent Events [Line Items]            
Warrant to purchase shares       7,994,181    
EXCEL 114 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 116 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 118 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 180 395 1 true 59 0 false 6 false false R1.htm 995100 - Document - Cover Sheet http://xbrl.sec.gov/dei/role/document/Cover Cover Cover 1 false false R2.htm 995300 - Document - Audit Information Sheet http://xbrl.sec.gov/dei/role/document/AuditInformation Audit Information Cover 2 false false R3.htm 995301 - Statement - Consolidated Balance Sheets Sheet http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 3 false false R4.htm 995302 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 4 false false R5.htm 995303 - Statement - Consolidated Statements of Operations Sheet http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations Statements 5 false false R6.htm 995304 - Statement - Consolidated Statements of Operations (Parentheticals) Sheet http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals Consolidated Statements of Operations (Parentheticals) Statements 6 false false R7.htm 995305 - Statement - Consolidated Statements of Changes in Shareholders??? Equity Sheet http://www.jeffsbrands.com/role/ShareholdersEquityType2or3 Consolidated Statements of Changes in Shareholders??? Equity Statements 7 false false R8.htm 995306 - Statement - Consolidated Statements of Cash Flows Sheet http://www.jeffsbrands.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 8 false false R9.htm 995307 - Statement - Consolidated Statements of Cash Flows (Parentheticals) Sheet http://www.jeffsbrands.com/role/ConsolidatedCashFlow_Parentheticals Consolidated Statements of Cash Flows (Parentheticals) Statements 9 false false R10.htm 995308 - Disclosure - General Information Sheet http://www.jeffsbrands.com/role/GeneralInformation General Information Notes 10 false false R11.htm 995309 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 995310 - Disclosure - Other Receivables Sheet http://www.jeffsbrands.com/role/OtherReceivables Other Receivables Notes 12 false false R13.htm 995311 - Disclosure - Inventory Sheet http://www.jeffsbrands.com/role/Inventory Inventory Notes 13 false false R14.htm 995312 - Disclosure - Intangible Assets Sheet http://www.jeffsbrands.com/role/IntangibleAssets Intangible Assets Notes 14 false false R15.htm 995313 - Disclosure - Leases Sheet http://www.jeffsbrands.com/role/Leases Leases Notes 15 false false R16.htm 995314 - Disclosure - Investment in Affiliate Sheet http://www.jeffsbrands.com/role/InvestmentinAffiliate Investment in Affiliate Notes 16 false false R17.htm 995315 - Disclosure - Other Payables Sheet http://www.jeffsbrands.com/role/OtherPayables Other Payables Notes 17 false false R18.htm 995316 - Disclosure - Short-Term Loans Sheet http://www.jeffsbrands.com/role/ShortTermLoans Short-Term Loans Notes 18 false false R19.htm 995317 - Disclosure - Derivative Liabilities Sheet http://www.jeffsbrands.com/role/DerivativeLiabilities Derivative Liabilities Notes 19 false false R20.htm 995318 - Disclosure - Loans from Shareholders Sheet http://www.jeffsbrands.com/role/LoansfromShareholders Loans from Shareholders Notes 20 false false R21.htm 995319 - Disclosure - Taxes on Income Sheet http://www.jeffsbrands.com/role/TaxesonIncome Taxes on Income Notes 21 false false R22.htm 995320 - Disclosure - Share Capital Sheet http://www.jeffsbrands.com/role/ShareCapital Share Capital Notes 22 false false R23.htm 995321 - Disclosure - Share Incentive Plan Sheet http://www.jeffsbrands.com/role/ShareIncentivePlan Share Incentive Plan Notes 23 false false R24.htm 995322 - Disclosure - Finance (Income) Expense, Net Sheet http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet Finance (Income) Expense, Net Notes 24 false false R25.htm 995323 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders Sheet http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholders Net Loss Per Share Attributable to Ordinary Shareholders Notes 25 false false R26.htm 995324 - Disclosure - Related Parties Sheet http://www.jeffsbrands.com/role/RelatedParties Related Parties Notes 26 false false R27.htm 995325 - Disclosure - Geographical Information Sheet http://www.jeffsbrands.com/role/GeographicalInformation Geographical Information Notes 27 false false R28.htm 995326 - Disclosure - Subsequent Events Sheet http://www.jeffsbrands.com/role/SubsequentEvents Subsequent Events Notes 28 false false R29.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 29 false false R30.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 30 false false R31.htm 996000 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies 31 false false R32.htm 996001 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies 32 false false R33.htm 996002 - Disclosure - Other Receivables (Tables) Sheet http://www.jeffsbrands.com/role/OtherReceivablesTables Other Receivables (Tables) Tables http://www.jeffsbrands.com/role/OtherReceivables 33 false false R34.htm 996003 - Disclosure - Inventory (Tables) Sheet http://www.jeffsbrands.com/role/InventoryTables Inventory (Tables) Tables http://www.jeffsbrands.com/role/Inventory 34 false false R35.htm 996004 - Disclosure - Intangible Assets (Tables) Sheet http://www.jeffsbrands.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.jeffsbrands.com/role/IntangibleAssets 35 false false R36.htm 996005 - Disclosure - Leases (Tables) Sheet http://www.jeffsbrands.com/role/LeasesTables Leases (Tables) Tables http://www.jeffsbrands.com/role/Leases 36 false false R37.htm 996006 - Disclosure - Investment in Affiliate (Tables) Sheet http://www.jeffsbrands.com/role/InvestmentinAffiliateTables Investment in Affiliate (Tables) Tables http://www.jeffsbrands.com/role/InvestmentinAffiliate 37 false false R38.htm 996007 - Disclosure - Other Payables (Tables) Sheet http://www.jeffsbrands.com/role/OtherPayablesTables Other Payables (Tables) Tables http://www.jeffsbrands.com/role/OtherPayables 38 false false R39.htm 996008 - Disclosure - Derivative Liabilities (Tables) Sheet http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://www.jeffsbrands.com/role/DerivativeLiabilities 39 false false R40.htm 996009 - Disclosure - Taxes on Income (Tables) Sheet http://www.jeffsbrands.com/role/TaxesonIncomeTables Taxes on Income (Tables) Tables http://www.jeffsbrands.com/role/TaxesonIncome 40 false false R41.htm 996010 - Disclosure - Share Capital (Tables) Sheet http://www.jeffsbrands.com/role/ShareCapitalTables Share Capital (Tables) Tables http://www.jeffsbrands.com/role/ShareCapital 41 false false R42.htm 996011 - Disclosure - Finance (Income) Expense, Net (Tables) Sheet http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables Finance (Income) Expense, Net (Tables) Tables http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet 42 false false R43.htm 996012 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables) Sheet http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables Net Loss Per Share Attributable to Ordinary Shareholders (Tables) Tables http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholders 43 false false R44.htm 996013 - Disclosure - Related Parties (Tables) Sheet http://www.jeffsbrands.com/role/RelatedPartiesTables Related Parties (Tables) Tables http://www.jeffsbrands.com/role/RelatedParties 44 false false R45.htm 996014 - Disclosure - Geographical Information (Tables) Sheet http://www.jeffsbrands.com/role/GeographicalInformationTables Geographical Information (Tables) Tables http://www.jeffsbrands.com/role/GeographicalInformation 45 false false R46.htm 996015 - Disclosure - General Information (Details) Sheet http://www.jeffsbrands.com/role/GeneralInformationDetails General Information (Details) Details http://www.jeffsbrands.com/role/GeneralInformation 46 false false R47.htm 996016 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables 47 false false R48.htm 996017 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives Sheet http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable Summary of Significant Accounting Policies (Details) - Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives Details http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables 48 false false R49.htm 996018 - Disclosure - Other Receivables (Details) Sheet http://www.jeffsbrands.com/role/OtherReceivablesDetails Other Receivables (Details) Details http://www.jeffsbrands.com/role/OtherReceivablesTables 49 false false R50.htm 996019 - Disclosure - Other Receivables (Details) - Schedule of Other Receivables Sheet http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable Other Receivables (Details) - Schedule of Other Receivables Details http://www.jeffsbrands.com/role/OtherReceivablesTables 50 false false R51.htm 996020 - Disclosure - Inventory (Details) - Schedule of Inventory Sheet http://www.jeffsbrands.com/role/ScheduleofInventoryTable Inventory (Details) - Schedule of Inventory Details http://www.jeffsbrands.com/role/InventoryTables 51 false false R52.htm 996021 - Disclosure - Intangible Assets (Details) Sheet http://www.jeffsbrands.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.jeffsbrands.com/role/IntangibleAssetsTables 52 false false R53.htm 996022 - Disclosure - Intangible Assets (Details) - Schedule of Total Intangible Assets Sheet http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable Intangible Assets (Details) - Schedule of Total Intangible Assets Details http://www.jeffsbrands.com/role/IntangibleAssetsTables 53 false false R54.htm 996023 - Disclosure - Leases (Details) Sheet http://www.jeffsbrands.com/role/LeasesDetails Leases (Details) Details http://www.jeffsbrands.com/role/LeasesTables 54 false false R55.htm 996024 - Disclosure - Leases (Details) - Schedule of Future Lease Payments Under Operating Leases Sheet http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable Leases (Details) - Schedule of Future Lease Payments Under Operating Leases Details http://www.jeffsbrands.com/role/LeasesTables 55 false false R56.htm 996025 - Disclosure - Investment in Affiliate (Details) Sheet http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails Investment in Affiliate (Details) Details http://www.jeffsbrands.com/role/InvestmentinAffiliateTables 56 false false R57.htm 996026 - Disclosure - Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account Sheet http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account Details http://www.jeffsbrands.com/role/InvestmentinAffiliateTables 57 false false R58.htm 996027 - Disclosure - Investment in Affiliate (Details) - Schedule of Summarized Balance Sheet Sheet http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable Investment in Affiliate (Details) - Schedule of Summarized Balance Sheet Details http://www.jeffsbrands.com/role/InvestmentinAffiliateTables 58 false false R59.htm 996028 - Disclosure - Investment in Affiliate (Details) - Schedule of Summarized of Statement of Operation Sheet http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable Investment in Affiliate (Details) - Schedule of Summarized of Statement of Operation Details http://www.jeffsbrands.com/role/InvestmentinAffiliateTables 59 false false R60.htm 996029 - Disclosure - Investment in Affiliate (Details) - Schedule of Activity in the Investment in SciSparc Shares Sheet http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinSciSparcSharesTable Investment in Affiliate (Details) - Schedule of Activity in the Investment in SciSparc Shares Details http://www.jeffsbrands.com/role/InvestmentinAffiliateTables 60 false false R61.htm 996030 - Disclosure - Other Payables (Details) Sheet http://www.jeffsbrands.com/role/OtherPayablesDetails Other Payables (Details) Details http://www.jeffsbrands.com/role/OtherPayablesTables 61 false false R62.htm 996031 - Disclosure - Schedule of Other Payables (Details) - Schedule of Other Payables Sheet http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables Schedule of Other Payables (Details) - Schedule of Other Payables Details 62 false false R63.htm 996032 - Disclosure - Short-Term Loans (Details) Sheet http://www.jeffsbrands.com/role/ShortTermLoansDetails Short-Term Loans (Details) Details http://www.jeffsbrands.com/role/ShortTermLoans 63 false false R64.htm 996033 - Disclosure - Derivative Liabilities (Details) Sheet http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) Details http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables 64 false false R65.htm 996034 - Disclosure - Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Warrant Liability Sheet http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Warrant Liability Details http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables 65 false false R66.htm 996035 - Disclosure - Derivative Liabilities (Details) - Schedule of Fair Value of the IPO Warrants and Additional Warrants Sheet http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable Derivative Liabilities (Details) - Schedule of Fair Value of the IPO Warrants and Additional Warrants Details http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables 66 false false R67.htm 996036 - Disclosure - Loans from Shareholders (Details) Sheet http://www.jeffsbrands.com/role/LoansfromShareholdersDetails Loans from Shareholders (Details) Details http://www.jeffsbrands.com/role/LoansfromShareholders 67 false false R68.htm 996037 - Disclosure - Taxes on Income (Details) Sheet http://www.jeffsbrands.com/role/TaxesonIncomeDetails Taxes on Income (Details) Details http://www.jeffsbrands.com/role/TaxesonIncomeTables 68 false false R69.htm 996038 - Disclosure - Taxes on Income (Details) - Schedule of Income (Loss) Before Taxes Sheet http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable Taxes on Income (Details) - Schedule of Income (Loss) Before Taxes Details http://www.jeffsbrands.com/role/TaxesonIncomeTables 69 false false R70.htm 996039 - Disclosure - Taxes on Income (Details) - Schedule of Income Tax Expense (Benefit) Sheet http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable Taxes on Income (Details) - Schedule of Income Tax Expense (Benefit) Details http://www.jeffsbrands.com/role/TaxesonIncomeTables 70 false false R71.htm 996040 - Disclosure - Taxes on Income (Details) - Schedule of Statutory Income Tax Rate to Effective Income Tax Rate Sheet http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable Taxes on Income (Details) - Schedule of Statutory Income Tax Rate to Effective Income Tax Rate Details http://www.jeffsbrands.com/role/TaxesonIncomeTables 71 false false R72.htm 996041 - Disclosure - Taxes on Income (Details) - Schedule of Deferred Taxes Assets and Liabilities Sheet http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable Taxes on Income (Details) - Schedule of Deferred Taxes Assets and Liabilities Details http://www.jeffsbrands.com/role/TaxesonIncomeTables 72 false false R73.htm 996042 - Disclosure - Share Capital (Details) Sheet http://www.jeffsbrands.com/role/ShareCapitalDetails Share Capital (Details) Details http://www.jeffsbrands.com/role/ShareCapitalTables 73 false false R74.htm 996043 - Disclosure - Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares Sheet http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares Details http://www.jeffsbrands.com/role/ShareCapitalTables 74 false false R75.htm 996044 - Disclosure - Share Incentive Plan (Details) Sheet http://www.jeffsbrands.com/role/ShareIncentivePlanDetails Share Incentive Plan (Details) Details http://www.jeffsbrands.com/role/ShareIncentivePlan 75 false false R76.htm 996045 - Disclosure - Finance (Income) Expense, Net (Details) - Schedule of Finance (Income) Expense, Net Sheet http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable Finance (Income) Expense, Net (Details) - Schedule of Finance (Income) Expense, Net Details http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables 76 false false R77.htm 996046 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders Sheet http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders Details http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables 77 false false R78.htm 996047 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Parentheticals) Sheet http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable_Parentheticals Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Parentheticals) Details http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables 78 false false R79.htm 996048 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Diluted Weighted Average Shares Outstanding Sheet http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Diluted Weighted Average Shares Outstanding Details http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables 79 false false R80.htm 996049 - Disclosure - Related Parties (Details) Sheet http://www.jeffsbrands.com/role/RelatedPartiesDetails Related Parties (Details) Details http://www.jeffsbrands.com/role/RelatedPartiesTables 80 false false R81.htm 996050 - Disclosure - Related Parties (Details) - Schedule of Transactions with Interested and Related Parties Sheet http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable Related Parties (Details) - Schedule of Transactions with Interested and Related Parties Details http://www.jeffsbrands.com/role/RelatedPartiesTables 81 false false R82.htm 996051 - Disclosure - Related Parties (Details) - Schedule of Balances with Interested and Related parties Sheet http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable Related Parties (Details) - Schedule of Balances with Interested and Related parties Details http://www.jeffsbrands.com/role/RelatedPartiesTables 82 false false R83.htm 996052 - Disclosure - Geographical Information (Details) - Schedule of Geographic Areas Sheet http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable Geographical Information (Details) - Schedule of Geographic Areas Details http://www.jeffsbrands.com/role/GeographicalInformationTables 83 false false R84.htm 996053 - Disclosure - Subsequent Events (Details) Sheet http://www.jeffsbrands.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.jeffsbrands.com/role/SubsequentEvents 84 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 13 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:EarningsPerShareDiluted, us-gaap:WarrantsAndRightsOutstandingTerm, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - ea0202280-20f_jeffs.htm 15625, 15626, 15627, 15628, 15629, 15630, 15727, 15737, 15738, 15739, 15740, 15741, 15742 ea0202280-20f_jeffs.htm jfbr-20231231.xsd jfbr-20231231_cal.xml jfbr-20231231_def.xml jfbr-20231231_lab.xml jfbr-20231231_pre.xml image_001.jpg image_002.jpg image_003.jpg image_004.jpg image_005.jpg image_007.jpg image_008.jpg image_009.jpg image_010.jpg image_011.jpg image_012.jpg http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 121 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0202280-20f_jeffs.htm": { "nsprefix": "jfbr", "nsuri": "http://www.jeffsbrands.com/20231231", "dts": { "inline": { "local": [ "ea0202280-20f_jeffs.htm" ] }, "schema": { "local": [ "jfbr-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd", "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd" ] }, "calculationLink": { "local": [ "jfbr-20231231_cal.xml" ] }, "definitionLink": { "local": [ "jfbr-20231231_def.xml" ] }, "labelLink": { "local": [ "jfbr-20231231_lab.xml" ] }, "presentationLink": { "local": [ "jfbr-20231231_pre.xml" ] } }, "keyStandard": 339, "keyCustom": 56, "axisStandard": 23, "axisCustom": 0, "memberStandard": 27, "memberCustom": 25, "hidden": { "total": 147, "http://fasb.org/us-gaap/2023": 121, "http://www.jeffsbrands.com/20231231": 23, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 180, "entityCount": 1, "segmentCount": 59, "elementCount": 809, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 746, "http://xbrl.sec.gov/dei/2023": 49, "http://xbrl.sec.gov/ecd/2023": 4, "http://fasb.org/srt/2023": 2 }, "report": { "R1": { "role": "http://xbrl.sec.gov/dei/role/document/Cover", "longName": "995100 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation", "longName": "995300 - Document - Audit Information", "shortName": "Audit Information", "isDefault": "false", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "c0", "name": "dei:AuditorName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:AuditorName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "longName": "995301 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals", "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)", "shortName": "Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "longName": "995303 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CostOfRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R6": { "role": "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals", "longName": "995304 - Statement - Consolidated Statements of Operations (Parentheticals)", "shortName": "Consolidated Statements of Operations (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": null, "uniqueAnchor": null }, "R7": { "role": "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3", "longName": "995305 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity", "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c9", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c9", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "longName": "995306 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c7", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R9": { "role": "http://www.jeffsbrands.com/role/ConsolidatedCashFlow_Parentheticals", "longName": "995307 - Statement - Consolidated Statements of Cash Flows (Parentheticals)", "shortName": "Consolidated Statements of Cash Flows (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c0", "name": "jfbr:IssuanceOfOrdinaryShares", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "jfbr:IssuanceOfOrdinaryShares", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.jeffsbrands.com/role/GeneralInformation", "longName": "995308 - Disclosure - General Information", "shortName": "General Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies", "longName": "995309 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.jeffsbrands.com/role/OtherReceivables", "longName": "995310 - Disclosure - Other Receivables", "shortName": "Other Receivables", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.jeffsbrands.com/role/Inventory", "longName": "995311 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.jeffsbrands.com/role/IntangibleAssets", "longName": "995312 - Disclosure - Intangible Assets", "shortName": "Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.jeffsbrands.com/role/Leases", "longName": "995313 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.jeffsbrands.com/role/InvestmentinAffiliate", "longName": "995314 - Disclosure - Investment in Affiliate", "shortName": "Investment in Affiliate", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.jeffsbrands.com/role/OtherPayables", "longName": "995315 - Disclosure - Other Payables", "shortName": "Other Payables", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.jeffsbrands.com/role/ShortTermLoans", "longName": "995316 - Disclosure - Short-Term Loans", "shortName": "Short-Term Loans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.jeffsbrands.com/role/DerivativeLiabilities", "longName": "995317 - Disclosure - Derivative Liabilities", "shortName": "Derivative Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DerivativesAndFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DerivativesAndFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.jeffsbrands.com/role/LoansfromShareholders", "longName": "995318 - Disclosure - Loans from Shareholders", "shortName": "Loans from Shareholders", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.jeffsbrands.com/role/TaxesonIncome", "longName": "995319 - Disclosure - Taxes on Income", "shortName": "Taxes on Income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.jeffsbrands.com/role/ShareCapital", "longName": "995320 - Disclosure - Share Capital", "shortName": "Share Capital", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.jeffsbrands.com/role/ShareIncentivePlan", "longName": "995321 - Disclosure - Share Incentive Plan", "shortName": "Share Incentive Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet", "longName": "995322 - Disclosure - Finance (Income) Expense, Net", "shortName": "Finance (Income) Expense, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholders", "longName": "995323 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders", "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.jeffsbrands.com/role/RelatedParties", "longName": "995324 - Disclosure - Related Parties", "shortName": "Related Parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.jeffsbrands.com/role/GeographicalInformation", "longName": "995325 - Disclosure - Geographical Information", "shortName": "Geographical Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.jeffsbrands.com/role/SubsequentEvents", "longName": "995326 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R29": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrTrmntdFlag", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrTrmntdFlag", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy", "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "31", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables", "longName": "996001 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.jeffsbrands.com/role/OtherReceivablesTables", "longName": "996002 - Disclosure - Other Receivables (Tables)", "shortName": "Other Receivables (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.jeffsbrands.com/role/InventoryTables", "longName": "996003 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.jeffsbrands.com/role/IntangibleAssetsTables", "longName": "996004 - Disclosure - Intangible Assets (Tables)", "shortName": "Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.jeffsbrands.com/role/LeasesTables", "longName": "996005 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.jeffsbrands.com/role/InvestmentinAffiliateTables", "longName": "996006 - Disclosure - Investment in Affiliate (Tables)", "shortName": "Investment in Affiliate (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.jeffsbrands.com/role/OtherPayablesTables", "longName": "996007 - Disclosure - Other Payables (Tables)", "shortName": "Other Payables (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables", "longName": "996008 - Disclosure - Derivative Liabilities (Tables)", "shortName": "Derivative Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.jeffsbrands.com/role/TaxesonIncomeTables", "longName": "996009 - Disclosure - Taxes on Income (Tables)", "shortName": "Taxes on Income (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.jeffsbrands.com/role/ShareCapitalTables", "longName": "996010 - Disclosure - Share Capital (Tables)", "shortName": "Share Capital (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables", "longName": "996011 - Disclosure - Finance (Income) Expense, Net (Tables)", "shortName": "Finance (Income) Expense, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c0", "name": "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables", "longName": "996012 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)", "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.jeffsbrands.com/role/RelatedPartiesTables", "longName": "996013 - Disclosure - Related Parties (Tables)", "shortName": "Related Parties (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.jeffsbrands.com/role/GeographicalInformationTables", "longName": "996014 - Disclosure - Geographical Information (Tables)", "shortName": "Geographical Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.jeffsbrands.com/role/GeneralInformationDetails", "longName": "996015 - Disclosure - General Information (Details)", "shortName": "General Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c0", "name": "jfbr:BonusSharesAndReverseShareSplitDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "jfbr:BonusSharesAndReverseShareSplitDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "996016 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable", "longName": "996017 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c34", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c34", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.jeffsbrands.com/role/OtherReceivablesDetails", "longName": "996018 - Disclosure - Other Receivables (Details)", "shortName": "Other Receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:OtherAdditionalCapital", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "link:footnote", "td", "tr", "table", "ix:continuation", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:OtherAdditionalCapital", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "link:footnote", "td", "tr", "table", "ix:continuation", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable", "longName": "996019 - Disclosure - Other Receivables (Details) - Schedule of Other Receivables", "shortName": "Other Receivables (Details) - Schedule of Other Receivables", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:Supplies", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:Supplies", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.jeffsbrands.com/role/ScheduleofInventoryTable", "longName": "996020 - Disclosure - Inventory (Details) - Schedule of Inventory", "shortName": "Inventory (Details) - Schedule of Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:OtherInventoryInTransit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:OtherInventoryInTransit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.jeffsbrands.com/role/IntangibleAssetsDetails", "longName": "996021 - Disclosure - Intangible Assets (Details)", "shortName": "Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AdjustmentForAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AdjustmentForAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable", "longName": "996022 - Disclosure - Intangible Assets (Details) - Schedule of Total Intangible Assets", "shortName": "Intangible Assets (Details) - Schedule of Total Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c43", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c43", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.jeffsbrands.com/role/LeasesDetails", "longName": "996023 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable", "longName": "996024 - Disclosure - Leases (Details) - Schedule of Future Lease Payments Under Operating Leases", "shortName": "Leases (Details) - Schedule of Future Lease Payments Under Operating Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "longName": "996025 - Disclosure - Investment in Affiliate (Details)", "shortName": "Investment in Affiliate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c0", "name": "jfbr:OutstandingDueAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c48", "name": "us-gaap:InvestmentCompanyDividendDistribution", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R57": { "role": "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable", "longName": "996026 - Disclosure - Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account", "shortName": "Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PaymentsForPurchaseOfInvestmentOperatingActivity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable", "longName": "996027 - Disclosure - Investment in Affiliate (Details) - Schedule of Summarized Balance Sheet", "shortName": "Investment in Affiliate (Details) - Schedule of Summarized Balance Sheet", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c58", "name": "us-gaap:AssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c58", "name": "us-gaap:AssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable", "longName": "996028 - Disclosure - Investment in Affiliate (Details) - Schedule of Summarized of Statement of Operation", "shortName": "Investment in Affiliate (Details) - Schedule of Summarized of Statement of Operation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c59", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c59", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinSciSparcSharesTable", "longName": "996029 - Disclosure - Investment in Affiliate (Details) - Schedule of Activity in the Investment in SciSparc Shares", "shortName": "Investment in Affiliate (Details) - Schedule of Activity in the Investment in SciSparc Shares", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c61", "name": "jfbr:InvestmentInExchangeShareson", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c61", "name": "jfbr:InvestmentInExchangeShareson", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.jeffsbrands.com/role/OtherPayablesDetails", "longName": "996030 - Disclosure - Other Payables (Details)", "shortName": "Other Payables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:AccountsPayableOtherCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "link:footnote", "ix:continuation", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:AccountsPayableOtherCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "link:footnote", "ix:continuation", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables", "longName": "996031 - Disclosure - Schedule of Other Payables (Details) - Schedule of Other Payables", "shortName": "Schedule of Other Payables (Details) - Schedule of Other Payables", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:OtherLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:OtherLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "longName": "996032 - Disclosure - Short-Term Loans (Details)", "shortName": "Short-Term Loans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c62", "name": "us-gaap:ProceedsFromShortTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShortTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c62", "name": "us-gaap:ProceedsFromShortTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShortTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "longName": "996033 - Disclosure - Derivative Liabilities (Details)", "shortName": "Derivative Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c76", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c76", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable", "longName": "996034 - Disclosure - Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Warrant Liability", "shortName": "Derivative Liabilities (Details) - Schedule of Fair Value of the Derivative Warrant Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c6", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R66": { "role": "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable", "longName": "996035 - Disclosure - Derivative Liabilities (Details) - Schedule of Fair Value of the IPO Warrants and Additional Warrants", "shortName": "Derivative Liabilities (Details) - Schedule of Fair Value of the IPO Warrants and Additional Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c79", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c79", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "longName": "996036 - Disclosure - Loans from Shareholders (Details)", "shortName": "Loans from Shareholders (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c7", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c105", "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R68": { "role": "http://www.jeffsbrands.com/role/TaxesonIncomeDetails", "longName": "996037 - Disclosure - Taxes on Income (Details)", "shortName": "Taxes on Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c0", "name": "jfbr:EffectiveIncomeTaxRateBlendedCorporateRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "jfbr:EffectiveIncomeTaxRateBlendedCorporateRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable", "longName": "996038 - Disclosure - Taxes on Income (Details) - Schedule of Income (Loss) Before Taxes", "shortName": "Taxes on Income (Details) - Schedule of Income (Loss) Before Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable", "longName": "996039 - Disclosure - Taxes on Income (Details) - Schedule of Income Tax Expense (Benefit)", "shortName": "Taxes on Income (Details) - Schedule of Income Tax Expense (Benefit)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable", "longName": "996040 - Disclosure - Taxes on Income (Details) - Schedule of Statutory Income Tax Rate to Effective Income Tax Rate", "shortName": "Taxes on Income (Details) - Schedule of Statutory Income Tax Rate to Effective Income Tax Rate", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R72": { "role": "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable", "longName": "996041 - Disclosure - Taxes on Income (Details) - Schedule of Deferred Taxes Assets and Liabilities", "shortName": "Taxes on Income (Details) - Schedule of Deferred Taxes Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.jeffsbrands.com/role/ShareCapitalDetails", "longName": "996042 - Disclosure - Share Capital (Details)", "shortName": "Share Capital (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c109", "name": "us-gaap:StockholdersEquityNoteStockSplit", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c109", "name": "us-gaap:StockholdersEquityNoteStockSplit", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable", "longName": "996043 - Disclosure - Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares", "shortName": "Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c135", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c135", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.jeffsbrands.com/role/ShareIncentivePlanDetails", "longName": "996044 - Disclosure - Share Incentive Plan (Details)", "shortName": "Share Incentive Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable", "longName": "996045 - Disclosure - Finance (Income) Expense, Net (Details) - Schedule of Finance (Income) Expense, Net", "shortName": "Finance (Income) Expense, Net (Details) - Schedule of Finance (Income) Expense, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DerivativeGainOnDerivative", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DerivativeGainOnDerivative", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable", "longName": "996046 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders", "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": null }, "R78": { "role": "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable_Parentheticals", "longName": "996047 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Parentheticals)", "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Parentheticals)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "78", "firstAnchor": null, "uniqueAnchor": null }, "R79": { "role": "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable", "longName": "996048 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Diluted Weighted Average Shares Outstanding", "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Details) - Schedule of Diluted Weighted Average Shares Outstanding", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "longName": "996049 - Disclosure - Related Parties (Details)", "shortName": "Related Parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c48", "name": "jfbr:Bonus", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c150", "name": "jfbr:ConsultancyServicesFees", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R81": { "role": "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable", "longName": "996050 - Disclosure - Related Parties (Details) - Schedule of Transactions with Interested and Related Parties", "shortName": "Related Parties (Details) - Schedule of Transactions with Interested and Related Parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LaborAndRelatedExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LaborAndRelatedExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable", "longName": "996051 - Disclosure - Related Parties (Details) - Schedule of Balances with Interested and Related parties", "shortName": "Related Parties (Details) - Schedule of Balances with Interested and Related parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c162", "name": "us-gaap:Supplies", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c162", "name": "us-gaap:Supplies", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } }, "R83": { "role": "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable", "longName": "996052 - Disclosure - Geographical Information (Details) - Schedule of Geographic Areas", "shortName": "Geographical Information (Details) - Schedule of Geographic Areas", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true }, "uniqueAnchor": { "contextRef": "c165", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "unique": true } }, "R84": { "role": "http://www.jeffsbrands.com/role/SubsequentEventsDetails", "longName": "996053 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0202280-20f_jeffs.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/OtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER PAYABLES", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r24" ] }, "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableOtherCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/OtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other payable", "label": "Accounts Payable, Other", "documentation": "Amount of obligations incurred and payable classified as other." } } }, "auth_ref": [ "r87" ] }, "us-gaap_AccountsPayableTradeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableTradeCurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables", "label": "Accounts Payable, Trade, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r20", "r23" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r284", "r285" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Liabilities and Other Liabilities", "label": "Accrued Liabilities and Other Liabilities", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r791" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in-capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r100" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in-capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r401", "r402", "r403", "r554", "r874", "r875", "r876", "r899", "r927" ] }, "dei_AdditionalSecurities462b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecurities462b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "auth_ref": [ "r835" ] }, "dei_AdditionalSecurities462bFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecurities462bFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "auth_ref": [ "r835" ] }, "dei_AdditionalSecuritiesEffective413b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecuritiesEffective413b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "auth_ref": [ "r833" ] }, "jfbr_AdditionalWarrantTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AdditionalWarrantTerm", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional warrant term", "documentation": "Additional warrant term.", "label": "Additional Warrant Term" } } }, "auth_ref": [] }, "jfbr_AdditionalWarrantsDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AdditionalWarrantsDescription", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional warrants description", "documentation": "Additional warrants description.", "label": "Additional Warrants Description" } } }, "auth_ref": [] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r797" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r797" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r797" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r797" ] }, "us-gaap_AdjustmentForAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentForAmortization", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization", "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives." } } }, "auth_ref": [ "r8", "r55" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification of derivative warrant liabilities to equity (Note 10)", "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature", "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature." } } }, "auth_ref": [ "r12", "r136", "r423" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Transactions with shareholders", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r65", "r66", "r369" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of warrants to third party upon initial public offering (Note 13)", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r12", "r58", "r136" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "jfbr_AdjustmentstoAdditionalPaidInCapitalDebtExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AdjustmentstoAdditionalPaidInCapitalDebtExtinguishment", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Debt extinguishment of shareholders\u2019 loans (Note 11)", "documentation": "Adjustments to additional paid in capital for debt extinguishment.", "label": "Adjustmentsto Additional Paid In Capital Debt Extinguishment" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Advertising expenses", "label": "Advertising Cost [Policy Text Block]", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r161" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing expenses", "label": "Advertising Expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r405" ] }, "jfbr_AdvisorWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AdvisorWarrantsMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advisor Warrants [Member]", "label": "Advisor Warrants Member" } } }, "auth_ref": [] }, "jfbr_AggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AggregateAmount", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "documentation": "The value of aggregate amount.", "label": "Aggregate Amount" } } }, "auth_ref": [] }, "jfbr_AggregateGrossProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AggregateGrossProceeds", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate gross proceeds (in Dollars)", "documentation": "The amount of aggregate gross proceeds.", "label": "Aggregate Gross Proceeds" } } }, "auth_ref": [] }, "jfbr_AggregateIssuanceShare": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AggregateIssuanceShare", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate issuance share (in Dollars)", "documentation": "Aggregate issuance share.", "label": "Aggregate Issuance Share" } } }, "auth_ref": [] }, "jfbr_AggregateIssuanceShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AggregateIssuanceShares", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate issuance shares", "documentation": "Aggregate issuance shares.", "label": "Aggregate Issuance Shares" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r753", "r765", "r781", "r809" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r756", "r768", "r784", "r812" ] }, "jfbr_AgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AgreementDescription", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement description", "documentation": "Agreement description.", "label": "Agreement Description" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r797" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r804" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r760", "r769", "r785", "r804", "r813", "r817", "r825" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r823" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r397", "r404" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for returns", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r197", "r288", "r295" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of loan discount", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r8", "r83", "r118", "r342" ] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest and amortization of discount on third party, related party and shareholders\u2019 loans", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r342", "r469", "r710", "r711", "r868" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition amortized (in Euro)", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r8", "r51", "r55" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r761" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted weighted average shares outstanding", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r250" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r43" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r43" ] }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "xbrltype": "dateOrAsapItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Approximate Date of Commencement of Proposed Sale to Public", "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r144", "r192", "r220", "r261", "r270", "r275", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r436", "r438", "r459", "r521", "r598", "r720", "r732", "r889", "r890", "r910" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "terseLabel": "Current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r186", "r200", "r220", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r436", "r438", "r459", "r720", "r889", "r890", "r910" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT ASSETS:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r220", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r436", "r438", "r459", "r889", "r890", "r910" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r761" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r745", "r748", "r761" ] }, "dei_AuditorLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLineItems", "lang": { "en-us": { "role": { "label": "Auditor [Line Items]" } } }, "auth_ref": [] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r745", "r748", "r761" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r745", "r748", "r761" ] }, "dei_AuditorTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor [Table]" } } }, "auth_ref": [] }, "jfbr_AuthorizedShareCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "AuthorizedShareCapital", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Authorized share capital (in Dollars)", "documentation": "Authorized share capital.", "label": "Authorized Share Capital" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r820" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r821" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r816" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r816" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r819" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r818" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r817" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r817" ] }, "us-gaap_BankingAndThriftInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankingAndThriftInterestAbstract", "lang": { "en-us": { "role": { "label": "Finance (Income) Expense, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of preparation of the financial statements", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "srt_BoardOfDirectorsChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "BoardOfDirectorsChairmanMember", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Board of Directors [Member]", "label": "Board of Directors Chairman [Member]", "documentation": "Leader of board of directors." } } }, "auth_ref": [ "r881" ] }, "jfbr_Bonus": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "Bonus", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bonus", "documentation": "The amount is bonus.", "label": "Bonus" } } }, "auth_ref": [] }, "jfbr_BonusSharesAndReverseShareSplitDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "BonusSharesAndReverseShareSplitDescription", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bonus shares and reverse share split, description", "documentation": "Description of bonus shares and reverse share split.", "label": "Bonus Shares And Reverse Share Split Description" } } }, "auth_ref": [] }, "jfbr_BrandsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "BrandsMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Brands [Member]", "label": "Brands Member" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r435", "r714", "r715" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r70", "r71", "r435", "r714", "r715" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Business Contact", "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r748", "r761" ] }, "us-gaap_CapitalUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalUnits", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share capital issued and outstanding", "label": "Capital Units, Value", "documentation": "Value of capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies." } } }, "auth_ref": [] }, "us-gaap_CapitalizedContractCostImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment loss", "label": "Capitalized Contract Cost, Impairment Loss", "documentation": "Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r299" ] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash Acquired from Acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r33" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r37", "r189", "r695" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r38" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR", "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF THE YEAR", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r37", "r122", "r216" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r122" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r795" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r171", "r193", "r194", "r195", "r220", "r244", "r245", "r247", "r249", "r255", "r256", "r292", "r311", "r313", "r314", "r315", "r318", "r319", "r347", "r348", "r350", "r353", "r359", "r459", "r542", "r543", "r544", "r545", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r586", "r608", "r632", "r674", "r675", "r676", "r677", "r678", "r843", "r869", "r878" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r62" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share", "verboseLabel": "Exercise price (in Dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r360" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r360" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants purchase shares", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r796" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r796" ] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Legal and other contingencies", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies." } } }, "auth_ref": [ "r57", "r681" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3", "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares", "verboseLabel": "Common Stock [Member]", "netLabel": "Ordinary Shares [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r722", "r723", "r724", "r726", "r727", "r728", "r729", "r874", "r875", "r899", "r921", "r927" ] }, "us-gaap_CommonStockNoParValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockNoParValue", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, par value (in Dollars per share)", "verboseLabel": "Par value per share (in Dollars per share)", "label": "Common Stock, No Par Value", "documentation": "Face amount per share of no-par value common stock." } } }, "auth_ref": [ "r99" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, Authorized", "verboseLabel": "Authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r99", "r586" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, Issued", "verboseLabel": "Issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r99" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance (in Shares)", "periodEndLabel": "Balance (in Shares)", "terseLabel": "Ordinary shares, outstanding", "verboseLabel": "Issued and outstanding shares", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r99", "r586", "r604", "r927", "r928" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares of no par value per share \u2013 Authorized: 43,567,567 shares as of December 31, 2023, and December 31, 2022; Issued and outstanding: 1,215,512 shares as of December 31, 2023; 1,153,461 shares as of December 31, 2022(*)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r99", "r522", "r720" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r801" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r800" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r802" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r799" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Computers equipment [Member]", "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "srt_CondensedBalanceSheetStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedBalanceSheetStatementTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable" ], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheet Statement [Table]", "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r172", "r226", "r845" ] }, "srt_CondensedBalanceSheetStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedBalanceSheetStatementsCaptionsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable" ], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheet Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r173", "r226", "r845" ] }, "srt_CondensedIncomeStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedIncomeStatementTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "label": "Condensed Income Statement [Table]", "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r173", "r226", "r845" ] }, "srt_CondensedIncomeStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedIncomeStatementsCaptionsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "label": "Condensed Income Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r173", "r226", "r845" ] }, "jfbr_ConsiderationPayableToSellerOfSciSparcNutraceuticalsInc": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ConsiderationPayableToSellerOfSciSparcNutraceuticalsInc", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration payable to seller of SciSparc Nutraceuticals Inc. shares included in other payables", "verboseLabel": "Liability to SciSparc (included in other account payable)", "documentation": "The amount of consideration payable to seller of sciSparc nutraceuticals inc shares included in other payables.", "label": "Consideration Payable To Seller Of Sci Sparc Nutraceuticals Inc" } } }, "auth_ref": [] }, "jfbr_ConsiderationPayableToSellersOfFortProductsLtd": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ConsiderationPayableToSellersOfFortProductsLtd", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration payable to sellers of Fort Products Ltd. included in other payables", "documentation": "The amount of consideration payable to sellers of fort products ltd included in other payables.", "label": "Consideration Payable To Sellers Of Fort Products Ltd" } } }, "auth_ref": [] }, "jfbr_ConsultancyServicesFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ConsultancyServicesFees", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consultancy services fees", "documentation": "The amount is consultancy services fees.", "label": "Consultancy Services Fees" } } }, "auth_ref": [] }, "dei_ContactPersonnelEmailAddress": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelEmailAddress", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Email Address", "documentation": "Email address of contact personnel." } } }, "auth_ref": [] }, "dei_ContactPersonnelFaxNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelFaxNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Fax Number", "documentation": "Fax Number of contact personnel." } } }, "auth_ref": [ "r748" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContainedFileInformationFileDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Description", "documentation": "The description of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContainedFileInformationFileName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Name", "documentation": "The name of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContainedFileInformationFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Number", "documentation": "The SEC Document Number of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileType": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContainedFileInformationFileType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Type", "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockAmountConverted1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountConverted1", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of shareholder loans (Note 11)", "label": "Conversion of Stock, Amount Converted", "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r40", "r41", "r42" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of shareholder loans (Note 11) (in Shares)", "verboseLabel": "Conversion of outstanding amounts into shares", "label": "Conversion of Stock, Shares Converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r40", "r41", "r42" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r115", "r502" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r116", "r220", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r459", "r889" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Goods and Service [Policy Text Block]", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r851" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r112" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "terseLabel": "Israel", "label": "Current Federal, State and Local, Tax Expense (Benefit)", "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r848" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r848", "r872" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total current income tax expense", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r141", "r422", "r429", "r872" ] }, "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndEquitySecuritiesRealizedGainLoss", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss an impairment related to investment", "label": "Debt and Equity Securities, Realized Gain (Loss)", "documentation": "Amount of realized gain (loss) on investment in debt and equity securities." } } }, "auth_ref": [ "r617", "r618", "r662", "r663", "r664", "r859", "r860" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate share (in Shares)", "label": "Debt Conversion, Converted Instrument, Shares Issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r40", "r42" ] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital amount", "label": "Debt Conversion, Original Debt, Amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r40", "r42" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Short-Term Loans [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholders" ], "lang": { "en-us": { "role": { "terseLabel": "LOANS FROM SHAREHOLDERS", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r134", "r218", "r320", "r326", "r327", "r328", "r329", "r330", "r331", "r336", "r343", "r344", "r345" ] }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAnnualPrincipalPayment", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount (in Dollars)", "label": "Debt Instrument, Annual Principal Payment", "documentation": "Amount of the total principal payments made during the annual reporting period." } } }, "auth_ref": [ "r19" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r19", "r93", "r94", "r145", "r147", "r226", "r321", "r322", "r323", "r324", "r325", "r327", "r332", "r333", "r334", "r335", "r337", "r338", "r339", "r340", "r341", "r342", "r470", "r707", "r708", "r709", "r710", "r711", "r870" ] }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instrument", "label": "Debt Instrument, Convertible, Beneficial Conversion Feature", "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date." } } }, "auth_ref": [ "r61" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding loan", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r84", "r85", "r321", "r470", "r708", "r709" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r30", "r226", "r321", "r322", "r323", "r324", "r325", "r327", "r332", "r333", "r334", "r335", "r337", "r338", "r339", "r340", "r341", "r342", "r470", "r707", "r708", "r709", "r710", "r711", "r870" ] }, "jfbr_DeferredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "DeferredAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred:", "label": "Deferred Abstract" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "terseLabel": "Israel", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r893" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Deferred Foreign Income Tax Expense (Benefit)", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r141", "r872", "r897" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r409", "r410" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in deferred taxes, net", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r8", "r141", "r168", "r428", "r429", "r872" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax liability", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r96", "r97", "r146", "r416" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax income", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r124" ] }, "jfbr_DeferredOfferingCostsIncludedInOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "DeferredOfferingCostsIncludedInOtherPayables", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred offering costs included in other payables", "documentation": "The amount is deferred offering costs included in other payables.", "label": "Deferred Offering Costs Included In Other Payables" } } }, "auth_ref": [] }, "jfbr_DeferredTaxAssetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "DeferredTaxAssetAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax asset", "label": "Deferred Tax Asset Abstract" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r417" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r895" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets after valuation allowance", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r895" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforward", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r69", "r896" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right of use asset", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r69", "r896" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r418" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesLeasingArrangements", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDeferredTaxesAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability", "label": "Deferred Tax Liabilities, Leasing Arrangements", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements." } } }, "auth_ref": [ "r69", "r896" ] }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Monthly contribution percentage", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "documentation": "Percentage employer matches of the employee's percentage contribution matched." } } }, "auth_ref": [] }, "dei_DelayedOrContinuousOffering": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DelayedOrContinuousOffering", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "auth_ref": [ "r773", "r774", "r788" ] }, "us-gaap_DepositsAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssetsCurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted deposit", "label": "Deposits Assets, Current", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter." } } }, "auth_ref": [ "r857" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization of intangible assets", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r8", "r56" ] }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeNet", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value amount", "label": "Derivative, Fair Value, Net", "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives." } } }, "auth_ref": [ "r458" ] }, "us-gaap_DerivativeGainOnDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainOnDerivative", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of derivative liabilities", "label": "Derivative, Gain on Derivative", "documentation": "Amount of increase in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r441" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivate liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r201", "r202", "r458", "r566", "r567", "r568", "r569", "r572", "r573", "r574", "r576", "r577", "r599", "r601", "r602", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r698", "r922" ] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Derivative Liabilities [Abstract]" } } }, "auth_ref": [] }, "jfbr_DerivativeLiabilitiesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "DerivativeLiabilitiesDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Liabilities [Line Items]" } } }, "auth_ref": [] }, "jfbr_DerivativeLiabilitiesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "DerivativeLiabilitiesDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Liabilities (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "derivate liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r201" ] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Derivative Liability", "label": "Derivative Liability, Measurement Input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r454" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r440" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of the Derivative Warrant Liability [Abstract]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r448" ] }, "us-gaap_DerivativeLossOnDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLossOnDerivative", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of derivative liabilities", "label": "Derivative, Loss on Derivative", "documentation": "Amount of decrease in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r441" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable" ], "lang": { "en-us": { "role": { "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r13", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r80", "r81", "r448" ] }, "us-gaap_DerivativesAndFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesAndFairValueTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "DERIVATIVE LIABILITIES", "label": "Derivatives and Fair Value [Text Block]", "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities." } } }, "auth_ref": [ "r142", "r143" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r13", "r72", "r73", "r75", "r79", "r225" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/ShareIncentivePlan" ], "lang": { "en-us": { "role": { "terseLabel": "SHARE INCENTIVE PLAN", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r368", "r370", "r398", "r399", "r400", "r717" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share Incentive Plan [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisclosureTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureTextBlockAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_DividendOrInterestReinvestmentPlanOnly": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DividendOrInterestReinvestmentPlanOnly", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "auth_ref": [ "r773", "r774", "r788" ] }, "us-gaap_DividendsAndInterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsAndInterestPaid", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Dividends and Interest Paid", "documentation": "The contractual amount of dividends (or interest on participating income bonds) that must be paid for the current period (for example, unpaid cumulative dividends)." } } }, "auth_ref": [ "r126" ] }, "us-gaap_DividendsStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsStock", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividing stock", "label": "Dividends, Stock", "documentation": "Amount of paid and unpaid stock dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r5", "r136" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r748" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r745", "r748", "r761" ] }, "dei_DocumentCopyrightInformation": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentCopyrightInformation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Copyright Information", "documentation": "The copyright information for the document." } } }, "auth_ref": [] }, "dei_DocumentCreationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentCreationDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Creation Date", "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different." } } }, "auth_ref": [] }, "dei_DocumentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Description", "documentation": "The description of the document." } } }, "auth_ref": [] }, "dei_DocumentDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document [Domain]", "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards." } } }, "auth_ref": [] }, "dei_DocumentEffectiveDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentEffectiveDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Effective Date", "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases." } } }, "auth_ref": [] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r745", "r748", "r761", "r805" ] }, "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Restatement Recovery Analysis [Flag]", "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)." } } }, "auth_ref": [ "r745", "r748", "r761", "r805" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationDocumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationDocumentAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information, Document [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Text Block]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Name", "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the <FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r746" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r734" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r748" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r748" ] }, "dei_DocumentSubtitle": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentSubtitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Subtitle", "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'." } } }, "auth_ref": [] }, "dei_DocumentSynopsis": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentSynopsis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Synopsis", "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'" } } }, "auth_ref": [] }, "dei_DocumentTitle": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Title", "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r789" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentVersion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentVersion", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Version", "documentation": "The version identifier of the document." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r737" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Net Income (Loss) Per Share Attributable to Ordinary Shareholders [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable" ], "lang": { "en-us": { "role": { "terseLabel": "Basic net profit (loss) attributable to shareholders per ordinary share (in Dollars per share)", "verboseLabel": "Net loss per share of ordinary share, basic", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r210", "r232", "r233", "r234", "r235", "r236", "r242", "r244", "r247", "r248", "r249", "r253", "r451", "r452", "r517", "r531", "r702" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted net profit (loss) attributable to shareholders per ordinary share", "verboseLabel": "Net loss per share of ordinary share, diluted", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r210", "r232", "r233", "r234", "r235", "r236", "r244", "r247", "r248", "r249", "r253", "r451", "r452", "r517", "r531", "r702" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basic and diluted net loss per share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r43", "r44" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholders" ], "lang": { "en-us": { "role": { "terseLabel": "NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r241", "r250", "r251", "r252" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "LOSSES FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r461" ] }, "dei_EffectiveAfter60Days486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveAfter60Days486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "auth_ref": [ "r839" ] }, "jfbr_EffectiveIncomeTaxRateBlendedCorporateRate": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "EffectiveIncomeTaxRateBlendedCorporateRate", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Blended corporate tax rate", "documentation": "Effective income blended tax rate for corporate tax rate.", "label": "Effective Income Tax Rate Blended Corporate Rate" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory tax rate", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r222", "r412", "r431" ] }, "dei_EffectiveOnDate486a": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnDate486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "auth_ref": [ "r839" ] }, "dei_EffectiveOnDate486b": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnDate486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "auth_ref": [ "r840" ] }, "dei_EffectiveOnSetDate486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnSetDate486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "auth_ref": [ "r839" ] }, "dei_EffectiveOnSetDate486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnSetDate486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "auth_ref": [ "r840" ] }, "dei_EffectiveUponFiling462e": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveUponFiling462e", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "auth_ref": [ "r838" ] }, "dei_EffectiveUponFiling486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveUponFiling486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "auth_ref": [ "r840" ] }, "dei_EffectiveWhenDeclaredSection8c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveWhenDeclaredSection8c", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "auth_ref": [ "r842" ] }, "jfbr_EmployeeProvidedServices": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "EmployeeProvidedServices", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee provided services", "documentation": "Employee provided services.", "label": "Employee Provided Services" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Employee-related Liabilities, Current", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOwnershipPlanESOPPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOwnershipPlanESOPPolicy", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Employee benefits", "label": "Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares." } } }, "auth_ref": [ "r67" ] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitiesTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAccountingStandard": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAccountingStandard", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Accounting Standard", "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element." } } }, "auth_ref": [] }, "dei_EntityAddressAddressDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Description", "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r736" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r740" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r736" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityContactPersonnelLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityContactPersonnelLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Contact Personnel [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r736" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r841" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r736" ] }, "dei_EntityHomeCountryISOCode": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityHomeCountryISOCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Home Country ISO Code", "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element." } } }, "auth_ref": [] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, Date of Incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r831" ] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Inv Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r830" ] }, "dei_EntityLegalForm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityLegalForm", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Legal Form", "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc." } } }, "auth_ref": [] }, "dei_EntityListingDepositoryReceiptRatio": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingDepositoryReceiptRatio", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Depository Receipt Ratio", "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'." } } }, "auth_ref": [] }, "dei_EntityListingDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Description", "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security." } } }, "auth_ref": [] }, "dei_EntityListingForeign": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingForeign", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Foreign", "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt." } } }, "auth_ref": [] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingParValuePerShare", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "dei_EntityListingPrimary": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingPrimary", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Primary", "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity." } } }, "auth_ref": [] }, "dei_EntityListingSecurityTradingCurrency": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingSecurityTradingCurrency", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Security Trading Currency", "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'" } } }, "auth_ref": [] }, "dei_EntityListingsExchangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsExchangeAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings, Exchange [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityNumberOfEmployees": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityNumberOfEmployees", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Number of Employees", "documentation": "Number of persons employed by the Entity" } } }, "auth_ref": [] }, "dei_EntityPhoneFaxNumbersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPhoneFaxNumbersLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Phone Fax Numbers [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r761" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r736" ] }, "dei_EntityReportingCurrencyISOCode": { "xbrltype": "currencyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityReportingCurrencyISOCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Reporting Currency ISO Code", "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r736" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r736" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r736" ] }, "dei_EntityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity [Text Block]", "documentation": "Container to serve as parent of six Entity related Table concepts." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r832" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Share Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r184", "r206", "r207", "r208", "r227", "r228", "r229", "r231", "r237", "r239", "r254", "r293", "r294", "r361", "r401", "r402", "r403", "r424", "r425", "r442", "r443", "r444", "r445", "r446", "r447", "r450", "r462", "r463", "r464", "r465", "r466", "r467", "r483", "r535", "r536", "r537", "r554", "r632" ] }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Equity losses", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment." } } }, "auth_ref": [ "r862", "r863", "r868" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning", "periodEndLabel": "Balance at ending", "terseLabel": "Investment accounted for using the equity method", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r266", "r291", "r853", "r884" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity losses", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r290" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r798" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r753", "r765", "r781", "r809" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r750", "r762", "r778", "r806" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "terseLabel": "Europe [Member]", "label": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r930", "r931", "r932", "r933" ] }, "dei_ExchangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExchangeDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exchange [Domain]", "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r804" ] }, "dei_ExhibitsOnly462d": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExhibitsOnly462d", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "auth_ref": [ "r837" ] }, "dei_ExhibitsOnly462dFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExhibitsOnly462dFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "auth_ref": [ "r837" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_ExtinguishmentOfDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtAmount", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial liability", "label": "Extinguishment of Debt, Amount", "documentation": "Gross amount of debt extinguished." } } }, "auth_ref": [] }, "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtGainLossNetOfTax", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest income", "label": "Extinguishment of Debt, Gain (Loss), Net of Tax", "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax." } } }, "auth_ref": [ "r59" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r14" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value of the IPO Warrants and Additional Warrants", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r14" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value measurement", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of warrants in connection with the IPO", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r82" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Classification to additional paid in capital", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning", "periodEndLabel": "Balance at ending", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r15" ] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinSciSparcSharesTable", "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value", "negatedTerseLabel": "Revaluation of securities -fair value through profit or loss", "label": "Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held." } } }, "auth_ref": [ "r456" ] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Changes in fair value of derivative liabilities", "negatedTerseLabel": "Change in fair value", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r455", "r457" ] }, "jfbr_FinanceExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "FinanceExpenseAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Finance expense:", "label": "Finance Expense Abstract" } } }, "auth_ref": [] }, "jfbr_FinanceExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "FinanceExpenseMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Expense [Member]", "label": "Finance Expense Member" } } }, "auth_ref": [] }, "jfbr_FinanceIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "FinanceIncomeAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Finance income:", "label": "Finance Income Abstract" } } }, "auth_ref": [] }, "jfbr_FinanceIncomeExpenseNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "FinanceIncomeExpenseNetLineItems", "presentation": [ "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet" ], "lang": { "en-us": { "role": { "terseLabel": "Finance (Income) Expense, Net [Abstract]", "label": "Finance Income Expense Net Line Items" } } }, "auth_ref": [] }, "jfbr_FinanceIncomeExpenseNetTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "FinanceIncomeExpenseNetTable", "presentation": [ "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet" ], "lang": { "en-us": { "role": { "terseLabel": "Finance (Income) Expense, Net [Abstract]", "label": "Finance Income Expense Net Table" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Loss from change in value of investment at fair value", "label": "Finance Lease, Right-of-Use Asset, Amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r475", "r477", "r719" ] }, "us-gaap_FinancingInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingInterestExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Finance expenses in respect of third-party loan", "label": "Financing Interest Expense", "documentation": "This element represents interest incurred for borrowed money which was used to produce goods or render services." } } }, "auth_ref": [ "r116" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful lives", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r190", "r303" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r129" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r503", "r504" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r128", "r504" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Total Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r503" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "lang": { "en-us": { "role": { "label": "Intangible Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossUnrealized", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Exchange differences on cash and cash equivalents", "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r124", "r606", "r730", "r903", "r904", "r926" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Functional and presentation currency", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r460" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r757", "r769", "r785", "r813" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r757", "r769", "r785", "r813" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r757", "r769", "r785", "r813" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r757", "r769", "r785", "r813" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r757", "r769", "r785", "r813" ] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "FormerAddressMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r747", "r772" ] }, "dei_FormerFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "FormerFiscalYearEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Former Fiscal Year End Date", "documentation": "Former end date of previous fiscal years" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Office Equipment/Furniture [Member]", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain from debt extinguishment", "terseLabel": "Equity amount", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r8", "r59", "r60" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r117", "r611" ] }, "jfbr_GeneralInformationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "GeneralInformationDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "General Information [Line Items]" } } }, "auth_ref": [] }, "jfbr_GeneralInformationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "GeneralInformationDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails" ], "lang": { "en-us": { "role": { "label": "General Information (Details) [Table]" } } }, "auth_ref": [] }, "jfbr_GeographicalInformationDetailsScheduleofGeographicAreasLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "GeographicalInformationDetailsScheduleofGeographicAreasLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "label": "Geographical Information (Details) - Schedule of Geographic Areas [Line Items]" } } }, "auth_ref": [] }, "jfbr_GeographicalInformationDetailsScheduleofGeographicAreasTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "GeographicalInformationDetailsScheduleofGeographicAreasTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "label": "Geographical Information (Details) - Schedule of Geographic Areas [Table]" } } }, "auth_ref": [] }, "us-gaap_GovernmentContractReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GovernmentContractReceivable", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable": { "parentTag": "us-gaap_OtherReceivablesNetCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Government institutions", "label": "Government Contract Receivable", "documentation": "The amount of receivables that are derived from government contracts." } } }, "auth_ref": [ "r497" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r114", "r220", "r261", "r269", "r274", "r277", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r459", "r704", "r889" ] }, "jfbr_IPOAndAdditionalWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IPOAndAdditionalWarrantsMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "IPO and Additional Warrants [Member]", "label": "IPOAnd Additional Warrants Member" } } }, "auth_ref": [] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPO [Member]", "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r745", "r748", "r761" ] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment loss of intangible asset", "verboseLabel": "Impairment of intangible asset", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r8", "r17" ] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of intangible asset", "label": "Impairment of Intangible Assets, Finite-Lived", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r868", "r887" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of long-lived assets", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r132" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Israel", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r221", "r430" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable", "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before taxes", "terseLabel": "Loss before taxes on income", "verboseLabel": "Income (loss) before taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r109", "r150", "r261", "r269", "r274", "r277", "r518", "r529", "r704" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofIncomeLossBeforeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r221", "r430" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity losses", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r8", "r110", "r149", "r264", "r291", "r528" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r305", "r306", "r616" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r306", "r616" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r11" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Taxes on Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncome" ], "lang": { "en-us": { "role": { "terseLabel": "TAXES ON INCOME", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r222", "r406", "r413", "r414", "r420", "r426", "r432", "r433", "r434", "r547" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofIncomeTaxExpenseBenefitTable", "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total tax (benefit) expense", "terseLabel": "Tax (benefit) expense", "verboseLabel": "Taxes on income", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r158", "r169", "r238", "r239", "r265", "r411", "r427", "r533" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r205", "r407", "r408", "r414", "r415", "r419", "r421", "r541" ] }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Tax rate differences applicable to subsidiaries", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)." } } }, "auth_ref": [ "r894" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Tax (tax benefit) computed at the statutory tax rate", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r412" ] }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherReconcilingItems", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Tax losses and timing differences for which deferred taxes were not recognized", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments." } } }, "auth_ref": [ "r894" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes paid", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r39" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (increase) in trade receivables", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in related party balance", "label": "Increase (Decrease) in Due to Related Parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Increase in inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInNotesPayableRelatedPartiesCurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in related party liabilities", "label": "Increase (Decrease) in Notes Payable, Related Parties, Current", "documentation": "The increase (decrease) during the reporting period in the current portion (due within one year or one business cycle, whichever is longer) of the amount owed by the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in operating lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r847", "r867" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in accounts payable and other payables", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease in operating lease right-of-use assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherReceivables", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease (increase) in other receivables", "label": "Increase (Decrease) in Other Receivables", "documentation": "Amount of increase (decrease) in receivables classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount payments", "verboseLabel": "Adjustment amount payments (in Euro)", "label": "Indefinite-Lived Intangible Assets, Written off Related to Sale of Business Unit", "documentation": "Amount of divestiture of an asset lacking physical substance and having a projected indefinite period of benefit to fair value. Excludes financial assets and goodwill." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r760", "r769", "r785", "r804", "r813", "r817", "r825" ] }, "jfbr_InitialExercisePriceExpire": { "xbrltype": "durationItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InitialExercisePriceExpire", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial exercise price expire", "documentation": "Initial exercise price expire.", "label": "Initial Exercise Price Expire" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r823" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r749", "r829" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r749", "r829" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r749", "r829" ] }, "jfbr_IntangibleAssetsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IntangibleAssetsDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets (Details) [Line Items]" } } }, "auth_ref": [] }, "jfbr_IntangibleAssetsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IntangibleAssetsDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "INTANGIBLE ASSETS", "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r300" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r54", "r499", "r500", "r501", "r503", "r699" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "verboseLabel": "Net Balance", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r50", "r53" ] }, "us-gaap_IntercompanyProfitToRegulatedAffiliatesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntercompanyProfitToRegulatedAffiliatesPolicy", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliates", "label": "Intercompany Profit to Regulated Affiliates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for intercompany profit on sales to regulated affiliates." } } }, "auth_ref": [ "r89" ] }, "us-gaap_InterestAndDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable", "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense on loans from shareholders and related parties", "verboseLabel": "Interest expenses on loans from related parties and shareholders", "label": "Interest and Debt Expense", "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity." } } }, "auth_ref": [ "r10" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseMember", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Expense [Member]", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r18" ] }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeAndInterestExpenseDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCE (INCOME) EXPENSE, NET", "label": "Interest Income and Interest Expense Disclosure [Text Block]", "documentation": "The entire disclosure for interest income and interest expense for enterprises that derive a significant portion of their revenue from interest collected on investments, loans, and securities." } } }, "auth_ref": [ "r152" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense on short-term loan", "label": "Interest Income (Expense), Net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r153" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r212", "r214", "r215" ] }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterimPeriodCostsNotAllocableDomain", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Interim Period, Costs Not Allocable [Domain]", "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred." } } }, "auth_ref": [ "r45" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/Inventory" ], "lang": { "en-us": { "role": { "terseLabel": "INVENTORY", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r296" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofInventoryTable": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofInventoryTable" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Gross", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r855" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://www.jeffsbrands.com/role/ScheduleofInventoryTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofInventoryTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Inventory", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r199", "r696", "r720" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r159", "r188", "r198", "r296", "r297", "r298", "r498", "r700" ] }, "dei_InvestmentCompanyActFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyActFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "auth_ref": [ "r774", "r775", "r776", "r777" ] }, "dei_InvestmentCompanyActRegistration": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyActRegistration", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "auth_ref": [ "r790" ] }, "us-gaap_InvestmentCompanyDividendDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCompanyDividendDistribution", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividing number of exchange shares acquired", "label": "Investment Company, Dividend Distribution", "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital." } } }, "auth_ref": [ "r551", "r553", "r554", "r631" ] }, "dei_InvestmentCompanyRegistrationAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyRegistrationAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "auth_ref": [ "r790" ] }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyRegistrationAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "auth_ref": [ "r790" ] }, "jfbr_InvestmentInExchangeShareson": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InvestmentInExchangeShareson", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinSciSparcSharesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Value of shares obtained in connection with share exchange on March 23, 2023", "documentation": "Exchange Shareson.", "label": "Investment In Exchange Shareson" } } }, "auth_ref": [] }, "jfbr_InvestmentInSciSparcTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InvestmentInSciSparcTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Activity in the Investment in SciSparc Shares", "documentation": "The disclosure of investment in SciSparc.", "label": "Investment In Sci Sparc Table Text Block" } } }, "auth_ref": [] }, "us-gaap_InvestmentIssuerAffiliationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIssuerAffiliationAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "label": "Investment, Issuer Affiliation [Axis]", "documentation": "Information by affiliation of issuer of investment." } } }, "auth_ref": [ "r540", "r552", "r570", "r578", "r589", "r590", "r610", "r611", "r612", "r613", "r617", "r618", "r623", "r624", "r642", "r643", "r644", "r650", "r651", "r652", "r662", "r663", "r665", "r666", "r668", "r669", "r671", "r672", "r673" ] }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedBalancePrincipalAmount", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinSciSparcSharesTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance as of January 1, 2023", "periodEndLabel": "Balance as of December 31, 2023", "label": "Investment Owned, Balance, Principal Amount", "documentation": "Amount of principal of investment owned." } } }, "auth_ref": [ "r566", "r575", "r641", "r649", "r661", "r724" ] }, "us-gaap_InvestmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Activity in the Investment in Wellution Account", "label": "Investment [Table Text Block]", "documentation": "Tabular disclosure of investment." } } }, "auth_ref": [ "r849", "r850", "r882" ] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliate" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENT IN AFFILIATE", "label": "Investment [Text Block]", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r849", "r850", "r882" ] }, "jfbr_InvestmentinAffiliateDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InvestmentinAffiliateDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "label": "Investments in Affiliates [Line Items]" } } }, "auth_ref": [] }, "jfbr_InvestmentinAffiliateDetailsScheduleofActivityintheInvestmentinWellutionAccountLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InvestmentinAffiliateDetailsScheduleofActivityintheInvestmentinWellutionAccountLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Activity in the Investment in Wellution Account [Abstract]" } } }, "auth_ref": [] }, "jfbr_InvestmentinAffiliateDetailsScheduleofActivityintheInvestmentinWellutionAccountTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InvestmentinAffiliateDetailsScheduleofActivityintheInvestmentinWellutionAccountTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable" ], "lang": { "en-us": { "role": { "label": "Investment in Affiliate (Details) - Schedule of Activity in the Investment in Wellution Account [Table]" } } }, "auth_ref": [] }, "jfbr_InvestmentinAffiliateDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "InvestmentinAffiliateDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "label": "Investment in Affiliate (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAndAdvancesToAffiliatesAbstract", "lang": { "en-us": { "role": { "label": "Investments in Affiliates [Abstract]" } } }, "auth_ref": [] }, "jfbr_IsraeliTaxLawsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IsraeliTaxLawsMember", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Israeli Tax Laws [Member]", "label": "Israeli Tax Laws Member" } } }, "auth_ref": [] }, "jfbr_IssuanceCostsOnDerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IssuanceCostsOnDerivativeLiabilities", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance costs on derivative liabilities", "documentation": "The amount is issuance costs on derivative liabilities.", "label": "Issuance Costs On Derivative Liabilities" } } }, "auth_ref": [] }, "jfbr_IssuanceOfBonusShares": { "xbrltype": "decimalItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IssuanceOfBonusShares", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of bonus shares", "documentation": "Issuance of bonus shares.", "label": "Issuance Of Bonus Shares" } } }, "auth_ref": [] }, "jfbr_IssuanceOfOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IssuanceOfOrdinaryShares", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares", "documentation": "Number of issuance of ordinary shares.", "label": "Issuance Of Ordinary Shares" } } }, "auth_ref": [] }, "jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares upon conversion of shareholders\u2019 loans", "documentation": "The amount is issuance of ordinary shares upon conversion of shareholders\u2019 loans.", "label": "Issuance Of Ordinary Shares Upon Conversion Of Shareholders Loans" } } }, "auth_ref": [] }, "jfbr_IssuanceOfPeriodTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "IssuanceOfPeriodTerm", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of period term", "documentation": "Issuance of period term.", "label": "Issuance Of Period Term" } } }, "auth_ref": [] }, "jfbr_JeffsBrandsHoldingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "JeffsBrandsHoldingMember", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Jeffs' Brands Holding [Member]", "label": "Jeffs Brands Holding Member" } } }, "auth_ref": [] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Labor cost and related expenses (included in general and administrative)", "label": "Labor and Related Expense", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r861" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements [Member[", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r131" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LegalEntityIdentifier": { "xbrltype": "legalEntityIdentifierItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityIdentifier", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Legal Entity Identifier", "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI." } } }, "auth_ref": [ "r733" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r476" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Lease Payments Under Operating Leases", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r907" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total future operating lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r482" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r482" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r482" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r482" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r471" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r27", "r220", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r437", "r438", "r439", "r459", "r585", "r703", "r732", "r889", "r910", "r911" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r104", "r148", "r525", "r720", "r871", "r885", "r902" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "negatedLabel": "Current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r29", "r187", "r220", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r437", "r438", "r439", "r459", "r720", "r889", "r910", "r911" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT LIABILITIES:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r19", "r90", "r91", "r92", "r95", "r220", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r437", "r438", "r439", "r459", "r889", "r910", "r911" ] }, "jfbr_LiabilityToConsultant": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "LiabilityToConsultant", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Liability to consultant (included in other account payable)", "documentation": "Liability to consultant.", "label": "Liability To Consultant" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r25" ] }, "jfbr_LoanPayableToShareholdersPureCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "LoanPayableToShareholdersPureCapitalMember", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan Payable to Shareholders - Pure Capital [Member]", "label": "Loan Payable To Shareholders Pure Capital Member" } } }, "auth_ref": [] }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/OtherReceivables" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER RECEIVABLES", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses." } } }, "auth_ref": [ "r880" ] }, "jfbr_LoansfromShareholdersDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "LoansfromShareholdersDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "label": "Loans from Shareholders [Line Items]" } } }, "auth_ref": [] }, "jfbr_LoansfromShareholdersDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "LoansfromShareholdersDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "label": "Loans from Shareholders (Details) [Table]" } } }, "auth_ref": [] }, "jfbr_LoansfromShareholdersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "LoansfromShareholdersLineItems", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholders" ], "lang": { "en-us": { "role": { "label": "Loans from Shareholders [Abstract]" } } }, "auth_ref": [] }, "jfbr_LoansfromShareholdersTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "LoansfromShareholdersTable", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholders" ], "lang": { "en-us": { "role": { "label": "Loans from Shareholders [Table]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Plant & Machinery [Member]", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r307", "r308", "r309", "r310", "r366", "r496", "r534", "r576", "r577", "r640", "r645", "r647", "r648", "r660", "r691", "r692", "r705", "r712", "r716", "r721", "r891", "r912", "r913", "r914", "r915", "r916", "r917" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r796" ] }, "jfbr_MeasureInputWeightedAverageCostOfCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "MeasureInputWeightedAverageCostOfCapitalMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measure Input, Weighted Average Cost of Capital [Member]", "label": "Measure Input Weighted Average Cost Of Capital Member" } } }, "auth_ref": [] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r796" ] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Discount Rate [Member]", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r900" ] }, "us-gaap_MeasurementInputExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExercisePriceMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Exercise Price [Member]", "label": "Measurement Input, Exercise Price [Member]", "documentation": "Measurement input using agreed upon price for exchange of underlying asset." } } }, "auth_ref": [ "r900" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Expected Term [Member]", "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r900" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Price Volatility [Member]", "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r900" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]", "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r900" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Share Price [Member]", "label": "Measurement Input, Share Price [Member]", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r900" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r453" ] }, "jfbr_MedigusMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "MedigusMember", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medigus [Member]", "label": "Medigus Member" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable", "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r307", "r308", "r309", "r310", "r366", "r496", "r534", "r576", "r577", "r640", "r645", "r647", "r648", "r660", "r691", "r692", "r705", "r712", "r716", "r721", "r891", "r912", "r913", "r914", "r915", "r916", "r917" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Owns votings rights percent", "verboseLabel": "Voting rights percent", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "jfbr_MinorityShareholderMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "MinorityShareholderMember", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minority Shareholder [Member]", "label": "Minority Shareholder Member" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r816" ] }, "jfbr_MrHakmonAndLIAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "MrHakmonAndLIAMember", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mr. Hakmon and L.I.A [Member]", "label": "Mr Hakmon And LIAMember" } } }, "auth_ref": [] }, "jfbr_MrHakmonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "MrHakmonMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mr. Hakmon [Member]", "label": "Mr Hakmon Member" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r824" ] }, "dei_NameChangeEventDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NameChangeEventDateAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event Date [Axis]", "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type." } } }, "auth_ref": [] }, "dei_NameChangeEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NameChangeEventLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event [Line Items]", "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table." } } }, "auth_ref": [] }, "dei_NameChangeEventTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NameChangeEventTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event [Table]", "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period." } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r797" ] }, "us-gaap_NatureOfExpenseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfExpenseAxis", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Nature of Expense [Axis]", "documentation": "Information by type of cost or expense." } } }, "auth_ref": [ "r45" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformation" ], "lang": { "en-us": { "role": { "terseLabel": "GENERAL INFORMATION", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r160", "r170" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash from (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r213" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r213" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS USED IN INVESTING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "http://www.jeffsbrands.com/role/GeneralInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "terseLabel": "Net cash provided by (Used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r122", "r123", "r124" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS USED IN OPERATING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/GeneralInformationDetails", "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "verboseLabel": "Net loss", "netLabel": "Net loss applicable to shareholders of ordinary shares", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r111", "r124", "r151", "r185", "r203", "r204", "r208", "r220", "r230", "r232", "r233", "r234", "r235", "r238", "r239", "r246", "r261", "r269", "r274", "r277", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r452", "r459", "r530", "r607", "r629", "r630", "r704", "r730", "r889" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NewEffectiveDateForPreviousFiling": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NewEffectiveDateForPreviousFiling", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "auth_ref": [ "r774", "r775", "r776", "r777" ] }, "dei_NoSubstantiveChanges462c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoSubstantiveChanges462c", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "auth_ref": [ "r836" ] }, "dei_NoSubstantiveChanges462cFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoSubstantiveChanges462cFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "auth_ref": [ "r836" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "jfbr_NonCurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "NonCurrentAssetsAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "NON-CURRENT ASSETS:", "label": "Non Current Assets Abstract" } } }, "auth_ref": [] }, "jfbr_NonCurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "NonCurrentLiabilitiesAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "NON-CURRENT LIABILITIES:", "label": "Non Current Liabilities Abstract" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r796" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r757", "r769", "r785", "r804", "r813" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r794" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r793" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r804" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r824" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r824" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of noncash investing and financing activities:", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoninterestExpenseDirectorsFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoninterestExpenseDirectorsFees", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Directors\u2019 fees (included in general and administrative)", "label": "Noninterest Expense Directors Fees", "documentation": "Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits." } } }, "auth_ref": [ "r154" ] }, "us-gaap_NotesAndLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesAndLoansPayable", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Liabilities", "label": "Notes and Loans Payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r19", "r147", "r919" ] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Notes Payable", "label": "Notes Payable", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r19", "r147", "r919" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Related party payables", "verboseLabel": "Related parties", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ObligationWithJointAndSeveralLiabilityArrangementAmountOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ObligationWithJointAndSeveralLiabilityArrangementAmountOutstanding", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding liability", "label": "Obligation with Joint and Several Liability Arrangement, Amount Outstanding", "documentation": "Amount outstanding, before the effects of recovery, of obligation under the joint and several liability arrangement." } } }, "auth_ref": [ "r133" ] }, "us-gaap_OfficersCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficersCompensation", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Chief executive officer salary (included in other account payable)", "label": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold", "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [ "r858" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Operating loss", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r261", "r269", "r274", "r277", "r704" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r478", "r719" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory storage (included in cost of sale)", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r906" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFutureLeasePaymentsUnderOperatingLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Present value of lease liability", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r473" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r474" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r473" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r472" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.jeffsbrands.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r481", "r719" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.jeffsbrands.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r480", "r719" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carry forward tax losses (in Dollars)", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r68" ] }, "jfbr_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OrdinarySharesMember", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares [Member]", "label": "Ordinary Shares Member" } } }, "auth_ref": [] }, "jfbr_OrdinarySharesNoParValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OrdinarySharesNoParValuePerShareMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares, no par value per share", "label": "Ordinary Shares No Par Value Per Share Member" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "General Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Other payables", "verboseLabel": "Other Accrued Liabilities, Current", "label": "Other payables", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r28" ] }, "us-gaap_OtherAdditionalCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAdditionalCapital", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/OtherReceivablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pure capital amoun", "label": "Other Additional Capital", "documentation": "Amount of additional paid-in capital (APIC) classified as other." } } }, "auth_ref": [ "r32", "r523" ] }, "dei_OtherAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherAddressMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Other Address [Member]", "documentation": "Other address for entity" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r191" ] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other income, net", "label": "Other Income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r532", "r609", "r667", "r668", "r670" ] }, "us-gaap_OtherIndefiniteLivedIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIndefiniteLivedIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consulting agreement amount", "label": "Other Indefinite-Lived Intangible Assets", "documentation": "Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill." } } }, "auth_ref": [ "r130" ] }, "us-gaap_OtherInventoryInTransit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInventoryInTransit", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofInventoryTable": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofInventoryTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goods in transit", "label": "Other Inventory, in Transit, Gross", "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported." } } }, "auth_ref": [ "r856" ] }, "us-gaap_OtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestments", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Investment at fair value", "label": "Other Investments", "documentation": "Amount of investments classified as other." } } }, "auth_ref": [ "r854" ] }, "us-gaap_OtherLaborRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLaborRelatedExpenses", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease and maintenance expenses related", "label": "Other Labor-related Expenses", "documentation": "Amount of labor-related expenses classified as other." } } }, "auth_ref": [ "r117" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities", "label": "Other Liabilities", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r88", "r520", "r580", "r581", "r732", "r923" ] }, "us-gaap_OtherLongtermNotesPayableCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongtermNotesPayableCurrentAndNoncurrentAbstract", "lang": { "en-us": { "role": { "label": "Other Payables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherNoninterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoninterestExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other finance expenses", "label": "Other Noninterest Expense", "documentation": "Amount of noninterest expense classified as other." } } }, "auth_ref": [ "r154" ] }, "us-gaap_OtherNonoperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total finance expenses", "label": "Other Nonoperating Expense", "documentation": "Amount of expense related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r119" ] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total finance income", "label": "Other Nonoperating Income", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r211" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Finance (income) expense, net", "negatedLabel": "Financial (income) expenses, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r119" ] }, "jfbr_OtherOperatingIncomeloss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OtherOperatingIncomeloss", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other income", "documentation": "The total amount of other operating income, loss", "label": "Other Operating Incomeloss" } } }, "auth_ref": [] }, "jfbr_OtherPayablesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OtherPayablesDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/OtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Payables [Abstract]", "label": "Other Payables Details Line Items" } } }, "auth_ref": [] }, "jfbr_OtherPayablesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OtherPayablesDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/OtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Other Payables (Details) [Table]" } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r796" ] }, "jfbr_OtherReceivablesDetailsScheduleofOtherReceivablesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OtherReceivablesDetailsScheduleofOtherReceivablesLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Receivables [Abstract]" } } }, "auth_ref": [] }, "jfbr_OtherReceivablesDetailsScheduleofOtherReceivablesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OtherReceivablesDetailsScheduleofOtherReceivablesTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "label": "Other Receivables (Details) - Schedule of Other Receivables [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherReceivablesGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesGrossCurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable": { "parentTag": "us-gaap_OtherReceivablesNetCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables, Gross, Current", "documentation": "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r196" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Other receivables", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r748" ] }, "jfbr_OtherWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OtherWarrantsMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other warrants [Member]", "label": "Other Warrants Member" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r755", "r767", "r783", "r811" ] }, "jfbr_OutstandingDueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OutstandingDueAmount", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding amount", "verboseLabel": "Amount of outstanding due", "documentation": "Amount of outstanding due.", "label": "Outstanding Due Amount" } } }, "auth_ref": [] }, "jfbr_OutstandingPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "OutstandingPayable", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding payable", "documentation": "The amount is outstanding payable.", "label": "Outstanding Payable" } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r758", "r770", "r786", "r814" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r758", "r770", "r786", "r814" ] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OverAllotmentOptionMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Over-Allotment Option [Member]", "label": "Over-Allotment Option [Member]", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "dei_ParentEntityLegalName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ParentEntityLegalName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Parent Entity Legal Name", "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r792" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "auth_ref": [] }, "us-gaap_PaymentsForFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForFees", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment to consultant service (in Dollars)", "label": "Payments for Other Fees", "documentation": "Amount of cash outflow for fees classified as other." } } }, "auth_ref": [ "r6" ] }, "us-gaap_PaymentsForPurchaseOfInvestmentOperatingActivity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForPurchaseOfInvestmentOperatingActivity", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase on February 23, 2023", "label": "Payment for Purchase, Investment, Operating Activity", "documentation": "Amount of cash outflow for acquisition of investment, classified as operating activity. Includes, but is not limited to, funding, origination, drawdown, and participation in investment." } } }, "auth_ref": [ "r929" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance costs (in Dollars)", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r35" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of intangible assets", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r121" ] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investment accounted for using the equity method", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r883" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r121" ] }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireRestrictedInvestments", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Restricted deposit", "label": "Payments to Acquire Restricted Investments", "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions." } } }, "auth_ref": [ "r120" ] }, "us-gaap_PaymentsToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToSuppliers", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Liability to supplier (included in trade payable)", "label": "Payments to Suppliers", "documentation": "Payments of cash to suppliers for goods and services during the current period." } } }, "auth_ref": [ "r865", "r866" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r795" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r795" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r794" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r804" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r797" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r793" ] }, "jfbr_PercentageLeaseAndMaintenanceExpensesRelated": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageLeaseAndMaintenanceExpensesRelated", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage lease and maintenance expenses related", "documentation": "Percentage lease and maintenance expenses related.", "label": "Percentage Lease And Maintenance Expenses Related" } } }, "auth_ref": [] }, "jfbr_PercentageOfExchangeShares": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageOfExchangeShares", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of exchange shares", "documentation": "Percentage of exchange shares.", "label": "Percentage Of Exchange Shares" } } }, "auth_ref": [] }, "jfbr_PercentageOfGrossCashProceeds": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageOfGrossCashProceeds", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of gross cash proceeds", "documentation": "Percentage of gross cash proceeds.", "label": "Percentage Of Gross Cash Proceeds" } } }, "auth_ref": [] }, "jfbr_PercentageOfGrossProceed": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageOfGrossProceed", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of gross proceed", "documentation": "Percentage of gross proceed.", "label": "Percentage Of Gross Proceed" } } }, "auth_ref": [] }, "jfbr_PercentageOfGrossRevenues": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageOfGrossRevenues", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of gross revenues", "documentation": "Percentage of gross revenues.", "label": "Percentage Of Gross Revenues" } } }, "auth_ref": [] }, "jfbr_PercentageOfIssuedAndOutstandingCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageOfIssuedAndOutstandingCommonStock", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of issued and outstanding common stock", "documentation": "Percentage of issued and outstanding common stock.", "label": "Percentage Of Issued And Outstanding Common Stock" } } }, "auth_ref": [] }, "jfbr_PercentageOfTotalConsiderationPaid": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PercentageOfTotalConsiderationPaid", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of total consideration paid", "documentation": "Percentage of total consideration paid.", "label": "Percentage Of Total Consideration Paid" } } }, "auth_ref": [] }, "dei_PhoneFaxNumberDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PhoneFaxNumberDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Phone Fax Number Description", "documentation": "Description of Phone or Fax Number" } } }, "auth_ref": [] }, "us-gaap_PolicyLoansReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyLoansReceivablePolicy", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Loans from shareholders and related parties", "label": "Policy Loans Receivable, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for policy loans receivable, including the basis for determining the amount reported for loans made to policyholders against and secured by future policy benefits. May also disclose the range of interest rates charged to policyholders on such loans." } } }, "auth_ref": [] }, "dei_PostEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PostEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "auth_ref": [ "r734" ] }, "dei_PostEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PostEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective." } } }, "auth_ref": [ "r734" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r741" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r742" ] }, "dei_PreEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "auth_ref": [ "r734" ] }, "dei_PreEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective." } } }, "auth_ref": [ "r734" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Assets", "label": "Prepaid Expense and Other Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement [Member]", "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromBankDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromBankDebt", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Loans received from shareholders", "label": "Proceeds from Bank Debt", "documentation": "The cash inflow from bank borrowing during the year." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from initial public offering, net of issuance costs", "label": "Proceeds from Issuance Initial Public Offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private placement transaction", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from Issuance or Sale of Equity (in Dollars)", "label": "Proceeds from Issuance or Sale of Equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r4", "r542" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from Lines of Credit", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r34", "r870" ] }, "us-gaap_ProceedsFromOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromOtherShortTermDebt", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term loans received", "label": "Proceeds from Other Short-Term Debt", "documentation": "Amount of cash inflow from short-term debt classified as other." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Loans repaid to related parties", "label": "Proceeds from (Repayments of) Related Party Debt", "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromShortTermDebt", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "label": "Proceeds from Short-Term Debt", "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from Warrant Exercises (in Dollars)", "label": "Proceeds from Warrant Exercises", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r864" ] }, "us-gaap_ProfessionalAndContractServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalAndContractServicesExpense", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management services cost", "label": "Professional and Contract Services Expense", "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support." } } }, "auth_ref": [] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Consulting fees (included in general and administrative)", "label": "Professional Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r730", "r924", "r925" ] }, "jfbr_PropertyAndEquipmentTerm": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PropertyAndEquipmentTerm", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment term", "documentation": "Description of the estimated life of property, plant and equipment.", "label": "Property And Equipment Term" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r519", "r527", "r720" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r9", "r164", "r167", "r526" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets are Depreciated Using the Straight-Line Method to Allocate their Cost Over their Estimated Useful Lives", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.jeffsbrands.com/role/LeasesDetails", "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment percentage", "verboseLabel": "Remaining useful life", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "jfbr_PurchaseOfAdditionalWarrant": { "xbrltype": "sharesItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PurchaseOfAdditionalWarrant", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase of additional warrant", "documentation": "Purchase of additional warrant.", "label": "Purchase Of Additional Warrant" } } }, "auth_ref": [] }, "jfbr_PureCapitalLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "PureCapitalLtdMember", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pure Capital Ltd. [Member]", "label": "Pure Capital Ltd Member" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r792" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r792" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable", "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r307", "r308", "r309", "r310", "r364", "r366", "r393", "r394", "r395", "r495", "r496", "r534", "r576", "r577", "r640", "r645", "r647", "r648", "r660", "r691", "r692", "r705", "r712", "r716", "r721", "r724", "r888", "r891", "r913", "r914", "r915", "r916", "r917" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheIPOWarrantsandAdditionalWarrantsTable", "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r307", "r308", "r309", "r310", "r364", "r366", "r393", "r394", "r395", "r495", "r496", "r534", "r576", "r577", "r640", "r645", "r647", "r648", "r660", "r691", "r692", "r705", "r712", "r716", "r721", "r724", "r888", "r891", "r913", "r914", "r915", "r916", "r917" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Other Receivables [Abstract]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r750", "r762", "r778", "r806" ] }, "jfbr_ReductionOfMonthlyFee": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ReductionOfMonthlyFee", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction of monthly fee", "documentation": "Reduction of monthly fee.", "label": "Reduction Of Monthly Fee" } } }, "auth_ref": [] }, "jfbr_ReductionToAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ReductionToAdditionalPaidInCapitalMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction to Additional Paid in Capital [Member]", "label": "Reduction To Additional Paid In Capital Member" } } }, "auth_ref": [] }, "dei_RegistrationStatementAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "RegistrationStatementAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Registration Statement Amendment Number", "documentation": "Amendment number to registration statement under the Investment Company Act of 1940." } } }, "auth_ref": [ "r734" ] }, "jfbr_RelatedPartiesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RelatedPartiesDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related Parties [Line Items]" } } }, "auth_ref": [] }, "jfbr_RelatedPartiesDetailsScheduleofBalanceswithInterestedandRelatedpartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RelatedPartiesDetailsScheduleofBalanceswithInterestedandRelatedpartiesLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Balances with Interested and Related parties [Line Items]" } } }, "auth_ref": [] }, "jfbr_RelatedPartiesDetailsScheduleofBalanceswithInterestedandRelatedpartiesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RelatedPartiesDetailsScheduleofBalanceswithInterestedandRelatedpartiesTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "label": "Related Parties (Details) - Schedule of Balances with Interested and Related parties [Table]" } } }, "auth_ref": [] }, "jfbr_RelatedPartiesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RelatedPartiesDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related Parties (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r365", "r487", "r488", "r579", "r580", "r581", "r583", "r584", "r603", "r605", "r639" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Member]", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r223", "r224", "r487", "r488", "r489", "r490", "r579", "r580", "r581", "r583", "r584", "r603", "r605", "r639" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total transactions with interested and related parties", "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r86", "r487" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r487", "r488", "r909" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Parties [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r365", "r487", "r488", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r579", "r580", "r581", "r583", "r584", "r603", "r605", "r639", "r909" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/RelatedParties" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED PARTIES", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r484", "r485", "r486", "r488", "r491", "r548", "r549", "r550", "r614", "r615", "r616", "r636", "r638" ] }, "us-gaap_RepaymentsOfBankDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfBankDebt", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Loans repaid to shareholders", "label": "Repayments of Bank Debt", "documentation": "The cash outflow to settle a bank borrowing during the year." } } }, "auth_ref": [ "r36" ] }, "us-gaap_RepaymentsOfOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherShortTermDebt", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Short-term loans repaid", "label": "Repayments of Other Short-Term Debt", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r36" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of Related Party Debt", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r36" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r751", "r763", "r779", "r807" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r752", "r764", "r780", "r808" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r759", "r771", "r787", "r815" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/GeneralInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r101", "r136", "r524", "r538", "r539", "r546", "r587", "r720" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings (Accumulated deficit)", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r184", "r227", "r228", "r229", "r231", "r237", "r239", "r293", "r294", "r401", "r402", "r403", "r424", "r425", "r442", "r444", "r445", "r447", "r450", "r535", "r537", "r554", "r927" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r262", "r263", "r268", "r272", "r273", "r279", "r281", "r283", "r362", "r363", "r502" ] }, "us-gaap_RevenueRecognitionCustomerAcquisitions": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionCustomerAcquisitions", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Asset acquisition", "label": "Revenue Recognition, Customer Acquisitions [Policy Text Block]", "documentation": "Disclosure of accounting policy for incremental direct costs incurred related to the acquisition or origination of a customer contract in a transaction that results in revenue deferral (that is, whether such costs are expensed as incurred or deferred and charged to expense in proportion to the revenue recognized.) Also describes the entity's policy for determining which costs are capitalized as contract acquisition or origination costs." } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognition", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r610", "r693", "r701" ] }, "jfbr_RevenueSharingPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RevenueSharingPayment", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue sharing payment (included in other account payable)", "verboseLabel": "Revenue sharing payment", "documentation": "Revenue sharing payment.", "label": "Revenue Sharing Payment" } } }, "auth_ref": [] }, "jfbr_RevenueSharingPaymentPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RevenueSharingPaymentPayable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofOtherPayablesDetailsScheduleofOtherPayables" ], "lang": { "en-us": { "role": { "terseLabel": "undefined", "documentation": "Revenue sharing payment payable.", "label": "Revenue Sharing Payment Payable" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r209", "r220", "r262", "r263", "r268", "r272", "r273", "r279", "r281", "r283", "r292", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r459", "r518", "r889" ] }, "jfbr_RevenuesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "RevenuesPercentage", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues percentage", "documentation": "Revenues percentage.", "label": "Revenues Percentage" } } }, "auth_ref": [] }, "jfbr_Revenuesharingpaymentincludedingeneralandadministrative": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "Revenuesharingpaymentincludedingeneralandadministrative", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTransactionswithInterestedandRelatedPartiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue sharing payment (included in general and administrative)", "documentation": "The amount of Revenue sharing payment.", "label": "Revenuesharingpaymentincludedingeneralandadministrative" } } }, "auth_ref": [] }, "jfbr_ReverseShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ReverseShares", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse Shares (in Dollars)", "documentation": "Reverse shares.", "label": "Reverse Shares" } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use assets obtained in exchange for lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r479", "r719" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r824" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r824" ] }, "us-gaap_SalariesWagesAndOfficersCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalariesWagesAndOfficersCompensation", "crdr": "debit", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Salary", "label": "Salary and Wage, Excluding Cost of Good and Service Sold", "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price per share (in Dollars per share)", "label": "Sale of Stock, Price Per Share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable", "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r240", "r367", "r844", "r877" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/OtherPayablesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Payables", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "jfbr_ScheduleOfActivityInTheInvestmentInScisparcSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfActivityInTheInvestmentInScisparcSharesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Activity in the Investment in SciSparc Shares [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfActivityInTheInvestmentInWellutionAccountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfActivityInTheInvestmentInWellutionAccountAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Activity In The Investment In Wellution Account Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Diluted Weighted Average Shares Outstanding", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r43" ] }, "jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Assets Are Depreciated Using The Straight Line Method To Allocate Their Cost Over Their Estimated Useful Lives Abstract" } } }, "auth_ref": [] }, "jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Balances With Interested And Related Parties Abstract" } } }, "auth_ref": [] }, "jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income Tax Expense (Benefit)", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r140" ] }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Summarized Balance Sheet", "label": "Condensed Balance Sheet [Table Text Block]", "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r852", "r873" ] }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Summarized of Statement of Operation", "label": "Condensed Income Statement [Table Text Block]", "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r852", "r873" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Taxes Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r139" ] }, "jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Deferred Taxes Assets and Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value of the Derivative Warrant Liability", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r13", "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r80" ] }, "jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Diluted Weighted Average Shares Outstanding Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/NetLossPerShareAttributabletoOrdinaryShareholdersTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Basic and Diluted Net Income (Loss) Per Share Attributable to Ordinary Shareholders", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r879" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Statutory Income Tax Rate to Effective Income Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r138" ] }, "jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of The Derivative Warrant Liability Abstract" } } }, "auth_ref": [] }, "jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of The Ipo Warrants And Additional Warrants Abstract" } } }, "auth_ref": [] }, "jfbr_ScheduleOfFinanceIncomeExpenseNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfFinanceIncomeExpenseNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Finance (Income) Expense, Net [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfFinanceIncomeExpensesNetTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finance (Income) Expense, Net", "documentation": "The entire disclosure for financing income expenses net.", "label": "Schedule Of Finance Income Expenses Net Table Text Block" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofTotalIntangibleAssetsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Total Intangible Assets [Abstract]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r52", "r54", "r503" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Total Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r52", "r54" ] }, "jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Future Lease Payments Under Operating Leases [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfGeographicAreasAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfGeographicAreasAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Geographic Areas Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income (Loss) Before Taxes", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r872" ] }, "jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfIncomeLossBeforeTaxesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Income (Loss) Before Taxes [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfIncomeTaxExpenseBenefitAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Income Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfInterestedAndRelatedPartiesTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of balances with interested and related parties", "label": "Schedule Of Interested And Related Parties Table Text Block" } } }, "auth_ref": [] }, "jfbr_ScheduleOfInventoryAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfInventoryAbstract", "lang": { "en-us": { "role": { "label": "Inventory [abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Inventory", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r21", "r105", "r106", "r107" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/OtherReceivablesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Receivables", "label": "Schedule of Other Current Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "jfbr_ScheduleOfOtherReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfOtherReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Other Receivables Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofAssetsareDepreciatedUsingtheStraightLineMethodtoAllocatetheirCostOvertheirEstimatedUsefulLivesTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Transactions with Interested and Related Parties", "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/GeographicalInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Geographic Areas", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r49", "r113" ] }, "jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Share Capital Composed Of Ordinary Shares Abstract" } } }, "auth_ref": [] }, "jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Statutory Income Tax Rate to Effective Income Tax Rate [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityTableTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share Capital Composed of Ordinary Shares", "label": "Schedule of Stockholders Equity [Table Text Block]", "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented." } } }, "auth_ref": [ "r12" ] }, "jfbr_ScheduleOfSummarizedBalanceSheetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfSummarizedBalanceSheetAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Summarized Balance Sheet [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfSummarizedOfStatementOfOperationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfSummarizedOfStatementOfOperationAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Summarized of Statement of Operation [Abstract]" } } }, "auth_ref": [] }, "jfbr_ScheduleOfTotalIntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfTotalIntangibleAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Total Intangible Assets Abstract" } } }, "auth_ref": [] }, "jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Transactions with Interested and Related Parties [Abstract]" } } }, "auth_ref": [] }, "jfbr_SciSparcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SciSparcMember", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SciSparc [Member]", "label": "Sci Sparc Member" } } }, "auth_ref": [] }, "jfbr_SciSparcUSMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SciSparcUSMember", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SciSparc U.S [Member]", "label": "Sci Sparc USMember" } } }, "auth_ref": [] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r898" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r735" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r739" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r738" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r743" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r281", "r282", "r568", "r571", "r573", "r642", "r646", "r651", "r673", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r694", "r713", "r724", "r892", "r920" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/GeographicalInformation" ], "lang": { "en-us": { "role": { "terseLabel": "GEOGRAPHICAL INFORMATION", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r257", "r258", "r259", "r260", "r261", "r267", "r271", "r275", "r276", "r277", "r278", "r279", "r280", "r283" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "jfbr_SeriesAWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SeriesAWarrantsMember", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series A Warrants [Member]", "label": "Series AWarrants Member" } } }, "auth_ref": [] }, "jfbr_SeriesBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SeriesBWarrantsMember", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series B Warrants [Member]", "label": "Series BWarrants Member" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee contribution", "verboseLabel": "Percentage of salary of employee", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate", "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan." } } }, "auth_ref": [ "r63" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase of warrants", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r16" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.jeffsbrands.com/role/ShareIncentivePlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total ordinary shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r718" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional warrants", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied." } } }, "auth_ref": [ "r64" ] }, "jfbr_ShareCapitalDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShareCapitalDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Share Capital [Line Items]" } } }, "auth_ref": [] }, "jfbr_ShareCapitalDetailsScheduleofShareCapitalComposedofOrdinarySharesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShareCapitalDetailsScheduleofShareCapitalComposedofOrdinarySharesLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Share Capital Composed of Ordinary Shares [Line Items]" } } }, "auth_ref": [] }, "jfbr_ShareCapitalDetailsScheduleofShareCapitalComposedofOrdinarySharesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShareCapitalDetailsScheduleofShareCapitalComposedofOrdinarySharesTable", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable" ], "lang": { "en-us": { "role": { "label": "Share Capital (Details) - Schedule of Share Capital Composed of Ordinary Shares [Table]" } } }, "auth_ref": [] }, "jfbr_ShareCapitalDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShareCapitalDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Share Capital (Details) [Table]" } } }, "auth_ref": [] }, "jfbr_ShareIncentivePlanLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShareIncentivePlanLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ShareIncentivePlan" ], "lang": { "en-us": { "role": { "terseLabel": "Share Incentive Plan [Abstract]", "label": "Share Incentive Plan Line Items" } } }, "auth_ref": [] }, "jfbr_ShareIncentivePlanTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShareIncentivePlanTable", "presentation": [ "http://www.jeffsbrands.com/role/ShareIncentivePlan" ], "lang": { "en-us": { "role": { "label": "Share Incentive Plan [Table]" } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share (in Dollars per share)", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SharebasedCompensationIncludedInDeferredOfferingCosts", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation included in deferred offering costs", "documentation": "The amount is share-based compensation included in deferred offering costs.", "label": "Sharebased Compensation Included In Deferred Offering Costs" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares acquired (in Shares)", "verboseLabel": "Ordinary shares (in Shares)", "netLabel": "Ordinary shares", "label": "Warrant to purchase shares", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBankLoansAndNotesPayable", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term loans", "label": "Short-Term Bank Loans and Notes Payable", "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer." } } }, "auth_ref": [ "r22", "r582", "r918" ] }, "jfbr_ShortTermDebtAdditionalInterest": { "xbrltype": "percentItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShortTermDebtAdditionalInterest", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional interest rate", "documentation": "Additional interest rate for short term debt.", "label": "Short Term Debt Additional Interest" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtPercentageBearingFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtPercentageBearingFixedInterestRate", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bears annual interest percentage", "label": "Short-Term Debt, Percentage Bearing Fixed Interest Rate", "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtPercentageBearingVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtPercentageBearingVariableInterestRate", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Short-Term Debt, Percentage Bearing Variable Interest Rate", "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoans" ], "lang": { "en-us": { "role": { "terseLabel": "SHORT-TERM LOANS", "label": "Short-Term Debt [Text Block]", "documentation": "The entire disclosure for short-term debt." } } }, "auth_ref": [ "r134" ] }, "jfbr_ShortTermLoansDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShortTermLoansDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Loans [Line Items]" } } }, "auth_ref": [] }, "jfbr_ShortTermLoansDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "ShortTermLoansDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Loans (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_ShorttermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShorttermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value amount", "label": "Short-Term Debt, Fair Value", "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r125", "r217" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r744" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofShareCapitalComposedofOrdinarySharesTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r171", "r193", "r194", "r195", "r220", "r244", "r245", "r247", "r249", "r255", "r256", "r292", "r311", "r313", "r314", "r315", "r318", "r319", "r347", "r348", "r350", "r353", "r359", "r459", "r542", "r543", "r544", "r545", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r586", "r608", "r632", "r674", "r675", "r676", "r677", "r678", "r843", "r869", "r878" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r31", "r184", "r206", "r207", "r208", "r227", "r228", "r229", "r231", "r237", "r239", "r254", "r293", "r294", "r361", "r401", "r402", "r403", "r424", "r425", "r442", "r443", "r444", "r445", "r446", "r447", "r450", "r462", "r463", "r464", "r465", "r466", "r467", "r483", "r535", "r536", "r537", "r554", "r632" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r174", "r183", "r281", "r282", "r568", "r571", "r573", "r642", "r646", "r651", "r673", "r680", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r694", "r713", "r724", "r892", "r920" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r227", "r228", "r229", "r254", "r502", "r540", "r565", "r578", "r579", "r580", "r581", "r583", "r584", "r586", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r599", "r600", "r601", "r602", "r603", "r605", "r610", "r611", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r632", "r725" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofActivityintheInvestmentinWellutionAccountTable", "http://www.jeffsbrands.com/role/ScheduleofFairValueoftheDerivativeWarrantLiabilityTable", "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r240", "r367", "r844", "r846", "r877" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r227", "r228", "r229", "r254", "r502", "r540", "r565", "r578", "r579", "r580", "r581", "r583", "r584", "r586", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r599", "r600", "r601", "r602", "r603", "r605", "r610", "r611", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r632", "r725" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r754", "r766", "r782", "r810" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow", "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of 35,345 ordinary shares to SciSparc Ltd. in consideration for 13,858 ordinary shares", "verboseLabel": "Issued to the minority Shareholder", "label": "Stock Issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r40", "r41", "r42" ] }, "jfbr_StockIssuedDuringPeriodIssuanceOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "StockIssuedDuringPeriodIssuanceOfOrdinaryShares", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares to SciSparc Ltd. (Note 7)", "documentation": "The amount is issuance of ordinary shares.", "label": "Stock Issued During Period Issuance Of Ordinary Shares" } } }, "auth_ref": [] }, "jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesToSciSparcLtd": { "xbrltype": "sharesItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "StockIssuedDuringPeriodIssuanceOfOrdinarySharesToSciSparcLtd", "presentation": [ "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares to SciSparc Ltd. (Note 7) (in Shares)", "verboseLabel": "Issuance of ordinary shares (in Shares)", "documentation": "The number of stock issued during period issuance of ordinary shares.", "label": "Stock Issued During Period Issuance Of Ordinary Shares To Sci Sparc Ltd" } } }, "auth_ref": [] }, "jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares upon initial public offering, net of issuance costs (Note 13)", "documentation": "The amount is issuance of ordinary shares upon initial public offering, net of issuance costs.", "label": "Stock Issued During Period Issuance Of Ordinary Shares Upon Initial Public Offering Net Of Issuance Costs" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares upon initial public offering, net of issuance costs (Note 13) (in Shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r12", "r98", "r99", "r136", "r542", "r632", "r675" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation to service provider", "label": "Stock Issued During Period, Value, Issued for Services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of ordinary shares", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r12", "r98", "r99", "r136", "r554", "r632", "r675", "r731" ] }, "us-gaap_StockOptionExercisePriceDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionExercisePriceDecrease", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price less (in Dollars per share)", "label": "Stock Option, Exercise Price, Decrease", "documentation": "Per share decrease in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement." } } }, "auth_ref": [ "r360" ] }, "us-gaap_StockOptionExercisePriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionExercisePriceIncrease", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price (in Dollars per share)", "label": "Stock Option, Exercise Price, Increase", "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement." } } }, "auth_ref": [ "r360" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet", "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable", "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "terseLabel": "Equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r99", "r102", "r103", "r127", "r588", "r604", "r633", "r634", "r720", "r732", "r871", "r885", "r902", "r927" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS\u2019 EQUITY:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapital" ], "lang": { "en-us": { "role": { "terseLabel": "SHARE CAPITAL", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r135", "r219", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r361", "r449", "r635", "r637", "r679" ] }, "us-gaap_StockholdersEquityNoteStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteStockSplit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of stock dividend", "label": "Stockholders' Equity Note, Stock Split", "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements." } } }, "auth_ref": [ "r137" ] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse split", "label": "Stockholders' Equity, Reverse Stock Split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r137" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails", "http://www.jeffsbrands.com/role/IntangibleAssetsDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r468", "r493" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails", "http://www.jeffsbrands.com/role/IntangibleAssetsDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r468", "r493" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.jeffsbrands.com/role/GeneralInformationDetails", "http://www.jeffsbrands.com/role/IntangibleAssetsDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r468", "r493" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "jfbr_SubsequentEventsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SubsequentEventsDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Line Items]" } } }, "auth_ref": [] }, "jfbr_SubsequentEventsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SubsequentEventsDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.jeffsbrands.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r492", "r494" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails", "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SubstantialModificationOfShareholdersLoansRecordedInEquity", "crdr": "credit", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Substantial modification of shareholders\u2019 loans recorded in equity", "documentation": "The amount is substantial modification of shareholders\u2019 loans recorded in equity.", "label": "Substantial Modification Of Shareholders Loans Recorded In Equity" } } }, "auth_ref": [] }, "jfbr_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "jfbr_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of cash flow information:", "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Supplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Supplies", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable": { "parentTag": "us-gaap_OtherReceivablesNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofBalanceswithInterestedandRelatedpartiesTable", "http://www.jeffsbrands.com/role/ScheduleofOtherReceivablesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Advances to suppliers", "label": "Prepaid Supplies", "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r697", "r706", "r886" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r803" ] }, "jfbr_TaxesonIncomeDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "TaxesonIncomeDetailsLineItems", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Taxes on Income [Line Items]" } } }, "auth_ref": [] }, "jfbr_TaxesonIncomeDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "TaxesonIncomeDetailsTable", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Taxes on Income (Details) [Table]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r881", "r908" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails", "http://www.jeffsbrands.com/role/RelatedPartiesDetails", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r795" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r802" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r155", "r156", "r157", "r286", "r287", "r289" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r823" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r825" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax", "crdr": "debit", "calculation": { "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable": { "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofFinanceIncomeExpenseNetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange rate differences", "label": "Translation Adjustment Functional to Reporting Currency, Gain (Loss), Reclassified to Earnings, Net of Tax", "documentation": "Amount of reclassification from other comprehensive income (loss) to earnings, after tax, related to translation from the functional currency to reporting currency, as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity." } } }, "auth_ref": [ "r3", "r108", "r905" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r826" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r827" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r825" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r825" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r828" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r826" ] }, "jfbr_UKTaxLawMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "UKTaxLawMember", "presentation": [ "http://www.jeffsbrands.com/role/TaxesonIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "UK tax law [Member]", "label": "UKTax Law Member" } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofGeographicAreasTable" ], "lang": { "en-us": { "role": { "terseLabel": "America [Member]", "label": "UNITED STATES" } } }, "auth_ref": [] }, "jfbr_UndefinedPeriodOfTime": { "xbrltype": "durationItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "UndefinedPeriodOfTime", "presentation": [ "http://www.jeffsbrands.com/role/RelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Undefined period of time", "documentation": "Undefined period of time.", "label": "Undefined Period Of Time" } } }, "auth_ref": [] }, "jfbr_UnderwritersWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "UnderwritersWarrantsMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underwriter\u2019s Warrants [Member]", "label": "Underwriters Warrants Member" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r822" ] }, "jfbr_UnitPricePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "UnitPricePerUnit", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unit, Price per Unit (in Dollars per share)", "documentation": "Price per unit.", "label": "Unit Price Per Unit" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r46", "r47", "r48", "r162", "r163", "r165", "r166" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofDilutedWeightedAverageSharesOutstandingTable", "http://www.jeffsbrands.com/role/ShareCapitalDetails", "http://www.jeffsbrands.com/role/ShortTermLoansDetails", "http://www.jeffsbrands.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant [Member]", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r722", "r723", "r726", "r727", "r728", "r729" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://www.jeffsbrands.com/role/ShareCapitalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants and Rights Outstanding, Term", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r901" ] }, "jfbr_WarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "WarrantsIssued", "presentation": [ "http://www.jeffsbrands.com/role/ShortTermLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants issued (in Shares)", "documentation": "Number of warrants issued.", "label": "Warrants Issued" } } }, "auth_ref": [] }, "jfbr_WarrantsToPurchaseOrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "WarrantsToPurchaseOrdinarySharesMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to Purchase Ordinary Shares", "label": "Warrants To Purchase Ordinary Shares Member" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average ordinary shares used in computing net profit (loss) per share, diluted", "verboseLabel": "Shares of ordinary share used in computing diluted net loss per share", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r243", "r249" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement", "http://www.jeffsbrands.com/role/ScheduleofBasicandDilutedNetIncomeLossPerShareAttributabletoOrdinaryShareholdersTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average ordinary shares used in computing net profit (loss) per share, basic (in Shares)", "verboseLabel": "Shares of ordinary share used in computing basic net loss per share", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r242", "r249" ] }, "jfbr_WellutionAccountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "WellutionAccountMember", "presentation": [ "http://www.jeffsbrands.com/role/ScheduleofSummarizedBalanceSheetTable", "http://www.jeffsbrands.com/role/ScheduleofSummarizedofStatementofOperationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Wellution account [Member]", "verboseLabel": "Wellution [Member]", "label": "Wellution Account Member" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r834" ] }, "jfbr_considerationOfOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.jeffsbrands.com/20231231", "localname": "considerationOfOrdinaryShares", "presentation": [ "http://www.jeffsbrands.com/role/ConsolidatedCashFlow_Parentheticals", "http://www.jeffsbrands.com/role/InvestmentinAffiliateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "consideration of ordinary shares", "verboseLabel": "Exchange shares (in Shares)", "documentation": "Number of consideration of ordinary shares.", "label": "consideration Of Ordinary Shares" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "835", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-8" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "810", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481827/980-810-45-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477092/405-40-50-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//820/tableOfContent" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.1-12)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.14)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "51", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-51" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-8" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column C)(Footnote 6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column D)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column D)(Footnote 6)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "Global LEI Foundation", "URI": "www.leiroc.org", "URIDate": "2013-08-21" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form F-3" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-3" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-4" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form S-3" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Investment Company Act", "Number": "270" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "413", "Subsection": "b" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "b" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "c" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "d" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "e" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "a" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "b" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Section": "8", "Subsection": "c" }, "r843": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r844": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r845": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r846": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org//705/tableOfContent" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-10/tableOfContent" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480369/946-230-45-1" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 122 0001213900-24-028253-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-028253-xbrl.zip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ea0202280-20f_jeffs_htm.xml IDEA: XBRL DOCUMENT 0001885408 2023-01-01 2023-12-31 0001885408 dei:BusinessContactMember 2023-01-01 2023-12-31 0001885408 jfbr:OrdinarySharesNoParValuePerShareMember 2023-01-01 2023-12-31 0001885408 jfbr:WarrantsToPurchaseOrdinarySharesMember 2023-01-01 2023-12-31 0001885408 2023-12-31 0001885408 2022-12-31 0001885408 2022-01-01 2022-12-31 0001885408 2021-01-01 2021-12-31 0001885408 us-gaap:CommonStockMember 2020-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001885408 us-gaap:RetainedEarningsMember 2020-12-31 0001885408 2020-12-31 0001885408 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001885408 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001885408 us-gaap:CommonStockMember 2021-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001885408 us-gaap:RetainedEarningsMember 2021-12-31 0001885408 2021-12-31 0001885408 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001885408 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001885408 us-gaap:CommonStockMember 2022-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001885408 us-gaap:RetainedEarningsMember 2022-12-31 0001885408 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001885408 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001885408 us-gaap:CommonStockMember 2023-12-31 0001885408 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001885408 us-gaap:RetainedEarningsMember 2023-12-31 0001885408 2023-10-01 2023-12-31 0001885408 us-gaap:SubsequentEventMember 2024-01-29 2024-01-29 0001885408 srt:MinimumMember 2023-12-31 0001885408 us-gaap:ComputerEquipmentMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001885408 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001885408 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001885408 us-gaap:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001885408 2023-03-09 0001885408 us-gaap:SubsequentEventMember 2024-02-29 2024-02-29 0001885408 2023-03-09 2023-03-09 0001885408 2023-09-20 0001885408 jfbr:BrandsMember 2023-12-31 0001885408 jfbr:BrandsMember 2022-12-31 0001885408 jfbr:SciSparcUSMember 2023-02-23 0001885408 jfbr:SciSparcUSMember 2023-02-23 2023-02-23 0001885408 jfbr:SciSparcUSMember 2023-03-22 2023-03-22 0001885408 2023-03-22 2023-03-22 0001885408 2023-11-30 2023-11-30 0001885408 srt:MaximumMember 2023-01-01 2023-12-31 0001885408 srt:MinimumMember 2023-01-01 2023-12-31 0001885408 jfbr:JeffsBrandsHoldingMember 2023-12-31 0001885408 jfbr:SciSparcUSMember 2023-01-01 2023-12-31 0001885408 jfbr:SciSparcMember 2023-03-22 2023-03-22 0001885408 jfbr:SciSparcMember 2023-03-22 0001885408 srt:MinimumMember 2023-03-22 2023-03-22 0001885408 srt:MaximumMember 2023-03-22 2023-03-22 0001885408 jfbr:WellutionAccountMember 2023-12-31 0001885408 jfbr:WellutionAccountMember 2023-02-23 2023-12-31 0001885408 2023-03-22 0001885408 2023-03-23 2023-12-31 0001885408 2022-05-09 2022-05-09 0001885408 2022-05-09 0001885408 2021-07-31 0001885408 2021-07-01 2021-07-31 0001885408 us-gaap:WarrantMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember 2022-08-30 0001885408 us-gaap:WarrantMember 2022-08-30 0001885408 2022-02-22 0001885408 us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-02-22 0001885408 2022-03-03 2022-03-03 0001885408 2022-06-02 2022-06-02 0001885408 us-gaap:IPOMember 2023-12-31 0001885408 us-gaap:IPOMember 2022-11-28 0001885408 us-gaap:CommonStockMember 2022-11-28 0001885408 2022-11-28 0001885408 2022-11-28 2022-11-28 0001885408 us-gaap:IPOMember 2022-12-31 0001885408 us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001885408 us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001885408 us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001885408 us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001885408 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001885408 us-gaap:MeasurementInputDiscountRateMember 2023-12-31 0001885408 us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001885408 us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001885408 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001885408 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001885408 jfbr:MeasureInputWeightedAverageCostOfCapitalMember 2023-12-31 0001885408 srt:MinimumMember jfbr:MeasureInputWeightedAverageCostOfCapitalMember 2022-12-31 0001885408 srt:MaximumMember jfbr:MeasureInputWeightedAverageCostOfCapitalMember 2022-12-31 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember jfbr:MedigusMember 2022-05-03 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember jfbr:MrHakmonAndLIAMember 2022-05-03 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember jfbr:PureCapitalLtdMember 2022-05-03 0001885408 us-gaap:IPOMember 2023-01-01 2023-12-31 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember 2023-01-01 2023-12-31 0001885408 jfbr:LoanPayableToShareholdersPureCapitalMember us-gaap:IPOMember 2023-01-01 2023-12-31 0001885408 jfbr:PureCapitalLtdMember jfbr:MrHakmonAndLIAMember jfbr:MedigusMember 2022-08-30 2022-08-30 0001885408 2022-08-30 2022-08-30 0001885408 jfbr:IsraeliTaxLawsMember 2023-01-01 2023-12-31 0001885408 jfbr:UKTaxLawMember 2023-01-01 2023-12-31 0001885408 jfbr:MedigusMember 2023-01-01 2023-12-31 0001885408 2022-02-17 2022-02-17 0001885408 2022-05-03 2022-05-03 0001885408 2022-06-16 2022-06-16 0001885408 jfbr:PureCapitalLtdMember 2022-08-30 2022-08-30 0001885408 jfbr:MrHakmonMember 2022-08-30 2022-08-30 0001885408 us-gaap:OverAllotmentOptionMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember us-gaap:IPOMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2022-08-30 0001885408 us-gaap:IPOMember 2022-08-30 2022-08-30 0001885408 us-gaap:IPOMember 2022-08-30 0001885408 2022-08-30 0001885408 us-gaap:CommonStockMember 2022-11-28 0001885408 jfbr:UnderwritersWarrantsMember 2022-08-30 2022-08-30 0001885408 jfbr:UnderwritersWarrantsMember 2022-08-30 0001885408 jfbr:UnderwritersWarrantsMember jfbr:FinanceExpenseMember 2022-08-30 2022-08-30 0001885408 jfbr:UnderwritersWarrantsMember jfbr:ReductionToAdditionalPaidInCapitalMember 2022-08-30 2022-08-30 0001885408 us-gaap:WarrantMember us-gaap:IPOMember 2022-08-30 0001885408 jfbr:FinanceExpenseMember us-gaap:OverAllotmentOptionMember 2022-08-30 2022-08-30 0001885408 jfbr:ReductionToAdditionalPaidInCapitalMember us-gaap:OverAllotmentOptionMember 2022-08-30 2022-08-30 0001885408 us-gaap:CommonStockMember us-gaap:IPOMember 2022-08-30 0001885408 us-gaap:IPOMember 2023-08-30 2023-08-30 0001885408 jfbr:AdvisorWarrantsMember us-gaap:IPOMember 2022-08-30 2022-08-30 0001885408 jfbr:AdvisorWarrantsMember us-gaap:IPOMember 2022-08-30 0001885408 jfbr:AdvisorWarrantsMember us-gaap:IPOMember 2022-11-28 0001885408 2022-02-17 0001885408 srt:BoardOfDirectorsChairmanMember us-gaap:CommonStockMember 2023-11-14 0001885408 us-gaap:CommonStockMember 2023-12-31 0001885408 us-gaap:CommonStockMember 2022-12-31 0001885408 jfbr:IPOAndAdditionalWarrantsMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001885408 jfbr:IPOAndAdditionalWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001885408 jfbr:IPOAndAdditionalWarrantsMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001885408 jfbr:UnderwritersWarrantsMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001885408 jfbr:UnderwritersWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001885408 jfbr:UnderwritersWarrantsMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001885408 jfbr:OtherWarrantsMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001885408 jfbr:OtherWarrantsMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001885408 jfbr:OtherWarrantsMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001885408 srt:BoardOfDirectorsChairmanMember 2022-08-01 2022-08-03 0001885408 srt:BoardOfDirectorsChairmanMember 2022-08-25 2022-09-01 0001885408 2022-08-25 2022-09-01 0001885408 2022-10-10 2022-10-26 0001885408 2023-03-01 2023-03-31 0001885408 2022-05-10 2022-05-21 0001885408 jfbr:MedigusMember 2023-01-01 2023-12-31 0001885408 jfbr:MedigusMember 2022-01-01 2022-12-31 0001885408 jfbr:SciSparcUSMember 2023-12-31 0001885408 jfbr:MinorityShareholderMember 2023-03-22 2023-03-22 0001885408 jfbr:SciSparcMember 2023-01-01 2023-12-31 0001885408 jfbr:MedigusMember 2022-09-02 2022-09-30 0001885408 us-gaap:RelatedPartyMember 2022-09-02 2022-09-30 0001885408 us-gaap:InterestExpenseMember us-gaap:RelatedPartyMember 2022-09-02 2022-09-30 0001885408 jfbr:PureCapitalLtdMember 2023-01-01 2023-12-31 0001885408 us-gaap:RelatedPartyMember 2023-12-31 0001885408 us-gaap:RelatedPartyMember 2022-12-31 0001885408 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001885408 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001885408 country:US 2023-01-01 2023-12-31 0001885408 country:US 2022-01-01 2022-12-31 0001885408 country:US 2021-01-01 2021-12-31 0001885408 srt:EuropeMember 2023-01-01 2023-12-31 0001885408 srt:EuropeMember 2022-01-01 2022-12-31 0001885408 srt:EuropeMember 2021-01-01 2021-12-31 0001885408 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 jfbr:SeriesAWarrantsMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 us-gaap:SubsequentEventMember jfbr:OrdinarySharesMember 2024-01-25 0001885408 jfbr:SeriesBWarrantsMember us-gaap:SubsequentEventMember 2024-01-25 0001885408 us-gaap:SubsequentEventMember 2024-01-25 2024-01-25 0001885408 us-gaap:WarrantMember 2023-12-31 0001885408 us-gaap:PrivatePlacementMember 2023-12-31 0001885408 us-gaap:SubsequentEventMember us-gaap:IPOMember 2024-02-01 2024-02-05 shares iso4217:USD iso4217:USD shares pure iso4217:EUR iso4217:ILS 20-F false true 2023-12-31 --12-31 2023 false false 001-41482 Jeffs’ Brands Ltd L3 7 Mezada Street Bnei Brak Israel 5126112 IL IL Viki Hakmon +972 3-7713520 victor@jeffsbrands.com 7 Mezada Street Bnei Brak Israel 5126112 Ordinary Shares, no par value per share JFBR NASDAQ Warrants to Purchase Ordinary Shares JFBRW NASDAQ 1215512 No No Yes Yes Non-accelerated Filer true false false false U.S. GAAP false false false false false 1197 Brightman Almagor Zohar & Co. Tel Aviv, Israel 535000 8137000 17000 629000 327000 597000 779000 2386000 1791000 4164000 11034000 59000 41000 1940000 67000 5714000 4452000 168000 110000 127000 138000 8075000 4741000 12239000 15775000 709000 131000 1533000 391000 66000 32000 86000 2308000 640000 1375000 2216000 45000 98000 1420000 2314000 3728000 2954000 43567567 43567567 1215512 1215512 1153461 1153461 16787000 16499000 -8276000 -3678000 8511000 12821000 12239000 15775000 10008000 5859000 6509000 9032000 5060000 4560000 976000 799000 1949000 833000 1198000 1314000 4262000 4113000 1480000 1249000 87000 -279000 -5089000 -4512000 -932000 523000 2305000 -629000 -4566000 -2207000 -1561000 32000 -6000 -21000 -4598000 -2201000 -1540000 -3.88 -3.32 -3.73 1184484 663411 413192 413304 287000 63000 350000 -1540000 -1540000 75000 75000 1250000 1250000 60000 60000 1058000 1058000 413304 2730000 -1477000 1253000 -2201000 -2201000 769000 769000 557774 6194000 6194000 26000 26000 209089 3461000 3461000 3319000 3319000 1153461 16499000 -3678000 12821000 -4598000 -4598000 35345 288000 288000 1215512 16787000 -8276000 8511000 -4598000 -2201000 -1540000 60000 -34000 738000 570000 524000 87000 298000 546000 14000 221000 -1249000 841000 2822000 -75000 1000 25000 -58000 -15000 -115000 1416000 302000 -39000 282000 40000 -182000 743000 290000 596000 564000 449000 -213000 241000 1304000 -579000 254000 -67000 -14000 -67000 -15000 -2668000 -4840000 -863000 25000 41000 2000 17000 3091000 1681000 4728000 -4814000 -41000 -4730000 752000 981000 86000 1518000 134000 13391000 4800000 100000 -1102000 1250000 -86000 12625000 5695000 -7568000 7744000 102000 -34000 8137000 393000 291000 535000 8137000 393000 28000 73000 116000 2000 477000 4000 86000 75000 2839000 35345 13858 288000 332000 98000 982000 57000 152000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 — GENERAL INFORMATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Jeffs’ Brands Ltd (the “Company” or “Jeffs’ Brands”) was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements the Company has five wholly owned subsidiaries — Smart Repair Pro (“Smart Pro”), Top Rank Ltd. (“Top Rank”), Jeffs’ Brands Holdings Inc. (“Jeffs’ Brands Holdings”), Fort Products Ltd. (“Fort”) and Fort Products LLC (“Fort US”) (the “Subsidiaries”). The Company and the Subsidiaries (“Group”) are engaged in the acquisition, improvement and operation of virtual stores (the “Brands”) mainly on the Amazon.com (“Amazon”) website.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">References to the Company hereinafter, unless the context otherwise provides, include Jeffs’ Brands and the Subsidiaries on a consolidated basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro, a private corporation founded in the State of California, was established on December 20, 2017, and commenced its operations in June 2019. As of December 31, 2023, Smart Pro operated four brands on the Amazon website.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April 2021, Top Rank, an Israeli company, was established as a wholly owned subsidiary of Jeffs’ Brands.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 23, 2023, Jeffs’ Brands Holdings Inc., was established and registered in Delaware as a wholly owned subsidiary of Jeffs’ Brands.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 9, 2023, the Company purchased all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information see note 5.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On April 23, 2023, Fort US, was incorporated and registered under the laws of the State of Delaware as a wholly owned subsidiary of Jeffs’ Brands Holdings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of common stock of SciSparc Nutraceuticals Inc. (“SciSparc U.S”). For additional information see note 7.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial public offering</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 30, 2022, the Company completed its initial public offering (“IPO”), for additional information see note 13.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration risk</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s activities are mainly conducted through Amazon’s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon’s terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Group is engaged with a small number of suppliers as part of the production process of its brands. Any material changes in the supply process, whether temporary or permanent, may affect sales performance, and may have a material effect on the Group’s financial position and the results of its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2023, the Group incurred a net loss of 4,598 thousand and cash flows used in operating activities were $ 2,668 thousand. As of December 31, 2023, the Group had an accumulated deficit of approximately $8,276 thousand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group has funded its operations to date through the sale of its products, through equity financings, loans from shareholders and other third parties, and sale of its Ordinary Shares and warrants. The Company intends to continue to finance its operating activities through the sale of products via its Brands and through raising additional capital, as needed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in">On January 29, 2024, the Company entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement with certain institutional investors for aggregate gross proceeds of approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Management believes that expected cash flows are sufficient to support the Group’s current operations for more than 12 months from the issuance date of these consolidated financial statements.</p> On February 23, 2023, the Company purchased approximately 49% of the issued and outstanding shares of common stock of SciSparc Nutraceuticals Inc. (“SciSparc U.S”). -4598000 -2668000 -8276000 7275000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of preparation of the financial statements</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to 2022, the Group prepared its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB), as permitted in the United States based on the Company’s qualification as a “foreign private issuer” under the rules and regulations of the U.S Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances, fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent liabilities, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group’s assets and liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Functional and presentation currency</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional and reporting currency of the Group is the United States dollar (“U.S dollar”) as the U.S. dollar is the currency of the primary economic environment in which the Group has operated and expects to continue to operate in the foreseeable future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group's transactions and balances denominated in U.S. dollars are presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts receivable</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivables are stated at realizable value, net of an allowance for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point of sale, therefore, no provision for credit losses has been recorded as of December 31, 2023 and 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are stated at the lower of cost or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in accordance with first-in, first-out Method (“FIFO”). The cost of inventory includes all costs of purchase, and other costs incurred in bringing the inventories to their present location and condition including shipment and freight costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers equipment</span></td> <td style="width: 1%"> </td> <td style="width: 29%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office Equipment/Furniture</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-7</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant &amp; Machinery</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of remaining lease term or estimated useful life</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 842, the Group determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical expedient to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Group’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option. An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Operating lease expense is recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset acquisition</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for a transaction as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs are capitalized as part of the asset or assets acquired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The estimated useful lives of the Group’s intangible assets (Brands) are 10 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of long-lived assets</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s long-lived assets (assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining the fair values of long-lived assets for the purpose of measuring impairment, the Group’s assumptions include those that market participants will consider in valuations of similar assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loans from shareholders and related parties:</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the borrowing date of loans received from shareholders or related parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with ASC 470, “Debt” (“ASC 470”), Subtopic 50— “Modifications and Extinguishments” (“ASC 470-50”). For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt is recorded as an in-essence capital transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. As of December 31, 2023 and 2022 a partial valuation allowance was recorded on the Group’s deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. As of December 31, 2023 and 2022, no liability for unrecognized tax positions were recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>n.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). The Company derives its revenue from the sale of consumer products mainly through its online Amazon stores. </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company considers customer order confirmations to be a contract with the customer. Customer confirmations are executed at the time an order is placed through third-party online channels.</p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligation is satisfied), which typically occurs at the shipment date. A performance obligation is a promise in a contract to transfer a distinct good to the customer and is the unit of account in ASC Topic 606. A contract’s transaction price is recognized as revenue when the performance obligation is satisfied. Each of the Company’s contracts have a single distinct performance obligation, which is the promise to transfer individual goods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the Group’s standard contract terms, customers have a right of return within 45 days. For contracts with rights of return, the Group recognizes revenue based on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance for returns in the amounts of $21 thousand and $70 thousand as of December 31, 2023, and 2022, respectively. The allowance for returns is recorded as (increase) decrease in revenues, respectively against other payables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group evaluates the criteria outlined in ASC 606-10-55, “Principal versus Agent Considerations”, in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these arrangements; therefore, sales are recorded on a gross basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Sales taxes collected from customers are presented on a net basis and as such are excluded from net revenue.<b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of sales</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with Amazon’s terms of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making binding sales. Sales commissions would not have been incurred if the contract had not been obtained.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cost of sales primarily consists of cost of goods sold, expenses related to Amazon’s commissions, storage costs and freight.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advertising expenses</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group expenses advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $719 thousand, $1,163 thousand, and $1,211 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee benefits</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Groups employees are employed by the company and by Fort and subject to the local labor laws.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s employees</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Group’s employees in Israel are entitled to a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve the Group from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group’s balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Fort employees</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">England labor laws generally requires an employer to make contributions to National Employment Savings Trust on behalf of its employees. Since April 2019, the minimum employer contribution is required to be 3% of an employee's salary. These payments relieve a company from future obligations with respect to its employees. The aforementioned contributions are not recorded as an asset on the Group's balance sheet and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair value measurement</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group applies ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining fair value, the Group uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent from the Group. Unobservable inputs are inputs that reflect the Group’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 1 - Valuations based on quoted prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts of cash and cash equivalents, trade receivables, other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value due to the short-term maturity of such instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s derivative liabilities in respect of Additional Warrants are classified within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable inputs. For more details, see Note 9.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s financial asset in respect of the investment in SciSparc Ltd. (“<b>SciSparc</b>”) as of December 31, 2023 is classified within Level 1 of the fair value hierarchy, because the ordinary shares have quoted prices as they are traded on the Nasdaq Stock Market LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, “Distinguishing Liabilities and Equity”, are indexed to the Group’s own stock and whether the warrants are eligible for equity classification under ASC 815 (“ASC 815”), “Derivatives and Hedging”, Subtopic 40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrants that meet all the criteria for equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings at each balance sheet date thereafter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal and other contingencies</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for its contingent liabilities in accordance with ASC 450, “Contingencies”. A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with loss contingencies are expensed as incurred. As of December 31, 2023, and 2022, the Group is not a party to any litigation that could have a material adverse effect on the Group’s business, financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>u.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted net loss per share.</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group calculates basic net profit (loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All outstanding share options and warrants for the years ended December 31, 2023 and 2022 have been excluded from the calculation of the diluted net loss per share since all such securities were anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>v.</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Investment in affiliates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The investment in affiliated company is accounted for by the equity method under ASC Subtopic 323-10, “Investments - Equity Method and Joint Ventures”. The Company uses the equity method when it has the ability to exercise significant influence over operating and financial policies of an entity but does not have control of the entity. Under the equity method of accounting, an investment is initially recorded on the balance sheet at cost, representing the Company’s proportionate share of fair value. The investment is subsequently adjusted to reflect the Company’s proportionate share of net earnings or losses recognized, distributions received, contributions made and certain other adjustments, as appropriate. The Company does not record losses of the equity method investee in excess of its investment balance unless the Company is liable for obligations of the equity method investee or is otherwise committed to provide financial support to the equity method investee. As of December 31, 2023 the Company held investments in SciSparc U.S.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company evaluates its equity method investments for impairment at each reporting date, or more frequently if events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when determining whether an investment has been other-than-temporarily-impaired, include, but are not limited to, the length of the time and the extent to which the market value has been less than cost, the financial condition and near-term prospects of the investee, and the Company's intent and ability to retain the investment until the recovery of its cost. An impairment loss on the equity method investments is recognized in earnings when the decline in value is determined to be other-than-temporary. The Company recorded an impairment loss of $955 for the year ended December 31, 2023 on its investment in SciSparc U.S.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>w.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recently Issued Accounting Pronouncements</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Recent Accounting Pronouncements Not Yet Adopted</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendment also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of preparation of the financial statements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to 2022, the Group prepared its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB), as permitted in the United States based on the Company’s qualification as a “foreign private issuer” under the rules and regulations of the U.S Securities and Exchange Commission (the “SEC”).</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances, fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent liabilities, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group’s assets and liabilities.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Functional and presentation currency</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional and reporting currency of the Group is the United States dollar (“U.S dollar”) as the U.S. dollar is the currency of the primary economic environment in which the Group has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group's transactions and balances denominated in U.S. dollars are presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with Accounting Standards Codification (“ASC”) 830, “Foreign Currency Matters”. All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and to be cash equivalents.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts receivable</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivables are stated at realizable value, net of an allowance for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point of sale, therefore, no provision for credit losses has been recorded as of December 31, 2023 and 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are stated at the lower of cost or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in accordance with first-in, first-out Method (“FIFO”). The cost of inventory includes all costs of purchase, and other costs incurred in bringing the inventories to their present location and condition including shipment and freight costs.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated at historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers equipment</span></td> <td style="width: 1%"> </td> <td style="width: 29%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office Equipment/Furniture</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-7</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant &amp; Machinery</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of remaining lease term or estimated useful life</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"> </p> The assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives, as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers equipment</span></td> <td style="width: 1%"> </td> <td style="width: 29%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office Equipment/Furniture</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-7</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plant &amp; Machinery</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of remaining lease term or estimated useful life</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"> </p> P33Y P5Y P7Y P5Y Shorter of remaining lease term or estimated useful life <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 842, the Group determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical expedient to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Group’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option. An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Operating lease expense is recognized on a straight-line basis over the lease term.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset acquisition</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for a transaction as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs are capitalized as part of the asset or assets acquired.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The estimated useful lives of the Group’s intangible assets (Brands) are 10 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> P10Y <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of long-lived assets</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s long-lived assets (assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization are reviewed for impairment in accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining the fair values of long-lived assets for the purpose of measuring impairment, the Group’s assumptions include those that market participants will consider in valuations of similar assets.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loans from shareholders and related parties:</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the borrowing date of loans received from shareholders or related parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with ASC 470, “Debt” (“ASC 470”), Subtopic 50— “Modifications and Extinguishments” (“ASC 470-50”). For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying amount of the extinguished debt is recorded as an in-essence capital transaction.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. As of December 31, 2023 and 2022 a partial valuation allowance was recorded on the Group’s deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. As of December 31, 2023 and 2022, no liability for unrecognized tax positions were recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>n.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). The Company derives its revenue from the sale of consumer products mainly through its online Amazon stores. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company considers customer order confirmations to be a contract with the customer. Customer confirmations are executed at the time an order is placed through third-party online channels.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligation is satisfied), which typically occurs at the shipment date. A performance obligation is a promise in a contract to transfer a distinct good to the customer and is the unit of account in ASC Topic 606. A contract’s transaction price is recognized as revenue when the performance obligation is satisfied. Each of the Company’s contracts have a single distinct performance obligation, which is the promise to transfer individual goods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the Group’s standard contract terms, customers have a right of return within 45 days. For contracts with rights of return, the Group recognizes revenue based on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance for returns in the amounts of $21 thousand and $70 thousand as of December 31, 2023, and 2022, respectively. The allowance for returns is recorded as (increase) decrease in revenues, respectively against other payables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group evaluates the criteria outlined in ASC 606-10-55, “Principal versus Agent Considerations”, in determining whether it is appropriate to record the gross amount of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these arrangements; therefore, sales are recorded on a gross basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Sales taxes collected from customers are presented on a net basis and as such are excluded from net revenue.<b> </b></p> 21000 70000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of sales</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with Amazon’s terms of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making binding sales. Sales commissions would not have been incurred if the contract had not been obtained.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cost of sales primarily consists of cost of goods sold, expenses related to Amazon’s commissions, storage costs and freight.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advertising expenses</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group expenses advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $719 thousand, $1,163 thousand, and $1,211 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 719000 1163000 1211000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee benefits</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Groups employees are employed by the company and by Fort and subject to the local labor laws.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s employees</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Group’s employees in Israel are entitled to a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve the Group from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group’s balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Fort employees</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">England labor laws generally requires an employer to make contributions to National Employment Savings Trust on behalf of its employees. Since April 2019, the minimum employer contribution is required to be 3% of an employee's salary. These payments relieve a company from future obligations with respect to its employees. The aforementioned contributions are not recorded as an asset on the Group's balance sheet and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p> 0.0833 0.03 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair value measurement</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group applies ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”). Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining fair value, the Group uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent from the Group. Unobservable inputs are inputs that reflect the Group’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 1 - Valuations based on quoted prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts of cash and cash equivalents, trade receivables, other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value due to the short-term maturity of such instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s derivative liabilities in respect of Additional Warrants are classified within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable inputs. For more details, see Note 9.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group’s financial asset in respect of the investment in SciSparc Ltd. (“<b>SciSparc</b>”) as of December 31, 2023 is classified within Level 1 of the fair value hierarchy, because the ordinary shares have quoted prices as they are traded on the Nasdaq Stock Market LLC.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment considers whether the warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, “Distinguishing Liabilities and Equity”, are indexed to the Group’s own stock and whether the warrants are eligible for equity classification under ASC 815 (“ASC 815”), “Derivatives and Hedging”, Subtopic 40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrants that meet all the criteria for equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings at each balance sheet date thereafter.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal and other contingencies</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for its contingent liabilities in accordance with ASC 450, “Contingencies”. A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with loss contingencies are expensed as incurred. As of December 31, 2023, and 2022, the Group is not a party to any litigation that could have a material adverse effect on the Group’s business, financial position, results of operations or cash flows.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>u.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted net loss per share.</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group calculates basic net profit (loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All outstanding share options and warrants for the years ended December 31, 2023 and 2022 have been excluded from the calculation of the diluted net loss per share since all such securities were anti-dilutive.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>v.</b></span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Investment in affiliates</span></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The investment in affiliated company is accounted for by the equity method under ASC Subtopic 323-10, “Investments - Equity Method and Joint Ventures”. The Company uses the equity method when it has the ability to exercise significant influence over operating and financial policies of an entity but does not have control of the entity. Under the equity method of accounting, an investment is initially recorded on the balance sheet at cost, representing the Company’s proportionate share of fair value. The investment is subsequently adjusted to reflect the Company’s proportionate share of net earnings or losses recognized, distributions received, contributions made and certain other adjustments, as appropriate. The Company does not record losses of the equity method investee in excess of its investment balance unless the Company is liable for obligations of the equity method investee or is otherwise committed to provide financial support to the equity method investee. As of December 31, 2023 the Company held investments in SciSparc U.S.</p>The Company evaluates its equity method investments for impairment at each reporting date, or more frequently if events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when determining whether an investment has been other-than-temporarily-impaired, include, but are not limited to, the length of the time and the extent to which the market value has been less than cost, the financial condition and near-term prospects of the investee, and the Company's intent and ability to retain the investment until the recovery of its cost. An impairment loss on the equity method investments is recognized in earnings when the decline in value is determined to be other-than-temporary. The Company recorded an impairment loss of $955 for the year ended December 31, 2023 on its investment in SciSparc U. 955 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>w.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recently Issued Accounting Pronouncements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Recent Accounting Pronouncements Not Yet Adopted</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendment also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Adoption of this ASU should be applied on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company’s Annual Report on Form 20F for the fiscal year ended December 31, 2024, and subsequent interim periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 — OTHER RECEIVABLES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Advances to suppliers</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">559</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">641</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Government institutions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">779</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Advances to suppliers</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">559</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">641</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Government institutions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">597</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">779</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information.</td> </tr></table> 559000 641000 38000 130000 8000 597000 779000 228000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 — INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Goods in transit</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">219</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,783</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,386</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,791</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Goods in transit</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">219</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,783</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,386</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,791</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 219000 8000 2167000 1783000 2386000 1791000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 — INTANGIBLE ASSETS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total intangible assets consisted of the following as of December 31, 2023 and 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net <br/> Balance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt">Brands</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">7,774</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(2,060</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,714</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net<br/> Balance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt">Brands</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,783</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(1,331</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">4,452</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was $730 thousand, $570 thousand, and $524 thousand, for the years ended December 31, 2023, 2022, and 2021, respectively. Estimated annual amortization expense for each of the next five years is expected to be $769 thousand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 2, 2023, the Company entered into a share purchase agreement (the “Fort SPA”), with the holders (the “Sellers”), of all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately £2 million (approximately $2.4 million) (the “Fort Acquisition”). As of December 31, 2023, the Company had an outstanding liability to the sellers of $332 included in other payables in the consolidated balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February 29, 2024, the Company extended a side letter to the Fort SPA to the Fort Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100 thousand (approximately $128 thousand). these adjustments were included in the outstanding liability as of December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 9, 2023, the Company recognized the amount of $1,991 thousand paid in connection with the Fort Acquisition amortized over a period of 10 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As part of the Fort SPA, the employment of these employees was terminated within three months, with all termination costs to be borne by the Sellers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Also, in connection with the closing of the Fort Acquisition, on March 9, 2023, Fort and the Sellers entered into a consulting agreement, pursuant to which the Sellers will provide the Company with consultancy services for a period of six months following the closing, at a monthly fee of £2.5 thousand (approximately $3 thousand). On September 20, 2023, the Company and the Sellers entered into a new consulting agreement for an indefinite period at a monthly fee of £3.5 thousand (approximately $4.5 thousand) effective as of June 1, 2023 (the “Fort Consulting Agreement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations.</p> Total intangible assets consisted of the following as of December 31, 2023 and 2022:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net <br/> Balance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt">Brands</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">7,774</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(2,060</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,714</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross<br/> Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net<br/> Balance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt">Brands</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,783</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(1,331</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">4,452</td><td style="width: 1%; padding-bottom: 4pt; text-align: left"> </td></tr> </table> 7774000 -2060000 5714000 5783000 -1331000 4452000 730000 570000 524000 769000 2000000 2400000 332000 100000 128000 1991000 2500 3000 3500 4500 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 — LEASES:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases office space and a warehouse with a remaining useful life of less than 3 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2023, the Company’s operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $138 thousand and $127 thousand, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2023, the Company’s operating leases had a weighted average remaining lease term of 3 years and a weighted average borrowing rate of approximately 10%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future lease payments under operating leases as of December 31, 2023, were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">43</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total future operating lease payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">138</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Less: imputed interest</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Present value of lease liability</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">127</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> P3Y 138000 127000 P3Y 0.10 Future lease payments under operating leases as of December 31, 2023, were as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">95</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">43</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total future operating lease payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">138</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Less: imputed interest</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Present value of lease liability</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">127</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 95000 43000 138000 11000 127000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 — INVESTMENT IN AFFILIATE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 23, 2023, the Company and Jeffs’ Brands Holdings entered into a stock purchase agreement (as amended on March 22, 2023, the “Wellution Agreement”), with SciSparc, a related party of the Company (see note 17), pursuant to which, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S, a wholly-owned subsidiary of SciSparc that owns and operates Wellution, an Amazon food supplements and cosmetics brand, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S, for approximately $3.0 million in cash. The Company reviewed the transaction and deemed it to be the purchase of assets for accounting purposes under ASC Subtopic 805 “Business Combinations” (“ASC 805”), and not as a business combination. The Company reviewed the guidance under ASC 805 for the transaction and determined that the fair value of the gross assets acquired was concentrated in a single identifiable asset, a brand. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024. See also note 17.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the <b>“</b>SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.Sfor the Wellution brand for a monthly fee of $20 thousand. Additionally, the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. In November 2023 the Company and SciSparc agreed to reduce the monthly fee to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.Sas of December 31, 2023, was $15 thousand and $8 thousand, accordingly. See also note 17.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Jeffs' Brands Holdings owns 49% of the voting rights in SciSparc U.Sand has the right to appoint two out of five directors. Management has determined that it has significant influence over SciSparc U.S and accordingly accounts for its investment under the equity method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by ASC 805, Business Combinations </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management assesses whether impairment indicators are present that may indicate an other than temporary impairment ("OTTI") exists. Management determined that the decrease in revenues and operating losses of SciSparc U.S were indicative of an OTTI impairment as of December 31 2023. Accordingly, management's fair valuation expert performed an impairment test of the equity investment and determined that the carrying value exceed the discounted cash flows. As a result, an impairment loss of $955 thousand was recorded within equity losses in the statement of operations for the year ended December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>The activity in the investment in SciSparc U.S account was as follows:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">February 23,<br/> 2023 –<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance as of January 1, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 88%">Purchase on February 23, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3,189</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Equity losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Balance as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,940</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Summarized financial information:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Summarized balance sheet of SciSparc U.S:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Current assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">924</td><td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Long-term assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,189</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(154</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; "> <td>Equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,959</td><td style="text-align: left"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Summarized statement of statement of operation of SciSparc U.S:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">February 22, <br/> 2023 –<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Revenues</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(2,137</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Cost of sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,409</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Impairment of intangible asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,042</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">748</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Taxes on income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,552</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company issued 35,345 ordinary shares, <span style="-sec-ix-hidden: hidden-fact-105">no</span> par value per share (“Ordinary Shares”) to SciSparc and SciSparc issued 13,858 of its ordinary shares to the Company in a share exchange, (collectively, the “Exchange Shares”), representing approximately 2.97% and 4.99%, respectively, of the Company’s and SciSparc’s issued and outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288 thousand by the average closing price of the relevant company’s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the closing.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The investment in SciSparc was accounted for as financial asset through profit and loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The activity in the investment in SciSparc’s shares was as follows:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 23,<br/> 2023 –<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance as of January 1, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 88%">Value of shares obtained in connection with share exchange on March 23, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">288</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(221</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Balance as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">67</td><td style="text-align: left"> </td></tr> </table> 57 0.49 3000000 98000 20000 51000 10000 15000 8000 0.49 955000 <b>The activity in the investment in SciSparc U.S account was as follows:</b><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">February 23,<br/> 2023 –<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance as of January 1, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 88%">Purchase on February 23, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3,189</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Equity losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,249</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Balance as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,940</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 3189000 1249000 1940000 <b>Summarized balance sheet of SciSparc U.S:</b><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Current assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">924</td><td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Long-term assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,189</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(154</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; "> <td>Equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,959</td><td style="text-align: left"> </td> </tr> </table> 924000 3189000 154000 3959000 <b>Summarized statement of statement of operation of SciSparc U.S:</b><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">February 22, <br/> 2023 –<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Revenues</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(2,137</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Cost of sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,409</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Impairment of intangible asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,042</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">748</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Taxes on income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,552</td><td style="text-align: left"> </td></tr> </table> -2137000 1409000 1042000 748000 468000 22000 1552000 35345 13858 0.0297 0.0499 288000 <b>The activity in the investment in SciSparc’s shares was as follows:</b><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 23,<br/> 2023 –<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">USD in<br/> thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance as of January 1, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 88%">Value of shares obtained in connection with share exchange on March 23, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">288</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(221</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Balance as of December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">67</td><td style="text-align: left"> </td></tr> </table> 288000 221000 67000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 8 — OTHER PAYABLES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="5" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 77%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Government institutions</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">428</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employees and related benefits</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-106"><span style="-sec-ix-hidden: hidden-fact-107">Operating lease liabilities</span></span></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">82</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liability to sellers</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(*)430</span></td> <td style="text-align: left"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue sharing payment payable</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">140</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued expenses and other payables</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">368</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">226</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,533</span></td> <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">391</span></td> <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0%"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td> <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="5" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 77%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Government institutions</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">428</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employees and related benefits</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: hidden-fact-106"><span style="-sec-ix-hidden: hidden-fact-107">Operating lease liabilities</span></span></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">82</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liability to sellers</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(*)430</span></td> <td style="text-align: left"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue sharing payment payable</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">140</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued expenses and other payables</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">368</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">226</span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,533</span></td> <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">391</span></td> <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0%"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information.</span></td> </tr></table> 428000 36000 85000 49000 82000 40000 430000 140000 40000 368000 226000 1533000 391000 98000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 9 — SHORT-TERM LOANS</b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 9, 2022, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $152 thousand from Amazon. The loan matures within 12 months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged its financial balances on its account on Amazon and its inventories held in Amazon’s warehouses, in favor of Amazon. The loan was fully repaid on February 27, 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2021, Smart Pro entered into a loan agreement with two third parties (“lenders”). The loans bore annual interest rate of 10% and were payable in January 2022. Smart Pro was entitled to extend the loans by an additional sixty days, with additional interest of 1% per month. In addition, pursuant to the loan agreement, in the event of an IPO of the Company, the lenders would be entitled to Ordinary Shares of the Company at an aggregate value of $250 thousand with a conversion price at the IPO price. In July 2021, the loan principal of $750 thousand was received. The proceeds from the lenders were first allocated to the liability (see note 9.a) to issue a variable number of shares based on its fair value at the date of issuance in an amount of $62 thousand, with a corresponding discount recorded on the third-party loan. The <span style="-sec-ix-hidden: hidden-fact-108">derivate liability</span> was revalued at each period-end and amounted to $137 thousand as of December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 23, 2021, the loan agreement was amended to extend the maturity date of the loans to the earlier of (i) March 31, 2023, or (ii) the closing of an IPO of the Company. Based on management’s assessment, the amendment resulted in a substantial modification to the loan in accordance with ASC 470-50. As a result of the debt extinguishment, the Group recorded, a gain in the amount of $14 thousand within finance expenses, net for the year ended December 31, 2021 as the difference between the net carrying value of the original loans and the fair value of the loan bearing the modified terms.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the IPO in 2022, the Group repaid the third-party loan. Furthermore, Effective as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreement (the “Issuance Date”), the Company issued 60,096 warrants to the lenders (“lenders warrants”) to purchase up to 8,586 Ordinary Shares, exercisable at an exercise price of $28.28 per share, exercisable for three years following the IPO. The warrants have cashless exercise mechanism.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the issuance date of the lenders warrants, all conditions for equity classification under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were reclassified to equity.</p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 22, 2022, the Company entered into a loan agreement with Bank Leumi Le-Israel (“Bank Leumi”) to provide for a line of credit in an aggregate amount of up to $1,000 thousand, which the Company may draw in two tranches at its request, but in no event after July 21, 2022. Pursuant to the loan agreement, amounts drawn bear interest at a rate of Secured Overnight Financing Rate (“SOFR”) plus 3.25% annually. On March 3, 2022, the Company drew $400 thousand under the line of credit. On June 2, 2022, the Company drew another $200 thousand million under the line of credit. Following an agreement with Bank Leumi, the loan was extended until October 31, 2022. All amounts outstanding under the line of credit were fully repaid on September 6, 2022.</span></td></tr> </table> 152000 0.0999 0.10 0.01 250000 750000 62000 137000 14000 60096 8586 28.28 1000000 0.0325 400000 200000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 — DERIVATIVE LIABILITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the IPO the Company issued 3,717,473 warrants to purchase up to 531,068 Ordinary Shares (“IPO Warrants”). Given their contractual terms, from the issuance date and up until the 90th day immediately following issuance, the IPO Warrants did not meet the U.S. GAAP definition for equity classification. As such, they were classified as a liability up until November 28, 2022. Upon issuance, the IPO Warrants (which included the right to issue Additional Warrants) were accounted for as derivative instrument which was classified as a liability and measured at fair value through profit or loss. The fair value was approximately $8.2 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 28, 2022, following the adjustment to the exercise price and issuance of 2,824,525 Additional Warrants to purchase up to 403,504 Ordinary Shares, the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair value of the IPO warrants as of November 28, 2022, at the amount of $3,319 thousand, was recorded as a component of Company’s shareholder’s equity. The term of the Additional Warrants is five (5) years from the issuance date and exercisable for up to 403,504 ordinary shares at exercise price of $14.14 per share. Each Additional Warrant holder receives semi-annual payments equal to approximately 2.3% of the Company’s gross revenues, calculated for the first and second six-month fiscal periods, shared pro rata among qualified holders (“Revenue Sharing Payment”). The Revenue Sharing Payment related to 2023 and 2022 was $269 thousand and $40 thousand, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The value of the IPO Warrants upon issuance and the Additional Warrants upon issuance and at year-end was calculated based on the binomial option pricing model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For the year ended December 31, 2023 and 2022, the Company recorded finance income of $841 thousand and $2,710 thousand, respectively to account for the change in the value of the IPO Warrants and Additional Warrants during the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The following table presents changes in the fair value of the derivative warrant liability (in thousands)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2021</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">137</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of warrants in connection with the IPO</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,220</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Classification to additional paid in capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,319</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,216</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(841</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,375</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The following table lists the significant unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">101.39</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77.57%-78.89</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">$14.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.71-13.055</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27%-4.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-4.74</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">WACC</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5%-23.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Additionally, the revenue forecast over the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of December 31, 2023 and 2022.</span></p> 3717473 531068 8200000 2824525 403504 403504 14.14 0.023 269000 40000 841000 2710000 <span style="font-family: Times New Roman, Times, Serif">The following table presents changes in the fair value of the derivative warrant liability (in thousands)</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2021</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">137</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of warrants in connection with the IPO</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,220</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,822</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Classification to additional paid in capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,319</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,216</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(841</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Balance as of December 31, 2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,375</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 137000 8220000 2822000 -3319000 2216000 841000 1375000 <span style="font-family: Times New Roman, Times, Serif">The following table lists the significant unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">101.39</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77.57%-78.89</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">$14.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Share price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.71-13.055</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.27%-4.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-4.74</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">WACC</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5%-23.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> 101.39 77.57 78.89 14.14 14.14 3.05 10.71 13.055 3.93 3.27 4.04 3.91 3 4.74 20.4 21.5 23.3 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 11 — LOANS FROM SHAREHOLDERS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"> </td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 3, 2022, Smart Pro had outstanding loans to Medigus, Mr. Hakmon and L.I.A. Pure Capital Ltd. (“Pure Capital”) of $4,010 thousand, $940 thousand and $109 thousand, respectively. On May 3, 2022, the Company entered into Assignments to Loan Agreements with Smart Pro, Medigus, Mr. Hakmon and Pure Capital, pursuant to which the Company assumed Smart Pro’s obligations under the outstanding loans and agreed that unless earlier repaid pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of IPO, all outstanding principal due to each such party will be automatically converted into a number of Ordinary Shares equal to the quotient obtained by dividing the outstanding principal amount due to such party, by the per Ordinary Share price obtained by dividing $10,000 thousand by the fully diluted issued and outstanding Ordinary Shares as of immediately prior to the closing of the IPO. Any accrued and unpaid interest due to such party as of such date will be paid in cash.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Based on management’s assessment, the modified loan terms including an equity conversion feature upon IPO represented a substantial modification in accordance with ASC 470-50 and is accounted for as an extinguishment of the original financial liability in the amount of $3,821 thousand and the recognition of a new financial instrument in the amount of $2,839 thousand. The difference between the fair value of the instrument bearing the modified terms and the carrying values of the original loans immediately prior to the modification, was recorded as an increase in equity in the amount of $982 thousand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As the convertible note was not issued with a substantial premium or with an embedded conversion feature required to be bifurcated under ASC 815, the convertible note was accounted for as a liability in its entirety.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with such assignment agreements, on August 30, 2022, the outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital at a total amount of $5,059 thousand were converted into an aggregate of 209,088 Ordinary Shares. In addition, accrued interest of $393 thousand was paid.</p> 4010000 940000 109000 10000000 3821000 2839000 982000 5059000 209088 393000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 12 — TAXES ON INCOME</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Jeffs’ Brands and Top Rank are taxed according to Israeli tax laws. The corporate tax rate in Israel is 23% for 2021 and thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Smart Pro, Purex Jeffs Brands Holdings Inc and Fort US are taxed according to US federal California state and Delaware state laws. The blended corporate tax rate is 28% for 2021 and thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fort is taxed according to UK tax law. The corporate tax rate is 19%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Capital gains are subject to capital gain tax according to the corporate tax rate for the year during which the assets are sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For financial reporting purposes loss before taxes includes the following components:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,866</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,081</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,096</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(126</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(465</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,566</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,207</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,561</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income tax expense (benefit) was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December 31</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current:</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S. dollars in thousands</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred:</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(53</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax income</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(53</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax (benefit) expense</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A reconciliation of the Group’s statutory income tax rate to effective income tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss before taxes on income</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,566</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,207</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,561</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Statutory tax rate</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax (tax benefit) computed at the statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,050</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(508</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(359</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) in taxes on income resulting from the following:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax rate differences applicable to subsidiaries</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(46</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax losses and timing differences for which deferred taxes were not recognized</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,128</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">612</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">416</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Taxes on income</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif">Deferred taxes are comprised of the following components:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Deferred tax asset</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">388</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right of use asset</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating loss carryforward</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,476</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">890</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,892</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,032</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,696</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(890</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets after valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">196</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">142</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">168</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets on losses for tax purposes carried forward to subsequent years are recognized if utilization of the related tax benefit against a future taxable income is expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Carry forward tax losses of Jeffs’ Brands were $6,418 thousand and $3,870 thousand as of December 31, 2023 and 2022, respectively. Jeffs’ Brands did not record deferred tax assets in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future. There is no expiration on net operating loss carryforwards in Israel.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Smart Pro, Fort, Jeffs Brands Holdings Inc and Fort US did not have any net operating loss carryforwards as of December 31, 2023, and 2022. The net deferred tax asset as of December 31, 2023 and 2022 is with respect to Smart Pro.</span></p> 0.23 0.28 0.19 <span style="font-family: Times New Roman, Times, Serif">For financial reporting purposes loss before taxes includes the following components:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,866</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,081</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,096</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(126</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(465</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,566</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,207</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,561</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> -2866000 -2081000 -1096000 -1700000 -126000 -465000 -4566000 -2207000 -1561000 <span style="font-family: Times New Roman, Times, Serif">Income tax expense (benefit) was as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December 31</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current:</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S. dollars in thousands</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred:</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(53</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax income</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(53</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax (benefit) expense</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 7000 78000 12000 94000 85000 12000 94000 -53000 -18000 -115000 -53000 -18000 -115000 32000 -6000 -21000 <span style="font-family: Times New Roman, Times, Serif">A reconciliation of the Group’s statutory income tax rate to effective income tax rate is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss before taxes on income</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,566</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,207</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,561</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Statutory tax rate</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax (tax benefit) computed at the statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,050</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(508</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(359</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Increase (decrease) in taxes on income resulting from the following:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax rate differences applicable to subsidiaries</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(46</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(110</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(78</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Tax losses and timing differences for which deferred taxes were not recognized</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,128</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">612</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">416</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Taxes on income</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> -4566000 -2207000 -1561000 0.23 0.23 0.23 -1050000 -508000 -359000 -46000 -110000 -78000 1128000 612000 416000 32000 -6000 -21000 <span style="font-family: Times New Roman, Times, Serif">Deferred taxes are comprised of the following components:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Deferred tax asset</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">388</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right of use asset</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating loss carryforward</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,476</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">890</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,892</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,032</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,696</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(890</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets after valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">196</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">142</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax assets</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">168</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 388000 110000 28000 32000 1476000 890000 1892000 1032000 1696000 890000 196000 142000 28000 32000 28000 32000 168000 110000 6418000 3870000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 13 — SHARE CAPITAL:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The share capital composed of ordinary shares as follows:</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of ordinary shares<br/> December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Issued (*)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,215,512</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,153,461</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Authorized</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,567,567</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,567,567</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0%"></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactively adjusted. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Ordinary Shares confer upon their holders the following rights: (i) the right to vote in any general meeting of the Company, (ii) the right to receive dividends, if and when declared by the Board of Directors and (iii) the right to receive upon liquidation of the Company a sum equal to the nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares which may be issued in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 17, 2022, the Company’s Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February 17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares. Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect to the two subsequent reverse share splits) ordinary shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On May 3, 2022, the Company’s Board of Directors approved a 0.806-for-1 reverse split of its issued and outstanding Ordinary Shares, effective as of May 3, 2022, pursuant to which holders of the Company’s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On June 16, 2022, the Company’s Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June 16, 2022, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85 Ordinary Shares held as of such date. The reverse stock split proportionally reduced the number of the Company’s authorized share capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The share capital before consummation of the IPO was comprised of 413,304 issued and outstanding ordinary shares. In accordance with an assignment agreement (see also Note 11) and in connection with the IPO (see above), on August 30, 2022, the Company converted outstanding amounts due to Medigus, Mr. Hakmon and Pure Capital into 209,088 Ordinary Shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">On August 30, 2022, the Company closed its IPO, and the simultaneous partial exercise of the underwriter’s over-allotment option, for aggregate gross proceeds of approximately $15.5 million, before deducting underwriting discounts and estimated offering expenses. The Company issued 531,069 Ordinary Shares, (“Ordinary Shares”) and 3,717,473 IPO warrants to purchase up to 531,069 Ordinary Shares. The Ordinary Shares and IPO Warrants were sold together in the IPO as units (“Units”) at an initial public offering price of $29.12 per Unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The IPO Warrants had an initial exercise price of $28.28 and expire five years from the issuance day. The IPO Warrants became exercisable immediately after the completion of the IPO (and until August 30, 2027). On the 90th day after the closing of the IPO, the exercise price of the IPO Warrants was adjusted to be equal to the lowest quoted share price during the 90 days. The daily quoted price used in the determination of such minimum was calculated as the weighted average price of each day. The exercise price, however, may not be reduced to less than $14.14.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The IPO Warrants contain a down round protection, so that for a period of two years from the date of issuance of the IPO Warrant, the exercise price is adjusted to the price in subsequent fundings of the Company, if shares in these fundings are sold at a price per share below the warrant exercise price at the time of such future fundings (or if other instruments with an exercise / conversion price at a price below the warrant exercise price are sold). The exercise price, however, may not be reduced to less than $14.14. On November 28, 2022, the IPO Warrant’s exercise price was adjusted to $14.14.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Ordinary Shares and IPO Warrants trade on the Nasdaq under the symbol “JFBR” and “JFBRW”, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In addition, On November 28, 2022, the Company issued 2,824,525 Additional Warrants to purchase 403,504 Ordinary Shares. Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. Each Additional Warrants holder will receive semi-annual payments. The total annual payment depends on the amount of the Additional Warrants outstanding. As of December 31, 2022, the payment will be equal to approximately 2.3% of the Group ’s revenues for the period from November 28, 2022 until December 31,2022. The Additional Warrants may be redeemed by the Company at any time at a price equal to three times the Initial Exercise Price, or $42.42.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As the IPO Warrants and the Additional Warrants are not separable at the issuance date, the IPO Warrants and the Additional Warrants were initially accounted for as derivative instruments which were classified as a liability and measured at fair value through profit or loss. See also note 10.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Applicable issuance costs, amounting to $2,193 thousand, were allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and was recorded in the consolidated statement of operations, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand were recorded in equity as a reduction of the paid in capital for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the IPO, on August 30, 2022, the Company issued to the underwriter 185,873 Warrants to purchase up to 26,554 Ordinary Shares (the “Underwriters Warrants”) exercisable beginning on February 21, 2023 at an exercise price of $36.40, and will expire on August 25, 2027. The Underwriter’s Warrants may be exercised on a cashless exercise basis in certain circumstances. The Underwriters Warrants were treated as issuance costs, which amounted to $109 thousand based on a third party valuation, and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $58 thousand was considered as issuance costs allocated to the Underwriter’s Warrants and were recorded in profit or loss as finance expense, while costs allocated as issuance costs of Ordinary Shares in the amount of $51 thousand were recorded in equity as a reduction of the additional paid in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 30, 2022, the underwriter partially exercised its overallotment right to purchase 425,912 additional IPO Warrants to purchase up to 60,845 Ordinary Shares for a total consideration of $4 thousand. These additional IPO Warrants were treated as issuance costs, which amounted to $1 thousand based on third party valuation, and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $0.5 thousand was considered as issuance costs allocated to the additional IPO Warrants and were recorded in profit or loss as finance expense, while costs allocated as issuance costs of Ordinary Shares in the amount of $0.5 thousand have been recorded in equity as a reduction of the paid in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreement (the “Issuance Date”), the Company issued the Lenders Warrants to purchase up to 8,586 Ordinary Shares, exercisable for three years following the issuance date at an exercise price of $28.28 per share. The warrants may be exercised on a cashless basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the issuance date of the Lenders Warrants, all conditions for equity classification under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were classified to equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, effective as of August 30, 2022, the Company issued 18,565 warrants to purchase up to <span style="-sec-ix-hidden: hidden-fact-116">2,653</span> Ordinary Shares at an exercise price of $28.28 per Ordinary Share (and an exercise price of $14.14 following the Exercise Price Adjustment) to an advisor. The warrants were exercisable immediately and are exercisable until August 30, 2027.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 17, 2023, the Company’s Board of Directors approved a 1-for-7 reverse split of the issued and outstanding Ordinary Shares, effective as of November 3, 2023, pursuant to which holders of the Ordinary Shares received one Ordinary Share for every seven Ordinary Shares held as of such date. The reverse stock split proportionally did not reduce the number of authorized share capital. The effect of such reverse split was applied retrospectively for all the number of shares, warrants, related par value and others presented in this note and elsewhere in the consolidated financial statements prior to the effective date of the reverse stock split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On November 14, 2023, the Company issued 26,706 ordinary shares as a result of rounding following the aforementioned reverse share split.</span></p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The share capital composed of ordinary shares as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of ordinary shares<br/> December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Issued (*)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,215,512</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,153,461</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Authorized</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,567,567</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,567,567</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0%"></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactively adjusted. </span></td></tr> </table> 1215512 1153461 43567567 43567567 The Ordinary Shares confer upon their holders the following rights: (i) the right to vote in any general meeting of the Company, (ii) the right to receive dividends, if and when declared by the Board of Directors and (iii) the right to receive upon liquidation of the Company a sum equal to the nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares which may be issued in the future. 664.0547 6630547 100000000 43567567 On May 3, 2022, the Company’s Board of Directors approved a 0.806-for-1 reverse split of its issued and outstanding Ordinary Shares, effective as of May 3, 2022, pursuant to which holders of the Company’s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share. On June 16, 2022, the Company’s Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June 16, 2022, pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85 Ordinary Shares held as of such date. 413304 209088 209088 15500000 531069 3717473 531069 29.12 28.28 P5Y 14.14 14.14 14.14 2824525 403504 P5Y 0.023 42.42 Applicable issuance costs, amounting to $2,193 thousand, were allocated in the same proportion as the allocation of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and was recorded in the consolidated statement of operations, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand were recorded in equity as a reduction of the paid in capital for the year ended December 31, 2023. 185873 26554 36.4 109000 58000 51000 425912 60845 4000 1000 500 500 8586 P3Y 28280 18565 28.28 14.14 1 7 26706 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 14 — SHARE INCENTIVE PLAN</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 19, 2022, the Company’s Board of Directors adopted the 2022 Incentive Option Plan (“Plan”). A total of 186,718 Ordinary Shares were reserved and subject to the Plan. The Plan is intended as an incentive to retain directors, officers, employees, consultants and advisers of the Company. As of December 31, 2023, the Company had not granted awards under the Plan.</span></p> 186718 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 15 — FINANCE (INCOME) EXPENSE, NET</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Finance income:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liabilities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(841</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,822</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total finance income</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(845</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,822</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance expense:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance expenses in respect of third-party loan</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization of loan discount</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate differences</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense on loans from shareholders and related parties</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">203</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other finance expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revaluation of securities -fair value through profit or loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total finance expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">322</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">517</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Finance (income) expense, net</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(523</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,305</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">629</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Finance income:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liabilities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(841</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,822</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total finance income</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(845</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,822</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance expense:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finance expenses in respect of third-party loan</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value of derivative liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization of loan discount</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exchange rate differences</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense on loans from shareholders and related parties</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">203</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other finance expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revaluation of securities -fair value through profit or loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total finance expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">322</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">517</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">643</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Finance (income) expense, net</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(523</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,305</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">629</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 841000 2822000 4000 14000 845000 2822000 14000 83000 77000 75000 37000 85000 91000 156000 10000 203000 381000 10000 38000 15000 -221000 322000 517000 643000 523000 2305000 -629000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 16 — NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands (*)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss applicable to shareholders of ordinary shares</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,598</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,201</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,540</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-128; -sec-ix-hidden: hidden-fact-127; -sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif">Shares of ordinary share used in computing basic and diluted net loss per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,184,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">663,411</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">413,192</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-hidden: hidden-fact-131; -sec-ix-hidden: hidden-fact-130; -sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif">Net loss per share of ordinary share, basic and diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3.88</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3.32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3.73</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">IPO Warrants and Additional Warrants (Note 13)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,541,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,541,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Underwriter warrants (Note 13)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">611,785</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">611,785</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,661</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,661</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-134; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,232,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,232,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-135; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0%"></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">except share and per share data</span></td></tr> </table> <span style="font-family: Times New Roman, Times, Serif">The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands (*)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss applicable to shareholders of ordinary shares</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,598</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,201</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,540</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-128; -sec-ix-hidden: hidden-fact-127; -sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif">Shares of ordinary share used in computing basic and diluted net loss per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,184,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">663,411</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">413,192</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-hidden: hidden-fact-131; -sec-ix-hidden: hidden-fact-130; -sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif">Net loss per share of ordinary share, basic and diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3.88</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3.32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3.73</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> -4598000 -2201000 -1540000 1184484 663411 413192 -3.88 -3.32 -3.73 <span style="font-family: Times New Roman, Times, Serif">The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">IPO Warrants and Additional Warrants (Note 13)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,541,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,541,998</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Underwriter warrants (Note 13)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">611,785</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">611,785</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,661</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">78,661</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-134; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,232,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,232,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-135; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0%"></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">except share and per share data</span></td></tr> </table> 6541998 6541998 611785 611785 78661 78661 7232444 7232444 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 17 — RELATED PARTIES </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions with related parties:</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Labor cost and related expenses (included in general and administrative) (c1)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">249</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">358</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors’ fees (included in general and administrative)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">282</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting fees (included in general and administrative) (c2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">180</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">218</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Inventory storage (included in cost of sale) (c2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue sharing payment (included in general and administrative) (c6)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income, net (c4)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(255</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-136; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest expenses on loans from related parties and shareholders</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">203</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,041</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,352</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balances with interested and related parties:</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Advances to suppliers (c2)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Related parties (c3), (c4)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief executive officer salary (included in other account payable) (c1)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue sharing payment (included in other account payable) (c6)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liability to SciSparc (included in other account payable) (c7)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-141; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liability to supplier (included in trade payable) (c2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-142; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Liability to consultant (included in other account payable) (c2)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-143; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">289</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional information:</b></span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During September 2022, the Group repaid: (i) a related party balance to Medigus, in the amount of $150 thousand and (ii) another related party balance in the amount of $175 thousand and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing of the IPO.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.</span></td></tr> </table> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions with related parties:</b></span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Labor cost and related expenses (included in general and administrative) (c1)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">249</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">358</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Directors’ fees (included in general and administrative)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">282</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Consulting fees (included in general and administrative) (c2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">180</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">218</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Inventory storage (included in cost of sale) (c2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">395</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue sharing payment (included in general and administrative) (c6)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income, net (c4)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(255</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-136; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest expenses on loans from related parties and shareholders</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">203</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,041</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,352</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.</span></td></tr> </table> 249000 358000 282000 172000 180000 218000 545000 395000 40000 6000 -255000 203000 1041000 1352000 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balances with interested and related parties:</b></span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">U.S. dollars in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Advances to suppliers (c2)</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">228</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Related parties (c3), (c4)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief executive officer salary (included in other account payable) (c1)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue sharing payment (included in other account payable) (c6)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liability to SciSparc (included in other account payable) (c7)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">98</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-141; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Liability to supplier (included in trade payable) (c2)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-142; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Liability to consultant (included in other account payable) (c2)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-143; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">289</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand).</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During September 2022, the Group repaid: (i) a related party balance to Medigus, in the amount of $150 thousand and (ii) another related party balance in the amount of $175 thousand and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing of the IPO.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.</span></td></tr> </table> 228000 228000 66000 32000 18000 21000 6000 98000 69000 17000 289000 38000 55000 23000 80000 23000 480000 140000 57500 16500 425000 121000 0.07 0.08 P3Y 352000 0.50 86000 0.50 10000 3000 43000 32000 0.49 20000 51000 10000 15000 8000 150000 175000 393000 23000 17000 12000 9000 98000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 18 — GEOGRAPHICAL INFORMATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Revenues are attributed to geographic areas: </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">USD in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">America</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,863</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,402</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Europe</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,145</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">437</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,008</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,859</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,509</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> Revenues are attributed to geographic areas:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year ended <br/> December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">USD in thousands</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">America</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,863</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,402</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Europe</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,145</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">437</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">107</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,008</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,859</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,509</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 3863000 5422000 6402000 6145000 437000 107000 10008000 5859000 6509000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 19 — SUBSEQUENT EVENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top"> <td style="width: 48px"></td><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 25, 2024, the Company entered into a private placement transaction, or the January 2024 PIPE, pursuant to a securities purchase agreement, with certain institutional investors, providing for the issuance, in a private placement of 1,884,461 Ordinary Shares; (ii) Pre-Funded Warrants to purchase up to an 820,000 Ordinary Shares; (iii) Series A Warrants to purchase up to an aggregate of 3,380,586 Ordinary, or upon the satisfaction of certain conditions, up to an aggregate of 13,373,208 Ordinary Shares in accordance with the terms therein and (iv Series B Warrants to purchase upon the satisfaction of, certain conditions up to an aggregate of 7,994,181 Ordinary Shares in accordance with the terms therein. The January 2024 PIPE closed on January 29, 2024. The Company’s aggregate gross proceeds from the January 2024 PIPE were approximately $7.275 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the January 2024 PIPE. Pure Capital participated in the private placement as a purchaser.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of the issuance date of these consolidated financial statements 2,900,036 Warrants were exercised into 2,900,036 ordinary shares of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with Aegis, dated January 25, 2024, pursuant to which Aegis agreed to serve as the exclusive placement agent for the Company in connection with the Private Placement. The Company agreed to pay Aegis a cash placement fee equal to 8.50% of the gross cash proceeds received in the Private Placement and to pay for expenses of the Purchasers’ and Aegis’ legal counsel up to an aggregate amount of $90 thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top"> <td style="width: 48px"></td><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 5, 2024, the Company paid to Pure Capital $100 thousand in connection to the IPO and in accordance to the consultant agreement.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top"> <td style="width: 48px"></td><td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 29, 2024, the Company extended a side letter to the Fort SPA to the Fort Sellers, pursuant to which the Company agreed to increase certain adjustment amount payments to the Fort Sellers by approximately £100 thousand.</span></td></tr></table> 1884461000000 820000 3380586 13373208 7994181 7275000 2900036 2900036 0.085 90000 100000 100000 -3.32 -3.73 -3.88 1184484 413192 663411 http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent P2653Y 1184484 413192 663411 -3.32 -3.73 -3.88 false FY 0001885408 Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13. Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13. Share and per share data in these consolidated financial statements have been retroactively adjusted to reflect the reverse share split effected in November 2023. See Note 13. As of December 31, 2022 Includes $228 thousand to Pure Logistics. See Note 17 for additional information. (*)Includes $98 thousand to SciSparc as of December 31, 2023. See Note 17 for additional information. Retroactively adjusted. except share and per share data On August 3, 2022, the Company’s Board of Directors approved the increase to the chief executive officer (“Mr. Hakmon’s”), monthly salary to NIS 55 thousand (approximately $23 thousand) plus applicable value added taxes (“VAT”), retroactively from February 1, 2022. Effective on September 1, 2022, the Company’s Board of Directors approved an increase to Mr. Hakmon’s monthly salary to NIS 80 thousand (approximately $23 thousand) plus VAT and a one-time bonus of NIS 480 thousand (approximately $140 thousand). On October 26, 2022, the Group and Pure Capital, a company owned by a family member of Mr. Hakmon’s, entered into a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousand (approximately $16.5 thousand). The Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousand (approximately $121 thousand) for their services to the Group from the day of the Company’s inception until the closing of the IPO. Pure Capital is also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. In March 2023, the Company paid to Pure Capital $352 thousand in accordance with the terms of the Pure Capital Consulting Agreement. The consultancy fees were paid in consideration with the investments in Fort and SciSparc and were capitalized. Additionally On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse storage agreement located in the USA. As of December 31, 2023 there is no advances to Pure NJ Logistics LLC. See also note 19. As noted in note 7, the Company purchased 49% of the voting rights of SciSparc U.S, a related party of the Company from the following reasons: the Company's chairman board of director serves as the director in SciSparc U.S, Chief Financial Officer (CFO) of and Chief Executive Officer (CEO) in SciSparc. Additionally, in connection with the closing of the Wellution Agreement, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S (the “SciSparc Consulting Agreement”), pursuant to which the Company will provide management services to SciSparc U.S for the Wellution brand for a monthly fee of $20 thousand and the Company received a one-time signing bonus in the amount of $51 thousand. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice. On November 2023 the monthly fee reduced to $10 thousand. In addition, The Company provides a variety of professional and business support services in accordance with transfer pricing work received in SciSparc U.S. The aforementioned services are provided in collaboration with SciSparc. The outstanding payable to SciSparc and SciSparc U.S as of December 31, 2023, was $15 thousand and $8 thousand, accordingly. During 2023 the Company paid $23 thousand to Medigus and $17 thousand to Pure Capital in connection to revenue sharing payment. The outstanding payable to Medigus and Pure Capital as of December 31, 2023is $12 thousand and $9 thousand, respectively. On May 21, 2022, the Company has entered into a short-term lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid $86 thousand plus VAT on December 30, 2022. Also, the Company participated in 50% of salary of Medigus employee which provided services to the Company in 2022 and till April 30, 2024 in monthly rate of $10 thousand NIS a month (approximately $3 thousand) The outstanding payable to Medigus as of December 31, 2023, and 2022, was $43 thousand and $32 thousand, respectively. As of December 31, 2023 the outstanding amount due to SciSparc in connection with the closing of the Wellution Agreement was $98 thousand connection. this amount was paid on January, 31 2024.

+SP2Z[QXIG#/+<%^/ @CRZ,)&F/?=D;PV&A1;!4' 2!U2=SQ >X_ MQ;;7:\>D4EGQ5HT1OVI\F!-@?1#,=^-=$>L5TPOGJ!>.IO.B6I]W9^ ]X-NB M-(M#-=3>'T26XPGQ):!HD%'A)Q9] M("<<2$%,<&[O)V3@>4^W2--;0=)BAQ5S]^W%5:8_SUDM;SI;V3N)X-$%!C_^ M1%M9V-;8:$W&7O3.EMT>^/@,(GZ(Y5"6]X;E3IAH"4VP'TP+*Z,B]A18KH&C M05 C@)]..2>L@J.9(:(8&4QA,$4B*F,.J_O0XEBHZ?C\V'2LFHX[QZ;C)9J. MZ1\6R>UKQ_MWK78&[_$7ZV*G/#FO_QFO^ M73\Q&:C8"9ZS(&89X/3,+Q/-6V_7ZMV3,M\?=\>LF[1YC5_-WZ[NKAY@0V[N MKN\?OO8>;^[O)&V +.LN@_^SFK'PQ8*F(6@:9 !D-@D6LE2/>/'%IEK&9[:6 M+^H1!\&2=7_$K>&5?A1IM>37_14;J?77 )-B[+AOGQ:]"%T;.O]E_+V)B);0 M@'C/BX4-)PF/;'(-OS$/F-R=7LBT55,ZI^DBM'R^/KGX.QN-5.CMS4S$;M4:]:O9":2VAF:3/U#7XY^ SYYE.]!.Q//,9GCAR7ICY M^@SGX[SQ!+2^$3TW\-+DNCY)_\UV4 2*3\V$VV=25R?U2V7$C]7#\2A$:>]RF M,NFWEZE+S>]]=37NJ]R^OD8:>4'5?-1(BO=&1M"O5+?^+?#C2;(,,(&9]P1V M!6UU1(;R'[$3.J@Y*J8SG@3^"VT;W=:72@5W^\4)HIAVUJ<2)HWYIMAJ#-XC M[BU_0F]L_=?WJD,3!2>8*4Z 7;#2_LW "IWP MG1);R88*O/4D<%Y05$D!Q^L)8S 0;$.P?S\2LNP2[@1FON=8%1*++$1EXH3/ MV#?CF5_8D(T'3-0B-FHH%.L@&I'DP-ECW%\X4QA55(88'K&_QQZ3OZF?2R&: MOENS7C% Q#8KIEJ]N LZHWXW+QGOC_?UJ@7JIX M!Q-]'A10<$\-$LI0)-,&X]=?1.0]&[#@";'U#J5S_N M"SU J(GXNT!+L!?%X)<$%MVHH$E%EG$E\V+',PAB9(/$M2H6RYS\)0>ACG^5 METS>:#QWD(DI;S6 @8_\S*BG)6)C])+1H0U, M4);P+K 9,C1-^$+T"PJ II]FP"W'H:K#].R_P"U0I$S ?!\Z2(VQ]69:-"#0 M##%F@4\@D0%;SN.M>,6S]0*_3];(^"]$A#1-F"0I-?%YIL.0D7+PZV(WH@6E M8[?OU!>_\90LKB24,IU0I85>G>C9L,QPC.$I+\8H-34!(**C@SVA%H)9)Y53 M$Y[0HK:IP!]B"D,0DP>MIDN[4Z;YT_8L>F7IF?RL[\$I.-B ?KC5D!"!SL')*9,+-9%T$[0Q-+ MWC FX#K+]%ADNCX7+J45M-^QB". W\*3EILHBV@TK4H[I^=0CS_'PY&HKG>,A M"XJD*FR!JO\PP*\9\J(FC6)\H5G$/Q#OW@]"@@,@3_.8)G_@4H%8C M YC9X;)RK=E80[!]$P^]AG.2('\)4BA**.%V-D^FX8B1:B,'A]($0\DE=X-G M+&"YY"\ "X]84A*5;!%X(;+ZC$XJ^X%PF31"AR "C,%;:L\Y8IC'.'5H!_#K MS(YN_DR4)CY/+KY:'M"!Z#%@X'>]D,2P(J(&>?.:(8'>?AB/4!4QSJ?H5F%F M.^OND$$%%VE52K KQAAW!A[@F?6&.8;U/POQ*:L32)C)ND]>ZUFD9T9D$/5@ M^X83 /G;4=8S9H47,X^O7WL/_\+9 MC_V;W^YNKF\N>W>/9N_R\O[[W>/-W6_&-]CFRYNK_J8[?%J-Z3[6&0T^(I24 MF]Q99F<_8SWT_6AJ'][X/Y?>V6)W2^_LV3&_7$:D+]NSM-5('W&"07X= T_3 MDHT4:%/EV4OS X+3I5B;.FV9&1CYSMUTR<1:1ZC!V7_YD[<%W9I-K.4;NH;6 MX40)AP%CGMAJ'MC#'O3 )LN9W!)+O29ZIG"3"68PGGA3&[AZ\#V;1$EKSG?P MMN O*C(ES[!'.V^I//OW:K]J_-;K?4OU&I I6AUK/$(8F],:K MJMES78IG!/*R@>5:U+A"$8C$=];?&-R3,= DXCT5":W@LAD.P-8#$[GE/DNS M[!9X#YQ6/T '3E5@\/?@03/)6Y2-RNVTRV$ZFEGG62(*<:U^]<#00T1>[&.= MJQ78H?GAYOJA_Y'B2*(45OC:Z9LD)#.2WW[VX5]PAU[_,[\#9NV<:"8[\YDU M(B6G-2_2B?LCQFX0W8^NX $8<"K< M=I[^52))T#J@),LXZEL6 (B#3\J8:#9EI1J@&\$'2.5D^1>0Y\]L(P98+7J$BO MK5+%1J#4%.@3QQ?)D"RZ#T_*<#W)7BPWYC83%G/ /Y]\O)#Z7LGLT:F15"U% MSWZ(J^291@RC4HD)V&;^*YE!%6.$O>AX>YXI\D#]/3DHZ3B]*IC4'<4NT.R% MFVPYEP0,>.._ CX+KU'SV2+KA[H*%!EJ.&R5EQOP)KI-2?4"90UM9RI(5'@' MBIF'@EWZ\? Y80F*$TNURR]X=C E@3*1B ]6(-H-%'OWX#6!X'$HPO!9!L*[ M\=BTC5F[ 9+."L%"@)>M3%=7O3X[L!9D:_J&;P5F0H!MD?8:MP[\F'/9T H" MVF$BN-+>4U5OBE%UD)O^5#<)6BS$RZ"'(\1'23PBE Y755XM[B0?D]21@I8*WDP& M9/#'(!&9]^($OH=* 8TBKD#TVJ P 4F0U@/63DP58HAKI!.*_F/(&,FH48P- M/WL=I-@$:VXS9O;G,!TFPHV1020#5*(O0D6X'1I3<-M$"!;<3S( P-0"XP26 M@3S*3<:J>>=[ISH[S7R<%J(*P!"U< ]6G5&ZKDY$9,DO*&%1BYU4'0%8]-7 M00&SBXTS"9X/!2GDMIE?K2@2Z.EP,07:#+T4Y;HI,X;[([(& CEPH))!"*LM=IXF92'6#I MH2:'JB.Q[%_:ZA3JH8H5.,!6-/,T':;=A=61<,[P7P@R#G8HFJ@KVEB%;I:R MIW "R]&>VKP]9>_6GD(.,%0Q,$MXX;",*%)0RYZ0+2DC61PFISN2%V\^.T_/ M[AOXTUB!;V!]7A!SIY/G9[!C!(/"PB@)&).U4 0*'ZKXA\22X($0BF^0 SR] MH7MD6Q26>6!4V RV]![=?J$+<=@"@Y<"-N1;6U3F%;J9+O,:]6.O]7OL>I%[ M;P1J\P]0VBU[-K8@[>0JS(2PHB(TXJY19,B (QPIBJ15J)L&*XV])+A)P;@A MF,A.)(S0_) J%;1KX#A6]OG<'5.P86'J.4;F.4DJ4.\-MUXLQZ6[\1RAHWZ% M':VB@U%6LUI L*>*.3NA[.ZW,'A52]3-;]9;R+.&3!C#.R$.=8AW! ,:_1'QF-X25[Z M+96-[W"K',/1%%@-J-H1MM'GP)"A&)0\15=TD87_(^8T6:F>&]5S1>3 E/-F M\(46C@'(E@07AQDJJ<1QN0+>QK& 5Q7PUFO'"MY]G83Q3LMV][0(=M]1CM:J M9Y8A[J7+H)>KLK[Q7H!]_6#5ZMM9OT_Y&.WFT<^]X*,7YOH3LL@E?DC&*[C$EW4PPH[H-7)BX'3:8.0$(0:@ M*P;_+ZQB^,JB9]].N.!U'U!U*FR^K=WG "K^F-Y !IXK6&,F_ M5!@)L*0!ELW(RAE'(SIOL@072J188"-E;26O*.'OJM7"A,_.1(T!&&$ZXSGB M3WQGI17? DQV1&_?7-1HGHU13'KS%150T?NE%-)9]ZB0RE!(3[M52)(7R+]F MDA$.2S>M>5JDV;C",=M*O3U?E9G:H*GPF195(G'-$P$I3!(0JT.'Z%4U_S9U MN1+HE#(%01L'3"NALQWX;431GBAP!C&7 J(K7AO.(LLQ*-E;%6-Q0J&R"(2" M5!$!QC\#$7@%X[S,;E)E*2)9IEYF\4:WDMIECQ(9F^3.YJKFGFQ&;A3;HPD M<^_R9MPM,%L_;T!UN8KN\33P_N6A/[^'I MW,6 MPVTS-CA#D5S$\,V1Y)99(>'FT7.UP9#A/%TP2Z_/V=E9'+O#'>^FIA+)74T; M:\$XO97@$?2?L;TMX&UMZ)2AY>LB'4T,')I^KC$[8H4X0(8'=A)D6YB[7_0) MY:52Z7QC8\FQI;/WS6/V/LG>UX_9^QR..F;JCYGZ0\W4-U?+U#>6##C=LC!D MC,R$53LBYMQ"3X\T6\<^B%+2(\\[1L*GC3_D=$B1,R S(,7.RU92_-F6M_ZE MV6TU-.QU0R6[0]/AE<*(?BW@)K"D55BV$MQAZ%IAF+3(4;;"BN1%E 9A!!^@ MB@4^F1_J'Y.)'V+N.>(&8SK<=U]82+, <%(,%BN;M@-OX.'7:)S"LZBB-611 MQ?S02-^)5RW[@X@:ZPB+@#+8A(T[P.)E'&"%61?7I:]5V^F >6Q$ $L2_C;F MP">1C'%+*&X)4\"3)SPS_Z&9MXYG0C!2*^ I'U-[-W7O5,TU;] 3W;'8*0B2 MQL LDBUQ?CT_HN)>$/3_96I+TG@1XL&G_N@4GR9K$1[NOVM=NOA:(VIR0?:4 M[3#<:X'EO3+8C:07QL 4F+Y4RPW]_/6:F?6&' .%:?R#O8K\+X3U\#VJCQZ) MR4!\2543%BQS# $3=0Q&:F?Y2"$^JM%2W2DZE$^:OV%1G8(P^&$E::C!+8:7-6_@,_DPOGDX /[W. M>.+2. TZD'CJ13=P,K) 2 1'!RK$8RSU@T)[X4T)FM2+0]$N0\SB*_/ M?A#XKWCC!WRDFACX^4%)H]3;YK>$6%$.E6#I$ MH:%$!P$VYJ(>A*A)!$5IW4+;X?)XQM2NFI=BV(#<)H']Z$ND'A#+/W! !0:? MQ(9%[#W*J-82,JJYE<8L3^R"M@G)&71"U9NJ@#-3,PRF65F)O!S=]8:1>^#$ MP%>Y%!UUO:2"JC"V9;&[I2(4G6/7G%PA&5\@5H+^ )@=4\\IC!2YIQ^F<)MA NI//\5%9WM \U0]8T9$\B9 M;.3P7> QC0'6QY$WW9M^T5.)1$D^A4&5G7S2%]F84W-8U3*G7G2/-.P236 2 M-).($EXCR=BM\\+LY> G%MXH)<2[[:,0+T.(_V?7;6&2"02J[6$)\56/AHP[ M+W.8=C)>(0.1:Y"O(1JC0)1]%H.D;Z8O3*KH4<9J'@HX+WP&-+8T"9'+])(+ MWH8V1LA#E*5YY<:&7FY<-:^LX;.LDT]\FP07@X+(*FB0U']D (&CG#?F+6XB M;HSZ.B+((3$LF]Q#)QC&8U1Y"$LA1E%B;)<)^ =1[)\\6*P5M0Q_3VM;#E>Q M;L?B?+PEKLPO-,]%'3:R._B!<^E'XJQYVJYX!:I&DRERS:HG:YX@',.4 *-Q MR^%FH#V6$&7%ZX)*P?E8W%VQ7-%0ZU@TE!0--8Y%0\>A?<>:HBW5%*W,61LM M*VJM5E;47!8 9(R-C9C_N ^^..'$#RWW?G3K>T^D"+FUL"HXR KWUCW$5N,( M<%^*A_C[CCU$Q1=8Z.$"/YRB[2?R;8?M+ZYSG)0+N=Z9W(E7F>PBIY9P+3\( M1\%;.LSV 7H;X'=;U_(=J??R4 M%V9P7,$7A[T*%!1'D3@7DKQ_:3;/$H!Q#:)<%KX1O(G<)%XG[=$H;Q6., M$H:\8F DE;WDN9QFQN4$/]H17;I6WG@6B2=)8KP!XB3VM.$(;D*[BH[Q<1,U0 MAU_SHH:(58V;T 7L7.8S>LM* 0N<&PX D]I3O\BG+N9[O]Z8FD[59+3*?@D MM4!1@8R>4&=Q$@?P1E0UR'D9[Y!L?"4;4,B92,7$/"HZ;V(W,> /=A9H(L*L M)H0@SFUX8'DL2@XZE%D*OK;R6& #$#RTS[>^Y:V,,SWG%BD#[EA)7HX!Y^ZX MDAPWWJ#RR_ 9A##V+;) SO_D630Z.PS!(@[)FN-X#X4.R#8*47A17E+>)@OU>4:0,EC4)",Q09%N-@%3!>_IO3#$[4F$.'\EPE>VU21<7CD2/^+"J03M*^@DZI.FO$=<8Z/VFF M"?M'%FKS^_":PQGGP!"WG65FMCJ)F?F%#2)A+.HS;_ :6:T)C!0/0%B!D&_7 M9.!$7/I5FYDCI^RBS1H[X3,5.,JQO5/W/FW7$I2\:W]ZQL]06GA4,H"P? .T M?_0[5^9Q1\#T:H()G'(FK%!^*[F1"#$X97!*IDR>1O!/@TB68DF4;4H\G>)> MX=-%VEY_CSTKP%HC58\3@1ZM'ROCM>;_/J6USX[55:5H[?&N$_.X]T9D_3CL M+K"%9R!)Q2\\++LKOA*SO6@WC!G*H=-*E -_&?,1KT\&F_&+J/!^&#@#H=&U M-J>D9ED@@%&1^^ M;PJNH8\??I/+32:\<:PQ! QBY4X]I&?@L%9A0H&8F\RP>2H#;!'S*+O[8>A7%">2D#:@Y@?&) MRU2^EE9/V; $CD4.0E8U_R%].D.;2N'@2(<0KYXQ/EB,TQ.F"^QN!9OX/(;X MNE;P5N&/L.,AR_TUCU819XRQI\-U?L=Y%/!"GH%A'37MERK1L'0M=ZR$*<=* MF!8W9H#XRD?5)H^\6IKR%'T?:>\X9Y%[5->65]VP4")L]:!CGX\7S Q.=4>@G7&P&+XL S21@DH1>'"XY7)@-N21\00P9'%I+1 M27'J>&O"-.]22!*_KXC!X"SA1B&="!J:^BQ1T43"24F]BSS1(9#9(KF#-XMM M)])#QW ^?3=6=9[>FW)_@.IP*4VO 1T6>U(GF$-JQRYTR XY; MQ-EG\5&GH32)R$;%$GM:B#/%1["G@1X /=:HK%>CTC[6J"0U*LUCCZ"(P%?93IH;E!_[," M.LBY?O&<^4>,M?,=.:N=5?A_2=ZAO,NESU%T1") =ON%J1!^^C;IH31R>#(8 M@50![Q#D"B> @CC!893H"F "&AD0/1@[QJ=B X+[9@B4'#XPU*-VY-[8^J^/ M!P9,JK ZSPS7W?C<(/9Z'"ZCWT7:%59E\.;2#+ZUH$!V.K8<0&J2Z8\-..#= MCRT%(C% ="$%ST1\114IXF=5Q65F^J<\KL6&L39$"KQ*ZLRA1Z&3.@$'@W"# MB&'X9D3/3F"?8M3HS1#<@SDOC[E%(C\'RC*MI5EF*T@6#U+XZ7 #/(Y)+.&K MYELA RAD@;DN&;7S4]QB?G"JK%I)(J&"'U5WS80%U"*#_IJ&P@1W#>&_0@3^ M^BAA?:*WB9C ZP^'<:!&M*L!5IBBKIH]<_9-+5SW&/MU*1(EV1S#8O(M=/2Q M)]_/OA*5_XE@-VP9!7U$N!INFI6X0OKUU--4K%-+$O+DI)&FNY4(8T7 @03 M'6QBHZ8HKE81BKXYV0FM7EI[@I$\06Z">'-)1IUP&)E[<>P8]",2;F_CMJN> MV?;29W8KD"'?$00M)Y(>2D,CX7($):IH(Z@%!ZCZ1A&5%>A0K3:0)^:' M:5.#?A(FO]%+/!0')^RK ST9Z02[U$R6Z/B7)9"B7(2BR"'/8E#)"1EIR@+A MU\N^T*F8,U^:F.6MK0I[*4>Q9QOIZ*56C)E[,U[Q @(F$OD@:KED%D<<$XDF M"1&H@6--;#5./36K4#[ D+*4KS?41H\+0$-:;0J_3L#V@7V*Z2%?#&BGW\C* M8D'[5%5)4K@P/0]>/-L0J& R*03+_)/PE*\#(:JF>QQM-H27 M/WGQ^-3VHU-QQ;0SW),K ;[XL>#:!2[_@XL+PA]^#<] N4N/ MCT,[W18))ZY1E^Z27/$%UE?&(9$5_C__A=K[]4+MDXM.;=X+Y4?I*UJ87B00 M@7G=-\X,N5NO%[8@(L<'!\'!# M#S-=PBG&H0:J/$L(9F9Q@1X2*J 3ADF2'W4+ M/]0FS9($3R42=0!8Z6I)*-HI@QG/"@>R)>.(=SQPX@()#63 M2_:0FA'PG((P&3FN*^?[:698A7!GD\FR@1/^SB7 LTH:1DZ$E>8.#;$-:FI'IR5H1"HDI9'@^@ M]@9Q$S[(F5ZYFLT1[--6%=ZS=O^!2- M),H; M>:_$C-!)IYS48C['XFP#]KPE0Y$?Y+,>R;!%7NM$#S, H>"S"X#.\7 M.@L[ KVG:'02=T$_V.#]?+JGA@":/."1:A@0L6PGP3;FYDE%"+I0Z"-=/VO6 MB>:C/H"HC54 MMJMB&2WFIG:S0CD1+/G@)BZJS%% !6][UBBPKF[LV:0D,+R(I%U502ZX34I+ MMDO,E[]#+3G9L9;4ME:=HCU3EDL=C:QL*WX&MALED"++TG9 R"-MI(&9MT$5 M0S0MVS).G'COO':M>'.#L[&#E75QYHSXO,BLC\ 1AA\%U8# ]K&GPL"9O,N"Q MS?I4;/,GJRF>46FY7"'QV;&0."DD;AT+B9?&_3A6#Q^KAP^U>OALM>KA]I+5 MPU?CB>N_,=:/X"[WKQX+L&0%1X=?]>^_+0=_4N1>*9_H_ AD5TH-\1^[K2&6 M?&#(*89[UE9=#'Q@SE%>ZM#(&.22)VT+XHP<+K!GQ<)$G23_2T*-&$.1.D2[ M%CZZ]@..3:%ARG&<$ARSZ%H#;"BT7@\DN[[4GC17VW$:U5 M-F(K-:HW86 QUTG.@3:N4&#PA'+N'\5SL<&><@$8SZ=$ONV$&(_EH(G8'2Q> MDI A\0(Y#TWDM/GWLK!*-DKSG'@*.[%J?HN#,+8(\L_H\REO?(OJ+9FT[ZL% M(3^!$\V?TQM&%;-^?M94U?M3OT^ >+0A..F:OT3,P/HXH2ACB]-K(E>,..33 M77ED.PJ<0XNL.OEK1\)F"9=KW M+$ _X'Y$7ZIXPVE#"SA,XF *'Q^LGFZUF0V5_"((A[B)@@S !X24,+9X?03_ M%M?-LT>.%\9\O[B<)J0F?86A08-HS>G]#H!-8:^U#!/EP5'2"QC+%&]RADUJ M>GFAI4!_(!6 ((%JBT4I%_J:^$OX!;,-?4M#515DKLK[\GE^"_2&LM30XEN"13GIX\H?'IGB4-PE:B9OO4" M8C T'X,XI*,Z8,^6.Y)C930AT,=QZV9O$CBNV:C5SWE"6XX'ED]/"89I8+P! MFR_OFTU=X#>6$OA]!*>CUI?.T]AAM9LA)(X!-&@:0)LKG!L,]VQF(A\T7")-Q9+9#^;*++T+U/J$Q;2*1AQL M&,*G@>/'H0[()^#@T# 1')QT!5"#W+,#IFPP?'X3@)&3&!@ AV8@[R1(]QIC M"_!Z,-JHQR[!@C3\0<@"ZGR2-Z):$;10IRX%0RY[\4#:TQR(47(A5>)E+V9\ ME=0OJ]#CJN:]NM*0:PC4CV;C[E/E9OF:8)= MJNW/'['/FUN=H<0@)SA"SG<"B9;F:F-60Q_SFK@JLGU)\AR&+X=#&J+]CT2: MJ;97+ED&2 I3SH>A0T-8IESUD^J4*\>6Q2#F3HWPI+71&GC:IE['%*^CQM$& MS+*Q2I@WKSW%X$7B7SK/6_+5#?[J%3.G84IU-"OO#"O-P:?'!GV5G89#]X1G M 7[VG]A^(J#&LM7O' 8HE?O;*W/_!H-G"[F_,8/[P<,W_("C*R1Q*1=@.V(T1XF-P, ;^U[MED+.5&62# M$<*%#-* MM#*$R\*I9+B1^!\&6K"P8ZAI*NAQV=+)HS[YBD@F)A_)BV0GO;Q"896)+WC/ MY7 8Q#A53-5U>[;Z)6]W3D\$(0?@!T%1B'27QE)VS"3#A<]^$)W2S!&X%FQ^ M&N/&^YYTW?E..:^[,N=U=C,*D7#<+-(C.JI]&D6^ET1T_\FGRXMQ=BX88;Q% M753V2PDFZG %KH#Y6J>[RL+KL@_W=WP3S(Z@3M\CF=HC,,]+IR> M)$LA^D.G#S)E:-Y&=E4%Q?XZN)!?8!14A9UF8)5@3&P6[]7%\:WMY?[AR)0..?Q M18F"53OO9M\AE=4X:QZS&F5D-<+=9C6D:CCD/$:!,R 3%X6.R^Y0:5^5H@X- MX>VA11F]G6J24P_/Z9]KEEKB?XB,0ACJ>#+B,0F&' >M&?*6>6YK8A1E2)%4 M*X[ /G0B;G \Q0ZUW.^K)EZ:-9K%66-K%:C:E@T5I*N&0F2\ZA;=*&",LE 4 MJU>Z7>.'"CB0C$?<*"WER*B4GE/BU6TTLJ^KC0PDP$@:C8>WOYV:HG1%[*D0 MHWCDVF8_$I#0M.F!T=Z0U"_^6@=62KT2 Z(H1"1^!)3Q(+"4U7*-;KV=SM35 MVTD1I9I\J':7GOPW9L.>/*F%JZ&'K9K\"=7^$18BV"E76%J9E 3?PVND7MV8 M6L!I2\L6/F*>4-M3AV"C,! X!:*+6%.<#' -%I@.F43;D1B$80P6,W:L11DX M0FRG-&B Y^NSX[(L57VPKP6?[',7Y1[W47:.?91)'V7[V$=Y[*,\]E&6V4>Y MF>[)5;H?STYFW*>02;4%U:*"6CRO3R62KIL"Q#1F6@^5-*P@%F%2Z:?O"3,Y M50_IV*?8$,*'_E;-])-MG_(ZN0M \\4HN =]Y?;! [F=QR:LJC%140H0P[J M3MD)&',2$RW!^DJ5;1 4OX' FE1Q;$700O\,Z@BBX1GXEG MD'L>-:<02A?R_\JP?D7OJ,=2.O7&,9921BPEVFTLY98]62YY1:)G3.>'PPJP M",BV%<[+#N<=1Z$&O6?H\G3&].-6._%S4Z^7C#_F0W=#U4XAY#45GG%46SA8 MSWC5@,XS3_0F7K6!M2UI+#\YCCX-D.\BIBTH9S&V,P35,W#?DLP*J)VIU@,7 MV0T3=A$A^.K(_"\.>^4E->#O13&A()*XYU<+GS*D^:1$MXD?88D.:AH5/V _ M)E0-6S5O! RQNH@6J[K<0+,Y8PI+T8IH\BFC8 1W="E^P0'P!RJ9J5%@SEOK MK\73GV$J9B'AA)($%"ZM:M)1%%A7"8@B18<\WK['9SUQJNM;KR8W>R'7RQI. MUF(0]A3*))5[4.4=+VD"4FD#8I%3C"%5XHD.#7R!@+(R-@V+E@.F\UOX<&0U M;&!%VS$YAY4 DV*7)ZC]B<3UQBVB=/4(:^CV*(!7'&)#F"_?6$#M1"NJ[06W M2>GJ8S='.;HZWJVN_FR%SI!TM>VX-,P*<:M)',!YXD^L>$[#0N'$<,R:KDY%I37,L!-<0$<6:?6E@Q M]017QB290>K=RS1QGZ>)M="G:<>!O#4/G%;-+YP)C"P3-\Q-F2M)+,+72H-1JI J32^FYKJ%_SU?ARR)OC)I+_W,1 MF)Z9FN2MX0JG$=O)8Q4;E%2K&K,/!@Z3&C)>MH@U0B$;8M$03:S!!D58G',J MZ7"(>N8& VFB%?0;<=ZC_T!EOT"0WF@$Q@?R\G*83DO=-*6#6K7W#7B;)Z(W M*>Q?YB+@3OUB5LAMDPM*W8P>9Z-G02?C$R6V<(X+=O_H93B6XA'U*N\$17<3 MIT^F^%<]NUO2AT[^EMJR\QR' PJWEG&X5*'L1!AQS*)GW]:2M2ISV6PT3^N) M0YOP3FB>BF2E^97_&E7"WWT'UO /^%[K>$S-B^5]9=EG2^R\\%BV[]BGC"GY.9*1;V:FA/IFXPZ]+6C*G5YL, M;H1'HJ^6VH)0AEA=#>Q$]CBE^^\CPH5'WTI,1I%&Q#1>%(X@PL0L.+,1D_I[ MI(5C.973RTCRNMA80KTN/(JK-W]EYFKF/PDUMHKTHE_NAQRY7LZT7.)13_2,Z&P.@/ MT"#A4IR9A( JHKHA_Z958T:L(+7B9^;:VLN%J5++[]7^OEA.Y1=!YKHRJZJ! MU$3D9% 8 :KD[!8G/040X2=.@'\;,CV2E%A@:J1BRM+D4:#.JC,R<=H1GV.& M(XV?>, QU?](C3I#GET1!1]3S00YE;=C]&X,/N:#3A!Z.=3G>LWG;FG!-:DE MY'N3C,X;WI:6?RHZ2?Q_"HOS3B,VAI>FJ1BGG"0@&"0.@+O)NG2,VDI9(6&>N#?6>\Q249_BEZ4T6]KUR*.-F69W)Y2S7I\OPAP@W/ MS-&=/1!SO'$!3FK(AXBF",F8@K>2M/DS[@8MAL*@B?(*&,FXJ5U Q<&S>F(+ ML#?"X,'F, )_S=,8ASM*0G_,YK;T & 4>%):JPG 8!#2D&SX4H,42,:J(9Z/ MD;-K;VD)K(\"S2QST=3/% )<;2E H$N>+,7WDW54.!KA1BWA%E:@T'UJ5U[W>F\RN&U^77LQO?JUGQRL7N7KNG\'PMA1_X'OSGD"-9K(5W ML^Q]4TYJN\3993]SH/1UMX%2'&B+>LZX"4-L/DL8Q$QSR&$%2S=TH*33N<:) MW [8^E\=L9.S-]"X XW^+]#'/=N?@%:'+;O8^=Q&6+?UG<]W]W!8H MC-)T/ .)>O"ZU_],Y4!X2OO?83NK].UI[;QBWGA@23/SD<9^?GBD@$&G5?OX MR025#$Z.P$$"LR*Y4D=$$D7,<%\%>TC8"_QKZA:5301HYC[Y <^[&V0XH>&+ ME@B8<&BT2^M-*[+2H43XM&IQ-6:1P;9)E7F9?R#VKNQ(0-R0\-EW;0&_!V]B MDZ8'L\4WA=T:&J(F0QCH"-W'7YR;:A3.A[MYTN_D5(B "LEKAA5Q.XK;QX%H MQP^MIZ> /:G@>?);%G(8IY%HU0=?,L90@Z&'1_X3!TX(W@$YJQJ=X5]J670' MRP-N=T6B (UE8!FR[:E8*V&)>IN,GU:5GV05TA?W!5IATAG,1PF50?-=I0&- M3^.S=W#+,]X'S)P:\B>[8B..SSM\T4'%QL=? :ACY@/R@\6 MLJ/1S9,=_#*R >4OIV0(HWUG/X!M@(4G\0!HP4-XHNP&"Y9#_EM#V_$T/M24 MY-$.D_AITB.O0;A(V!9>'Y/XS,-GAXVTL"2Z-%3Q@^B8@?'AY/+^R]>3C\2$ MTU/1M"@!?"BJ+SD>.5^(2%R**!S%'X7#3SS-%-RIC'91&2JOXZ#R42ZWY.U( M%E;$4K!<9*R?"][2$R2[('ZFAR:UU:@ZH$C;&Y*:%L$LT01X*:0-$?&2[\@' M>X<3Y/6S_RK2M?Z0ZR,!SY6\>D;BYD5W>R2%#<[J*,&N MX7%PEJ[5+T8.NK7S_-)610Y^D+T\75S3]ZGV^O^IK77-(B5@YD M]H?/S(Y==C\BFEYR+=8CB^01:;MT"+/X'=-;U"DO>#FSJ&8J9 GB9D[4DHNQ M$R&4(ELOJYDN9N%U;F.;(=:!O&UCWUFC\.DI M^,[H+O$[VB@;@I"#Z/*9R>%RRRG\VB"98(^> G!&;91.?O#)#)X&'QJU5J71 M[%8:[?;'A#13R8_.V2_9S,=T 1@OIY.;AU?(Q$+/?N%Y<40^CRD,%63>4TK' M7_+)/7U57B8F?S_%3\ZG?A(@1=70S_R4:&N-L=I]_J)AH6':=3 :VNWLZ/*9 M1%KZ]?>*KNVEZ,KI].]ZY]\CN-G2=+XX:V5GE"]%V,VEV#[\GX^9$LYBIS=[ M-K/K_ T+%CR1]P9K+>*%7?)=Y^U_T4W?Y@E*7D<6%21F>+%3U3ZY:'87[OVB M=]\%W98[(9NFV]G)1;U96Y-PY6JFK#::8='<3X&P9A3/$I908>NG*%LL=R?) M.%ILY#1DPU/GQ^FS8X,:_F3R?Y^BH 2%W#BY.!4N<3$;J^BZ#X]F91VVZ?# M;X$?AL(1+7;8P!E=+*-6VJ]UM,OB'7ZW[+".SIIFASL6+<4,7; #SSOEL,-[ MW:]-'M]E]^O\Y*+366RWKW5\9Q55&=N+\>4 #*T2S'NW)8-Y6TFV?I$"/J#O MR/URLI M-K,@,9N_U$[35M(6L_([J^Y6.*)9*4"05,FU.(J%;(K33,9%P3"0<$PG'1,(QD9 D$G[SL1067Q+' MFSK1(<2ZUS:WE#ZZ\1[Y:Q>SMT W->K'E$+99&X6"=\4IL4F$P(S9'/QXW;M M>#@[UC:?\-R][R#".L=4L8XD&,FI8NS3@E-:J9\=0SY;.^WK[%;[Y*)>Z72; MNX[7KJ*"CQ'=]=CECA74"&=XI)O=L^.1WOJ1+KQ''3K(YXL+ \J(W,Z(/;VK MVN+EZN7/C_7R2;U\YU@O7[R"?7L#) ZW;+X@N=:)0D>61R.<> )H03#ZO+V) M8;S[979Z_>O'C=9(T__;'5G @EN'UIIA7)\-(0C=HN8 M8-,[N6Y=?N%;I]5S]^3BT8\HRR-_)%H75?,A8KU1=^#(Q_9%ZHQ.)<94Q#@- MC/HIJXVWSPGS 0W6V1F)4;'>[AY85F.V3B\YD%VO;2'C86XNDK]\;'MYTLXR MK/8S;T#U6J2XS1YU:A=YG773*(=%HMYP&(\Y$)\B%##-?TET'*Z6[FFO$<>:8*B2GB\5VL":OTNFTELG*Y&S+"OFP=[&]'W:R MOYJ2T=6+ON.(_ */G+/US1J&7FMGBUL7IO>ID;_?F0J^][75Y>WT]/:"4KSZ M(<"T,-_RZKC%R@:;X(RT*YUZV:W;EFW[NC5';VZG]067*>"8B->7;-!=F"!TINC5[>"5U?2_F[&JVMB ML4:SN7RQ1F-6L<9/[=>M5PVU*;^N=7+1JK3:C??@UVT[SZN?)0E^:[Y:BSK_ M:FML?$]-@;KV@UEG>?9NMT\N.CF($LH@J!CSEWZVNZ6?@>+IS%LZI9;G+[^S MN^5W8/F-;/1$6WZAP:(5,?-:I-'K%3F<',2^^U8UK]1,;@%<;FDK-22/XJ,( M1%F,[?& 0N8( 7CYPQ&3]P?>50Z]*;&7=9[:TM9^Q9=^!\]\?&7N"_L*"W@N M:+1T@>W/LCT8BOB[F3Y3^M/N/?.K%< V-R3SZ-.JR$%@MN%XB- L!ME-8KC> M A:QG@)&2,3F!_R1F&]XC?#+_6\],;GPHX!,QBMP& #WM$O[S/7A<^2JQ$2 MV553! 7X.?*R-GS7X"L9\J9FO!:?"BPOIS42UG^ @Y>0/V,U@M"U7JGRY,I[ M<@ED&_[_3V .CJ7,O"?KB0]^PHM#^ (OGC".I$W3#2>!;\@8OYND9O'+KO[Y7C7^O((U"G(60S-7R):'/\PAM#6EV@[WXU[,JGI0,.^FU4%;963YN:U?A/.,$TE[3GV7V&X^[<6[FD'@Z] M?B(YP.-W]\G""XG>5OWDHMG,80R%Z:\&7$ZL-\+^D"&@NZAKC.D9,S MI>H.Q/4U&P0QCB]OG$O,^I3(QGE^-%C.Q!&$8&='.(1$\(T4SNF_.3/E2"TC M):-0W).RAXT)&&H .7XT&3PJARC 3JGI$],/POD.2XNJUCHF\0U09#3;B/AG M@.C]WOUH],#( W[T^Q9F;C['H8.39U!2Y/+RM(AK-< !KLTQ0:>DW );>C]? M.G. T>N?AQ<"D@]X "V&9$ MGTBO'W%DDWRA9^6+S?=NDN5:"LE\2CJOT8QL1-U(,U*Q@]'"R-!Y3AM/%:C!M%*DA_(S!"C#PP$>5 MDL84LW)P4!>ED,MR\/,&?N Q.:-'B'1.ZG=':3?T*S,X MTL"V"113^C9H#%K)L?CI&CGU5BI#X6.9PL="DR9V^1AVZ5_E^1.X!'D+#.6I MD=BI:<.X6'%'L(W>P&X,7AS$=R:()NW,A,X/P0%:E3Z96/PUP;?" 6]T"2CL M$0[H'AG+NQB-5=K]Y^JQ8N*GC09\SK#:&7IY.>]C)0R#Y5\JHW?/P'">JW5! ME?39)))CQ7(]S_GLZ,%)2EC22%Q^/O@.I^>)]Y#,E,,GA>R[QE[P20=(NCD^ MVW+1FO=2'[7Q6MS6^GL,(KY>H8%S6=_V,I%1/3 M>N:\'6ZE[# $YO]DQP'&#*8W^UN XV>CMV^N1<'O*U"0$S1WOM-S;^&Q:5/K M7#/)I6Y[[]&(A2D--:,UF>5+FRWL# /M:OZ!C/GAD/(/()NYQ2.FJ)*O G0] ME7_3[&/,OJ!Q,W5OC%9$%MI>\TWTM=#H4D+@ 2MZ[D? &62;%S+-VS60^3X,R#6R7#3, HJI&)B1 MEO8VSNZE\"U]2,/HX7>+';DG/?MY[?A%,\0!K^,:"H3[@ M ",(ZB1.XB"M?-J8A\GFGGYYIYIG*0B5/*M-I;"_6E$*(YP3!P@A5A^YRXS8S6[Q\[U-9._C=DZX8LZ]^ M8/J&ES(6V\XN;.?BCJ>9K4V[%@[4-?4-]A5#*B^6&XM(FAZ/>5O$FVNW7JTJ M$F;=H_2!#_F<5(QCSO-C)@6(O'83U182;T5<@ZT,\5HR"5<_)N&2)-SY,0FW M!([M,3.W.7HM$]9!.'E>4+QTV";GIWKRKM[:PAB^CLSH<7K@++[^(VZ(>7-G M]JZO;VYO8(?*G\R7E_LK*2 M5$M)2C* MS/X);!:3P98I,!,5ROVATY_ #2J4#J8&!BJ+?I,%N7+U'\#L-ST^F?1C3B5M M)6\I<;:4J9F'SO^PAMJ!U3V94VS+ZDE,$R9F&^Y[8+/A;O,I6G9VOU1X;//<'DU\#C6EE[H7;),TS%57.ZH&2K)U8V MPC.H?%'K;'EQV"NS,X6,2"D;A0!(F$@T(> U2L)@XHY7+!*9>,TCTA2NF/B8 M,N&9%*Q+[,<#4!]@6'1K;2EM0PN<6< MUWN*'9N:%9.%X7ID?W_V[7EFEWYM\5K,D>4$B;M.-T6('DD)):2P#!18 YF< M=T-CS:J)-?TN#K'&HS9R+ 7;CT>?SN+,#'*F44OT(-FP$M@G^B9R M)'U)^!ATW+63_25F2T1YSIHG%^?S"C62=\5N-R>49,&7H(>_6Q[JV0K0 MDEHWJR:.S8:7\*6&2ID%Y,TK7WX[%&$+(XZ,UY0#5+-XCG;3@Z&<%%B+/?O+F= QY M8_]T0\4"X;\.B,FWP!^!(*/1[: *+Q'W ![2%\L6(!O%S@R.3)S3# LB1DV) M=]\R?8X,.QY@(WV/G4; <01 A7LQ\+U8]8 7[H#LKBHS/N/CBKUP&ZRN.2V. M7"/,92\LZA&]-;$G:^J3/BVB [+%V'HC/9AT\PW@!#BB31[M8&+U9LVTK3<0 M1O8+Z1L0,["+51-.X9W_0H+=4$)=-_@5:R9MWW"VXB%7O3H[PC<+*+]*MQ11 M_@&?R+M.O_(G7K."K'>66PNC[<0-MJW;H@%"5]3BS*)6?[$"AW&78J(="RI8 M5!H?;5KLBE$'&Q4LV" !U_!&!#2,+C\ M=%' VL3!TABP! MST037-Z>,%CX&A&9A?O, X0Z40)5WHS?2-?5 D$A)7Q2VPV/GUU?LE OMS>A MF+_Q-1;;9\RES>O76EP_V5ZE-7JM-7?S!A%K %N<>]!">\NU$-YC-1=YW'_. M^-KD7,[?OL;JA7A?'<_'6J,;D=B\!V(5?G[[9@7%:_#.SNLE/A]+E'7GT699]T!1Y3\/H0><6,7GT\R7@C@N&RP;H?1GX05L$H4M;% M,W5BI;T%AW],VG/D#,%B ;$QT%9Z[4^V?D]?Z9N^G],Z9Z_\S=]?YM=.?V@CNTLX>4P_^! M,\#(#G. :9R P!@ MYH>3^\?'FY./)OOAA%'Z_.=$"@P0?ARN!Y@J8"_,BYD>L*,2(#_DO3=I42 P M6FAIR-^X\9Z)3]?7D[$7.#J+V4N$2$7S@/X<&BIV82E<3#"@X!\HNRDVIM\_ M0OPU$2X08D830;/B(T,K"-[PW7B,A/T8,A%\26H]#(Q"F2,LEJ5P!X:2T2*O M3*T R;/8PVBO,X;C"QO(!J/HK<^&6 /KL/"! ,\ MJPCE R+)!'8" R)(*UA!8N!%P)1$ WA]P2]PCF6DRL#Z^EE E._44EDU0;E2 M+ Y.2B.9Z3U/-.#G#'8&VHR7%P; M7H!@!U$ O@>S44H8K:!G"GF= 0\)4ZJL_JOX*#- A8]CV.5PS(.C]/?^%SBQ MG' S9S&42[WE"@XOQ+0-B2#"0]WFU%#4Y4I&%T\CD65^6N41=IB=.C].GQW; M9G )__?I"$3C:;W6/+DX%84F"PLT-U57F[1UG%Q\4TFKG+Q["=T=MU;Z.XHM5[_2K?(=E.7 MO\30@T7%^?-KN]=AJVFC&>%JP9%^X'VQ7[2VV&NPZ/^!_L"-,N[1JNX1$/H2 MV< .XGQ6&CF1GI6+^)>N!I\I>C.&>-G"MZP::[ZO7RFDE$B)@CX0C2(Y;RT> M,+E<0?4F;>!EJ[-WBU'4.)9'J_+H1NU8'GW$*%IWY=MNAUBJZMC\@)*I^K$T MA+2%5>!S@P.Y<8&-K*H?CW&P T(+C\!J\(:.Y8(KQO46+&6SL$L;C5TM&9Q* M1M1>^IZ-91VVL"3ZB*&_7,0J#*)/2]U0#V$UJ-H^1?L4G/]T9+K<*%5>.?R" M&;_+$?#=1[!F*>[]C+7H!K,6U2IM;JA0R\=1P*O$O':T"V4 >EQ*7#-*N1Y" M\*>]2A&=&B- KRE>NI@3USJY.,\9B;9J8&?9+2_4(N\#XQ$.5GH;=^%LK[4] MA#F#F#4_<4'W9]?^7&&_IC MUI=5"AMQ6>;>,^6UG#>GO994O41^\<3A^#)%B?ONW9G]-9EE"I$_%_MBDEQ[ M*BMO9IR<8S[^7>?C\Y+/#Z+Z;T]_OM,]N6A4ZLW%T#QS M:;%.*N_2Y\6..'QVM[[$.N3'M[@?X9CYD$:&\M:5/K)^(?,( 9(JK=J:YM'6 M?8DDJXQ;Z*AA/=PU/-C=3%XK._WOZ@=.< 2AAYN-/8^%-A@G(]0KM59VZNOV MJG*R=_Z->3C:EG= V&/'V,%NG7@E.(2]U LMT\;9!0NOTUJ,5[A? M9[&OQGJ#1?P[P[*B@]U%',Z&95&>_56^RU(;V#BY:)UM;P/7@2BU?F ?@D<# MW,=L>H4'5_14HE F @&]!"=\AI,^*CBQMPM^:V.Q[#T K-N3BSO&^S,.]G## M"_"]+-S?T:5ANNWVIK1GF8&C(BT;)44/"M3_3,41YF..S7@5(^L6U*H-' [_ MEQR/@7^5=X@V!^DU2*.(S,46V^1SOPE #$,,?<\%\5@9%F8A_H< 5II_4EO+ MXW!1KS<%>CE U)X+^KF*EMFU_S#K?U?,$2" XA6N(F+.!X8 KC2+Z#R5]"0IW, M1@LHE>0(X.+8(FHZ3>#"-,741K/2;>=TW*./%H6*M!(<37"O8"N#XR41G=B/ MX3-X/ZR"Q5&N*X<:I:#KKL0U4S1<'=JLG8+R:JT&;297-46\^''I$"; VV>Y"08,O^%#FV5_0 M470&<0KR;:Y)<@ZLTIV'CR4&QLO92U+>(R"*0C +F,M>$%%I.+4E$K:0-S7> M6:%M_6%>6A,'!QIPG\B0 $K-&D$_L6%,/G<#6+S"= M\9C9#C^4L#*\HZ^KIY1B-@':2:1A-AGQDH;&#;J"J1Y-@" MT3-8]$_/A)?C\.YLM,XWWPN\T]))E%1:->J-)XFT7 *2!-[BV^@YQ^99MUBS M;U:$B4.T5_V^RQ/RF&S<60Y,&-_-RC''>,PQ'E#/;VO'/;__D"BMTHPA]"". M^S;M"Z<=#>U?#OTT%N!+SD[ ,,DN+\''QR? MG_]?B8ND9Z,:?>]8] 7T^PMEO2AEF4R:9%8(SJ-][SU@ZS &=3Y;H1-R6M]X MW[U@%?2=\SH&UQ M\\EV.B-WT(ZY7%=Q\]A5G'05UX]=Q86;65?+6B2O).(X&SL4"_),N4=EU7>8 M:GDV-M'RO&EZE+1]4S)MQJKGAW+F :[U!-JI /3%PIGA$*ZSM=8*'-'N^F@[ MY(9H6LTR1T>M03AD"Z.;[OZ^!Q9Y,+_U_M7[?'LUS0HE3IS:]/[S^-(*K01% M-GPU[+YUGI'BIU9[]U&O(H&71?&N34^ M^&ZLB+1Q#JY\-UO>NU=;\#[V>AUIMJ&]/LN=!;63+2C- MS@JI>H:#];ZNK. MR<5],NJ&1N&DT'X$F=+_.@K7)0_<.@C>:GMN<7>P>[S8"8.=[>9U0>T1S=_' MYI[M8'.QCC\/OGN?Q6=IPE%5K6!%>LADS[\GX\;M 4Y7_Z[WOTW MZI1,"ZV>E;&B3Z^_.6-E\XE,4/="\ M3R^40TC%R'JB]QN=VR O$0Y.\0S$+GAIXU;KIKGK:)[L]RL=:5>:R30M#UHE MVB3;?%:NHH 'FK8?@Y6V:Y4U:R5[:_WPT0H9M;5$,JE=XYA?S>;*RJJU>[/G M)V>AM0LLUF0AA)ROU;? ?'9R/M;AE:EZ5AQ(<.#E:) M%#[H!IFD/!1537;/Z1:;WR &4XBM '7 0=&YK? -ZE[@9!E0/9:INO#$RV)H,H19GICZ[\@3TV) MUBHA[M+7ZC<-0&@[+X1^"!? %4\6B&N+0!90J,]75V>--?05/'[(F!U>!_XX M)9"**:@.SC7+%@@E&FH$]U44>914@-7%!)4&]'(\L]XPQ_!&SSQA,6#8U&%Y MH%Y00R&]P\BTX']F@'0!@LRG1W-Y9,QZ=G[@T":^H@F;C,?D(&C'1L0#',ER.[ M1PI&$/_DQ"?*XC>(80>\&X#U:SXSES"2^"4*Q^[5"ACN'YX0 L1Y\0EL,[.- MB'0WBEWW#;%7+",'J!T: MK2)1 M[%"U5C5"HS1!].8()!P*07A?ACY.0K$W4I")^Q+""XM=0_39"M^-E'\CZ%H& M23ELN4[/GGJRI&%!^M6QA&6&=B#-2.I!OEC%G"PP+01>*19=T+O#MS??[B4* ML, BYJC:@D/-5S]V4?>FMF *KWSJ!J23=8OE1>+P+3!85HG3$;5[\E'% :C: M=80+:V>9,[%1.-?@&D%RAKA<#IIL1?2V2#GZ@#9A6E H\D\D.%9)!-B,Q59O MG%QTYE,#CJ$T2+F\FH@GOK M *DG$(/+EB#4,:^3,W P8?C\P%F=$+5+,SD2X*_2'@%.[)W_PE]*H)OJ\DJS M81"P>HQ'>EKODI^&1UB>MT09BU,.=H/K\)/[P?DHL%1E[+$"'@U\#)]/32#) MU4=5\[,\]/#&8)3@XI*A 2'X(R%7;X1SCPNFY<-!B=V(H[U:9A@/<'A A%[1 MV+>=$5C"Q(RZJL0KAWB42'9PK[U_:;8ZM=-VK6KV0O0UZ;9RC3:<=:0,O$#L MA,_).GX+_'BB#F8%?OAD.9[4P$4%4F>-LX$-'UBA(^94%3P6;2R:7: 4T?DC M%Y.IDL**Z;'(E*, T',U.>-DS@^>*Z*<,QJ!FL";#%CTRABG#-YF: 7!&[*$ M,ASP&_!-@;=A^SBC68(7-26@,2)%"_ 6Q*ZTW\C%()W##1W@K9S5:P*+E^^! M9P-HSV-/.I.1DYTO^*_C ',-8_ J*N85D)RF< CAUHN?X$EFLU;1;BK/HWZV MXHT#(#0'=7+"W-GRJM3U^ES?(!PPV?L@(0-@S_GOW)G^5=.K!!\ MI27?&=OY*NUNSBM/6?H5./#@'#HA66??L&2DR (CJ[N.FPJK^(;/R7TW MD&;@N^:](0X8[E9S "^2:4SI=^.B#/B:A)D,_70N34V&WJ.BEM%*XGS(7-ERV#J+4!=TG M"5X1!&_H+J7T]PKDS#Y;WN_F+8O'#OSS]"8,+.:*0R"\K.2*E'\5^#A"D5>R MF:[CD>4XA*B2UG$-3$X#4*P?SC@>?_:# M@%R*2PO9/WHK%J'!G%JE5IL3JZ^8K\_.\#E%^K'U9MJ!]4H1*,Q+@C4]?,9> MT(ABZ0%:&R'8XH.8Z.7Y(DUDC6#/]/0&C^,T%A>R<"J']%@>D)E1MM&GL@;; MO$?T22P$!YN"*AC V\)LHW*P^_?7#VK3)VXC.[6R*C[^(1(4*^1$&^## M-<$3R,V*8M;7?:N:]W+\5#/O&-D!',P%@<-UAOCHJ23DWU R<"$&;5!+]KQ4 M$G<$>3)(/Z?TWG^/X:-TI1T[Q>8;DC1S7O!]&OA9WA?/: T==GDE]ENZL=8@TWE0A3Y]- M(A[1/1,W7M!)D#-^9Z,69;>@^]UH3;DT*]?W)EDGC*^K5-_2E;Z+[J/7_'9J M90ZWX 8IW"]MD7ZY>KCY1^_QYA]7YNU-[_/-[*;'_FK@>(%H=*>Y9FB6E@MW+!*\;W?=# MH=;)11OD9RT']B!3 R-M%.2J?TXE *KF;W#(*:KJ!$0NO U6>%%&JF*H"HIT M3).4Y40(=/SZO :\.STP.PE-RU]7%'_+E9@V2&]0G>:8,5XJH>*PALU&CD?1 MV]G!6TI^JOCL&U<-6JP54\5::8=:=))I[DHU]'V"+J.^4B.UT@_<>'5X4P[/ M:U%[8%(ADA14J9]]Y$M*S1!S34J/ *UIS'X'4M5B5"':JUI, M>FK8-CR)9FU31D"[C!+H$[@(S'V^5N1^E'QXQQ+KY6R>]8(X MN=6<4A1AM&QTGOA,U;T=M9 JA.A*BS.5Z#$L&R\GGI&5#>ET%]5/RT.[J)RP MTWH_LO$,S-Q*M]&JM'-\F;P3NJPBZ;3?#[$ZZ!(U*^U:3FE%)L6*?*=\'H8: M@H861\]6M'ZR3=5HZ#(WFX$SLADX_,%4%B[G^(A"/*W I5EIUL_UV 0O).0% M:R1SA_"ROL=K4N6;JP(?(N>S[]HX64E\)M)Z)&^1/G*)>5SG8#\$2/\/[8\R ME3M3V1K3&> B;+I"?<*^LFEW#IOZDDU%)286_BV9^4^3:KG,_R6R]_U(;.M] M\( 608H(ZLM0?!O6ERL2:&!DK57-*W]210)5\PJK';.,9G(6E26RH1&RL7,J MZO@%FB0Q+AI]_I19,)]JJ6J0):JBDZC5_>BW P4@;87%HQ4-7&F=S7K&OPR M5:"GCN43/@1+0^DI%1,>,HSY# 4I=411,$B;D*$<,T+GQRF5LL-7N"I12 J_ M)GK;:&-AH-!"D0)*&0G(S35.\,3PEA"> DS0%&B"Z1Z+J8L,<9&:]0!;@Q6* MM$(4:"2MYG/U9A$N"\68L/^W<9;M&].*5^'_"Z+:.UAV(Q>L4=,-6-S,*]1< M7K6Q?\@36^M=7F.-P.E&1GJC$J4Z;SP:VA%7I?EX MMX'C^6/'<@V?5!!I"#R48]]F;G6SU./_K&;0)WZ.O;[V V-!S6TBSM(!=66% MR6I>\+G]<1%%WMQ(S?Y"3W6N,&F"I]K*=DR4+)9UD74@FW"4]3;O?1Y MC$DMRU3I8KDJ8<-0B47PI@ISPI+U,<4&2!,$-C\C[T_QWVNJ0PK7:])2"_,KCZ7@&_NE$S]\] M?Q"RX(674DSB"%Q4>"I6R=!9PC_C %739RMT0C6+I7AG9;.=W^:WB%NV ;A7 M[+QE3],&5W:C1:Y5;,_)39?2*L"8F*)JW"TXD#D)ZYZA&4>(.H2*]00V MS[ ]J-&8/V9AJY#!Y:FJ#:[]4AGEB:5T/#US'_2A_.,#?EEBDO7"D$7J3(B3 M9=]/'9I%1^PWR_%N_3 4.)+VC7=E!1[\NN#YZO!4VOR!>N7L[,?2M-+FQYA< MIC-<&$57KBRMADK44'M9$R>RW!G4*W^DR31I=CR*8F>3*+9PFC>C#!_!\ E' M+ BG@C8AD '6-N_L=K&(JEF?/VYVJZ,L5CW2RVC+LKRXQE$_KFY=KH,>M$,/ M[1RU7Z,^?QK,'EJ7.U&!BTW*HYK;+S6WSGCF/39:6[7\],N[5GNSWF:]F3#S M56*S($4W/9>FT.G>VF"1O9PKL@Y:W.X4;JN.#83-3K9JLSBG;2L\NBF@CO(; MSHM./R@1EJ-+$F Y_(WV$7\CP=]H'O$WYK+6_L SY/%0(<[X>8 V]FW+MH*H M4;R!T=P1ID:)\VFR50A+-*J6]\++%-"H)9*/@XO6<%US/!T^.RE(F43X>Z+! M(QL^>P["&LR!+"HH,[2",BQ,_+2;*M^7V#&9ZXUH-G&Q3KS8+)W[+V9U? MCARW 8[+P\:;QX+=VCZP(#@+G4ZUG2UN_>5T_NKK^[#Z%JR^6^WNU?E9)?F[ MCO[0VZU3F^DQJ&@^&>K=7-S&\#[#;W@8?.]HJ' M]JUNC$ QCI)R'4FYQGC(S7%Y!]%/:X5SST=!N27F6=H$;N\#-W71"ZMVLF5( M"RS@L^4A53:_>(2;P;.P)X=A3UK2'ISP]],1#MY)3;\]S'.['X7!WG-4V MX5Z?9^&$RF?VZ2#)D7G6DOQKS._:'#?5"45]^=C'/@0/VXB#5,T!6=OV43B8 M5LHO#@YW\&SS#8N=?L+C/']<[[DXPP57S4?7:(6S4GAB"*KWF.J.C M^;>&^7>^#R'2=I/,O\(-(T=9M,\VX/D:8Q VQU(M8*DE/?_S?0B"M=MH_W6. MD=[<)?ZS=WEY/*QKB/M49*Z^(Q9'>/A:=?S,'1WI6W/W,XUR;G>AP(NN>J:TQJWMVW"N'O"MAS9#$VM,+( M]%_45+416S"AP$K5YU-)/C;YR^D/"IM5XNS/N)4QHX58X?_JL*ZSAK-M9SI; MJ9TP<_I-YL]C&T1?G'#H^GC,\UHT.K5:N\16F97M =G^5$^W/]$88?/ZX?ZK MV?];[^'J;_>W7ZX>IKO/2A_GDS^);YVWE2PP_1X_^83A&3_*W9*L&; Q@Z)' M4NBK)2;&-N5LF#[P3&1^"WSSV;)3(RAQB"4-"/K*;.E#@@RA!][VVAJQ' M\V\*]>.WS\$;K-3F X O6/PZ$XK76OQ9[>3B?-Y,AP(H['"L=K9\Q$*HS1FD M,362@@_FG>;KF2.N>R&J=3[Z!?Z\Q5&M/3G.->30JNI05.8SO\[6%1RDI68O M9X<]6V$(U+"3>ZL1+?X Q(#%ATCRW9 MEGCS[;Y"P[#TI8-YY V="0@$&X?T^;#3E/ QTT,>U?P>7-,?L0]KQZE5@\BB$5V#-]/&3)6TU_(7)V9CB34F MRZO@[P4$_]23I>67]Z!%AVN=2= R[Q;2^*EB1XHZ(^8/*)W*FQ;_,Q3R0[N&#A(T'%6&PY]HX.;TC#2YD5H9 DH8%=RB"E^.@"W''8 MQP'R5.3 $>1W%T"BL),X3R.P"86)9%.O?VFT.K73=DT,>,P.%L4E_ #?Z2EV MPN"F0HL$Q" &WTZE8ID#8.+KF@=^!P?F8> P: M5TJ M!KKF_%.,-C2UI9O3_J5HPP>. 9^-0+X@9PU8],K8K-D9&HD&S%+=\_(<&/P( M2'H/P>-_PVOH'F&&][@6GRDD=?[/F>WE\7&R7P%D_[^9,LU5[M)GY-N]+3*\>% L-8:O)8X8CI_D<9)P] M+10\2=BT/ 8Y/7;B,4Y2YM\"UX$-9B-#YDCX %DRX./Z!CAL;!0'0QI"1C:M M >+;[-;;%7/FM3[@IZ5D#@)[10%PV@KM?6&*JV?$%=GL=I&3E M$O4\>'7^S&_@$!3;9(0+SZF!3@PJ%$[H7U15B#Z#(;BG %6SPK)+H!&>'=$( M$S3"UA&-,,.SAX)HMS9JRP'!#>Y&CBR#*G=#8TT?K1\YR;VB8'#S[I%*$&*A MXS[2E"<(&S)!:#[V_B]PT/V=>7-W>?_U:O,YP6WQQ5Z;Y']GHU&H#G& HR_) M8GWT)^:#Y?UN8G WLGZ@XTU6-/G]OGD3!A9S'?S*=*W7D <3X(*)C]UP]#G] M!_@J_%H,4BTP>\Z6KWVDB=]7,C:O#L$#//JS2].&+^6:\+."D^7/<.9#WF!Y M=,9PF*.,PTVG?F@*W>4H_9(8,R3^A _3")64W!I7_S763&$*SM M(6W'M1]$YO?^+(Z%;T8,S"YPNRYAB;"3G@-.?H1,BC__PH"/\;?\HX2I!YR/ MC#SF7L#2*\#PE,/0';!,&EG_YE"^;E"&VU) M[(9IZVR@X)=CI*J4U8K(DO&$06F2?V$\^ ]L*7*6 GXI?$3"F^B_)Y3-;!"'+'P12N(Q=?3_!ZM7FL_.3^)F(E0V?PX-6 M XY>\S$I=Z+364\@&DD2+F# AA'5(L3 D2'\$AR9T.0A I*:,L?*.&AT B<- M2Y_X'H9PYT(Y;V:_Z\WL=*#\4D+BC&W .V^.Z!>NL)H7>/ MU/LO4 :T1+(+5!6W2)3,&G"_WX"]/PLC[1GB<]&A8=MAEN-NS=^M6?CBF=MPYW09#NH^6>M=3#$>6SZ M"%*^YX-FN2.#]7;7@3^^Y.X/"+/["0O("PJG'!X62I=GN7GIG0;539X5GO9< MSNY]/'+D%CCR[" XLHD<6>L61J8Y:%-NIKK(4W-)4+9CRIDN$R:R'ORL>\^A$%EB_:$6\B-@[O M? \7%/BN"S^5_8!+&C9=!(!J%X^)3W->8V?V^I'GM\_S6W9 2^)Y[ "I-&K9 M 2Y'GC_R_*[]TW)XOEO#8&/[K'"F:=L\OPV X%U5]>YK(?JE*JR6I<7 @3CZ MQ L%2%&T;A'ZTH_0"] ;S>8ZY1_T. /['AA_H/EAP!_YD>.PA*+(?'Y=^8%U M/2PH(5]GSTLK'R^*<;N[8K,R[UFD)'PP/T*[9IE9'B+O8'%-^."B;!+MN,1P M.[L^L\9T%YO."[C+W]F?D[2-(VG+(NU[DTWDU')(E2UOWO;!W]UDH'5BK^(477/ B#XB0O0\^]:'G9I U MQU[:LW5LMDYZ%[)>]L6O)-X;(-ZS^#J[YZ,]XY)]6<=NN76=#-E&N+6)Y9=' M;CUR:Q%N72>WM1%N;>$(ISW@UOUW]QX)57S(B8Y0.?Z8@SJ)Y,9!&\COP:&< MD4TI=@[:)Q?=^>7%A[:G[Y-/-J#>U^*3L\+:_5#V]'WRR084ZUI\TBFL5W?N M]6]P2[ZP$0/:V5N+D!\&\[Z'(WVD]"'?\W I79)C,%UFA[5T6'Q6;ZQ3?K;S M+-$N>6=^Q+RY[Q'S0[OG9K:E==R6?=R6]KYORT8;M41[;NFRN$ &:O^:TO>H M(W[C+EQY#5[2$Q%;7L"7*U##WSVY:&?WH6AG,?([=5?5B\?O=3;\^Q(^=*)PR<-:/YI11S;>H1FU(39N' VH(QOOT(#:$!LW MWY'I5&+A#UH\2?OREFM^YE:UM8BG.2[#]FOJ]*'!.,DJ"UQP. M8$@69R>#@6([+Q?&7_^"_^+_+?\H_2UQ?:DG_J_34_/:8:[]R?QF/0'[]]D? M,?.&N#G-SO]K[\V_&T661.'?]5 M=][I@T7*YA8&-8N7_NN_B$Q ;)) + *9.3,]94F0D1F1L2_XIU#V(7 M3+;XH:4OX.<"+NM\XEZP/GZ6P&CP-AZMA68$D^8P&#R=&'!8S/#0OVMWOS]S M=V\+V/7$D.Z5V<_<%=PN=B97.AZ#T/,_]LM=WIW^NIG=GM]S=E+O[ M]8P[F5[=3B\O3B=W9Z?<^<75Y.KD8G+)W=[!!U_/KNYN:[;STM&5"Y$A2EJ\ MP%&4"< #)O\-*)I><1=7)].O9[@=[@,R\Z./==I6 F3$-K5:3D!6S)FJF[:Q MHFM55?NOG7PS=7CA\QX072Y9MZ<:;OZB)C:S7.>*"'_E2>:<-W#(13XV?J-@BGQ[Q='590;MNR6JBLTR;N:$UPE;S9SP.F&K M[G/"*\"CRY/P1=/#>Q\A'NU:GC^/P!;O''.744 L#(MSJ+U'LM3B>EF4RK02 M,ZH=3.9-#-1>SSDJTW2_%C3- M-S3=T'1BFA[4@J:%*M-TL)^FM*]!V;PBN7.?2 M;@BN>S#N==97:3;D5CURRZ6V80?DUCL8B[W1SLDM3Z]+!J#@) TBX=Q70!7] MUT<:]@S&YCB#F+9J@7)%09D;^A-5&UAJ(7S\N;E*^2Q4Q(8:9#3(:)!1=G)% MSO8;3>B6%3"]#2Q3,CEIL5 !5DQ5MG3.M.]-158D0R'A5)6&XG9LMH7;:*'2 M*>%4W313LFLQ9RI-K;/EE/J"6>WE49H^!-G_PQ0O\@M-TB\-J ML@=-^9O(3?BERN&7 M2,*5CDAO>1]D"369(TR.EW:+8*+R2^I,5'6M;BL:'A M2M!P 2K-]C3,=P[&_0USOQH*;BBX:-TI P7S8-CQB2V[G5!PG5PF:XI+&@NC M;%4E?=L^8.8;V_:M._9/#:)WXJ/(T*ZLSXN;.N8U'HCJD[&+G=E M>AC<%G>1OG%U:[.27U.@K?O_N)V4@4(FIDDL[*-\J4CWH%M9"C&SMOY)]7I_ MUY]!OY^I70A;ML6\-Y)!:$:>H9A$=CL >;%U^I6N$^A7J]_ 'D5AO'J+)<,7<=CUL&TV_GMK26,5ZBC3]>NJ$K6KUZZGEK2]- MA#0-8-)219Z G?J'BDFHK)5A,,?PC<(SSRK\NOTYEU*Z&@WZ^?92N- L27M0 MT/*@-V 50_ J^0L-Y^R@7T1!W2#6NI:Z.0QA\NS++[HNORBJ"G;F$IGLJV0. M:2P=&"8.DN\.10WMY4%[O4K17C]5=EYI**I(&8O3X$5[@!=A-0LE#/2DV28I M3V&IL8>_/"Y, ^3):'X 9MHN$@>;PHU*\%4_+2^ GS!58-IE7CO@/FR+%JG#X+P9U//ER19+5Y@@]$"A5$B>-5Z?ZE)JK2$E,J1@X[5:[+K@8 MHZ0QM@LUMILN<@TRJNU[#61MJLO*FH:6JDI+#3(JA(Q&*C?TTB"CILBH=K>W M<+JB*YS?&@.VR@9L3JX67Y'S): ?$#LQ#$E[($]8XYW,JDV5&MFX7QKJS,UV?'*F(=CRQJS?@-9V&K6#73!6FX/!U&> MZML 18[;.),3^3:'#0_IQK"77AMGQ"+I*\]$?3L*H)'1F(-+69&]246&W(K+ M1%8T]V7.9<00&260-L*!M]-_8;$] ($?PNW#%[LW$*^^/IO9!FOCAAUUX:V$ MT O+[N\1=X?/PI,M3<<'%F(9$U"-Z;9HKG@^TM[". MU;HV]#9WKAM6FU$2YU#/K[J*TMSD+K09I3W\#??MUB.K1^F9P!=OF_&W@J+; M'DD?M8 ZZ'NB1+KQ/B UOBC6HT?)0(UT:QQLS2\L ,01:'W.&A\WNJ M]+-'X#\NG&SU0TM?P,\%O)?.)ZXJV8YC08/)T8<"@2 MS@_]NW;W^S-W][: 74\,4+=G/W-7(#[8F5SI> Q"W__4)_D*41MVS6756 M]P:1?AS>$^2QG[D%/6P_O/T8>/%,_:?CP_:2F%8N[H<7-[+$9G-UPCO)N5GJ M+_?CW\[.SV\]+>UFG?YR;WP:MZZF=V>WW-V4N_OUC#N97MU.+R]. M)W=GI]SYQ=7DZN1B 1Q1@SS M["];L=ZN=!RS:7G$,T4;F Y'RJ:3/#MAT(VOQ/LSZ6D\#X*FFW@&V"P M9M#!P7B=TQL8.?U!N,M@YTA@(S[R@D\T\RDX9P$)ZADH*J:C8VI2 W>DSFU7N?C0*7$"Q8"F/T M\E*%+C(O)5T>160#NXG6OA?:JMB4C68F2IVP5<^9*-D'!>0;5[XP31#SW(?_ MLZK+C:\_=^4BVCMH[YX4IE+[O_-B("1S<76^(2;#U.T_^=&? M=(TJ;+=4M#(B\0(T'5^ ALE>[-DD\+UV+_E8\_5TM8-!! U]5YB^^UO1M]#) MD;[YGMCN]A//;MTM?6"+#2Z M\=/!IW+B$2%S<7,D(K](".!XKNN6IEO$5?-Z?[J?''"O3^IG54+L$.WPV^W! M^(98ABXYR5Z<)"-,-.?1]R+TY8?NRKJ;DL]%X5<$ZTNX)T4%4=?$F_C.T&6_ M_Y[?&Y\G#P:A==BGQ)P9R@)/UA\&$CI9\H;O'DEKZKJ'&6]'<.;$X.P%R\-3 M#,YA!:$9]E1BF9^Y#\I'=G8TQ99.Z;)T[IG2G4;SMAZ(1@Q)Y9X(H9E;3CHN MB!4 ^ZT-;_"]HN6]PB S M3(RL\889QV[^F:<\>W1^T,9GYWTXZ MF0>ABP;,DM;9*<)N39JAYL3@7AX5>,N3],;=8[HC=4^Y:9$L%7)E:*[B^8)E M7L5M89QJK7-R;]AXY &T!2*)>]Z_ 14UJEUKUD*I0LUG.54;+<$J;D+53%"JAO M76 R_7[WJ-/K#L+DQ'U8& KF[.N.U*!=(V@:OR]-WR @G4TWQFSB"A\C8>4@ M8Z"O(!(0>9!%.<3>PJNFVY9IP3^0K4C>"S ]AIVG;2H:,6EY001="+B.9XEX MD"QZR>:.1@JWVX$)+A=U0L.O9/U%\W@ P6^MU@L<(?Q% VX?:<:TK5(F1WD? M)ST _WZ0+!^:'7;E\1=VIY$CR/B[)297Z/*(RJ4NWTFDR3NBQ('EP@&%GF:L M!A].)^_RF _?%SMM'P$L4\K34$#+1P'FQQ!JS2-N DHDPX#ZUO8Q=N_.P*DJ MVLR@798YAO&$)N'6LM":CB6BO.Z3?^ P*+@"9SWU2S7K1-[ #,\(/\BJXB>;7&BR\ MU8E+N"W2PMR95LEW-O-_EQYB1 #JF:-LTO(K*"KBMG)2 D5CV.D? FD?\DOB M02#Q"04K3)@&%!8*(?[2;C&R1"V,<=X 7 O;0-9(J9;I5Z[N&^0D'M!AY=G1 M\&0&+SX%!Q827[")%N[@#:0267Y):;Y@G>T]:FKK[P6?Z5X@3^Q2\O[-!ESR M_>T)G&?$?33L1>E;QXJG+>D[!-A:"L=U5E)T@%@]2N88)5.X0X^V'HDJA_6; MHXCZ>$[VP,= MB!?;8J<;58!67-*P7L-=@&4PPV)):A'0HC(T%DP3<(#*2RS)=L$&<57(BL/Z*KX:AQQOTH_GJA+0N:NL6#:T74!HHWJ-2]DP1T" M:L)+'000(K!!2&O MQ)@IIN"\6(H%F;A.K(++JT!6U)U:D.SI77J]&VW4-HN_0D/.*\1A>2, M$)G*6*I,O )16NC!7U^:SO/!ZOI>*B*_=E8]-_0GUYDP-6XE#!XQG">'?\B*.:/=%"$ M#&J(OBZ(9L*EH,6_+NH<5KWAE'K;Q5L,O>JMD '9([P3=PK M@!@AN<\+@;G&1:Z)@?]>Y?:"K^-.5 "9/#J*2=[D%G *^,+LDK=0J5:B 7'G M$(1'-X^2[,>])PXITEL)D#Y,CW3O-DI>8H.+_K7>[Q7X%[%I[E%,WUPF>[#; M"%D?B.%' ;@/33+[+-O&"]@")M$"M'K!#NK,.2<*]QE=(@A4]V \1WN?=D** MF-=SD-'!.),LO;&;'L#./9G!TBY66 NDIR=0_)DZP5R[-+@"[$PE(2.N]0$/ M *2PHH;LC<''(V[*V,.H8Z$3(/ R4*!\(6&J1.$_@L3AMQ:7; @XC9NF@*S\ MGK H; /8V.&]GFC3^"XV0<$PE.L!T3D58UK6(]RF37=FM/V=.<& \W3N'/C4N,&M!*C1 M^])TOC7CS9O5%PJ'3G:/^*@IG5,'GHI:+H4[8 (W!4E"PG@DBV#2<"9:#A;S M'K1!F+,(*+4P4)0I.G7$8-"&]5?SN(@;H_1'K4-7,WB#'9FN!"\K_L+Y0O/' MA>:VQIH!A7-$%"_O@=U&DRQ_*[GZ""H7SFM1'K,[?T^ $[#+R. +,Q=XBD:H MX!"]6^TT@_.6^ G R#HCK;CJ62>[\9[YR?'I8(N@.4"#E@M"@RW#AAG+Q^+ MY0N=7@99BE+445']W."4L*AL2A;07\D"4&Y<@45,G;W"T#' 6R%R\VSGT$F& MY M!^;:>7NZUU7.,6Y^.S^^<6P;^B+?Q]^=ST-M]/R=9JIV/-%>..$P9* W3O+& M7*.F,=>R,=>@:'!6&@/ MA6Z[)T2C++Y42Y_RXW.1Y[]!ZM>Z=MX_G2\!<-9/O+'1P;C;$=N]N"!\)*7T M#%TMR[5:SF(< $%M3SA5=+2I+#'71#<8>GI,MS/QQ#RXEZ6KV<0$8Q'U#-"^O$MR*/AN M"=S:H%^X#YQ6.(K&Q7YR#^6+H=L+SC.?#6EE;,21+/KBD+F9 M9"$9-"+B\/8 @VQ'0Q/K7HK1TY83 \.XRHPF+[#Q%BAP@ \JSQ)-X SX&6FN M)@V]TD(P9:[0* /<%&_<)UWWB4BH>%%GZ%Q2#*=*#>Z/;C\\HLC"L1>P%O9/ M/VK=NMEEM%"4[[R/S*'L59K\>LEKKBK7'/2R$/!BH2HSI,261X(SW;1PB *5 M=S2LI7/_);3YD>A->F@SNL&THAD-3CD!+:KI+--L777'^9TOP!?,-3KB)IJS M'HW:\FV^/UJ.E6#IG)H)BI'!2#0(JP\.)Q#PXK\W^#@;)+$$%%^'_AWZ$ AM MBZ5&8L8R&P< W[=;<$74Z!K1]6/ZF2IAI0$VU1&ZODT19\","Q:AQ@Z[@ 9+ M3*+GU6(*@\(R-)W42%>BHI[%$5I+%ADSL)O,_Z7KI[@U)BP%+A#CW9"6VG), M+(= ?)ERFXP2OLX9.WWQ8,P/>^UA7#I3K(F6)(M)R)!UNTU:5K\+BF>_W>MM MMLVX#XA>+U'(P[+I[=9+'/(E)K3N"1"=1O,&?'6=@C>PPPI$Y)(F%07/J7*Q M\CY(#K%_U(U6"+*\4VJ=."DHWO5B]UOHL50,IIU_B\D[=6%K.6JZ>WC,G@-& M9C[2V*)WJ*SL&'D<,6AP>:88,_L)+:J9FTD6BU#&2BV#Q'/G-M-T6HP5)XG< MA>Y\RCE+SCTV';W>S68]05@235KJ8_RR$Y-@Z\D[1^M1,63*#=^H7B8Q MEQ/^BDZYN2=$RRJG6UY.L&?0 \OU">TD5T'0AI)5:/ MV*Z79E%(4SJJO[8S7:'9^'48IR) ?6LM^2RFS&+VOY?\OVQ5DM0AFS59/:V< M1R+3GO8C?&7AR\Q2Y=BWDB7'5%^G""9 MM9-E.*"__L(Y65?72':A!SR@;O5]IN+;)"N1F$B$Q4EQMKFVXKN&$#R$-V# MG2*CNPD92\I-+,#W3VJ?A:KF8T6XFZR.?JB6WYN!Q^@OK&?IY[3]CU?&ZS-T M72QRI_ BU\"-#3'C1Y?H,/(;4#X1VDID_YKABPB"7Z6*'Q--3!]T^*8;HW$$ M/$L?_79T>\1]F4RNFVGQ ?A:X:@0< 0& MQAXP9NR4X*7FA'N;A+ET*W66CI@A2V?W_N(!%E #J^W'R/=U1:_^^!-RT4/E M]?!1D64")\_^_R'. SC$BMZQT.[WW(D_T>+0[5RM(E]I5^M@M)85AKK@? MX,,5+PE.H=H.YV%G52%"2#H&JF0H@N8 MJ^BV5O5(6]E!:L-M6--UA:IZ<"/6JWK'V#UU33O#2(K4D#\8ZQK9I*?Z^EP5 MLX7XSISQFXB[J,+!V,3LKNE2(233/):.8+-N%UFRK)GEY1$X4EVO _ :*I+:\K -\F]/LU/(V1MM4 M^U3%F'YF!?.I6F349.C%X_$AOAO#(1,J>]UR#>&A2 /A@TZ,)1PS45=RN@>>Z K5NIRE0 M6Q:H#9L"M1K1>E.+5FXMVOIA\>L&O2_+HJ9SO\O@ANDNU*D?\1B8L=/?1:%3 MP3HJKRRN&RJ+N[@Z 6JX^/V,N[Z<7(6.MX(*QRI*J/38#.Q"+&F8"L=@YT=I MNQ'+^L)RH@ZTQN-"0W:"RBWS5W'7*H#F-O;"/]SHQ1$W<0+A^KR5O/ZB+(<; M-1RF\VVGEPV[Z&<#38Z/>H2"G=1<.\N)29K$>':L[M"4%SP\9AK1,Z6Y=!9+ M#495D,XX<,Z>#HZA.7:RBZHVMDQ39J#\M5OD::'J;P0)@7;8Q;Z33F24^EVB MW6P 5X.=LFNSP?9-L?W6@[;9L?%!/H9]P'8]_3KV4?N[+^O MSZYNS]KT&8T9[1 MG 7U^7-HPV7QACPGK<=27?B4H5AI@WWHT6XFS" M>ZX8^=A060E4UM\AE?593[QHS6)#9Q6AL_4IR0/';$H(U&&I:,TDG=>;80A9 M_C:V&ZIP%/0TYFNA%+K9FB^+<--!4EWI?/:*[:%LQ7S$N.AT?DKN+>2@E[J) MX8SI_$YZ3<9!!W'%P^D<'R5PTH9FL]#L>AX\S(<'%T\<:T^IH9!J<+5!);@: MUE)5EJT5:^)O5C.R-0>]HYE!\X K,.'!YMJ5-.F-A$4Y6;?O5;+C"[D*D.IJ M&5.LN+C2-:=E/Z# MADS?,YEFT6TRD2F?19TIFD;S](ED .H\V!:HE.AD_KM8>Q4*CV25M:$&&0TR M&F24'?PMCMG21FK.9$16GZ 8\B'MK<<"O[JDO4.J6^]W&^7C=VO80[GLH3!# MAMTIJAD&*DZ2J8@"F-O11O,-S52?9K)8%=EH1CP8#P;5H)F*&!&;$YG6)#&] M!ZI?*]*$3B/2ZH$HOD%451!5"3FRS+O"6%OJ/*Q1%R1)8E]_523)CFVHR1.V MX_I;FC.P@:*LS.=@E>(0L8;2MZ?T M+"D<=X:DF2HE]&4KWW-;F[%&H'?Z#:%=0;6'$]M 5+VY"5 --RU0C27133OEN8P]:\7;=+9$%WUB2Z+2-\MT8UP;F0U M:*XV]J]7K>($$7'@"-K SK LVKK-Z49.H< F:+[.T(T#-L9*%ALKN2J(JH0H M=N_81)/1RDD1'1IT,#>RTX04ZT@R601I%I+A#\;BL"(*?T4L8IKW&9Y9^!X% M5R7,83<+5TD?+A]TA.HH>0W)E"9",Y&,B RQ(9D:DDP>N?Y;D0RVIZZ=4[F8 M0L6L-;PWQ!OL3 <-D9EMT,0="LJA+\7'>@3@'QY#TX:;4N-DU3B%E1H7I@>< M ^I_1\Q?$6N9ZS Q36)=.OE=;U^)A&V^Y:EV@X1C ,J/<0@JRQ&[T+YI!H%] M_DUDUY/DO^ F' " M>ZF]\# $A)KRTU]?8V)?KW7IMMT8&@H9"V%]&I,(=7N MF11L9[#"/F](?&\D?Z0.-Y5RW@=[;OMJ\88AOT=JS;6Y02IJ'1R,>WSB[+:& M6AMJS;G'02IJ'1Z,^]W$\::*JS)5[-SD%NU^8$V;/KK:3IL"HI%PTOFJHVY: MC^Q%&Z=4EW,$HD38^G(V;7+>$ZT6T,TI#:WRM*F3V&EZCS746K*^LY)8-WN# M>1[4'V&T+3CK_(D__9-?/V1TY0O\DR<'/1"Z59RF?$7'0O>]L=!79W?7IV4UXGG@S.CH(=!J* M7$XX#9,6AJQFF,NEJ+9%Y."@TZ3TNN7K ]3<'V3QTCZ2UEQ75?T%%N?8-%:3 M6"9R:^N1#C &SKNP+2_8>X^ T9QAF8&&!@Z-ZG+ K5EV,2=9EJ'/ VU)UD,1ZQPYF2R8&JCZS=(%J6&0@?9(X+QR,N^W> M*'$1T2:"*G?P:4/5U:;J+*':+%0M8HA6Z&PS'[JAZH:J"YS3DX6JL72OW>LF MKA'>(55ODY1?825S'\I1FR$P#3(:9%0,&<48K]N#>$HT_0GLRK*\50W5-%>X M04:#C/H6@ZXOK!W^S*W_P6#3#_KI2G-I4DV,@Y"S32)C\(7E,6&:4Y(4IJ:8 MJLK%5 &GX<75>2I+]#L-KA%Y C=$>B!7-F;-3.>,@*:V95I &DY3BIEGJ79\ M!BKS/ =MU![:J/RPV^X.MYXHVU0&OD=B[E>/F/L'XWY?;'?YIHM*0\HI2'E0 M/5(>'(R[O-CF1]7N+K#3[M)K%3&1WZ"IB9U-JES*B:Q7T83RB%K7CFIQC7&2 M5QA62'5O8S/;_?.Z2?$=*/F)C7 M-_13$?H95(-^A [2SV 7W=GCXXAN4>@.ZSPCQ4[TN M$%7^S%V#EOG0TA?P;-&)_^6_-PZ MOIEGO]P;G\:MJ^G=V2U6%=_]>L:=3*]NIY<7IY.[LU/N_.)JJC#K;KSZE$?:%;0$N*I*IOG NGKP$YIR_]1-RC!-_=$Z)QQ(&?3<"* MJ6IW T$OC@^*DY@3RDDR][^VW;HG,\DVX3M[]NA?^U&"YS3XW^41M/MBSJ;BO@:%?G4@I(I5!3<5]W7"5E-Q7R=L M-8RX>$=T[:MGFW-ISJ4Z ?IUU=89CN7B>LI]EPP#3%*3ALHGP '9X&[OW%BB5VA.S0XJ[0JJHUL;Z^+%3'DR&4W>R1.0II4T?T; ]JGM7I=O MC[:JE2X9CPV!YD.@PW0$R@CF3X'_$S-^2B?8AD(KL+$D%+H^CTS(9QA7:4=0 MD4G8WS0PN5[@4A&#>W&%_2J!WF2EI.&#W4R%!N4*:A'8(,^W!\.*#+EM:"TE MK?';R5QA5S*W(;:RB6V]^!3S$9]5D9G5''U-1U-X8K:I1JER-0K?%>LCOGL' MX\&PW>\W%5<-C:>B\>YV:H.X([6A(?)W0^3KU94Z#V=ONGS5R[BJD1D_ !8) M&J[0[G83]Q%H;*L*T5K*)RC7T)Q6L2CP_&ZW082U_0'X0C*YV?#C[%?GXD]!1M:YPX5&\J?Q.VQX-Q M:$S&JJL<*+>8Z[JE8?##X:S]/]U/#KC7)_6S*N&9PFW[=ILGJ.1U1E U9O/O M--G7O$"6+,E? .#"X[M):^Y1S">TZ*6Z-4L)*JW2E,7<$%6RB'PM&=;;G2%I M)I-/YJEBSE3=M+>H=TGQ2G\A"S_L%E@JE.'$KVB5V"!8)79S=DF+]ZXG-W<7 M9[>Q6,F+27>'8:/+V5>$;V<;Q;QF<&@-&2D"A'ZZ66^).D9L"^^& MHK%VS8L5WBV-"16BL::@K&;8JE9!62UO?;5$2);\S8WC0G=R).54O SZ^:;I M7DIP<0&+ID6=,*Y*35X71#.)4^RB:$X["#CD!Z(10U+IKR7Y2=$4TS(D=/%] MY#[,^*8@INSPW,:Y4F[$I!<;,:$$,-%D1[<_8XCW#YP*S)D:"]U14S3P/L@L MW5 ^E\SZN9"9V*M>;4I%ZA=.%8/,+-TPG;YDW)S S^.8-)L.&V74[S""N"/> M&YKIIVL**C_$M)P+X.'RG!!SY6WP)SR(//#@X2X:MK[;Z/..&&H!M",FJ[B!6![DV]#DQ35K.O_;. MC/EAXMFI#8.M$+5LI[$.,U*+P.^B_WYU%=0+[9EH()C>X&&==H4,L$SJ;-#G MG FGV3#)W3')42S93Q<$Y9?V<$DDDVRTTWK=IJ*QCB2S%:<4.WF0C#BJ",G4 M1@.](@,.FLOF!R?8;)ELVDQ6#U>;_GM\;GQUL.LAT<.EB M$CYA> 04!C&X^D)U&V6UC@2U'0L62R"H?C7HJ2+J+"MAA_/4GTB;CK[],.LV MK'3]0BFFIR4F_?AN610]%Q0[?HJ.'6($MEIO%\K'>Z26]34[*:=5-\TWMC/$ MF#>7N)YP+6IBO!*H"S)?>GNDAY+Y7H&L&BG*S; M]RK9\2U:!4B%;/]$M7.LU-RZ6_>$Z>Y2"C3$6SKQ9I$ MN1,O9B"TQ=[6P^5+(-Z\1\EN52:6=6SL7M2VI9B$*S23<+U)N&*GF82;DJ + M)]YFM&TM.%&DRTE-!MXF;650RC#;BB!K?5GT-ETRW(KH[3ILU+)W34U;+MP7 MVW(!PVZ^NGC73P)?>A4.U\R?FJ[S @WG;?%>?^>%KMC+^3"/,7@X(T[7!<4# M*E QUC1A6,-M,M.+PWERH+N:3>M=K6SO>0%V/]P5H[IS?)N6##6EL8K-(6U: M,M0)6TU+AJ8EP[ZT9-@F22S4CG<=*]_%8-GRMMF<:0%GNKO&)OD+ MVHG\3&U9"H6EY3[G<<6)4 M0TV%4E-N<7.^+VR5IAS?9^>6,9IU9:3"-BU/:I\YM2]*P!XF(:YGS*,F3?7= M4\C.F&VX5I\L),7M*C719%H4PFRN9'E)W53\M^),=^MJ!#A>W:#QB\]P5D ; MJJ*1#+NX5*1[156([U%SI%C&OI3>,YY[8AD%\H\NB-;T5*>IM**84(S2^N4LJBA&;1G'I M8#]Y5,B<(Z]D1D>>72;(;)]-C4 ]$2VT6Y MN3*IKHRXU96)GR@Y94@T<50=&!?2VE*'<54Z@;T/DEGKG^AV]JO$?/<=ABB_ M8OV%HCRK:2ZT Y[5[:SL!G/+,'G-$+FN>6'#L6I),-VM"(;/3# 5L2-JHQ6Z M/K W##??SI1;,*EG,8S59:H4%!]C'32,=0>,-:9O&_:!5F3"_*..$76GWQ)5 M)<9T[F+VRK8 $&)34C0OM-GJFS1JE,7**(M\HRQNQ]'J%'+'?ZB4K@]E78/ MQN+6&8<[Z(,6:4?6JEGWADB_&-C CENRK)>CM"G+BGJISI'04[1">44^*\7W M%)E%&K2LL_*R=DJ*AV$""+?H?"\PY=B5Q\S7,&#AB^ G^T 7MV@/MYR)=7U' MHV5?D%7]B58T!1&=MD9;OT XV-!M*7/?$C&G_B="R1WKDB'CK#IOUBHG+1:&_DQD M^GM%FQDX\PK=1/CW;$4&V =\H]#Y^:MQQ/TJ_7C2-7<)^@7_\\JP23.=%)4,ZC)] [&,6,UO.)_[@,] MM%< PB*PP_^JXJ8BZED?C(AH_W)O4Q^YA6I3994FW# 4I XI%=, MFG;0_OOD;HEG@UB&CF][QK.@,QC.R;UA(])Y1HQ'W-E\3F:,A#0@XH5%&^ZX MWZH!/D-#L8Q\UJW)K^=;"I"?L-$Y >4Q8:] 9V00PN8 M'H@>#;X ,DB O^$66Z4^SV-<)!EV1@?C;I[H*0#F\.'W07'C8Z:J+4]_*?E\ M,LRG+JZQFF+LJ'S,*%[14EA1RY:\Q2F6W:R*I5BX8MG-2;$4ZZM8)M$C\]2] MA#1J8[R6."Q-2YR"($7)*_3]HO>+H=L+RGBO;0,DL;10+$EM QN>,:',Z2\: MB-W[-_B(K25?S)&3'@Q",%;?YA:V8=KX&?SF MY5&9/0:6!T)150X%OB*3Y1MF(-.)\:Q@ T]'367@ ]^$E5RY/RM$_YPKL# MQZT8J^X6JO7XIRR](3+B]'50R$&QQRT"QA25&9"J;B).G4=O Z>N@!KD>"^ %[,QI$ M_\G=^@.^$?D@OM)D=\C9N8,"-H5>TPC;%6UKC!^#X6[,%),RPA?) /W$ M;\ M\DAHE@>@'"0.-V-U#(:TLN;0,'W+\6X;NRM@2M'1:5&6R+,%13L"] 8=&IL M4U:,:S_!3;]GEU#1Z,ZD.?S!K>LK3LG!1P&8-/ 9;O0;D8P ]K^Y*U_3A8$$ ME*<06L$*%L,=MSE\D3/H,:S)X'D2A5(V%GF_'=L0#R-G#RWC9#M;(+8+"KX\8/+>41T#GFYFBY=!?9YLB2:B4LT 7*B.ACH5R;W CJ>_S;Y[IBWD*(]@^7QY-P2[EPW M+$I?7ND _D%?-&, @,(J'W'+8 9PIAC%-4YOO?J-N]0?X.HI,Y.[O#QI+]76 MZ#7D9,>M%))G$=WUA0X/M8$EF/!K'.:RO$M@,]&KX6@KWVXG #D]5K>I-"(/P 8X/9INDN+ID=D8="/0(DG3#120X$?)3?1LUK?P?DVF^W]F$_HX(HB MYCBM:/2:;KB2V Q76@Y7XIOA2D5/)RIU"D\S2ZF9I53)64IY;S#EN*2M)QT5 MGPW0R\EIVZVOT[9ZV0!B =D O%B:H_WTELO* T6+-Z:@U4Q:N'KS!2N(S^PLN$4*X$E\E'-VD MH1[M-$HTG5N2U',P.ACWHE$QSW7@' 6UA;VE..*LY4Z*8J91P')<;REF20>@ M?2 O);B SE;=G2@V@^C]>Y+6]&+P0+,2P.FXT;Q)V".A WE%,COI4>] M%X=^!"/L&/T>_LCS!%U:#Y1.C]^6/W%J 2=@N &1O"I/]M/9TT+5WPBYM>_- MF:%0-^6-9)&$E#+@5U.*DV" <1#G5A!G,2>FX40PY(AKU>>]HQ8M8L#"F,=D M82BJ>^Y=_-Z-:H!Q33U3ZREL:T^$>TS7#LBN.R*1:WR L8!U@7'TX#L!FG1> M\G+V$[DMHL\#%>4>@";17;-W"OXFH-.5]^8 ="^VQYL'-*8JF0OB9"IER'C(GM]03KI" M+VNZ0K=PS;>?D^;;JZ_F6W:Z0C=[NL*H'"UV8E+?)U4LZ/*#D/+AA&KD33IG M=WO%XZNBZ89BO;DD.7W1B&$^*HNE/GK\!K3I;S&T09?H PZBQ5R>UOFL4]<[ M+1&BTL-SE'\[NL64#/^$TG P=AFH709%,4L2[OAG_^_^M\G-W-C2O9MGZ3G$ M45$A5'C1D*_[,: A" L+79TKJ!@KDNJ%KCZXWS;]Q6296*)[H1VA'1/>B4]."4;)Z'K^[7(?\!5.!JSW M15RP9)D;&TUP\8,1R&\!3$A,E0WHB0$(G"B];\\T-AF?^;))//>RI(5:P'PO M3!/$ )],-@]PQMX&A<)_-D!R1*&9OHD31-9ON(P\R\$0S(0U>1;,5%Q+.]M' M9\/A3TK ;O@S'/N<:MR5_LR44C4%#/X%YTX\>2@D-LDQ&!A.$21#BLZ3<-)0RHN@8CY8"@ M7]SK_J#JDE^N,4 "T=4 $UEIDB0Q1+;Q7631Z8>8N;PNVVJS(5*Z'3+DXQ)2 M?&8(HQ]X:R8K9-=V26:=?9"3[M]O=/^D&G4OI>Z?V\*G+*MO6?D3SCUF V^< MQ+V0BGLOJ939+OTJ[;32G^]EJ8*Y(4YBH1DTH4_)_>K&. &6@*ZQ& =BD(_1 M=#M)8SV8XH\@];:WT7KRV[:([8$VL6_8-NQ[TT:V43/RVPCV-ABM LX@P0^#J%6QT0)+5G,278&#H"I"GS//, MJQ0AP@P>_W3=KP-,KK>^1#,0U]CL_^]O';7)L(5^;#^ZP!:"Y0UN@AP?CJ!LU_VC/#F1H MH4U6*KR8$:G-IE0 MR).QHU%L _PE#UWN]0@^Q+HW=BRX&:H2P!Y^DS3LF]&&LZ2I'[FRK4!2?FTX M6(JT_FZ3UK],ZQ>:M/X8]V;^67A#,$2%$BN:Q;Z44?QH* P/JI?&[]4I#-TZ!>[+V?3+S>3ZUXL3 MP._%U?GTYNOD[F)Z%4)P#OTZRU# JP8C'/@&FEN=?T:-XW-#?SI[A9NO2>H) M@*/#6\R)91G*O0V6PYU^#C(#@#U!_0:[1QV_?2'Z@R$M'I79!.1*U)[@-Q!Z M<2 $E+A1QQL=:+8P%"MYKT35]<%[!<9I)9P!'ZI/KB>%;G33%H?VE&;D2GLP M9#Q-'6N99K-L6EM0\VCZHA>"*5^XIBH7TP<7#@L__>"[!^GDON%W:WA"-4B&[0U[ ;TFC.WSE_ MH3G_G9X_W[#&RI!&I63JM]M3"B'-%V$.2+.AE7+&[\4PBSQG?Q2^D>94*-=6L$777ORIS)FDO _E3>IR%ER]%.I,XFRE)OX'! G M\%9C/OM;J=Z9)C7G/CL*L.9 M;>@+4N(0[WT:(9OC_GB_>&[T7J'/1PNW]!E+%UFJU(IB"Y[V,PE M\93NABKWC2H'VV1#%DZ5F*K?J0A5%NO!J*LCXF'USSJCCO[/29Y MO1Z9HZU=%P%NJ@%LK:@!_!3CQ\Q4N!>>'EZ8^C_UJL0XH<<:!*]M;K!,35MV6J"3K/!A[Y78;_CZXOHLV+M.XDPRLPT%*T*7$[)\DQQI]9[; MWT+18).6S3KY.?-_= .VP!I;87&?V\E.,7&-&:$-7>* U><;FCL. @W%#_NI M1,R)*IGF=/Z=S4:;&C&PV^[V8]K#3;$9%)X^;6%M_LP:P5P;Y/#*PT^[%-5AW]TWOF]?J!9N8FW,'?MB2>W]@*ZQU M'5R9K3;?+7GSV.8'=C\0VT*,]1G&^OJ)9'1*%OZ"=@9Z=FGC>!5MQ)]E.^8P MMSO+7LEGV3T8#]JC4;?-#S>SBD1'R7I71#@\+;0F_K)C3A@Q@1(8:>#-]UR> M6F@BI==S-KH&G>N6:B#J8.L6@Q,7/O\(SG@>'3()AAVQSZ5X6(]HHRC4ZJ .!=CQ)K'DNDU=Z?- M.JKG^JZQU=_Z8.W6=9<1LT=#;;B/*)4V=RHW<$$>M5R.Z6#_#77L9OQW0AX46)I>[*BQU8HV]:8/L#5IG2CMG^ZV3R>O,]4V ML?-Y&$C7"-H@"JX=MNY!3\7S\CB\94'"N*!P,\E\]"V(+9V33<$.A#:Z&69@ MGP $$2&\MC7^L#,$V^%HW4@FIGFPS;GJA[_1#5AI3J=S6\'=Q#;8#=%JL+%N%T62<6M,F#))YW94CEL(;=R@T8^T)?Z\WB3(DE1QP69E*!:Y1%7@ M A01[4$!VL7@H&5^!YL 3FTZ=UL.W^FW$K:V.';F/'R#1V-Y"+&-( _A-_"0 MU9>_V#C>CGJN]9J>:\N>:V+3;LV+[J269V$[5G.HBNXPMH*5OH"6*45N+0X\^"%<4R\H_$:*2!4[@<-P?\B[4R998HQQK1!9> 95F0 8=( MWY-'29T?U1HC&XAJQQKS^BQFIC27G)ZF)RZ5S+\J/O'28K^$M;=%3;YPG8+-\-D9R\VZ7'?7 M'5#!5'W\]CE%&NI]M/0$3#^+'"(_@G=J^HLA+?*$[Y/YB<+TN_)#X7Z5?CSI M6O50NIG,2[]64:SD>[]B4(4HHG T:-K%>C$863$N=VW*<)Z-W4O.!WXOX*YU M..1LQ/&=7NGGOQ#TEC Y1Y]>U6+-N5F+''/V MZ>ZBWI/()NM'X_1_HEXI63$7JO2&,DDCK-[CD4AP]&..H[V#'Q493"OWK]6# M6)DCE?WZ$'/U#CO1 .="-\%29&[;$]M@@]6#(9U74_FL*:I3)O!IC PZ_=I\ M>.TS,)BMMZ\$3%[Y@B8M4^-Y\^JIEQ;"2T\Q52S5FAMWW(TN*T83%,%"W5*X+[HNORB MJ D@V@9Y?(155@$H(9!^1#GH=$%P4+KV<*'-]">B K8V+IZ:;'BQC(4#6=!" M#!01/GHF&1I 8,+5I'JR[X6#P28V;_);A0ZP&,<-P, M YBQE(FN%WK 8SPY@P #F/*'E(!>'%U'@-BA'5_IWUZB3P!4QSCCD[:JP,I M*PKPC3"+IKB.>7[8[0Z[,>"FP'<\M!$FGQW:+B_RHQCJ3'%YXF&-,/_LL/;[ M8I>/J=E8#^LP1CV," $JJQ]U%<,O3$HE8*KKU^5CKH008?17Q&(L[3()2]N\ MJ!BS:$0;SGO1N)U&=6$\8E:KPP;WPOU6=)GJ1NSC<]T ^I9F9&LS)V/T12% M"$,O%:*X,XIP\'40@;5)OTF"L"U.)\*L2X(E[EPB7'GB94>9=_I$9O5FF)"K M@![I9$-2#G(LF43&="NB8<&:HX1/%[0^[08CMF#\$@>G;$,W9*8_:/2-.5R% MN*.-L.WZ;"<..Q'.GG@[]^'M;-Q"0LLQ/5+$B BH_"YB+$\Q(D^V$F2;5A[% MK%RT4!%BC#T5P!NGA\2N1AVW :? Q@ MO0H %GMB_0!@*P3)A5/T-YV[-;=,!_RVT+4+O#< NWVO*K/I?$[P,< U&,/. M4R>ZFS9;R5LG!H^MY(ZLSLA]ERWDAMY0Q9W9MV(+#C1M6=, MQ-*UZ9P2 )M3S3X&:X7/@;_%'%$WPLY+ "3V1"+B<3O- MQ,7S8($QGLWN<-= Q3A#NA&^7 0UQFASO:@*KJKZ3'*]01'CYXR5E6:^DS$T MVHMPWAW"$F&^[MQ7&JV=O=TM^TNY,9-OFN%$4;*C*H9P>Q$&6RY(<=038:+K M8B;GM'1)Q=*E[-#$X2S"6$N#)NYL(AP7U :0=']3TIW.SUDO#>V!ZJ$33<:Y MYJA7Y,%CXN").'202$RD$F).M:!%,IVC-"[D8D5TX]V $6&X#!_D$BL":1.- MZ?R;R6C%C[A"KG8_PH5+@R;F;/K12*BG*-#QV,6DD,2=2X0+[PR2"/.]H+TY M3$>)4])>S_7VBG-KG3G3K8:VPCE024]%,'H8G8R^93!;#9083-E@))W)E$5-L()&&-L@A6 M-XCHM&ZW(91_-"W'RV],J"MM T6$X?JA<,5 K,LU?Y8RB/#=6X1$&ZYEF^6!$^716@GPPB/K2+@$F#\ M!I%= 4 M%393 [4J*C\=A3B'7-8(,*-= 1-S,J-. )CX+(HE-+' %L/#1GPE M((L[,R'6WHV+-P>"A/BIX[NG!2>%.(U&8E6 B\/IND2_! '3]*>Q+H\O\X)Q M.PPF6, 18Z,R@Q*K=B$J^M9MZXZ6+I:%H4,Y;<_H"^#F65!047DM=ELZ2PV'$ MGL:ZFL2M"O-<(&+':\42140+7T&4#EG/CDK/!)Z CB?U+:F\QF +GLV_G*R?>&KY/(I)V>*CA9BEP!);?1E-NV/'?DY0-*L4 MV6!-7NH@?N^D5R?@=DPT,E?R<&;$B3P^(DY*!BJ.@/B(?'$MHGR@V@)W$8E3 M)D2QB(M(G6(@BN=H8NQ=BT@A=V@'^DCHU Y?Y1WZ\P_&UT*_)_X1QWBV.9.( MM%A>=LS!\ =P"["7^&CE9%RRAYNY1%.UZ;#3_+7L:%VDEXSC1O63IY9M T"T M]M''=UGU?:&HB)9 %K=^[/ZCJ%E<#7K6;A/1JLK< MVTUD[3<1+9G,O>%$UHX3T7K(W%M.;"S CRFGX:/5DA/-4F2$!1C5,IF$M78! M39&.9'\"B\>12N%M1/PFZYH);2R/C3W*:$U-E4".\TF($:%6(9!C&]U$)%F) M *=7&L2H,XNU5<,LU")T-3$FQ;$0%8GOQYE-T5K*6WNQ4),D?6VU7$Q.#<&Y M3\XN8<_,^94LXVL3"''NRF@EI-,=U?3'0W,X[MC%@['8PD(CVX*W)E/1H0LC ML\[(]V-;407#K9Y.>Z>?>-.QLOD-/+S+1 &#B&@R[NQNX#P@5O1V#I^9P;5&!^/S& =$\G7.@)E:;R>PDB&I M.,#H]5_D+;!&OW,P[G0Z_'#8ZRX':_N*%+^-[I+F+J MMD'7H'^I]!:8C\J"#H.&QJQ70P@-];Z5!="4^N 6>[F'H/3&*>6(8 M_',4@(Y/"QWO.[#EB?'+(^.79\8O#XWO+?_)-A@ 0PB"L0F&0?0-8N -FUXP MC+Z@F^H%HR6Q=*+OZJ7:CN"CO.4Y"LMS%+K1)?IAQ&U:9(D 84EA8C>.Q#J! ME09I5QHL5UI2IK \,;$3LZ@XI%\MH13[<: )]*O8BR$&H!ZF)6R1CX.J3]=; M;D,<15$Q2GE HH^_^!C,\F)U^>@B?&H^L@%J7@R]<,/KND+AT(8.CL@/$@1,(DY4G#._JFE_)F,@RB&R3F,X_<([=Y%4Q#\;XFV-G"")H M:Q80%WL1@RKR_K$#UZ<08/N":*&.B%[F]3EA_Q-5,DVW)0O%,^M5&TA_7*:8 MN/;Y!LQS>XY[<9]Q[X94[W1WW'F0&MXY[KL[P7WJHU,TFO48[ M,Q!R/X-^/B&>R%Y6#(ONF)U#1V/3/K$ M)+=NE#4Y"AL?M^CDSBU&[P!O*]K3E68E%(I 'DWB?<;>#6&5!VXH;F^N'L^7 MCKF*'8"PYZ2[(X%11?V %_<G?/D;Y+V51)A/?V'.&[-P'X_,5P M?\^1MFO67"SV!GN.O8KH_P5@;E@K_;^ QCM.>E60?^OB&M5V',%8D>0?D>G7?!T0O-&13VW0NU:]9<*/;$??D#+1165"&*7#<^BA//!<.[>, M:5B?;[#9$\,J_OE5T90G^ZD\3!;+LFKK:[DV=-BK]7:MPA%,-!EES@+?=_P6 MO8:L PHQO!_MB:I0.W]+Q@M5&(&N^O$\CT_V:B_ _\[RI'ZN_5UGM3&E!2V,26%?$W);OU<+0%23\H@ @_E M<6[ENUHR,HC1H=#)DT'4S@?A:_JN6.12><:11<%1OL=O7Z5_ZP;M,N%K+W%L M2)I@XM@*ZP)^?"76!?P/Y:$+U-;>KPF2Q4-!V$+A6SZ4!Y)K M4))3R7.K@24=CN7RAV(G[;D%'LKAW'JU,\ S^IKWUI?4JUVI2Q6BM97$9.WR M*Q!U./S5P,Z[/K'^&YG/368:_:JK.&]G5QIW[GW^:NN7J(DR5HF+6%L'1G(D M[RP_O@I:8^\=>#EVDSH3P%0>_+9V'HXJ:C>5N'.U*H!"9KF[IPH3T3 MT\(77)BF38S)?*ZHBA3BH-^)BF/:X+,9G16[-[IK;>M-*H^W//S&>6NQ_?)= M/-72'?JU3#ZH .'4(/D@W(.DESII(_10'N=6OF\@RX4+'4 >%ZY\NSG+ ?"' MG4'.$Q#*MRNSW1QZ!.F[=P;.+8^;4SLKSZM881-CG DQ4^,&IY '$P*=[W;6 MCVN8.MP4>B@/!-?.^$LP&VBKVO1BC(40QO)@9;4U\BIX)8O%5 U"X,$#$/+5 M\P>UBV6[=/B[9"@X_/H&>$PHBQPGQ!-Y^DP,#>GW7-$D;:9H#_C36WUN>-_0 MZ<>W+]("O]DA_\D;J74SW@2:!)[2> L]E,:*IM@'6VO2C*@!IY5OA M%3N \JW4K+(S< 2)FR_['\I#=M;65JPV4\Y;=M8V_O>52":80S0 J"WLF*K; M\"^N#65&?M=5R5)4V.7>-'\8UL[6+;&53%W))/^K/MR+I/""6LDT9.*12>TR MSK?'X=DK,6:*22@N]\0:'M;6:5%'_!5P_VKKS4B/O]M'R4B&O/I2_ M!\\/?[QIWT[MER\#8S3XE_#O;W=OICIXGOW=47^S/EFWY+>_!^*/5WYV:77^ MY_QCOC)Y\F5V=_VWI/E&7CT^77XTO] M:72NWMS^2[SZUX^WLWM=^_W[E]ZOUZ=__.,+KWX7CY___?LC__CEIGMGGGU_ MU;__83[_VQ9'#]_^^NV+/50?_V'\)GZR?GSZ].-__CA;",^_WP]/A)/?Q7/M M\;\?_OCKV\/@;^'A[;C?^;>B_>.O;_SM/V8#X1_S/ZRSFZ_??WR2OU_^-3F] M7QA?5/-L-KUZF_:^DK/GKR]__9A>S+]VWBX6?]Q=B,^*(D]FSY]>_OG/_\>= MW-X<'HYW*C!O%//'N4'(!5"+04PK67RW+J*S=B[#2HO."M%* 2RR=G[+2@O1 MO::54>W\H]LC\E0Q:9U+ @361"J,:N>VK"_V"KA[[\J;N" SB\AWQ-C$T^MR M]VKG2ZRT1K9K BG@>M?.65EI-6P/":1V[M#-V*.%Q<[7]*OO!).NB3QY)H;T M0$YTTYK.DPVV*TR-+D 8[(7?LG1A4 MJ*>#BUZZZJQ*2X;U22^U VI3(C -0"NZ09G';_YO M0F M*P_V#ON58\EYGAVP1[7S#=:-F/S48_PJ_7B"CS3Y\F*RHQR,O"F([Z#+L*&A MDFC(!\"E)>\-#?&UI:&JI,0>8UYL,)^7=&A831*"Z]:. MX-!\OE,L1.F%)BO/BFQ+:C:9OW/%=>_,L"JV!>([O?*)?4].KE\[-K'LYCG3 MG\B=]#JQK4?=4 )7X\(T)*(J\.VE]++QANR[+!CL)Y*__8OAM[2X5S6Q.ZPM M=H]M4]&(:4YF?]F*J83%;2+QMN_8'=50M F'_""U:/,_E,?)\3MPR&4^N=XV MO9]Z^?9^XOD=N*$RGUS_D.^G/CG_0[F<7'T=/-7UN592<>;KZ]!);NCN1O16 M!L7U)JNIT'L)T@12PT9&P[PC?@1LA+X07TE]X;[RRE:&P^KI; M:D%ANV5JA?9GYOGZ>G$:WI $O_7UXU0-OP5?Q#JX9(H] J&^R4YUF<20=U=2 M7JAO[_505JNY(LVP!EUR$FW^HW1+:I M2_5.G\@R#6M*ZK6DR!=:XK2X?:>]^KK:\AT,U9A9*TFDOKZR0@317KG*JLF4 MZNMA*T$8-?17./W5V -8A^C /@G''?@@]]19'$[[2\\*Q/Q9@5A?!^LFVVPB M/RNF;A1EEE6:O*HB:<3]]06_,_(J5LR(^^M&?L]TDGML2=R!XSKC5?&GF^=R M!/7SIJXIN,2OCG7)D*?S4\4@,TLWS)-'23&>I$19H;NW'?*^-2+>&KZ;*\G4 MUPE:&YSEW'6*%^OKE:P'SO+O%,:+]?7K3>"ULJ+:EO),;LG,-A1+(>;9ZTRU M92*?&_H3CA:V+>I?GL[/)$-3M ?SFABT(G6CRQ M;I$QLW^46A4=H%M?]VQ#J>]* >C6UT'<4.K[DO[US:TNGE*GUB-)&@K9:@M5 MI]+*2/[Z11$:*GU_4K^^@8N&2M^/Q*]?J*; B&PAW&BX!3?"AW)M5]:M7WBG M?G@6>JGQ//(11RYXWD%D9$].K@X="T(GQW?@?U-K.IU#(=>&?KW:-9$$2T;< MPI*!A_*5OKTZ-I'L;4%S\)"0[\G5UZ>6H+7@KGO65\72[]77'U4#+%?%4N[5 MSY^#"NCT12.&^:@L?#B]G2FW"\F8?;O=HW2^7GT]&>G'A2@:[:#O&]6SNRHK M\5 0MM!1E@_EJ]^CD'ZB5FP59->9'I0_G6L_7JFS2Y M%LMQ/]IAE7PU<%W?G,/8+@W+IB$6,8AI)>P)TE!:X936KV_"8$VF.51%2^C7 M-^&NRK>Z6-NMOZ=^LNH@K8!:K/Z>NKVJ)#\KPU7KY_RJ':ZKXNCLU\^1AHY. MKR;V"]$?#&GQJ,S<0/Q,MS7+>/O\[?:]^D[Z]7./51:GE;FG]?.'51:G54ET MZ]?/^[4!I_CUF6WHBUWUZ*X,"ZZ?LZOJJ*T*)Q[4S[M4==16A2$/ZNM.2I!< M?FTHSW!"UZHTHX101(X[MD\C?]GP]K-G^,_=VR+D+0_]H#R"\[E'NDANR_3. M/-PC@_KZM';;%_]=$DM]?6F;NC/>PE$0C8**IGVLO'9LY;MA,SA13/\=A]5$6L'1"2$MFZ80>RL72 MJ9\[L<)EM,7&RP?U2MG!_D56^^QM(4!^K "K20FH0.')^\LI^((5EZ2(=+#%, _:$71A8[ M)9K^!)8 ^W;%@FO/-G;)T&O]Z/;VO>'L%O#V-9C&KV-WO_:EQ#8VHOKLV\T6 MJ%94<^.;+RYOD[SYD_+Z&4Y:MXT9,=F?CT22J?2&G\(!CMW_WNORVQ@^>[2> MU/'_#U!+ P04 " #W1H%8IO[CD><& "6) &P &5A,#(P,C(X,# Q M97@Q,BTQ7VIE9F9S+FAT;>U:WV\:.1!^1^)_L)!:)=+F!VG3AY BD81><\JU M48I.ZJ/9]8(OWC6UO1#NK[]O[%T@0!J2)M=*31X"ZQU[9G:^^69L]OAC[Z^+ M=KUV_+';.<,GH[_CWGGOHML^W@N?N+M7WCX^^7SVE7WI?;WHOF^D.G='K+D_ M10&(O9%&)DV,!%3+Q\ZK\4R;@8R/V(DNM]B3MRX':[D M $-&#H:NT3X^:7=OAK(O'6L>[#:/]TY@]N62PL5YLVN>3=<_ MA74RG3;:YQ'[6UY+]I%?9QHKG ZE2%GW1L2%DV/!/J>IC(6)8)VA&?6:&W)W M]-QF+<6VUSFYZ++3[L7%9>?L[/S3'^\;^PU__>6R',K\]08D4L&[N@@3.V@M3 MU@>.#3GB8\18BHE(F!M*RSIY7G#%KL1(&\=TSCYHD[&#_9T/3*?L3Y&F]K6Q MWPK=JM=.#,\3RRYE=$0?2TE\)[ZU&M/JC?.F('FT7LA%O$"4') MINPZUQ,EDH&(0N!,B%BBX7RN'8OQ1+C,&<^GK,B=*42]9AUW(@-)4"PY/ =; M2$0[Y3&&#-,9&-EIYN56!'(1"VNYF9)(QJ\%% LV6]-B+($UT*F(YDD'"<32 MQ$4&L1S384HB3+TV&8(+;%AEW0C"Q))"TH\L=;\U M)-]N!LG>/'IEH;(!<57_072B0T^R9;=]:,\9-Z!'PA P(?M*4+29 '+[2MHA M32&Y#(1*I$K7B;2QTK8PPE.MT"?(MO;X3R,V$Q@&C[$GH_%B,J[S$O0-=H M S:;0W6V+X"K4I4OW4P7!DK!@6-I/:]"2N1^'>KKYXR\R.I&*.Z!6I;N$FQ1 MO1;XGFY)<#,LL5K)A#OO6M_*1'(CR7X9^@M?9G):I[!4\GUJ6]\?>!;65L < M!\ZG22-.42P4I](!I[P)\]8!,WPC0EN2>0N%;WU!DB!X+""2%T+_*:G0?TPJ M;,R9P-XL)1XX=?/$0#*-94)[+&YUSJFP<(MEDFY* M7<@ZO92?'KX>F"&U;HDN]-*^@-V4'HT*,T)F6-\VQ;$VB;? =]4#D:,;4@H; M<]P2(TH]DL&F(20!4E2.4$->TN"GI$&\61ITQUP5GC<)(=BGHQN68\36+C>U ML[9H7@+JM;MJ0+AQ" \"!K5H]1?0_@S0)AMR=T#$*K*H$RU[6']G!;S4.6Q,U]27Z#@N#(%G MM0VX!2LP=#@"*RWQDX?2RJH1W.^(O[,M'6(,1W=+U 7$=_FKM@ MVZ=8,V('^P=OGTSE=])A$?[+Z?%@I0M(;Z&6&6S/=V*M%!]9^%9]:_@W)[Z? M"(WR[8I58+]]%5Y'V+&@F6!6HWTRKTJ32B"H?3Q2/KUES]Q"^^ .OFF*&0NKWB]\I[V_@G%WO*3PZQFZ M=1G.7T R*]9N;V+NC(.>/GOWZ+VB\*(1O8_T'U!+ P04 " #W1H%8NU63 M";<& .) &P &5A,#(P,C(X,# Q97@Q,BTR7VIE9F9S+FAT;>U:36_; M.!"]&_!_( QLD0#*9YL>DC2 '3O;++)MD/K2O=$297-#D2I)V?'^^GU#2;:3 M.*W3UFVQZQQBBYKA##5OW@QIG;[M_WEUUFR]-ZW4:'_,#O9SS_HR$XZ]$Q-V8S*NHW(@8A^$E6D+ MBE"]?J[>"=WN))##%DY'/G6V6GGK'S?]RXO+\W;_\OV[_\CR_BZ9-781"9^ M1//M_X;H]&]J,V-Z(#%7M>^8Y8G%T *ZM5HUW?[NX9'4]Q642)%1![O(^^[9 M@LKRT+$1'PMFQ5B*B4B8'TG'VEH7"-J-R(WUS&AV86S&#O=W+IA)V1\B3=T+ MZSX5YJ39Z%BN$\>N?+)[$BP2S?1OB'7H:7^?\/ZO(WFX6B0[W"%^"%8V9;?: M3)1(AB(J VK+2"8&B]?&LQA/A$O-N)ZR0GM;B&;#>>Y%!OJ@&'.L'#Q"J9OR M&$.6F0SD[ T+(B!^A"6Z7,3!0YHXAV\F MP4(1%3R6P73Q06R NA:@OOQ&H J6S@K&// 14 IQW 8TY@)2IR E[B4FDCI6 M18)) :^%,$> IK1JRG* @X!-B%=JCMP*,^Z!;61'(FGBB"0*!0' U0!2P9QK M-LBCF+L12Y69N!F839931G$:*=V&C]$"'EWMRB-?-Y!<"R1?K0;)_CQZ56%S M)>+J?H5HQI0]S);;#J&]9-R"-@E#P(0<*$'19@+('2CI1J1"-RF/N)X M@^)O17'K["%BOPCR+;Z]$LJ[PF$ T0ZE]5 MJ5#2F2DLC((#Q](%7H64T&$>V@?,&7F1U:U0/ "U*ND5V*)FH^1[NB7!S?#$ M&243[L/2!DXFDEM)_LNR[PAE1M,\A:-6(*2V"WU#8&'C!-SQX'Q2RCE%L5"< M2@<6%5R8MQ30" T*;6'FK16^#01)@N Q@4@VA/Y34F'P-:FP,F<">[.4>*;J MZHF!9!K+A/9DW!G-J;!PAURA'AF#0VX)^@0_NE22#Z22?DI=R#*[E)\!O@&8 M96K=$UWHL4,!NZM6E!VL+9J7@&;CJ1I0 M7BYO= /DH0@&)\1#>& *_[3]%A<2TEB4#P(.G=#L M&]#^#- F*W)WB8C'R*).M.IAPYU'X*7.866ZIK[$Q'%A"3R/VX![L )#ET=F ME2=!><3=K+%!)\$#ND52UI#@=<7O4Z;DK5#5T,Z;!_@;J(^%9O91ZTU3/?.#IK;ZRK&P>P*XV0 M7":]%^*IRC PZ$SH9B+A6IAB"TA'OCCB>7Q2;U^GD?A42'A.*T@+'8>#E>W- M_O%7WC^V%9I%#$E@E2-N='@02P%@535_MHV;"'Y+1;QL'@.(RL8W'"37!VG/ MPFNYZ:(SE^7$R1,H.C'CS>7\7_?*4 !&T=)&92/A$$%79 B6_$>$M51,OO3 M<4.JO_K^KHU6(+4@K@BX$8%M@;SPNT&%T:@LTE*/C1H+JM2:#\,V*-3GDJ%% MEBLS%;@]&9GRES)^+P6 V*>:C=6AO?OCH+2FWUF[>*C'K(UMGV('$3O,QL%\A MB3K38U8%_(%09;3.OX[B\2T[V#V"[^& :^;CR]>89\_MW?_5??FDEM91%[?G@9SQ8A[DGWBM8O^&MZ_)( S8?6=]>Q?Q:TWJ/WN566V_:,!1^K]3_* 5\=.;:MZLJDC0>"S_G._>/$WEGP>=C>W_/._$X? MGV _7C (AG[;JZR?J*T4:J\[[E_ ++@8^A^<6 K3A%HU-1"PA&H8T1N8RH0( M=RUP8485BQTT1-/)<^U:D!"U8*()%EIM@:&WYHAPMD"18HNE<=I>M^W?+MF< M&:C5RS6OTL6T)Z\1,*3"4)5'/!!SG;9V$ZOG3X/!Z:#7"0;C$4S.I[/SSBB M8+R;\+5W<%Z>E7ME- L-DP+;W*CN(/:FQZ\2Y&NF#8M7A9")B%JGU7*#":<] M$!!*(8IR;YA9@EE2B!EG8K&_)^/\V!$B(QRF-)7* )/I4K@N'IT"K%4.23% M/&0$%-U'T*940;WF(NRX#H<6<\"CJTRVUFX.5'XHP7P%GV@2F_): S^+0TSPZXIC..8 MA9A,44SAR(4E512#HPK[P["[::9T1H0!(^%Q+KCH@1C7 I(57 IYPVFTH,V_ M,;HMT@2=[M"'GC\HPL-6UD'_">0Q0EM@DSS2[!M=9^JT#VNEQPVW MD(\VT6G;X1<4CC/.U\_:0$2.D\[EHU!R3E*-T]C\>AEU MWEK?#]C0QW$TH9,JQF']OCEYDE8G]S*<2V-DTH0Y)^$EU,H-+%1+SJ)'XE1T M!;ZP2P9GY#*18FMBOUO2D\1_$'/7\7[Q[MP=.ROVTKV^A=O+^G=02P,$% M @ ]T:!6&BV2\HM P H0L !L !E83 R,#(R.# P,65X,3,M,E]J969F M[V+P17,_*OQ\,2)I# M:-03 SZ+J89S>@M3&1/AY@(79E2QR$%'=)V\ MU*\-,5$+)EI@3>MM,/3.'!#.%BA2;+$T3L?K=89W2S9G!AJ'U:97ZV'9D]=( M&%!AJ,HR[HFY3MK;R=4?3OW1Z:C?]4<7YS"YG,XNN^<^^!?;2=_X )?56;5? M1;? ,"FPS0N>_PJ2;ZEVK!H50B9"*D-6J\>,^%T1@("*42QW5MFEF"6 M%"+&F5CL[L@H6W:%2 F'*4VD,H"&IU+%T*P?G$(D56:28!TR!(KA0QC0@,9S MJN"PX:)9\Q#VK#V]2V<[#[*EL48'Y"C[3*-)[2EL!]!01H8:Q"7_SZLLX M(6)5NKF[.U:98CZE<9\T=('HK)3^DM$(3ID@(F!8]D44L0"+*393!')A217% MY*C"_C#L;I(JG1)AP$AX&@LN1B#&M0;Q"JZ%O.4T7-#66XQN#31^MS<>0G\X M'L\FW?[H_-.)4W>R]:0[&)3K%U=WRT*SM*;U=TY&F9X_+:-\MYT+""_+-3)Q M"EKU_$%I5418J]H?/&/91-,VV"(/-/M!\TJ=SGZC\K3CFN63370Z=O@%A*.4 M^3"B#4[P7'^V&E1!0*4\6,C32\"Y9$ M+/#(!,:J&Q\/C]J @,X*Q[]IWL1:-J[./T#,FP#A>1!LZ+^M;0,J\NYL1,+# M<)Q&%@K-RKK/QIDS@205DVQN2':&,&0+E,)#0!"F$!&)HMK.'MD%]81S[#4R MM&41U"0X?.T6!%FR"T8,618;IVRM4IYC1R(E9DGU&O-4"Q!G:/B_D="&N53( MP >!Y)PD&@]@^?9W;/'>QGY$ ,<1@NZB6(<\B_+T;-,HP;U9*S\(D\-5W#K0LJX"OA9$7-VNG]TTT]RW:/LFX_XX8OY?:XJF:O MV/F=VU[-?P)02P,$% @ ]T:!6')=R]5$ @ Y@8 !L !E83 R,#(R M.# P,65X,34M,5]J969FDO#O.\80T52* MVM:4OE \P\ )%O9HV"Z_M-L^;@_'R^D#^,'#PO[6B*70-V!V,@T!3S$'%Y_ MDRD31FDPP$?%XP8%4NCJ%)'B!CH-HEB]VGPOZ !>8,BU,P"-S[K)$KXA MD^*;K2;T\UP!85/+[$#Z8@BEUC(]VLYE1"@TJL;H0H1Y M-OB@7$\DE.QDZ?JV&\!R!HX[M5;TV<[R[:D[F37D?>@:_=KGF\;XQ^H$029$3)V@)>HO 1215)A737 H(]Z P M1H4BPGJ-BX.+AQN>ZZ.'KYG&M "@Q4RJ%/QF'SZYL@6]7J_9_7IMFM>7P,0: MWA<^:_;.PJ^NS'[_T@ 9@]RI>DTA:=.PIJ@U6)GB"9@&=#O=SP8I30A4;$ZI MQ%PP$7&60'YBR0N@[QC'^87*_^SD ,:*I.6PT&L#6)8A4P7"4:HEQ(["O9)4 M"JI^(;';:<[> &I!+-4A?D]P@&)-6J<881JB@EZIM]>JK+:57Y9#<[3S-N54 M_!C(':PD91O*ZJ?<4DH7+,T&,)&M2ANA[$E4=#4YG=AJ%R8\ BN*Y$YH1L6K MGLV"&:>"'LL]Q41RK1'FB0RI[B[J)ZE^5TP;8 +6(W\TP,D5PZ1"Z'\:XG_< MLT'RZL:TBSE5#JYBOOT%4$L#!!0 ( /=&@5@8KYB5_#0 $$3 0 : M96$P,C R,C@P,#%E>#(M.%]J969FESW$:2[W=&\'_ \YM12!$0 M+5*'K6,505'RFA.RI"?1XYB/U8WJ;EAHH(V#K=Z__N59!X F*<](UC:Y&[L6 M2:!01U:>O\Q\]O/9+Z^?[^\]^_G5\4OX;X+_\^SL].SUJ^?/ON?_PE^_ES\_ M>_'VY;^2#V?_>OWJO[Z;567[)#F\MVJ3LWQIF^2-72?OJZ4I4_Y%FGRP=3[[ M#EZ$5]]][GM/DZ6IYWGY),%'[SU-6ONIO6N*? Z_JO/YHOWN^;,7SU]]6N23 MO$V.#GY\]OT+F/6[+_B]6^6D63W]0M^8VK*U-2WJY:L/)^]/WYV=OGV3O/TI M^?#JY-?WIV>GKSY\P27JY[_H&G_OFC:?;>27>9E9'/3>P<.\_.[Y/^QLUMRJ MFS^ZZFGRHC9EUB2OVRQ9F&9_KUU7R;0P30-?KF9)8Z==G;=[ U&V6 M=#!@#=.8MGE5)H='^&2[L/@;??K5I^G"E'.;'$];_//AX_L/TL0TB5E:>#M[ MDE1UEI>FWB3-PM2XK+)*5J9.SDW1V?V]%7R!_I+"D\E;??B#/ RS3M:FAMFW M3=+"FUT-'VSL<%AX^_3=V^0W>?@@>6]GL(IR"K-%ST) MV]F:%G^HVWQ:,(4 J533G#Z4[N_!9A\'?SP._I@8F.>*%KE>Y-,%SFB6%S#< M.F\7??K![SD:@FU=YDU#H\ 7Z-%7)TQ.96*%-<&,VP4,>ER6G2GV]]Y;7&X" M&_ 3;$5R=._N3P=_Q7W[6MSL[?N7IV^.WX/D^/GX_8[SL&,BKY=V:I<3(-C[ MARF<[]%]I$ DVJY=5'7^/T!;Q 62J5GEK2GPHC3(Q#)\^\']].&C'_#_^NSE M(#GFFX2#55T+9%]F>/MZSP'+/+?)Q-H2N5:>%9O]/:#3SF9I,NN*8@,,+==; M7MXEKMJ826$/DK?=@*DE.%.\SL!BK5WB<_2J_AK8PN_ 58W(F[=TOQH5H2+,GWU_^GQ7EKW]*JUX(U"DBI '?0+8W_[> M%DJ OT^+#M21Q)Y;N(*%60/+TW%VEADIX:!6]JY:V]J1R\N\!NJIZN9Z$,RD M,C6)T4S7C;*V +V+?T&R6#,[EM*F-+7*Y]:B"OC;KY%:9F6;Q%,R7QX^=[AD]0K_E87#^6VX+ M&%85* IN:AF-93Z"YC#9T(NDJ"RJ @9J=O[VO$>%!33UMC73!6P&; Z+\.MQ M=_IZBUP? -4<7;\XO6KY.35Z]?/GMTZS]H%/GKO[]^1?^S9V7L=!:0+7"E3Z'3;:O6=^-"> MG;W4IV2$!S^N/OE)G[W<^B"H4Y^>)CC#NPT8"CQ->//_/G[TP^,MK_:>WD): MP%I T225G%3UMK4EVP#PTWG5@HQMU5+'BS^WI:WAC:6U+=@8L"GKA<4C1X]+ M5Y@:646SLL!)BI1M90NWID=$"1Q:WA9HI'C24*6N> #\C6:UXKL^7QE M>&[X9Y@G_#5-;$XS 5T >'4#= ES 89EP/JH/FW<3VNPVEOD9;"N"M1K=!Z4 M-(KEO83_]_[S#O;"0QR>V]4?OH0C?(W)_L>)+#Q!.*L,;* ZGW2DIY%X/,_A M5F= 6_D,C4=/8RNS(4,3WIJ"I,,3A7].JK)KG =M9$0T95%3IJ?)=46CA8^E MZ'DQB?/C(0[NZ&-KTH;*/04'%'$@"/:,(;$%H034_TD(H>(."O*LMA9&:64/O8Y^@7*-/ASX+2E* M[DUT+Z/#NLZG+:O;0)#D*$;O$$JMLA+9!@]U2UA-FIC5"@P6HF^P9U7?KSOY MIG-^ M;"Y>MLP/INJF]P&-=_\!D."?IA8.$Z^KGR[.B,8P!;ZYO]=42YM,JZYL,>C@ MC*74>SCI:^L<]):))8YAV%% _GQ3LV+"']U9\V7\R^Z;_^?NW>2GW!;9D^2= MF=NG,/ ?'0::X/M/D[<4M&F>X 0T=';WKC+YEZ?_U!GS/.Z"%('WCI#-RV\F M5=M6RR?)(_S=I*KA6KC?O2C,]&-R>/ 0)@^,/<]@7N_B$6EEX48]^QZ^.C*! M26W-Q[L3B@@]@0N-2PDG]6AD3CC1S_UDL%_?XX;Q=NP>V:A@>%7(L6/HXOIX MBWZ]E']SU&;,FX/^=@G:X%^050JG-ZBS@+!(0/W T/$2PY?\Z[4MSJT?Y2!Y MA?:2*#3NUZGHK#(4^F9 ))7&>;#H&>2;ZT6U5 LLL7J(XD-:$D='P;$)O$D] M%Q&*/WBDRDOD\&0R-?ER!6)F:7ZOP'C:L&4('0H)>Q$,22 &%;$MK:GB4U500)&5',3SXRZI&]Q[) M7XY-9R RYR7'G$&+.,%1DM,TD7^TCX" M"@OV>Y;732O[O;_77QK[7A<@:9#>,%!,4W&OYS6>Q!08"W[&!W65[OG8Y/<;B35YWAPW]GAOM[.,4M[GOD0O,2 MOHQLP2FV+^AA4X!NDFTH.,4SAXG1+5+0DMSM%D17\ ?X[)3#5A,[K5#,V=D, M[]FYA$$443 OV<02A92FIY:=? NZ8P"UR5?PZM88N_;L0#$XFP";/_ M&F? ][=UZS?+BIUV^WNZ!EC3TGRD&,FRSRSN *9"CT7S*E]UR;'/O M'"3'[B?06@,1>=$=*D%0?P;O)HE%\CU0O_!GEA'Q:9+QJ*D&(<&^O\?*E\JE:5Y/NR4"=Z8*%Y2158C.ZFJI3&35U4TGP#C5='HX )%A M!Z -.[C?:0OW\]'!R8%PIW>LOZ##X]:2 X=N1YS"KY@2CJ\+6BVY%F"UGCWT M4MS2=#JOHU7$S.-*%);Q@,'$P8GJDK MD2_R?%XK*\,PNF,(&&$Z2'[=9JCH!"+7KOCO,HO7(A\(L(B#D-9>A4%VUBI6 M,,%SX^"IL98Y(VPHH6U"5]Y4T;2$FVT<[)2X3H [Q<7CM-F@6^>-X.NVR<7> M_(*Y1/,TX[O!(3/^(IP3>LK&=TT93KQOX^)X9^_Z^)??]?BMH\+]/2+#030" ME"20@*B-%?D27;CZYIR$,4G+VB+G)T.O+I'.44"[?[.D)%?PN=#^JK;G>=4! ML:TK%3]LQ, ;SNH]Z5'ALFJ0=A #"YH@#F'7[& V7493F\'E+,E90!Y2]A#< M=F0M:X$9ZP1@'+=:TBJ#<-W^GD!"NZD*+1+FLJX[J=)BQEY;^F.9Z45;P4%5 MF1?L;"R-S*^V!44/V1_MO2E-_@E^*ML%G,T*QJIUYS-Q_O;/"A34&8+*Y9:A M9B**> V[4^>&CK?$1XCYN87[=8,8A"TA(W(*]Z5UU_(IN0$\LR@$S%LR#ES@ MXHC8)7;@O> +L(7AV-/>>(ESOPL>*)==0V[:V-[%SQO5]S!JP5RH1/T<_3>U MU12$_HFL"7,$=X'N/FB/0"65-VS!_OX77%H%GSU "\&X;9^(4N9GD!6>3 /$XDDXI MQT;BVA+0BMCO9^I;*BCRNJ]EG2%@D>+PY/=<6_@6'Z^/SJ,@R<]MR/-%;3#D MH/#*UAS3ET1J4 (3V5". JL:_=8!MZH98S=^IL*%W04!?3T+?S+3;#Q+P@VJC:$R8%U5>R^-7U& M\ILB612H0/4<1+D N_?W)'RQT1UQH N2NQ310UV#/$81:@[_-@S%L)6\ M,853B/L2@UR%B'AI6DJ2K!1\Q\IW6VU#B$0 CLAJ7B\J6JSX6^F=/H(C\(5K M)JT'='#0YOJA./2&B.<-E;$/$MS]13"XNW]9?ATD/A1H>*\M^WJ<002427&B MSXHN)Z@R2U[0%&Y%F0%IH8&=(DF2A<$TB9X4D%]6O)R;@O:#8HP&W92=&Z=Q.\:B,!Q:$[ Z_+L63Q*;=BXH@H8N+I!B!4\U(G9[ MB%8K5X+"X9CZO[9PPN[?S.\ * M_N[>&\E+%FBEJ/-XZ(=_)_]$_\$8&@"+R"\?/'QG9X7"95RRG_-56I+C6P\2 M"::P!DCTT*$S9"/%MA+A?!D/P3NIU.X@.^>F,K[6B[WT6M2"%*VLP_?F M8/.#J"J%QO%C1=5TZ+5I[;*)4$MB^.),)E(\HK=<\;PA!!:5JR%'_A!'LFGY M#2N+(Y%!5PN$TW98JX1WEEV!]QAC.JB@4I@RC;>=804;). SPHJR<_O1( MN(R%4H @JII]HBSQ^% SX+89>1-H(J/RE*0PE]6XHHM5Y8>X"":V72/J8T:I M ^SE:C?L6!PXCXE!!;E(6)E%[,J3I)HGN M\B2ZWJPOR**[=W $CWZ9/#JJ/./,HPMP+C<99E]B^QD1R]G*>I$&/,,%Q23) MFH")_5NXU4&/\J-C)SNW;M]$-ME^NKM):C7"&85R!PC #@= M?!-_':?CD'4PB"T;ON2BC=WA4+7+ X[SZ&YHYDO0#-Q2@ALWG#>0=>K(5KX[ M7@/M)N_ZBUUBN)+U'*C_MA$8!0%<03O)["P/[.GH&M[Y*S*C=6N^5DKTFXI@ ML;OO5C_;EO.RO8Z6ATF2#5O25JFB*XYF7P&DYQP2&3"QWCGC'4\/\+VCP]C\ M9NM?7T12]/3JFVE'6UI?@#-0$X.+=+T!G3 MAF7 UL-=U*P1W+]-+1AZ5B8DNF5?8[?*VDV O&- Q"0\U&/^_=X[#*CZG& M6^BQA?KB1?ND7TI,F*4/Z:I2P(DBCKW@O.$CF];YQ"NQ+.0<2CZ.>_/7. ;D M9B[K(D1N604[H8=TV?Y2!7>?B>D"NN&W]_?B''F9K?LV;RK2:9NWC"3FB5PS MN7LZVQZ"YS3'IELN*5O5$Q='MS3RC@/XG9=B\B-':+AZE!XXGP!2O\\21CP] MGFNH:$I11(Q'(B2K*&RVTQ67$9&452OUG0:QL-V711?$@3'KA+.[V$ J"+?G MPH1C:!&UJ,:+;+AJ42Y;;*P<;&S$H12ZL'#!<118QF@HQ6T)8#>(APS%WI9" MBCO+DY3@3S":C'MRC0O"_MJG1K47"?HVR$8.,#Z]A@"QTY6%Y++*?.D#! O'/,UIK\:!UG'E;_77**WZS)HH4/P;A2LUZ:/@4\ 0"QPM%',.%S6 M5;7FX@M!>RLMQ[!-PI^6X[4E&$,=-)ABM3;*+7#P55^97F^ ZV&5RR\:#7]O?T\\1ZFO6 MU6P%.F-O8D'UW_E+=4R%BY P3JIZ56&:..C?"*.[%OK'MJ)U*&\C62LB'.N\ M(8WW$ADIP7B9EV!5.[U\6-R\IZV[6K#);0\[Z.,XEX82QWO3N7-A]2/^XUBJ MNQ;^RZII)]7[&B];QF)TJ0MOZSM@(MLD2I284 L4J:"$%64FH(QI%GN89_&> M%EP;$GK^,U6<+HC8T"HQ,3_&$'!6AVQ1,UYH8XO)=9"X MXBCXT;&Y!S/'M0;YW)*1$+HKT*-!Y0A,1F;9O*JR9&9@VJF'5;L!!7LL.-@E MLD@D(2SP13$MDR ^5S!/_;==O,GCD[E5G]=DP"PU>4T'I#&MW55=_GS@Y\&. M!WX>W 1^O@'ZY'YG99O?/3,?+56'>>>@4[LB^[VJ \RXR44O)=ZK(@>X[BYI M.]_AM#+GV-/B%N*IY&=):2 MB3DZO2S/^AL7O=O;OZ//VC^7OA1NH'HC^WN8AC3C'&Q:AYIOJ,Q*TL!\]21. MB0X[8HA_3=_C'.D5EC?3VC>H0!_W3078ZXP;3$O;L2H:E0HY@9DF1>X"YH#5 MDB2RY\N!^<('DE<-^G]X5I(Z6!31GJ>2V,6NO9GK0T2^C\A F .IN*7*NYAA MJ%J^>[5_K!R^Q'OKCW:&ZC9U%N*@OCQ)QRV^UB@M4 _&S8%+HX(99?+& M5^RA.<>A>HR@V2E7 D-?.NJ8Q-\+Q.\)Y$W7H!DW2M1BP\@9^UKTFV>J==Y\.Q @>"M\ MC-J",)Z::PM* 7NL3R'_CNQ_R95Y@+XV+JG,D%YZ!%K'\6H>0;#\#=!_Z MS0A"&@^W%%"(MR.-MAF8$6]O*')[7%^1@DW\,2<=+CMTZY$C[$96-5T/'0MW M]-=/732"T4J\4F*3U?DY:E($NF,GL],Y CDE%0.S<72X^?'\>6TEP?^]JFZ[FI]O:SR3J1%H-;%L"Z#*7K>'/TLM@ZA<,Q+S$C415 M5/HG34HH"NI8[]/Z()^[,2A4^5KY((5;-,+DX$&&F/YICI)*19C/7XR[0/M[ M5]S^B]>3C"[GLWG"P?[>\3BC4L:&":YE)D"8HAA 2XR_\-M&XLH7:/AVRR47 MF"[]_5>L\?[>8,I!34)1:MUIDFHPSN2[,%D42C3]/VN\SJP MS!R6LQM[1]B'VQ>"'?6,L^0VC"#QN^@LN=ZJU-PKW#*TL]+^7K#=?^92X'_E M[H(>RC1S-6_"0%%.J:8/#$AEFNB-'&D1X:QA6C1^D@Q6_HX[*XI^H1E"$R/S M+0]UY[S6?;BSLUKP%8KZJC7,UTD)4E6(AK2-U%\]M[V75Q>SGQ!OUA#%5:N\ M)(DK)Y^=@YU,%8%CAQ1Q/0$;FTE#" ]B=3*8'KB.Q\'&J'0%"/ZF&JF/-"=: MX# DUI-FKP25'X8/(7UHTZNQ@DZ,NS)%4SDK/"#VD+A%Q7/K\ONS,*-5D<99 M&?>S"8QX$H_X.C)2UW%)&#)A6V._+O()JF"&"C'6FD2/H%F9*>XY=Q"*QDAQ M+>A1X.9"TU!#U" VQY!9VD]-UUB6O3.3%UUM>U W_&A86'OK,FDXB<(20UFX MLI]T/(Y-I-QS0$^:)E>U7"69E!$16(3'[/N-,[,T<^NA;)QH$>VBT9ZO/B!- M8Z&K+BA"/J^K#BN14BVG(H=[E"PL$ZYE?Q?N'O66XP5-;&EGN5/!G11S?JM^ M=N683Y_])W9><65YY]-Q.Q!(;%2**,XJ.UM7HIG%*+V1 _'=>11_-/@D-M.3 M-$^"*>AWN*2\L J%E11 MQ#^^<4HXI3QF&K;A:-;0K>]B)=RH$K^6,R@)E9UKQJX^2QGL44=L)K*VKNH_ MMOM!G7L361MYRYU4J3MG %+@:MI#O8#=K;MJH^D@I.B1B2^UEZE4OF*7:8M@ <8PJ?$ZX85?!N M(A:?$['XA0[FVL4H*/4=K"RARZC\"+<,JK77,O4F(D3K1:8H-1N2F^-K9969 M8*U\5'9;KCWAB9<62W@/$A?U?HY"3/S\?"T17A3Q5D(I2QZ6@!K$J5*5P=-D MB.[OC=4ZT>(FW+N)&4MH>?+B(T,40$063UVE4ZYQ=WJSUU*6/*V_8T$@;.<%A,B=+H5" MM00SM[?PE9J%D"[&S.-":O45^*A^Z*"F+-Q1^F67IF93UM+;6CVI1)>]5U*7 MG#B0@(%3WY<%'W5@7K'JM][W/SF/%F^R2\W0/L\CWM7HB"_XHO U[2W'$M;A MV=.0Z837B[,%M= 3]]?;FCB*9Y4YGG11X?#!=@6^9^]9:^YX!HB'2^&T>)=; M!@%)5P=MRC)@I&['QW3-SXAU\2^!0H(/B2;X;QP6C9.J+CSBN@X\UZTTAA4_ M-1'K5'*>B.&IVLN2S_L4EZE4(I]C7D0;R8VH3X04#\-V-I[URE8%[ .#1Z8) M T;:(.$3/.>SAJ&P+<&5L M+NOC#O#8X]Q\@":8$H._AFC=+9$E?6'"D>5NL*- BRM[VX!6P)LS M%X LUM9QC5J4S3DZHHV>(XX:4XO@O$%5K4VEV9G#$GC;HF8[:Y%\9HHB=W[O MBW;B%-@HXER\T0AYQ7PZ+ _@.IL&)^JT$"YJDKAZ_%/"Q\4Y1$A'24 M[4'RZ\B]-6X@XBGY4.",ZK">3<"J#,D,[34:TB4%IE CI *-/@FNMLEERG0Z MAMNY@AH-_-B'P52))M'DE6C&& UUBK[7G[ <>+-J+65+=1GQ +R(9 :KIW'- M[H&7LHXQBK;/=9(J-!JYG!NK:RH;'DIS7Q)]TC$C=@")&R[2Q_N&02 >VTI&?1,Q?^PN/?'9; _8)Z#703Y_D& MZ-/W4 S3)G\!9M-=BZ)-0X*^TZZ'";?1 (FPAIU.">*_&P T"Z+#E8 M@YLZ#&V7*ZJ?S$,?)' QW0=#CXHO0;^_QT[/RRJLD+],NHV!.K-&3[P?)AUN MJP2.9HA95C.P/YV=1?4KI?!\>";1;QUZX* MAN**L/I#W:$(;&VHI2%01NZ(;O&:RL#H X,:=D00L-HB_Q^!M'G,!?:I[9:< MC\F^DOJC;26'J1IM0,LH(]U)(RE>Z(QM@-BET%Z08SFRC:SPN=IZ\+XV:+JD M/U/:KP/!>FX^HF&XK,=JS$^T%3>)'[\X$?.J[<%XG[@!'GDXG>HC]4/[9NJ% MO=O4*Q!AU";6J2^)=^3JG%2K;J+>)J\*NS4$[0(AW MZ5^N.V#CRBU'6:0!9)= >C W;PR2O3(SYQ6H?<6&?;+8,E7GTQSL[Z&WWWXR M:.0,YPO\.-4H_UB=KM1=J6$>II\X A?[U;)#OJ=G-N4;JGYQ/^. MBOJ'/<%E#)>_H162^]O8K,UJ9XDPJOS).THUZCCM\7HHCGTY1*2+?3G'"]9& M]./R/>-+G\W]*$S>4;HRS24FC]EDTN]1Q9LGC92]@@82C.H^)0 MT"Y.8>@YJ:HYR;5EU?XI2Y@#GI-%O/F!4CP26U')]"HX%"C;X8 E:" MH-]&X67[@YR"]QD*#YR=F-;'EPEASG'IZH?P(M_][Y-DL@B/$#)D_Y M)YO=]-S[4B=+?0_MR)%I9N"LXSQ3;._%C6OT"7B5'%F8TE5RL713EF$CB[$B MZR"P\XQ<.LZYQ2]HH7(U]=/1BE1_1;,_T+;U6+Z.=LW??,7X")!G/UV/ADI7 M;F+AX%1KZ\@&2!!+WDO--E+WK?A;),#0AGIJI MHV , A+?<[YLI%+(=%%)AT?>;=>GEZO$DC\L=E(X MV''@9Y[4-LM$\U"G>68.8B^E:ZF4#VE)N;-B@HU$Z/K MV/6/F3'.KT?5FK _8A 6 (995!LK(5VXT0TPZ@"Z?+$:+* MBBZ!&?(&]Q##9-$S#F36-5HF*9Q8XN9%M*M3@I/S-Z1@I),BK-:(@:#2S.R5 M;?K=D2]PE\(2?04F#.ZDG$]B$2_)M)M0BV3-?KAJX B?MAQ4,0/-Z"(OYXZ2?$]DX*:R?&O7)P?)*L)1NM\(?'SX^ M3!\>'@UQ-6+R^PX\JUJ4CK\=_7AP]"/J/.ZM_3UZ+;G]M\,'!X MF"8S?P0&6;-93JI"@_G_^.G%^]\T9 _*&BSPN)LC8/KH$6WPT>[=G) _A\2Q MV_R87#!$9:*"'B3H@SE#-$ET14SMZ)&,&:DE1,GM9M:ZTE55G<_)P^GZQA'U M!4_S!8O!O>0#/>>D\V9T/*X"CP,R^B::G.)A@@FZ]L:^62IEYVA-H9R*^!56 MZAG1?9IL-"$@\+"<*"0!]/5B0[VPIAU>(W<[Q>Z@U-YH6YQ8HQFXWD(NO*.! MV;#%W@@LBZ]IL=''8>G[>V[M6YTJL*<.0<.'<&[RPMGV_0_[VMH-MQPU&VWX M0^5^,?]V">866I5H"^I@(+&IZ)".Z*R5R3&;I"C/$ MC,FT";XYJ]D9X;L_ZKT3N;2EN'?4SPY$IQOSM 219#MRS8\&ZL[+L,I9O$]\HDOG^ ML19:] FZPR9N;O-JY=^#>4AH2;)Y MW1_HC**-HJ:._3J#$I62LO5E?_BX?:OG@'!_\B)Y="A9.:JK[N^)S'.H$EE. M+#.OV\6Z@H_IQQWW,?UXXV/Z=NDS8/SO2/!Y7;]GSJX8\UKT=5'5X4@C(C7$ MO3C"\JATV=\>'-QCRY>]^*CMB\&J:ER::%;]J?RE/\^S@36,W#B,NF.. /R! MPF_>D,[#(F)ATCTYDACN@")!>PF@5G"YH#!J3XIVFUG$@IEP:;U"B( M?6IOO\S49B)A3O&'%JD5J.M5MI+Z652IAJ@_UR&M#*HHP>U'IT1B[J MANNWDB-,,1/\5R$8ZTG0RHK(4^[29.#2*U! M 6XL0YS"0F,E@]#4B8&/I,F<- *$,JTT\LE_P()#;#G%V1BLEF^"OF2)2W_7 M^M22B(JO^P8^0Z?)-1-!%QTS9?^ZXW4'[E+*^:,\X)B![_=G1P[RCU-7]#-N"O M/@'RHRL<7E[Q.DM(49*=\-93Q@+%X%R(;W [N-- 4,&&.E\0;$CX"\%:4/D* M3,S;!*V=J?(8:,MWPLO-H6KN[*"-41)PY",G2=@'8!+:!XJ+;-*1":A)V3C[ ,(L$(%78*+;/)]&I2M<)E]0 MX)%31OP6LU+*:)(1NTV0KE<@&BK.,6*=]CZ8ABZBJ&S*X=&]]/#Q423=4@7* MJ%F. ?T@$B]-VVE3:-S@95='BF:@'RR]5PP_[N9UP\1B)H9(/818$HABZ$E\ M? ]HI@"Y;J2&:V@'SJ*J9J?J2'H)?V6HU'L<7 DGN++4Y)X+?7L.-A0X+EL/ M78#DU<*B[R//!2@&-LL<*Q8G?# 1ESW'J!CJKT.X?((+<"$%["-QZ57P71\P M-\(5MP7#%(C\O"JZ)>RU14,?&2 8JZ@D._8\IL%0JQIRS&5=3:8ACC@X@@NV M_6G/5.T=@FP4W-ZR$F8Q"67^%B'"\^B%1JB2$.9 $&M08($TU$E4Y>*OW*J]AN0WK2$HQ]Y#_QN1 MZ06,PGFLTJ6E$;GY""Q*=@ Q?$H:4/KR2#R-340\WO D*'95$%,1#5ZC5Z(K0 M<9\DSM3G?I/D&F6T9S"',:RG.C47?=AB?X6@N'AU.:JD(JDBN)' M7M-UAL)2S.[ *0H<]C>O&#&7#MI0J-)T/4N8 0$KN"4*QWY@"X>=P+[1)T)A M1[B.U*+0LGED"!F,B#85]NP.N_E2(S4L[B P7*!YDO("FKQ^VZ^T2<"L;;'P M-?>#TYA7D*U'1>$XP&@<+0O,R3E&-.]]#,Y$*F?T8NJ*1*A7?7]O& "G&;&R M4VRB2L[49VRRB>#&\Z*:> L%==P5B%"'Q<:/]>?0@)4(8AVD(S5+XIJAI'CB M9%[R !7POC,L;:)S)27JY=E)&J"\PJYBI>':^"<6#.A;9KEZ"F\>8.4R2I2R M]$=ZGUO^>< P([TYI@WX0:OEWZ!&T+V"#F\B!B_RQT M_+ R=MKSS)MDRPL7^K'I]=ZK;57/32F^O73@[2/H?=^%O\7,35V= M#B\_O>L=TV0JWS174G_15P[ZH[!D^B6/+9YZU938O<_Y*SZ9..>\B;!Q1^6\ M["X(W.#"<&J]OKV^"::X!'#PT+DW6%_4)"6HFN-Z;'I%C3(]*"S>\]E&I9=" M&83BY[()^"AR,VI?>9!74$LI0L1<&(JZ!#4@^3?=%*/H7$S(IZ0$15QH9^3I MDZ!:,C?[XS%\#53W6LJQ?:(2'\7P>\0;[&O-IRXU-4KM":HBHW,8U\Y@O+@L M*_F?MEVGR::_S=NW) >=YW78^A--+[/10I(NDE%)?!+;SW>9C/)N_A_>&R:7#SZ$J2%$2Q3$0 -SU9@4 M$9QXDQ""'+JM;#DW4DPKZCD6=)*_2-4:$[]A*4-7J&QDY%ZA0O$'24$$[7WD ML*?HGKK>M/+?5/T?KQ56@]B&R!>WP#8W TIH;B/ &IA+?2JHPL1N;NFUK2N! M^H\[^T8.WG7YB0@GKC*!9(0:C$_,CA[NA\6"8ID M2_IVED[_BUBJ\FJ??%%Q!@/\\A=3+K#$;ND[HF947\+9TJ)>+[24! -&@DFO M34Y=;M#<05(B:#'9 E101*ON8!I]JO5$HEH(:5"$1(M92":'-FWAO0D%4']+ MW#1I$U(::']/Y-FV+U./ER5;\](O',LYE5(8&,D9_MM9:5N&@&OW+ALLVU@W M]YP1J(^4A6FT_+6OQGL1]Y=+'O3M.0EJJP[?)(0*'48,]C=P_W*J+KB_![NV MT0,9W1 M]$)AA%E2:1,I;QIMF>Y!\BKH'.=7$;&QB#%Q5N,5=L!O +K\YA6' M_UU\+*M\^(LG+!5RZ(W1LCD^34<8"Y=DB6NM^"RCJ"Q#$"6C>K6[*H>_M2]? MQ6%^" .^997[28(5CW?2;7YX[^I^\V_/B1W^+RAT;U_^"\NB??_SV2^OG_]_ M4$L#!!0 ( /=&@5@,[\T ,3L #]F 0 ; 96$P,C R,C@P,#%E>#0M M,C!?:F5F9G,N:'1M[7WK<]-(UO=W5_E_T,/[S!14*2$)$&8(2U6 L&27 8ID M=FJ?;VVK[6B0):\N"9Z__CVW;G7KXCAQ0F#Q5NW,Q+;ZIM/G?G[G^=O3W]Z] M& Z>OSTZ? W_#O!_ST^/3]\=O7C^D/\-WSZ4KY^__/#ZW\')Z;_?'?WMWB1+ MRV?![LZ\#$[CF2Z"]_HB^)3-5!KR!V%PHO-X<@\>A$<_^L^-LB1:X>*;R M:9P^"_"GSO\/@E)_*;=4$D_ARSR>GI7W7AQ].8M'<1D\WM[;>?[PX]>;^.=T M5,P/;FC*K3*;/^.IY(-15I;9[%E[^K%.2YW?>_'JP_N3W]^='K__>W#X]T]' M1[\=O3_M6\V5]^Y/F>@);/CY2[OGER]N:"9_GC^KHHPG"YKJ].WQ2;VQ .>\ M7Y[IX>#G)/I/E1W 3PZGN=8S. [\\N>*O>ZS%\?J;+X*0<#A[!IG02')['Y\'^KT]W=_9_"8/C(E?P(:XSJ)?Y M*IO-5;KP%@FS!>^VC[ERI9LH"]G>"3RJHD^$,EB4YA']/A MX*2$$R@;2_EU=[]_*6E1):7RCVP[.(5?R3*#YV\^P'D[+W6KB/_2_&;OO<"% M/W^(/WE19E,-P^?#P45!=[F%!.7#.(TT#D];[Z;_T\.7[XZ"5T?OWGT\?/T: M;N/?[NWS;/FPYTSEP[)7<1PKXH& M!<&J@WF>G<=PEYT?"[6-88LJ3H-"Y^?Q&!Y&8FH,8(;-@ES#B\R#H@*2M$_ MY\ZX1(ZT@Z\%0Z[20;PW\!L09\ KIMK%2W" MX> _%8PVB74$G#E.DCB=$K6I4:+QZ;'*9WFDTK$V% Q:X:P0H9I&,9-@ ?K*),N!8\:B#UFM:?O6 MJ&PIC=V.(KG*I.\__!&\IG\RO'L;B^[>G)7?W^!2NZ)"/_G#W^706^:^'=W MMO<-FVWQC6XV:UYSPZ)<]]W=[6L3RKWDQ2U_=?:XYF +@0#=(M-;5N7:+'AU M1XM IU,U;2N2"KEB@*<]UW3DR"#ME\R$AP/G 1F.& $I"*@S$DM0[J,-S0%' M,@KKJ"KB%(VW2(-ED\V1WX)1EI[KHLQRYM+S"E2%<)BF?!;S^KV?S@$*?''?!H:+7%R#E#,^//>8%6 M6A',LX+DCQER+.8M4-=G7<(#<)07.DGH2".65?!UK"&36< MS"3/9D$)Y$O[Q'^/%CQZSWZR'+Y2<0Y'@.8__G24@?Z%?T0@9L?T*N0;\Q8; M%G/-,!Q[>3A XF-JH[- @JG8Q#@#\QS>R0P^!]&L)Q.V;G%+,-,N7+QYJ6=@ MOH?LAVC,=V0?> UDX,UZ:_SJEQ^8775N=SD/6^&1W>V]51B;86*6HQCJR>8: MN0#ZL)!VY::/5 'Z&YF_9,GJV3S)%AK/I^9*!2@PK ("(^FD<(5<"95%X%"1 MN4/FR]8E.Z"O83T%+ ;GEBMM;?>S3)8-MQ6^@QN73_$.#@>E?TGL,AK;'6FY MQ5>]JIE8]!EZH*\W HQ'T*@+G)^G+A=S3:LS M;RI.0>>>$5O'-P',*"5^6CHJ2&.EK96A&Y#\:SA/FI6.*H_L)DYOB2'\R,K+ M;7^NJ.98,C3N!M!Q5!AY%V?L$=P$)$,B*;P5\S/J)_@+J0T'>UN$ KOX_ M)V!;_E^<@#S"JW>_RU5LI?HGXS11**!\#_*1NK=1VC?1GB/1MH]@%$&IX<,#W^'8S9]-4FL1G%".DW'BO#" MQA.X?,&%:NF85@/8#@YA]%Q/X(/4<3/B1>]]J&OM- 2PC*RUC);;H.]$_@1F M5,J;+T 1S?$88('P%D8Y^>=IDZY3H)8'S<&'@\;H\#[Q+.TKO?3MYXWG^^6! MG((RRVPMZE+>Y_&&-F?H#]]=^J!]Y'^VMH(WJ" _"S["%@_@'H*N"N\P MM26AU>>OC__5-?;N7@?'VL?/1ED.)&$_>YFH\>=@=_L),,0B2^((EM!8K;"* M>DO/'\*L'0O X_R\-=+ '&"5S$:2 MN)+D\77TRN4<$TS4#'1-PQ13#5RK4/F"M1%0Z42:D&(#:D]4D;L,F0H,-H=9 M8L,U63PU6$H(&JDCFX $D2&/$JMJ-970&[_<&Q)R2>C)C2DCM8-$2,2ECT@7 MXSP>P=ME=14I2043!2;$I$I"4.MA0B /ME= MYX V;$? (XW!4EZ2_KME;3; M1T_F[5R/#3W!(WPRN]O[:UBZQ Z$A23H>5_,WG$Z,6S+7TK%52HQ* M?2._F@B(;6^[&V>?3Z[//]QFZ3Z;M4)SK00%# 81TB>IO 6P1U/:4G+ND M0!=E'H]+L8G09^VX-;*1W!MRC&B-(6?^IM;1Q4EB':U"[H4"29^J$E.1Q+8Y ML2YGX^:XB O-XSD*03T5F2I&#I"?:4S^#WRF/:/)&-AWOFO4;E7 MHA2SX[U5@T8@0U%*%,#MK7M4C;)S'39EJ@11:PI C9ID(9KV:E)JUH!9XMU_ MA(G)*1!2SOHQA23.G"CF<("IU"UOG+@"W4 +_#F-S\WJ1/E T1L\VL%\[$(T M^4!%YR3B0 J"E$*]X"*/2;PW(J/O^0M\#H&L.3(3U3YQ-Z)CM]\\ M'HJFD,!%4^"5JD#!N4]AF0G%9-AP?4 R&?/[_+5N!X=V:+Q',(;-3J>Q3)XS M)G![OXPJC/(\(]5B)4^N_1@TD//8ZE5P:> /$UPC11#N<;HX& Y(N5"P?9@W M!I.Z]O=2SB&>5T&CM!S ."Y8\9KK*HK@XBR&!^$GI %5Z*ZY'T^,BQ8^H#Q( M__4_D$@A9A 6[K_Y &][%P62 O_Y*;(QT4F$E0CO4B?\ZG$Q ZT-*=LD4[HSA MY4^W=YF7TQ'E.@.V=A]6%:?G67)NYF@NH\\_2/G57RK8RIG*55&XE&:\_1TK M=6][3 '05);7I=S:2$M]D##&_7-XRV.%:3338)HK6LV?%7HE^>68#!M4Y0O* M*;%61B'!AJH4S?R2LY23VAX.C'4B'BOC'\VS*?ZN28SVV$AF%RT:(D)N< CF M,LW@%@W B49XP!/DLS-*95)3A63;1X^OZN2?-^B*ZR&+1Y8L[BAHO'%I?'W% MKF:*4 M*B]'7E]6/O.7M^U-V-W=?K1B<[/DZH(_G5X&F+:C1LK3A3HM]VEK:3K$[U>(7/V M;I-%]@Z"#W/26Y\AP8G.=A#\2R45?OVU'P3OU4SS*;W/<.][7E*)>0J_V?JJN2X]Z35WE?'R?3.P%5U=A\Q$ M9E2I">S!%TJ!$U$IJM&?8GBX:GBQP9406CQ451H0]*?2%[&WCI_>*!Y,G0H_AGFZ<:_BM,D)U# M7%I?&\R&_0T'DGU\VX;<1A*O1L@WD]IK32*5:_8-%)(B:2J+*#U+?<&==]2- M$HT/!R.M\F!240*JDYG%J0XR@I?U*A-\AE=):>8< N:2)$S X-S[9&&\C?Q7 MV/"0F>N("[.A8INZVA& #$[;1A]I#>0QP5T:UW4\FV<%7"H;[+#%34TO;Z2C M:BS>0[Y*?),QOVA1,Q&^7LUT4J\*H&6\X@-X$\_0HL)-REP<#'='KC-ZW?NB=29=E63\SSFK(S)OPHJSS;J0O7BN- B(H96SX'+H0<Q5\DU=G:%V(_,LO3*=-83E-YD M00(A9_07G8\Q/04SP%2>8QU4JWYF7.5@V1 SJTH3/#NH4S%^^22VS/N@-O9!GV97^MPX.3@FI=K7Z6JRK,LC_^Z?%Y< MXZM&2=9++,EJL"$@LUXFY*2\W%[UXOZ&KUR1KZR1 'QH(U-^T@&+X_$2YD%9 M6$ G>HM+=[.T EH5[F L_\=[3\*=G4M-?]1FD+QMTE8=_\UD(6ZY'WP0B2/" M?($5/!IX *A"Q1ER-DF5D)\DV@T<'7_\P&RI* +10MZK(E+_"4Y0EL+E 6Z1 M3EG_L??5F$,O)&YW\;=6"F;N?MN?/0%ZYH,F-/BU^7 5TCZ MVW@IVM2P1JYOAP:VCN:%%H@H-FRLF+_(8I1D#+#^4F,KH3."TA1(V8#?. X2 M+JUF#40E&\JX!F7\8BECQ9#(&@''3OBI3;CQ>G'Q1Y>X'FW(\9..9Z,J+VQB MSA&7F]PB=M#E613+06=O?KZV6R0WQ^(AYJ!&5A?6$ %# 'SPU\6"T?J=5#] M(5N,1*!?\>W"FCEF3A-=)HG'G,.O9ABKZ@*'"8$-XG__[QYIE'-@N&0!]T*( MWO8%-6'8S0V]/%"]8E; 2S0B?J3K>*F.H +,/J/D0SR;VFU*IMEL9A/B2*6< MZ%Q*50K0/G,NX6UDRX5R)1U\*-7!#,$T">(F"OX7+'G[R>7I1&Q-\AX=&Q)&V<'K?L >'4J*'@YN:NPG M-';M:KF:H@_\\GJN%L0WWN@3[]@V##M*XY1N_;,:3>$9W2W/YDS6?!1@5+WXK7LO)) I-:0L:+D#8 MK1MK0'9I.$'9=8X[4&6IQF=RZ?$B%P%G$I_@IU6B@T.31;RYI]_X/5T>(G1\ M9#4J/5HNMF/+INS\;KV<3]9%UO9!\#02U^0 .A,J]0!R^"F1;'[8/!.700_IY$JS@Z"W5^?/N[(^W9_ZQ4&2Z8< M+"_EPC[JG-#,6,'O.\%',E9!RKQB))(QV"4&A\0&CTU:%1Y8JG.\"2$#+P8H MGJH<3HAK)6DVMX]#B&Y+E8[/*',E#\ $2<<+'R=34DR\YZP7I5'5B-6ZMJJQ MLR..Z&F7@SN& A:.+U*TQ3%A:.+[9]61SJVK;+9&CDDS4R::;]EZ46\GQKX%AA0TA[)[[Q\DP1Z MTU^PWR5C+Q0LM:!%F-+0X4 %2:S3+B>YT=Z?.&@PW@7R2(I2"4\[YU7CSVEV M 4SN2&*7O[V'GQ%D M=!O?9P-W?,<29:64_95P XLS3==>D>_S898S'XCT1&.6'9[U+(7!B)XHZ=;- M_*4+V0!TPO0'O)@C#8Q\$F*]^BQ!BA3\J\@64A.$2J+B&::^XJ1<:!T&289Y M?8*2S($J-W76PE9J+%R29@TVHH4>=7@+>:H719T&[:$:%B%[XQT !-@F9Q\^ ML"G7U@*V2=HA6-R4E9UA37V!8;)&3G2- X;03XHQ>4V^,HVIOM0.8XN)T-U@ M@IF>"0B Z56ECOB"-41Q8;"GX$"KG+$0G&1([D/44?B/V5!P7&S.TS&<=Z9' M9CEE5[(C M4-SJFB[:H R&Q>,7EO+(_X171:L7YWM)@ N46VYY=+ 5 M](@B(^%K.71E =LC= XXF8=B$@W1(4!IL.%97!2"ZY'J*6%CCK5)).M"0!2> M/F&X#M,+P."JX+4P>68^VD*.()Q)Q6VF7*2P8IS-+8AB)Y3KA@??,0^^.2#Y M/E%_&2;(F>+&>$S2Z Q<,*D4999%-C6\L+GAC+E"#,PH!#VJK+$Y.OOUB#Y3 MJ_2K*;*T7F%T.JJ+L9#SJ AY'BYKG%7 QA.'-Q:8?7[UI1O7!PH'G/E,81$9 MQOEB8I]SK-VJ4F2>\+,H W:[N5-W?*?6*;,@VT&4YX9I5"OO4TS4TZUB!OC3 M(!*)&@3,&;&WM/;=VVT)"9.:06.4&,2IP=A">:R;++\)5(2/D!,?+P/:/;@0 M$!\DXF2[>+L=D=DM,;NDY!JFV3=>IOUX$]YON&@X4^QL\!$6TR21 MZ7FTS.M "B [L9\$J*D8$1\-UVL!+%X/X >5SBREJV:O&3G+ M;-LGSX:C)LK64)-X#?-^B<^(;Z:9%T+GW=JT M&Y&\P,ZC$MFYK?IN16NH?GZD%YGP#*:JH).H6EUO9?B3:N8'5,4=R>6T:.0: M'[8Q8%G"VQRR,E<(45QT\!)@51QC[1ISS'?0+Y0#_HX/(HQ/Z#$JJWK M[0 MRD#/:9P&*O2ED+<8N"8VA89\#\CMYM[=\;W[98T*=K@:#GEWT09)NHY[:.ZH M4TE)Z0*Z !F;Q.GGVL>3*-!KT<&:NDD-134#D-7KL;C(@QQ^TX"AJ[#F+YA7#8ZV"]1X\3" MU;6_BUW=2R M=G>V?]V(@-5$P/ZJD,J--QEEFE/.R ]6 U/5K7OLEYV06UI:GA1N*XLZ[XZX M98UQY4!'(:>L6Y8QV#JE$A@9Q)ZV9I>SB6\;V^"ND]89LAM#&0L>2!79N6Y* M"))HA+&#B61.1XAZ<&['X/>=\WJ?N0(':P$6P\&%6C1:U;I'LM&4[OB:K)D[ M9DL8!'TQP1Y%BR[ORV6Q3XK,DP^G2L "34QU;YVW(-1'%P)NX;/@OGK@%$ 1 M2L'%699HQL0DCU=(1NM$ 5&&P7F<27H2MD7B'C!LR')",5\N;([#2%2+^J(Y MRHV; .;U%MAZ)XEA8)F4 MG9R-.IS8UMRHNN:&\/72+7&)2H&.JV\&]T>VTZ%HA[8LC38[Q_X2E/[$R7U2 M.VVKU1G!CY*0#: .:9/PKUX>"T>59 MEL9E?S"MXH 0!LI.%D6I9WZ[+.Z/Q6F-XVR.&0I@7A43"7,A(2884R* :2"@ M<9G#?&.2QE4JDHFI#AW?))UQ@!FVN*-0&^8GP/HX:8N&D7603D&ND;BT"GX3 M]2C14Q"MV%RN1E0R[D?)9;\*?E+,875NG-Z!GM2 OV]A4;_Q0VUUOJ=XZ\/: M9''B"KQ?)Z8@6@A>5\P"F70N.+M(*50P'%#N0D3< G2QO'"]1HF: S$6#T(@ MA%$,ZYR?9:EVT_'E\TB+G?19+^"?'U\?PC_'\%[@],O?KP H^P8U!<\=L:PT,W4[YAZIQ0?>2]&FDAWFY0O=$ MV\W1E5<]CUGH?"3B:3P!Q5M"X$# ZAS++I(,C]HK%^..B' S@;WJ$L7P.2JQ M)A/(*.%@$@T'[$N(D<44F JV,.O0T=)> CJ6J1S>YO."T!9Z$(OO:.D(V=S=U9]>ZLD:73>W=FZK.6]$"_W!!]6]9Y+!PLXTY9FLH@VR7*;8=MW5J'6A*>)F??D-^$>^1DD[:_1(8S6\%-<'G&/+O@>C]>*'T&+QQ8F0G' MJ,E$Q3G#$K2B)/#[/*NF;!.BBD*@-<1QSS-! S!HP"$J+$8KOE:BS>9"W=:% M6C.F"EJ FJ$[SQ05% +39JN8^?(0/ #58Y=ZFJN$D05:*O#V<(#-.L^TPMF< MI(1Q[1<]J4:%^;NM0W/KPY( W4F" ]V!GA*; I]<3S1K*GZ:!.@#5<%.58O> M1%'-#7;!-T6O:V 7@#RO,1Y1F&_#-HW/R".B5#0_XQDG6@;*D+:+'+7&]/!V MZ8MKYOMFO<2IF[XDKVDD3L"C4R*,"1TTEN?7Z] 6"PHY//0RVL.VM6DW6!N9E<]YDJ,4XAR3$<'$+%0D>"4R;9N>AIFTH*B\""2!(:AF^< M_!8X]!$($S_!V$\!_DB7T-&;WF?<\,,D[9!O#U.! M2?L,843#V;)"(UH4Z^ M6WVI?#Q"DWX-0F>L*<15I80>Y6&5*>('I!\1#S&^'!_[@U89Z421,ND@[9C$ MEZ;SGM12O^K,>[TF/FY>,J[#;)JUU_II5?![4Z7OP\>4<9SP&T^0V=\DR)@$ MF?U-@LQ_GV!8$6(!A, [=7$0_ .,L ++YP3 OL7YK3]LBF #DM*U$6M@9>8 M,@!_<"%2<)_Q"8GP"WB,(M^8<:,+R87@1#U3[#S.JKPL'E+G%P2U MP\=.=;)U>!Z?RWHH;=GZO&%;]2X"7&<@>3USDEC&,_@5.L5NTMI7IM0U0G1 MO<#"_B 1):IZ9N4@%662;*QQLVS797*7B.V).*#ZTQ_Z-Q%DL>B<2,J2^-D0?M (CSH'X;!$T%6S#%T['62MAYD=V;R']EK0H\^&&X'_:H!62MV^T M$\]3?@ZO#)N#D@.<-3J!\[5* 2SM^[)&(3@"Y"-DBH!J M\I4YEBNQ1"\DX#'!HV"VS$AVPJF' X_QQ _PP';9J5A0%C7LQ4S GODZ87IAMI&ZYJ/&E."A%I_I'&SL:@ M*LV M27BB>.,EN&.6L4;,*I&/M=U7E.R5F[H+2O65!8N\ XQXI!?%''L%"FI LP'!4)9?@@ M2;(+-VLK3FU1GOXRCTTOM(Y53@A\'-@#*MV,^WY;]-M."KFY*O.EQ-;ES[KW M8NL$_E2(>#P>7W#)V" MZ'WU 1?V_F_W]NRJ+F<0#XN'P;_BSW'P%KZ:H2L81)$=TQZ)^^%U)NH213CU M/T'3#/XO3D8:@U:U'%QG\R_^ 6*Z"%Z"RA@5P;LRVK[FIMI+?K=]O'VX'7Q$ M;^,K-8]+4/7M!&LO?$G*X4UMP'GR>LOM&=G2[A.@W)>+9XVU7?;4(WQL"1TV M%,\]O!^=AW";R[L56NW:Q3?X?N^].$7TL!4/[MZ+GF[TJ^SSQE8@/>]1;U^V MG/J<'-W[I@3\+Q07NDU%W+=56Y/9N-\QA\ZPNTHGW@XHY81*[,+'^M[78X.[ M2]Y>POE@O.+(*[ G-P>CG8A3TO8 LOGV;FDTS?I O+3'V"G)=.BSS=GPX[@+ M"?X""VJ#%K]OMW&D'!07;=2B^=+28_+MMK*VQ#="U<]ET9E"M>2\^BL,3!#' MW4Q=86#WY:3/,(8P%5 PYDM'8ZN)F_UUQ;5.O(P.7 W!=/LX;9N49O:?GN\%J0TGM=KP=-<1[,Y M: ]D\5(U;+^AAEUK]9=J0-<;]358IJ H[@WBJSW$18^I:< M=ZNXEG[9N):,:^F7']2U='5U\R9K\[K=K2>OWAZ]_OW=T7!P>'>+N.M#^/W] MZZ-/IX?_!*GYK1["M?V8?27?+U^-F]=2V7=D3EMS=WN,@WDO[ZE]>M:KW=L(RGJ*W/#S90UV=,@.6 MK4BNB-67+\@/?GA"?O"5TFA;Y3W%F3:(^M1CG-,.6J8ID%,7_;U5[_48/C_3 M)=!=\"@,/*+;V?\EM"FVE]JV!VA5B*IS:U'Q#?W=*?U)/Q+,I8&5.BW>ZE[= MJ,;GY^Q9F.=9B9'K&"O"7CG J\%Q2@4CW*BEA5AGN[1Q-1F&Q(\-2FL7PIVD ME9'+A+I3,>_6"::78&*,@4<(Z_QO'UF6.#[ECZZ=;AUH(O_WN6, MPI? *1#%C0'#?V5W3\\7V7M6HB*,8856H[Y%!'8@$%C#6A>W3%N>FG X]VD5%(']9SA6?4BU: M]*H=:P"./-K??M+IU-Y CEP'*'UA"+*&DU&C%2=C_5^$B3";PK M"/5$ZC(*7F;>?;J/L''DZ ^V@UX-R6/R8= %;>^L#&U-C?NGNAY&$LP_\QXC M75 Z'*<.NUCXB-P*2\\I31^TMK,T2[+I@@!?L6\3 ;X66N7C,^E8< ZZUYS3 M"^<*D_'QY63S!2MM#K ^OA[LFJ<1A24G*J"B L;+*B@[<58E2@O6-5 *?!BI M4H44WM@ZRRY"WD1)T+3PJUG&6[49N11/LK1%M..#:"-I(40NR,P2BZFF]'E1 M@;*Z(*I1R<)M(CQ6A4^OWA$;*H27P%C%)A15",BR,O3J=#K@P7%CSF'701,Z M/XO$'6)S+(P7%P9G-#/4#?20:R1(^'()V5@;D&P>]03)2- M*]P&];,6L C,E48"F:EI"F]@'#IYVPI! 9T\Z=!"\;B8E4QZ,RSXSNT'%BEX MJE,J;XO\O0P'[3N U&R4'7=7U"Z(TNC/@*Y'(.EGVD%U04SG$9!"$&648XO# MD$[/),B@0A+C;-78PS6ZZ&PLZS,\D_K^ .T)MV$89OL+TC87!:@+4S<8K,R]-284IWRNR MH-5D$WE^H?5GA%EB^PTU/7+,VU(,T/;F:%/EJ"9*71^3I@DRUPLU=4E4Z2-E M2?")J8SJGL"4(\;<4R@;E2I.>33?@!! GPJN4G'&18$,()#E;HE1[QV1)B*$ M14ZT;-YDEMS,5TQ'6<#MI4SF8T M!S:S;[&\5\5;)< PWJ=6=+M$L\3&1QEXQ,BNJJU$+5 MA2$,"F@K0^J2<9-XP[RLR56%ZWW6>DX%I=REK(M(31U+H29Z6JG$X >#%G%^[ M3-@B\J)E10B*3WH_@45D,ER-YV+1D]L]&$P?O1KY651; LU:)I);_A"38@J& MI1;PONW@CY8M;Z9$FIYF9.\VW3;DJ&#VW_+@,#CL+,/@'QAVHRS#KBO BW7= MLB5$FU/%B5?QBM8GV)6^/6Z0-908LV3M.AX68RX6P7VL920EG4IET9! TY*J M#HL,394' ;>YQW8&Z%(@^ (T N,$U6VJ-CXGTP8Q(%@J=)E=/:U ^I4TT\73 M;;UI759-">);G>TH>_VN?U,8,\(*TCH(&M;IMEU.^&6TY^7J ]R>"BQ A<1.Z7F-^S>&TL3FE1S>#FQ[KHM(C,5MP%4 DYO8!F9G2#LH-J MCM3>5X^ZFB[3U$CP3U9MM,K1QT!Q4$EZJZ-*-YPD%K0#:3( Q4). MR6A#MUS'O5&;+Q,3:_0=NI;:W&X>U.U4X-:>,ZQ.L'C^K39>Y*(K&()? R<5 MZ,CNVR40C"*[&/J$4$SJO@8>^VN"R-#O78 MTZ4&:;&-TWADVXRPJ1 C6^QTX73O-,8.(^1-P?.+KG2 />:(:0(!/$#XFG=J M[#]".QF1OIG]HEF"5HQ!GFGT?K4N_.X]\(D0$D8OPS3M%F/3@H';IN%VDDR M2E0AWK>$8MC21\J8:[2 ZM:QQS=LZ#(VM 8^W"VQ(=.O.8AG3%Q 0-3Q,:]; M-XIO%XQ:;F0F_9@MH7H1*P)*<<,P%I&&0,=I$UEJ&HC*=;1]2VJ?%]:'D$.] M.(.[7>N (L-MM@VEYZ13P=TQ80?$D>.(1^Y#NHIO@!I 6W91'P=Z]L'^=\!O M'=>9N=*".XW-F_&HZEZ*W6$SVL\8SF0FZ'&(1RMG1.;IBW?50;%TS:#X M8+I1$%ZI#8FNE$FQ\?O[![Y&YD/#[V^8'OS>;X7;A@JS[-EP-[JLP!:=6'K# MX.SJ/9LT LC$T\]-R-B)E3./QFAWP1VA.3!(;?B0CD()XIM?@KIJV'EG')UB M^3&:2VXTW02B;>A7&M)+*)_X&$%V,CR8 ZYH0_SF0*2/ZW" $+TA&?G"]-B@ MYW'(X.<,48[$DXX$QEW:9>2'IG^F2K"S(?STSRQ.2U/M2_("X^*UX.UJ/[=$ MV@;WR6_=B,1=Z;4T7T2P]#V IMA\$8'W)LAEQ?E_K!E2SO[FP\^\:SO[OSO;OV[X#(?C"YOD8\O^T6MUYP9)A.V0!U)R>.2(%XXO;. MUXCK&ZSQ/T]5\)S Y/3M"S&82@?IXN-D6O?_I&-XZGFVW@90RL(N')CMR/GS!"%'*-!#75HX<)OE]#E.23-@;+YPO;77358P\"&A(Y+?K5 ! MB7Q'#V\ZFP0 (0;)>YZA2%Q(7HA-5V5KCS/=14E<;_7V10O1UD"/S1P00P[X MRWH/G/AVO9?'_['>^D5[$#V)?(\TJO,:S.MQ-R#@E\;?F+,SE,%AQ#=_P EU M9C]%D8VY,(%S>44Y7G/UCF9=+[0F:O$<&J77V^QP\!O1VR?^94]ETDP5GVFQ MLI$#07WP1[C:A^T137GL=RHV0 RK_2 M-DH%IXZ&AS9=FYRZ&QNV=5\ A:SP3\Z#X63N#.W"/%NHA//=N76O.84%N]2Z M.$#/3"U6II(B,_P,?XS8K]1WP53KL,!,Z0LR,A#4Q3M'C[S[B@/(^]ZYTF/' M?B+(Z*X4I8GK%06B'VD0;Y,6-DUM^[B+/M8O3?>,7V3/G@5+7B-],&&=\LD81N- M.#-X:-9CPG5^I=#E\J#%4C\*>[;4N"P,I+W-CUXX 3HI/6$_4L-;QLN;Q9+0 M6&"'"5!XP\!/3'>6\V4.>@+UUI-L:_+O8X:/_0/$L$XCLU7NK&%<18[6+]40 MM4J"MQ*X\79P@GHB[0OYG*V]&57:/64,=$JFWQ-WQ MT"_&W7RD&(/RSME/I*G-["H:J74]%IR!#*(5W6-%I]U @5AF@?%?Z(Z3LA)> MVY3U0-5D[S9DQ;^09%-@BJE>%'!5MR9*V.789&_ 0K)F1T8[C'!UEL1%B8" M+8JC0BL^2"T%/0F'N/P#Q3[1F6-9 %]%R/2%VXN$7AW\T-P%2M(FJ$'3IMI7 M(N1%M%#7&2%0%M7AJ=S$;>^8;:Z19=A@FU[_98K\)=KJB;,L9;68>N!$NJYC MLMHS9K.YW^DO8STG"@*.A6D6Z+]N=1SIQ#.\5EZ@PR%H*=A/PZEB:"[N:DO" ME YD5[&NC XC"NY$:KF )]?%6,0UL1$>V,8]"7L.&^YJV\3!:5)7NW0ZJSB[ M_6'<#3;T46ZX9N=T;3V>71H^!+N/'INC9NR3./C(YNP[6-16L/OK_E/N3T-J MJ-<1-FSTJ#%5I;7HE 69O)& F]"ZC6@X!!!RX28FU$O]Q:YW6A-C%D M"NM3^6WHIS_F=6HDNJD<%QD5 5R26,32YAJ91=R*: 6,!CY&*C5.%B3%YJ)\ MESGH^J /8UF\.'K&XRI7XSKA,==N=38)=K(4])C;[Z$:3C:?:^]M--YOA!G< M4OEKS0X:(.T-,"S!]Z)D/'2J3G/,@W6+[1W&L03].]>3A'0SRN>W1=523"T9 MA3[70-HF^WG;OE,R]2KV\['>%6Q* +X)BKXYUQ=6.$U3 MT)?[ZJ,\) (/]P%]!%2BG5(O4XL&T;H '=E*+I$2@$(UF0!YH44&%X/H^DPQ MX@:[^:W<"YGUHU47-NW../VS2@D> 2O8$NPF09R9G12M==UO"R(;,B@=4 4X M!<&@P);4<-O*Q0-IQ.X.!W^Z3=@E]%2 >,'SZ6A0*R[NOC;MM:"GXC]X+-+N.L,_W6>PS,)M>R#3JKD=1%V!J,[K[N$[&: M_3[QG$4MK>+);P9O1I\C%0P'E///IAH]*T4&IIO\UC\0Z,A@:GZ=!GPW[M3_ M9M*XW(7<0@[7[B:'R^9P[?Z8.5S7I[ ?3'ZOX8/M;0O?$$5^.W )H2[K!FZ* M9\&0A'5$80#"EES\%&-M]EJGTE/2%,-6TW9I B2/6+DQ4U_B634S-7RVKHMZ M.M,ON-.Y+: Q0'1LZFT'QV*-C1,E93WUI&.5BB.ZL!(_:BVM%FJ(T?$9IJV; MV+OGA[A(4DS81)3Q9%YL )%66%>]*)OA0$7V!./493;(6C&<* ?)L15)PK[L M+76MYDQ%P?U&*26LSGGL@:0WC+0F)4%*U&,"+_17""\D18!LP22,:_R1>%RA MZ\ Y!6>@OIWZ%6<8GY7-W]C8MTQBUZCROIT!9_ ZNVLX?Y?J9^U M4<1=? ==7FCM00$%;8]D=]?KEIWCEGNS:T/D ;S % MT,W,U=9Y-T:(A'NM! M+;>6P'Q@>9I&T$^D:<:Z%62Z>I%+<9<@_/K45C]-R(WM MEHBQ8+:XH*M[V *P),"J2"/VXU-])Z(LG U6S#DZ$D/*=RP+<=_)E"N=%38T3(9 M\A*$O7$I\I(;A.+2G8#R&NVX4CI9'V;I(;HI:=3@_,)B#V%F#PUT:Z'L#8M< MD44^O3D6&=99T2T_/](6T7EM7+@2%2]B1Y*U+T?TX/ZU>BV_=*,[+F\1Z'MAW7\?CCXX_CT_=')24"] ML3Z\H=Y8Q.-8728E,B24>9L3W*6*"7^-R%X$P8&Y?)3.8GJ/WUQK/E-J\7BE MEN_?:6=E,\B3G[KV^#&/23>F:]>CPSSQVP:W9KB\3[,,]*A[#7VM'Y MRNT0W'KD:>,1HO-[+ZP >L9/M__9'&_=#6.'ZF:;Z;Z>QM^%F'?^W]^,'0O> MZ,J408!*JC'PN &HA<=LA(OW=Y0!,T'=C(RMYF_1D6J 3N@'G$[#SO)C ML(2:I1K8M]THO18<,"',;>RBUFX'N4(W1VN/WEPW,09[7:V=F*V;P1IK@PQ. M!Q.3;=A&A14UNDM[;;T.X_(;:5L>XIR;==B1J[O=A\XX]B5#I',ICF)_Z8K8 M<)AX#@#C+^Q0U+L'N?%.K_V7X+]#H/!*.,_Y*@M:HH;V,,2;ZR_?D 2/=X O M>VG;F-!^[X6_AF:9B+W#GSPC=:F8VM_QA>>U5M\I?=B8<31:Q^4QIX-&B?S3-4J\1:X)O0]R[L/K?U,KUK>GO[U[\?\! M4$L#!!0 ( /=&@5C6&W2[+ 8 )LD ; 96$P,C R,C@P,#%E>#0M M,C9?:F5F9G,N:'1M[5IM3]LZ%/Y>J?_A*-+0)H629H7IEE*IKQM3*14-'W:_ M7+F)TWA+[IU_:R__AV+W]=:YZVO\#0^]+K'%FAX+H*92?1X+$)5="G,S@3 M$\+M[($-0RI9:.%$G#I8S-/T4N^2F(UY%20;1_H0)D2.&=_5(JF"1%OU+AW)*9%SJ'5/^]ZRWMV03%@\K]ZE.1VKV ^:&8K^ MG]?=?VI[YQ@(([-N%PNNXU9>PKO'Q_5>:CQ1A98D; R#B,4L@3:Y8"B5\&#+ MNO/0,!Y0(W77*3G[QJ(AD22"SX33W);=IA0DB*92:7BK(UHL[,3!]ZDXQ!(< MTCBF4IGJVY'IPWA>OOZ;U+%+"= +N2$Q%;]C%;SXD?[SNM= M(34,I BFOE;0TT$)WN;P,Z^N07>^@3R?N%81[XOX;5ILEOW].E6:A?.,XI[0 MA#,:4DFY3X$I'!!0T )T1#1&6&K".$KSIY)IPR&#J?0CHK!@&V-)Z01S8$- M- V *! AG! < *X-2++OT]J&I=(>-);+VH;1W+ 2C*B>40M- MB:_2_*R+:8E)0OA\652Q8.2883E]E*!%$J8Q=C_0-@3*1"$>- 0T9!R?1.@S MNJ8B$L<0D0N:3IY0PAD?(UL9TI#2&#)W% M#,Q!H),2$BDNF&*"+[EMIQ=YR(L%3#X0D_H C)#ED!L$A"*.Q4Q5GSM67J/9 MZT"KT^L-&NWV58Z3VZT%K<;X>A\^ZK[#AOL*"]LX6:"RP?YI-X4< H M997!\HHVK6O-:Z\UM+4S8*Q5)54\*U*6>L8&W2 M^J'TWA3IIM1"0MA*!9F2 C(14Q2!D MA($WC/N2(A-M%I,R2X)XOF039*=XOK ?LV0[CK-.*8T@8"9")+XI:YEGLM"; MS8IW9O8N!G9_@;XEH+OW [H7"6S25K#,,K(7(QR:+DZ8>N2W'/<&/BF'X46Q MH*:(XQ1:V6J&NS\N.,6Q,54YV2DS!:&[ LX,>#_'30D:OH_](D(_GMN :YNI M0EQI-JR4N"O9C.-5PV<,5ZL178!Y/RO&%P?E5GO?]71O6KZN%RX19I',TVPN MD:.TQ$VEO7B 4DV$TQYG??95J'%6&#/3(5ZMH)E:ERGSE4R,MSV*QWV M".N;RET?USB2*(J[DOS*2L^Y;B=)*S\+,P37.C56]H\L=]..YEZ''^ENXG.G MVQU>M=!GC7Y["#VOG6TOTCU03A:YXHZ\E9JMEL/_F M$9%KSJL;/5S(RFMF4;K-F/C?H%S:QVI3(F;!5:/Q_E%F[*D]?,%Q6_DOB4MZU_14GEC/KV?\X=K[V"QMSO!#96XXMKT[NO.)YW-UA/ M&W'LM#)[-GQU?+X\O*#WD'[@S"RY_LH)UQ\Y7\.&QGPXV92?WV-C:+X>K7U% M7HGOJA?7,;XZ#?N]CUC^+#4_.3 ZH3](0."##4U.F?D ^ V.E20TAOVR>U N MNX__,^7%1]FLC\Z.D_P%02P,$% @ ]T:!6&Q1?CL; @ HP@ !H M !E83 R,#(R.# P,65X."TQ7VIE9F9S+FAT;<56;6^;,!#^/FG_X834:9/R MOD;J$HH4 FVH6!H!4]6/#AABU;&1[2S=?OWL$+J71%.K)"T2&'SGN^>Y>X1M M3Y*OH?/^G3WQ1YX>P5QV$B2A[]CM:M36]M9LN[?>/<3)?>A?6CEG:@#=3JD@ M(4LL88K7$/$E8HUJH@$Q%B2W]$*]=/;2=4-8(E$0-@#CVAF"PH^JB2@I])0@ MQ4)9CNTZ_N."S(F"BU;7;KL:]>P4^5+,%!:6\X'-93D\<1+-*@SB!&ZO(/[F MQH$7C*+ CU^!GLY<,_PC5S)R0Q_&?AC&L]$XF%Y?6AUK\ST;>5[]_6(\:Y*I MA7'MG UACM*'0O 5RYHIIUP,8+T@"FL#%QD69I*B4F*-=?MF;?1J)U&=^3L6 MBJ2(UJ3F7"F^M+:RMA.O=MR&K.S:C^KH)U_T<@,H:8D/W'% MJA(=4T3]@"E:XJI2B;>;9AND=_9;-OO<#D=SLQ)$9B15A#/@.00LY:+D IF) M)WSZ$3VO9/NZ(8KYQU[GO-'[?-'H]?N?]I1U!UJL%:<@PB4B F:"_\W_OT79 MB376"',N&$%'('-GI/4_,*=(^P;1]\"=P*VS2&C.G68P\DO4$L#!!0 ( /=&@5@R/=AL M)18 *![ 9 96$P,C R,C@P,#%E>#DW7VIE9F9S+FAT;>T]:W/;MI;? M-:/_@/7,[<0SDF,[C][$KF?LV&F]Z]@>6VTG'R$2DM!2) N05GQ__9X'0((4 M)3MIFGC7OG>FL40".#@X[P>T_\OHP]E!O[?_R\GA,?PK\'_[H]/1VSDY\V)EE:O!4[VWDA1GJNK#A7"W&5S64ZX"\&XEH9 M/=F @3#TLCENG"7Q/0;OB;DT4YV^%?CJ]IXHU*=B*!,]A:^,GLZ*C8.33S,] MUH5X\^/^\\M_;+%(I84R&P<_I&.;[WV+E?[[Y/W[ZQ^,_:O,]L31U>'Y\;4X M&QWO'UW!TI<79Z?O/HKW%U?BZN3=Q6\G5Q_%Q7MQOUV4=Q^/OA MU?')L7AW\>'RY/SZ<'1ZW+HO=1HKG'1[ZY5. 6-J,K$5 MQHQ,8RO.BE@\*V:JW_LAB?'!_M'!_NG!NVR>R_1V__DI$/K1P0^&GFV*F;1" MQEE>J%@4,VW%99;HZ%9,,B.N5)3=*',KLHDX,29+55;:Y%8<+J2)X7V<4Z56 M%CI+:4W16))G:J\XZ/< :A45^D8)6!SFOHB*;*R,V!V(W>W=%QU3G50CCF6A MVE-NB7(V+PMYV=K:^Q_&V"&MT>'1V(MZ=G)U='AX?GY[__-/&]@9]OKX\ M?.<__WYZ//KEIXV=[>U_;?PMFA\664XP5U^,LZ+(YO3=QL'^Z,I/#S12Z$@F M?E,P$(7@_NC8O['0<3&#@1LH98\/.I[PCO??7YR/_"-"20%4;8$88=DRSY6) MI%4;!W@>^&HUW<'^KP>7RM@LM>*Z'/\!!P=@"$^"O[H7GX^N\#^(R-9IWF// M>^+^*N#[R8110/!V)I-$R#P'IBVR?@\$A!@K,88A.IT*_*A20&ZDY#A1 B@] M*HV!V>@18AVX\F(RT1&@=DN< H/$L4:6& CD41 7L7;IRG:(Z BAT?2MI6S M49&"1S&R."AV.0'&(?9H*M8M\1Z>YJ7),ZM(-0?\RRP?PVLXRV*F@4_7+=KO MP5"GQ?WZ3F,[X,]U*M-( MPZM7*L^ 5>"U#TK:$L0:[%P6A:1] 481%CO1*@;C9Z&+60:&B%%3E$Q R(N9 M0H.$9I\"7Q0#<:,LS8>G(6_G*)'I,-3ZS681R&\;'*\"*4@# 4V\H2>)]Z D MWHLNB1?:W>'Y/BI9=\KT(",]H"9!3R MS" 'A-.O94R"'T"^RXL:@!0$@6?7&C,S>=,0G#AYOV<\T4Q@-TU)Y8TZ MD"9-FTXLLC(AD_!TGAL9%2QUMVK/KQ+4%;([\$/H0.F*5F6_9]$OQH%T:#/\>GS[LE $E6 MPB[[/?PR( 9"8C=$,"'\B5J2W@;+MQ+MU7!+YNI$)PUC$PF+E6:42*,+IR1- MS<#]WIV>LU=\M6Y?:$ ZFL93U,P&]PZ[1"ISV*J4%86$\.%-EI1I 3"@.4"4 M@8I:S?,D(_W1[Z%'[S3A-,MBQP!>&<+#N.1E_%N 9%N8DLT#/Z>NASQ#2P(9 M2\\U[)Y>0;0F^D]8F0R+3;\!LH.3FI-IXMS $9YH:Q0=5T93G M7+<.O*?Q' %B8;=V2==]J!TVW&'+FKN!1FCT? PV M+TL.&(-V !O,XUL6.Q1R$+9V'!L^#:![X%4(G T.S!&C1<&"/I$+? G G5A5 M6>$=D/5[#?#E%*Q_ZV*-H*^"1P @:;[/PQ? 2*$1WL^6.,\*/!]04!S,P7>! M)=4T@T^ &6=(U-H3!"_E#6H%MNQG-1$1JB3G<5D*#)O/" SW>S(!51/?^E%+ M"A0=3ENBH0++>UOKQ?9+CX%K:<8R579X\2E1L$A$Q["[O;V+.+L@!%<&RZ$! MV31EE1SK5SS.A@[IP<>6NL^CU@WE@'E@L#>*\@ M>VCRCE4 9HC"1A@?X0WIY@&HS&^X9E/A8#(U0/Z_QNS'8RSST,BQCO;$N9PK1M)Y MAEO?"0<]]Z/P"2)W_SG@I ,]8^"C/X=CA1+I+4@\1'D(XNL.$!&-(4*"0P]I MJ+%D"!O"S(?U9!$^#(OP59=%>!B#O:+!LWA\,8WE^"T(<>GP@7(<]+9&?@9O M&A4$VH+."^O(<7B;#8.-)5AJAM.?&8 '#AC.[JU#PK05*;CHUDJ#9D\."CTW M;&B X1'?:$N& *IWU!?@J'$8>$N,&GD=HX88G706J4I81SL "K)3ZAVAX>JV MT]A,0T=U1!3J^$"_YRPPB@R0)N.0D%$3P!B,L#YYZ]2I\UXK-'7$G,$\J%5H M-8T;3UO="C,-%'"JK4*C;C10ACN.()3!>,:H@8I*0(:&2=6G:(8&"6'9VBS2 MS@AL*.PN6ZSC $+F+*.M*6/V:RW'A ,Z!?8P3C'>!DP.F Y6\I M,8^90I1B7"T*M%4MUR*\T7N-/PE_ 6=7DG!=C^;X\E2Z6I#=8 MJ6E<^U H+^;EW*]4:3I\#MX3YN30!P>YA#H&74:%"SZQ[X-BWQ^[V!?+%L3D7K MAF[CH/@BDN2[G'&""M4P\ MS*4I;GD[Q+:4+T!+@(13$-4@ZP&,![8+ &BPN2AGTN]-2E]3Q*]6F9,\0TF! M.9YL#(AW%M92+@8#;6D[&#=8']GD#X+G';$R>^"N_Q2;23 M3Y&"(3(,5=?)[7YOR;\)V<=%>+%^F7(&3?\FS@!@E(^4P'!.I"7[Q]L.55FA M+VR$+P><:6W$E?N],+"\)7X/4R/+X7=?6\2N*C(L&E(3@*H &Z98*-6L3/9) MGX;P#9?[EBJXL@.N($ D MU_%H,MWJ#PQ11F?/N7726[00X 4\0D&J3: )C%(:L<6!?2$18(Y9N#.X M;RK,(,)K\J^B_./;ECOJBQA*3KD]"/?S@87S=Y\B]RYRO_L4N7\R6;[09'G3 M9;)<*Q+NC\]&&37#J$TUT^]A95AH5(Q5%5)QBF!2)@D&S5UXPLE_$.A[/K$. MILPL6R@J36Q'363A/"0'0=O.T>@TE1@;YL7+M-'5@?KJ!K89!\58[2@G>TC5 M E2 MKR-N?P41EFJT.D@T*FRA+.51*[H""Y';,(H4SNZA/'CC/0]*&K;0D0C MJ(/F%!"M=Y/J$I6@+K0=T*571BAZ,$ MF6DZ0?T>M5@AE@9BGL4P!;U3%7ZV\FN+6>8E@<"HBG BI0 XN=>+ZEKP$_(< M_MM=<89IFV:=*@B=:M4&[W--;2,\Y/TQ#G=@S2S'HH)\68+B@/I4Y&?ETW3* MV:A?MZZ?./QA<7AGL^8Q=MF2VV4?%4\WVIK;F8Y68S-PN9+8T.K;D+>/JP)$ MSP:'43&@P?ATN$.]#&4RE=S/K8PB)>B"")J[B@RNY6?Z#";K]ZK&KZ[&J6 " MM(B8D]DT:)D<-\ M2\X.]W(LVPB/_#C9%%O##XW 9Q# GH3<8JI@L1Q;"M#X@F*,&5>E7N@R_<$5 M5FX\0I8S8 MJ]AR3O">"]! #K23Y3Q6JKDJD/&9OKZ+6; M@SD'S_WX 3&C6@-:IB;5E%!E;G83SF)&)5+D"F52'6'EK-=>8ZCJ-VD$,[%GG$9XV1A_6 M>+^N!CU&V^<^*=(73RE2ER)]\90B?;"4W!0CX?T4*^3),[E)DH&=(;"TT8)6 M<#[:); T^%NH8#6GEJ3%W!,YN)0NH]"8KYIA&8W$2"W^+V6&\!\,&&<1>6<31DR&.JYP;NH M)T=5#^_#@ I&>MT/E[[^I7%OB(\7KHB> 0CCS6:M$6/M1F<))R$ZK*-9-L=: M;!#6AKJK:\$."A-S&)DXA\FH=G+WWW0CY&ZC#A6;L7.=NCQH8SK\UZJD3JJN M/ GPC\?N?J:[YQLX_4Y']ME((A!:&'*5G)BT<*X^XXQZD/FLVD?E8?SL]>'S MLVBS#0%>T@&D15>JP)* CZK\"+R\X5\EL"@65:$]Z*]5H1L\7%:5PZ9CL( F MVEV.,C:9C-$8\G505%"ULO<&'D[@16I84ZI8ZBR@CNW=UY31>;P0_!DL%A:UKE9"1HJZB0;J^ M#(/^2IH4_X6CPFY!--LH"%$Y.U2L1]Y.F;M0%=^8YB\["[NYUERU9EU)7!B" MX9KIMZ00^"ZTL%9\K*; \A0GBU!*X@P^5+)'(@TOI\3GB@*@]=-&UM1=#$<= M=LI@Q(5KU/G:."YBA_=#-.T1(P+G)*HMDP".KYD.W6,I$F^&8 8)F-',*#7\ M"*LPHIG9<)K:H.WWQD--Z01H&B72&19!J&F4QPQ1W5Q1GR?KJ2 MB'-XSZ 63;,TZ(;DCGN\W*8C!!->J\>'7&L?JJ=KQ"8#8*S7?PP/ *W I3$N M?@KF+KDVVMIRU85[[,^Q85&!7C6UMZ;H#KN2\3O>##,HE>E-*34W*Y805%C4 M3/8,[D)1ZRAMPM\HKZI9W M&J&(W +GXLY>Q1YW*YK/*!M#CMZS]S/9P7H_X*AAAQ3N+5WU&* M%\'5"4#_5CQ8=G!77(Q*4#3P1YGG"5KJB?850LW;G1$CI2D&WJE"J[VJU,&K M&BCT7>]XG,6^![11Q; .#KX'PA'($FEXMT0F-O/WTEF^CX.*S;AOQW'A,^=I M(W];3J+ #MB:6G_7,]++)M&;)LT94LX$')9LX2FG17 H=4**0ZIGM]DM6-.= MOQ5U2_SBZ[RE6-Y$W1V&.M06<"2W+2*K6UB=$'3;Z/<0"KKSV7O#$VWJ*=!D M28&U Y!K'P4O&;7L.Y%$FXB4;A7,Q,XN.&%I,;/+/?C=G/< M#?__RNO[W_O MY3XA]I=/(7878G_Y%&+_1C\55-'GT<'AN_\YO_C][.3XYP\GYR-Q>(Z_BG1^ MC7^/+E#7\H\JP9M?_+M*1_^4#1-LPZ/K'UO+B10NM2?SUL+W^'M TM9!)91S M>26%?=?/W_J%))ZD^A6F(+>Y[C>=@KNM6!'P<+[%A4&6+/QY+P6-KH%>^4-) M_I>16C^'%%Q.0.T_8)>!*L,H1V3TF T,4N@T567R?I-+"+Z-/;MQ<&BY>=OU M"//=ND 7J-/7__Q%=5=H'?)N41FYVK;N\/H:O^&!!F!PV:VI@B7M>\'X^!M$ M#<98J_5LV>BH\@C<'NW;VFWM1OHK;],"4W8ENI/XJJMY"_>/32Q$7>TKOY=1 MU21H9_-V;,'1K"TQ9*=B54=CE@':ZO=&:V?INAV )G2MX9,@HM2X9&4)\E6A M#CK)9H/:-^[Q7M.Z$K:JM%M9/AL2USR"O2Z571.!;2US"QK>_[5!BOGN?A7^ MW<:J,^4N.ZE:_B6NOA8+H^/EZ=W@W>U_K7_OZX)![3!?A([.F1O].GANPXF< MZ^3V[5W-,OR3>W4'3[7<6EQ\71BN81Y94*U?T$KT=1'4M9O/W^)7.< ?XN#7_];=\?]5].0>B7/!'/_T/B^0;'\L5$-])%LH+J.ML< M_^\9R.UHS-<,--_1[MGE-+[Z]KOM"@=A\\/0QQ-6A7U6;BPPE38:HXGT+#AO M\# (#]%L';$A?PX8[W#_#>,=#2"_$\Z>XR]L']!/;N,O<_\O4$L#!!0 ( M /=&@5ANZ^[#R!8 *D; - :6UA9V5?,# Q+FIP9^58=U"33;=_ J&# M$03IO1=!D%Y5! 0$!(4@78J4&)#>B:*(A-Z4#E*D"8CTKD@3I(J $8%(!^DU M$)(;OO)^.O=][]SO^^O.W'WFS.S.GG/VE&?/_G;Q$_@9X*R.IK8F *! !O" M!^"_ >H .2DI&2D).1D9&04%.24U/0TU%14U,]TY"#T["R<'.PL;&Q>?N" 7 MCQ@O&YN0G+#814EI:6E.0045>2EE\4O24J=*0.04%-14U$PT-$Q2W&S<4O]V MP[\#:,F!5) -,8@'(*(%$=."\!T )P" 2$!_:\ _&HB(&$Q"2D9.04E%8*@Y M"Q"!B(F)P,0D)& P83:8, ^ :4GHN"6OD)XSO$O&XTXO]2C^)3GOUAC^+0"8D)B4_?Y&2FI:;EU_PJK"HN.1M575- M;5U]0V/[AX[.KNZ>C[TCGT>_C(U/?$6A?\S.S2\L+BVO;&WO[.[M'QQBCD[] M @'$H'^V/_6+EN 7$1A,#"8[]0M$Y'O*0 LFX98DI;MB2';7_1R/U"-R^JOQ M+RO?4_!>,MIDL/48ICS/)XWFWSIU[6^>_>\<"_V///O#L7_YA0*HB4&$Y!'3 M FK P9%0[D/*/R$%B6?3VT+]>,#R'&8\&OHV2 ,/Q&M:'RUE#S1/7ZY\VXS$ M3D>)7'W)/P"^\0FP6^L/9%(0&H8?*&.OMN@R>4&M)<*EOX55'TL_T6!_G:#+ MP^%H']Q@L'VURZI7BUW# M>Q4="0L/F_A4LGP__4*AX0#:K!WW8 MDA'CT0)%NV$?KN.!U44\X,#P?M5,61'>TCRVK2WF0?=*\QWX(05KP.-!=&._&]8JF,_.+T.29490\=_37H(C55L+Y[LOVNTGU MB2Z^YNS$(,Q&WP[=E]&%;W73- ZZCEQ;-R"8%USM.3F+W..WDO1Q9'DUUF_S">W/Q#5&#E/MJ,HU&@&[KJNSH?H(G:?C'WP899=Y M+:PZ1B+29)Q><&F"E,*+Z7&55!8J&3&VR)5;[6-E%WE^+.?$M5>"HQBM)3VH M8M[=AEJQUM9]7G3W%K74@.\G$$'$HN)U(8U%#1S ON.U!NLK[A8*6_(.C/CGVCLMQ#.KHJ&\;I]',O?[*K)/ M1! 9\WC ;UKR8#%M5^+0F!<7VHW#(O:6?M/5I%JGWC9S]Z>(C[RE&K3ILX.S MC/+*IKPS53V.0D5?=*@-?3OVB(KS>(OP[^3A&*[C M@9Q*/-#&>1*@6A/>LG$(F?BBO&X>L2Z+^?Q1?#AL:KX2,UZ$O8 'XO@73X(0 M/W.+$>W%G+OGU0X(?VB%I4%8LQ(>()^/&IMVN81)P*0CX=V W6ZYA0E/TK)' M9]IP@?S MB*+4&YS5;50+A+X)^E_^:%*$(SO/<81$TQ [J/0WAL C:-9&G;% M2CN=*;9O\$JLVF%0JFB MX)/N,?78U6'$7_JU%W(:(/=CRLQ8Q01G!SQP1[1- 9.2Y;13\%'U?BH7D2_' MY271/Q3L_/? G,ISM!?:#:;MK^7?85GW6.ZMC)L/R=C2@Z4_M>U7+HCQ%_<< MM!YH@?PFI_:+205[C81-".PS*'$$LG__="UE7> JU%F4FYDC6\:EMLT3KA"3VY)!0!8;Q &4^8L@4#TS'XEK4RH8V#LG>%$_LA!WW M[3'L&K=A SIQ,SCCQ<=H4S#GFMU[/)!%6'C7-+$OXI8""NCWG^@=*G;5]$(O M]S(N\.50?1.'+)J;FP&,P^,X$EPXHU' MPX>KA/@A12I%Q ^?65T[N(AY 97M\H*E5\M1MO-R3Z:;MRH5WC4KE9G93!HJ MM?+_]CT/8_WI6"[[T: %!K$I\G,I!Z+2,GT2+A^V<5#P.5/^7O#:6:IWW;>: M'EAB0Q@\CMCM]%JS_.P3_.8J-;[4JUG%5?W/-2!Z7RY$L/O/QN4YWVVKSV7?=D+P7P[;W^R:4# M18>^::<;\57LG^\H=%P*C%V7JY\=JW V^UY;V'J1@ZJ^/@UU-X)737]VTEVO M3+R6+IBY0H/>2$@H-\_7=+3IC;%A0L<,)1!\Q=V3IJ!)SUU$@XZZJLD&TE7) MV2$UU3/D)-L&MWDPKN_SK1!+==@:J5^W.?/"S\>4M! M&@-O4!Z?B#VVQ0,F2M*B-F^RZL9U3-0.B?;V>F+ QDYH^):#KZ M>SB0>6$<[;4 8&,T-#],TE@)H^I(V:[>OGC@DGC=?B#LKBSK9H-MF!(ZXRE\1J41F49ER4EM>T7EP\\C;98Q>UYAUK M]3FV',1B!_$ @A7K]&O?/] 5._U0S+B1 U-D,?GMZXNJ6KE;=$3=S5R+#8(Y M#,^EF?<8S\'&K\X1)U>%BQ*=:$&Q")$M1,TD'AC\A <.MMJZ8G\=I+W3ADN\ M,Z#+6CIBD8X1&I/_8DAO(Q(%J(1IUP>,#[3!&O! =BH>V)A%1'/^,5A%1!OL M!^)L6ZN;.#5<.:JAOS,&2CRRS&Z7O?'S4[>/+EO6JX95M"73CM5"4FF@%HR= M<#):%%XVU* '_E-ZVIS]PPX3PO_8T=@P\]F0SMW M.'>,<0TZW"VUM)0":YUXL6*3H09R9D(7X>TQ?W_--F:2*8\[Q-$B<<>+_KF9 M3R+,AON!."KXAEEDF(928JAD5F9 #"Q-#V84LP)+;D[JESOJLLO$I9(A(VJ4 MQKEJ/CV):-X:U%9KV:LPF!BMR8@1]YM:9M>;BBQT"8C& U\CQ>)N#/'GBSR; ML,"^.[>#4)RO*.=.8[V-!)U3A[S@)CZQL\=V%42:C;[<"6IJH._MG-Q*Z"X> MM TN";>J*9/747KKP+>OY5FT;&9G:OG>#0[?3[F/SKSFTKL<)W=)$AVN(BJ% M@)AVEO;9L=7=HO+#]D5<+"JZ2*X@6"B3*-M08F$>G&:^G,9&(IQ%S@[:?R50 M5J3ESX^RO"X8[].T-ZD"*;OF?!MYB/2,7'*S\+/3KV(\-VEE(?.6G)E:IR!% M._M#E'?Q!:R,P]T22&V?V'!YSO-*'B[,$5MK #4;5$&U#.%57O7](U=PTV.. MII"->:/."IE5H;[)B(VH5=,D8,IH?]JQFG/@N/2ZKP*^7A\'!;/J M959;B0CGNVSWTO01;?E]>P<6JYW6MI$?O-L;L<=-VSJ_9"RHG9K7N??T;/^]HB/?M11&/A9BY7A&= M3SN00V.H]2Y#..Z$/P:.HXJQP/M)8T$X)!O?4 =]$^'!#>8Y _Y^H"'AB.MB35*BK) M$G^;J)W(0H^:V,8#?UN /O(7RWC^;MFHE(H&,T=NX:IW4_)/X7WEMM]F&S;W M$U "T22/>_F=JEX0 W.+!; _0N5H5*.#''&XFL2U'F[X1S2](XK^T_A+ ]6_ M8&5^#\5[$84KOHK5![537KFX:]0#DP C\6-+[[M^GALPSGVZ%Y@+TBC]CAJ? M<$(T^%\2*EPH ?7 <=*(7TY5T26!XS3NRAQ,D^H3S_TC>_;?CI M.%SDI^W_3RW=#&@$S3*CHLA'F80F_Y&H#=='/>RK;CC:"Q!<$!1W[+95U,R) M![A(\$#Y#F*IJVP]^5920U9^ETB?.NO?N1A/N?)^Z9>5B/AG>S1 [1C_DD%H M(?A#LH\D DTWA <6WR,V:O$ B]IO(U1NC..DPO\E)>EMFZW1YS.]ENU+^JCB MU.O(R*:JE14[FQ5>5=&9?M/45C'H%>DJ) 2KJ>UH!@\<493@6 DE#7:#0RK,' '\;0CF@?&D$LCFQL(%&$!X<3)M M7V (X1>UX9Y-N?4&AV8L!M@C2YPZEJ E[&4^(8D%TW-J7;$E8[B;^T/KOL;A MZ('&[I,G#CA=4[7-:NELS&X3-OQPS"=YBTKO3>"&%&KN)'=YT;)$'GP&HN+W MZLV7^RI4?3)[\O^8L]1F=L\!'YFT5?C0?:_ M%B;<0JC4M0GP0+>MAX B"(I>KKV<7"^&)0XK>Q:NIB5,?'O_X*W4LZ M+@E-H8<2^9FJK6&9J?+7UM>=!I #Q3ZPCD2KH9V/ ?[X[1P[ MZHX8W!XAM51:IVZ9G[IU>_.+1;JA@$S.\__1>ZU30ZP(AJPD;I:S_K;\BA?< MA!UV WD$]HJQ0%M7D#%$5M.\7$T7&_$/V]@7G M[+TU3ERH:&+386*!Q9U!RF^6I FREZ^S7^\N4R_ :GP6\XI4TKY0GHH.L[/- ML8F37#4_,:NXT!"0&FAJ[3DB5'[N-Z-_"6;Q:?9%"?%;,#^6.4)G6/7LG MWAE:LOA*^T=>UE@@+#S4M"?Y#-,9=XS)JTI,ACO%AS8M+]O'W%1Q M[^&IM=DB32Z<)/F.5A1;'25BDM MZM;<B6RR EU'Q8T,*0Q_]&UU\_&H#\K MD[QT$];H]*:V6A[I]G._3NX1A5-*@LYL8WR75MF9 OW;(R1,TYY)J&_J<"4# M8/:Q9E!=_=>ZAXUOIJ?OV>NI^Y7AQ5#F$"^Q2WH7F0"P>WU=R.1;6YCMD' MDP]X:1+JB7EE1 IT+3M<)5NC8M'CV.A-Q+@@SOAG9FEOD*BW6^"6@&[ZM6]@ MY+SF]P:,O_Q:8G] G;N5J\Q4;LCUM0_+D)0CH=SZF(>Y2"&0Z,<0(43/>V<\ M8)6'!ZZZ[)5L6R,YMR^:(<:+"+@QK7'3NLOZ4C;M)MME9OFRB*!+)>I.KID7 M.H!SS1;< Z37V;:#2SEJN4?%9H>E5YUO?0H,W,\RK=V\&;:Q\=BJWY'?]5:H ML,JG1+;'KG8/S)-[LT*2HF)2SD3E1T5_8&:80JWL^P:TY%\]7HL5SUML-Y/* MG5(IG%OO_:YDZ8O*CR4F1$;H4XA. MO@I2*0E^8D7E?3&E&1U!7SNX 1]PO_-4&&RKSOI$A:GX/196SL'UV:J+2OF9 M Z[__,*FIFX71L' 6T5**-%T9'9SK3/*5T\PU2F"S8-,C _L6-%+9F%;8%Q4 M]VR2=SCCM6SBH/+-U_=9H+3%-I<_RK.-6)CKPI3?]-8[971U>$TJ1HW;>?Z( MU(U,SSF04JEOK'W^78=-Y)5<_/()3*+CJ"RF;%[;?HTN/X$87KVF8!OT+M@@ MZ$M7_F2"^Y"^I*ZF9\U:UBD 5^S#$<[ZERQ;BON#($1/IAT>(#I%['=3$#0! M:>@06:]10PV_PIQ?'S;E:OS&D5['F0;=+$_.%Y5Q@086* %**0_85]C'&M@Q M7*D;55UG(PUWW0KCBNO(>2?_$U8'1B6E376K<@LD'V"9MSZ'*YEO'Y&]5 MSYRH.%.^ 2?;@-[S>:DF3ZR@]I+7(K6WBH6/G"T Z$\X4VQI_=)?;9 M7N %HS&&JN2D3NZ=F]UU@_W0?3IW#7G?WTY9T( MFH"]29 )_8QKT<(]^;)J/#=-KS9G4TW #8:$7,AXS[1%M3JJ\L[(!PCEMNST M ]<5P(_7?GFS!UE]G9' G'N-F+$^HJTX5W'_]*HUIK8I<4(^GGV:N$Q3Z^A, M&7I#*^&EWYX\K#AGLS%LWI"#%X3S@F&= 8U3(!CR@6"-/V*7UA*#V.)\V8<\ M/!. %*JXO]..%,J!X+_^%U!+ P04 " #W1H%8ES'/$^X" "7 P #0 M &EM86=E7S P,BYJ<&?[?^/_ P8!+S=/-P9&1D:&!"!D^'^;P9F!@XV-G8V5 M@YV=G9.3@XM'A)>'FYM'4DB87T162EY.5DI&1D%%3UU!24=91D;#7%/'P-#$ MQ$1>W=+6PLA&S]C$"&0((PQ*A2)&C1,78 MN(2DE*J:NH:FEHFIF;F%I96SBZN;NX>G5W!(:%AX1&1445E57-+:UM[1V?7I,E3IDZ;/F/FK$6+ERQ=MGS%RE6;-F_9NFW[CIV[#AT^ MLW;MYZ^.CQDZ?/GK]X^>KCI\]?OG[[_N/G+Y"_&!F8 M&6$ J[\$@?YB8F%A9F$'^8N1J1RD0)"%5=&03<@QD#VQ4%C)J)%#Q&GBPHT' M.96-@SZ()A5=Y!)3,7FH^A'D-;#/B/-8$UD^@WL,X:];##S,C,#(8Q9DL&?X M?K@G7'W?]Z/FFY>(&T5E!ECV+NEX^$ZB].";K5?\)-<^X?[>-<%NQQI^ECWU M'WINNRT65!SI'ZGQ14_N3P=5F[__6O'>>S.+_L4$>Q5]V/EB377SZ]BXXB_KTH^S^K>?#MG/=RL^,BB\>><_PSM>XNM%*_I M*=?F^V[QV'?AR?ETY42U_PRY_,D^FSZ]EJS?%"UNY^4]->O>W[[J?T*Z'NL./CQ]W_S"IK?G MKYM$9HI__S6E:MZ6B^WM_VS?*EMZ;/[C\CWKI:'?VDK[F7<.S_\9VO__)@!0 M2P,$% @ ]T:!6'\2#@2* P + 0 T !I;6%G95\P,#,N:G!G^W_C M_P,& 2\W3S<&1D9&A@0@9/A_F\&9@8.-C9V-E8.=G9V3DX.+1X27AYN;1U)( MF%]$5DI>3E9*1D9!14]=04E'649&PUQ3Q\#0Q,1$7MW2UL+(1L_8Q AD"",' M)R7L MXNKF[N'I%1P2&A8>$1F5G)*:EIZ1F55<4EI67E%9U=S2VM;>T=DU:?*4J=.F MSY@Y:]'B)4N7+5^QN0X>/'#UV_,3)4Y M/GK\Y.FSYR]>OOKXZ?.7K]^^__CY"^0O1@9F1AC ZB]!H+^86%B86=A!_F)D M*@PSXCS61);/X!Y#^.L6 P\S(S#RF 49[!F^WS\VX9/5M=1_.Y=EKO*]^R7P M07K>AXB_#,]VZ M4; ZZND8OWKLKNM;(1F>[>EO-G(2JTK?!FBOF1/2D:FG> MO?LM^C_# 2O>]*/G\LY-7^BD]_X\S]\@^_CUG];<7L^1)?[MD]WJM9ZFKQ=+ MO+VXS^% NL1_AM?A\V[&Q[R\/O%NE-?%LY(G%+Y^LUNT-R4VL^R"\[JXN$JG ME,CDGGE%[@I\R_<_RYYG]'R_X>,+1]PES[PJ>5FMLOOG)G^VK+4K*VJ5IWK' MW)JO%FI;\:)>_ZEKL939=J&*4Z_>'>*>O/RNIE&2\N''E@>^_RL)NSBO?6G[ M>G9?3>VM2W_?**E2FYO\^/NF*[I!V=5;C:*GG1/=]?C^CC^K%^_?G!ONN^M2 MJ&*7F9O@(DVY:,W'MAL\5M24)EUZ:?BJ8,)V,2'.T./L>97_VE8<7_%C]I$3 M0NKO)UYO7M%;<.!9R_, M[NNZ>9J^M.)O##)M>QU37%K0):J8/*73W?']G]7YSA_N3FM:.KGD>M%'U2-S M-M$EX>; MFT=22)A?1%9*7DY62D9&045/74%)1UE&1L-<4\? T,3$1%[=TM;"R$;/V,0( M9 @C!R/!"^OA)&BC*(1R>#_ 09!#@85!A5F1B4&)D%&9D'&_T<8Y!D8 M&%D9P8 !"AB9F%E8V=@Y.+FX@0JV"C P,3(S,[$PL[*RL !E:X'R#"R"K$** MAHYLPH&)[$J%(D:-$Q=R*#MM/"@:=/&#BG%241,GEYBXA*24JIJZAJ:6B:F9 MN86EE;.+JYN[AZ=7<$AH6'A$9%1R2FI:>D9F5G%):5EY1655D MR5.F3IL^8^:L18N7+%VV?,7*59LV;]FZ;?N.G;L.'3YR]-CQ$R=/7;I\Y>JU MZS=NWGKXZ/&3I\^>OWCYZN.GSU^^?OO^X^+"C0:CZ$>0UL,^(\U@363Z#>PSAKUL,/,R,P,AC%F2P9_AZG_^U\:MR<4XC!0YF MO8L7A"\M^,BWN9SU"8]7"'5B_9QWI2]LIYUZI[)!A&/ W=V2*RW MNVHJ::I]V68FAX7+%]$;%7,F+CS??&7%W^Q)%Q[V/8[] M_]KB6:IK"K,-C*:=\P]^ZRJZU/[A1O_'[JZ/3/@7G>&T./'RZ[IBIVV]IK/+ M6#>?#WZ3L6BN_4.#^4?Z7G5IK',N_G\3 %!+ P04 " #W1H%8)^(8V<P=05-VR[H8A*R("2D8!)8M*E#0H MDH4A@Z"@ BH@(#D(#(*($@45$8$A9QQ1D,R 2E1R4J+D)!DD37AK1O]S]-S_ MW+KGO:I7]:K>6-N:O5=WK^ZU.GR]]D#X0O@&'=12TU2#R,C(H*O@'T08A%0@ M&BHJ:BI*&FIJ:EI:&KK]S/3[]^W;SW:(B8&9BYV'FXN=D_,H_TF!H[RB?)R< M@C)"HJ=.2TI*\@B<590]HW!20O(,40@9#2WM_GW[6>GI6<\""(C)*,](%^?.G;Z'!63_C5J7A?F,_=B4FGXSA?5L1ATKO!+ M7'<-HJ4[?(25C?WX"0%!(6%)*6D9V;-R*A=4U=0U-+4,C8Q-3,TNF5O;V-ZX M>F[?%)>]* MR\HKWG_X6-_0V-3.TUUZ)P^]347)MXS]VB8S\>D M%M71\DD8K+!<=^VD.\PO.79\E6@:R;+_F6%!_UN6_<.P?]HU .V'D8'-@S%" M<&CKG>":Z>8CT**YDM'1YP:?__Q__I8P-]Y9!%5:Z< ME&NJS'IDJN<4AZ0_ATNPC-S)MN-3FF'EB;Q0D?DD_GV;Q+'W01ENC9:R\W*[ M85"Y*O/+YWL?UE,HTUY6(ZO@ N[/5,D-;X.$PITW\ M"G9V!#/"DP3)_;R;\R*1[E,]\=N8&//P FYLIY,D"_)@?MD/A*?_E 45&Y)8 MU$CT9#T_[[1_DIH+D6;6_(OQOQ-C0-+JEX;0O% E<33S+P5(M!E_J/H/Q75^ MD_JW,W8M_S+X3\K*W^>?_\GXRXQ;/ZPPV"1.R@F8%$N\&!.W360V5WD#MR!Z419];1UR-Q M)P;>3,G(%C"'/']Q,Y,QPA2IIS2)W(9]89 13)$2?FN#N61RBHQJKQ>;I MI'<8'EFFBPUD H0-,*]S.T;/./SG25)RH)N ^!;^F#*=;Z>6;Z+J9G+F85RP3)'$=>2S ZL MH;G:7E8@'Z E6]BRZ^G=*YZ'5#IZ/([-VLM!0G-=+Q"Z3Z%Y>7UU>R@,2*<6 M\/4_+=\]"^7DF8<%TKEZ9'4_*824P A-M+F@XBU ,)+=S;1L""C:#0V,;N:F M4&1:56MJ87P#^8D*2>\UQ#ZK6P%\IJ;V]W]'9_SS-"WPGOKJ":#1>=E\#]ZF+D8:C 9)!(KDBA>$!>,K-)B;V:- MA3?_JM_,&O, 6$ZPP:.C\,<9PE_@9[$A2F!94V@\2P&;X "R!GE,-RV0Q9@X MI= @D9-9?#A;#T;WCJ$->4R?-)-18RI1+()(,EL8#5@TB?W2;2ZY"X7!94(;I"%!"%^&D*HAJ10O53.5L+@1GXX]P\B9X. MF#11A)"QA1>@R00;J7R 1)Y.FC1)%3K?,E@#U#M!4E*1N*\4QHZC8"R#1)>% M'F$Y#LF0J,OM7NI=*HG_,(IHB>?F;2X)OZIV1OZ.]OX(4U,S_/$^W7OIGW)H M%' 1^5/+@XF)'G5Y]SDGT[F^GHF-N(Q243K<5U!2QEH,:\:99\T MJ]99.!'SW7'$UN-9NL'\]A 'YPS7;&Z[N$#':'F](<4',&W,7L[.U( \NX/V0*I .>U*M%$_<;B-C,55E MRK-RW7;-?8$\Q 2L7D@,%-B39<.Y1UNY@.)F;JXPV#5R _1(!G&S#A$5XO"? MT-0:]>[2H[Q;N>"O=#QAZH5Q(F_(^8]%LQ"4X-)3J-+V,K&*#LU+\^4Q1Q;5 MV5E?([FL1"D+ZN*3#WFV!T[M^3>F;BCFOKFULZ>ON;9U4)U,XNCC:V[-G#?E MHVZ1:WHD*7'(.HU\\V':WU"G.70Z]@[5'8A_UU1\ J?6M?Q^JZ]#ES].B/5+2V[VQZ@3K4]ZWZNN"=?1!- WGMB"75K< B0[>K@TQ MW1]G7U2M'[HM$B7SZ@PRG+5V@[ND]SZH7Z%YISXBJ2Q#G_=G8@4)D'$> <(< M6;-?U]K A/#,EUAMC>-UK'1>$*"*3U,[R=S4VZL[>/5TL$KJDJ:-*#5-XN8I M4QJ7UD1-CVOH\U,I!-7?H:6FH'OSF5&;\]O^%8E+[*8) R'=BR+[_%JDSZQI MXK>067(=E.%S2VF5I0?)9^O>A)5_LHY(O,KPT5@0[2%]B\Q4V&Q_/,WHEBO# MEO(GMU&>Y$5FR-"+$_=A)PPDF.%6XA<'">LEGL]&3_OWBLD.3^/'L/4K!G+V_M@&]>,L1[4V(!M)9PW M=9^&>('*^J%E45Z8?0I8A3QN(2"L! M3ND,JTIEVG(,>*+Q>1#1A#R-R'"NN$7.U0BXF)W@0_!X$.UT!5^(MXNDZ9F6 MNG/(0EY23\+C<[9XB)K\3$ D'69;HX$H4@)R<@9C^N5%)-4\4VADB+3Z903H M#OXZ"'::UG;B;$.C8(H,W8U=R(EDBNI/ E(*(DEL:D4!B:IGY3K(EWY*)"H+ MLN(QT:]$I5Z2J!H+F2$1Z0 @ .Z&!/PQ2IM*@1PD4OVXVZC'^.M9H(0H[R=- MEVGB. IHXH@%5)Y$'MGZ%G_)3)80D7S\^;5QS'LIN8%!W86.KJL" MSN4_QJO>-CSOC]G^H*^QM&2MO!!R*9YL3?RJ0Y?U2F2&O0G'X%/Z,Y_K/ _6 MNP5^<.)XY>HCRS9G:341O<,E!=_J)T#*YC]&.\NW45O6[MZ&R!XJ[T/[;+_W>C9R)EW\@$;-1D'2TP=G)+_W@ M>5E:[NZ(1"3-7'?N=,G7H-SK=Z#F/.EHV^-#A8[%Y7J?OSIA5QBX=AH#BLD" M_@% "!! (,C_BD J]7LBMP"L$%;=*^'2P'@&'@:5,Y/DO'*":8'<*,"&J-1- MH5"D5S?@?I">0IZ<)/1T8T[Y $ "P!USTL(@5R\ +ZJ5 NG",G-R( #('(&; MP6;!R,/-M&" PUS]Y_U/$UV)+F)3ZC@1?FD9[_4\S=_*(=<"D\BB'DU&[SM! MRS-GUSW;.RG_T_@U740N$VP*XS=CR"%(>5^.#\<73LQ1(#Z-3 ;QRS/ MH!:8<&/8A:\U?,BFEVX$Z IIQRWAN/%H] Y3")[>2J5^H0O/C,SK18Z&[TCY M9/I:O8_>-$?OK2)/%+Z%;UWRPTB(,JQ.K&.CU0 &VTRK4=@]H]NC/Q &L%R? M9Z*-Q*E3>6JY(2)D#V&)$]1G"X7;7E?$.GR*G_229UVD.#ED$W6Z>4-I ]H; M-AEY[WWM*79M)E =(G?;O9ZBXWBIDWVX]Q$'_JHGK)1Z=)FNV[M+I[)'NCLF M)I$]Y+88TZ=!QX-KS3;OHY\FCP>*&GJEP$&;,2](5G,=Z8^4<]"(W_NTT_,S M]6V0NAD4:#@ H'%M>JG^&9,D'H\:M6I[1G01*LE'IPT"4]%P'(-<.02C61L^0H-(4U,=#Z.:8$M(+"4)+#'"!J> ]U6=^R%=F 8\^2"\C[2>/IG M!%$<2'LG7Y!Z.J+=LIMI@90Q$H 1L'9U3& 9>V8U>UQ/SOV(MSF=-']]J%6:.>WT8,1! M!!^7O$E ]NH9>@GCBB+'DW;T55EGQO5@UABM!Z/C2=7U/:?H3]B>:?'S#>^*/;V*EW["*IN M@;[)]#Z;H,D$3K[#8HBOZ0:>2GGW*V*OM!4?^H042X;;1G7NX=C'\"YUJRU* MEV29H]OMAD=G9JQP9 [%VX8$Z"A(:KL[/+O0*_%&GC4Y>^0R&A]8$L>#5V/Q MAS=UE>YEP%]-T_U*A3;;82U^7*YDU%LQ7@3HEFGD/P+,ZO< ,XT&#],7\!?& MD,&F':MA&Z@040K?'/[]55;-^:WYOP66XR_@\.(J,IH'->FKR/P@; Q+SN40XDN6$^2+OMQ!EZ:"? M_8D409L6L @10:(V0(\=%.[ZJI"B$N #Z5&9QI<]*@.D1V5*13E#T)X%P:QL&CKZY'IZA8/N'JD4 .<2<:XH$H-JNWD7L_N=9 > M(1:V>7NMB$U)"*3%7"'393WJH.ULO%JK!;X&M=,K)H,_WV>UN6DM4ZMH;O,@F#F&\C0)5Z0VR?P!Y M GT4;?7'[2O.;-S@- %2R3^%EVGFSEW)QI\[0H VU^ ;9)>MHN"3[CT$:/1_ MZ ,5HTN/\97Q0O@B^ A/6_7+<1GLHU+X9IE7-YWW9KLO4*L'P?#\)?X)^@C)M9FYLPY%/?=G'=X5KZ2V3H5$S:C%[E$ M7_=BYN!K49=BI@?SZ=E.I\ZET&\[%]Y,,+M>%CD9BKN>.V7/6E(H-1[E417= M$O.#+S$0T8-3GS$6W3A;L,Q^S?-5L&M:\>7O7B/?$M?<.G:-:,<&2TJ#OCI? M/[QPY\9=:R;6EM62(]--4,2$;/-NJ>?Y@=O' MJ@0(YQ>-@TR/_(Y/O^-93KJ'XQ%8OZA0GEJ1B-6RQHC-7V.?&("B=#6H23L+ M7!=/OQLEO$]@[\-._UL_-8"CI&?P%4!F*MWJ4P)DAEIFF+%L7F5Q^3:8C-AM MJD#]^!/9-#ATU?P3V13ZFKZ/B=^T1(R&I_ZP'Y0@0![//ZV?J25 W'!XTP8 M>"I]8=OKL\W$E"P(%11*F\A%?I?G,N9\S'YQ\VR387>U?9_E2_Y(I"\;K_$! ME_O'HA6;%]3UI 0!0B1>0N@MNQZ 1: 6 ;YK2J$[$B'CFI$1 JB)(4<=%?Z M/>%;M_[E<&P.L/7\GQZ.T615OWM[J_[SW)'X04.?!D3FZH M"F-UC$+]VI=\M?*66 N^HX$N]QIA"=!0 KYK./72*SZ5TQ]]G*LWL(TSE^$? MQ1R?:[Y[HM5SZ9)3A*M4509/A>X!$:3^RL9N9&]$P[Q@2#HV+":FQ#4[RF>O M;(:/.DO5Q5*^L^U)AMJTWHA_5UY:G B[\+M>CD>*K9[?#GG'"PQ-U[_+T4R/ M)4#W0RT \*W>PA$@YU6TX;:+CYO_6&/@-K\@6K.;Q+IQ_]Q^S]W^44E9L (P#>^1AT?*!*^VHB-2D#M+0 +Q6Q# MP=Z$6"'63OZ)0?ZE'9OXN[ID/$& 1@1!3_#X-:8N?]:[^C?XCI9$:V_KX_.- M"5" ^&3ONYOX!?'GT[;W\ H!R)C9CVZJS*9-/#_/+33(W[KOY695E3^P8XNX MJ+Z;%(SFG)R)SM;J5 B^-' ELCZ_9>NXMM*I0S=M81TB[KM;*?3"PB$K%0[Q ME*^?*>_7#I*^R4D.1]\V9DWK#3[WY)3>AP<>_/[#@SCUD0;%')AGF%!V@+=( M="9$@BC1J%ZDL(-SHS$V!Q09+#Y_1W]]%SVES"0^S%Q?AC:!" M@%C!^'!. -(8FZ#$.=*(L_TL'D0+ M='5VYC'/(&U5&>)@Q-EY4^[W@>R^"5HS2JVYE^T&_"NU_;GJRNZLBX9HJ;$F M8EX901(+!N]+7W/I?O.OKNKS7DQUM:(\)]\0,"N0[41="+G3]E7)&*]REQXN M\N?TK9Y/&]+(2[L!08V0:>IM]=(M DF]5D6T?R)S#[Z#=!.[;"JV+?/?QB4B(N-V*8M@.-4=]3+"1L.]_ MG8WWT-8!SEWX'.>G3LS[2]E8RKE=SKR:2X7( K,+GG_ MS95\KQ^J^-.@E/&A]X+*VCEF\$R*"-FVS3G\>)\9(G"Z9LZ)SFYHO:QP-1W?F MWV[']5F)?_X$PWICP71=@AF*M]#12A%/2I@]TP+I!'^['' #'@#P0V= : E M5AGB44@@8\VBNH',\,_W,#T>O+@!B%AEXD@O$8CG&+[^@$V)^ YK0XI+ Z"K M0#I?]RS#;A"74:"E#^0EEJ/F$=1%X@FLWO-L[ M;*K5(T5OV39^W)N<4S[4L,@X6MCML1D/XN)&"I4WIEY\['ZQS5N+Z&*)X(KS ME9X37W;[P?[L,W?>A=43H'O4!.A103OK7+^YTXL;SU6<7]Q9/.3R3.\AK2R_ M3;*N2!0ZL_9;CG$J6YN,[]:2=WR5CIFQ2WC'%F:_@PYZMG.> 0JLE/M.7\DJ MNV#)5X!L.4^GLT-Y ;,TG\,M<-> MC-K=(^&H63@+J7/HF/8ZQZ-JT>$26#F;+7 M[$DS_7$_UH(D'O+,.$7,X^B0TXR(H%X/J R2_WV?WS^%%Z(GV-8* _Z M^W,F[Y:_+V5_!86H^(K]+K>XY?.5=)Q)/AY+;)I%NO 9_Z;KODT9Z=N/I@Y8+GKKUH@B!WY'LL\E"FCFEP!I"54VIB-'3T1.=&*6G_PJ M12[%=T:WFC-_DOZL1K*#Q'']9>Z?;!X:&,]4,+XFQ5M&&E%FR'"NL).)!FBU M1H=/=L#;>6^R W8KZQ<#&,!&0EJ@W];/CW '8]VE/TDA(0#\7%R"/P =THD" M)4GEJ91(K\AI350MD#^]1,9[ S!U5OG*X-9ND3TU86E_-%84M;GT?>:A^9L4 MNI9I$R?ER]QEDS,I^:4#]87W?^@U5V=6/E5GSYE#C2N%=Z-\H2X0W!-2,M6K M2BB*A-L,/$_NU'5F7I[<3_]!@0'K?4?U4K#TE5B6N'-/FQ70 M.5!4ULCC)*T:]%AC7BYL4A7_*C>3R@[;S'LQ^,AN_SIT!^MROWG1B.E# M0FUIA) [4H&UKN&8_MN3=QH/>#YI\$T^6XA@]FZ!TU^V^/C#X++/?.LS__@Z M6-E6H9!!TB77NBLQ!AG7N.WDCYE,Z 5K8Y($*F,UK]0T/5%CBSGRP(G98S+0 MGU(GZ_+\H>$O$MKR@V?+.)).5Y-Q6\C ***S_$4 L A!4^/(I@D09@(K4MRQ M:=OG'NY_[IKW_7G=#^O6%%%E/PKMQT3T+_?RV=Q$,.KF%[--K6$U5P_I\(86 MOR^';2F%+IA;*? M[C(A)DJ NJU!8"3LAGW1HGN:$%2-FO1V7V6Y^7IL;-EZ+G'E%@%A8N=@;05J+3N]!OK9?M5KN"4#F MY" K>A3>5"/'D-BP+F3_( $Z3JJH5VN]+2_.X)50*3_,"P9Q@],8 U<"-.'W M8D;IOQ3IDK^*=/GO=7U$RN*O3G.8U$Z>M<6:+NPF%Z["\:HV@+T8KV-YSK)R M]>R]E3<'D!.+\G>E?%CN3)'.R;DNA:[6:&S^=ZGH"NI]%DP#TX:#D-J%XD0"] Y7]/Z_=!0S!KWP)4$%X#@&Z]0]P'2-K]:UW0^%&M?@8_-=Y MCFF":::?X%'UO,V]5<^_:2?SA$BU^VRKWS%H(S\F8V!.=8W%\]8WH M]#?U:1:SKX&6/OS[#X2&014@U9CMQA5.>7N4R+-97WO[.:(,DEV(CD=O[QE; M(!B;E:I_:*8>-/=_K'7"W79DY_*WF$C,*5C-+5BJH@@75C4SPUE@P$M8U['9 M2& &QG_WFU>Z1@_*Z*6>BB33X 6\N>:1%LW)4WP"J1,*-Q/2Q8,VYL0BJQ * M^FQ5'96E(?+G5RME^=BHNMF^52HUK)>#K# MQJ&I$%4]__I==%T-6\])L;?PI_L'.6AH:UG?1QQ(3'1UM4\](L1?RIP0YAB[ MU)/272+;Z<0]-1-O_I9^4&T(+9#2YG*)QJ/;[<;5N]W[+I.QZW*>:2SWD@QE M57""I!DNFO!@Q<+1NQ0J! C93H"8KC#<]W.0>52R+]Q.U&!(]4@\FXU8LDM4 M4*6P[7:8OEMLIT]Z FN%U/%/1_*EQ!TE61<*?7J1=BXB$+TCCO/+HQ]^.9AKR:MYS$2Z.TB?#I@"K":+)GVF$,=AO?862U_PL95M96[MF^9 ?@L MX>>U"M)[],UM9X \/# XC^= ?:G)BD9LJ!3#[BZX4Y%:L*('.$:W%$S_!N02 MM:KG(&L_GDX%@,@ W-\H?PU?-JY&&MXV70'9[@HM%D0YG\D_VJ%JZG$T]EX! M? &H-DM5M?OV99JVTKH&(Q:O,' 6JV?^N\ MY9R T_Q$@"+7_C=.+RI320W2_YM'Y[0$Z/>S<_C?GYUGZJL2(6 H\> <8M8G M7GJM7I15,8VB]\Q50J@QVQ[,9%(V]N;C<[M))3'A2O;+/A:>/5?JU)5]^+=J MMPI]F_J6BK69'%T*%!@?$Z!RGW,+_:7=\!"CZY-=864O]4UMO'QW2OJZ=:5K M::D.J5]/2\[<@@N_DLGTU5.NK+# VL<'&/3KW5I? M;1]K'O:Y-5IY^EHI8_$FZU9S8>MA_Y,3%PW3%9QO%!C[57UC['$S%98ZBA8L M6;,1?ORDV/R&TY-Q_;M/HV'<-ULC8$=0SB90,W2[=S=NEM51?FUNG;)7"_.[K*"_T) M&GYV8Q:5"QYJPW=L!O=Q&#[^?)?3)=:W+WR?9?^DY\;Q<2'+H:;N7BGM3_LJ M2^Z+/N)ZE,24VR:")M1_[C,( A96 ;*0N>KD!,]N6,. M1M&2O .TXT+G!@PT7_:YS=/[B$5^SUEZY]+4>LCQX_W7MSGW7"X-5BDS*0]R M9AW_XJQY;?IT'<4IOI2%)1?SA",/1;'JMF*]L1=S.9,OK1O!$F%?4.934NB' M77-RO2/)DDU3AY??^L1'#L&ZN3>-5I[EZ71'>%B@%WH,/QK>9Q[L3/"2,5_8 M#E(K"G)SZ@/]0]15?9CCWF>-1LO1NWQ=6=W%PUK372UWQP3+#QL.MGW_IJ5] M:L![HDBI]W/CJLG-9TQ[O*?+@V86J^<'T@6W/H$E?6Y Q*=7H MJHWK.?ZHS=NSZ)/9SA[\+A?Z^E(/>4#E3R/+E5+5SPVA[->MMB\I\1.@Y#[, M%D ;Z"N8P"K5G.T'?;A-JD<)1XP18M(KYTZ4H)^;I%,;>+Y9WV'49M/-*.>[ M^]SP_9WJDK3+P^VB/[IV\N5L]R7517T[0"L[N9G?J.DCI>TPYR2C2?XFMHC2 M3B*9-2I/HKOG1E5IX_/2.]LM/V1?+?$I%XT9F.@IG?O"/AV5B2PF0-G#R%&0 M@MCG,Y]J93#O;/5;T[T(NY_HX[FNV#95H* X]DRFY69)L3%%_ >F)FBB_T01 MQ[CI@]'EX]TN48[K./O1R+<$B Z_@MJ9.8Q:] MVT2\S5ZZ%X.4+HA^9+4F4XJ[JXYSN"S&VME8X?)5?$T";6)\*LQUA !-N^I( M#B*6,^=PZY:=!8<"6#]K-N/;$#@*TS"98;C6CVIKO&8$YL#6*L9KC36GU10O4F +(-!"K4?F_L&'TZ=PU\+QRM4 M(^R+"%#L5ESNZ<;<LY%_+LL+,]NE- M'*LMICX E3L.VNS&SZ.;G9@7A6@J9--4)K*?U-'4H_!*-P!+)+;5T5L"KRXF M@J_DP5'T9UIMG]E QM1K;Q=M6KWHQ_[1X;2'\\Q+HK:F\-J6-R^7W]PK"$"^ MJ)'?7ML)4'^+E0%:R(WB*T!12V5?NV*-5TD W8DVN$O81#\@0&L"%L#:2\@- M/DMMXE&-_J^CFLM?>+;R1C"Y[T1P(ZC-#M2_+; .[57_I327_K,THUGP./69 MW;#_*VX M P4?MD?Y?;/?HW8H !#H;P)]&J5+ (!U,=V@[OHC-RA?=?_;P\M_M#B\"__M M+X%._75"@_^[7P+MVX=EKT%-DUX?(']_?:#S;UX?S!GIJ_KY;%S[^:-'8C]C M7/XZ;-YLTO..81#SRH>CW_!'C?,$H8)/T0=N/7^B4"JG&M$E[W0CEO(Z LU; M/%\RO''XKA]PXU,"4^>_P')E9ZE4(1!-[_G&,+N0'6J;#C6&L-HW2W,J02HH M6K54#_Y,,\/RRO"%]TODF0'?:Z_9OP;Y[H MI85GPMY;LD%+Q:/VVF6V;QZ9*8%GY '(L ,&(J?6""2USLJJL%;F MYJJX)K*#1=]L$@_TJFOT3-?LV(:SZ@SN+*"R3OE&,#6:,UV[BMAWBS'B1/C5 MX$[''N0Q'6?:;8_XM[?,'9AZ7AKQXY\573J2\-*GUJ+)Z(*VW,Z%%T&/6844 M7-I.=%SQK(F\^J&SL"=ZRGQ8S9[C9?RB M-<-1ZR=TN&/ ML^P2,GOKUS_PBL:<%>-\Z+UOHU%WI+RI,.]DO8UUZ7VLW&+YAMC9E[V%CU%3 M( !HHD$TSI)E(;\)(T/D]7HF#X4[G+DPV!(G]%B#K98_\.[-Q FI@ :O\C=C MJH3&9N11*MWQNR5OF+#YU_,0[O6301T-_?J!K?#,Y<@Q4C1KHR#56\.,5*9!2)XSNE^ M%[7YT_-T$73;OA)/.R4W!"H&C^+/9UKTZYSG]S$QV2PJJFYZI>@9^2%=6MU5!N8KU% M=FF,31'Z[Q)S^7*IN\)?OQ%&OA=/"?DBZ M+/_<*R%A\-^G,NS_P$XG:-SYW5A=^;4@3\NK2Y>;[[PI>!T_/)Y!^H MRG?C&&R<&6A)MQ:4%9#E2SU635:[8"%Y)23F,?[P"C9^7?**XFJW1T5BP/67 M_^(WMX8O%\A?/\2+.'G!HF[ OMC^6+WY+.46S,W?-)<(Z8\ES9DYYIXBFHF8)8J4PH:&F5P!Q8KR)OV^L1:LJ MB*-C-69Q2=U::^)U.L@5!G2S)/^7,"4AN8Y,E5_6+6:/2H96)0Q;G21J>1\QI*!P? MJW65Y#K%L[N)6$E;-WJ,V3UF:[9>G7R8#_XA>4^79D@^K#=(192QJ4GOS0-A M7S0Q[&Z4_I:VU->RD+\[L;FIJNE._)T47T^(^IAXT=9_9KY MKW[W4%0*[='W/"R4'5),T\"D^EKYKEA%]*00!]A!3]&!PPF??9_8WR= PE\* M*A=5G]W8D[S'_O5B= VO2J /M.O1#!(6XQ_S(4 ..%EII?;ZVFP'R '%8\]N MAMCJU9G9.+'*[AHZ.1WJ8^(+Y4NAR7RT2P9"SO;/D#.H&RNDZS..'54O"ND- MIHH:-@J2XZ:4&UB;',EPI8ACZ_J//U&B M><4?)QNNM\E^"YO-DQ4; M*WFH2N' >?5)B1H5PAPRNZYQ3".=]8)>GF*([?R3MJY]+JR1M"WE+V^^B+!U M/7MY)C@Y/=.AQ]7B@V2,)K_6,N-0R //Y!?,9*A,.]0-?Q?D MEBS;/"%;2)O4Q=O9. VW;9/8[GFJ1RW[;HO]V_PF7;/RW1F7NMLV-\L:? J%"L?*OLZH MH:=>>PQ)/.":UX)N1S1SG#GF"0NA9I-J;Z9OR_34%B) 9JF=3O!>1UD%EY@& M%>B 0UK.>.D#JIBT1_J9CDO*4]&Y*52#%L<+E,P/\QT//]W,GQAKGYRO,,?S MA/V^II*50G.QT&2TGTMS4X-WH7#476\G:\;V0TWW@AVOQ3QV%82)Z'8SQ/F\J3I;B #;Q1]Z 8T;4A>V$-*CH4] MJ1/!>)9L!<;+[SO:V9LY/$S8J*LU( @Z10D=DZ684'K_VLFFIJ)"R3P^.^+: M=8L(%H6#7V8_))Y2E#?!J;U;R?S05B3XHM;DSMFC[FQ@308;;X=8*]^++]+S MIMALS%3-N:SM[&0N&Q[!]9F5/KC'%V5?>C&./UD@S)B!(Z@@.Y7J 95:TDW1 M4)S S".Z8N<99]RW;V^X4[B_[84-9*6)WLH)8V&^*L@*&>; Z':U/[U,>1C- ME#;%9Q%8\+6-U9/?\:QA3+#YN[@%"IM%X]B+"O<0GS"5(WROM.2!V'3*O+X@9@_'H^]>=$919K80()G]Z\3?#12'Q1N.,LT3:T+WCM MS9;:/ VGK\F@<,694Y1F5X.'#*\]D/-\2_>.C%8Q93OL<,E_4H#A]NW:]DDT?Y M,9 M+)DMU,^]_96P1:[M _*5#]-E^$.#ZN/V]G(1>K5UQ:4):S?6W<0RRL\< M?GYGYAGK_*MJV0F,^3 ,.N"]F76.PJ2CX)1:44,UBQH$G)[',&%UD$N(P7-SOO?U(O& MB"A<>'K]C%%R&7"/LR,7'A;K^T1WG%Q,7U4,N6ZAKKC9[,5M6_5QIZ5K22_# M_WWU0Q!_?/U/SOL7.;0/E4>69HTE9??H4=(K-1A[E%?X M5/52LG K!UQ./-QH,AE!@,P[GB7QWHB2X(L*3[3!V6WH42OE>]WU;,L(<7MG M?&F-S]+X*3K@?CX9RGSP7:F%A7O(I2'!O;:O-Y0RNCXXT]> _'L<<3J\IC,2 MI&,#/:H;^0IC"O?UV34;D[L]#_R]>#(2O_PM02P,$% @ ]T:!6/J(4*?0@*5*\<'#74MP"%;1(*1;<-8$ P27 U_.M*R_WX=[[GS5/>\^L]5O[ M8>9^]GX50*FC"=8$ (% @/V?!;A? *@!'A 0$!+@/R D)"0B>D!,2DM&2D)" MRDA-0T'+R@1B8V5B86'G%N9CYQ3B8F'AEQ80$A&5D) \7CU] 4$)22EI& M5DY-74-32QNL8V)J]MST=/WIZ^_H'!G\.34Q.32-F9N?FU]8W M-K>V=W:1*,SQR>G9^<7EU?4_+B %_B?^1]=5']<.'AXN'B$_[B . '_-%#A MX7.($E"K&!&^]*;A%'OW@%8UN;#^.Q&7N/$1G8//.#$]M\0:#^8?VK]E_SM8 MY/]+]E^P_W;- TAQ@7^&ATL%4 9<7/./\@ >\T(@_( BF/A3?-HT0YP)(W V MP,I*AQ\(X1^E!=J=GY.0N+:W>26S;V9O/.GF5*%-K@$^')$Q_-8(^F82QF4@ M:FVMGK L/=RR/,OJEC!YBGS^:WV-HS]L6H.4'D58&1+0$.C+\H@IB_8FF:LE'$C"7% M &"(EY8>5^&VYPSUH)^ %!!F/3S8F$&"*6+1?*TG)'@\)%4I2B\3IQ6&'5_] MKN09R8BN:2BQ6.Q!+DX155I+;%.($!&Z,'P.Z1TF&KO,; H:>P"B'' ]CG2^W6EM6 M6KUSO[A4GJ,TY7-TXK/UF*RFBQ:M) HM2Q+T 8I:WC9.4BU?(-'R&L 7/.VC M[GKKN\6:)Z1OR54(";ZL39V"N;D'.>);GHDF)Y6Y9=04\Q5.:N@0E<5G'&&O MF\O/G;.%#%,4D(#- D6BNW04PDO+U1D?_K;$Z/V+ KHXYPKD;PLN"*9N+N[[ M]Y]DAU89 7&\2[7I'EEH6]K"H43HI(]+1-%'(VN&Q**43%H 8M6<" .R""%3 M(I&9RT3+M](=%+?NV2Z$+C]Z?YE<.%:)]+*STIS0?=7;P/_32='[M,_U.39Q MP ,X:1$;8OO95TY]W.XR>,@05X.G UOBI2D*PR0QSRU>>MJER/ DNZ]<(+!Y M!,%A!)W*T=<7!]R_#_ZF[M==V#PCK+K5LE+B0R(#RBV7\!:/AK=NU?RQ?4YH M8Z+B\9*M]_TZU)>V=V@KATMYTX4@]T>1 OW <(YO.N\,N_PKSW9O+[J]W8V"UJG2<.'F_=0%X\D?G1$A[+-"$* MLO!T.11E&F,;;)PJ6YB65(T_ DJ4Y M1F"^%2<[/1=D" J<^W&D-CJ=41.]/_CRM^]NT3NRMO0"A\'CW-&V,^X+2?+J M !QM:T(3F3T&)KJ/, MXJV;YWI;6LM6EOH(YTHBI5_+-QY\4Q2U-=N)\ WD4$W19[Q"D04=)!4O4-U6 M5]NDU;=PY+R6<T_I.\I_YQ;++ M4N,:10UK)/CI)&2)Q?=:#,DDT)*AU=Y"/![IN+Q&H3'P9CZ)2#:4T4&J?UG> MY;@H/B==97#LJ^0LW:@+"5V#6-!;[A3/@7(ZJ1F]!%O=OO).YI]\$_5^JM3T MYLK"_LF+22>C[J(]0)L#^("88+XF[4CR]*NXK5U$Y6X^ I;ZC&$"';Z7<@\0 M%(A->MXI964[.K3:Y)W!B,R;7@^.SO<9X]EL8'1*O8A? H\&SWPX> XB7Q2P M9S)J5CFT7C%YZ8.A2_$/-'?&G#=O!1"( MZP]B-K/S-KH>B=Z< @JX.6%TM- JQL:F% +P>DL-UKD*PGRZP.SF2$MN^@RU MHES9[Y:=\J'34PTI:E+-+&C4&0IR[#XBA)7.%.8ASN+:(S:=O=.08UW^63M= M07PQ?JSJ>]6U/SV)'WDD.GJ(?-;>X%)\HUD;%%1T.6DPI33M-?ZK<(G)6&6' M%'Z.M,54OEJ\Q&KBSCOP,%C)V2V@,BH.T+#=NR=YDP<+J"H/SE,:?N# NDBX M')+0SBT?HU?2RO04WFBS/"O3&<4*?@'_"MM\WO?7IES"7UV;9!T"&]0"YYPM M"JIEL=U/NYJ4C_O76NX!'2LB=W[.;5/%2A4:9IHB@=D6UX]'V[SOCG- OV&M MR@];!F[7GM(;6!F!ES/^/*EH#0"=U<9%C&NYB FXG+32I\ +B0C*H*.U=KT"ZS>Q@L MXA$2!3M"JQE_[34,E7W<^YC!0QSTMRF#]LG 5\5#5X^KRT"._4,4H;+ M_1Y7D RJTQ#*#E+EM/]B=; M"Y=(S_BVS?+Q+K@ (LX#5R=\H63/:!W/-@?2>2*TTMNM:*O$J^S8H &>]?TF MRX51,'?WV?&EF#N#&(M#WEN-WND*\IPQ^J]P!HTUB@ MS>:[NSVG,,[6]S"G>0:/TQH0[9-SWW,V#I71M#S;?OEOFP381.:CVM3V3;&[ MVIL$M6>=+$#1N*3&^' %LX5NWF;ETTE0J>F,X\FI91:Y#E"0ZNXG07E[FJZG MF]PMPN_EY215 ,O$^#(,($!4BM:3 .9^AHZ_FE>_:* Z?C)(@1'=?;13^_S. M^J;],Z__DT<>+R>ST7?<@:GH"RW]UO!%ZU9N$'QZ>T(G[ #A8' THVXNR('2 M'#ZY!^B<4<2P$8B!Z3LKRJCT]P)C;P9N!N;;OI) DE'!M[GMML,2!8!@2EG' MT[KB9&H)BPW#B@)\0QF<(H]Y,@H)0_X:F,R2W9/]#S<,Z#PC_.F?8EH7F=M[ M\:>L=TU77(()=%FF ;%837 M )\E+ -\JPZ.B2WY>E2]-!<=Z;!'F[-:9N"XH-1LT)]-UKQTVX5MU")Q9^Z1 M-I9!6F9DMWQ80RNA1AT>YK_V%-,N>QLAY]!NFBO;UEHXHY^@ MT_!G@H($!_=,-,F)RI?R?'/G!@/-S4QH\QB[(""C^A6/S4J.8L;9WIO/RH+U MI7:V>@5BPTQ/YGB/37=23#?R)RKW7OM2L"*S9Z^$SJAN\X-V037/PEE@;<7[ M,]?H_*>6PH8ATB^FGF_F*H2,V'=+L[653W*ZCW.0_!2(MV(017[_ E14G M3K@HA)5=%/?"VD&QYW?A[_E.P51QISN,MY !7[[ZM0!I%U?7CSFIJ8>&/;29 MC#PZZ@0['ILFPI34@WUIB3*2G:$%W\M>961ZV37WFEQD0L>\QGBK_ZNB8 MC2J_!)?SUE;JUM(3MSCU)R<6K"9MV0T^VEK"?3$%5ZS)VE^C/_;]F*=>/#G) M=G;Z.:E"JQHBU3IN+S3($!&&/%"6V\D.R?AP:DPL2."PU](?WD"IO[MESK(A M4UGG[F[N42R,/M+*(P?BEFF%-66/"WX1(?:Z!TAMQ%-8Z3EI"'^($\8S:EG, M/Z10.:M,W=)+:VYP30N,5J94$8=F-@R$O)Z@).7C% EV\J=K7/,DFD/-^T#G MTX2.%1(V^T>/T_:UK[<[Z!$2>Q*)XQS)^D&KE%A?&>1DU^MB 77^3L.((=%X MW%&?B?>"81CYXND\1Y/9&]KV%WYEN?%M37-O967<2+1[A0@.!93N ?6'V2-, MX"^7A2Q?YI\YP!L"Q.Q?QT<"\:Y/J^QD,#SHQ&;6YJY+&/I MT7OY4)?<=9+.48 >-WKGPYO7B30L#\T6R<-<^O4\#\I=7"H1FV:>F)ONX-S; MC')GOS<\N34_S%L-0?8\YBWBDTK313'9)RN $?WZ$ ^N^3A/&H*=W,55_V]( MN\@NZ&3[0&SQOLO:KM-EL:8!9:#'A;Z"0EP'[]W^AW_^1%NGM3:H(TA'6M3K M"_J4.5N..\9BA:C+*+NH"7BG51Q%0EHB@V M\_>KI*JD+1.S$)J.(6KY@FI:@'_-K<-/25:FZU\JZ1GT-B$;L.Y@8U=:X/$2 MJLDG/S0<7=#V7.\_D7L#J"O9H MM)W4=IESS O>,LK^/N- >GV])O.4/EA,[TKBQ6C]=0B7K%(LG1=7)W?X)#J_ M-]_%O'H/B)W+"R4/$D\_L<>[ 42[\.]UXK761G?,RO-$5A*W\[8H<*:5[/= M3SOH6UFGB,?U<#$G3A1&X)!!*:52 ECDKTT[BX7%2F/>A!=;LBRP1]2PCK81 MR'?%0+KT=4LV,@(B!.=X ?Y1NR#)E]1$G#KX(VFH8 LMCJOR\HKJ1OMLT%_KG +5R-O9)&BGZR;(T4Y9VB? M?_KV,L*RZ\:AH\NQ+U@IRK[.+X!F,,QB#?9TC&.?L'QJ1A1#]?HSG(H;T?(8 M2H]D)F,TOAK<-(__;F^W3FV8+/0.B WJ\XQZSZ,VSSL_$RHE6S6=V70.@8:R M5C+KN?[(N$X8_3SIAP=%)_3C\7ES87"S!V';UPM&P/T#H?T2O"L''OZ2S^+) M5S<(UJ0/9Y9-]>76&FYD::)7[-J,/Y^%-><*EZ]S?Q(R!W*N="CD"+"'Y-P1 MP&M4*\V6LQM.E!*CS6/G?N())1<&:I$I2BLMO;4Y+Q,7[WR!I=E.B?7%\@U5%3^%O EXNKU5]'J M1+?K@=B]T3">0$0_&;>EA09;L8\3J9D3!PU+Y.Q-SWQDFO4SH6@MXY> MCUTLTXOU+NTU]_T'H*ANRB5+ZSDHCEM;47N&2LO#CSAF6H84"+C4@;A2F<>A MZ\AQRF%K5"K2%O0.[=YLP IIL8H0%ZH'$[\7*N'K=0#T3&D74_ MT=^ZRV.W67Y>%#SA3?K*1MD6W2R[3W![E&/JA/1%>*-W1I2MTC9;2(S=*@W6 MI!.%)8G06&F>ABN1'X>LWSVS(F2_L45)F'TEQBI/*#Q:K_!$\TX?>BR*/=*C M'UPSEA7R'J6%ZKXZE)P]Z*4:A:J(2FVK*EUO'-R8@>>?M[:F,.2J)T>:"@P. M'L*0EF;O\)R8(BQ5\DRXOO#!,FDO5+.U7M^.D/3V&VS]5]Y'VV,4' "'HKY#('B:*=-I0?+DF8R@Y*V,FYXX) M*DEXLIL9&AN;*9<#_=0_I3J+'?58>"L[Z?AZT6;Q5PCV.^'FH\9Y<1V"1SP/ MBG]7)O6:!OBTED6[9!8AK^7D+!9J5'[9).J"?-RR+A-J1XMFK<0*4X@L$1;3 M+?4,^VYMG%^P1FO#GC20<,=VH3;YY,FJ?*/G3;(\?'Q!\HT##IC1E(&&\;Z* MN\UD]*T6[<)7.KT CT'G=U.11."(7^%,C158AFE'%RFY]S1\+\72E,LT[(>/ MBOMV>Q_'4U.8Y8;7LHQHC,K;QN@W6ZA9T;&L@TW?G3+VZ4K'"^EK]/45@I82 M D ]. T#/\(94N\![&TQB#7E_J;7W62!>2X$:_NUF;>5)/F_C;QG5X[.6T$? MG)-Z#+^+U@XN1KT'XS MTJ UQ D>UZ %D#?].1-^/_O2_7D8)R6"B10\A8O1N2 9#]![EYG]N.R_.BW/O=Z_GU?.L MO==G[;WVU=35$G!=31FA#(! (,#RSP*N9@%%@)R,#$Q&2@X&@RDHR"FI&6BH MJ:BHF>EOT#*PLW!RL+.PL=WF$;YW^XX@-QL;GP2_X .1AP\?T6ON^] ]@1\?&)R:GIF=P MRRL_?N)7U]8)NWO[!X='QR>G9W^[0 QZ+_S+UUT?UQ$)"3$)."_72 BG[\' MZ$A(N43(Z.5UP%;N-^Y 0\D9%)(*ZCHHN$5U=QB?O1RAO,GS$,>[^S?M'[)_ M#Q;V_Y+]#^Q_73, -3'HS^41TP&RP/&^LB,- X I$NOS+5N^EHECG:K:ML2D M.UKOWQK0B;-)*/Z-%+W7)W277YM=8*>WCS1M+.DD^'"->/Q-<8^?<,%N'K3\ M8:M08P/"N?1SWW<#]L5>3GIRFV0^03U+H?C7!V=9P+&3!LL.Q>7]DPSM#_(, MW@VV[XB^5]P[K$*UL_M6=>\+8SQKPE^&*(L>] "!_$- >)X*NU]M1MEN4#NJ MZGX R@QV.PZ2QGQ&;>#UK2#XA:[A=DV:^O.W%._(P)-9P%G"-:P*!O++=BQ3R+.U']8BF%1>'P2Z"2 ^"MEN68IA*0^P=G7:(@9Q^.Z"L MA;-XB!"\:W7'/BGR,C+9).*M\ V\WMLQT"%O65R+]*O!AIF>[/J*9]39;N @ MI_G::,_8T899_?IW*S#$V.[I9'^MJ)3+#/"+P%^J;!7F>\ .F+04X&ZQCSV ME.V.([\0,-YW#;.\ CII(!S']<%97*J6/I&;H M3B5K'\S!(>-!L!"Q0-Y62_,FL4M.80 .K=FL;@'$ M28\S=)]#TCK8=C7*?WY3P8:0)B7SQC]A8$LT=I9^ FC/\VMIQCN_KK4BLN[K"H;9C?3=BX)OR]E:[%#'EA87%6P("62 M.)%=LO2T7#::\N@7-\X^@EL_8&->8?/8@$,W_[/'V:19F:]SA[$(K6/)5'?7 MI;%J=O:^RX@;)F5'W]"7F.?!O!\_,]-*S('YN#DVP'$)B;9Q\(@0B:.LFWGW MGVPU+U[ UFF&+*FZ,%ZMDZHZG-+&'+D6@!0*V$GIE&#F)YDHO@*&^;\0[P\] M/ZDA+&,A]HUI17/=XM*[ILO.2-F]<0.MH,B2@4Y,:,4K=JQ57&MCM$WLC$-7 MXFC6BM=]T+R1N) 7E7/'Y4!]L-3AQPFA.1"/2WNDDBJG%F:;^='YTWW*U?"O MN N#&_M&'P(*:(SV#,V9)[@<93,O%@7Q;9&!'-_,%6A/:!0>4KE-]_>5/++$ MX!HN&>$_7(+2:I_OG"T_DYE-/WN#K;DNG@*AM!Z1LI\N._EI87IAHQ2P9J M-2M[%7=+3>QD?4/@G[!4-[109D,CZ5QKA?4D_A'S$^O0.K*EE.3.CZ7B$^G; M@M@>^I!@/PAP:S$+[W*.Q/D=1H0]?V'T0S'W^VQ+-.U?MW7LI#D:<>6#Q@SD M[CEU*QLFBB7:V)5(N/CLYAXSE\U<@C*4%BYP4FW0 RI,C[&4>HL=D6-;C%VA M=731;K.)Y MYOZ[0L)Z(R$M)Z4ITZ&"7>FNJ!+Z(G+@DQ:WSF6U) RB3#9P@>^^.7 MT L:K8LB7Z1]WM3AMLZIW 'L+Q/,BR*.CZ1Q_&*Q&[T0>[OM/)G^1& 5+/LM MG5U6M\E. EE,1.GGGO#@I>BF/U*AX8M(GJ--.JO-/'>Q,^$)7Q,66M4"=W:Z M?-:7*=V<4U>MU"#G=YK8^HSPB+\!'3H(,@LY-=9#BYYO1+O>]$V_]*&_R!3: M[QTL[ZLC.-X+C'5S/_D(%U[5^?#A2[HM23#1GE/3KD64=0@&@_F4$_P5W>*[ M.C],U+('4:]6TRP;;.*YZ&:RZ+L":LT8HR)R!+(K2)QD?^8$K^CBBZHR/SI\ MRI*W&,S0WX4O8.CJ8K70:+1'*+TR;U);55?M=X.HJ"#6!9G;V;Z>&]X_?KQ: MW>&IT/VAR6!">@,M9FO>J-5U0;? M.A?&#>N[F.3ZVL@$OJ\;!7%FF>2RS!C-M51A[."G8BBS-_.F^[81;9>,BR8HC<+_,;->>/,'6"KI[(N.!APPSN?<8# MNX(*^=(9L<'?#41@XIPL_(L6$\&EZF*'Z(#&P6"! 2]NFFFT#%RMG5+&IU.J M-!_'K$A#]FUW?Q!+STL\6WY!ZO-\99O4WZRGOD0G=\MO%[2\9RRJ')L,[Q'74^T5L[[I M*_ Y)V!\I79*P/7:H/NQPKZYEQ]N2'FH$8YZP-E'-[R'K[_O>G\YWBK![](Z MOM7DW!'5FIE:F/)Q>631*4_,Q$W.,_Q[X*ILE--*[2L=#Q\N$9O@4<03_#E8 M'E'B>P\Y%IWN]5M0L]^O;?=<:M*]Q%=";?3!+V;,NV"VEM #=@%>F(J/1V$N M2\K)+0'8O*CJF)_Y"UPB^ NX3QNU0&U4A:PJ68BM_CRLYDR6T!_&9J(_5>WI(] M8TF)K_?3DI)P0^Y&(ZYZC.D'[=S%CQ#DVOZ /-;F^AF99@_?%7 MR!I"LDF/'T>V%?4[3JN7BDF+P0:7^J-/8NRS+9B%DNL.(EY3N-HRZ)1VZW^V M4$.;YG>=>/')/'Q3,>0ET]R/$,X61J*].9:49X4XY>1,W[6.P!(Q$KD(X5#A@P[U MR:JM>^:3=KG^_EH4"==_@CC+0E-E/JUE>N$AHEA!R #=CNOCV%*&#@VOD==\ MT-@IC^&YY1JAT\F_NBO6,&Q=(I\XWYE?<06P["^R^2Z:U<<'UR4O\#&M#'F3 M&1R1!QC4Q?EA3,:6*MYDQR8;^TBOOW!Y&"U>6144791B*O%&QF&+ SO_3I2: M:=DU?]<55P/;.%LH<;FYBP6[MHP0MUY\F-U!W?37H93YK*,EK;(@JZ>G\Q(U MYFV6H4>NGCN3U;QUQE!]L.(NDJR#%Y&E2AI8X(ZK MU>&PAD?:2=?:TFI*[FB^+P6V$S3=]'M;"PJEUW&ZK\8Y'\;G2G2S5(<]OK_5 M,Q FL:5]37JY>E0O-US(TKH2Q:F:UP2-6.=V6&L[L=#U*\VU-R M-F]\-&.YC+])72^#54$D4<93"H>- :M!9F7>%\8HN(G*L45UPU5TL*\>C#KZ M*,S\_&EX/A_:$)X7,CF4%>M;(Z2)%JV<'W:?'$8\V1YHB]_5BCG8"#"JSOOZ M:XH3*F4K>W8%1/A&X$LSD#43$WD:-E< BF3W]*#&_DW9T%>/ JM*]&!2(X[S MC3E7#*/4Y'2-T*U$D83IQ"6IRSNMK*J[$U&HMV\\?F@$_\Q9<3RG5=N-C9<= MTI)2][$X^MQQOBY88S.:_TC#!W$Y>>U15(FML&/ V.;7\+C @8K20# \(I=P M><2T"&?R.M_@.S$?_J6V8--F3L&?OV'*D;C"-YX.$UX R^X-!(D>#'.F><4N MOQF4:X'@5\)HR3!FAM4"$-$:D0KGT;01;*6QX_?KL6PB"64E'F>UL3>9%C=# MY8@SBW%*[C-70/SM1CLC&PD)]D+%O=JQHTNO#G/"662K9UW;.C1(E9N3[USZ M0O-I8(E263,'7M5$]Y1>@YQK/*[J-5VUF383R0S$Y]Z ML6XCV3"QR:U7)\1Q85$2P$BAEIT:HG-I#YS$S#_ MM%9"PM>ZC++UK7H0FU_05D!PA*O2<_;V1>E%; [;;8KK,W GPR2/YD,Q_%,4 M?W.#_X/7EM6,-C"R%T\8_/6&!]I"7B+6^.^F0QR,C>946*X .D)@A/E(BZC? M,M(D7MY\5AW,#U;.F&]MK<#M[-="A.(VD/&\WMJCF[7GFFZ6H[&*-F7T"]:L MK0K!\?[*;_XR=!!7=[6];K$MX?VH>/RWNJI@-9;5=P(V9BD0IY]U9OJ(A<': M(8_=::]RJS.&KZ8(A![R;3>][!]M:%I1\P7M''0WRF;6QN*H4CJ>:.#G^9H.2=MK M@SNJ$J^*BWST%CX^KV4GQ[*46YF*<3:JAB7+_,Y3LIUS.,JP;*;E&MZ] MSWP.>1^N_6;2)::J+([%MC?%V;.Y>M8ZV/.@LDQ7VR>V+F>%&:5INJ\^?^TG ME)&T.ZA2L@];O]K24O_1H>!3+K=U9**/%@&"%1;<_WO11X+"T;AQ>M)M>D)QW+',7/ M_/T,1D+ZMB5_)HZ-KQ4FZWWN3-P_T:]C^9P=2WI7 MLZY!R9BIP"_MW;\G M7\8PR@& %.A)CU @J91[&8=A44_.3PD_*B4&@V)2!ATYFMMTX:;XUJ7J^R9W M[>*Z/!]M[KIU?E*3&FLJK>HMGBC?#;3O8FF(43?M=!520> LWM&Z7S)F4$6Q MXMS6?XT%.B]D,HZA /E-YY1)&8HRPI-)\